data_1r6h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1r6h _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.641 0.258 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.99 162.48 40.88 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.505 2.137 . . . . 0.0 112.355 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.424 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.1 t -144.16 126.89 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 pm0 -108.94 121.31 44.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.94 0.4 . . . . 0.0 111.652 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.433 HG13 ' CD2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -106.8 118.66 54.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.7 p -140.63 140.01 34.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.135 0.493 . . . . 0.0 112.156 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' CD2' ' HE2' ' A' ' 127' ' ' MET . 0.0 OUTLIER -138.98 139.4 37.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.746 178.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.447 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 11.1 mmmt 65.93 -88.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.295 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -129.46 -39.76 1.47 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.5 ptm -73.61 161.77 29.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 111.565 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 164.22 30.78 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 2.5 m-85 -133.05 154.23 50.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.277 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.544 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -126.32 130.68 51.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.056 0.455 . . . . 0.0 110.939 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.572 HG23 ' HA ' ' A' ' 107' ' ' CYS . 2.6 mm -114.46 106.58 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -130.86 167.34 19.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.908 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 51.0 p-80 -80.99 152.2 28.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.875 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -62.64 154.29 74.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 9.6 Cg_endo -54.45 141.76 72.04 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.61 2.206 . . . . 0.0 113.464 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.445 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.2 p -98.98 174.37 6.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.009 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -97.96 -10.43 24.52 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.61 -30.43 14.96 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.7 p -139.19 90.01 2.39 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.373 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -79.99 -52.18 8.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.043 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.428 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -57.62 -44.02 85.21 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.091 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.3 m -57.93 -33.51 68.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.849 0.357 . . . . 0.0 111.233 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.51 ' CD2' ' HA ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -73.71 -47.93 35.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.046 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 34' ' ' SER . 12.6 pt -55.94 -39.53 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.53 . . . . 0.0 110.697 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.12 -52.14 60.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.519 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.512 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -68.99 -50.11 51.82 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.863 0.363 . . . . 0.0 111.843 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.423 HD22 ' CE1' ' A' ' 36' ' ' PHE . 41.9 mt -56.52 -44.47 80.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -77.86 -26.67 49.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.081 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.512 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -52.9 -45.37 67.5 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.268 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.544 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 15.3 t80 -63.51 -38.32 90.69 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.779 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.644 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.63 -177.92 40.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.946 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.63 117.9 20.18 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.605 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.7 m -164.9 -170.63 2.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.88 177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.405 ' H ' ' CG2' ' A' ' 46' ' ' THR . 2.9 t -64.87 153.36 40.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.507 0.67 . . . . 0.0 110.565 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 55.8 t -131.42 133.33 62.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.944 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.613 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 6.4 p -115.57 105.4 18.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.346 0.593 . . . . 0.0 111.279 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -114.22 111.06 20.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.113 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.583 HG11 ' HD3' ' A' ' 113' ' ' ARG . 10.7 t -104.12 91.59 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.402 0.62 . . . . 0.0 110.093 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.1 m -157.74 171.3 20.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.552 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.95 130.41 43.29 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.75 122.23 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.4 p -120.23 -47.8 2.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.868 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.455 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -130.74 83.92 2.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.384 178.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -79.11 -37.15 39.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -80.08 -48.42 13.28 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.418 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.19 -53.05 24.53 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -177.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.455 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 11.0 Cg_exo -72.58 -42.76 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.412 2.074 . . . . 0.0 113.983 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.53 -45.23 62.94 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.42 -28.7 68.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.473 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -80.5 -34.01 36.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.882 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB2' ' CD1' ' A' ' 66' ' ' ILE . 44.9 p30 -101.25 -11.33 19.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.03 34.62 52.6 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.804 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' A' ' 46' ' ' THR . 6.0 mt -108.61 147.35 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.646 0.26 . . . . 0.0 110.967 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 t -78.41 132.79 37.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.5 HG22 ' N ' ' A' ' 69' ' ' VAL . 7.4 p -144.99 151.11 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.133 0.492 . . . . 0.0 111.965 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.5 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.3 t -103.34 131.93 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -101.21 106.72 17.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.164 0.507 . . . . 0.0 111.09 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.412 ' CH2' ' HA ' ' A' ' 84' ' ' VAL . 5.2 m0 -110.96 103.93 55.47 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.302 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.447 -1.239 0 C-N-CA 123.321 2.681 . . . . 0.0 112.993 -179.043 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.491 0.186 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.1 m -53.98 -49.05 62.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 151' ' ' TYR . 7.5 t -54.57 -42.87 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.5 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -56.15 -31.53 63.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.99 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -68.49 -50.4 52.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.009 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.613 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -67.8 -28.09 67.3 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.421 HD13 ' CE2' ' A' ' 155' ' ' TYR . 11.1 mt -63.5 -43.95 95.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.25 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.2 -41.51 94.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.205 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -59.35 -51.34 70.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.673 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 95' ' ' PHE . 11.6 p -71.36 -35.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.072 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.03 -45.92 86.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.96 86.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.599 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -23.9 61.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.157 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.417 ' CD1' HG23 ' A' ' 91' ' ' VAL . 1.7 m-85 -79.28 -52.04 8.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.775 0.322 . . . . 0.0 111.184 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 25.4 t -65.02 -36.82 85.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -76.11 -32.82 59.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.268 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.45 88.58 51.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.526 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.37 130.71 19.03 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.816 2.344 . . . . 0.0 112.063 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.34 57.81 17.82 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.448 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.415 ' CB ' HG21 ' A' ' 46' ' ' THR . 4.7 m -101.08 -164.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.719 0.295 . . . . 0.0 111.212 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.644 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -123.11 113.55 19.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.373 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.3 t -107.45 151.06 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -122.2 139.97 53.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.982 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 106' ' ' HIS . 10.8 t -140.09 166.73 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.597 ' H ' HG12 ' A' ' 105' ' ' VAL . 2.0 t60 -66.81 156.35 35.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.516 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.572 ' HA ' HG23 ' A' ' 24' ' ' ILE . 20.8 t -68.13 104.49 1.8 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.451 ' CG1' HD12 ' A' ' 24' ' ' ILE . 34.5 m -75.56 0.25 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.06 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.4 -8.53 2.73 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.25 -127.49 3.12 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.48 ' HG ' ' HA2' ' A' ' 142' ' ' GLY . 0.0 OUTLIER -128.14 127.27 42.69 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.42 -144.44 4.1 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.607 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.583 ' HD3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.29 -25.96 4.74 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.163 0.506 . . . . 0.0 112.017 -178.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.646 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.23 -46.22 83.08 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 6.2 Cg_endo -51.72 -48.54 20.92 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.306 2.004 . . . . 0.0 113.275 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.454 HG12 ' HG2' ' A' ' 148' ' ' GLN . 57.9 t -61.68 -46.66 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.818 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.441 HD12 ' CG2' ' A' ' 49' ' ' VAL . 11.6 mt -54.77 -46.55 74.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.847 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.489 HG22 HG11 ' A' ' 105' ' ' VAL . 57.6 t -57.37 -55.28 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.726 0.298 . . . . 0.0 111.671 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.98 -48.76 67.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.336 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.584 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 5.5 mt -59.06 -30.55 68.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.389 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.527 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.12 -42.43 66.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.967 0.413 . . . . 0.0 110.227 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.407 HD21 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -70.75 -16.11 62.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.595 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 128' ' ' LYS . 1.4 mt -57.42 -30.97 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.124 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -15.97 14.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.539 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.87 11.29 5.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.27 -83.79 0.35 Allowed Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.4 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.502 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.9 76.92 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 121.337 0.589 . . . . 0.0 109.534 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.601 ' O ' HG12 ' A' ' 123' ' ' ILE . 11.3 mttt -62.56 -67.4 0.42 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.088 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.467 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 6.1 t80 -73.61 -31.68 63.68 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.069 0.462 . . . . 0.0 110.762 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.3 -46.4 55.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.061 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' A' ' 127' ' ' MET . 47.9 t0 -70.24 -47.19 62.45 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.457 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.456 ' O ' ' CG2' ' A' ' 136' ' ' ILE . . . -57.97 -50.06 74.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.821 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 133' ' ' ILE . 32.0 mm -70.8 -37.78 70.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -74.37 -49.71 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -70.19 -35.44 73.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.501 0.191 . . . . 0.0 111.066 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.456 ' CG2' ' O ' ' A' ' 132' ' ' ALA . 4.2 tt -74.25 -32.7 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.782 0.325 . . . . 0.0 110.662 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -64.93 -43.99 90.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.497 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.82 -44.19 94.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.527 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.05 152.08 22.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.667 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.96 117.73 15.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.378 . . . . 0.0 110.33 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.411 ' HG3' ' CD1' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -114.13 163.9 14.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.433 -179.109 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.48 ' HA2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.45 -165.42 0.05 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.039 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.419 ' CB ' HD23 ' A' ' 111' ' ' LEU . . . -82.1 99.0 8.95 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.715 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 148' ' ' GLN . 45.8 mt -88.73 108.88 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.828 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -114.03 -78.09 0.58 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.021 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.6 t -101.32 -61.23 1.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.802 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.7 tmtt? -48.99 -51.54 30.01 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.471 ' HB3' ' CG2' ' A' ' 144' ' ' ILE . 7.2 tm0? -56.28 -51.51 67.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.433 ' CD2' ' CG2' ' A' ' 144' ' ' ILE . 3.9 mm? -75.19 -37.69 61.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.5 m -73.08 -42.68 62.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.033 0.444 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.802 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -64.0 -50.11 69.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.034 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.467 ' HB3' ' CE1' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -64.28 -38.16 90.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.709 0.29 . . . . 0.0 110.871 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.56 -43.98 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -24.76 57.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.497 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.429 ' CE2' HD13 ' A' ' 123' ' ' ILE . 0.9 OUTLIER -66.42 -23.75 66.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.651 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' A' ' 129' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.217 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.103 0 CA-C-O 120.598 0.237 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.03 162.41 40.99 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.458 2.106 . . . . 0.0 112.479 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.7 t -144.07 126.92 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.85 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.7 OUTLIER -108.64 121.96 46.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.576 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.454 HG13 ' CD2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.75 120.6 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.02 147.03 41.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.195 0.522 . . . . 0.0 111.978 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CD1' ' HE2' ' A' ' 127' ' ' MET . 20.5 t80 -155.12 127.62 7.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.225 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 7.2 mmpt? 55.06 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.521 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -129.26 -46.45 1.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.4 ' HE3' ' CD2' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -73.66 139.84 45.68 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.099 0.476 . . . . 0.0 111.266 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -115.35 164.4 14.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.276 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.42 ' CE1' HG11 ' A' ' 118' ' ' VAL . 1.4 m-85 -131.97 138.39 48.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.562 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.532 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -114.88 133.74 55.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.422 . . . . 0.0 110.962 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.422 HG23 ' HA ' ' A' ' 107' ' ' CYS . 1.5 mm -115.85 106.52 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 107' ' ' CYS . 1.6 p -132.33 162.89 29.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.27 0.557 . . . . 0.0 111.936 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.535 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.7 p80 -81.41 152.13 27.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.937 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -62.74 154.36 75.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.987 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.4 Cg_exo -54.55 140.83 75.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.343 2.029 . . . . 0.0 113.275 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.468 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 32.3 p -98.47 174.33 6.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.161 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -93.37 -11.64 31.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.69 -31.04 14.61 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -139.69 89.65 2.34 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.519 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.468 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.3 OUTLIER -80.38 -52.16 8.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.173 0.511 . . . . 0.0 111.272 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.415 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 1.1 p -56.79 -45.64 82.03 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.359 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.1 m -57.72 -33.47 68.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.936 0.398 . . . . 0.0 111.439 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.535 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -74.27 -47.93 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.174 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 34' ' ' SER . 12.0 pt -55.91 -39.08 55.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.216 0.531 . . . . 0.0 110.696 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -65.21 -51.86 58.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.487 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.533 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 4.0 m-20 -68.64 -50.05 54.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.873 0.368 . . . . 0.0 111.906 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD22 ' CE1' ' A' ' 36' ' ' PHE . 58.7 mt -55.93 -44.84 78.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.871 0.367 . . . . 0.0 110.412 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -78.53 -26.62 45.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.028 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.533 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -53.36 -42.8 67.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.406 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.532 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 17.9 t80 -63.37 -38.56 91.61 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.241 -0.583 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.634 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.64 -177.71 40.12 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.958 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.54 117.71 19.99 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.604 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.7 m -164.8 -170.23 1.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.63 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 67' ' ' THR . 2.9 t -64.7 158.65 24.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.411 0.624 . . . . 0.0 110.443 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.437 ' CG2' ' HB3' ' A' ' 104' ' ' ALA . 59.8 t -136.47 136.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.333 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.642 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 2.4 p -115.64 105.17 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.282 0.563 . . . . 0.0 110.699 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -113.99 110.72 20.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.705 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.602 HG12 ' NE ' ' A' ' 113' ' ' ARG . 18.5 t -105.39 90.94 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.537 0.684 . . . . 0.0 109.817 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 t -158.4 171.77 19.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.582 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -65.51 130.02 41.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 m -74.33 122.39 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.412 HG23 ' CE1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -120.26 -47.6 2.35 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.182 178.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.413 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.2 m-85 -130.54 84.29 2.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.628 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.56 -35.87 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -78.84 -48.42 14.76 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.408 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.64 -49.82 25.56 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 8.2 Cg_exo -73.16 -39.44 2.18 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.737 2.291 . . . . 0.0 113.336 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.426 ' CD2' ' CG1' ' A' ' 68' ' ' VAL . 3.7 mm? -66.95 -45.26 78.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -75.35 -33.34 61.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -81.12 -32.05 33.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' CB ' HG12 ' A' ' 66' ' ' ILE . 71.1 m-20 -101.37 -11.5 19.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 44.6 34.77 3.83 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.051 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.48 HG12 ' CB ' ' A' ' 64' ' ' ASP . 4.3 pt -114.69 148.82 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.694 0.283 . . . . 0.0 111.001 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 47' ' ' THR . 81.9 p -77.53 135.2 38.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.497 HG22 ' N ' ' A' ' 69' ' ' VAL . 7.9 p -144.9 151.73 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.084 0.469 . . . . 0.0 111.941 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.497 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.1 t -103.43 132.59 49.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -100.87 106.71 18.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.189 0.519 . . . . 0.0 110.365 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.437 ' CD2' HD13 ' A' ' 117' ' ' LEU . 4.0 m95 -111.93 104.07 55.74 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.136 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.447 -1.217 0 C-N-CA 123.599 2.866 . . . . 0.0 112.6 -179.425 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 120.57 0.224 . . . . 0.0 110.818 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.414 HG11 ' CZ2' ' A' ' 71' ' ' TRP . 21.8 t -56.09 -48.0 79.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.51 HG13 ' OH ' ' A' ' 151' ' ' TYR . 94.0 t -55.98 -37.9 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.024 177.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -59.46 -31.33 69.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.529 178.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -66.16 -50.74 62.89 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.23 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.642 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -67.97 -26.98 66.2 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.421 ' CD2' ' O ' ' A' ' 120' ' ' LEU . 18.2 mt -61.05 -41.5 96.71 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.111 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -67.58 -42.54 82.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.872 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.32 -51.48 69.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.772 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.42 -43.94 83.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.25 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -54.7 -40.33 69.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.907 0.384 . . . . 0.0 110.833 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.64 -45.78 77.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.992 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -74.6 -24.81 58.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.652 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -82.1 -45.53 15.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.747 0.308 . . . . 0.0 111.109 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.92 -37.86 69.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.915 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -76.11 -32.99 59.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.04 88.82 53.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.451 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.24 133.89 13.76 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.58 2.187 . . . . 0.0 112.319 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.2 46.42 34.91 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.45 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.416 ' CB ' HG21 ' A' ' 46' ' ' THR . 0.4 OUTLIER -101.21 -165.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 111.269 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.634 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.0 m -127.42 113.71 16.56 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.199 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 5.4 t -110.65 151.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.437 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . . . -118.97 144.73 46.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.308 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 106' ' ' HIS . 3.5 t -140.37 167.08 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.591 ' H ' HG12 ' A' ' 105' ' ' VAL . 2.6 t60 -66.97 156.34 36.21 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.463 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 25' ' ' THR . 25.6 p -68.19 101.72 1.22 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.471 0.653 . . . . 0.0 112.593 -177.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG21 ' CG ' ' A' ' 115' ' ' PRO . 5.4 p -75.55 0.08 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.065 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.46 -8.53 2.8 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.18 -125.84 3.08 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.755 -0.735 . . . . 0.0 111.391 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.525 ' HG ' ' HA2' ' A' ' 142' ' ' GLY . 0.0 OUTLIER -132.06 127.31 35.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.58 -142.73 3.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.644 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.602 ' NE ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.31 -22.06 5.65 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.043 0.449 . . . . 0.0 111.965 -178.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.662 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -49.85 -46.33 80.67 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 5.7 Cg_endo -51.6 -48.38 21.64 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.482 2.121 . . . . 0.0 113.107 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.419 ' O ' HD23 ' A' ' 120' ' ' LEU . 43.5 t -61.1 -42.59 93.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.805 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.437 HD13 ' CD2' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -57.56 -55.07 39.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.687 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.445 ' CG2' HG11 ' A' ' 105' ' ' VAL . 61.1 t -52.93 -55.2 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.01 -53.14 54.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.249 0.547 . . . . 0.0 110.72 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.627 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 2.4 mm? -54.34 -30.78 52.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.793 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.21 -48.88 39.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.954 0.406 . . . . 0.0 110.467 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.416 HD21 ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -62.92 -14.66 49.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.712 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.3 mt -57.01 -30.86 35.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.832 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -16.65 62.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.574 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.5 m -83.13 11.02 6.95 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.27 -101.85 1.08 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.016 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.462 ' HE2' ' CD1' ' A' ' 17' ' ' TYR . 3.3 ptt? -62.53 78.67 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.86 -67.65 0.55 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -176.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.434 ' CD1' HD23 ' A' ' 152' ' ' LEU . 5.6 t80 -67.42 -32.05 72.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.856 0.36 . . . . 0.0 111.092 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.38 -51.35 20.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.199 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.2 t0 -69.61 -38.36 77.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 111.009 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.515 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -60.36 -49.93 75.61 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.972 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.7 mm -73.56 -38.0 51.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.562 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.09 -49.72 22.71 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.543 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -69.84 -36.38 75.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.675 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.4 tt -74.29 -27.83 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.775 0.321 . . . . 0.0 110.434 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -49.67 66.65 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.542 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -45.14 93.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.61 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' A' ' 136' ' ' ILE . 19.6 mmtm -84.15 152.08 24.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.412 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.13 117.34 14.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.96 0.41 . . . . 0.0 110.454 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.43 163.6 15.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.216 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.525 ' HA2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.32 -171.21 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.59 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.412 ' CB ' HD23 ' A' ' 111' ' ' LEU . . . -80.63 98.88 7.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.378 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.403 ' CG2' ' HG3' ' A' ' 148' ' ' GLN . 2.3 pt -88.71 108.53 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.062 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.89 -77.32 0.58 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.094 -0.643 . . . . 0.0 112.449 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.2 m -100.67 -60.68 1.48 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.722 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.4 tmtt? -54.27 -52.03 62.7 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.403 ' HG3' ' CG2' ' A' ' 144' ' ' ILE . 8.5 tm0? -56.31 -51.91 66.46 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 149' ' ' LEU . 3.2 mm? -75.09 -44.46 47.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.2 m -68.88 -34.9 76.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.718 0.294 . . . . 0.0 111.441 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.722 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 1.8 t80 -68.66 -50.6 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.321 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.434 HD23 ' CD1' ' A' ' 129' ' ' TYR . 0.6 OUTLIER -69.36 -33.32 72.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.475 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -57.4 -44.65 84.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -27.52 65.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.596 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.512 ' CD2' HD13 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -66.44 -29.22 69.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.832 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.767 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.688 0.28 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 60.3 Cg_endo -72.76 161.14 44.61 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.499 2.132 . . . . 0.0 112.252 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.3 t -143.98 127.38 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.061 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -105.14 116.63 32.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.031 0.443 . . . . 0.0 111.396 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.513 ' CG1' ' CD2' ' A' ' 135' ' ' PHE . 21.3 t -107.22 118.31 54.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.5 p -141.59 149.57 40.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.55 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -144.08 153.61 42.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.015 178.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 51.08 -97.81 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.406 0.282 . . . . 0.0 110.82 -176.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.439 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 2.6 m80 -124.78 -25.03 4.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -73.8 164.31 26.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.747 0.308 . . . . 0.0 111.269 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -142.54 161.52 37.86 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.015 0.436 . . . . 0.0 111.3 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CE1' ' CG1' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -142.99 140.65 31.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.147 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.523 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -114.69 134.59 54.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.107 0.479 . . . . 0.0 111.23 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.52 HG23 ' HA ' ' A' ' 107' ' ' CYS . 2.1 mm -116.91 106.51 20.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.329 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -133.33 167.26 20.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.183 0.515 . . . . 0.0 111.669 -178.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.6 p80 -80.92 151.9 28.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.847 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.65 154.26 74.82 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.045 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 53.1 Cg_exo -54.81 140.92 77.89 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.348 2.032 . . . . 0.0 113.376 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.441 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -98.72 174.34 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.125 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -94.41 -10.31 32.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.84 14.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.9 p -139.54 89.62 2.34 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.431 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.441 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.21 -52.18 8.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.261 0.553 . . . . 0.0 111.196 178.099 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' HG13 ' A' ' 37' ' ' ILE . 17.2 p -57.56 -46.31 84.09 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.418 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -57.75 -31.96 66.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.823 0.344 . . . . 0.0 111.295 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -74.47 -47.78 31.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 34' ' ' SER . 11.6 pt -56.84 -39.36 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.191 0.52 . . . . 0.0 110.742 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.26 -52.14 60.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.466 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.525 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -68.49 -50.04 55.29 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.82 0.343 . . . . 0.0 111.757 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.437 HD12 ' CD1' ' A' ' 36' ' ' PHE . 25.3 mt -55.81 -45.35 78.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -26.62 49.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.108 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 17.2 mttt -52.88 -44.31 66.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.447 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.523 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 14.2 t80 -63.36 -38.42 91.07 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.897 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.673 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 167.01 -177.56 41.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.616 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.84 121.08 24.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.565 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 4.2 m -164.72 -171.82 2.43 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.489 ' H ' ' CG2' ' A' ' 46' ' ' THR . 8.8 t -65.74 166.9 10.11 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.754 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 44.0 t -139.84 134.74 37.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.193 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.636 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 3.6 p -115.67 105.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.222 0.534 . . . . 0.0 111.483 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 110.81 20.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.984 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.61 HG13 ' HD3' ' A' ' 113' ' ' ARG . 7.4 t -103.86 91.86 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.453 0.644 . . . . 0.0 109.737 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 t -157.28 171.66 20.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.336 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.42 130.33 43.33 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.4 t -68.91 121.67 18.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -120.73 -47.49 2.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.898 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.415 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 3.0 m-85 -130.44 84.47 2.2 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.263 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.52 -36.25 45.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -79.21 -48.58 13.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.427 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.81 -48.24 29.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 59' ' ' THR . 33.6 Cg_exo -60.9 -42.27 38.86 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.551 2.167 . . . . 0.0 113.787 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -45.75 61.83 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.85 -49.12 18.88 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.61 -28.08 61.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.421 ' HB3' ' CG1' ' A' ' 66' ' ' ILE . 4.6 t0 -98.49 -11.43 22.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.91 22.39 9.08 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.151 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.421 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 2.7 pt -122.02 148.61 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.626 0.25 . . . . 0.0 110.376 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' THR . 19.5 m -77.43 135.0 38.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.83 0.348 . . . . 0.0 110.192 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.24 150.53 19.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 0.0 111.756 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.73 134.42 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.135 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.83 106.69 18.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.19 0.519 . . . . 0.0 110.109 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.514 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.0 m95 -111.43 104.38 56.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.229 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.446 -1.3 0 C-N-CA 123.303 2.669 . . . . 0.0 112.433 -179.685 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.129 0 N-CA-C 111.359 0.133 . . . . 0.0 111.359 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.11 -48.83 78.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.487 HG13 ' CE2' ' A' ' 151' ' ' TYR . 15.7 t -53.81 -41.16 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.218 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -61.07 -31.37 71.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.02 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.28 -50.36 68.2 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.395 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.636 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -70.31 -28.32 65.08 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.969 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD12 ' CE2' ' A' ' 155' ' ' TYR . 13.8 mt -61.64 -40.63 95.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.15 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.57 -39.93 70.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.132 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -58.03 -51.27 70.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.522 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.441 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 14.9 p -70.42 -35.83 63.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.666 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -46.34 77.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.381 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.71 85.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.446 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -26.96 66.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.814 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.441 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 2.4 m-85 -79.81 -47.23 15.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.008 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.88 -43.3 98.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -33.03 59.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.97 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.55 89.38 36.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.32 113.6 3.52 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.597 2.198 . . . . 0.0 112.361 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.32 60.38 7.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.648 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.5 t -101.23 -163.85 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.627 0.251 . . . . 0.0 110.809 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.673 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 2.2 m -112.41 114.09 26.63 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.505 ' CG1' ' CE1' ' A' ' 22' ' ' PHE . 10.6 t -109.79 151.31 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -116.02 140.86 48.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.088 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 49' ' ' VAL . 3.4 t -140.36 166.35 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.489 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 1.7 t60 -67.54 156.08 37.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.621 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.52 ' HA ' HG23 ' A' ' 24' ' ' ILE . 18.7 t -68.51 105.81 2.35 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.443 ' CG1' HD11 ' A' ' 24' ' ' ILE . 35.7 m -75.51 0.42 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.194 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.22 -8.6 2.61 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.72 -140.49 5.24 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 mt -114.97 127.34 55.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.64 -146.46 4.81 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.834 -1.174 . . . . 0.0 113.593 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.61 ' HD3' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.34 -21.68 5.75 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.031 0.443 . . . . 0.0 111.877 -178.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.65 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -52.8 -46.22 96.79 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 8.3 Cg_endo -52.41 -48.48 21.63 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.237 1.958 . . . . 0.0 112.904 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 57.5 t -60.9 -52.19 64.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.386 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.407 HD11 ' CG2' ' A' ' 49' ' ' VAL . 3.8 mt -51.89 -44.48 63.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.942 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.446 ' CG1' ' CD1' ' A' ' 22' ' ' PHE . 4.4 t -58.55 -54.62 30.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.68 -44.4 66.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 111.34 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.598 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 12.5 mt -63.95 -30.73 71.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.383 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.495 ' HB3' ' CZ2' ' A' ' 87' ' ' TRP . . . -68.67 -37.53 79.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.069 0.462 . . . . 0.0 109.793 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.6 tp -78.88 -15.68 58.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.256 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.598 ' HB ' ' O ' ' A' ' 120' ' ' LEU . 1.8 mt -57.59 -30.86 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.73 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -16.33 64.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.1 m -79.54 -23.36 42.91 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 152.95 -96.1 0.16 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.994 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.482 ' HE3' ' CD2' ' A' ' 17' ' ' TYR . 3.2 ptt? -63.2 71.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.58 ' HB3' HG21 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.44 -67.62 0.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -176.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 8.6 t80 -66.26 -32.67 74.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.9 0.381 . . . . 0.0 111.128 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.59 -52.22 16.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 30.0 t0 -70.12 -39.43 75.45 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.821 0.343 . . . . 0.0 110.975 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.552 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -60.45 -50.01 75.29 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.811 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.1 mm -73.38 -38.69 53.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -74.44 -49.95 20.35 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.602 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -66.83 -37.09 83.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.31 . . . . 0.0 110.165 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.23 -27.87 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.437 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -47.93 78.98 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -44.71 93.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.598 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.1 OUTLIER -84.9 152.03 23.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.44 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 116.7 14.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.009 0.433 . . . . 0.0 110.514 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 163.61 15.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.14 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -56.77 -168.8 0.09 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.649 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.21 100.03 12.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.286 0.543 . . . . 0.0 111.516 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 144' ' ' ILE . 10.4 pt -87.93 109.52 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.373 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -113.25 -76.87 0.58 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 6.8 p -99.6 -61.01 1.42 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.808 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 11.7 tmtt? -66.48 -48.6 69.36 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 144' ' ' ILE . 23.5 mm-40 -56.12 -51.84 66.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.402 ' CD2' ' CD1' ' A' ' 144' ' ' ILE . 2.0 mm? -74.2 -45.34 48.92 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.766 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.9 m -64.62 -37.31 87.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.795 0.331 . . . . 0.0 111.425 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.808 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -66.41 -50.51 63.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.157 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.473 ' HA ' ' HB2' ' A' ' 155' ' ' TYR . 0.4 OUTLIER -61.52 -34.61 75.82 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.171 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.33 -43.4 88.21 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -23.76 65.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.482 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.473 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.18 -39.67 89.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.49 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.956 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.668 0.271 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.14 165.15 33.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.537 2.158 . . . . 0.0 112.339 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.78 126.88 28.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.0 pt-20 -105.96 116.74 32.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.978 0.418 . . . . 0.0 111.559 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.518 ' CG1' ' CD2' ' A' ' 135' ' ' PHE . 45.3 t -107.82 118.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.06 151.9 42.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 0.0 112.223 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.591 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -145.13 151.07 37.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.962 178.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.591 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 44.71 -78.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.455 0.702 . . . . 0.0 112.623 -177.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -129.81 -41.58 1.31 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.431 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -73.58 154.22 39.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 112.027 -178.511 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -135.7 164.25 28.29 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.064 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 7.9 m-85 -139.28 150.08 45.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.527 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -121.24 132.0 54.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.466 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 107' ' ' CYS . 2.6 mm -117.27 106.68 20.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.512 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 107' ' ' CYS . 31.7 p -130.45 167.23 18.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.202 0.525 . . . . 0.0 111.773 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.497 ' CD2' ' CE2' ' A' ' 36' ' ' PHE . 42.1 p-80 -80.89 152.29 28.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.39 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -62.45 153.93 74.66 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.3 Cg_exo -54.71 142.4 73.3 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.393 2.062 . . . . 0.0 113.46 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.484 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.1 p -98.5 174.44 6.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.053 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -94.01 -12.48 28.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.7 -31.02 14.61 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.4 p -139.86 89.81 2.34 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.691 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.484 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -80.23 -52.32 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.212 0.529 . . . . 0.0 111.136 177.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.543 ' O ' HG13 ' A' ' 37' ' ' ILE . 1.5 m -57.45 -36.11 71.0 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.211 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -65.88 -35.48 80.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.919 0.39 . . . . 0.0 110.927 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.497 ' CE2' ' CD2' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -73.94 -47.97 33.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.072 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 34' ' ' SER . 0.8 OUTLIER -58.62 -37.02 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 110.472 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.48 -51.94 60.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.262 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -69.78 -49.88 48.63 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 111.552 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD12 ' CD1' ' A' ' 36' ' ' PHE . 27.3 mt -54.96 -44.82 74.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.99 0.424 . . . . 0.0 110.502 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -78.4 -26.76 46.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.181 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 11.9 mttt -54.56 -41.89 70.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.351 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.527 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 13.3 t80 -63.58 -38.7 92.13 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.804 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.63 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 168.84 -178.84 41.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.706 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.83 118.36 20.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.579 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 3.3 m -164.7 -171.35 2.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.305 -0.862 . . . . 0.0 108.696 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.469 ' H ' ' CG2' ' A' ' 46' ' ' THR . 1.6 t -65.52 163.09 16.7 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.064 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 50.0 t -137.26 133.5 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.082 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.605 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 14.9 p -115.4 105.18 18.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.55 0.69 . . . . 0.0 111.514 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -114.64 110.84 20.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.845 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.544 HG11 ' CD ' ' A' ' 113' ' ' ARG . 14.5 t -105.87 91.83 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.629 0.728 . . . . 0.0 109.936 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.41 172.04 19.3 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.229 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' CD ' ' N ' ' A' ' 53' ' ' GLU . 1.5 mm-40 -64.28 130.33 43.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -69.07 121.95 19.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 m -120.53 -47.45 2.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.074 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.425 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 6.7 m-85 -130.41 84.51 2.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.34 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.52 -35.86 45.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -78.97 -48.45 14.47 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -45.67 -49.79 34.99 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.215 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 44.6 Cg_exo -57.44 -42.22 63.8 Favored 'Trans proline' 0 N--CA 1.471 0.189 0 C-N-CA 122.63 2.22 . . . . 0.0 113.572 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -45.52 62.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.57 -49.1 19.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -75.15 -26.72 59.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.446 ' HB3' ' CG1' ' A' ' 66' ' ' ILE . 2.5 t0 -101.06 -11.39 19.67 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.95 25.53 3.81 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.138 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.446 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 4.2 pt -122.22 148.73 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.649 0.262 . . . . 0.0 110.531 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 47' ' ' THR . 1.3 m -77.29 135.05 38.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.965 0.412 . . . . 0.0 110.233 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 69' ' ' VAL . 7.1 p -142.56 148.52 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.697 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.414 ' N ' HG23 ' A' ' 68' ' ' VAL . 2.2 t -103.63 131.2 52.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.138 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.1 106.65 17.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.097 0.475 . . . . 0.0 110.651 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.432 ' CD2' HD11 ' A' ' 117' ' ' LEU . 4.6 m0 -109.21 103.5 52.62 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.815 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 N--CA 1.446 -1.319 0 C-N-CA 123.553 2.836 . . . . 0.0 112.559 -179.206 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.467 0.175 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.425 HG13 ' CZ2' ' A' ' 71' ' ' TRP . 18.4 t -56.2 -52.34 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.616 HG12 ' CZ ' ' A' ' 151' ' ' TYR . 1.4 t -53.81 -40.01 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.391 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -60.55 -31.34 70.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.955 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -50.29 63.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.284 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.605 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -67.86 -33.75 75.36 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.427 HD12 ' CE2' ' A' ' 155' ' ' TYR . 11.8 mt -59.32 -44.88 92.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.525 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -65.99 -39.91 90.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.203 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.16 -51.23 70.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.623 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.455 HG21 ' CE1' ' A' ' 95' ' ' PHE . 14.5 p -72.46 -35.99 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.295 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -56.41 -45.02 80.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.686 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.31 -42.23 72.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.709 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -67.49 -27.15 66.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.455 ' CE1' HG21 ' A' ' 91' ' ' VAL . 2.7 m-85 -81.97 -52.06 7.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.835 0.35 . . . . 0.0 111.331 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.3 t -57.08 -37.43 71.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.101 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -76.11 -33.05 59.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.339 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.13 84.63 61.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.539 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -66.27 136.75 44.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.714 2.276 . . . . 0.0 111.987 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.58 56.9 22.22 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.46 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.51 ' HB3' HG22 ' A' ' 46' ' ' THR . 0.7 OUTLIER -101.05 -161.8 0.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 111.189 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.63 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 1.5 m -125.36 114.05 18.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.268 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 39.1 t -106.88 151.05 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -119.0 140.9 49.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.79 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.56 HG13 ' CG2' ' A' ' 118' ' ' VAL . 99.4 t -139.36 166.37 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.491 ' N ' HG12 ' A' ' 105' ' ' VAL . 2.8 t60 -67.06 156.19 36.72 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.147 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 25' ' ' THR . 44.3 t -68.46 105.68 2.28 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG11 ' HD3' ' A' ' 115' ' ' PRO . 34.7 m -75.32 0.28 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.107 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.54 -8.56 2.89 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.08 -138.42 4.87 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mt -114.36 127.4 55.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.9 -156.29 8.71 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.154 -1.022 . . . . 0.0 113.121 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.544 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.31 -17.11 7.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.977 0.417 . . . . 0.0 111.758 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.654 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.67 -46.37 98.33 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.654 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 8.6 Cg_endo -52.82 -48.45 21.99 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.059 1.84 . . . . 0.0 112.506 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 59.8 t -56.55 -51.74 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.007 0.432 . . . . 0.0 110.285 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.432 HD11 ' CD2' ' A' ' 71' ' ' TRP . 10.3 mt -52.97 -48.35 67.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.614 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.56 ' CG2' HG13 ' A' ' 105' ' ' VAL . 41.6 t -51.76 -50.56 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.721 0.296 . . . . 0.0 111.464 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.8 -46.91 67.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.327 0.584 . . . . 0.0 110.484 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.539 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -57.51 -31.41 66.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.623 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.493 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.28 -44.33 62.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.4 . . . . 0.0 110.517 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.412 HD13 ' HE2' ' A' ' 20' ' ' MET . 7.3 tp -66.82 -15.84 63.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.656 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.5 mt -57.23 -30.53 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.696 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -17.2 63.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.013 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.9 m -79.99 -23.31 41.65 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.13 -96.64 0.17 Allowed Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.778 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 1.3 ptt? -63.55 72.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.95 -67.42 0.43 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 7.0 t80 -67.74 -32.73 73.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.004 0.43 . . . . 0.0 110.959 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.48 -52.11 17.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.252 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 41.6 t0 -69.32 -35.86 76.38 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.554 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -61.63 -50.31 73.05 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.771 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -73.92 -37.99 48.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.537 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -74.08 -49.71 22.82 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -70.19 -34.32 72.8 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.72 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.23 -29.86 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 110.473 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.16 -43.23 82.81 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.633 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -45.55 91.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 110.598 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.37 151.41 23.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.223 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.7 116.47 14.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.568 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.35 163.67 15.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.074 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.04 -174.86 0.08 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.555 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.4 9.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.56 0.68 . . . . 0.0 111.443 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.412 ' CG2' ' HG3' ' A' ' 148' ' ' GLN . 1.6 pt -88.4 109.57 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.543 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -113.13 -76.72 0.58 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.75 -60.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.8 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 10.5 tmtt? -55.94 -52.05 65.51 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.412 ' HG3' ' CG2' ' A' ' 144' ' ' ILE . 17.6 tm0? -58.3 -51.52 69.43 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.02 -41.0 68.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 50.0 m -70.53 -39.69 73.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.779 0.323 . . . . 0.0 111.524 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.8 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.35 -50.97 63.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.228 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 129' ' ' TYR . 0.7 OUTLIER -66.87 -31.23 71.69 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.708 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.57 -37.7 87.19 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -23.94 59.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.545 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.492 ' CE2' HD12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -66.21 -40.63 90.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.286 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.563 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.766 0.317 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.52 160.22 49.07 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.596 2.197 . . . . 0.0 112.378 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.408 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 18.5 t -143.26 126.89 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.853 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 5.5 pt-20 -109.38 116.68 32.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.895 0.379 . . . . 0.0 111.618 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.417 HG13 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -107.42 118.53 55.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.3 p -140.97 140.53 34.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.106 0.479 . . . . 0.0 112.056 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.478 ' CD2' ' HE3' ' A' ' 127' ' ' MET . 0.0 OUTLIER -141.03 147.56 38.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.701 178.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 1.3 mmmp? 64.59 -90.73 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.273 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.51 -45.02 1.21 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.403 ' CE ' ' HG ' ' A' ' 122' ' ' LEU . 2.7 ppp? -73.68 164.76 26.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 111.728 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -139.2 164.32 30.11 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.475 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.463 ' CE1' ' CG1' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -134.18 141.63 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.4 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.542 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -114.9 133.86 55.63 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.107 0.48 . . . . 0.0 111.038 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.517 HG23 ' HA ' ' A' ' 107' ' ' CYS . 1.7 mm -117.92 106.56 20.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.156 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -134.67 166.83 22.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.15 0.5 . . . . 0.0 111.509 -179.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.522 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 7.3 p80 -81.31 151.77 27.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.175 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -63.02 154.42 77.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.023 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.514 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.3 Cg_exo -54.72 139.03 77.17 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.329 2.019 . . . . 0.0 113.245 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.439 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 29.8 p -98.59 174.21 6.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.096 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -92.75 -9.89 39.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.64 -30.85 14.73 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 p -139.79 89.56 2.32 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.244 -0.582 . . . . 0.0 112.357 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.439 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.27 -52.27 7.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 0.0 111.169 178.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.427 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -58.59 -46.09 87.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.352 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.7 m -57.83 -32.45 67.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.841 0.353 . . . . 0.0 111.148 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.522 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -74.16 -47.99 32.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.114 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 34' ' ' SER . 10.8 pt -56.12 -38.84 55.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.55 . . . . 0.0 110.539 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.1 -51.94 61.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.369 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.535 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.1 m-20 -69.43 -50.21 47.91 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.866 0.365 . . . . 0.0 111.72 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD22 ' CE1' ' A' ' 36' ' ' PHE . 57.6 mt -56.12 -44.75 79.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.958 0.408 . . . . 0.0 110.326 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -78.18 -26.67 47.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -52.74 -44.13 66.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.311 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.542 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 16.8 t80 -63.45 -38.17 90.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.73 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.697 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.41 -176.96 40.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.943 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.71 118.05 20.33 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.579 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.3 m -165.06 -170.27 1.89 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.822 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 67' ' ' THR . 1.5 t -64.91 150.75 47.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.458 0.647 . . . . 0.0 110.122 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 48.2 t -126.33 133.69 68.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.817 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.623 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 8.5 p -115.24 105.45 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.155 0.502 . . . . 0.0 111.184 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.52 110.9 21.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.755 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.511 HG13 ' NE ' ' A' ' 113' ' ' ARG . 39.6 t -103.28 91.27 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.55 0.691 . . . . 0.0 110.236 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.2 171.43 20.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.05 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.78 130.7 44.51 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.55 121.93 18.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.0 p -120.63 -47.38 2.32 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.948 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.43 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 4.2 m-85 -130.23 84.4 2.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.288 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.4 -35.85 46.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -78.84 -48.43 14.74 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.404 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -45.67 -50.26 33.39 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.226 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.43 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 39.4 Cg_exo -61.64 -42.13 34.72 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.543 2.162 . . . . 0.0 113.639 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.406 ' CD2' ' CG1' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -71.32 -45.65 62.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.68 -49.29 18.78 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -61.41 -39.4 90.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.479 ' CB ' HG12 ' A' ' 66' ' ' ILE . 45.8 m-20 -101.76 -11.39 19.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 53.2 25.17 24.63 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.771 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.479 HG12 ' CB ' ' A' ' 64' ' ' ASP . 8.9 pt -107.52 149.08 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.854 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 47' ' ' THR . 63.9 p -77.46 135.44 38.26 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 69' ' ' VAL . 11.7 p -140.17 150.08 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.505 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.6 t -103.35 132.08 50.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.86 106.65 18.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.172 0.51 . . . . 0.0 110.706 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.441 ' CE3' HD11 ' A' ' 117' ' ' LEU . 4.5 m95 -111.25 103.73 55.3 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.498 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo . . . . . 0 N--CA 1.447 -1.222 0 C-N-CA 123.472 2.782 . . . . 0.0 113.008 -179.02 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 2.6 tttt . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 120.341 0.115 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.4 HG13 ' CZ2' ' A' ' 71' ' ' TRP . 21.6 t -54.73 -48.17 72.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.517 HG11 ' OH ' ' A' ' 151' ' ' TYR . 78.4 t -59.34 -38.05 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.207 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 8.1 mt-10 -58.16 -31.18 67.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.57 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.07 -50.68 63.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.912 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.623 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -67.1 -27.03 67.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 120' ' ' LEU . 26.3 mt -63.42 -39.29 94.1 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.966 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.4 m -66.8 -44.95 79.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.029 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.27 -51.41 69.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.483 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.0 p -69.77 -35.87 67.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.718 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.65 -45.22 73.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.81 -43.91 74.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.687 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -26.22 65.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.126 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.04 -52.0 7.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 111.192 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 15.9 t -67.05 -34.96 78.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.176 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -33.08 59.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.161 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.12 96.3 37.26 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.386 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.94 132.42 23.01 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.457 2.105 . . . . 0.0 112.058 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.04 56.12 27.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.174 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.5 p -101.07 169.38 8.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 111.232 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.697 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -100.68 113.78 26.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.573 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.4 t -107.85 151.29 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.438 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . . . -120.94 140.87 51.25 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.323 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 49' ' ' VAL . 3.0 t -140.07 166.54 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.458 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 2.7 t60 -67.97 155.84 38.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -68.84 105.61 2.41 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.432 HG11 ' CA ' ' A' ' 115' ' ' PRO . 32.0 m -75.39 -0.04 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.01 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.77 -8.5 3.06 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.97 -128.77 3.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.543 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.535 ' HA ' ' HA2' ' A' ' 142' ' ' GLY . 0.1 OUTLIER -132.09 127.4 35.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -171.31 -142.31 3.63 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.397 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NE ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.44 -21.8 5.67 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.994 0.426 . . . . 0.0 111.89 -178.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.649 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.17 -46.8 82.9 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.5 Cg_endo -52.13 -48.49 21.42 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.296 1.997 . . . . 0.0 112.867 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.23 -41.79 84.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.674 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.441 HD11 ' CE3' ' A' ' 71' ' ' TRP . 7.1 mt -61.06 -50.08 74.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.737 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.451 HG13 ' CD1' ' A' ' 22' ' ' PHE . 12.0 t -53.76 -55.52 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.417 ' HB3' ' CB ' ' A' ' 132' ' ' ALA . . . -60.2 -47.14 87.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.129 0.49 . . . . 0.0 110.839 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.57 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 3.3 mm? -54.59 -30.76 55.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.044 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.512 ' HB1' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.33 -49.99 30.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.046 0.45 . . . . 0.0 110.54 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -62.62 -15.67 52.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.083 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 120' ' ' LEU . 1.2 mt -57.45 -34.58 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.637 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.31 -15.38 15.65 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.81 11.38 3.28 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 116.99 -85.53 0.39 Allowed Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.158 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.42 78.39 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.534 ' CB ' HG21 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -62.37 -67.71 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.54 ' HA ' HD22 ' A' ' 152' ' ' LEU . 6.4 t80 -74.98 -30.52 61.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.122 0.487 . . . . 0.0 110.544 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -72.6 -46.64 53.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.034 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 127' ' ' MET . 51.5 t0 -70.22 -47.3 62.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.381 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.525 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -58.32 -50.32 74.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.871 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.445 HD13 HG23 ' A' ' 133' ' ' ILE . 32.7 mm -69.54 -37.85 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.46 -49.93 20.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -69.61 -34.67 74.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.647 0.261 . . . . 0.0 110.977 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.8 tt -74.21 -34.05 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.0 110.645 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -63.46 -45.9 88.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -39.79 85.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.023 0.44 . . . . 0.0 110.499 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -87.09 152.27 22.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.68 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.66 117.89 14.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.413 ' CD ' HG12 ' A' ' 136' ' ' ILE . 0.1 OUTLIER -114.28 163.34 15.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.946 -179.081 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -62.26 -156.55 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.329 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.2 98.71 11.93 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.942 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.1 pt -88.9 108.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.815 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -113.66 -77.38 0.58 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 119.88 -0.728 . . . . 0.0 112.756 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.49 -60.8 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.696 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -53.21 -51.78 61.02 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.84 -52.09 66.47 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.28 -40.0 59.14 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.3 m -69.47 -42.71 74.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.878 0.37 . . . . 0.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.696 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -63.59 -50.56 68.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.54 HD22 ' HA ' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -65.29 -36.51 84.3 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.784 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -55.92 -39.82 72.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -74.13 -24.85 59.5 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.213 178.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.407 ' CD2' HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -66.17 -39.99 90.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.34 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.168 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.708 0.29 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 58.7 Cg_endo -72.1 152.03 56.19 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.468 2.112 . . . . 0.0 112.305 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.409 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 19.1 t -144.09 126.94 11.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 mp0 -112.77 116.84 30.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.904 0.383 . . . . 0.0 111.611 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.485 HG11 ' CD2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -106.84 118.33 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.5 p -141.29 143.68 34.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.589 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -133.36 158.8 42.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.248 178.167 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 45.7 -93.16 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.302 0.241 . . . . 0.0 111.384 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -127.04 -29.31 2.8 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.417 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 4.3 ppp? -73.65 159.13 33.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.58 0.228 . . . . 0.0 111.183 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -141.63 164.06 31.22 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.143 0.497 . . . . 0.0 111.807 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' CE1' HG13 ' A' ' 118' ' ' VAL . 3.4 m-85 -138.14 144.31 40.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.933 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.534 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -119.39 135.49 54.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.033 0.444 . . . . 0.0 111.002 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.455 HD12 ' CG1' ' A' ' 108' ' ' VAL . 5.1 mm -118.51 106.69 20.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.64 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.9 OUTLIER -130.36 165.31 22.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.48 0.657 . . . . 0.0 111.943 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.525 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.4 p80 -81.89 152.58 26.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.941 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -62.42 154.76 70.81 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.417 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.1 Cg_exo -54.09 136.65 68.14 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.246 1.964 . . . . 0.0 113.162 -177.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -98.64 147.03 25.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.302 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -68.68 -12.36 61.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.49 -31.41 14.58 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.2 p -139.97 88.81 2.26 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.119 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.91 -52.23 7.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.221 0.534 . . . . 0.0 111.359 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.421 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 1.7 m -56.44 -46.17 80.44 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.49 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.8 m -57.62 -31.92 66.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.853 0.359 . . . . 0.0 111.286 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.525 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -75.3 -47.77 26.34 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.421 ' CG1' ' O ' ' A' ' 34' ' ' SER . 11.8 pt -55.83 -39.12 54.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.192 0.52 . . . . 0.0 110.648 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.38 -52.08 56.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.46 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.505 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 7.1 m-20 -68.06 -50.12 57.13 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.82 0.343 . . . . 0.0 111.799 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.441 ' HG ' ' CD1' ' A' ' 36' ' ' PHE . 63.4 mt -55.76 -45.78 78.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.427 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -77.05 -26.64 53.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.119 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 7.0 mttt -53.12 -44.74 67.93 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.288 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.534 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 14.0 t80 -63.43 -38.56 91.6 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.709 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.679 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.35 -179.57 39.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.038 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.55 117.25 19.31 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.608 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 0.8 OUTLIER -164.9 -169.77 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.892 177.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 67' ' ' THR . 9.1 p -64.59 160.08 20.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.455 0.645 . . . . 0.0 110.686 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 104' ' ' ALA . 57.2 t -139.0 137.01 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.078 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.556 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 11.3 p -115.52 104.3 16.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.479 0.657 . . . . 0.0 111.385 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -115.21 111.04 20.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.028 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.559 HG13 ' HD3' ' A' ' 113' ' ' ARG . 11.9 t -106.49 91.48 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.405 0.621 . . . . 0.0 109.914 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.4 p -157.68 171.24 20.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.77 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.403 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 2.2 mm-40 -66.62 130.5 43.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 p -73.37 122.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.9 p -120.0 -47.7 2.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.254 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.4 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.2 m-85 -130.6 83.67 2.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.467 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.2 -36.61 39.89 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -79.6 -48.58 13.55 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.458 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.56 -56.97 7.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 61.5 Cg_endo -72.99 -34.71 6.11 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.47 2.113 . . . . 0.0 113.811 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.422 HD22 HG11 ' A' ' 68' ' ' VAL . 2.0 mm? -71.1 -45.44 63.68 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.21 -28.91 60.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp -78.92 -36.57 41.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.499 ' O ' HG13 ' A' ' 66' ' ' ILE . 1.2 m-20 -101.76 -12.27 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.28 23.95 6.52 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.11 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 64' ' ' ASP . 28.1 mt -93.15 147.38 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.728 0.299 . . . . 0.0 111.029 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 47' ' ' THR . 27.8 m -78.52 129.58 35.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 48' ' ' VAL . 6.1 p -145.07 152.46 14.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.261 0.553 . . . . 0.0 111.945 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.402 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.6 t -103.76 129.25 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.258 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.0 106.72 18.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.972 0.415 . . . . 0.0 110.946 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.535 ' HH2' ' HA ' ' A' ' 84' ' ' VAL . 5.2 m0 -107.38 103.55 49.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.626 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo . . . . . 0 N--CA 1.444 -1.397 0 C-N-CA 123.617 2.878 . . . . 0.0 112.439 -179.22 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.675 0.274 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.457 ' CG1' ' CZ2' ' A' ' 71' ' ' TRP . 26.1 t -55.05 -41.55 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.535 ' HA ' ' HH2' ' A' ' 71' ' ' TRP . 0.5 OUTLIER -53.55 -41.65 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.402 ' N ' HG13 ' A' ' 84' ' ' VAL . 24.7 mm-40 -65.83 -31.21 72.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.504 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -64.08 -50.94 66.37 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.556 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -67.52 -32.85 73.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.696 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.468 HD12 ' CE2' ' A' ' 155' ' ' TYR . 12.0 mt -57.01 -45.67 82.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.467 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -43.13 94.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.493 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -58.35 -51.66 68.87 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.009 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.437 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 13.8 p -70.96 -39.96 75.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.376 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -58.55 -41.02 84.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.924 0.393 . . . . 0.0 110.547 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.75 -48.17 75.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.642 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -25.7 62.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.437 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 2.0 m-85 -75.11 -51.73 12.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.7 t -60.0 -42.26 93.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.788 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -76.09 -33.06 59.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.08 92.12 46.55 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.275 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.22 138.29 15.89 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.637 2.225 . . . . 0.0 112.489 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.24 56.35 25.69 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.712 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.452 ' CB ' HG22 ' A' ' 46' ' ' THR . 0.8 OUTLIER -101.24 -172.49 2.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 111.176 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.679 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 m -108.29 113.55 26.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.145 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 46.0 t -111.3 149.55 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.183 0.516 . . . . 0.0 112.306 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.468 ' O ' ' CG1' ' A' ' 48' ' ' VAL . . . -119.96 144.3 47.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.949 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.539 HG11 ' CG2' ' A' ' 118' ' ' VAL . 96.5 t -140.17 166.32 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.711 0.291 . . . . 0.0 111.6 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.481 ' N ' HG13 ' A' ' 105' ' ' VAL . 3.2 t60 -67.34 155.74 38.19 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.344 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 26' ' ' HIS . 0.2 OUTLIER -68.61 106.59 2.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.413 0.625 . . . . 0.0 112.615 -178.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.455 ' CG1' HD12 ' A' ' 24' ' ' ILE . 28.0 m -75.33 0.53 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.221 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.19 -8.58 2.57 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.07 -124.86 2.87 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.4 mt -128.15 127.34 42.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.98 -158.17 9.17 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.261 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.559 ' HD3' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.19 -18.81 6.74 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.063 0.459 . . . . 0.0 111.776 -178.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.659 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -52.75 -46.2 96.53 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.6 Cg_endo -52.78 -48.44 22.01 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.043 1.829 . . . . 0.0 112.509 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.519 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 58.5 t -55.95 -51.88 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 0.0 109.94 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.423 HD22 ' CH2' ' A' ' 71' ' ' TRP . 8.8 mt -54.47 -46.2 73.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.583 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.539 ' CG2' HG11 ' A' ' 105' ' ' VAL . 17.0 t -51.42 -50.58 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 111.076 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.522 ' O ' HG13 ' A' ' 123' ' ' ILE . . . -54.03 -48.04 70.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.29 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.531 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 1.2 mt -53.97 -31.32 50.33 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.205 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.51 -50.61 29.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.716 0.293 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 17' ' ' TYR . 8.5 tp -66.55 -14.63 62.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.714 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.2 mt -58.49 -30.95 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.063 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -70.49 -16.55 62.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.411 ' HB2' HD12 ' A' ' 122' ' ' LEU . 0.5 OUTLIER -80.44 -23.24 40.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.67 -96.96 0.17 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.792 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.521 ' HE2' ' CD2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -63.12 74.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -70.73 -67.47 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.459 ' CD1' ' HB3' ' A' ' 152' ' ' LEU . 6.9 t80 -65.49 -34.86 79.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.933 0.397 . . . . 0.0 111.341 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -71.77 -51.5 22.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.454 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 32.8 t70 -70.14 -32.51 70.53 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.943 0.402 . . . . 0.0 111.06 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -62.3 -50.16 72.76 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.97 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 32.9 mm -74.5 -40.32 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.269 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -50.03 19.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.604 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -66.48 -38.98 88.47 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.29 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.0 OUTLIER -74.43 -27.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.709 0.29 . . . . 0.0 110.877 179.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 1.9 ttp85 -65.08 -42.2 94.31 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.797 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -45.43 91.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.888 0.375 . . . . 0.0 110.41 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' ILE . 6.7 mmtt -87.72 151.72 22.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.273 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 117.0 14.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.163 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 163.81 14.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.288 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -53.52 -173.61 0.05 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.011 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -84.13 99.5 10.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.213 0.507 . . . . 0.0 111.473 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.414 ' CG2' ' HG3' ' A' ' 148' ' ' GLN . 1.8 pt -88.17 109.5 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.407 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -113.13 -76.5 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.313 0.856 . . . . 0.0 113.313 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.7 p -99.63 -60.84 1.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.871 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.3 tmtt? -56.81 -51.87 67.27 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -176.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.414 ' HG3' ' CG2' ' A' ' 144' ' ' ILE . 9.8 tm0? -56.73 -51.22 69.68 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.98 -43.09 62.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 m -70.27 -39.71 74.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.771 0.319 . . . . 0.0 111.661 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.871 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -66.54 -50.91 61.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.468 ' CD2' ' CD1' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -66.49 -30.17 70.44 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.413 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.93 -40.12 96.66 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -22.72 61.46 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.58 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.541 ' CE2' HD13 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -66.21 -47.95 72.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.608 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.514 0.197 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.03 161.91 10.0 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.408 2.072 . . . . 0.0 112.126 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.411 ' CG1' ' HD3' ' A' ' 139' ' ' LYS . 3.7 t -137.74 126.97 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.817 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 11.6 pt-20 -107.42 116.92 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 111.752 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.463 HG12 ' CD2' ' A' ' 135' ' ' PHE . 0.7 OUTLIER -108.92 118.53 56.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.499 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.9 p -140.99 147.56 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 111.95 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CD2' ' HE2' ' A' ' 127' ' ' MET . 0.1 OUTLIER -144.04 126.35 15.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.282 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 38.0 mmtt 77.92 -87.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.278 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -129.38 -40.62 1.43 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.43 ' CE ' ' CE2' ' A' ' 22' ' ' PHE . 2.7 tmm? -73.74 154.41 39.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.884 0.373 . . . . 0.0 111.289 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.11 161.66 35.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 8.6 m-85 -132.09 145.75 51.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.3 mm? -117.81 129.21 55.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 110.791 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.518 HG21 ' HA ' ' A' ' 107' ' ' CYS . 2.1 mm -112.56 106.63 21.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -130.89 164.54 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.243 0.544 . . . . 0.0 111.987 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.519 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.4 p80 -81.24 152.33 27.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.797 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.6 153.46 77.76 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.521 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 9.6 Cg_endo -54.43 139.58 74.34 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.564 2.176 . . . . 0.0 113.475 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.439 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.6 p -98.86 174.38 6.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.095 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -98.24 -8.08 27.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -30.6 14.91 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 p -139.37 89.73 2.36 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.487 -0.485 . . . . 0.0 112.112 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.439 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -79.99 -52.28 8.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.122 0.487 . . . . 0.0 111.421 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.405 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.2 m -57.62 -45.38 85.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.083 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -32.03 67.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.797 0.332 . . . . 0.0 111.464 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CD2' ' HA ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -75.57 -48.01 24.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 34' ' ' SER . 11.9 pt -55.88 -39.21 55.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.178 0.513 . . . . 0.0 110.746 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.12 -52.08 51.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.58 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 4.8 m-20 -67.67 -50.14 59.26 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.905 0.384 . . . . 0.0 111.945 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.435 HD21 ' CE1' ' A' ' 36' ' ' PHE . 80.0 mt -55.79 -46.35 78.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.359 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -76.95 -26.71 54.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.083 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 5.3 mttt -52.91 -44.46 66.98 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.537 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 15.4 t80 -63.54 -38.62 91.81 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.734 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.672 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.6 -178.82 39.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.991 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.38 19.54 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.617 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 0.9 OUTLIER -165.19 -169.93 1.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.92 177.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 67' ' ' THR . 3.0 t -64.55 152.52 41.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.705 0.764 . . . . 0.0 110.437 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 104' ' ' ALA . 83.6 t -132.2 136.5 56.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.006 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.618 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 14.9 p -115.66 105.31 18.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.147 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.406 ' HG2' ' CG2' ' A' ' 68' ' ' VAL . 17.1 ptt180 -113.59 110.85 20.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.748 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.493 HG11 ' CD ' ' A' ' 113' ' ' ARG . 41.9 t -108.57 91.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.571 0.7 . . . . 0.0 110.327 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.7 p -157.82 171.03 21.02 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.041 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.27 130.25 42.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.6 t -70.22 122.19 21.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.5 p -120.51 -47.93 2.31 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.179 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.422 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.3 m-85 -130.77 83.91 2.15 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.623 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.13 -36.78 40.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.65 -48.58 13.5 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.444 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -45.92 -54.3 17.28 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.444 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 8.2 Cg_exo -73.1 -35.6 5.07 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.659 2.239 . . . . 0.0 113.653 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.417 ' CD2' ' CG1' ' A' ' 68' ' ' VAL . 2.1 mm? -71.03 -45.24 64.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.01 -28.97 60.72 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -81.02 -35.09 32.33 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.516 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -101.56 -12.45 18.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.48 25.61 4.6 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.378 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 64' ' ' ASP . 20.8 mt -95.36 147.72 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.672 0.272 . . . . 0.0 111.079 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 47' ' ' THR . 1.8 m -78.16 127.94 33.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 69' ' ' VAL . 10.5 p -145.18 153.95 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.151 0.501 . . . . 0.0 112.209 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.506 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.7 t -103.33 132.75 48.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -101.08 106.84 18.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.124 0.488 . . . . 0.0 110.931 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.454 ' CH2' ' HA ' ' A' ' 84' ' ' VAL . 4.8 m95 -111.4 103.25 54.8 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.739 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo . . . . . 0 N--CA 1.446 -1.316 0 C-N-CA 123.62 2.88 . . . . 0.0 112.657 -179.14 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.283 0.087 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -44.7 63.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.557 ' CG1' HD12 ' A' ' 120' ' ' LEU . 39.4 t -55.33 -43.53 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.344 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -55.37 -31.62 61.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.263 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -50.07 70.15 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.419 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.618 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.9 -30.3 70.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 22.9 mt -59.6 -48.32 82.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.451 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 m -63.63 -40.45 96.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.189 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.57 -51.26 70.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.616 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.438 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 14.8 p -69.92 -35.92 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.092 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -48.06 78.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.76 92.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.748 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -26.78 63.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.139 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.438 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 2.7 m-85 -82.08 -52.0 7.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.229 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.0 t -59.51 -37.95 79.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.25 -33.05 59.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.278 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.09 95.31 39.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.509 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.46 134.12 15.14 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.553 2.169 . . . . 0.0 112.223 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 56.09 27.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.494 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.448 ' CB ' HG21 ' A' ' 46' ' ' THR . 0.9 OUTLIER -101.0 -164.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 0.0 111.248 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.672 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 m -117.74 113.51 21.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.32 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.0 t -108.71 151.03 11.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 111.983 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.462 ' HB2' ' CG2' ' A' ' 48' ' ' VAL . . . -122.99 141.79 51.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.963 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 49' ' ' VAL . 10.1 t -140.3 166.9 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.474 ' H ' HG11 ' A' ' 105' ' ' VAL . 3.1 t60 -66.76 156.1 36.37 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.441 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.518 ' HA ' HG21 ' A' ' 24' ' ' ILE . 49.8 t -68.34 106.05 2.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.314 0.578 . . . . 0.0 112.457 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.443 HG13 ' HD3' ' A' ' 115' ' ' PRO . 28.8 m -75.2 0.21 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.097 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.65 -8.63 3.03 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.47 -131.31 3.67 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.0 mt -124.42 127.42 47.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.75 -151.49 6.5 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.33 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.493 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.19 -21.26 5.95 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 111.805 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.647 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -51.28 -46.42 89.46 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 6.2 Cg_endo -52.02 -48.51 21.24 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.2 1.934 . . . . 0.0 112.978 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.1 -41.09 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.67 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.45 ' HB3' ' NE1' ' A' ' 87' ' ' TRP . 13.0 mt -60.24 -45.25 93.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.531 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.457 HG22 HG13 ' A' ' 105' ' ' VAL . 38.2 t -57.34 -55.14 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.72 -51.74 59.15 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.264 0.554 . . . . 0.0 110.94 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.581 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 6.7 mt -55.27 -30.48 60.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.16 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.467 ' HB1' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.93 -40.08 69.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 110.148 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.4 HD12 ' CE ' ' A' ' 20' ' ' MET . 6.4 tp -71.26 -14.36 62.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.8 mt -57.2 -30.7 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.661 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -16.61 63.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.9 p -79.53 -23.39 42.91 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.55 -96.66 0.17 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.805 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.519 ' HE2' ' CD2' ' A' ' 17' ' ' TYR . 1.4 ptt? -64.0 72.61 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.16 -67.61 0.42 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.475 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 5.8 t80 -67.73 -32.68 73.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 111.046 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -72.29 -51.91 18.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.321 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 46.8 t0 -67.12 -39.78 86.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 111.043 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.513 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -59.43 -50.0 75.63 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.203 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 35.6 mm -73.94 -36.28 44.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.645 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.22 -49.51 23.09 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -70.37 -36.91 74.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.627 0.251 . . . . 0.0 110.793 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.5 tt -74.22 -28.23 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.815 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 8.0 ttm180 -68.35 -47.92 66.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.818 0.342 . . . . 0.0 110.399 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -59.89 -45.02 93.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.443 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.411 ' HD3' ' CG1' ' A' ' 13' ' ' VAL . 1.0 OUTLIER -84.7 151.73 24.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.319 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.6 116.48 14.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.063 0.459 . . . . 0.0 110.667 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -115.39 163.47 15.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.844 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -55.07 -176.78 0.15 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.247 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.05 98.75 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.772 0.786 . . . . 0.0 110.751 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.433 ' CG2' ' HG3' ' A' ' 148' ' ' GLN . 1.0 OUTLIER -88.94 109.68 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.972 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -112.88 -76.71 0.58 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.397 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.8 p -99.77 -60.79 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.709 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.8 tmtt? -49.04 -51.44 31.1 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -177.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.433 ' HG3' ' CG2' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -56.29 -51.67 67.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.27 -39.37 59.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.3 t -74.12 -36.25 64.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.577 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.709 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -70.16 -50.68 37.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.193 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.548 ' HA ' ' HB2' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -67.11 -35.08 79.0 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.216 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.1 -43.58 82.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -25.24 65.27 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.336 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.548 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.11 -32.53 74.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.373 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.747 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.725 0.297 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.09 165.2 33.38 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.628 2.219 . . . . 0.0 112.327 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 t -141.07 126.96 19.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.671 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -109.6 116.99 32.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.974 0.416 . . . . 0.0 111.607 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.473 HG12 ' CD2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -107.06 118.6 55.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.603 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.6 p -140.78 144.76 35.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.97 0.414 . . . . 0.0 111.72 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.525 ' CD2' ' HG2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -142.46 122.71 13.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.467 179.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 16.0 mmtt 84.12 -88.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.274 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -129.41 -40.46 1.43 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.733 0.302 . . . . 0.0 111.763 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.408 ' CE ' ' CD1' ' A' ' 122' ' ' LEU . 10.2 ptm -73.77 162.83 28.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.23 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -143.34 164.04 31.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.121 0.486 . . . . 0.0 111.5 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.473 ' CE1' ' CG1' ' A' ' 103' ' ' VAL . 0.7 OUTLIER -135.35 142.37 45.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.892 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.54 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -114.67 136.44 53.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.061 0.458 . . . . 0.0 110.939 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.426 ' CD1' HG21 ' A' ' 108' ' ' VAL . 14.4 mm -118.3 106.46 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.37 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -134.55 165.34 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.218 0.533 . . . . 0.0 112.008 -179.08 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.46 ' CD2' ' CZ ' ' A' ' 36' ' ' PHE . 48.6 p-80 -81.4 152.09 27.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.454 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -62.89 154.73 74.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.679 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.5 Cg_exo -54.64 139.93 76.27 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.187 1.925 . . . . 0.0 113.171 -177.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.457 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -98.69 174.31 6.47 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.108 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -93.78 -10.7 33.32 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.84 14.74 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.3 p -139.62 89.73 2.35 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.403 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.457 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.29 -52.22 7.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.077 0.465 . . . . 0.0 111.228 178.139 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.423 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.7 p -57.55 -45.8 84.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.33 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 m -57.72 -31.98 66.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.851 0.357 . . . . 0.0 111.187 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.502 ' CD2' ' HA ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -75.39 -47.78 25.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 34' ' ' SER . 10.9 pt -55.64 -38.85 51.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 110.609 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.19 -51.4 58.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.486 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -68.27 -50.19 55.41 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.87 0.367 . . . . 0.0 111.989 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.434 HD23 ' CE1' ' A' ' 36' ' ' PHE . 85.6 mt -55.7 -45.52 77.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.481 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.98 -26.57 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.02 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 12.2 mttt -52.49 -44.56 65.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.358 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.54 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 11.0 t80 -63.45 -38.43 91.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.664 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.661 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 162.99 -178.41 38.71 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.921 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.52 19.76 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.608 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.3 m -164.9 -170.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.833 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 67' ' ' THR . 2.6 t -64.51 159.64 21.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.355 0.598 . . . . 0.0 110.456 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 104' ' ' ALA . 57.7 t -138.48 138.83 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.322 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.676 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 12.4 p -115.57 104.71 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.261 0.553 . . . . 0.0 110.816 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -114.56 110.79 20.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.322 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 6.3 t -107.17 90.95 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.421 0.629 . . . . 0.0 109.376 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.3 p -158.02 171.38 20.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.938 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -66.45 130.41 43.11 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 m -76.0 122.35 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -120.15 -47.66 2.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.44 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.425 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -130.63 83.88 2.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.708 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.09 -36.54 40.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -79.51 -48.57 13.66 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.437 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.34 -54.13 19.75 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 8.1 Cg_exo -73.26 -34.67 5.82 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.623 2.216 . . . . 0.0 113.48 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.417 ' CD2' ' CG1' ' A' ' 68' ' ' VAL . 2.1 mm? -71.09 -45.19 64.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.21 -28.86 60.13 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -79.04 -36.63 40.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' O ' HG13 ' A' ' 66' ' ' ILE . 3.8 m-20 -101.57 -12.4 18.51 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.03 23.95 6.06 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.285 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 64' ' ' ASP . 24.6 mt -92.82 147.38 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 110.927 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 47' ' ' THR . 82.2 p -78.69 129.19 34.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.417 ' CG1' ' CD2' ' A' ' 61' ' ' LEU . 5.9 p -145.16 154.44 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.2 0.524 . . . . 0.0 112.123 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.75 133.59 47.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.108 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.99 106.78 18.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.139 0.495 . . . . 0.0 110.396 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.4 m95 -111.91 104.27 55.91 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.049 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo . . . . . 0 N--CA 1.448 -1.198 0 C-N-CA 123.162 2.575 . . . . 0.0 112.645 -179.586 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.099 0 CA-C-O 120.503 0.192 . . . . 0.0 110.977 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.45 ' CG1' ' CH2' ' A' ' 71' ' ' TRP . 40.1 t -56.98 -47.8 82.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG12 ' CE2' ' A' ' 151' ' ' TYR . 54.4 t -55.22 -40.87 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.817 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 2.7 mt-10 -57.3 -31.39 65.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.532 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.04 -50.46 68.33 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.257 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.676 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.08 -29.9 70.32 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.7 mt -62.46 -38.61 90.47 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.312 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.57 -43.78 79.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.036 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.47 -51.29 70.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.603 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.491 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 10.2 p -69.14 -35.9 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -57.3 -46.38 83.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.756 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.5 84.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -26.58 64.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.241 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.491 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 3.8 m-30 -81.99 -50.88 8.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.25 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 51.4 t -59.88 -38.04 81.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.921 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -76.21 -33.09 59.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.96 90.21 50.76 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.425 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.12 135.77 25.71 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.879 2.386 . . . . 0.0 112.231 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.07 55.39 30.91 Favored Glycine 0 C--N 1.329 0.154 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.696 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.457 ' CB ' HG23 ' A' ' 46' ' ' THR . 4.5 m -101.3 -163.46 1.02 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.25 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.661 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.0 m -119.34 113.87 21.48 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.319 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.497 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 38.1 t -109.2 151.0 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . . . -120.65 145.12 47.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.224 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 49' ' ' VAL . 4.0 t -140.31 166.78 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.458 ' H ' HG13 ' A' ' 105' ' ' VAL . 3.4 t60 -67.29 155.52 38.68 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.018 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.55 ' N ' ' O ' ' A' ' 25' ' ' THR . 38.5 t -69.0 98.36 0.95 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.506 0.67 . . . . 0.0 112.37 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.461 HG11 ' HG3' ' A' ' 115' ' ' PRO . 2.7 t -75.76 1.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.854 -1.067 . . . . 0.0 112.347 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.42 -8.62 1.87 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.86 -120.62 2.55 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.412 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 8.3 mt -126.46 127.29 45.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.91 -154.34 7.47 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.839 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.554 ' HD3' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.25 -17.65 7.06 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.082 0.468 . . . . 0.0 111.834 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.652 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -51.44 -46.21 90.22 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 9.4 Cg_endo -52.11 -48.51 21.27 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.491 2.128 . . . . 0.0 113.303 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.427 ' O ' ' CD2' ' A' ' 120' ' ' LEU . 24.0 t -61.64 -44.6 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.029 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.404 HD12 ' CG2' ' A' ' 49' ' ' VAL . 2.3 mt -59.66 -46.06 90.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.573 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.493 ' CG2' HG12 ' A' ' 105' ' ' VAL . 97.5 t -56.44 -55.19 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.645 0.26 . . . . 0.0 111.562 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.76 -48.61 66.65 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.181 0.515 . . . . 0.0 110.835 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 3.3 mm? -56.88 -30.87 64.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.588 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.428 ' HB3' ' CZ2' ' A' ' 87' ' ' TRP . . . -70.92 -34.23 71.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.4 . . . . 0.0 110.092 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.408 ' CD1' ' CE ' ' A' ' 20' ' ' MET . 1.4 tp -75.32 -16.66 60.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.528 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.687 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.9 mt -57.28 -30.66 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.179 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.409 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 10.6 pt-20 -73.81 -16.72 61.14 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.3 t -79.49 -23.29 43.08 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.66 -97.6 0.18 Allowed Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.576 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.528 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 1.1 ptt? -63.03 73.61 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.687 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.03 -67.58 0.42 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 152' ' ' LEU . 5.2 t80 -69.33 -32.3 71.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.042 0.448 . . . . 0.0 110.914 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.28 -50.44 27.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.36 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 127' ' ' MET . 43.3 t0 -67.59 -37.17 82.19 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.575 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -61.05 -50.2 74.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.991 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.486 HG23 HD12 ' A' ' 133' ' ' ILE . 24.6 mm -72.8 -38.45 57.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 111.681 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -49.6 22.9 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -70.64 -34.11 71.71 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.864 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.9 OUTLIER -74.07 -30.64 27.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.798 0.332 . . . . 0.0 110.393 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -65.42 -48.95 71.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.29 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -59.93 -45.1 93.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.593 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -83.19 151.89 25.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.637 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 117.46 14.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.6 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.459 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -114.44 163.17 15.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.968 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.412 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -61.02 -157.49 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.274 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.43 98.71 11.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.568 0.684 . . . . 0.0 110.461 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.444 ' CG2' ' HB3' ' A' ' 148' ' ' GLN . 61.4 mt -88.71 109.0 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.058 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -113.87 -77.74 0.58 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.854 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.5 p -101.13 -60.95 1.43 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.801 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.2 tmtt? -48.99 -52.06 27.07 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.444 ' HB3' ' CG2' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -56.2 -51.82 66.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.431 ' CD2' ' CG2' ' A' ' 144' ' ' ILE . 3.1 mm? -73.24 -47.0 46.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.5 m -66.92 -37.24 83.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.801 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -67.89 -50.92 53.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.319 -179.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -70.71 -31.32 68.15 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.344 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.14 -39.02 81.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -29.17 64.78 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.448 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.449 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.06 -30.17 70.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.665 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.743 0.306 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.38 152.67 66.22 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.565 2.176 . . . . 0.0 112.386 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.467 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.5 t -144.07 127.64 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.903 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -110.71 116.8 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.805 0.336 . . . . 0.0 111.353 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.433 HG13 ' CD2' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -106.72 118.33 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.1 p -141.2 142.84 33.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.624 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 1.4 p90 -134.51 170.21 16.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.113 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.624 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 43.63 -96.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.053 0.141 . . . . 0.0 111.167 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.432 ' H ' ' CG ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -128.92 -30.78 2.21 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.483 ' HE3' ' CD1' ' A' ' 22' ' ' PHE . 3.9 ppp? -73.74 169.13 17.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.687 0.28 . . . . 0.0 111.23 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -147.94 161.23 41.74 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.979 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CD1' ' HE3' ' A' ' 20' ' ' MET . 1.3 m-85 -134.11 150.72 51.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.377 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.533 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -121.13 136.36 54.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.122 0.487 . . . . 0.0 111.557 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.535 HG21 ' HA ' ' A' ' 107' ' ' CYS . 1.9 mm -118.19 106.58 20.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.13 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -134.78 166.99 21.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.287 0.565 . . . . 0.0 111.745 -178.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 36' ' ' PHE . 49.1 p-80 -81.33 152.03 27.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.103 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -62.88 154.53 75.66 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.043 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.7 Cg_exo -54.77 138.91 77.5 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.389 2.059 . . . . 0.0 113.312 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.44 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 28.9 p -98.72 174.41 6.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.231 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -93.79 -9.73 36.53 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.59 -30.81 14.77 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -139.62 89.58 2.33 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.274 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.44 -52.27 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.138 0.494 . . . . 0.0 111.174 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.413 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 2.1 p -58.49 -45.21 89.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.162 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 m -57.99 -32.78 68.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.9 0.381 . . . . 0.0 111.339 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.502 ' CD2' ' HA ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -74.51 -48.11 29.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.148 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 34' ' ' SER . 12.0 pt -56.08 -39.15 56.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.265 0.555 . . . . 0.0 110.645 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.3 -50.9 63.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.513 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -69.63 -50.13 47.26 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.887 0.375 . . . . 0.0 111.813 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.432 HD23 ' CE1' ' A' ' 36' ' ' PHE . 53.0 mt -56.19 -44.19 79.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.305 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -78.89 -26.75 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.021 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -52.92 -43.48 66.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.29 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.533 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 14.6 t80 -63.41 -38.4 90.99 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.663 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.663 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 166.31 -177.43 41.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.793 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.56 117.47 19.62 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.639 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.4 m -165.25 -169.93 1.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.687 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 67' ' ' THR . 5.1 p -64.81 144.49 57.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.572 0.701 . . . . 0.0 110.448 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.461 ' CG2' ' HB3' ' A' ' 104' ' ' ALA . 61.0 t -122.18 128.14 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.868 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.659 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 2.1 p -115.44 105.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.355 0.597 . . . . 0.0 111.692 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 111.02 21.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.737 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG12 ' NE ' ' A' ' 113' ' ' ARG . 38.8 t -101.22 92.38 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.498 0.666 . . . . 0.0 110.405 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.18 171.46 20.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.072 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -64.62 130.7 44.62 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 m -68.73 122.05 19.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.411 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 6.5 m -120.45 -47.0 2.36 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.143 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.444 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 2.8 m-85 -129.79 84.89 2.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.362 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -78.21 -35.64 48.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -78.81 -48.49 14.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.45 -51.24 36.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 47.5 Cg_exo -57.13 -42.33 64.62 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.242 . . . . 0.0 113.83 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -45.47 63.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -49.12 19.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -74.46 -26.86 60.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.438 ' HB3' ' CG1' ' A' ' 66' ' ' ILE . 3.1 t0 -99.92 -11.57 20.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.54 25.98 3.49 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.14 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.438 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 4.7 pt -122.76 148.73 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.601 0.239 . . . . 0.0 110.573 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 47' ' ' THR . 10.3 t -77.15 132.87 39.03 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.495 HG21 ' N ' ' A' ' 69' ' ' VAL . 8.0 p -139.71 149.38 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.155 0.502 . . . . 0.0 111.984 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.495 ' N ' HG21 ' A' ' 68' ' ' VAL . 2.8 t -103.3 131.6 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.91 106.63 17.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.585 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.443 ' CH2' ' CG1' ' A' ' 83' ' ' VAL . 4.4 m95 -110.22 103.46 53.86 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.555 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 N--CA 1.445 -1.372 0 C-N-CA 123.538 2.825 . . . . 0.0 112.882 -178.866 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 5.7 tmtp? . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.609 0.242 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.443 ' CG1' ' CH2' ' A' ' 71' ' ' TRP . 42.1 t -56.56 -46.71 82.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.419 HG13 ' OH ' ' A' ' 151' ' ' TYR . 89.3 t -56.08 -40.37 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.039 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 2.0 mt-10 -58.2 -31.44 67.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.746 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.72 -50.74 63.72 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.498 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.659 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.03 -28.9 69.21 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.419 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.418 ' CD2' ' O ' ' A' ' 120' ' ' LEU . 11.3 mt -64.74 -38.5 91.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.228 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.8 m -66.93 -39.99 87.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.994 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -63.44 -51.3 66.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.874 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.46 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 13.5 p -69.76 -43.42 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -60.82 -34.76 75.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.393 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.2 -47.96 72.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -74.6 -25.59 59.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.46 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 3.3 m-85 -82.02 -34.48 29.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.992 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.1 t -72.26 -46.4 56.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -76.35 -33.36 58.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.35 141.99 41.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.91 159.32 53.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.406 2.071 . . . . 0.0 112.125 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.09 90.75 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -81.44 -83.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.68 0.276 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.663 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.6 m -153.26 113.05 3.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.792 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 23.5 t -108.07 151.21 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.461 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . . . -122.4 140.45 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.27 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.547 HG13 ' H ' ' A' ' 106' ' ' HIS . 2.5 t -139.6 166.79 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.612 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.547 ' H ' HG13 ' A' ' 105' ' ' VAL . 2.0 t60 -67.16 156.27 36.64 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.52 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.535 ' HA ' HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -68.06 105.07 1.93 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.444 ' CG1' HD11 ' A' ' 24' ' ' ILE . 29.8 m -75.28 -0.02 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.025 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.72 -8.72 3.17 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.93 -136.32 4.68 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.409 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 13.0 mt -120.9 127.46 51.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.74 -147.42 5.22 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.374 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.49 ' NE ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.24 -20.01 6.32 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.907 0.384 . . . . 0.0 111.89 -178.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.652 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -52.64 -46.56 95.87 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 6.5 Cg_endo -52.1 -48.31 22.31 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.264 1.976 . . . . 0.0 112.73 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.4 ' O ' ' CD2' ' A' ' 120' ' ' LEU . 39.0 t -60.95 -44.47 98.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.917 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.427 HD11 ' CE3' ' A' ' 71' ' ' TRP . 9.4 mt -58.12 -45.31 87.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.212 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.461 HG13 ' CD2' ' A' ' 22' ' ' PHE . 94.9 t -55.0 -55.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.776 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.36 -49.25 74.95 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.147 0.499 . . . . 0.0 110.748 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.609 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 2.7 mm? -53.91 -30.91 48.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.732 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.51 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -69.58 -43.32 73.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.05 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.432 ' CD1' ' HE3' ' A' ' 20' ' ' MET . 0.7 OUTLIER -66.98 -15.63 63.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.757 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.6 mt -57.04 -30.64 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -72.45 -17.02 61.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.424 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.5 m -84.54 11.25 9.09 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 113.79 -99.5 0.98 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.763 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.497 ' HE3' ' CD2' ' A' ' 17' ' ' TYR . 3.0 ptt? -62.45 79.73 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.9 -67.69 0.54 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 5.2 t80 -67.33 -32.05 72.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.959 0.409 . . . . 0.0 111.001 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.37 -52.04 17.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.25 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.538 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 32.3 t0 -68.24 -38.13 81.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.816 0.341 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.502 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -60.04 -49.98 75.54 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.007 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.4 mm -73.67 -37.61 49.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -74.17 -49.6 22.92 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -70.57 -35.8 73.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.583 0.23 . . . . 0.0 110.902 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.4 tt -74.14 -29.26 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.395 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -66.31 -48.44 70.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.477 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -44.94 93.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.443 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -82.81 152.25 25.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.29 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 117.25 14.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.503 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -114.53 163.54 15.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.01 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.409 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -59.15 -164.08 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.485 -0.865 . . . . 0.0 111.173 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.06 98.96 11.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.709 0.755 . . . . 0.0 110.745 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 pp -88.48 109.03 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.074 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -113.45 -77.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.456 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.4 m -100.27 -60.7 1.48 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.79 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.5 tmtt? -53.19 -51.8 60.91 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -56.03 -52.03 65.68 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.04 -45.3 42.56 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.4 m -67.09 -35.0 78.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.629 0.252 . . . . 0.0 111.622 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.79 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -69.51 -50.87 41.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.387 -179.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.433 ' HB3' ' CE1' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -69.47 -32.25 71.04 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.323 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -59.73 -39.55 85.08 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -27.46 63.52 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.585 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.44 ' CD2' HD11 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -66.23 -33.77 76.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.621 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.662 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.634 0.254 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.02 165.16 33.55 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.538 2.159 . . . . 0.0 112.368 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.93 126.83 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.534 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -116.82 136.01 53.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.015 0.436 . . . . 0.0 111.898 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.471 HG13 ' CD2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.8 137.02 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.12 129.3 37.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.245 0.545 . . . . 0.0 111.963 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CE1' ' HE1' ' A' ' 127' ' ' MET . 25.7 t80 -145.57 132.74 20.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.268 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HG2' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 64.08 -103.49 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.204 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.4 14.04 6.07 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.421 ' CE ' ' CD2' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -119.26 169.0 10.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.775 0.322 . . . . 0.0 110.96 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.8 mtm-85 -141.79 164.08 31.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.122 0.486 . . . . 0.0 111.733 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 3.9 m-85 -134.59 150.19 50.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.872 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -126.21 135.49 51.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 111.143 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.424 HD12 ' HB ' ' A' ' 105' ' ' VAL . 10.9 mm -118.33 106.27 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 107' ' ' CYS . 1.2 p -131.07 163.74 26.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.197 0.522 . . . . 0.0 111.756 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.527 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.5 p80 -81.24 152.44 27.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.261 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.38 154.81 70.29 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.802 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.417 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 51.8 Cg_exo -53.89 136.6 66.73 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.32 2.013 . . . . 0.0 113.15 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.53 143.53 28.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.21 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -64.79 -12.78 51.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.338 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -31.31 14.59 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.4 p -139.97 88.8 2.26 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.282 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.89 -52.28 7.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.259 0.552 . . . . 0.0 111.256 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.444 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 2.3 m -56.84 -46.36 81.76 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.624 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -57.58 -31.9 66.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.961 0.41 . . . . 0.0 111.145 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.527 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -74.85 -47.59 29.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.175 -179.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.444 ' CG1' ' O ' ' A' ' 34' ' ' SER . 11.6 pt -55.62 -39.06 52.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.136 0.493 . . . . 0.0 110.605 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -65.18 -52.03 57.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.51 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 2.4 m-20 -67.99 -50.15 57.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.902 0.382 . . . . 0.0 111.935 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.445 ' HG ' ' CD1' ' A' ' 36' ' ' PHE . 74.2 mt -55.84 -45.2 78.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.556 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.8 tttm -77.34 -26.71 52.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.085 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.2 mttt -53.04 -44.99 67.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.217 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.549 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 11.5 t80 -63.57 -38.32 90.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.748 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.659 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 161.05 -177.74 37.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.934 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.67 122.33 27.17 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.569 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 4.1 m -164.54 -171.39 2.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.513 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.491 ' H ' ' CG2' ' A' ' 46' ' ' THR . 1.7 t -65.44 162.22 18.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 91.8 t -138.01 137.99 44.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.538 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 11.2 p -115.23 104.2 16.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.421 0.629 . . . . 0.0 111.002 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.22 110.98 20.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.05 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.553 HG11 ' HD3' ' A' ' 113' ' ' ARG . 6.1 t -105.8 91.26 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.462 0.649 . . . . 0.0 109.704 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 t -157.87 171.29 20.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.911 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -67.61 130.45 43.08 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.83 122.48 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.4 p -120.16 -47.66 2.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.376 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.423 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -130.56 83.34 2.11 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.457 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.17 -36.38 40.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -79.06 -48.55 14.17 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -43.91 -60.22 2.9 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.249 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.61 -34.31 15.35 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.551 2.167 . . . . 0.0 113.871 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.406 HD23 HG13 ' A' ' 68' ' ' VAL . 1.6 mm? -71.13 -45.19 64.08 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -75.1 -29.37 60.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -33.8 33.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -101.31 -12.41 18.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.11 24.19 4.48 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.473 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 64' ' ' ASP . 12.7 mt -96.4 147.47 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.946 0.373 . . . . 0.0 110.835 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 47' ' ' THR . 3.4 m -78.47 132.57 37.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.425 HG22 ' HB ' ' A' ' 48' ' ' VAL . 7.5 p -145.05 152.78 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.337 0.589 . . . . 0.0 112.125 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.83 130.54 54.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.001 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.09 106.84 18.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.082 0.468 . . . . 0.0 111.044 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.5 m95 -109.35 103.9 53.82 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.51 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 N--CA 1.446 -1.266 0 C-N-CA 123.262 2.642 . . . . 0.0 112.94 -179.185 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.647 0.26 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.429 HG23 ' CH2' ' A' ' 71' ' ' TRP . 31.2 m -58.65 -44.4 89.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.492 HG13 ' CE1' ' A' ' 151' ' ' TYR . 0.8 OUTLIER -53.42 -39.41 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.229 0.538 . . . . 0.0 109.591 178.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.63 -31.35 70.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.726 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.04 -50.88 64.5 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.538 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -68.86 -34.76 75.99 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.785 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 mt -55.17 -43.67 74.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.411 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -40.6 82.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.316 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -58.39 -51.35 70.18 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.9 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.2 p -73.9 -36.06 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.878 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 -44.06 64.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.934 0.397 . . . . 0.0 110.597 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.08 -43.6 57.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.951 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -27.62 69.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.263 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.06 -40.71 21.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 111.0 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 7.2 t -67.0 -46.05 75.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -76.1 -33.04 59.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.08 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -109.37 87.99 5.63 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.293 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.27 115.91 4.04 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.584 2.189 . . . . 0.0 112.363 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.15 52.14 19.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 t -101.17 -174.16 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.62 0.247 . . . . 0.0 111.179 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.659 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 3.1 m -112.94 114.12 26.48 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 16.3 t -106.81 151.28 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -121.33 145.7 47.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.643 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.562 HG11 ' CG2' ' A' ' 118' ' ' VAL . 97.5 t -139.86 166.25 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.489 ' N ' HG13 ' A' ' 105' ' ' VAL . 3.0 t60 -67.81 155.43 39.36 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.825 0.345 . . . . 0.0 110.725 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.541 ' N ' ' O ' ' A' ' 25' ' ' THR . 43.7 t -69.36 104.23 2.21 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.495 HG12 ' HG3' ' A' ' 115' ' ' PRO . 3.0 t -75.73 1.39 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.417 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.16 -8.37 1.54 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.73 -121.32 2.62 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 mt -132.12 127.32 35.74 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.13 -154.48 7.55 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.146 -1.025 . . . . 0.0 113.255 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.553 ' HD3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.37 -15.12 7.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.91 0.386 . . . . 0.0 111.943 -178.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.661 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.34 -46.79 97.79 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 10.1 Cg_endo -52.98 -48.1 23.97 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.352 2.035 . . . . 0.0 112.446 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 41.8 t -55.84 -53.23 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.859 0.362 . . . . 0.0 110.479 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.423 HD12 ' CE3' ' A' ' 71' ' ' TRP . 2.7 mt -54.44 -48.76 71.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.773 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.562 ' CG2' HG11 ' A' ' 105' ' ' VAL . 17.0 t -51.28 -49.71 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 111.354 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 123' ' ' ILE . . . -55.91 -45.26 78.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.668 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.527 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -57.54 -30.88 65.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.766 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HB1' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.05 -44.76 62.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.939 0.4 . . . . 0.0 110.597 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.433 HD22 ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -69.63 -15.9 63.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.791 179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.551 HG23 ' CB ' ' A' ' 128' ' ' LYS . 1.3 mt -57.77 -41.72 80.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.871 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.52 -15.81 3.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.83 11.24 4.06 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 117.79 -88.08 0.44 Allowed Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.307 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.532 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.97 79.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.288 0.566 . . . . 0.0 109.662 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.551 ' CB ' HG23 ' A' ' 123' ' ' ILE . 20.9 mttm -62.61 -68.08 0.36 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.005 -177.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.47 ' CD1' ' HB3' ' A' ' 152' ' ' LEU . 7.1 t80 -74.34 -30.47 62.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.229 0.537 . . . . 0.0 110.499 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 7.5 mt-10 -72.57 -47.15 50.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.107 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 127' ' ' MET . 50.8 t0 -68.88 -47.23 66.39 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.349 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.477 ' HB2' HD13 ' A' ' 152' ' ' LEU . . . -59.07 -50.16 75.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.941 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 35.4 mm -72.44 -36.18 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 75.8 mt-30 -74.21 -49.56 22.9 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.471 ' CD2' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.69 -37.5 76.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 110.815 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 3.3 tt -74.44 -28.55 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.464 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 0.9 OUTLIER -69.51 -46.73 65.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.944 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -41.52 91.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.118 0.485 . . . . 0.0 110.027 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -87.14 152.64 22.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.154 179.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.38 117.81 14.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.112 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -114.19 163.66 14.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.234 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -57.95 -163.36 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.946 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.17 100.18 13.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.156 0.478 . . . . 0.0 111.51 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.51 ' O ' HG12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -87.91 109.17 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.482 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.65 -77.52 0.58 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.6 m -100.48 -61.41 1.37 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.778 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 8.8 tmtt? -64.29 -46.39 83.85 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -176.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.432 ' CB ' HG21 ' A' ' 144' ' ' ILE . 0.9 OUTLIER -56.23 -52.13 65.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -176.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -75.35 -37.19 60.81 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.963 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.1 t -71.76 -37.11 70.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.844 0.355 . . . . 0.0 110.968 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.778 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.85 -50.56 64.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.643 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' A' ' 132' ' ' ALA . 0.7 OUTLIER -66.7 -31.64 72.44 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.643 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.82 -37.45 84.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -23.0 55.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.883 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.486 ' CE2' HD11 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -66.22 -43.84 85.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.507 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 48.0 ttt85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.607 179.582 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.747 0.308 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.26 165.14 32.51 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.99 126.85 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -106.89 132.64 52.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.448 . . . . 0.0 111.657 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.521 ' CG1' ' CE2' ' A' ' 135' ' ' PHE . 2.1 t -106.78 124.78 62.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.224 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.6 p -122.32 140.88 52.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 111.823 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.447 ' CD2' HD21 ' A' ' 122' ' ' LEU . 26.5 t80 -155.25 131.04 9.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.7 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm 59.04 -100.24 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.082 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -129.56 14.09 5.98 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.436 ' CE ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -117.06 164.65 14.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 110.949 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -132.72 164.01 27.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.421 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 1.2 m-85 -142.89 146.22 33.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.847 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.527 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -122.66 136.28 54.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 111.259 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.463 HG23 ' HA ' ' A' ' 107' ' ' CYS . 5.6 mm -118.49 106.3 19.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.69 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 107' ' ' CYS . 1.9 p -132.38 164.79 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.057 0.456 . . . . 0.0 111.506 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.509 ' CD2' ' CZ ' ' A' ' 36' ' ' PHE . 31.3 p-80 -81.46 152.12 27.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.074 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -62.8 154.54 74.99 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.978 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.03 134.7 61.07 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.425 2.083 . . . . 0.0 113.068 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -98.5 152.96 18.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.267 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -71.81 -11.41 60.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.53 -31.58 14.49 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -140.08 88.75 2.25 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.135 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -52.38 7.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.184 0.516 . . . . 0.0 111.533 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 1.6 p -57.2 -46.78 82.57 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.635 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.2 m -57.82 -32.27 67.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.881 0.372 . . . . 0.0 111.255 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.509 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -74.67 -47.95 28.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' CG1' ' O ' ' A' ' 34' ' ' SER . 12.0 pt -55.93 -39.03 55.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.207 0.527 . . . . 0.0 110.623 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.83 -52.01 59.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.558 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 3.7 m-20 -68.88 -50.08 52.77 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.929 0.395 . . . . 0.0 111.832 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.432 HD23 ' CE1' ' A' ' 36' ' ' PHE . 53.5 mt -55.92 -45.21 78.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -26.77 48.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.027 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -53.32 -43.36 67.56 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.367 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.527 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 14.0 t80 -63.28 -38.65 92.0 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.689 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.626 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.68 -178.38 40.5 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.821 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.56 117.4 19.51 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.604 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.3 m -165.18 -170.41 1.9 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.806 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 67' ' ' THR . 3.6 t -65.09 159.83 22.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.484 0.659 . . . . 0.0 110.617 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 104' ' ' ALA . 60.0 t -136.27 138.15 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.073 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.551 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 14.9 p -115.55 104.65 17.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.551 0.691 . . . . 0.0 111.211 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -115.13 110.79 20.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.251 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.59 HG11 ' HD3' ' A' ' 113' ' ' ARG . 12.9 t -106.62 91.84 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.366 0.603 . . . . 0.0 109.722 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.32 171.42 20.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.719 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -64.69 130.47 43.71 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.61 121.86 19.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.424 HG21 ' CE1' ' A' ' 56' ' ' TYR . 2.0 m -120.66 -47.38 2.32 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.133 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.429 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 9.0 m-85 -130.33 84.62 2.21 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.483 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -78.33 -36.05 46.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -48.55 14.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.429 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -45.14 -49.99 28.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.153 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 34.2 Cg_exo -60.93 -40.67 50.82 Favored 'Trans proline' 0 N--CA 1.471 0.193 0 C-N-CA 122.646 2.23 . . . . 0.0 113.605 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -45.05 64.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -49.13 20.18 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -76.16 -25.72 55.54 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 2.8 t0 -99.35 -11.48 21.16 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.42 26.85 2.61 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.278 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.422 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 4.2 pt -122.54 148.12 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.688 0.28 . . . . 0.0 110.737 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 47' ' ' THR . 11.0 t -77.83 135.11 37.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.064 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 p -141.59 154.46 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.277 0.561 . . . . 0.0 111.733 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.68 131.28 52.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.145 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -100.8 106.81 18.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.201 0.524 . . . . 0.0 110.193 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.568 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.5 m95 -111.26 104.51 56.24 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.447 -1.239 0 C-N-CA 123.204 2.602 . . . . 0.0 112.344 -179.757 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.563 0.22 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.424 HG11 ' CZ2' ' A' ' 71' ' ' TRP . 11.6 t -59.93 -48.23 88.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 1.1 t -53.52 -38.69 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.227 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.45 -31.19 71.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.355 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -63.35 -50.64 69.17 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.551 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.551 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -67.44 -32.64 73.64 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.89 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.423 HD13 ' CE2' ' A' ' 155' ' ' TYR . 13.5 mt -55.93 -48.02 76.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.607 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -41.34 95.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.487 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -57.68 -51.59 68.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.445 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 13.2 p -74.75 -35.82 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.383 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -55.04 -40.95 70.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.963 0.411 . . . . 0.0 110.513 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.28 -46.75 39.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.227 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.3 -37.57 86.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.631 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.425 ' CE1' HG23 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -82.02 -33.49 30.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.763 0.316 . . . . 0.0 111.171 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.04 -46.04 58.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -76.1 -31.5 58.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.273 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -117.35 87.25 23.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.479 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.45 136.35 42.8 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.745 2.297 . . . . 0.0 112.168 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 20' ' ' MET . . . 58.12 58.23 15.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.662 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.421 ' CB ' HG22 ' A' ' 46' ' ' THR . 51.8 p -101.2 -169.98 1.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.808 0.337 . . . . 0.0 111.263 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.626 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -123.46 113.67 19.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.091 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.425 HG23 ' CE1' ' A' ' 95' ' ' PHE . 7.4 t -111.98 151.38 14.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.135 0.493 . . . . 0.0 112.323 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.439 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . . . -118.93 145.34 45.85 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.422 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.537 HG11 ' H ' ' A' ' 106' ' ' HIS . 7.6 t -140.3 167.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.708 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.537 ' H ' HG11 ' A' ' 105' ' ' VAL . 9.8 t60 -66.87 155.49 38.22 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 25' ' ' THR . 10.5 t -69.1 122.5 18.89 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 140' ' ' ARG . 5.1 m -75.75 -0.2 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.475 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.95 -8.78 3.43 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.99 -156.38 6.8 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.5 mt -92.91 127.27 38.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.83 -169.38 16.61 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.223 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.59 ' HD3' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.22 -24.63 5.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.069 0.461 . . . . 0.0 111.407 -179.252 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.486 ' N ' ' CD ' ' A' ' 115' ' ' PRO . . . -54.48 -43.07 97.5 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 114' ' ' ALA . 58.4 Cg_exo -52.35 -48.38 22.07 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.844 1.696 . . . . 0.0 111.67 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.52 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 91.3 t -55.98 -51.14 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.46 ' HA ' ' HG ' ' A' ' 120' ' ' LEU . 8.5 mt -51.97 -45.3 64.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.137 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.479 ' CG2' HG13 ' A' ' 105' ' ' VAL . 15.9 t -51.81 -53.18 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.951 0.405 . . . . 0.0 110.909 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.414 ' HB3' ' CB ' ' A' ' 132' ' ' ALA . . . -53.5 -43.27 68.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.177 0.513 . . . . 0.0 110.519 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.549 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -58.64 -30.83 67.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.529 179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.26 -40.38 71.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.115 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.447 HD21 ' CD2' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -71.59 -16.68 62.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.734 179.026 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.7 mt -57.31 -30.7 36.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.284 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -16.61 62.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.7 m -79.76 -23.34 42.28 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.43 -96.58 0.17 Allowed Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.946 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.5 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 6.1 ptt? -63.87 71.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.61 -67.37 0.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 6.0 t80 -65.88 -32.42 73.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.894 0.378 . . . . 0.0 111.139 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -72.55 -52.43 15.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.259 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 5.2 t0 -67.05 -36.75 82.74 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 110.486 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.536 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -61.07 -50.42 73.36 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.162 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 133' ' ' ILE . 32.9 mm -73.43 -39.3 54.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.569 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -49.97 19.79 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.58 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -68.28 -37.35 80.59 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.581 -179.31 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -74.16 -28.72 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.736 0.303 . . . . 0.0 110.407 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -63.8 -44.92 91.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.399 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -45.1 93.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.668 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 136' ' ' ILE . 2.5 mptt -87.08 151.44 23.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.633 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.475 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.93 116.78 14.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 0.0 110.972 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.14 163.21 15.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.81 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.31 -179.99 0.18 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.307 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.09 99.4 4.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.62 0.71 . . . . 0.0 111.015 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 144' ' ' ILE . 11.3 pt -88.22 109.53 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.763 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -112.95 -76.62 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.628 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.91 -60.93 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.767 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.6 tmtt? -52.49 -51.81 57.6 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.408 ' HG3' ' CG2' ' A' ' 144' ' ' ILE . 1.3 tm0? -60.23 -51.75 68.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.03 -34.77 66.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.9 t -75.29 -40.77 58.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.082 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.767 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -64.03 -50.76 67.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.502 ' HA ' ' HB2' ' A' ' 155' ' ' TYR . 0.8 OUTLIER -69.0 -33.82 74.28 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.932 -179.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.22 -38.03 78.95 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -25.43 55.35 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.551 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.543 ' CE2' HD11 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -66.43 -31.34 72.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.471 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.427 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.713 0.292 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.78 165.13 33.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.596 2.197 . . . . 0.0 112.265 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.51 126.99 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.776 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -114.37 128.95 56.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.993 0.425 . . . . 0.0 111.698 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.482 HG13 ' CD2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.87 127.66 62.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.509 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.41 147.63 42.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.119 0.485 . . . . 0.0 111.786 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.451 ' CE1' ' HE1' ' A' ' 127' ' ' MET . 26.4 t80 -155.15 117.93 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.642 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 29.2 mmtp 64.28 -95.77 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.408 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.39 13.99 6.07 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.434 ' HE3' ' CD2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -121.67 169.05 11.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.754 0.311 . . . . 0.0 110.886 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -145.62 164.03 33.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 111.697 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 3.0 m-85 -134.29 148.9 50.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.561 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.538 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -122.48 135.77 54.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.21 0.529 . . . . 0.0 111.334 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 107' ' ' CYS . 2.5 mm -118.17 106.58 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.223 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -132.54 165.34 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.286 0.565 . . . . 0.0 111.644 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.52 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.2 p80 -81.1 152.08 28.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -62.83 154.04 77.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.514 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 10.0 Cg_endo -54.38 138.53 73.47 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.64 2.227 . . . . 0.0 113.439 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.441 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -98.93 174.24 6.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.249 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.8 -8.66 30.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.53 -30.67 14.88 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.6 p -139.36 89.62 2.35 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.109 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.441 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.18 -52.18 8.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.19 0.519 . . . . 0.0 111.22 178.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.429 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.6 p -57.8 -45.67 85.75 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.225 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.4 m -57.85 -32.13 67.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.747 0.308 . . . . 0.0 111.276 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -75.3 -47.89 25.75 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.148 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.429 HG12 ' HA ' ' A' ' 34' ' ' SER . 11.6 pt -55.66 -39.03 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.179 0.514 . . . . 0.0 110.761 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.32 -51.83 53.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.543 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.1 m-20 -68.13 -50.12 56.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.838 0.351 . . . . 0.0 111.915 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 36' ' ' PHE . 87.9 mt -55.8 -46.22 78.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.986 0.422 . . . . 0.0 110.42 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -77.05 -26.63 53.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.102 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -53.13 -44.48 67.77 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.532 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.538 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 10.9 t80 -63.56 -38.53 91.48 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.959 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.674 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.93 -178.35 39.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.006 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.53 117.4 19.53 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.613 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.0 OUTLIER -165.19 -169.69 1.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.166 -0.924 . . . . 0.0 108.853 177.416 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 67' ' ' THR . 3.5 p -64.48 146.49 54.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.555 0.693 . . . . 0.0 110.544 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 59.5 t -125.38 132.72 70.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.565 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.663 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 12.9 p -115.41 105.52 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.372 0.606 . . . . 0.0 111.315 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 110.64 20.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.735 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.559 HG11 ' NE ' ' A' ' 113' ' ' ARG . 23.0 t -104.08 90.44 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.635 0.731 . . . . 0.0 109.734 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -158.78 171.62 19.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.352 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 1.8 mm-40 -64.95 130.35 43.07 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.4 t -77.56 122.63 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 p -120.2 -47.87 2.35 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.169 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.8 83.45 2.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.363 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -79.36 -36.77 38.8 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -79.44 -48.65 13.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.405 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -43.95 -51.66 17.18 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 12.6 Cg_exo -71.51 -42.62 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.491 2.127 . . . . 0.0 113.973 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.4 ' CD1' ' CG1' ' A' ' 68' ' ' VAL . 2.9 tp -71.44 -45.19 63.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -56.27 -46.47 79.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -20.45 41.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.436 ' HB3' HG12 ' A' ' 66' ' ' ILE . 72.7 m-20 -101.0 -11.52 19.61 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 42.64 52.78 5.36 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.852 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.436 HG12 ' HB3' ' A' ' 64' ' ' ASP . 4.2 pt -133.01 148.53 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.733 0.302 . . . . 0.0 111.144 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' THR . 73.8 p -78.1 135.21 37.66 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 69' ' ' VAL . 11.2 p -141.75 149.54 19.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.45 ' N ' HG23 ' A' ' 68' ' ' VAL . 2.0 t -103.55 130.22 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -100.72 106.88 18.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.161 0.505 . . . . 0.0 110.474 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.433 ' CH2' ' HA ' ' A' ' 84' ' ' VAL . 4.1 m95 -111.57 103.63 55.28 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.094 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 N--CA 1.447 -1.246 0 C-N-CA 123.64 2.893 . . . . 0.0 112.487 -179.445 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.395 0.14 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.412 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 26.1 t -56.12 -48.1 79.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.434 HG13 ' CE2' ' A' ' 151' ' ' TYR . 86.5 t -55.72 -39.22 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.216 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.26 -31.46 69.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.914 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -66.85 -50.84 61.27 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.619 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.663 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.23 -26.89 65.92 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.534 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.3 mt -63.88 -47.2 81.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.319 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -42.09 98.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.298 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -53.91 -51.37 63.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.795 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 92' ' ' LYS . 8.6 p -72.33 -41.73 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.488 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.433 ' N ' HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -54.56 -38.92 67.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 0.0 110.992 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.42 53.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -73.17 -20.53 60.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.909 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.418 ' CD1' ' CG2' ' A' ' 91' ' ' VAL . 1.9 m-85 -82.07 -40.71 21.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.9 t -69.1 -42.73 75.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -75.99 -31.19 58.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.106 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.68 90.78 48.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.327 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.27 137.38 18.92 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.606 2.204 . . . . 0.0 112.363 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.78 57.38 20.19 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.588 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.436 ' CB ' HG23 ' A' ' 46' ' ' THR . 51.5 p -101.22 -168.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.328 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.674 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -120.91 113.44 20.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.053 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 43.8 t -105.46 151.02 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -123.92 139.43 53.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.207 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.584 HG11 ' CG2' ' A' ' 118' ' ' VAL . 45.1 t -140.12 166.71 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.451 ' N ' ' CG1' ' A' ' 105' ' ' VAL . 2.7 t60 -66.97 155.97 37.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.381 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 25' ' ' THR . 49.3 t -68.5 106.94 2.72 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' A' ' 24' ' ' ILE . 34.1 m -75.42 0.09 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.022 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.45 -8.72 2.9 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.37 -139.4 5.31 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.417 HD23 ' HA2' ' A' ' 142' ' ' GLY . 11.7 mt -117.93 127.34 53.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.19 -146.28 4.82 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.349 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.559 ' NE ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.3 -20.94 5.99 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.018 0.437 . . . . 0.0 111.936 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.639 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -51.93 -46.29 92.56 Favored Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.4 Cg_endo -52.59 -48.65 20.82 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.223 1.948 . . . . 0.0 113.274 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.418 ' O ' HD21 ' A' ' 120' ' ' LEU . 39.4 t -62.25 -41.0 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.079 0.466 . . . . 0.0 110.127 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.413 HD11 ' CG2' ' A' ' 51' ' ' VAL . 6.4 mt -59.06 -41.11 87.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.81 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.584 ' CG2' HG11 ' A' ' 105' ' ' VAL . 17.6 t -64.15 -55.53 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.32 -53.07 61.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 110.903 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.728 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 3.1 mm? -55.25 -30.31 59.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.038 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.544 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.56 -50.62 24.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 110.614 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.434 ' CD2' ' HE3' ' A' ' 20' ' ' MET . 0.4 OUTLIER -65.27 -10.09 29.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.586 179.04 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.728 ' HB ' ' O ' ' A' ' 120' ' ' LEU . 1.0 OUTLIER -56.78 -34.26 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.687 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -62.28 -16.56 54.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.908 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.0 m -79.88 11.06 3.53 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 120.27 -98.8 0.71 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.251 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.49 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 1.1 ptt? -62.61 73.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.36 0.6 . . . . 0.0 109.469 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.614 ' HB3' HG22 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.9 -68.03 0.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.536 ' HA ' HD21 ' A' ' 152' ' ' LEU . 5.3 t80 -68.71 -32.68 72.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.946 0.403 . . . . 0.0 111.186 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.26 -49.44 34.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.479 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 39.2 t0 -70.04 -45.6 66.81 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.914 0.387 . . . . 0.0 111.294 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -57.84 -49.72 75.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.649 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 33.5 mm -70.29 -40.81 78.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -74.28 -49.8 21.61 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -67.87 -35.19 78.1 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.937 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.4 tt -74.24 -32.79 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.707 0.289 . . . . 0.0 110.74 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -63.95 -43.05 97.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.714 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -44.69 93.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.46 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -86.21 151.84 23.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.256 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.26 117.11 14.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 110.63 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -114.82 163.66 15.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.417 ' HA2' HD23 ' A' ' 111' ' ' LEU . . . -57.71 -165.83 0.09 OUTLIER Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.42 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.26 99.22 11.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.589 0.695 . . . . 0.0 111.0 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.4 pt -88.45 109.44 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.809 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -113.14 -76.65 0.58 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -99.78 -60.74 1.47 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.837 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.0 tmtt? -52.83 -51.9 59.13 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -56.59 -51.63 67.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.24 -40.94 58.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 m -69.95 -40.53 75.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.933 0.397 . . . . 0.0 111.1 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.837 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -65.46 -50.02 66.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.536 HD21 ' HA ' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -65.02 -38.03 89.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.919 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -55.77 -44.0 77.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -24.31 62.83 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.685 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.469 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -66.28 -32.62 74.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.731 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.039 -179.861 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.71 0.29 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 57.2 Cg_endo -71.03 165.01 33.77 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.635 2.224 . . . . 0.0 112.443 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.43 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 19.5 t -144.02 127.44 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 10.3 pt-20 -110.07 116.73 32.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.476 HG12 ' CD2' ' A' ' 135' ' ' PHE . 0.6 OUTLIER -108.01 118.7 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.4 p -140.83 145.26 36.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -136.4 159.93 40.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.734 178.183 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 9.4 ptpt 48.64 -103.79 0.11 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -177.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -120.44 -26.68 5.34 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.141 -0.349 . . . . 0.0 111.643 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.417 ' CE ' HD12 ' A' ' 122' ' ' LEU . 5.6 ppp? -73.84 165.71 24.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.654 0.264 . . . . 0.0 111.316 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -147.6 164.05 34.71 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.088 0.471 . . . . 0.0 111.507 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.436 ' CE1' HG11 ' A' ' 118' ' ' VAL . 1.7 m-85 -137.89 146.5 43.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -119.36 133.61 55.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.988 0.423 . . . . 0.0 110.954 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.466 HG21 ' HA ' ' A' ' 107' ' ' CYS . 2.1 mm -118.17 106.68 20.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.404 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 107' ' ' CYS . 60.4 p -131.61 165.52 23.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.283 0.563 . . . . 0.0 111.876 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.52 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.2 p80 -81.25 152.44 27.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.728 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.42 154.38 72.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.411 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.7 Cg_exo -54.2 137.24 70.3 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.472 2.114 . . . . 0.0 113.264 -177.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.63 145.89 26.4 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.197 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -68.58 -11.13 59.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.26 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.5 -31.71 14.46 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -140.12 88.73 2.24 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.064 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.01 -51.9 8.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.106 0.479 . . . . 0.0 111.515 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.9 m -55.77 -45.48 78.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.438 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -57.81 -36.14 71.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.408 . . . . 0.0 111.321 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -72.92 -47.91 41.58 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 34' ' ' SER . 12.1 pt -55.87 -40.06 60.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 110.882 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.67 -52.1 59.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.497 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.6 OUTLIER -67.62 -50.17 59.36 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.799 0.333 . . . . 0.0 111.807 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' A' ' 36' ' ' PHE . 62.9 mt -55.04 -46.29 75.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.614 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -26.77 52.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.2 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.1 mtmt -53.85 -42.33 68.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.382 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.529 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 16.8 t80 -63.3 -38.48 91.33 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.933 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.634 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.31 -178.59 40.2 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.885 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.64 117.43 19.49 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.61 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.0 OUTLIER -165.18 -170.03 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.732 177.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 67' ' ' THR . 2.5 t -64.58 160.46 19.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.367 0.603 . . . . 0.0 110.502 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.494 ' O ' HG21 ' A' ' 68' ' ' VAL . 57.5 t -138.4 135.74 44.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.226 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 14.6 p -115.62 104.68 17.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.474 0.654 . . . . 0.0 110.974 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 110.86 20.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.724 178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.529 HG13 ' CD ' ' A' ' 113' ' ' ARG . 25.0 t -108.0 91.6 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.592 0.71 . . . . 0.0 110.141 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.77 171.22 20.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.005 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.91 130.32 43.0 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.22 122.49 26.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -120.2 -47.67 2.36 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.227 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -130.63 83.8 2.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.535 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -78.95 -36.22 41.97 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.09 -48.55 14.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.46 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.0 m -45.71 -48.32 38.59 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.46 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 8.4 Cg_exo -73.19 -41.19 1.36 Allowed 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.613 2.209 . . . . 0.0 113.503 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.447 ' CD2' ' CG1' ' A' ' 68' ' ' VAL . 4.0 mm? -65.5 -45.27 84.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.34 -31.06 60.45 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -81.09 -34.22 32.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.483 ' CB ' HG12 ' A' ' 66' ' ' ILE . 17.2 m-20 -101.68 -11.53 19.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.54 27.75 3.15 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.294 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.483 HG12 ' CB ' ' A' ' 64' ' ' ASP . 1.1 pt -105.01 148.74 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.775 0.322 . . . . 0.0 111.072 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.7 OUTLIER -77.42 133.34 38.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.494 HG21 ' O ' ' A' ' 48' ' ' VAL . 4.0 p -145.06 149.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.048 0.451 . . . . 0.0 111.796 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.405 ' N ' HG21 ' A' ' 68' ' ' VAL . 2.0 t -103.07 128.96 55.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -100.94 106.71 18.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.097 0.475 . . . . 0.0 111.198 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.449 ' CH2' ' HA ' ' A' ' 84' ' ' VAL . 5.5 m0 -109.72 103.51 53.31 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.188 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo . . . . . 0 N--CA 1.445 -1.338 0 C-N-CA 123.498 2.798 . . . . 0.0 113.028 -178.86 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.348 0.118 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.42 HG13 ' CZ2' ' A' ' 71' ' ' TRP . 35.4 t -55.38 -50.99 61.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.535 HG13 HD11 ' A' ' 120' ' ' LEU . 2.6 t -53.77 -43.4 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.307 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -56.34 -31.21 63.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.876 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.7 -50.4 62.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.651 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -65.14 -33.93 77.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.743 179.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.87 -46.89 84.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.723 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.83 -42.21 99.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.28 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.05 -51.46 69.97 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.757 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.43 HG22 ' CD1' ' A' ' 95' ' ' PHE . 11.2 p -69.7 -35.86 67.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.075 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -56.94 -45.02 83.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.319 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.04 91.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.497 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -24.1 61.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.229 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.43 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.1 m-85 -81.76 -51.86 7.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.793 0.33 . . . . 0.0 111.179 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.4 -40.51 97.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -76.07 -32.94 59.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.213 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.53 90.81 49.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.323 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.78 132.49 14.45 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.539 2.159 . . . . 0.0 112.375 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.5 56.3 25.81 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.584 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.447 ' CB ' HG22 ' A' ' 46' ' ' THR . 1.1 m -101.21 -164.77 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.816 0.341 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.634 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 m -117.88 113.54 21.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.43 ' CG1' ' CE1' ' A' ' 22' ' ' PHE . 38.5 t -110.03 149.73 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.148 0.499 . . . . 0.0 112.243 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.464 ' O ' ' CG1' ' A' ' 48' ' ' VAL . . . -119.11 143.29 47.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.946 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.584 HG11 ' CG2' ' A' ' 118' ' ' VAL . 92.7 t -139.98 166.16 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.511 ' N ' HG13 ' A' ' 105' ' ' VAL . 2.7 t60 -67.36 156.12 37.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.126 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 25' ' ' THR . 48.5 t -68.38 105.52 2.2 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.443 HG12 ' HD3' ' A' ' 115' ' ' PRO . 34.3 m -75.42 0.62 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.185 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.07 -8.55 2.45 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.29 -129.24 3.46 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.406 HD21 ' HA2' ' A' ' 142' ' ' GLY . 14.0 mt -127.9 127.42 43.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.59 -150.45 6.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.273 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.529 ' CD ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.47 -19.02 6.52 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.025 0.441 . . . . 0.0 111.775 -178.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.657 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.15 -46.39 97.79 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.1 Cg_endo -52.41 -48.15 23.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.179 1.919 . . . . 0.0 112.428 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.512 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 23.0 t -56.85 -52.04 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 110.341 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.418 ' HB3' ' NE1' ' A' ' 87' ' ' TRP . 8.0 mt -51.88 -48.79 63.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.889 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.584 ' CG2' HG11 ' A' ' 105' ' ' VAL . 17.4 t -54.01 -54.09 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.62 -42.79 64.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.039 0.447 . . . . 0.0 111.17 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.597 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 9.6 mt -64.12 -30.78 71.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.195 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.498 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -69.24 -38.25 78.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.211 0.529 . . . . 0.0 109.748 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.417 HD12 ' CE ' ' A' ' 20' ' ' MET . 6.0 tp -77.26 -15.97 59.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.204 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.636 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 1.7 mt -57.78 -31.74 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.816 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -16.53 63.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.0 m -83.81 11.04 8.13 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 118.08 -99.99 0.83 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.193 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.453 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.9 ptt? -62.48 76.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.52 -67.51 0.55 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -177.09 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 7.5 t80 -67.52 -32.46 73.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.926 0.393 . . . . 0.0 111.102 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -72.03 -52.1 18.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.152 179.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 29.5 t0 -68.7 -41.02 79.74 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.127 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -58.53 -49.03 78.89 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.288 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 133' ' ' ILE . 32.3 mm -72.25 -40.19 65.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.804 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 2.7 mp0 -74.35 -49.6 22.13 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.551 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -66.63 -37.25 84.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.711 0.291 . . . . 0.0 110.525 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.6 tt -74.17 -27.93 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 110.465 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -65.47 -46.28 80.4 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.629 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -45.07 93.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.61 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 136' ' ' ILE . 3.9 mmpt? -86.76 151.97 22.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.196 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.14 116.8 14.11 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.46 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.81 163.79 15.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.133 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.406 ' HA2' HD21 ' A' ' 111' ' ' LEU . . . -54.92 -171.08 0.07 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.86 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.78 100.17 12.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.24 0.52 . . . . 0.0 111.349 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.599 ' O ' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.63 109.73 19.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.825 178.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -113.62 -76.8 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.6 p -99.9 -60.87 1.45 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.786 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 9.7 tmtt? -63.09 -49.81 73.01 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.445 ' CB ' ' HB ' ' A' ' 144' ' ' ILE . 0.8 OUTLIER -55.87 -52.42 64.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.38 -40.53 57.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.8 m -70.72 -33.8 71.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.805 0.336 . . . . 0.0 111.475 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.786 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -70.48 -50.69 35.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.057 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.42 ' HB3' ' CE1' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -64.6 -31.42 72.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.638 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -61.81 -38.68 89.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -26.5 66.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.118 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.472 ' CE2' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.04 -41.49 90.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.936 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.349 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.67 0.271 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.99 164.81 34.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.566 2.177 . . . . 0.0 112.314 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.14 126.84 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.2 pp20? -114.16 129.56 56.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.034 0.445 . . . . 0.0 111.844 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -108.2 120.34 59.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.01 158.1 21.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.156 0.503 . . . . 0.0 111.977 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CE1' ' HE2' ' A' ' 127' ' ' MET . 9.7 t80 -150.06 107.48 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.528 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp 62.9 -83.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.165 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -129.3 14.11 6.12 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.411 ' SD ' ' CE2' ' A' ' 95' ' ' PHE . 24.2 ttp -110.6 162.02 15.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.683 0.278 . . . . 0.0 110.969 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.5 mtt180 -148.53 134.9 19.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.093 0.473 . . . . 0.0 111.623 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 3.6 m-85 -115.34 151.35 34.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.729 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.536 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -124.45 135.93 53.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.113 0.482 . . . . 0.0 111.424 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.441 HD12 ' CG1' ' A' ' 108' ' ' VAL . 15.9 mm -118.34 106.54 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 107' ' ' CYS . 2.2 p -129.84 163.47 26.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.358 0.599 . . . . 0.0 111.896 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.523 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.7 p80 -81.16 152.58 27.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.933 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -62.41 154.6 71.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.968 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.429 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.5 Cg_exo -54.27 138.21 72.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.396 2.064 . . . . 0.0 113.433 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.7 p -98.54 145.49 26.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.217 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -68.47 -12.26 60.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.56 -31.25 14.6 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.3 p -139.81 88.99 2.28 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.172 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.7 -52.3 7.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.175 0.512 . . . . 0.0 111.417 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.426 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 74.9 m -55.95 -45.64 78.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.59 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.2 m -57.65 -33.11 67.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.874 0.369 . . . . 0.0 111.314 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -74.52 -47.71 31.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.426 ' CG1' ' O ' ' A' ' 34' ' ' SER . 11.5 pt -55.81 -39.5 56.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.133 0.492 . . . . 0.0 110.63 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -65.12 -52.16 57.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.46 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.6 OUTLIER -67.68 -50.04 59.69 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 120.803 0.335 . . . . 0.0 111.831 -179.153 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.442 ' HG ' ' CD1' ' A' ' 36' ' ' PHE . 76.2 mt -54.95 -46.2 74.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.6 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -77.65 -26.82 50.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.05 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 5.9 mttt -52.4 -43.21 64.63 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.07 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.536 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 12.5 t80 -63.48 -38.49 91.36 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.585 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.678 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.96 -178.54 39.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.078 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.47 117.52 19.77 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.625 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 0.7 OUTLIER -165.2 -169.67 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.973 177.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 67' ' ' THR . 7.8 t -64.37 156.81 28.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.463 0.649 . . . . 0.0 110.51 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 66.5 t -136.78 134.29 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.135 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.611 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 13.1 p -115.66 105.07 17.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.393 0.616 . . . . 0.0 111.49 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -114.77 110.88 20.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.108 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.607 HG11 ' HD3' ' A' ' 113' ' ' ARG . 14.6 t -105.25 91.62 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.468 0.651 . . . . 0.0 109.736 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.63 171.55 20.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.851 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.39 129.97 41.58 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -77.33 122.66 32.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.9 p -119.87 -47.73 2.39 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.063 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.413 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -130.57 83.45 2.12 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.398 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -79.44 -36.84 38.26 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.73 -48.54 13.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.504 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -47.02 -55.39 15.46 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.504 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 64.0 Cg_endo -73.37 -42.79 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.261 1.974 . . . . 0.0 114.204 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.44 ' CD1' ' CG1' ' A' ' 68' ' ' VAL . 27.1 mt -71.66 -45.36 62.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -66.24 -32.1 73.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.68 0.276 . . . . 0.0 111.565 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.23 -30.67 34.14 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.12 -11.46 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 45.52 67.2 1.31 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.804 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.1 mt -136.36 147.69 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.624 0.25 . . . . 0.0 110.84 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' THR . 70.9 p -78.07 128.02 33.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 69' ' ' VAL . 8.3 p -145.23 151.73 14.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.091 0.472 . . . . 0.0 112.1 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.518 ' N ' HG23 ' A' ' 68' ' ' VAL . 2.3 t -103.52 130.69 53.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -101.1 106.85 18.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.04 0.448 . . . . 0.0 111.143 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.489 ' HZ2' ' O ' ' A' ' 83' ' ' VAL . 5.7 m0 -110.89 103.96 55.44 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.367 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 N--CA 1.446 -1.277 0 C-N-CA 123.258 2.639 . . . . 0.0 112.841 -179.251 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.578 0.228 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.489 ' O ' ' HZ2' ' A' ' 71' ' ' TRP . 15.2 m -55.12 -43.03 68.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.079 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.449 HG12 ' CE1' ' A' ' 151' ' ' TYR . 0.8 OUTLIER -53.49 -41.08 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -64.96 -31.38 72.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.324 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -66.48 -50.34 63.61 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.611 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -66.87 -30.34 70.48 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.439 HD11 ' CE2' ' A' ' 155' ' ' TYR . 18.2 mt -61.05 -46.71 89.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.339 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -64.05 -40.08 95.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.31 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.67 -51.34 70.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.725 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.439 HG22 ' CD1' ' A' ' 95' ' ' PHE . 14.4 p -71.07 -35.92 60.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.066 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.52 -46.85 76.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.46 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.89 -43.41 83.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.66 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -69.13 -25.71 64.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.439 ' CD1' HG22 ' A' ' 91' ' ' VAL . 1.7 m-85 -76.58 -52.02 10.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.948 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.2 t -59.67 -39.8 85.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.13 -33.08 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.126 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.09 88.23 54.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.304 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.95 128.15 12.09 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.536 2.158 . . . . 0.0 112.194 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.51 57.48 19.35 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.321 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.418 ' CB ' HG22 ' A' ' 46' ' ' THR . 1.5 t -101.03 -163.08 0.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.616 0.246 . . . . 0.0 111.123 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.678 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 m -115.44 113.26 23.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.337 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 25.7 t -110.42 150.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 112.016 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -121.58 142.0 50.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.188 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.607 HG13 ' H ' ' A' ' 106' ' ' HIS . 20.0 t -140.1 166.14 20.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.357 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.607 ' H ' HG13 ' A' ' 105' ' ' VAL . 3.3 t60 -67.17 155.37 38.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.95 0.405 . . . . 0.0 110.81 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.5 ' N ' ' O ' ' A' ' 25' ' ' THR . 34.4 t -69.27 110.33 4.57 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 140' ' ' ARG . 13.2 m -75.6 0.63 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.372 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.04 -8.66 2.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.35 -137.7 4.44 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.427 HD23 ' HA2' ' A' ' 142' ' ' GLY . 4.1 mt -111.49 127.13 55.6 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.69 -162.42 12.52 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 119.952 -1.118 . . . . 0.0 113.522 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.607 ' HD3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.38 -19.88 6.29 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.08 0.467 . . . . 0.0 111.735 -178.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.638 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.43 -46.42 98.06 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 8.0 Cg_endo -52.69 -48.51 21.6 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.948 1.766 . . . . 0.0 112.359 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.587 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 89.4 t -55.87 -53.34 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.444 HD12 ' CD2' ' A' ' 71' ' ' TRP . 10.6 mt -52.28 -45.57 65.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.692 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.469 HG11 ' CE1' ' A' ' 22' ' ' PHE . 13.8 t -51.42 -52.63 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 111.177 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 123' ' ' ILE . . . -54.99 -45.6 75.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.025 0.441 . . . . 0.0 110.436 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 116' ' ' VAL . 1.5 mt -55.16 -30.92 60.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.039 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.493 ' HB1' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.96 -49.19 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' A' ' 122' ' ' LEU . 22.5 tp -67.08 -14.02 62.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.805 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 120' ' ' LEU . 2.1 mt -57.74 -32.41 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.977 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -16.21 63.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.75 -23.45 42.23 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 151.2 -96.46 0.17 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.899 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.504 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.17 73.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -72.07 -67.8 0.51 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -176.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.436 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 5.3 t80 -66.14 -34.58 78.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.931 0.396 . . . . 0.0 111.227 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.27 -52.75 14.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.414 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 25.8 t70 -70.78 -32.65 69.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.716 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.549 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -60.42 -49.98 75.4 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.1 mm -71.04 -41.18 76.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.576 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.86 -50.37 17.28 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.566 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -66.1 -35.82 81.54 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.704 0.287 . . . . 0.0 110.55 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.3 tt -74.24 -40.47 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.677 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.0 ttt-85 -58.6 -36.61 74.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.177 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -59.52 -45.55 91.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.819 0.343 . . . . 0.0 110.747 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.78 151.28 23.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.61 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.466 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.73 116.71 14.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.842 0.353 . . . . 0.0 110.155 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.466 ' HD3' HG23 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -115.39 164.1 14.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.355 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.427 ' HA2' HD23 ' A' ' 111' ' ' LEU . . . -53.39 -172.8 0.05 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.586 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.18 9.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.62 0.71 . . . . 0.0 111.616 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.62 109.75 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.457 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.63 -76.55 0.59 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.67 -60.78 1.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.819 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.9 tmtt? -53.42 -51.74 61.64 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.79 -51.98 66.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.62 -41.31 62.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.9 m -69.74 -41.3 75.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.793 0.33 . . . . 0.0 111.265 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.819 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -62.84 -50.66 70.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.223 -179.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.489 ' CD2' ' CD1' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -67.19 -31.22 71.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.923 -179.401 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -39.56 90.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -23.1 55.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.91 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.515 ' CE2' HD12 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -66.4 -39.56 89.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.72 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.755 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.733 0.302 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.37 165.27 31.09 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.651 2.234 . . . . 0.0 112.345 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 t -130.32 126.69 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.795 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.424 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -103.81 122.67 45.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.536 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.501 ' CG1' ' CD2' ' A' ' 135' ' ' PHE . 2.3 t -106.82 134.17 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.317 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 p -132.17 133.63 44.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.171 0.51 . . . . 0.0 112.16 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CE2' ' HG3' ' A' ' 18' ' ' LYS . 41.2 t80 -155.13 141.98 19.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.371 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mmtt 61.97 -103.59 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.932 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -129.84 -1.62 4.75 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.442 ' CE ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -113.34 168.43 9.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.038 0.447 . . . . 0.0 111.478 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -125.9 164.2 21.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.009 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.431 ' CE1' HG11 ' A' ' 103' ' ' VAL . 1.5 m-85 -136.65 137.44 40.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.339 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.535 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -114.88 132.8 56.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.002 0.429 . . . . 0.0 111.134 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.436 HD12 ' HB ' ' A' ' 105' ' ' VAL . 1.2 mm -115.85 106.35 20.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -135.33 167.1 21.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 111.921 -178.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.425 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 3.0 t-80 -81.09 151.53 28.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.689 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -63.42 154.84 77.63 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.83 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.417 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.7 Cg_exo -54.57 140.11 75.59 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.222 1.948 . . . . 0.0 112.954 -178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.465 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 67.8 p -98.61 174.27 6.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -92.52 -13.06 30.35 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.57 -31.04 14.68 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 p -139.72 89.56 2.33 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.49 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.465 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.3 OUTLIER -80.4 -52.19 7.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.106 0.479 . . . . 0.0 111.31 178.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -55.97 -45.38 78.92 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.549 -178.637 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.7 -34.47 69.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.897 0.379 . . . . 0.0 111.354 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.438 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.17 -47.75 33.73 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' CG1' ' O ' ' A' ' 34' ' ' SER . 12.5 pt -55.54 -39.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.155 0.502 . . . . 0.0 110.605 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -65.43 -51.97 56.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.483 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 2.5 m-20 -68.35 -50.2 54.89 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.438 HD21 ' CE1' ' A' ' 36' ' ' PHE . 84.9 mt -55.69 -45.38 77.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.556 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -78.45 -26.63 46.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.102 0.477 . . . . 0.0 110.059 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.3 mttp -52.01 -43.98 63.91 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.283 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.535 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 20.2 t80 -63.31 -38.39 90.98 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.696 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.725 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 166.24 -178.83 40.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.928 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.17 19.23 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.602 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 0.6 OUTLIER -165.22 -169.38 1.62 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.853 177.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 67' ' ' THR . 2.9 t -64.33 143.07 58.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.692 0.758 . . . . 0.0 110.557 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 104' ' ' ALA . 25.4 t -122.23 132.12 71.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.113 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.629 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 9.8 p -115.47 105.25 18.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.181 0.515 . . . . 0.0 111.175 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 110.93 20.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.906 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.476 HG11 ' NE ' ' A' ' 113' ' ' ARG . 44.0 t -103.98 91.74 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.556 0.693 . . . . 0.0 110.493 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.6 t -157.79 171.19 20.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.733 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.74 130.2 42.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -72.36 122.0 23.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 p -120.57 -47.71 2.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.046 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.411 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -130.75 84.24 2.18 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.503 179.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -78.77 -36.51 42.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -79.5 -48.59 13.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.402 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.5 -49.7 24.91 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.411 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 9.6 Cg_exo -72.97 -42.46 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.702 2.268 . . . . 0.0 113.731 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -71.39 -45.21 63.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -70.54 -28.9 65.28 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.02 -34.72 32.65 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' CB ' HG12 ' A' ' 66' ' ' ILE . 44.0 m-20 -101.54 -11.37 19.33 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.56 41.56 49.69 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.423 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.463 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 1.1 pt -118.77 148.71 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 122.313 0.245 . . . . 0.0 111.047 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 47' ' ' THR . 21.9 p -77.39 135.03 38.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 69' ' ' VAL . 7.4 p -144.98 149.68 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.073 0.463 . . . . 0.0 112.054 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.472 ' N ' HG23 ' A' ' 68' ' ' VAL . 2.2 t -103.31 131.04 52.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.11 106.55 17.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 111.021 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.453 ' CH2' ' HA ' ' A' ' 84' ' ' VAL . 4.9 m95 -110.53 103.47 54.28 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.199 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 N--CA 1.444 -1.387 0 C-N-CA 123.469 2.779 . . . . 0.0 113.042 -178.73 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.428 0.156 . . . . 0.0 110.93 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.404 HG13 ' CZ2' ' A' ' 71' ' ' TRP . 55.3 t -55.36 -47.98 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.453 ' HA ' ' CH2' ' A' ' 71' ' ' TRP . 88.0 t -56.13 -39.8 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.05 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 2.8 mt-10 -58.21 -31.25 67.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.481 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.87 -50.25 67.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.988 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.629 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.04 -26.79 66.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.402 ' CD2' ' HB3' ' A' ' 120' ' ' LEU . 25.9 mt -62.79 -41.44 99.26 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.159 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 t -67.78 -41.72 82.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.026 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -58.98 -51.23 70.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.779 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.459 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 7.8 p -71.81 -41.06 69.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.261 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -55.34 -38.49 68.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.936 0.398 . . . . 0.0 110.706 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.04 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.763 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -29.58 67.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.145 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.459 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 3.3 m-85 -76.78 -52.06 10.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.032 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.3 t -59.8 -36.95 77.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -31.87 59.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.06 94.4 41.59 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.287 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.13 129.09 16.61 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.425 2.083 . . . . 0.0 112.219 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.95 59.46 10.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.292 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.433 ' CB ' HG23 ' A' ' 46' ' ' THR . 83.5 p -101.2 -170.09 1.79 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.927 0.394 . . . . 0.0 111.442 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.725 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.6 m -113.03 113.61 25.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.308 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 76.0 t -104.23 149.98 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.483 ' HB2' ' CG2' ' A' ' 48' ' ' VAL . . . -122.52 140.58 52.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.787 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 49' ' ' VAL . 2.2 t -140.6 166.74 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 2.4 t60 -67.49 156.14 37.35 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.651 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.576 ' N ' ' O ' ' A' ' 25' ' ' THR . 50.4 t -68.41 102.44 1.42 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.381 0.61 . . . . 0.0 112.287 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.432 ' O ' HG21 ' A' ' 108' ' ' VAL . 7.1 p -75.27 -0.02 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.025 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.81 -8.68 3.21 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.424 ' O ' HD21 ' A' ' 111' ' ' LEU . . . -122.3 -134.06 4.39 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 22.3 mt -125.29 127.58 46.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.2 -143.19 3.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.993 -1.099 . . . . 0.0 113.597 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.476 ' NE ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.13 -19.37 6.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.968 0.413 . . . . 0.0 111.794 -178.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.656 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.62 -46.46 85.68 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.0 Cg_endo -51.98 -48.39 21.84 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.46 2.107 . . . . 0.0 112.869 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 120' ' ' LEU . 22.1 t -61.73 -38.51 80.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.932 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.431 HD23 ' CZ3' ' A' ' 71' ' ' TRP . 6.8 mt -64.61 -49.1 72.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.527 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.425 HG13 ' CD1' ' A' ' 22' ' ' PHE . 12.5 t -54.59 -55.4 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.4 78.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.214 0.531 . . . . 0.0 111.091 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.602 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 1.2 mm? -53.92 -30.66 47.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.532 ' HB3' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.24 -47.66 55.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.04 0.447 . . . . 0.0 110.085 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.442 ' CD1' ' CE ' ' A' ' 20' ' ' MET . 14.4 tp -61.58 -16.99 53.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.746 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.9 mt -57.08 -30.81 35.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.494 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.402 ' OE2' ' CG ' ' A' ' 95' ' ' PHE . 3.3 pt-20 -68.14 -17.29 64.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.557 0.218 . . . . 0.0 111.456 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.7 t -84.75 11.04 9.83 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 104.02 -81.69 0.35 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.873 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 51.8 ttp -63.16 66.47 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.665 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -74.63 -67.91 0.59 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -176.239 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.446 ' CD1' HD21 ' A' ' 152' ' ' LEU . 5.1 t80 -71.59 -31.54 67.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.057 0.456 . . . . 0.0 110.806 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -72.53 -47.32 49.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.311 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 10.8 t0 -70.09 -43.77 70.44 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 110.836 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.51 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -58.36 -50.04 75.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.879 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 133' ' ' ILE . 35.0 mm -71.65 -42.38 71.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.904 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -49.33 27.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -68.62 -39.66 80.7 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.189 -0.204 . . . . 0.0 111.016 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.7 OUTLIER -72.62 -27.79 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.318 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -47.18 79.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.949 0.404 . . . . 0.0 110.034 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -45.13 93.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.667 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -86.5 152.54 22.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.346 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.83 117.07 14.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.004 0.43 . . . . 0.0 110.299 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.406 ' HA ' ' CG2' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -114.82 163.29 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.158 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.426 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -58.06 172.47 3.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.197 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.23 99.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.528 0.664 . . . . 0.0 110.447 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.414 ' CG2' ' HG3' ' A' ' 148' ' ' GLN . 2.2 pt -88.31 109.06 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.098 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -113.55 -76.88 0.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.562 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.06 -60.61 1.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.631 ' O ' ' CB ' ' A' ' 151' ' ' TYR . 0.8 OUTLIER -54.76 -51.93 64.14 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.295 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.414 ' HG3' ' CG2' ' A' ' 144' ' ' ILE . 1.1 tm0? -56.35 -51.87 66.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 149' ' ' LEU . 3.4 mm? -75.22 -47.46 28.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.7 m -64.96 -34.82 79.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.733 0.301 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.631 ' CB ' ' O ' ' A' ' 147' ' ' LYS . 6.9 t80 -68.2 -50.95 50.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.281 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.447 ' CD2' ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -72.01 -32.76 67.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.525 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.59 -37.7 79.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -28.24 62.4 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.642 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.521 ' CD2' HD12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -65.88 -34.34 77.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.679 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.763 0.316 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.29 163.43 39.15 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.526 2.151 . . . . 0.0 112.297 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.05 126.83 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -108.5 126.25 52.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.523 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.513 ' CG1' ' CE2' ' A' ' 135' ' ' PHE . 2.4 t -106.65 129.79 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 p -132.87 139.25 47.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.222 0.534 . . . . 0.0 112.136 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.44 ' CZ ' ' HG3' ' A' ' 18' ' ' LYS . 10.8 t80 -155.12 129.17 8.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.104 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 2.0 mmmp? 63.46 -92.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.198 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.42 -39.06 1.52 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.77 151.66 40.56 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 111.273 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.62 164.24 21.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.067 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 103' ' ' VAL . 2.0 m-85 -136.76 139.16 41.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.646 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -117.77 138.5 52.01 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.118 0.485 . . . . 0.0 111.343 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.518 HG22 ' HA ' ' A' ' 107' ' ' CYS . 2.6 mm -118.22 106.64 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.211 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -131.05 164.29 25.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.476 0.655 . . . . 0.0 112.451 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.532 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.8 p80 -81.74 152.55 26.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.248 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -62.48 154.44 72.75 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.495 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.2 Cg_exo -54.85 139.03 78.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.391 2.061 . . . . 0.0 113.601 -177.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.7 p -98.97 145.94 26.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.977 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -71.3 -10.12 59.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.83 14.74 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 p -139.59 89.43 2.32 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.382 -0.527 . . . . 0.0 112.244 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.38 -52.25 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.177 0.513 . . . . 0.0 111.23 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.434 ' HA ' HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -56.7 -45.19 81.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.321 -178.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.5 m -57.69 -31.91 66.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.532 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -75.22 -47.56 27.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.142 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 34' ' ' SER . 11.3 pt -55.44 -38.39 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.227 0.537 . . . . 0.0 110.334 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.43 -51.75 58.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.374 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.507 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.2 m-20 -68.8 -50.29 51.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.918 0.389 . . . . 0.0 111.953 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.455 ' HG ' ' CD1' ' A' ' 36' ' ' PHE . 83.6 mt -56.89 -44.45 82.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.993 0.425 . . . . 0.0 110.303 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -77.19 -26.65 53.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.886 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 2.1 mtmt -52.79 -47.52 67.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.306 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.549 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 11.6 t80 -63.63 -38.5 91.37 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.656 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.655 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 160.03 -177.44 36.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.041 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.62 122.93 28.34 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.579 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 3.8 m -164.52 -171.2 2.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.46 177.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.485 ' H ' ' CG2' ' A' ' 46' ' ' THR . 1.8 t -65.33 149.63 49.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.329 0.585 . . . . 0.0 109.862 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 74.4 t -126.64 135.18 64.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.882 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.624 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 9.3 p -115.46 104.91 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.111 0.482 . . . . 0.0 111.27 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.414 ' CD ' HG23 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -114.74 111.01 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.399 178.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.593 HG11 ' CD ' ' A' ' 113' ' ' ARG . 8.1 t -103.71 90.39 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.451 0.643 . . . . 0.0 109.303 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -158.63 171.87 19.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.953 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -65.06 130.62 44.02 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 m -81.07 122.32 36.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.6 p -120.15 -47.52 2.37 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.663 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.419 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -130.33 83.86 2.16 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -79.4 -36.6 38.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.65 -48.58 13.48 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.435 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.22 -56.65 10.21 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 65.4 Cg_endo -73.17 -42.35 1.0 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.493 2.129 . . . . 0.0 114.182 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.462 ' CD1' ' CG1' ' A' ' 68' ' ' VAL . 28.9 mt -71.19 -45.21 63.89 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.3 -30.83 70.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.817 0.341 . . . . 0.0 111.422 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -81.37 -32.67 32.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 66' ' ' ILE . 18.1 p30 -101.23 -11.35 19.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 61' ' ' LEU . . . 48.11 31.29 8.25 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.284 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 64' ' ' ASP . 5.6 mt -97.42 147.53 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.679 0.276 . . . . 0.0 110.974 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 47' ' ' THR . 50.1 p -78.41 131.14 36.82 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 69' ' ' VAL . 9.1 p -145.36 152.24 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.494 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.3 t -103.63 132.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -100.57 106.79 18.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 109.947 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.459 ' CH2' ' HA ' ' A' ' 84' ' ' VAL . 3.4 m95 -111.72 104.07 55.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.677 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 N--CA 1.447 -1.216 0 C-N-CA 123.573 2.849 . . . . 0.0 112.344 -179.909 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.561 0.22 . . . . 0.0 110.763 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.415 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 41.4 t -56.79 -48.3 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.459 ' HA ' ' CH2' ' A' ' 71' ' ' TRP . 90.3 t -55.34 -37.47 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.986 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 1.8 mt-10 -60.42 -31.32 70.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.429 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.91 -50.17 69.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.245 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.624 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.56 -27.42 67.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.49 -38.16 90.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.095 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -69.03 -41.42 77.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.803 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -59.53 -51.32 70.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.381 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.466 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 8.5 p -71.74 -35.9 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.909 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -56.23 -47.19 78.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.502 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.31 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.636 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -68.0 -24.28 65.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.077 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.466 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 2.4 m-85 -82.09 -52.04 7.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.167 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.3 t -63.93 -39.87 95.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.992 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.11 -31.72 58.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.226 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.15 89.1 52.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.52 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.64 135.07 14.19 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.594 2.196 . . . . 0.0 112.236 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.95 46.23 89.94 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.468 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 t -101.04 -176.59 3.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.66 0.267 . . . . 0.0 111.118 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.655 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 2.2 m -111.98 114.05 26.71 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 28.0 t -101.94 151.28 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -122.05 141.74 51.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.146 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.482 HG12 ' CG2' ' A' ' 118' ' ' VAL . 2.5 t -140.68 166.95 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 2.3 t60 -67.38 156.51 36.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.639 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.518 ' HA ' HG22 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -68.01 98.79 0.79 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.375 0.607 . . . . 0.0 112.469 -178.042 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.457 ' O ' HG21 ' A' ' 108' ' ' VAL . 7.5 p -75.41 -0.08 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.96 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.66 -8.76 3.13 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.03 -124.71 2.96 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.429 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 13.1 mt -129.11 127.39 41.36 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.86 -144.41 4.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.807 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.593 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.14 -20.56 6.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.033 0.444 . . . . 0.0 111.931 -178.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.671 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -52.11 -44.94 93.63 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 6.4 Cg_endo -51.62 -48.3 22.05 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.524 2.149 . . . . 0.0 113.165 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.42 ' O ' HD23 ' A' ' 120' ' ' LEU . 62.1 t -62.48 -46.45 96.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.02 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.429 HD13 ' CG2' ' A' ' 51' ' ' VAL . 13.4 mt -58.85 -41.89 88.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.973 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.482 ' CG2' HG12 ' A' ' 105' ' ' VAL . 54.0 t -61.63 -55.44 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.609 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.09 -52.51 65.24 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.157 0.504 . . . . 0.0 111.032 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.622 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 4.3 mm? -53.82 -30.82 46.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.668 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.482 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.26 -42.38 65.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.078 0.466 . . . . 0.0 110.115 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.4 tp -67.51 -14.04 62.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 120' ' ' LEU . 2.4 mt -57.25 -30.77 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.031 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.28 -16.87 63.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.6 m -83.93 11.2 8.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.19 -101.58 1.06 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.211 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.455 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.7 ptt? -62.49 77.78 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.65 -67.59 0.54 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.473 ' CD1' HD21 ' A' ' 152' ' ' LEU . 4.1 t80 -66.26 -33.77 76.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.926 0.393 . . . . 0.0 111.187 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.26 -51.67 19.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.294 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 30.0 t0 -70.03 -36.25 74.92 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.841 0.353 . . . . 0.0 111.029 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.537 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -61.31 -50.16 74.09 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.654 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.411 HG21 HD12 ' A' ' 133' ' ' ILE . 27.9 mm -74.31 -37.61 45.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.531 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -74.24 -49.68 22.27 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -69.24 -35.84 76.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.473 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.3 tt -74.0 -27.91 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 0.0 110.227 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -65.14 -52.31 55.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.539 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.86 -45.17 93.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.633 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 136' ' ' ILE . 7.3 mmtt -81.54 152.22 27.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.253 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.83 117.21 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.344 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.411 ' HA ' ' CG2' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -114.64 163.39 15.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.12 -179.649 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -60.15 -163.35 0.14 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.276 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.1 99.28 12.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.427 0.614 . . . . 0.0 110.633 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 144' ' ' ILE . 6.8 pt -88.35 109.26 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.119 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.67 -76.98 0.58 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.605 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.23 -60.69 1.48 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.6 tmtt? -57.35 -51.89 67.59 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.42 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -56.14 -52.09 65.61 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.412 ' CD2' ' N ' ' A' ' 149' ' ' LEU . 3.4 mm? -75.27 -45.55 39.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 56.3 m -66.44 -33.47 75.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.807 0.336 . . . . 0.0 111.147 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.61 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 2.2 t80 -68.68 -50.93 47.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.473 HD21 ' CD1' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -70.25 -34.26 72.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.407 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -36.44 76.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -26.26 60.55 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.71 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.464 ' CD2' HD12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -65.93 -37.58 86.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.451 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.614 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.81 0.338 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.83 163.67 37.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.577 2.185 . . . . 0.0 112.306 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.4 t -144.26 129.26 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.964 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -111.34 116.6 31.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.868 0.366 . . . . 0.0 111.269 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.438 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -109.05 118.29 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.41 ' CB ' ' HA ' ' A' ' 21' ' ' ARG . 70.3 p -141.24 142.46 33.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HG2' ' A' ' 18' ' ' LYS . 1.2 p90 -136.61 164.48 28.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.413 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.576 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 pttp 50.09 -95.99 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.202 0.201 . . . . 0.0 110.973 -177.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.488 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 t-160 -128.92 -32.36 2.09 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.494 ' HE2' ' CD1' ' A' ' 22' ' ' PHE . 3.8 ppp? -73.65 168.05 20.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.645 0.259 . . . . 0.0 111.329 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.41 ' HA ' ' CB ' ' A' ' 16' ' ' SER . 3.4 mtp180 -146.05 161.54 39.9 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.012 0.434 . . . . 0.0 111.752 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CD1' ' HE2' ' A' ' 20' ' ' MET . 0.9 OUTLIER -135.05 148.78 49.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.555 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.548 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -120.28 135.96 54.83 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.106 0.479 . . . . 0.0 111.206 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 107' ' ' CYS . 2.2 mm -117.98 106.66 20.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.25 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 107' ' ' CYS . 1.3 p -132.62 164.44 26.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.197 0.523 . . . . 0.0 111.819 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.463 ' CD2' ' CZ ' ' A' ' 36' ' ' PHE . 45.4 p-80 -81.31 152.17 27.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.738 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -62.71 154.42 74.65 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.485 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.9 Cg_exo -54.61 140.58 75.86 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.296 1.997 . . . . 0.0 113.2 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.462 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.5 p -98.69 174.38 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.129 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -94.26 -11.4 30.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.66 -30.75 14.76 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.0 p -139.5 89.61 2.34 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.45 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.462 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.27 -52.22 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.19 0.519 . . . . 0.0 111.173 178.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.8 p -56.86 -45.05 82.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.308 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.1 m -57.92 -32.82 68.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.828 0.347 . . . . 0.0 111.288 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.485 ' CD2' ' HA ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -74.8 -47.92 28.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.146 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 34' ' ' SER . 12.1 pt -55.7 -38.93 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.233 0.54 . . . . 0.0 110.655 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -51.9 57.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.46 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -68.7 -50.29 52.07 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.437 HD21 ' CE1' ' A' ' 36' ' ' PHE . 72.4 mt -56.47 -43.64 79.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.437 . . . . 0.0 110.392 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -78.6 -26.73 45.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.077 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 3.7 mttt -53.25 -44.6 68.28 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.374 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.548 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 16.5 t80 -63.52 -38.56 91.6 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.949 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.641 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.32 -178.47 39.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.951 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.64 117.67 19.84 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.605 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 0.8 OUTLIER -164.88 -170.16 1.89 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.966 177.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 67' ' ' THR . 16.8 p -64.94 155.11 35.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.474 0.654 . . . . 0.0 110.788 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 65.6 t -134.0 139.1 49.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.04 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.61 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 3.3 p -115.77 105.37 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.164 0.507 . . . . 0.0 110.936 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.23 110.92 20.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.22 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.555 HG13 ' HD3' ' A' ' 113' ' ' ARG . 10.8 t -105.62 91.38 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.331 0.586 . . . . 0.0 109.914 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 10.4 p -158.01 171.28 20.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.948 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.64 130.48 43.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.59 121.75 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 p -120.77 -47.63 2.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.212 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.426 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.7 m-85 -130.43 84.29 2.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.488 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -78.61 -36.24 44.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -79.1 -48.49 14.24 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.411 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.56 -49.88 24.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.426 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 17.2 Cg_exo -68.08 -42.1 6.5 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.574 2.183 . . . . 0.0 113.427 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.414 ' CD2' ' CG1' ' A' ' 68' ' ' VAL . 1.4 mm? -66.19 -45.43 80.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.61 -41.08 55.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -80.92 -27.51 36.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.439 ' HB3' ' CG1' ' A' ' 66' ' ' ILE . 2.7 t0 -101.15 -11.49 19.53 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.45 29.5 1.16 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.522 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.439 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 2.4 pt -117.56 148.06 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.714 0.293 . . . . 0.0 110.982 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 47' ' ' THR . 24.6 p -77.77 135.15 37.96 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 69' ' ' VAL . 9.4 p -143.87 154.91 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.491 ' N ' HG23 ' A' ' 68' ' ' VAL . 3.3 t -103.46 134.18 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -100.82 106.77 18.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.241 0.544 . . . . 0.0 110.319 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.1 m95 -111.96 104.35 55.97 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.091 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.446 -1.292 0 C-N-CA 123.225 2.617 . . . . 0.0 112.275 -179.725 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.392 0.139 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.414 ' HB ' ' CH2' ' A' ' 71' ' ' TRP . 0.0 OUTLIER -55.01 -46.86 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.847 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.475 HG12 ' HG ' ' A' ' 120' ' ' LEU . 79.7 t -55.02 -43.13 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.268 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.27 -31.28 63.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.802 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.94 -50.54 62.02 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.61 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.63 -26.96 65.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.411 ' CD2' ' HB3' ' A' ' 120' ' ' LEU . 18.8 mt -61.34 -50.98 70.74 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.117 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 m -60.53 -41.09 93.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.12 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -56.84 -51.12 70.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.725 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.467 ' CG2' ' CZ ' ' A' ' 95' ' ' PHE . 11.3 p -70.67 -36.66 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.383 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 3.2 tmtt? -64.87 -41.37 95.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 110.71 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.07 -48.07 77.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.36 -26.79 62.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.467 ' CZ ' ' CG2' ' A' ' 91' ' ' VAL . 3.6 m-30 -82.01 -33.91 29.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.885 0.374 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 16.0 t -72.24 -39.44 68.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.067 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -76.16 -33.07 59.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.535 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.56 137.33 26.89 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.679 0.276 . . . . 0.0 111.486 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.58 -166.75 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.547 2.165 . . . . 0.0 112.046 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -46.76 96.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.727 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.437 ' HB3' HG21 ' A' ' 46' ' ' THR . 0.2 OUTLIER -101.1 -160.72 0.81 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.726 0.298 . . . . 0.0 111.017 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.641 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -116.09 113.48 23.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.86 0.362 . . . . 0.0 111.266 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 25.1 t -106.84 151.18 8.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.229 0.538 . . . . 0.0 112.147 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -123.17 139.87 53.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.986 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 49' ' ' VAL . 5.4 t -140.09 166.8 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.458 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 1.7 t60 -66.9 156.1 36.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.391 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.553 ' HA ' HG21 ' A' ' 24' ' ' ILE . 25.5 t -68.3 105.61 2.2 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.433 ' CG1' HD12 ' A' ' 24' ' ' ILE . 35.2 m -75.47 0.25 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.099 178.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.66 -8.77 3.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.53 -135.81 4.39 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.401 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 12.8 mt -120.51 127.29 52.05 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.2 -144.03 3.93 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.822 -1.18 . . . . 0.0 113.671 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.555 ' HD3' HG13 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.19 -25.63 4.84 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.925 0.393 . . . . 0.0 112.005 -178.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.642 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.94 -46.36 87.71 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.1 Cg_endo -52.26 -48.44 21.73 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.29 1.993 . . . . 0.0 112.964 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.401 ' CG1' HD21 ' A' ' 120' ' ' LEU . 59.6 t -61.01 -46.74 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.097 0.475 . . . . 0.0 110.105 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.431 HD11 ' CE3' ' A' ' 71' ' ' TRP . 14.4 mt -59.37 -40.2 85.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.743 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.463 ' CG2' HG11 ' A' ' 105' ' ' VAL . 47.9 t -59.96 -55.65 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.613 0.244 . . . . 0.0 111.629 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.7 -47.13 83.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.609 0.719 . . . . 0.0 110.23 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.606 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 4.5 mm? -54.52 -30.26 53.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.667 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.469 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -70.32 -47.47 60.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 110.164 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.435 ' CD1' ' HE2' ' A' ' 20' ' ' MET . 3.7 mp -63.61 -16.01 59.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.698 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.3 mt -57.06 -30.92 35.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.401 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 2.4 pt-20 -73.58 -16.58 61.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.405 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.3 m -85.18 11.03 10.68 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 117.51 -102.65 1.01 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.182 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.495 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 3.6 ptt? -62.42 79.56 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.85 -67.77 0.54 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -176.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.411 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 6.3 t80 -66.81 -32.03 73.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.0 111.054 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.46 -52.05 17.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 29.9 t0 -69.24 -36.21 76.93 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.546 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -61.25 -50.26 73.76 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.812 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.4 mm -74.35 -37.62 45.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.551 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -74.07 -49.71 22.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -70.07 -34.98 73.88 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.666 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.546 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.19 -27.86 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.327 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.18 -48.19 68.7 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.52 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.79 -45.23 92.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.594 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' ILE . 73.7 mmtt -85.51 152.01 23.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.114 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.23 116.81 14.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.055 0.455 . . . . 0.0 110.62 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.12 163.57 15.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.86 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.401 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -57.57 -169.16 0.14 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.496 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.51 99.63 11.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.391 0.596 . . . . 0.0 110.762 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.429 HG23 ' HG3' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -88.05 109.4 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.989 179.189 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -113.16 -76.32 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.4 t -99.75 -60.51 1.52 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.879 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.0 OUTLIER -57.65 -52.65 64.57 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.429 ' HG3' HG23 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -56.88 -51.68 68.12 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.05 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.26 -42.55 62.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.2 m -71.76 -40.76 69.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.785 0.326 . . . . 0.0 111.486 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.879 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -63.75 -50.29 69.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.409 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.45 ' CD2' HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -67.5 -34.07 76.38 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.645 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -55.95 -44.96 78.93 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -27.97 63.63 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.728 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.502 ' CD2' HD12 ' A' ' 123' ' ' ILE . 0.9 OUTLIER -66.73 -25.98 66.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.891 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.673 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.673 0.273 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.02 163.55 38.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.613 2.209 . . . . 0.0 112.344 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -144.09 126.84 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.9 pt-20 -102.93 118.5 36.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.364 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.501 ' CG1' ' CD2' ' A' ' 135' ' ' PHE . 18.4 t -106.74 118.53 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.814 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 p -141.24 149.3 41.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.889 0.376 . . . . 0.0 111.957 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.497 ' CD2' ' HE1' ' A' ' 127' ' ' MET . 0.0 OUTLIER -149.57 120.22 7.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.157 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 40.4 mmtt 84.4 -87.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.262 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -129.41 -38.51 1.55 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.417 ' CE ' HD13 ' A' ' 122' ' ' LEU . 4.8 ppp? -73.54 163.8 27.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 111.473 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -145.67 164.05 32.95 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.067 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' CE1' ' CG1' ' A' ' 103' ' ' VAL . 3.0 m-85 -135.67 155.37 50.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.38 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.524 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -125.27 124.75 42.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.315 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.569 HG23 ' HA ' ' A' ' 107' ' ' CYS . 2.0 mm -106.37 106.85 21.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.9 OUTLIER -130.71 165.66 22.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.463 0.649 . . . . 0.0 112.546 -178.407 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.528 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 12.0 p80 -81.61 152.64 27.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.907 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.3 154.35 71.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.4 Cg_exo -54.96 138.36 77.92 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.482 2.121 . . . . 0.0 113.527 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.0 p -98.85 139.57 34.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.929 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -65.65 -10.27 34.57 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.49 -31.14 14.69 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.4 p -139.85 89.04 2.28 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.238 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.75 -52.2 7.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.005 0.431 . . . . 0.0 111.485 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.559 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -55.92 -38.68 70.6 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.187 -178.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -33.71 76.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.913 0.387 . . . . 0.0 111.035 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -76.12 -48.03 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.205 -179.16 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 34' ' ' SER . 0.7 OUTLIER -57.36 -37.18 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.092 0.473 . . . . 0.0 110.458 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -52.14 51.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.189 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.2 m-20 -67.94 -50.06 58.15 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.811 0.339 . . . . 0.0 111.688 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.432 HD22 ' CE1' ' A' ' 36' ' ' PHE . 31.9 mt -56.17 -39.52 72.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.013 0.435 . . . . 0.0 110.418 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -26.74 34.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.085 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -55.11 -43.0 73.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.181 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.524 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 13.5 t80 -63.58 -38.42 91.04 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.621 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.679 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.69 -178.52 39.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.912 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.57 117.93 20.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.596 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.4 m -164.71 -170.66 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.045 177.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 67' ' ' THR . 4.6 t -65.18 158.7 25.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.338 0.59 . . . . 0.0 110.718 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 63.1 t -136.39 136.55 48.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.927 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.654 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 14.8 p -115.87 104.73 17.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.364 0.602 . . . . 0.0 111.288 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -114.58 110.94 20.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.046 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.534 HG11 ' HD3' ' A' ' 113' ' ' ARG . 15.5 t -107.18 91.46 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 121.29 0.567 . . . . 0.0 109.798 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 m -157.81 171.28 20.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.865 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.406 ' CD ' ' N ' ' A' ' 53' ' ' GLU . 2.2 mm-40 -65.26 130.51 43.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.4 t -76.01 122.27 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -120.2 -47.69 2.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.309 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.6 83.54 2.13 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.522 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.43 -36.74 38.47 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -48.54 13.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -45.84 -54.14 17.63 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 8.3 Cg_exo -73.11 -41.97 1.14 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.645 2.23 . . . . 0.0 113.575 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.423 HD22 HG11 ' A' ' 68' ' ' VAL . 1.3 mm? -63.68 -45.34 90.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -75.27 -28.65 59.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -76.41 -37.78 56.58 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -101.74 -11.98 18.71 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.88 24.75 6.53 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.017 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.2 mt -94.47 147.68 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.638 0.256 . . . . 0.0 110.975 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 47' ' ' THR . 23.0 p -78.21 129.21 34.83 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 69' ' ' VAL . 8.5 p -145.08 153.04 14.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 111.977 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.483 ' N ' HG23 ' A' ' 68' ' ' VAL . 2.3 t -103.56 131.36 52.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.09 106.85 18.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.147 0.499 . . . . 0.0 110.849 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.458 ' HZ2' ' O ' ' A' ' 83' ' ' VAL . 4.9 m95 -110.74 103.83 55.11 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.445 -1.339 0 C-N-CA 123.395 2.73 . . . . 0.0 112.605 -179.396 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 tttt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.599 0.238 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.458 ' O ' ' HZ2' ' A' ' 71' ' ' TRP . 14.9 t -55.19 -42.93 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.506 HG13 ' CZ ' ' A' ' 151' ' ' TYR . 0.4 OUTLIER -53.24 -42.31 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.301 178.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 84' ' ' VAL . 22.2 mm-40 -62.8 -31.47 72.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.164 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.39 -50.6 69.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.63 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.654 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -66.42 -28.87 68.96 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.872 179.249 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.496 HD13 ' CE2' ' A' ' 155' ' ' TYR . 33.0 mt -62.68 -44.0 97.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.641 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.1 m -66.52 -38.35 86.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.392 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -61.9 -51.47 68.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.988 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.427 HG21 ' CD1' ' A' ' 95' ' ' PHE . 14.3 p -74.36 -37.69 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.353 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -44.21 89.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.387 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.78 -43.77 78.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.523 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -69.93 -23.91 63.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 91' ' ' VAL . 2.1 m-85 -81.76 -52.07 7.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.068 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.5 t -59.51 -37.6 78.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.94 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.99 -33.09 59.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.97 93.2 44.39 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.36 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.89 133.95 20.86 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.504 2.136 . . . . 0.0 112.251 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 59.35 10.97 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.432 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.422 ' CB ' HG22 ' A' ' 46' ' ' THR . 4.4 m -101.1 -163.7 1.04 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.679 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -121.01 113.56 20.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.251 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.457 ' CG1' ' CE1' ' A' ' 22' ' ' PHE . 44.6 t -105.97 150.23 8.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -122.22 135.14 54.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.361 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 24' ' ' ILE . 34.0 m -140.68 167.81 17.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 1.5 t60 -66.87 155.75 37.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.115 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.569 ' HA ' HG23 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -68.46 109.11 3.54 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.396 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.443 ' CG1' HD12 ' A' ' 24' ' ' ILE . 18.7 m -75.79 0.26 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.2 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.48 -8.58 2.84 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.78 -143.37 5.69 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.403 HD21 ' HA2' ' A' ' 142' ' ' GLY . 7.1 mt -115.05 127.27 55.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.99 -144.85 4.23 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.981 -1.104 . . . . 0.0 113.408 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.534 ' HD3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.4 -17.11 7.15 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.646 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -55.18 -47.03 99.51 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.6 Cg_endo -52.49 -48.19 23.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.31 2.006 . . . . 0.0 112.773 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 22.0 t -60.06 -54.15 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.702 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.478 ' HA ' HD12 ' A' ' 120' ' ' LEU . 2.4 mt -52.26 -51.23 59.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.969 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.443 HG11 ' CE1' ' A' ' 22' ' ' PHE . 21.9 t -52.08 -55.19 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.19 -50.18 65.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.333 0.587 . . . . 0.0 111.053 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.597 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 13.5 mt -54.38 -30.55 52.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.977 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.49 ' HB3' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.94 -39.79 69.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.034 0.445 . . . . 0.0 110.004 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.417 HD13 ' CE ' ' A' ' 20' ' ' MET . 3.4 tp -69.45 -15.54 63.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.636 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.597 ' HB ' ' O ' ' A' ' 120' ' ' LEU . 2.4 mt -57.12 -30.6 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.886 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -17.0 64.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.403 ' HB2' HD11 ' A' ' 122' ' ' LEU . 45.0 m -79.79 -23.41 42.17 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.11 -95.79 0.17 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.749 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.497 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 2.7 ptt? -63.84 71.85 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -66.37 -67.52 0.44 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 8.0 t80 -65.69 -33.24 75.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.948 0.404 . . . . 0.0 111.068 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.52 -52.34 16.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.219 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.2 t0 -69.99 -35.91 74.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.857 0.36 . . . . 0.0 110.864 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.54 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -61.36 -50.04 74.5 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.605 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.53 -37.32 43.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.49 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -49.87 21.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.59 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -68.76 -36.96 79.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.668 0.27 . . . . 0.0 110.485 -179.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.6 tt -74.18 -27.85 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.488 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -66.63 -45.79 77.89 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.465 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -45.01 93.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 110.434 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 136' ' ' ILE . 6.2 mptt -86.18 152.12 23.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.107 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 116.57 13.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.11 0.481 . . . . 0.0 110.531 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.13 163.82 15.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.135 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.403 ' HA2' HD21 ' A' ' 111' ' ' LEU . . . -55.64 -170.4 0.09 OUTLIER Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.689 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.93 100.0 12.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.258 0.529 . . . . 0.0 111.303 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 144' ' ' ILE . 14.5 pt -87.75 109.54 19.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.571 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.32 -76.71 0.58 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.0 t -99.65 -60.95 1.43 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.833 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 8.9 tmtt? -62.55 -50.8 69.9 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.407 ' NE2' HG22 ' A' ' 144' ' ' ILE . 1.7 mt-30 -55.61 -51.76 66.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.58 -45.34 53.83 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.2 m -67.42 -37.4 82.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.754 0.311 . . . . 0.0 111.559 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.833 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.67 -50.31 65.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.147 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.481 ' HA ' ' HB2' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -63.85 -34.68 78.49 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.477 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -57.24 -45.22 84.14 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -22.79 62.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.658 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.496 ' CE2' HD13 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -66.5 -36.21 82.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.923 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.671 0.272 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.02 162.63 40.45 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.518 2.146 . . . . 0.0 112.368 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.5 t -144.2 126.81 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.739 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 mp0 -110.51 129.8 55.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.396 . . . . 0.0 111.503 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.518 HG12 ' CD2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.61 118.89 55.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.95 153.07 29.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.529 . . . . 0.0 112.206 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CE1' ' HE1' ' A' ' 127' ' ' MET . 18.5 t80 -155.16 112.71 3.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.11 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 9.8 mmtm 65.88 -82.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.27 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -129.26 -42.59 1.34 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.457 ' HE1' HD13 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -73.8 149.53 41.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.945 0.402 . . . . 0.0 111.154 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.02 164.19 26.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.528 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 12.2 m-85 -127.59 155.58 43.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.269 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.546 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -125.6 135.88 52.67 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.128 0.489 . . . . 0.0 111.205 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.472 HD11 HG13 ' A' ' 108' ' ' VAL . 21.3 mm -118.23 106.42 19.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.275 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -132.27 163.14 29.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.233 0.539 . . . . 0.0 111.824 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.531 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.0 p80 -81.29 152.41 27.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.026 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -62.52 154.54 72.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.455 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 50.6 Cg_exo -54.38 136.53 69.5 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.369 2.046 . . . . 0.0 113.279 -177.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -98.75 146.57 25.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.041 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -69.39 -10.32 57.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.256 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -31.24 14.61 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 p -139.85 88.97 2.27 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.127 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.79 -52.22 7.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 111.396 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.437 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 1.9 t -56.11 -46.94 78.96 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.596 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -57.67 -32.09 66.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.89 0.376 . . . . 0.0 111.195 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.531 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -75.15 -47.6 27.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.437 ' CG1' ' O ' ' A' ' 34' ' ' SER . 12.1 pt -55.54 -38.78 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.158 0.504 . . . . 0.0 110.573 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -65.74 -51.75 56.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.511 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.505 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 9.4 m-20 -68.52 -50.25 53.53 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD21 ' CE1' ' A' ' 36' ' ' PHE . 75.2 mt -56.45 -44.98 81.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.417 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -77.43 -26.54 51.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.997 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 4.2 mttt -53.12 -46.17 68.64 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.416 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.546 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 14.1 t80 -63.61 -38.52 91.43 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.809 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.668 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.87 -179.31 38.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.01 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.58 117.79 20.07 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.6 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.3 m -164.78 -170.29 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.857 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 67' ' ' THR . 2.9 t -64.85 154.02 38.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.43 0.633 . . . . 0.0 110.707 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 57.8 t -131.42 135.39 59.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.992 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.597 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 11.7 p -115.6 105.06 17.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.273 0.559 . . . . 0.0 111.1 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.08 110.79 20.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.69 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.604 HG11 ' HD3' ' A' ' 113' ' ' ARG . 14.5 t -102.26 90.97 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.1 171.59 19.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.737 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -67.1 129.9 41.39 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.43 122.53 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.09 -47.65 2.37 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.448 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.447 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 0.4 OUTLIER -130.63 83.63 2.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.611 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -78.91 -35.73 43.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -78.26 -48.11 16.43 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.447 ' OG1' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -40.88 -60.04 1.83 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.24 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 59' ' ' THR . 33.3 Cg_endo -65.16 -42.43 13.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.436 2.091 . . . . 0.0 113.837 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.419 ' CD1' ' CG1' ' A' ' 68' ' ' VAL . 5.4 mp -71.37 -28.98 64.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.04 -44.6 46.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -81.18 -28.36 35.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.845 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.433 ' CB ' HG12 ' A' ' 66' ' ' ILE . 40.4 m-20 -101.48 -11.61 19.19 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.05 32.44 1.51 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.34 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.433 HG12 ' CB ' ' A' ' 64' ' ' ASP . 1.3 pt -102.56 148.22 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 0.0 111.303 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.2 OUTLIER -78.02 135.36 37.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.498 HG23 ' N ' ' A' ' 69' ' ' VAL . 11.3 p -145.02 152.03 14.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.117 0.484 . . . . 0.0 111.919 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.498 ' N ' HG23 ' A' ' 68' ' ' VAL . 2.2 t -103.23 132.05 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -100.66 106.76 18.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.289 0.566 . . . . 0.0 110.31 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.508 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.5 m95 -112.88 104.64 55.94 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.794 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.448 -1.2 0 C-N-CA 123.096 2.531 . . . . 0.0 112.707 -179.479 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.683 0.278 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.426 ' CG1' ' CZ2' ' A' ' 71' ' ' TRP . 39.4 t -60.27 -46.49 94.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.489 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 1.2 t -53.47 -38.69 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -65.29 -31.5 72.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.993 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.95 -50.5 70.54 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.332 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.597 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -66.84 -30.29 70.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.199 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.444 HD12 ' CE2' ' A' ' 155' ' ' TYR . 16.3 mt -60.64 -48.03 83.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.558 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -62.81 -42.16 99.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.172 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -55.08 -51.19 67.14 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.558 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.407 HG13 ' HB1' ' A' ' 121' ' ' ALA . 7.1 p -71.4 -35.94 59.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.047 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 1.7 tmtt? -55.85 -45.36 78.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.903 0.382 . . . . 0.0 110.543 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.67 -41.18 75.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.977 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -30.61 69.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.363 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' ' OE2' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -82.13 -37.21 26.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.99 -46.1 58.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.873 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -76.26 -33.02 59.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -115.52 89.87 23.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.08 129.23 11.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.607 2.205 . . . . 0.0 112.228 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.37 56.15 25.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.422 ' CB ' HG22 ' A' ' 46' ' ' THR . 0.4 OUTLIER -101.13 -164.75 1.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 111.066 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.668 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -124.76 113.53 18.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.33 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 42.0 t -104.45 150.5 7.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -123.46 135.9 54.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.098 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.598 HG11 ' H ' ' A' ' 106' ' ' HIS . 8.0 t -134.05 166.42 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -177.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.598 ' H ' HG11 ' A' ' 105' ' ' VAL . 2.0 t60 -67.45 155.72 38.34 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.862 0.363 . . . . 0.0 110.873 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 25' ' ' THR . 42.2 t -69.07 106.08 2.66 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.472 HG13 HD11 ' A' ' 24' ' ' ILE . 2.6 m -75.88 0.57 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.3 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.05 -8.65 2.49 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.69 -140.8 5.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mt -106.56 127.08 53.04 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.65 -158.82 10.21 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.423 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.604 ' HD3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.62 -14.35 7.77 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.375 -0.413 . . . . 0.0 111.861 -178.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.639 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -58.06 -46.93 99.65 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 9.5 Cg_endo -52.52 -48.49 21.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.131 1.888 . . . . 0.0 112.381 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 87.0 t -58.65 -52.44 59.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.232 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.434 HD11 ' CG2' ' A' ' 51' ' ' VAL . 9.4 mt -51.9 -49.08 63.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.732 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.463 ' CG2' HG13 ' A' ' 105' ' ' VAL . 85.7 t -51.46 -49.68 31.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.914 0.388 . . . . 0.0 110.638 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.444 ' O ' HG13 ' A' ' 123' ' ' ILE . . . -54.65 -47.85 73.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.672 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 1.6 mt -55.03 -31.63 61.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.87 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.482 ' HB1' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.24 -51.68 19.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.219 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.457 HD13 ' HE1' ' A' ' 20' ' ' MET . 5.8 tp -68.31 -13.98 62.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.581 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.621 HG22 ' HB3' ' A' ' 128' ' ' LYS . 1.1 mt -58.15 -36.38 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.157 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.403 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 4.5 pt-20 -63.03 -16.04 58.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.77 11.17 3.39 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 116.89 -95.44 0.67 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.79 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.493 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 4.8 ptt? -62.67 75.48 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.621 ' HB3' HG22 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -71.76 -67.59 0.52 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.429 ' CD1' ' HB3' ' A' ' 152' ' ' LEU . 9.8 t80 -68.65 -32.19 71.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.977 0.418 . . . . 0.0 111.165 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.45 -50.56 25.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.301 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.0 t0 -70.09 -40.05 75.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.772 0.32 . . . . 0.0 111.363 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.6 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -61.89 -48.51 80.16 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.005 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 34.6 mm -73.06 -41.23 59.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.494 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -74.73 -50.12 18.58 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.563 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -67.99 -39.75 83.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.594 0.235 . . . . 0.0 110.812 -179.222 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.2 tp -74.54 -28.61 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.774 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 5.8 ttm-85 -64.53 -41.68 96.22 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -41.6 90.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.016 0.436 . . . . 0.0 110.061 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -87.17 151.85 22.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.102 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 116.73 14.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 110.607 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.97 163.5 15.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.209 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -57.06 -166.64 0.07 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.715 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.19 100.0 12.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.298 0.549 . . . . 0.0 111.599 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.421 ' CD1' ' CD2' ' A' ' 149' ' ' LEU . 12.5 pt -87.87 109.46 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.476 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -113.2 -76.64 0.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.9 t -99.8 -61.1 1.41 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.767 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 10.0 tmtt? -65.78 -49.87 66.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -176.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.41 ' CB ' ' CG2' ' A' ' 144' ' ' ILE . 0.9 OUTLIER -56.33 -52.04 66.02 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.308 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.421 ' CD2' ' CD1' ' A' ' 144' ' ' ILE . 0.5 OUTLIER -72.86 -46.6 52.02 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.528 -179.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 81.2 m -62.61 -39.16 92.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.23 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.767 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -62.34 -50.56 71.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.761 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -62.01 -37.1 83.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.501 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -57.08 -37.95 72.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -22.74 58.81 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.646 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.527 ' CE2' HD13 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -66.19 -34.08 77.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.993 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.374 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.657 0.265 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.58 162.47 42.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.496 2.131 . . . . 0.0 112.272 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.426 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 24.6 t -144.13 127.04 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.805 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.17 116.67 31.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.836 0.35 . . . . 0.0 111.46 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.438 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -109.66 118.45 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.1 p -140.96 142.69 34.31 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.518 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -137.37 162.08 34.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.162 178.291 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 3.0 pttp 48.92 -100.65 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.014 0.126 . . . . 0.0 110.76 -177.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.469 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -124.35 -25.68 4.05 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.157 -0.34 . . . . 0.0 111.908 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.426 ' HE1' ' CD2' ' A' ' 22' ' ' PHE . 5.1 ppp? -74.01 165.91 24.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 111.464 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -143.5 156.74 44.71 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.282 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.469 ' CE1' ' CG1' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -137.42 138.39 39.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.299 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -115.09 135.53 54.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.051 0.453 . . . . 0.0 111.359 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.469 HD13 ' HB ' ' A' ' 105' ' ' VAL . 1.9 mm -118.23 106.61 20.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 107' ' ' CYS . 1.4 p -131.01 166.55 20.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.606 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.536 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 5.9 p80 -81.25 152.0 27.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.731 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -62.64 153.71 77.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.465 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.1 Cg_exo -54.94 142.37 76.0 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.476 2.118 . . . . 0.0 113.291 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.483 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 6.4 p -98.7 174.35 6.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.158 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -94.95 -12.35 26.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.54 -30.83 14.8 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -139.51 89.77 2.36 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.452 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.23 -52.2 8.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.055 0.455 . . . . 0.0 111.16 178.23 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.433 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.0 m -55.96 -43.51 77.57 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.358 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 m -58.04 -37.38 74.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.878 0.37 . . . . 0.0 111.257 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.536 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -71.21 -48.13 53.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.433 HG12 ' HA ' ' A' ' 34' ' ' SER . 13.7 pt -55.94 -39.63 58.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.183 0.516 . . . . 0.0 110.79 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -62.85 -52.01 64.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.336 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.516 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -69.84 -50.28 44.3 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.884 0.374 . . . . 0.0 111.774 -179.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.432 HD22 ' CE1' ' A' ' 36' ' ' PHE . 48.5 mt -56.27 -43.68 79.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.046 0.451 . . . . 0.0 110.265 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -78.6 -26.83 45.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.098 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -53.0 -43.81 66.75 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.151 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.529 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 13.5 t80 -63.35 -38.52 91.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.671 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.713 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.21 -179.92 39.45 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.803 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.44 117.07 19.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.606 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -165.42 -169.12 1.51 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.94 177.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 67' ' ' THR . 9.8 t -64.05 154.0 35.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.676 0.75 . . . . 0.0 110.578 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 104' ' ' ALA . 60.3 t -134.2 137.57 51.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.453 -178.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.606 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -115.56 105.18 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.067 0.461 . . . . 0.0 110.445 178.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -113.6 111.0 21.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.637 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.47 HG11 ' CD ' ' A' ' 113' ' ' ARG . 44.0 t -107.9 92.09 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.642 0.734 . . . . 0.0 110.59 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.42 171.15 20.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.453 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.62 130.2 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 m -68.89 121.91 19.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.61 -47.65 2.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.82 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.414 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.8 m-85 -130.74 84.36 2.19 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.213 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -78.55 -35.92 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -78.93 -48.52 14.41 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.403 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.53 -50.92 22.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 32.3 Cg_exo -59.25 -40.37 69.39 Favored 'Trans proline' 0 N--CA 1.471 0.196 0 C-N-CA 122.622 2.215 . . . . 0.0 113.653 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -45.02 64.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -75.2 -49.31 19.83 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.418 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -64.7 -35.53 81.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' CB ' HG12 ' A' ' 66' ' ' ILE . 49.1 m-20 -101.22 -11.45 19.5 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.09 24.81 9.49 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.789 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.466 HG12 ' CB ' ' A' ' 64' ' ' ASP . 16.2 pt -110.78 148.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 47' ' ' THR . 6.7 t -77.7 135.1 38.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.075 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 69' ' ' VAL . 7.4 p -145.21 151.91 14.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.052 0.453 . . . . 0.0 111.649 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.447 ' N ' HG23 ' A' ' 68' ' ' VAL . 3.6 t -103.5 133.33 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.97 106.64 17.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.156 0.503 . . . . 0.0 110.478 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.434 ' CH2' ' HA ' ' A' ' 84' ' ' VAL . 4.3 m95 -110.03 103.24 53.16 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.63 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo . . . . . 0 N--CA 1.446 -1.32 0 C-N-CA 123.547 2.831 . . . . 0.0 112.82 -178.838 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.398 0.142 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.1 t -56.33 -48.46 79.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.434 ' HA ' ' CH2' ' A' ' 71' ' ' TRP . 71.4 t -54.19 -40.99 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.092 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.84 -31.47 66.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.456 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -50.32 70.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.274 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.606 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.08 -33.2 75.24 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.554 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 11.1 mt -55.94 -47.75 76.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.4 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -63.0 -39.89 96.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.083 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.56 -51.17 69.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.94 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.456 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 14.7 p -68.79 -42.49 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.639 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 0.8 OUTLIER -53.87 -47.39 71.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 111.038 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -48.08 76.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.826 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -66.12 -26.54 67.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.018 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.456 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 2.4 m-85 -79.27 -51.92 8.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.969 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 t -56.89 -33.71 67.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.047 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.0 -33.06 59.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.046 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.25 84.02 62.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.52 128.23 26.49 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.601 2.201 . . . . 0.0 112.101 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.37 59.8 10.08 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.282 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.416 ' CB ' HG22 ' A' ' 46' ' ' THR . 84.9 p -101.1 -171.26 1.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.308 . . . . 0.0 111.425 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.713 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.1 m -106.21 113.77 27.49 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.324 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.469 ' CG1' ' CE1' ' A' ' 22' ' ' PHE . 44.5 t -111.26 150.86 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.472 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . . . -122.45 142.5 50.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.069 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 106' ' ' HIS . 3.2 t -140.09 167.08 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.727 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.57 ' H ' HG12 ' A' ' 105' ' ' VAL . 3.6 t60 -67.2 155.61 38.37 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.7 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' THR . 26.9 p -68.86 105.18 2.27 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.32 0.581 . . . . 0.0 112.433 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.45 HG13 ' HD3' ' A' ' 115' ' ' PRO . 26.6 m -75.22 0.02 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.919 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.65 -8.79 3.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.424 ' O ' HD22 ' A' ' 111' ' ' LEU . . . -123.74 -134.87 4.39 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.439 ' HA ' ' HA2' ' A' ' 142' ' ' GLY . 7.3 mt -118.83 127.46 53.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.41 -153.97 7.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.63 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.47 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.3 -20.2 6.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.114 0.483 . . . . 0.0 111.669 -178.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.644 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.81 -46.29 86.9 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 6.6 Cg_endo -52.01 -48.5 21.3 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.157 1.905 . . . . 0.0 113.078 -178.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.7 t -60.95 -39.99 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.693 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.405 HD11 ' CG2' ' A' ' 51' ' ' VAL . 9.7 mt -59.5 -55.0 40.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.633 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.449 ' CG2' HG11 ' A' ' 105' ' ' VAL . 55.6 t -52.01 -55.21 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.85 -53.22 51.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.009 0.433 . . . . 0.0 111.31 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.618 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 7.7 mp -54.92 -30.18 57.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.98 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.473 ' HB1' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.27 -47.72 48.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.886 0.374 . . . . 0.0 110.403 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.1 -13.06 57.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.816 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 120' ' ' LEU . 2.1 mt -57.05 -36.37 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.311 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.425 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -63.22 -16.79 61.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.7 m -80.03 7.45 9.05 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 114.39 -99.09 0.92 Allowed Glycine 0 N--CA 1.46 0.246 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.922 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.504 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.6 ptt? -62.56 75.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.3 OUTLIER -73.4 -67.86 0.55 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -176.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.462 ' CD1' HD23 ' A' ' 152' ' ' LEU . 4.4 t80 -66.72 -32.86 74.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.949 0.404 . . . . 0.0 111.162 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.17 -51.86 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.208 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 25.8 t0 -70.12 -40.39 74.9 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.918 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.545 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -58.01 -49.17 77.75 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.315 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.7 mm -69.7 -42.56 80.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -49.76 21.84 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -66.27 -34.29 77.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 110.724 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.7 tt -74.27 -33.34 34.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.974 0.416 . . . . 0.0 110.49 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -40.76 96.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.087 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.58 -45.29 92.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.984 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -87.33 151.65 22.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.682 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -73.31 117.25 14.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.896 0.379 . . . . 0.0 110.419 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.469 ' HG2' ' CG1' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -115.36 163.43 15.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.691 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -55.45 -176.05 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.346 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.54 98.81 3.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.692 0.746 . . . . 0.0 110.716 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.3 pp -88.67 109.24 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -113.22 -76.59 0.58 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.214 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.5 m -99.77 -60.62 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.643 ' O ' ' CB ' ' A' ' 151' ' ' TYR . 1.2 tmtt? -48.66 -51.43 28.42 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -55.77 -52.08 65.17 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 149' ' ' LEU . 3.2 mm? -75.66 -45.29 37.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -67.78 -34.37 76.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.361 . . . . 0.0 111.34 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.643 ' CB ' ' O ' ' A' ' 147' ' ' LYS . 1.3 t80 -68.17 -50.8 52.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.3 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 155' ' ' TYR . 0.6 OUTLIER -71.25 -38.92 71.91 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.519 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -36.48 68.0 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -26.35 59.92 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.465 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.555 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -65.82 -29.46 69.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.205 179.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.882 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -96.31 -51.36 4.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -142.26 35.86 1.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.83 143.17 50.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.59 156.35 39.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.142 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.53 178.27 7.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 60.74 157.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.57 96.66 3.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -79.45 147.88 69.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.01 137.12 62.05 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.547 2.164 . . . . 0.0 112.339 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.86 143.6 54.07 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.021 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.99 162.48 40.88 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.505 2.137 . . . . 0.0 112.355 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.424 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.1 t -144.16 126.89 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 pm0 -108.94 121.31 44.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.94 0.4 . . . . 0.0 111.652 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.433 HG13 ' CD2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -106.8 118.66 54.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.7 p -140.63 140.01 34.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.135 0.493 . . . . 0.0 112.156 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' CD2' ' HE2' ' A' ' 127' ' ' MET . 0.0 OUTLIER -138.98 139.4 37.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.746 178.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.447 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 11.1 mmmt 65.93 -88.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.295 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -129.46 -39.76 1.47 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.5 ptm -73.61 161.77 29.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 111.565 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 164.22 30.78 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 2.5 m-85 -133.05 154.23 50.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.277 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.544 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -126.32 130.68 51.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.056 0.455 . . . . 0.0 110.939 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.572 HG23 ' HA ' ' A' ' 107' ' ' CYS . 2.6 mm -114.46 106.58 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -130.86 167.34 19.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.908 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 51.0 p-80 -80.99 152.2 28.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.875 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -62.64 154.29 74.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 9.6 Cg_endo -54.45 141.76 72.04 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.61 2.206 . . . . 0.0 113.464 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.445 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.2 p -98.98 174.37 6.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.009 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -97.96 -10.43 24.52 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.61 -30.43 14.96 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.7 p -139.19 90.01 2.39 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.373 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -79.99 -52.18 8.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.043 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.428 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -57.62 -44.02 85.21 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.091 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.3 m -57.93 -33.51 68.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.849 0.357 . . . . 0.0 111.233 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.51 ' CD2' ' HA ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -73.71 -47.93 35.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.046 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 34' ' ' SER . 12.6 pt -55.94 -39.53 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.53 . . . . 0.0 110.697 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.12 -52.14 60.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.519 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.512 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -68.99 -50.11 51.82 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.863 0.363 . . . . 0.0 111.843 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.423 HD22 ' CE1' ' A' ' 36' ' ' PHE . 41.9 mt -56.52 -44.47 80.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -77.86 -26.67 49.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.081 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.512 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -52.9 -45.37 67.5 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.268 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.544 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 15.3 t80 -63.51 -38.32 90.69 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.779 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.644 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.63 -177.92 40.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.946 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.63 117.9 20.18 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.605 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.7 m -164.9 -170.63 2.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.88 177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.405 ' H ' ' CG2' ' A' ' 46' ' ' THR . 2.9 t -64.87 153.36 40.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.507 0.67 . . . . 0.0 110.565 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 55.8 t -131.42 133.33 62.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.944 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.613 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 6.4 p -115.57 105.4 18.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.346 0.593 . . . . 0.0 111.279 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -114.22 111.06 20.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.113 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.583 HG11 ' HD3' ' A' ' 113' ' ' ARG . 10.7 t -104.12 91.59 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.402 0.62 . . . . 0.0 110.093 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.1 m -157.74 171.3 20.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.552 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.95 130.41 43.29 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.75 122.23 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.4 p -120.23 -47.8 2.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.868 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.455 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -130.74 83.92 2.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.384 178.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -79.11 -37.15 39.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -80.08 -48.42 13.28 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.418 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.19 -53.05 24.53 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -177.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.455 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 11.0 Cg_exo -72.58 -42.76 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.412 2.074 . . . . 0.0 113.983 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.53 -45.23 62.94 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.42 -28.7 68.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.473 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -80.5 -34.01 36.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.882 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB2' ' CD1' ' A' ' 66' ' ' ILE . 44.9 p30 -101.25 -11.33 19.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.03 34.62 52.6 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.804 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' A' ' 46' ' ' THR . 6.0 mt -108.61 147.35 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.646 0.26 . . . . 0.0 110.967 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 t -78.41 132.79 37.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.5 HG22 ' N ' ' A' ' 69' ' ' VAL . 7.4 p -144.99 151.11 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.133 0.492 . . . . 0.0 111.965 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.5 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.3 t -103.34 131.93 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -101.21 106.72 17.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.164 0.507 . . . . 0.0 111.09 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.412 ' CH2' ' HA ' ' A' ' 84' ' ' VAL . 5.2 m0 -110.96 103.93 55.47 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.302 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -106.13 164.6 0.14 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.321 2.681 . . . . 0.0 112.993 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.422 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 8.3 t80 -126.21 95.93 4.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -125.33 -171.41 2.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -54.96 -27.27 42.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.044 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -114.68 41.25 2.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.529 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -85.95 119.42 71.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.43 0.157 . . . . 0.0 110.911 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.462 ' C ' ' HD2' ' A' ' 80' ' ' PRO . 18.9 Cg_endo -59.98 108.13 0.46 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.543 2.162 . . . . 0.0 112.541 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 82.3 Cg_endo -78.3 -23.68 8.59 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.683 2.255 . . . . 0.0 115.442 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 32.8 Cg_endo -65.52 152.34 82.14 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.368 1.379 . . . . 0.0 113.284 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -56.65 -20.71 32.77 Favored Glycine 0 C--O 1.236 0.234 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.334 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.74 -34.08 37.6 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.491 0.186 . . . . 0.0 110.972 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.405 ' CG1' ' HG2' ' A' ' 78' ' ' PRO . 1.1 m -53.98 -49.05 62.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 151' ' ' TYR . 7.5 t -54.57 -42.87 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.5 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -56.15 -31.53 63.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.99 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -68.49 -50.4 52.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.009 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.613 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -67.8 -28.09 67.3 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.421 HD13 ' CE2' ' A' ' 155' ' ' TYR . 11.1 mt -63.5 -43.95 95.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.25 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.2 -41.51 94.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.205 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -59.35 -51.34 70.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.673 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 95' ' ' PHE . 11.6 p -71.36 -35.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.072 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.03 -45.92 86.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.96 86.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.599 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -23.9 61.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.157 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.417 ' CD1' HG23 ' A' ' 91' ' ' VAL . 1.7 m-85 -79.28 -52.04 8.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.775 0.322 . . . . 0.0 111.184 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 25.4 t -65.02 -36.82 85.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -76.11 -32.82 59.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.268 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.45 88.58 51.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.526 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.37 130.71 19.03 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.816 2.344 . . . . 0.0 112.063 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.34 57.81 17.82 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.448 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.415 ' CB ' HG21 ' A' ' 46' ' ' THR . 4.7 m -101.08 -164.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.719 0.295 . . . . 0.0 111.212 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.644 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -123.11 113.55 19.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.373 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.3 t -107.45 151.06 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -122.2 139.97 53.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.982 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 106' ' ' HIS . 10.8 t -140.09 166.73 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.597 ' H ' HG12 ' A' ' 105' ' ' VAL . 2.0 t60 -66.81 156.35 35.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.516 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.572 ' HA ' HG23 ' A' ' 24' ' ' ILE . 20.8 t -68.13 104.49 1.8 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.451 ' CG1' HD12 ' A' ' 24' ' ' ILE . 34.5 m -75.56 0.25 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.06 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.4 -8.53 2.73 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.25 -127.49 3.12 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.48 ' HG ' ' HA2' ' A' ' 142' ' ' GLY . 0.0 OUTLIER -128.14 127.27 42.69 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.42 -144.44 4.1 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.607 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.583 ' HD3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.29 -25.96 4.74 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.163 0.506 . . . . 0.0 112.017 -178.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.646 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.23 -46.22 83.08 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 6.2 Cg_endo -51.72 -48.54 20.92 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.306 2.004 . . . . 0.0 113.275 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.454 HG12 ' HG2' ' A' ' 148' ' ' GLN . 57.9 t -61.68 -46.66 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.818 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.441 HD12 ' CG2' ' A' ' 49' ' ' VAL . 11.6 mt -54.77 -46.55 74.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.847 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.489 HG22 HG11 ' A' ' 105' ' ' VAL . 57.6 t -57.37 -55.28 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.726 0.298 . . . . 0.0 111.671 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.98 -48.76 67.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.336 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.584 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 5.5 mt -59.06 -30.55 68.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.389 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.527 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.12 -42.43 66.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.967 0.413 . . . . 0.0 110.227 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.407 HD21 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -70.75 -16.11 62.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.595 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 128' ' ' LYS . 1.4 mt -57.42 -30.97 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.124 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -15.97 14.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.539 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.87 11.29 5.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.27 -83.79 0.35 Allowed Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.4 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.502 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.9 76.92 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 121.337 0.589 . . . . 0.0 109.534 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.601 ' O ' HG12 ' A' ' 123' ' ' ILE . 11.3 mttt -62.56 -67.4 0.42 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.088 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.467 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 6.1 t80 -73.61 -31.68 63.68 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.069 0.462 . . . . 0.0 110.762 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.3 -46.4 55.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.061 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' A' ' 127' ' ' MET . 47.9 t0 -70.24 -47.19 62.45 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.457 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.456 ' O ' ' CG2' ' A' ' 136' ' ' ILE . . . -57.97 -50.06 74.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.821 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 133' ' ' ILE . 32.0 mm -70.8 -37.78 70.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -74.37 -49.71 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -70.19 -35.44 73.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.501 0.191 . . . . 0.0 111.066 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.456 ' CG2' ' O ' ' A' ' 132' ' ' ALA . 4.2 tt -74.25 -32.7 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.782 0.325 . . . . 0.0 110.662 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -64.93 -43.99 90.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.497 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.82 -44.19 94.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.527 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.05 152.08 22.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.667 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.96 117.73 15.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.378 . . . . 0.0 110.33 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.411 ' HG3' ' CD1' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -114.13 163.9 14.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.433 -179.109 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.48 ' HA2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.45 -165.42 0.05 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.039 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.419 ' CB ' HD23 ' A' ' 111' ' ' LEU . . . -82.1 99.0 8.95 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.715 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 148' ' ' GLN . 45.8 mt -88.73 108.88 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.828 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -114.03 -78.09 0.58 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.021 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.6 t -101.32 -61.23 1.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.802 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.7 tmtt? -48.99 -51.54 30.01 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.471 ' HB3' ' CG2' ' A' ' 144' ' ' ILE . 7.2 tm0? -56.28 -51.51 67.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.433 ' CD2' ' CG2' ' A' ' 144' ' ' ILE . 3.9 mm? -75.19 -37.69 61.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.5 m -73.08 -42.68 62.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.033 0.444 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.802 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -64.0 -50.11 69.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.034 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.467 ' HB3' ' CE1' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -64.28 -38.16 90.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.709 0.29 . . . . 0.0 110.871 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.56 -43.98 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -24.76 57.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.497 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.429 ' CE2' HD13 ' A' ' 123' ' ' ILE . 0.9 OUTLIER -66.42 -23.75 66.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.651 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -106.8 126.92 29.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.217 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.09 153.42 62.73 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.556 2.171 . . . . 0.0 112.202 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -146.88 123.5 11.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.028 0.442 . . . . 0.0 110.574 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.97 -26.85 68.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.052 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -58.94 -30.38 67.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.829 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.99 -28.34 24.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -96.23 40.45 1.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -97.83 102.54 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -112.23 128.12 56.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.6 136.55 32.85 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.24 -62.11 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.44 2.093 . . . . 0.0 112.265 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -86.69 114.12 23.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.1 p -149.61 179.21 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.45 145.97 51.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -131.88 138.97 48.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.7 m -143.17 -52.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.5 p -139.04 153.42 48.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.369 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -77.18 148.34 35.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.1 mmt -135.46 140.19 44.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.37 132.89 16.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 ptm85 -150.0 149.94 31.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.94 109.11 8.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.974 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -117.74 -40.31 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -132.92 150.99 77.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.961 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.91 145.86 30.96 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.655 2.237 . . . . 0.0 112.424 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.3 143.63 65.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.012 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.03 162.41 40.99 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.458 2.106 . . . . 0.0 112.479 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.7 t -144.07 126.92 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.85 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.7 OUTLIER -108.64 121.96 46.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.576 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.454 HG13 ' CD2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.75 120.6 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.02 147.03 41.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.195 0.522 . . . . 0.0 111.978 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CD1' ' HE2' ' A' ' 127' ' ' MET . 20.5 t80 -155.12 127.62 7.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.225 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 7.2 mmpt? 55.06 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.521 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -129.26 -46.45 1.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.4 ' HE3' ' CD2' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -73.66 139.84 45.68 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.099 0.476 . . . . 0.0 111.266 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -115.35 164.4 14.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.276 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.42 ' CE1' HG11 ' A' ' 118' ' ' VAL . 1.4 m-85 -131.97 138.39 48.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.562 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.532 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -114.88 133.74 55.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.422 . . . . 0.0 110.962 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.422 HG23 ' HA ' ' A' ' 107' ' ' CYS . 1.5 mm -115.85 106.52 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 107' ' ' CYS . 1.6 p -132.33 162.89 29.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.27 0.557 . . . . 0.0 111.936 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.535 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.7 p80 -81.41 152.13 27.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.937 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -62.74 154.36 75.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.987 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.4 Cg_exo -54.55 140.83 75.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.343 2.029 . . . . 0.0 113.275 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.468 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 32.3 p -98.47 174.33 6.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.161 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -93.37 -11.64 31.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.69 -31.04 14.61 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -139.69 89.65 2.34 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.519 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.468 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.3 OUTLIER -80.38 -52.16 8.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.173 0.511 . . . . 0.0 111.272 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.415 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 1.1 p -56.79 -45.64 82.03 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.359 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.1 m -57.72 -33.47 68.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.936 0.398 . . . . 0.0 111.439 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.535 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -74.27 -47.93 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.174 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 34' ' ' SER . 12.0 pt -55.91 -39.08 55.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.216 0.531 . . . . 0.0 110.696 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -65.21 -51.86 58.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.487 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.533 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 4.0 m-20 -68.64 -50.05 54.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.873 0.368 . . . . 0.0 111.906 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD22 ' CE1' ' A' ' 36' ' ' PHE . 58.7 mt -55.93 -44.84 78.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.871 0.367 . . . . 0.0 110.412 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -78.53 -26.62 45.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.028 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.533 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -53.36 -42.8 67.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.406 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.532 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 17.9 t80 -63.37 -38.56 91.61 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.241 -0.583 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.634 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.64 -177.71 40.12 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.958 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.54 117.71 19.99 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.604 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.7 m -164.8 -170.23 1.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.63 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 67' ' ' THR . 2.9 t -64.7 158.65 24.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.411 0.624 . . . . 0.0 110.443 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.437 ' CG2' ' HB3' ' A' ' 104' ' ' ALA . 59.8 t -136.47 136.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.333 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.642 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 2.4 p -115.64 105.17 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.282 0.563 . . . . 0.0 110.699 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -113.99 110.72 20.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.705 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.602 HG12 ' NE ' ' A' ' 113' ' ' ARG . 18.5 t -105.39 90.94 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.537 0.684 . . . . 0.0 109.817 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 t -158.4 171.77 19.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.582 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -65.51 130.02 41.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 m -74.33 122.39 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.412 HG23 ' CE1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -120.26 -47.6 2.35 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.182 178.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.413 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.2 m-85 -130.54 84.29 2.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.628 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.56 -35.87 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -78.84 -48.42 14.76 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.408 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.64 -49.82 25.56 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 8.2 Cg_exo -73.16 -39.44 2.18 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.737 2.291 . . . . 0.0 113.336 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.426 ' CD2' ' CG1' ' A' ' 68' ' ' VAL . 3.7 mm? -66.95 -45.26 78.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -75.35 -33.34 61.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -81.12 -32.05 33.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' CB ' HG12 ' A' ' 66' ' ' ILE . 71.1 m-20 -101.37 -11.5 19.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 44.6 34.77 3.83 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.051 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.48 HG12 ' CB ' ' A' ' 64' ' ' ASP . 4.3 pt -114.69 148.82 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.694 0.283 . . . . 0.0 111.001 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 47' ' ' THR . 81.9 p -77.53 135.2 38.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.497 HG22 ' N ' ' A' ' 69' ' ' VAL . 7.9 p -144.9 151.73 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.084 0.469 . . . . 0.0 111.941 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.497 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.1 t -103.43 132.59 49.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -100.87 106.71 18.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.189 0.519 . . . . 0.0 110.365 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.437 ' CD2' HD13 ' A' ' 117' ' ' LEU . 4.0 m95 -111.93 104.07 55.74 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.136 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -106.85 169.5 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 123.599 2.866 . . . . 0.0 112.6 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.455 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 9.0 t80 -126.11 95.96 4.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.752 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.43 -173.99 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.833 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -57.48 -26.96 62.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.97 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.19 64.9 0.53 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.417 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -95.26 106.87 28.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.345 0.117 . . . . 0.0 110.903 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.423 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . 72.8 Cg_exo -40.16 97.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.945 2.43 . . . . 0.0 113.024 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.669 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 52.9 Cg_exo -55.92 -42.05 70.9 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.107 2.538 . . . . 0.0 114.339 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 2.7 Cg_endo -47.67 151.72 3.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.303 2.002 . . . . 0.0 113.507 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.496 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -65.97 -19.7 68.02 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.362 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -50.52 -29.74 11.31 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 120.57 0.224 . . . . 0.0 110.818 -178.131 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 78' ' ' PRO . 21.8 t -56.09 -48.0 79.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.51 HG13 ' OH ' ' A' ' 151' ' ' TYR . 94.0 t -55.98 -37.9 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.024 177.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -59.46 -31.33 69.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.529 178.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -66.16 -50.74 62.89 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.23 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.642 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -67.97 -26.98 66.2 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.421 ' CD2' ' O ' ' A' ' 120' ' ' LEU . 18.2 mt -61.05 -41.5 96.71 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.111 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -67.58 -42.54 82.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.872 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.32 -51.48 69.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.772 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.42 -43.94 83.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.25 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -54.7 -40.33 69.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.907 0.384 . . . . 0.0 110.833 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.64 -45.78 77.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.992 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -74.6 -24.81 58.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.652 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -82.1 -45.53 15.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.747 0.308 . . . . 0.0 111.109 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.92 -37.86 69.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.915 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -76.11 -32.99 59.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.04 88.82 53.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.451 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.24 133.89 13.76 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.58 2.187 . . . . 0.0 112.319 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.2 46.42 34.91 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.45 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.416 ' CB ' HG21 ' A' ' 46' ' ' THR . 0.4 OUTLIER -101.21 -165.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 111.269 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.634 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.0 m -127.42 113.71 16.56 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.199 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 5.4 t -110.65 151.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.437 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . . . -118.97 144.73 46.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.308 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 106' ' ' HIS . 3.5 t -140.37 167.08 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.591 ' H ' HG12 ' A' ' 105' ' ' VAL . 2.6 t60 -66.97 156.34 36.21 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.463 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 25' ' ' THR . 25.6 p -68.19 101.72 1.22 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.471 0.653 . . . . 0.0 112.593 -177.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG21 ' CG ' ' A' ' 115' ' ' PRO . 5.4 p -75.55 0.08 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.065 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.46 -8.53 2.8 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.18 -125.84 3.08 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.755 -0.735 . . . . 0.0 111.391 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.525 ' HG ' ' HA2' ' A' ' 142' ' ' GLY . 0.0 OUTLIER -132.06 127.31 35.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.58 -142.73 3.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.644 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.602 ' NE ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.31 -22.06 5.65 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.043 0.449 . . . . 0.0 111.965 -178.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.662 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -49.85 -46.33 80.67 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 5.7 Cg_endo -51.6 -48.38 21.64 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.482 2.121 . . . . 0.0 113.107 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.419 ' O ' HD23 ' A' ' 120' ' ' LEU . 43.5 t -61.1 -42.59 93.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.805 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.437 HD13 ' CD2' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -57.56 -55.07 39.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.687 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.445 ' CG2' HG11 ' A' ' 105' ' ' VAL . 61.1 t -52.93 -55.2 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.01 -53.14 54.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.249 0.547 . . . . 0.0 110.72 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.627 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 2.4 mm? -54.34 -30.78 52.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.793 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.21 -48.88 39.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.954 0.406 . . . . 0.0 110.467 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.416 HD21 ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -62.92 -14.66 49.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.712 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.3 mt -57.01 -30.86 35.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.832 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -16.65 62.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.574 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.5 m -83.13 11.02 6.95 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.27 -101.85 1.08 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.016 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.462 ' HE2' ' CD1' ' A' ' 17' ' ' TYR . 3.3 ptt? -62.53 78.67 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.86 -67.65 0.55 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -176.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.434 ' CD1' HD23 ' A' ' 152' ' ' LEU . 5.6 t80 -67.42 -32.05 72.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.856 0.36 . . . . 0.0 111.092 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.38 -51.35 20.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.199 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.2 t0 -69.61 -38.36 77.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 111.009 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.515 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -60.36 -49.93 75.61 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.972 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.7 mm -73.56 -38.0 51.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.562 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.09 -49.72 22.71 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.543 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -69.84 -36.38 75.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.675 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.4 tt -74.29 -27.83 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.775 0.321 . . . . 0.0 110.434 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -49.67 66.65 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.542 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -45.14 93.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.61 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' A' ' 136' ' ' ILE . 19.6 mmtm -84.15 152.08 24.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.412 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.13 117.34 14.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.96 0.41 . . . . 0.0 110.454 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.43 163.6 15.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.216 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.525 ' HA2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.32 -171.21 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.59 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.412 ' CB ' HD23 ' A' ' 111' ' ' LEU . . . -80.63 98.88 7.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.378 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.403 ' CG2' ' HG3' ' A' ' 148' ' ' GLN . 2.3 pt -88.71 108.53 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.062 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.89 -77.32 0.58 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.094 -0.643 . . . . 0.0 112.449 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.2 m -100.67 -60.68 1.48 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.722 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.4 tmtt? -54.27 -52.03 62.7 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.403 ' HG3' ' CG2' ' A' ' 144' ' ' ILE . 8.5 tm0? -56.31 -51.91 66.46 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 149' ' ' LEU . 3.2 mm? -75.09 -44.46 47.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.2 m -68.88 -34.9 76.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.718 0.294 . . . . 0.0 111.441 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.722 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 1.8 t80 -68.66 -50.6 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.321 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.434 HD23 ' CD1' ' A' ' 129' ' ' TYR . 0.6 OUTLIER -69.36 -33.32 72.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.475 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -57.4 -44.65 84.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -27.52 65.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.596 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.512 ' CD2' HD13 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -66.44 -29.22 69.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.832 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.73 114.6 61.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.767 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.7 153.15 76.76 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.531 2.154 . . . . 0.0 112.506 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -147.16 123.62 11.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.502 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.08 3.32 23.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.675 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -58.89 -29.12 66.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.77 0.319 . . . . 0.0 110.983 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mt -65.45 -39.25 91.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.819 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -99.98 177.66 5.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.813 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 2.4 p90 -120.88 -56.01 1.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? 59.29 110.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.08 103.88 11.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.51 62.63 3.65 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.447 2.098 . . . . 0.0 112.19 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.51 112.72 22.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 p -137.52 156.04 48.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -76.72 -46.75 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.42 166.16 12.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 24.5 m -115.57 143.56 45.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.833 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 p -81.92 -53.94 5.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -113.33 129.72 56.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.1 ttm -61.54 128.88 38.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.952 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.06 -45.76 3.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.079 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.96 155.32 38.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.61 156.14 35.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.814 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -82.0 -73.08 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.09 143.56 27.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.857 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.49 96.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.489 2.126 . . . . 0.0 112.324 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.38 148.47 83.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 60.3 Cg_endo -72.76 161.14 44.61 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.499 2.132 . . . . 0.0 112.252 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.3 t -143.98 127.38 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.061 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -105.14 116.63 32.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.031 0.443 . . . . 0.0 111.396 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.513 ' CG1' ' CD2' ' A' ' 135' ' ' PHE . 21.3 t -107.22 118.31 54.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.5 p -141.59 149.57 40.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.55 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -144.08 153.61 42.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.015 178.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 51.08 -97.81 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.406 0.282 . . . . 0.0 110.82 -176.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.439 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 2.6 m80 -124.78 -25.03 4.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -73.8 164.31 26.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.747 0.308 . . . . 0.0 111.269 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -142.54 161.52 37.86 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.015 0.436 . . . . 0.0 111.3 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CE1' ' CG1' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -142.99 140.65 31.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.147 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.523 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -114.69 134.59 54.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.107 0.479 . . . . 0.0 111.23 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.52 HG23 ' HA ' ' A' ' 107' ' ' CYS . 2.1 mm -116.91 106.51 20.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.329 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -133.33 167.26 20.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.183 0.515 . . . . 0.0 111.669 -178.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.6 p80 -80.92 151.9 28.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.847 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.65 154.26 74.82 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.045 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 53.1 Cg_exo -54.81 140.92 77.89 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.348 2.032 . . . . 0.0 113.376 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.441 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -98.72 174.34 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.125 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -94.41 -10.31 32.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.84 14.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.9 p -139.54 89.62 2.34 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.431 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.441 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.21 -52.18 8.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.261 0.553 . . . . 0.0 111.196 178.099 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' HG13 ' A' ' 37' ' ' ILE . 17.2 p -57.56 -46.31 84.09 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.418 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -57.75 -31.96 66.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.823 0.344 . . . . 0.0 111.295 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -74.47 -47.78 31.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 34' ' ' SER . 11.6 pt -56.84 -39.36 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.191 0.52 . . . . 0.0 110.742 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.26 -52.14 60.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.466 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.525 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -68.49 -50.04 55.29 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.82 0.343 . . . . 0.0 111.757 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.437 HD12 ' CD1' ' A' ' 36' ' ' PHE . 25.3 mt -55.81 -45.35 78.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -26.62 49.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.108 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 17.2 mttt -52.88 -44.31 66.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.447 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.523 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 14.2 t80 -63.36 -38.42 91.07 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.897 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.673 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 167.01 -177.56 41.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.616 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.84 121.08 24.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.565 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 4.2 m -164.72 -171.82 2.43 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.489 ' H ' ' CG2' ' A' ' 46' ' ' THR . 8.8 t -65.74 166.9 10.11 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.754 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 44.0 t -139.84 134.74 37.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.193 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.636 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 3.6 p -115.67 105.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.222 0.534 . . . . 0.0 111.483 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 110.81 20.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.984 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.61 HG13 ' HD3' ' A' ' 113' ' ' ARG . 7.4 t -103.86 91.86 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.453 0.644 . . . . 0.0 109.737 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 t -157.28 171.66 20.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.336 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.42 130.33 43.33 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.4 t -68.91 121.67 18.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -120.73 -47.49 2.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.898 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.415 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 3.0 m-85 -130.44 84.47 2.2 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.263 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.52 -36.25 45.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -79.21 -48.58 13.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.427 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.81 -48.24 29.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 59' ' ' THR . 33.6 Cg_exo -60.9 -42.27 38.86 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.551 2.167 . . . . 0.0 113.787 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -45.75 61.83 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.85 -49.12 18.88 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.61 -28.08 61.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.421 ' HB3' ' CG1' ' A' ' 66' ' ' ILE . 4.6 t0 -98.49 -11.43 22.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.91 22.39 9.08 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.151 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.421 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 2.7 pt -122.02 148.61 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.626 0.25 . . . . 0.0 110.376 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' THR . 19.5 m -77.43 135.0 38.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.83 0.348 . . . . 0.0 110.192 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.24 150.53 19.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 0.0 111.756 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.73 134.42 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.135 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.83 106.69 18.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.19 0.519 . . . . 0.0 110.109 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.514 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.0 m95 -111.43 104.38 56.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.229 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -104.56 138.57 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 123.303 2.669 . . . . 0.0 112.433 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.42 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -114.97 95.96 5.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.894 0.378 . . . . 0.0 110.913 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.31 -162.15 1.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.542 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -55.04 -23.5 20.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.121 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -115.52 49.36 0.86 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.599 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -115.41 102.93 54.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.476 0.179 . . . . 0.0 110.944 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.414 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 93.0 Cg_exo -43.32 99.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.774 2.316 . . . . 0.0 112.918 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.669 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 52.9 Cg_exo -55.83 -41.43 77.4 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.985 2.457 . . . . 0.0 114.256 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 2.4 Cg_endo -47.46 153.97 1.81 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.275 1.983 . . . . 0.0 113.609 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.33 -20.22 67.24 Favored Glycine 0 C--O 1.237 0.284 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.527 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.3 -33.18 27.82 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.359 0.133 . . . . 0.0 111.359 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 78' ' ' PRO . 0.1 OUTLIER -56.11 -48.83 78.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.487 HG13 ' CE2' ' A' ' 151' ' ' TYR . 15.7 t -53.81 -41.16 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.218 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -61.07 -31.37 71.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.02 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.28 -50.36 68.2 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.395 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.636 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -70.31 -28.32 65.08 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.969 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD12 ' CE2' ' A' ' 155' ' ' TYR . 13.8 mt -61.64 -40.63 95.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.15 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.57 -39.93 70.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.132 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -58.03 -51.27 70.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.522 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.441 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 14.9 p -70.42 -35.83 63.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.666 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -46.34 77.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.381 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.71 85.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.446 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -26.96 66.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.814 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.441 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 2.4 m-85 -79.81 -47.23 15.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.008 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.88 -43.3 98.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -33.03 59.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.97 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.55 89.38 36.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.32 113.6 3.52 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.597 2.198 . . . . 0.0 112.361 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.32 60.38 7.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.648 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.5 t -101.23 -163.85 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.627 0.251 . . . . 0.0 110.809 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.673 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 2.2 m -112.41 114.09 26.63 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.505 ' CG1' ' CE1' ' A' ' 22' ' ' PHE . 10.6 t -109.79 151.31 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -116.02 140.86 48.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.088 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 49' ' ' VAL . 3.4 t -140.36 166.35 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.489 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 1.7 t60 -67.54 156.08 37.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.621 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.52 ' HA ' HG23 ' A' ' 24' ' ' ILE . 18.7 t -68.51 105.81 2.35 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.443 ' CG1' HD11 ' A' ' 24' ' ' ILE . 35.7 m -75.51 0.42 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.194 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.22 -8.6 2.61 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.72 -140.49 5.24 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 mt -114.97 127.34 55.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.64 -146.46 4.81 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.834 -1.174 . . . . 0.0 113.593 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.61 ' HD3' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.34 -21.68 5.75 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.031 0.443 . . . . 0.0 111.877 -178.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.65 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -52.8 -46.22 96.79 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 8.3 Cg_endo -52.41 -48.48 21.63 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.237 1.958 . . . . 0.0 112.904 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 57.5 t -60.9 -52.19 64.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.386 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.407 HD11 ' CG2' ' A' ' 49' ' ' VAL . 3.8 mt -51.89 -44.48 63.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.942 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.446 ' CG1' ' CD1' ' A' ' 22' ' ' PHE . 4.4 t -58.55 -54.62 30.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.68 -44.4 66.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 111.34 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.598 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 12.5 mt -63.95 -30.73 71.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.383 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.495 ' HB3' ' CZ2' ' A' ' 87' ' ' TRP . . . -68.67 -37.53 79.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.069 0.462 . . . . 0.0 109.793 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.6 tp -78.88 -15.68 58.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.256 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.598 ' HB ' ' O ' ' A' ' 120' ' ' LEU . 1.8 mt -57.59 -30.86 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.73 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -16.33 64.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.1 m -79.54 -23.36 42.91 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 152.95 -96.1 0.16 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.994 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.482 ' HE3' ' CD2' ' A' ' 17' ' ' TYR . 3.2 ptt? -63.2 71.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.58 ' HB3' HG21 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.44 -67.62 0.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -176.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 8.6 t80 -66.26 -32.67 74.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.9 0.381 . . . . 0.0 111.128 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.59 -52.22 16.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 30.0 t0 -70.12 -39.43 75.45 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.821 0.343 . . . . 0.0 110.975 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.552 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -60.45 -50.01 75.29 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.811 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.1 mm -73.38 -38.69 53.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -74.44 -49.95 20.35 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.602 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -66.83 -37.09 83.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.31 . . . . 0.0 110.165 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.23 -27.87 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.437 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -47.93 78.98 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -44.71 93.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.598 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.1 OUTLIER -84.9 152.03 23.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.44 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 116.7 14.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.009 0.433 . . . . 0.0 110.514 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 163.61 15.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.14 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -56.77 -168.8 0.09 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.649 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.21 100.03 12.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.286 0.543 . . . . 0.0 111.516 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 144' ' ' ILE . 10.4 pt -87.93 109.52 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.373 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -113.25 -76.87 0.58 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 6.8 p -99.6 -61.01 1.42 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.808 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 11.7 tmtt? -66.48 -48.6 69.36 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 144' ' ' ILE . 23.5 mm-40 -56.12 -51.84 66.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.402 ' CD2' ' CD1' ' A' ' 144' ' ' ILE . 2.0 mm? -74.2 -45.34 48.92 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.766 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.9 m -64.62 -37.31 87.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.795 0.331 . . . . 0.0 111.425 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.808 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -66.41 -50.51 63.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.157 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.473 ' HA ' ' HB2' ' A' ' 155' ' ' TYR . 0.4 OUTLIER -61.52 -34.61 75.82 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.171 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.33 -43.4 88.21 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -23.76 65.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.482 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.473 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.18 -39.67 89.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.49 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.7 141.03 21.97 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.956 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.08 153.42 62.79 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.656 2.238 . . . . 0.0 112.34 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.56 123.45 11.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.526 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.83 -12.58 61.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.508 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -28.12 65.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.763 0.316 . . . . 0.0 110.967 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.2 tt -75.04 -31.56 61.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.869 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -177.9 6.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -108.9 -66.33 1.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -66.61 121.96 16.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -94.03 138.05 22.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.801 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.85 -48.5 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.492 2.128 . . . . 0.0 112.36 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -177.6 37.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.948 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.8 p -134.64 116.56 15.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -86.99 127.67 35.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -148.46 -47.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.9 m -120.39 -62.08 1.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.54 116.34 14.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.815 0.34 . . . . 0.0 110.898 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -119.45 114.96 23.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.87 103.49 10.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -121.63 140.5 52.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.138 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -132.2 -65.92 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 mmt -112.89 130.78 55.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.906 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -163.75 31.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 ptt-85 -175.89 112.34 0.26 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.3 109.85 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.499 2.133 . . . . 0.0 112.37 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.07 57.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.053 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.14 165.15 33.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.537 2.158 . . . . 0.0 112.339 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.78 126.88 28.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.0 pt-20 -105.96 116.74 32.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.978 0.418 . . . . 0.0 111.559 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.518 ' CG1' ' CD2' ' A' ' 135' ' ' PHE . 45.3 t -107.82 118.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.06 151.9 42.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 0.0 112.223 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.591 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -145.13 151.07 37.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.962 178.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.591 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 44.71 -78.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.455 0.702 . . . . 0.0 112.623 -177.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -129.81 -41.58 1.31 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.431 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -73.58 154.22 39.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 112.027 -178.511 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -135.7 164.25 28.29 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.064 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 7.9 m-85 -139.28 150.08 45.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.527 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -121.24 132.0 54.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.466 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 107' ' ' CYS . 2.6 mm -117.27 106.68 20.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.512 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 107' ' ' CYS . 31.7 p -130.45 167.23 18.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.202 0.525 . . . . 0.0 111.773 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.497 ' CD2' ' CE2' ' A' ' 36' ' ' PHE . 42.1 p-80 -80.89 152.29 28.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.39 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -62.45 153.93 74.66 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.3 Cg_exo -54.71 142.4 73.3 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.393 2.062 . . . . 0.0 113.46 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.484 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.1 p -98.5 174.44 6.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.053 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -94.01 -12.48 28.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.7 -31.02 14.61 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.4 p -139.86 89.81 2.34 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.691 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.484 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -80.23 -52.32 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.212 0.529 . . . . 0.0 111.136 177.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.543 ' O ' HG13 ' A' ' 37' ' ' ILE . 1.5 m -57.45 -36.11 71.0 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.211 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -65.88 -35.48 80.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.919 0.39 . . . . 0.0 110.927 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.497 ' CE2' ' CD2' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -73.94 -47.97 33.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.072 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 34' ' ' SER . 0.8 OUTLIER -58.62 -37.02 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 110.472 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.48 -51.94 60.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.262 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -69.78 -49.88 48.63 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 111.552 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD12 ' CD1' ' A' ' 36' ' ' PHE . 27.3 mt -54.96 -44.82 74.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.99 0.424 . . . . 0.0 110.502 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -78.4 -26.76 46.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.181 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 11.9 mttt -54.56 -41.89 70.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.351 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.527 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 13.3 t80 -63.58 -38.7 92.13 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.804 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.63 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 168.84 -178.84 41.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.706 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.83 118.36 20.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.579 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 3.3 m -164.7 -171.35 2.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.305 -0.862 . . . . 0.0 108.696 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.469 ' H ' ' CG2' ' A' ' 46' ' ' THR . 1.6 t -65.52 163.09 16.7 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.064 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 50.0 t -137.26 133.5 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.082 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.605 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 14.9 p -115.4 105.18 18.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.55 0.69 . . . . 0.0 111.514 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -114.64 110.84 20.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.845 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.544 HG11 ' CD ' ' A' ' 113' ' ' ARG . 14.5 t -105.87 91.83 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.629 0.728 . . . . 0.0 109.936 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.41 172.04 19.3 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.229 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' CD ' ' N ' ' A' ' 53' ' ' GLU . 1.5 mm-40 -64.28 130.33 43.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -69.07 121.95 19.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 m -120.53 -47.45 2.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.074 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.425 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 6.7 m-85 -130.41 84.51 2.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.34 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.52 -35.86 45.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -78.97 -48.45 14.47 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -45.67 -49.79 34.99 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.215 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 44.6 Cg_exo -57.44 -42.22 63.8 Favored 'Trans proline' 0 N--CA 1.471 0.189 0 C-N-CA 122.63 2.22 . . . . 0.0 113.572 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -45.52 62.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.57 -49.1 19.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -75.15 -26.72 59.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.446 ' HB3' ' CG1' ' A' ' 66' ' ' ILE . 2.5 t0 -101.06 -11.39 19.67 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.95 25.53 3.81 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.138 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.446 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 4.2 pt -122.22 148.73 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.649 0.262 . . . . 0.0 110.531 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 47' ' ' THR . 1.3 m -77.29 135.05 38.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.965 0.412 . . . . 0.0 110.233 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 69' ' ' VAL . 7.1 p -142.56 148.52 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.697 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.414 ' N ' HG23 ' A' ' 68' ' ' VAL . 2.2 t -103.63 131.2 52.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.138 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.1 106.65 17.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.097 0.475 . . . . 0.0 110.651 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.432 ' CD2' HD11 ' A' ' 117' ' ' LEU . 4.6 m0 -109.21 103.5 52.62 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.815 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -108.46 171.22 0.09 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.553 2.836 . . . . 0.0 112.559 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.446 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -126.34 139.99 52.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.768 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.4 p30 178.85 -175.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.692 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -54.86 -24.25 22.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.927 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.7 41.34 2.26 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.511 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.81 102.82 29.31 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.489 0.185 . . . . 0.0 110.922 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . 89.2 Cg_exo -47.02 101.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.676 2.251 . . . . 0.0 112.775 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.659 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 27.1 Cg_exo -63.27 -36.91 53.94 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.88 2.386 . . . . 0.0 114.677 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 9.5 Cg_endo -53.36 154.09 15.7 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.948 1.765 . . . . 0.0 113.697 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.68 -20.09 51.08 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.462 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.15 -29.63 14.24 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.467 0.175 . . . . 0.0 111.081 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.425 HG13 ' CZ2' ' A' ' 71' ' ' TRP . 18.4 t -56.2 -52.34 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.616 HG12 ' CZ ' ' A' ' 151' ' ' TYR . 1.4 t -53.81 -40.01 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.391 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -60.55 -31.34 70.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.955 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -50.29 63.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.284 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.605 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -67.86 -33.75 75.36 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.427 HD12 ' CE2' ' A' ' 155' ' ' TYR . 11.8 mt -59.32 -44.88 92.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.525 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -65.99 -39.91 90.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.203 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.16 -51.23 70.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.623 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.455 HG21 ' CE1' ' A' ' 95' ' ' PHE . 14.5 p -72.46 -35.99 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.295 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -56.41 -45.02 80.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.686 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.31 -42.23 72.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.709 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -67.49 -27.15 66.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.455 ' CE1' HG21 ' A' ' 91' ' ' VAL . 2.7 m-85 -81.97 -52.06 7.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.835 0.35 . . . . 0.0 111.331 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.3 t -57.08 -37.43 71.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.101 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -76.11 -33.05 59.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.339 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.13 84.63 61.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.539 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -66.27 136.75 44.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.714 2.276 . . . . 0.0 111.987 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.58 56.9 22.22 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.46 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.51 ' HB3' HG22 ' A' ' 46' ' ' THR . 0.7 OUTLIER -101.05 -161.8 0.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 111.189 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.63 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 1.5 m -125.36 114.05 18.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.268 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 39.1 t -106.88 151.05 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -119.0 140.9 49.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.79 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.56 HG13 ' CG2' ' A' ' 118' ' ' VAL . 99.4 t -139.36 166.37 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.491 ' N ' HG12 ' A' ' 105' ' ' VAL . 2.8 t60 -67.06 156.19 36.72 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.147 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 25' ' ' THR . 44.3 t -68.46 105.68 2.28 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG11 ' HD3' ' A' ' 115' ' ' PRO . 34.7 m -75.32 0.28 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.107 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.54 -8.56 2.89 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.08 -138.42 4.87 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mt -114.36 127.4 55.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.9 -156.29 8.71 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.154 -1.022 . . . . 0.0 113.121 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.544 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.31 -17.11 7.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.977 0.417 . . . . 0.0 111.758 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.654 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.67 -46.37 98.33 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.654 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 8.6 Cg_endo -52.82 -48.45 21.99 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.059 1.84 . . . . 0.0 112.506 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 59.8 t -56.55 -51.74 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.007 0.432 . . . . 0.0 110.285 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.432 HD11 ' CD2' ' A' ' 71' ' ' TRP . 10.3 mt -52.97 -48.35 67.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.614 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.56 ' CG2' HG13 ' A' ' 105' ' ' VAL . 41.6 t -51.76 -50.56 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.721 0.296 . . . . 0.0 111.464 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.8 -46.91 67.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.327 0.584 . . . . 0.0 110.484 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.539 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -57.51 -31.41 66.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.623 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.493 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.28 -44.33 62.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.4 . . . . 0.0 110.517 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.412 HD13 ' HE2' ' A' ' 20' ' ' MET . 7.3 tp -66.82 -15.84 63.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.656 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.5 mt -57.23 -30.53 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.696 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -17.2 63.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.013 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.9 m -79.99 -23.31 41.65 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.13 -96.64 0.17 Allowed Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.778 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 1.3 ptt? -63.55 72.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.95 -67.42 0.43 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 7.0 t80 -67.74 -32.73 73.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.004 0.43 . . . . 0.0 110.959 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.48 -52.11 17.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.252 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 41.6 t0 -69.32 -35.86 76.38 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.554 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -61.63 -50.31 73.05 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.771 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -73.92 -37.99 48.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.537 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -74.08 -49.71 22.82 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -70.19 -34.32 72.8 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.72 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.23 -29.86 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 110.473 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.16 -43.23 82.81 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.633 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -45.55 91.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 110.598 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.37 151.41 23.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.223 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.7 116.47 14.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.568 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.35 163.67 15.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.074 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.04 -174.86 0.08 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.555 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.4 9.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.56 0.68 . . . . 0.0 111.443 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.412 ' CG2' ' HG3' ' A' ' 148' ' ' GLN . 1.6 pt -88.4 109.57 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.543 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -113.13 -76.72 0.58 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.75 -60.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.8 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 10.5 tmtt? -55.94 -52.05 65.51 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.412 ' HG3' ' CG2' ' A' ' 144' ' ' ILE . 17.6 tm0? -58.3 -51.52 69.43 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.02 -41.0 68.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 50.0 m -70.53 -39.69 73.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.779 0.323 . . . . 0.0 111.524 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.8 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.35 -50.97 63.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.228 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 129' ' ' TYR . 0.7 OUTLIER -66.87 -31.23 71.69 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.708 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.57 -37.7 87.19 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -23.94 59.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.545 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.492 ' CE2' HD12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -66.21 -40.63 90.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.286 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.9 88.21 3.45 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.563 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.68 153.08 79.73 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.669 2.246 . . . . 0.0 112.521 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -147.24 123.47 10.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.477 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -57.99 -32.6 68.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.035 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.3 -30.8 69.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.95 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.38 -41.41 76.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.38 92.73 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -74.11 156.04 37.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -138.18 132.63 32.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.56 138.1 44.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.415 ' HG3' ' CE1' ' A' ' 169' ' ' HIS . 42.9 Cg_endo -67.58 158.74 55.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.495 2.13 . . . . 0.0 112.29 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -75.62 -37.4 59.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.977 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -143.03 147.1 34.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.415 ' CE1' ' HG3' ' A' ' 166' ' ' PRO . 1.7 m-70 -116.71 154.95 29.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -101.24 -33.49 10.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.85 175.94 9.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.879 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -107.32 98.72 8.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.878 0.371 . . . . 0.0 110.894 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -115.37 -39.82 3.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -150.07 -60.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.906 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.17 110.81 3.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -76.33 -37.9 56.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -167.69 162.79 14.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -156.15 159.63 39.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.0 133.96 9.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.771 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.16 90.94 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.357 2.038 . . . . 0.0 112.364 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.33 153.71 95.62 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.011 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.52 160.22 49.07 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.596 2.197 . . . . 0.0 112.378 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.408 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 18.5 t -143.26 126.89 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.853 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 5.5 pt-20 -109.38 116.68 32.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.895 0.379 . . . . 0.0 111.618 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.417 HG13 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -107.42 118.53 55.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.3 p -140.97 140.53 34.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.106 0.479 . . . . 0.0 112.056 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.478 ' CD2' ' HE3' ' A' ' 127' ' ' MET . 0.0 OUTLIER -141.03 147.56 38.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.701 178.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 1.3 mmmp? 64.59 -90.73 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.273 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.51 -45.02 1.21 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.403 ' CE ' ' HG ' ' A' ' 122' ' ' LEU . 2.7 ppp? -73.68 164.76 26.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 111.728 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -139.2 164.32 30.11 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.475 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.463 ' CE1' ' CG1' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -134.18 141.63 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.4 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.542 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -114.9 133.86 55.63 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.107 0.48 . . . . 0.0 111.038 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.517 HG23 ' HA ' ' A' ' 107' ' ' CYS . 1.7 mm -117.92 106.56 20.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.156 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -134.67 166.83 22.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.15 0.5 . . . . 0.0 111.509 -179.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.522 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 7.3 p80 -81.31 151.77 27.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.175 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -63.02 154.42 77.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.023 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.514 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.3 Cg_exo -54.72 139.03 77.17 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.329 2.019 . . . . 0.0 113.245 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.439 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 29.8 p -98.59 174.21 6.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.096 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -92.75 -9.89 39.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.64 -30.85 14.73 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 p -139.79 89.56 2.32 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.244 -0.582 . . . . 0.0 112.357 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.439 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.27 -52.27 7.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 0.0 111.169 178.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.427 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -58.59 -46.09 87.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.352 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.7 m -57.83 -32.45 67.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.841 0.353 . . . . 0.0 111.148 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.522 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -74.16 -47.99 32.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.114 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 34' ' ' SER . 10.8 pt -56.12 -38.84 55.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.55 . . . . 0.0 110.539 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.1 -51.94 61.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.369 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.535 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.1 m-20 -69.43 -50.21 47.91 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.866 0.365 . . . . 0.0 111.72 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD22 ' CE1' ' A' ' 36' ' ' PHE . 57.6 mt -56.12 -44.75 79.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.958 0.408 . . . . 0.0 110.326 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -78.18 -26.67 47.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -52.74 -44.13 66.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.311 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.542 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 16.8 t80 -63.45 -38.17 90.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.73 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.697 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.41 -176.96 40.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.943 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.71 118.05 20.33 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.579 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.3 m -165.06 -170.27 1.89 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.822 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 67' ' ' THR . 1.5 t -64.91 150.75 47.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.458 0.647 . . . . 0.0 110.122 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 48.2 t -126.33 133.69 68.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.817 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.623 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 8.5 p -115.24 105.45 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.155 0.502 . . . . 0.0 111.184 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.52 110.9 21.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.755 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.511 HG13 ' NE ' ' A' ' 113' ' ' ARG . 39.6 t -103.28 91.27 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.55 0.691 . . . . 0.0 110.236 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.2 171.43 20.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.05 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.78 130.7 44.51 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.55 121.93 18.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.0 p -120.63 -47.38 2.32 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.948 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.43 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 4.2 m-85 -130.23 84.4 2.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.288 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.4 -35.85 46.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -78.84 -48.43 14.74 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.404 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -45.67 -50.26 33.39 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.226 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.43 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 39.4 Cg_exo -61.64 -42.13 34.72 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.543 2.162 . . . . 0.0 113.639 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.406 ' CD2' ' CG1' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -71.32 -45.65 62.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.68 -49.29 18.78 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -61.41 -39.4 90.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.479 ' CB ' HG12 ' A' ' 66' ' ' ILE . 45.8 m-20 -101.76 -11.39 19.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 53.2 25.17 24.63 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.771 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.479 HG12 ' CB ' ' A' ' 64' ' ' ASP . 8.9 pt -107.52 149.08 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.854 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 47' ' ' THR . 63.9 p -77.46 135.44 38.26 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 69' ' ' VAL . 11.7 p -140.17 150.08 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.505 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.6 t -103.35 132.08 50.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.86 106.65 18.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.172 0.51 . . . . 0.0 110.706 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.441 ' CE3' HD11 ' A' ' 117' ' ' LEU . 4.5 m95 -111.25 103.73 55.3 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.498 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -107.43 178.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.472 2.782 . . . . 0.0 113.008 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.435 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -126.27 120.48 30.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.686 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.34 -176.28 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -54.9 -24.82 25.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.843 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.42 88.19 0.2 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.441 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.451 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -85.71 124.65 70.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 O-C-N 122.91 -0.17 . . . . 0.0 110.749 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.71 101.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.68 2.253 . . . . 0.0 112.582 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.641 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 51.3 Cg_exo -55.05 -44.06 53.27 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.813 2.342 . . . . 0.0 114.021 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 5.0 Cg_endo -49.27 147.94 11.05 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.277 1.985 . . . . 0.0 113.465 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -66.1 -19.32 67.91 Favored Glycine 0 C--N 1.33 0.208 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.103 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 2.6 tttt -50.23 -29.53 9.67 Favored 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 123.457 0.151 . . . . 0.0 111.146 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.4 HG13 ' CZ2' ' A' ' 71' ' ' TRP . 21.6 t -54.73 -48.17 72.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.517 HG11 ' OH ' ' A' ' 151' ' ' TYR . 78.4 t -59.34 -38.05 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.207 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 8.1 mt-10 -58.16 -31.18 67.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.57 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.07 -50.68 63.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.912 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.623 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -67.1 -27.03 67.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 120' ' ' LEU . 26.3 mt -63.42 -39.29 94.1 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.966 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.4 m -66.8 -44.95 79.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.029 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.27 -51.41 69.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.483 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.0 p -69.77 -35.87 67.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.718 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.65 -45.22 73.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.81 -43.91 74.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.687 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -26.22 65.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.126 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.04 -52.0 7.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 111.192 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 15.9 t -67.05 -34.96 78.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.176 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -33.08 59.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.161 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.12 96.3 37.26 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.386 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.94 132.42 23.01 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.457 2.105 . . . . 0.0 112.058 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.04 56.12 27.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.174 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.5 p -101.07 169.38 8.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 111.232 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.697 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -100.68 113.78 26.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.573 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.4 t -107.85 151.29 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.438 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . . . -120.94 140.87 51.25 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.323 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 49' ' ' VAL . 3.0 t -140.07 166.54 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.458 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 2.7 t60 -67.97 155.84 38.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -68.84 105.61 2.41 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.432 HG11 ' CA ' ' A' ' 115' ' ' PRO . 32.0 m -75.39 -0.04 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.01 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.77 -8.5 3.06 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.97 -128.77 3.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.543 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.535 ' HA ' ' HA2' ' A' ' 142' ' ' GLY . 0.1 OUTLIER -132.09 127.4 35.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -171.31 -142.31 3.63 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.397 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NE ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.44 -21.8 5.67 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.994 0.426 . . . . 0.0 111.89 -178.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.649 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.17 -46.8 82.9 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.5 Cg_endo -52.13 -48.49 21.42 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.296 1.997 . . . . 0.0 112.867 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.23 -41.79 84.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.674 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.441 HD11 ' CE3' ' A' ' 71' ' ' TRP . 7.1 mt -61.06 -50.08 74.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.737 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.451 HG13 ' CD1' ' A' ' 22' ' ' PHE . 12.0 t -53.76 -55.52 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.417 ' HB3' ' CB ' ' A' ' 132' ' ' ALA . . . -60.2 -47.14 87.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.129 0.49 . . . . 0.0 110.839 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.57 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 3.3 mm? -54.59 -30.76 55.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.044 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.512 ' HB1' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.33 -49.99 30.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.046 0.45 . . . . 0.0 110.54 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -62.62 -15.67 52.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.083 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 120' ' ' LEU . 1.2 mt -57.45 -34.58 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.637 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.31 -15.38 15.65 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.81 11.38 3.28 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 116.99 -85.53 0.39 Allowed Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.158 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.42 78.39 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.534 ' CB ' HG21 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -62.37 -67.71 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.54 ' HA ' HD22 ' A' ' 152' ' ' LEU . 6.4 t80 -74.98 -30.52 61.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.122 0.487 . . . . 0.0 110.544 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -72.6 -46.64 53.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.034 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 127' ' ' MET . 51.5 t0 -70.22 -47.3 62.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.381 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.525 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -58.32 -50.32 74.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.871 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.445 HD13 HG23 ' A' ' 133' ' ' ILE . 32.7 mm -69.54 -37.85 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.46 -49.93 20.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -69.61 -34.67 74.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.647 0.261 . . . . 0.0 110.977 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.8 tt -74.21 -34.05 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.0 110.645 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -63.46 -45.9 88.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -39.79 85.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.023 0.44 . . . . 0.0 110.499 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -87.09 152.27 22.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.68 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.66 117.89 14.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.413 ' CD ' HG12 ' A' ' 136' ' ' ILE . 0.1 OUTLIER -114.28 163.34 15.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.946 -179.081 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -62.26 -156.55 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.329 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.2 98.71 11.93 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.942 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.1 pt -88.9 108.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.815 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -113.66 -77.38 0.58 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 119.88 -0.728 . . . . 0.0 112.756 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.49 -60.8 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.696 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -53.21 -51.78 61.02 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.84 -52.09 66.47 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.28 -40.0 59.14 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.3 m -69.47 -42.71 74.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.878 0.37 . . . . 0.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.696 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -63.59 -50.56 68.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.54 HD22 ' HA ' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -65.29 -36.51 84.3 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.784 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -55.92 -39.82 72.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -74.13 -24.85 59.5 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.213 178.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.407 ' CD2' HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -66.17 -39.99 90.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.34 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.97 113.91 62.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.168 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.05 153.31 26.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.57 2.18 . . . . 0.0 112.063 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -141.21 123.27 15.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.118 0.485 . . . . 0.0 110.45 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -71.6 -21.0 61.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.17 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -61.27 -36.8 81.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.09 -48.06 8.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.181 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -171.9 3.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.16 160.62 27.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.34 124.67 10.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -89.6 106.96 15.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.41 177.11 4.91 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.439 2.093 . . . . 0.0 112.286 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -157.04 130.44 7.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.5 m -147.54 158.66 44.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.19 -38.8 3.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.9 -53.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 3.9 t -151.28 -48.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 46.0 mtt85 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.904 179.901 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.3 p -98.34 120.24 38.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -91.9 -64.31 1.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.9 mtt 60.55 92.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.93 124.39 24.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.067 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -98.12 106.14 18.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.8 mmt -142.66 123.92 14.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -105.04 105.84 16.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.95 101.98 1.44 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.63 98.36 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.345 2.03 . . . . 0.0 112.428 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.31 151.48 53.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.014 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 58.7 Cg_endo -72.1 152.03 56.19 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.468 2.112 . . . . 0.0 112.305 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.409 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 19.1 t -144.09 126.94 11.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 mp0 -112.77 116.84 30.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.904 0.383 . . . . 0.0 111.611 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.485 HG11 ' CD2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -106.84 118.33 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.5 p -141.29 143.68 34.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.589 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -133.36 158.8 42.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.248 178.167 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 45.7 -93.16 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.302 0.241 . . . . 0.0 111.384 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -127.04 -29.31 2.8 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.417 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 4.3 ppp? -73.65 159.13 33.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.58 0.228 . . . . 0.0 111.183 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -141.63 164.06 31.22 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.143 0.497 . . . . 0.0 111.807 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' CE1' HG13 ' A' ' 118' ' ' VAL . 3.4 m-85 -138.14 144.31 40.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.933 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.534 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -119.39 135.49 54.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.033 0.444 . . . . 0.0 111.002 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.455 HD12 ' CG1' ' A' ' 108' ' ' VAL . 5.1 mm -118.51 106.69 20.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.64 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.9 OUTLIER -130.36 165.31 22.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.48 0.657 . . . . 0.0 111.943 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.525 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.4 p80 -81.89 152.58 26.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.941 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -62.42 154.76 70.81 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.417 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.1 Cg_exo -54.09 136.65 68.14 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.246 1.964 . . . . 0.0 113.162 -177.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -98.64 147.03 25.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.302 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -68.68 -12.36 61.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.49 -31.41 14.58 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.2 p -139.97 88.81 2.26 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.119 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.91 -52.23 7.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.221 0.534 . . . . 0.0 111.359 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.421 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 1.7 m -56.44 -46.17 80.44 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.49 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.8 m -57.62 -31.92 66.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.853 0.359 . . . . 0.0 111.286 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.525 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -75.3 -47.77 26.34 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.421 ' CG1' ' O ' ' A' ' 34' ' ' SER . 11.8 pt -55.83 -39.12 54.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.192 0.52 . . . . 0.0 110.648 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.38 -52.08 56.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.46 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.505 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 7.1 m-20 -68.06 -50.12 57.13 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.82 0.343 . . . . 0.0 111.799 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.441 ' HG ' ' CD1' ' A' ' 36' ' ' PHE . 63.4 mt -55.76 -45.78 78.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.427 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -77.05 -26.64 53.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.119 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 7.0 mttt -53.12 -44.74 67.93 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.288 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.534 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 14.0 t80 -63.43 -38.56 91.6 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.709 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.679 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.35 -179.57 39.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.038 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.55 117.25 19.31 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.608 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 0.8 OUTLIER -164.9 -169.77 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.892 177.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 67' ' ' THR . 9.1 p -64.59 160.08 20.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.455 0.645 . . . . 0.0 110.686 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 104' ' ' ALA . 57.2 t -139.0 137.01 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.078 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.556 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 11.3 p -115.52 104.3 16.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.479 0.657 . . . . 0.0 111.385 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -115.21 111.04 20.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.028 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.559 HG13 ' HD3' ' A' ' 113' ' ' ARG . 11.9 t -106.49 91.48 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.405 0.621 . . . . 0.0 109.914 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.4 p -157.68 171.24 20.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.77 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.403 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 2.2 mm-40 -66.62 130.5 43.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 p -73.37 122.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.9 p -120.0 -47.7 2.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.254 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.4 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.2 m-85 -130.6 83.67 2.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.467 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.2 -36.61 39.89 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -79.6 -48.58 13.55 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.458 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.56 -56.97 7.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 61.5 Cg_endo -72.99 -34.71 6.11 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.47 2.113 . . . . 0.0 113.811 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.422 HD22 HG11 ' A' ' 68' ' ' VAL . 2.0 mm? -71.1 -45.44 63.68 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.21 -28.91 60.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp -78.92 -36.57 41.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.499 ' O ' HG13 ' A' ' 66' ' ' ILE . 1.2 m-20 -101.76 -12.27 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.28 23.95 6.52 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.11 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 64' ' ' ASP . 28.1 mt -93.15 147.38 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.728 0.299 . . . . 0.0 111.029 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 47' ' ' THR . 27.8 m -78.52 129.58 35.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 48' ' ' VAL . 6.1 p -145.07 152.46 14.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.261 0.553 . . . . 0.0 111.945 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.402 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.6 t -103.76 129.25 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.258 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.0 106.72 18.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.972 0.415 . . . . 0.0 110.946 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.535 ' HH2' ' HA ' ' A' ' 84' ' ' VAL . 5.2 m0 -107.38 103.55 49.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.626 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -107.96 -163.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 123.617 2.878 . . . . 0.0 112.439 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -119.51 95.78 4.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.888 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -176.97 -99.57 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -76.22 -34.05 59.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.078 0.466 . . . . 0.0 110.509 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.08 76.63 0.39 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.781 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.437 ' O ' ' HG2' ' A' ' 80' ' ' PRO . . . -85.74 154.75 58.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 0.0 111.541 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.497 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 35.1 Cg_exo -61.9 -40.69 42.23 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.971 2.448 . . . . 0.0 113.768 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 78' ' ' PRO . 87.6 Cg_exo -40.24 -55.18 1.92 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.629 2.219 . . . . 0.0 113.915 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.488 ' CD ' ' HB2' ' A' ' 79' ' ' PRO . 18.0 Cg_endo -59.37 135.09 62.85 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.671 1.581 . . . . 0.0 111.823 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.455 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -67.07 -33.63 84.11 Favored Glycine 0 C--O 1.239 0.418 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.612 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 -45.46 69.16 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.675 0.274 . . . . 0.0 111.165 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.457 ' CG1' ' CZ2' ' A' ' 71' ' ' TRP . 26.1 t -55.05 -41.55 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.535 ' HA ' ' HH2' ' A' ' 71' ' ' TRP . 0.5 OUTLIER -53.55 -41.65 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.402 ' N ' HG13 ' A' ' 84' ' ' VAL . 24.7 mm-40 -65.83 -31.21 72.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.504 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -64.08 -50.94 66.37 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.556 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -67.52 -32.85 73.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.696 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.468 HD12 ' CE2' ' A' ' 155' ' ' TYR . 12.0 mt -57.01 -45.67 82.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.467 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -43.13 94.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.493 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -58.35 -51.66 68.87 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.009 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.437 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 13.8 p -70.96 -39.96 75.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.376 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -58.55 -41.02 84.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.924 0.393 . . . . 0.0 110.547 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.75 -48.17 75.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.642 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -25.7 62.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.437 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 2.0 m-85 -75.11 -51.73 12.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.7 t -60.0 -42.26 93.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.788 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -76.09 -33.06 59.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.08 92.12 46.55 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.275 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.22 138.29 15.89 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.637 2.225 . . . . 0.0 112.489 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.24 56.35 25.69 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.712 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.452 ' CB ' HG22 ' A' ' 46' ' ' THR . 0.8 OUTLIER -101.24 -172.49 2.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 111.176 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.679 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 m -108.29 113.55 26.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.145 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 46.0 t -111.3 149.55 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.183 0.516 . . . . 0.0 112.306 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.468 ' O ' ' CG1' ' A' ' 48' ' ' VAL . . . -119.96 144.3 47.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.949 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.539 HG11 ' CG2' ' A' ' 118' ' ' VAL . 96.5 t -140.17 166.32 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.711 0.291 . . . . 0.0 111.6 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.481 ' N ' HG13 ' A' ' 105' ' ' VAL . 3.2 t60 -67.34 155.74 38.19 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.344 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 26' ' ' HIS . 0.2 OUTLIER -68.61 106.59 2.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.413 0.625 . . . . 0.0 112.615 -178.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.455 ' CG1' HD12 ' A' ' 24' ' ' ILE . 28.0 m -75.33 0.53 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.221 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.19 -8.58 2.57 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.07 -124.86 2.87 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.4 mt -128.15 127.34 42.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.98 -158.17 9.17 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.261 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.559 ' HD3' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.19 -18.81 6.74 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.063 0.459 . . . . 0.0 111.776 -178.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.659 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -52.75 -46.2 96.53 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.6 Cg_endo -52.78 -48.44 22.01 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.043 1.829 . . . . 0.0 112.509 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.519 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 58.5 t -55.95 -51.88 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 0.0 109.94 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.423 HD22 ' CH2' ' A' ' 71' ' ' TRP . 8.8 mt -54.47 -46.2 73.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.583 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.539 ' CG2' HG11 ' A' ' 105' ' ' VAL . 17.0 t -51.42 -50.58 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 111.076 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.522 ' O ' HG13 ' A' ' 123' ' ' ILE . . . -54.03 -48.04 70.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.29 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.531 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 1.2 mt -53.97 -31.32 50.33 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.205 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.51 -50.61 29.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.716 0.293 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 17' ' ' TYR . 8.5 tp -66.55 -14.63 62.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.714 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.2 mt -58.49 -30.95 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.063 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -70.49 -16.55 62.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.411 ' HB2' HD12 ' A' ' 122' ' ' LEU . 0.5 OUTLIER -80.44 -23.24 40.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.67 -96.96 0.17 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.792 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.521 ' HE2' ' CD2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -63.12 74.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -70.73 -67.47 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.459 ' CD1' ' HB3' ' A' ' 152' ' ' LEU . 6.9 t80 -65.49 -34.86 79.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.933 0.397 . . . . 0.0 111.341 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -71.77 -51.5 22.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.454 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 32.8 t70 -70.14 -32.51 70.53 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.943 0.402 . . . . 0.0 111.06 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -62.3 -50.16 72.76 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.97 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 32.9 mm -74.5 -40.32 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.269 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -50.03 19.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.604 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -66.48 -38.98 88.47 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.29 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.0 OUTLIER -74.43 -27.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.709 0.29 . . . . 0.0 110.877 179.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 1.9 ttp85 -65.08 -42.2 94.31 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.797 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -45.43 91.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.888 0.375 . . . . 0.0 110.41 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' ILE . 6.7 mmtt -87.72 151.72 22.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.273 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 117.0 14.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.163 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 163.81 14.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.288 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -53.52 -173.61 0.05 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.011 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -84.13 99.5 10.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.213 0.507 . . . . 0.0 111.473 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.414 ' CG2' ' HG3' ' A' ' 148' ' ' GLN . 1.8 pt -88.17 109.5 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.407 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -113.13 -76.5 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.313 0.856 . . . . 0.0 113.313 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.7 p -99.63 -60.84 1.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.871 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.3 tmtt? -56.81 -51.87 67.27 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -176.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.414 ' HG3' ' CG2' ' A' ' 144' ' ' ILE . 9.8 tm0? -56.73 -51.22 69.68 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.98 -43.09 62.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 m -70.27 -39.71 74.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.771 0.319 . . . . 0.0 111.661 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.871 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -66.54 -50.91 61.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.468 ' CD2' ' CD1' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -66.49 -30.17 70.44 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.413 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.93 -40.12 96.66 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -22.72 61.46 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.58 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.541 ' CE2' HD13 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -66.21 -47.95 72.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.608 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.98 97.07 16.45 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.42 133.01 33.12 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.37 2.046 . . . . 0.0 112.189 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -147.15 123.58 11.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.67 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -77.99 -2.83 38.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.422 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -58.88 -31.08 68.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.876 0.37 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.25 -36.86 78.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -102.54 30.34 4.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -101.09 -62.8 1.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.63 136.89 36.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.8 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.36 129.81 94.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.817 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.29 -44.27 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.486 2.124 . . . . 0.0 112.304 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -75.92 -40.63 53.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.7 m -71.11 128.48 36.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -92.44 123.47 35.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.29 107.6 12.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.922 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.4 p -96.06 137.32 35.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.194 -0.907 . . . . 0.0 110.902 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -162.67 90.06 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 110.937 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -108.25 109.26 20.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.35 -47.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.82 108.6 18.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.073 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.18 -48.18 3.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.824 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 36.2 mtm -115.71 164.41 14.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -127.45 -45.3 1.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.2 130.59 49.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.36 122.91 12.06 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.412 2.075 . . . . 0.0 112.292 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.52 129.01 67.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.028 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.03 161.91 10.0 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.408 2.072 . . . . 0.0 112.126 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.411 ' CG1' ' HD3' ' A' ' 139' ' ' LYS . 3.7 t -137.74 126.97 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.817 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 11.6 pt-20 -107.42 116.92 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 111.752 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.463 HG12 ' CD2' ' A' ' 135' ' ' PHE . 0.7 OUTLIER -108.92 118.53 56.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.499 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.9 p -140.99 147.56 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 111.95 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CD2' ' HE2' ' A' ' 127' ' ' MET . 0.1 OUTLIER -144.04 126.35 15.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.282 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 38.0 mmtt 77.92 -87.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.278 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -129.38 -40.62 1.43 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.43 ' CE ' ' CE2' ' A' ' 22' ' ' PHE . 2.7 tmm? -73.74 154.41 39.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.884 0.373 . . . . 0.0 111.289 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.11 161.66 35.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 8.6 m-85 -132.09 145.75 51.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.3 mm? -117.81 129.21 55.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 110.791 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.518 HG21 ' HA ' ' A' ' 107' ' ' CYS . 2.1 mm -112.56 106.63 21.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -130.89 164.54 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.243 0.544 . . . . 0.0 111.987 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.519 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.4 p80 -81.24 152.33 27.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.797 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.6 153.46 77.76 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.521 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 9.6 Cg_endo -54.43 139.58 74.34 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.564 2.176 . . . . 0.0 113.475 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.439 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.6 p -98.86 174.38 6.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.095 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -98.24 -8.08 27.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -30.6 14.91 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 p -139.37 89.73 2.36 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.487 -0.485 . . . . 0.0 112.112 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.439 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -79.99 -52.28 8.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.122 0.487 . . . . 0.0 111.421 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.405 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.2 m -57.62 -45.38 85.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.083 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -32.03 67.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.797 0.332 . . . . 0.0 111.464 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CD2' ' HA ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -75.57 -48.01 24.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 34' ' ' SER . 11.9 pt -55.88 -39.21 55.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.178 0.513 . . . . 0.0 110.746 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.12 -52.08 51.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.58 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 4.8 m-20 -67.67 -50.14 59.26 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.905 0.384 . . . . 0.0 111.945 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.435 HD21 ' CE1' ' A' ' 36' ' ' PHE . 80.0 mt -55.79 -46.35 78.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.359 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -76.95 -26.71 54.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.083 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 5.3 mttt -52.91 -44.46 66.98 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.537 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 15.4 t80 -63.54 -38.62 91.81 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.734 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.672 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.6 -178.82 39.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.991 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.38 19.54 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.617 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 0.9 OUTLIER -165.19 -169.93 1.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.92 177.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 67' ' ' THR . 3.0 t -64.55 152.52 41.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.705 0.764 . . . . 0.0 110.437 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 104' ' ' ALA . 83.6 t -132.2 136.5 56.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.006 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.618 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 14.9 p -115.66 105.31 18.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.147 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.406 ' HG2' ' CG2' ' A' ' 68' ' ' VAL . 17.1 ptt180 -113.59 110.85 20.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.748 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.493 HG11 ' CD ' ' A' ' 113' ' ' ARG . 41.9 t -108.57 91.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.571 0.7 . . . . 0.0 110.327 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.7 p -157.82 171.03 21.02 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.041 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.27 130.25 42.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.6 t -70.22 122.19 21.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.5 p -120.51 -47.93 2.31 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.179 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.422 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.3 m-85 -130.77 83.91 2.15 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.623 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.13 -36.78 40.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.65 -48.58 13.5 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.444 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -45.92 -54.3 17.28 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.444 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 8.2 Cg_exo -73.1 -35.6 5.07 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.659 2.239 . . . . 0.0 113.653 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.417 ' CD2' ' CG1' ' A' ' 68' ' ' VAL . 2.1 mm? -71.03 -45.24 64.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.01 -28.97 60.72 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -81.02 -35.09 32.33 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.516 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -101.56 -12.45 18.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.48 25.61 4.6 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.378 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 64' ' ' ASP . 20.8 mt -95.36 147.72 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.672 0.272 . . . . 0.0 111.079 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 47' ' ' THR . 1.8 m -78.16 127.94 33.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 69' ' ' VAL . 10.5 p -145.18 153.95 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.151 0.501 . . . . 0.0 112.209 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.506 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.7 t -103.33 132.75 48.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -101.08 106.84 18.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.124 0.488 . . . . 0.0 110.931 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.454 ' CH2' ' HA ' ' A' ' 84' ' ' VAL . 4.8 m95 -111.4 103.25 54.8 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.739 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -109.45 -177.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.62 2.88 . . . . 0.0 112.657 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -126.41 122.22 34.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.848 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.16 -164.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.442 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -20.99 50.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.951 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -102.22 20.9 43.41 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.911 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.406 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -107.46 102.71 45.58 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.718 0.259 . . . . 0.0 110.711 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.14 109.42 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.745 2.297 . . . . 0.0 112.502 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.635 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 52.5 Cg_exo -53.02 -45.53 40.45 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.692 2.261 . . . . 0.0 113.852 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 8.0 Cg_endo -51.39 154.09 9.06 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.422 2.081 . . . . 0.0 113.662 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.73 -19.55 58.51 Favored Glycine 0 C--O 1.235 0.216 0 CA-C-N 114.979 -1.01 . . . . 0.0 113.52 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -50.85 -35.68 33.78 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.623 0.211 . . . . 0.0 111.009 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -44.7 63.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.557 ' CG1' HD12 ' A' ' 120' ' ' LEU . 39.4 t -55.33 -43.53 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.344 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -55.37 -31.62 61.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.263 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -50.07 70.15 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.419 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.618 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.9 -30.3 70.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 22.9 mt -59.6 -48.32 82.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.451 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 m -63.63 -40.45 96.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.189 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.57 -51.26 70.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.616 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.438 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 14.8 p -69.92 -35.92 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.092 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -48.06 78.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.76 92.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.748 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -26.78 63.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.139 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 2.7 m-85 -82.08 -52.0 7.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.229 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.0 t -59.51 -37.95 79.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.25 -33.05 59.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.278 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.09 95.31 39.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.509 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.46 134.12 15.14 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.553 2.169 . . . . 0.0 112.223 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 56.09 27.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.494 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.448 ' CB ' HG21 ' A' ' 46' ' ' THR . 0.9 OUTLIER -101.0 -164.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 0.0 111.248 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.672 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 m -117.74 113.51 21.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.32 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.0 t -108.71 151.03 11.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 111.983 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.462 ' HB2' ' CG2' ' A' ' 48' ' ' VAL . . . -122.99 141.79 51.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.963 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 49' ' ' VAL . 10.1 t -140.3 166.9 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.474 ' H ' HG11 ' A' ' 105' ' ' VAL . 3.1 t60 -66.76 156.1 36.37 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.441 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.518 ' HA ' HG21 ' A' ' 24' ' ' ILE . 49.8 t -68.34 106.05 2.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.314 0.578 . . . . 0.0 112.457 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.443 HG13 ' HD3' ' A' ' 115' ' ' PRO . 28.8 m -75.2 0.21 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.097 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.65 -8.63 3.03 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.47 -131.31 3.67 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.0 mt -124.42 127.42 47.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.75 -151.49 6.5 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.33 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.493 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.19 -21.26 5.95 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 111.805 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.647 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -51.28 -46.42 89.46 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 6.2 Cg_endo -52.02 -48.51 21.24 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.2 1.934 . . . . 0.0 112.978 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.1 -41.09 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.67 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.45 ' HB3' ' NE1' ' A' ' 87' ' ' TRP . 13.0 mt -60.24 -45.25 93.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.531 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.457 HG22 HG13 ' A' ' 105' ' ' VAL . 38.2 t -57.34 -55.14 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.72 -51.74 59.15 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.264 0.554 . . . . 0.0 110.94 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.581 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 6.7 mt -55.27 -30.48 60.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.16 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.467 ' HB1' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.93 -40.08 69.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 110.148 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.4 HD12 ' CE ' ' A' ' 20' ' ' MET . 6.4 tp -71.26 -14.36 62.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.8 mt -57.2 -30.7 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.661 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -16.61 63.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.9 p -79.53 -23.39 42.91 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.55 -96.66 0.17 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.805 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.519 ' HE2' ' CD2' ' A' ' 17' ' ' TYR . 1.4 ptt? -64.0 72.61 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.16 -67.61 0.42 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.475 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 5.8 t80 -67.73 -32.68 73.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 111.046 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -72.29 -51.91 18.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.321 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 46.8 t0 -67.12 -39.78 86.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 111.043 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.513 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -59.43 -50.0 75.63 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.203 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 35.6 mm -73.94 -36.28 44.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.645 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.22 -49.51 23.09 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -70.37 -36.91 74.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.627 0.251 . . . . 0.0 110.793 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.5 tt -74.22 -28.23 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.815 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 8.0 ttm180 -68.35 -47.92 66.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.818 0.342 . . . . 0.0 110.399 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -59.89 -45.02 93.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.443 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.411 ' HD3' ' CG1' ' A' ' 13' ' ' VAL . 1.0 OUTLIER -84.7 151.73 24.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.319 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.6 116.48 14.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.063 0.459 . . . . 0.0 110.667 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -115.39 163.47 15.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.844 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -55.07 -176.78 0.15 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.247 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.05 98.75 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.772 0.786 . . . . 0.0 110.751 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.433 ' CG2' ' HG3' ' A' ' 148' ' ' GLN . 1.0 OUTLIER -88.94 109.68 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.972 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -112.88 -76.71 0.58 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.397 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.8 p -99.77 -60.79 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.709 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.8 tmtt? -49.04 -51.44 31.1 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -177.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.433 ' HG3' ' CG2' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -56.29 -51.67 67.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.27 -39.37 59.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.3 t -74.12 -36.25 64.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.577 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.709 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -70.16 -50.68 37.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.193 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.548 ' HA ' ' HB2' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -67.11 -35.08 79.0 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.216 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.1 -43.58 82.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -25.24 65.27 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.336 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.548 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.11 -32.53 74.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.373 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.54 91.77 6.33 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.747 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.46 153.29 78.87 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.663 2.242 . . . . 0.0 112.585 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -146.98 123.56 11.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.44 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -53.72 -23.94 13.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.347 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -58.8 -27.86 65.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.016 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.17 -48.02 74.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.42 -169.49 1.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -115.47 156.25 26.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.983 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? 60.08 164.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -83.52 109.63 19.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.28 111.15 2.42 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.425 2.083 . . . . 0.0 112.325 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -90.78 -42.48 10.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.955 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.9 m -95.53 139.06 32.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.91 176.57 5.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.52 89.12 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.4 p -81.71 -46.38 14.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.951 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.947 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -104.94 -31.83 9.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -133.64 155.79 49.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -129.46 147.13 51.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.47 160.61 30.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.097 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -56.14 3.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.824 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.71 149.26 28.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -104.68 145.73 29.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -141.17 147.06 45.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.81 115.02 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.516 2.144 . . . . 0.0 112.31 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.6 145.76 40.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.09 165.2 33.38 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.628 2.219 . . . . 0.0 112.327 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 t -141.07 126.96 19.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.671 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -109.6 116.99 32.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.974 0.416 . . . . 0.0 111.607 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.473 HG12 ' CD2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -107.06 118.6 55.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.603 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.6 p -140.78 144.76 35.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.97 0.414 . . . . 0.0 111.72 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.525 ' CD2' ' HG2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -142.46 122.71 13.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.467 179.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 16.0 mmtt 84.12 -88.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.274 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -129.41 -40.46 1.43 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.733 0.302 . . . . 0.0 111.763 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.408 ' CE ' ' CD1' ' A' ' 122' ' ' LEU . 10.2 ptm -73.77 162.83 28.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.23 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -143.34 164.04 31.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.121 0.486 . . . . 0.0 111.5 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.473 ' CE1' ' CG1' ' A' ' 103' ' ' VAL . 0.7 OUTLIER -135.35 142.37 45.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.892 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.54 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -114.67 136.44 53.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.061 0.458 . . . . 0.0 110.939 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.426 ' CD1' HG21 ' A' ' 108' ' ' VAL . 14.4 mm -118.3 106.46 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.37 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -134.55 165.34 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.218 0.533 . . . . 0.0 112.008 -179.08 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.46 ' CD2' ' CZ ' ' A' ' 36' ' ' PHE . 48.6 p-80 -81.4 152.09 27.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.454 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -62.89 154.73 74.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.679 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.5 Cg_exo -54.64 139.93 76.27 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.187 1.925 . . . . 0.0 113.171 -177.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.457 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -98.69 174.31 6.47 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.108 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -93.78 -10.7 33.32 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.84 14.74 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.3 p -139.62 89.73 2.35 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.403 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.457 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.29 -52.22 7.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.077 0.465 . . . . 0.0 111.228 178.139 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.423 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.7 p -57.55 -45.8 84.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.33 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 m -57.72 -31.98 66.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.851 0.357 . . . . 0.0 111.187 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.502 ' CD2' ' HA ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -75.39 -47.78 25.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 34' ' ' SER . 10.9 pt -55.64 -38.85 51.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 110.609 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.19 -51.4 58.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.486 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -68.27 -50.19 55.41 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.87 0.367 . . . . 0.0 111.989 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.434 HD23 ' CE1' ' A' ' 36' ' ' PHE . 85.6 mt -55.7 -45.52 77.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.481 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.98 -26.57 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.02 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 12.2 mttt -52.49 -44.56 65.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.358 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.54 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 11.0 t80 -63.45 -38.43 91.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.664 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.661 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 162.99 -178.41 38.71 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.921 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.52 19.76 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.608 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.3 m -164.9 -170.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.833 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 67' ' ' THR . 2.6 t -64.51 159.64 21.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.355 0.598 . . . . 0.0 110.456 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 104' ' ' ALA . 57.7 t -138.48 138.83 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.322 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.676 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 12.4 p -115.57 104.71 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.261 0.553 . . . . 0.0 110.816 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -114.56 110.79 20.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.322 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 6.3 t -107.17 90.95 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.421 0.629 . . . . 0.0 109.376 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.3 p -158.02 171.38 20.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.938 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -66.45 130.41 43.11 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 m -76.0 122.35 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -120.15 -47.66 2.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.44 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.425 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -130.63 83.88 2.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.708 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.09 -36.54 40.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -79.51 -48.57 13.66 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.437 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.34 -54.13 19.75 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 8.1 Cg_exo -73.26 -34.67 5.82 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.623 2.216 . . . . 0.0 113.48 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.417 ' CD2' ' CG1' ' A' ' 68' ' ' VAL . 2.1 mm? -71.09 -45.19 64.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.21 -28.86 60.13 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -79.04 -36.63 40.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' O ' HG13 ' A' ' 66' ' ' ILE . 3.8 m-20 -101.57 -12.4 18.51 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.03 23.95 6.06 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.285 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 64' ' ' ASP . 24.6 mt -92.82 147.38 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 110.927 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 47' ' ' THR . 82.2 p -78.69 129.19 34.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.417 ' CG1' ' CD2' ' A' ' 61' ' ' LEU . 5.9 p -145.16 154.44 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.2 0.524 . . . . 0.0 112.123 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.75 133.59 47.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.108 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.99 106.78 18.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.139 0.495 . . . . 0.0 110.396 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.4 m95 -111.91 104.27 55.91 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.049 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -104.08 160.43 0.22 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.162 2.575 . . . . 0.0 112.645 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.444 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 15.9 t80 -126.25 95.99 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.833 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.1 -175.99 3.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.703 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.83 -24.08 21.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.049 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.46 75.61 0.39 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.584 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 73' ' ' PHE . . . -85.97 148.91 49.25 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.497 0.189 . . . . 0.0 110.901 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.428 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . 65.9 Cg_endo -73.72 109.64 2.9 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.637 2.225 . . . . 0.0 112.597 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.624 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 26.5 Cg_exo -63.44 -37.76 46.81 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.895 2.397 . . . . 0.0 114.492 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 18.3 Cg_endo -61.49 144.89 98.26 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.934 1.756 . . . . 0.0 113.596 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.1 -19.8 68.37 Favored Glycine 0 C--O 1.236 0.275 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.088 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -50.58 -29.52 11.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.503 0.192 . . . . 0.0 110.977 -178.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.45 ' CG1' ' CH2' ' A' ' 71' ' ' TRP . 40.1 t -56.98 -47.8 82.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG12 ' CE2' ' A' ' 151' ' ' TYR . 54.4 t -55.22 -40.87 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.817 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 2.7 mt-10 -57.3 -31.39 65.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.532 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.04 -50.46 68.33 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.257 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.676 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.08 -29.9 70.32 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.7 mt -62.46 -38.61 90.47 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.312 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.57 -43.78 79.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.036 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.47 -51.29 70.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.603 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.491 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 10.2 p -69.14 -35.9 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -57.3 -46.38 83.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.756 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.5 84.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -26.58 64.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.241 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.491 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 3.8 m-30 -81.99 -50.88 8.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.25 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 51.4 t -59.88 -38.04 81.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.921 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -76.21 -33.09 59.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.96 90.21 50.76 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.425 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.12 135.77 25.71 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.879 2.386 . . . . 0.0 112.231 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.07 55.39 30.91 Favored Glycine 0 C--N 1.329 0.154 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.696 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.457 ' CB ' HG23 ' A' ' 46' ' ' THR . 4.5 m -101.3 -163.46 1.02 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.25 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.661 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.0 m -119.34 113.87 21.48 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.319 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.497 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 38.1 t -109.2 151.0 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . . . -120.65 145.12 47.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.224 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 49' ' ' VAL . 4.0 t -140.31 166.78 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.458 ' H ' HG13 ' A' ' 105' ' ' VAL . 3.4 t60 -67.29 155.52 38.68 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.018 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.55 ' N ' ' O ' ' A' ' 25' ' ' THR . 38.5 t -69.0 98.36 0.95 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.506 0.67 . . . . 0.0 112.37 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.461 HG11 ' HG3' ' A' ' 115' ' ' PRO . 2.7 t -75.76 1.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.854 -1.067 . . . . 0.0 112.347 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.42 -8.62 1.87 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.86 -120.62 2.55 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.412 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 8.3 mt -126.46 127.29 45.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.91 -154.34 7.47 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.839 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.554 ' HD3' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.25 -17.65 7.06 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.082 0.468 . . . . 0.0 111.834 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.652 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -51.44 -46.21 90.22 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 9.4 Cg_endo -52.11 -48.51 21.27 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.491 2.128 . . . . 0.0 113.303 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.427 ' O ' ' CD2' ' A' ' 120' ' ' LEU . 24.0 t -61.64 -44.6 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.029 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.404 HD12 ' CG2' ' A' ' 49' ' ' VAL . 2.3 mt -59.66 -46.06 90.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.573 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.493 ' CG2' HG12 ' A' ' 105' ' ' VAL . 97.5 t -56.44 -55.19 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.645 0.26 . . . . 0.0 111.562 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.76 -48.61 66.65 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.181 0.515 . . . . 0.0 110.835 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 3.3 mm? -56.88 -30.87 64.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.588 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.428 ' HB3' ' CZ2' ' A' ' 87' ' ' TRP . . . -70.92 -34.23 71.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.4 . . . . 0.0 110.092 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.408 ' CD1' ' CE ' ' A' ' 20' ' ' MET . 1.4 tp -75.32 -16.66 60.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.528 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.687 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.9 mt -57.28 -30.66 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.179 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.409 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 10.6 pt-20 -73.81 -16.72 61.14 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.3 t -79.49 -23.29 43.08 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.66 -97.6 0.18 Allowed Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.576 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.528 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 1.1 ptt? -63.03 73.61 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.687 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.03 -67.58 0.42 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 152' ' ' LEU . 5.2 t80 -69.33 -32.3 71.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.042 0.448 . . . . 0.0 110.914 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.28 -50.44 27.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.36 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 127' ' ' MET . 43.3 t0 -67.59 -37.17 82.19 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.575 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -61.05 -50.2 74.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.991 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.486 HG23 HD12 ' A' ' 133' ' ' ILE . 24.6 mm -72.8 -38.45 57.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 111.681 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -49.6 22.9 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -70.64 -34.11 71.71 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.864 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.9 OUTLIER -74.07 -30.64 27.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.798 0.332 . . . . 0.0 110.393 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -65.42 -48.95 71.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.29 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -59.93 -45.1 93.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.593 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -83.19 151.89 25.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.637 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 117.46 14.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.6 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.459 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -114.44 163.17 15.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.968 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.412 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -61.02 -157.49 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.274 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.43 98.71 11.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.568 0.684 . . . . 0.0 110.461 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.444 ' CG2' ' HB3' ' A' ' 148' ' ' GLN . 61.4 mt -88.71 109.0 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.058 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -113.87 -77.74 0.58 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.854 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.5 p -101.13 -60.95 1.43 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.801 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.2 tmtt? -48.99 -52.06 27.07 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.444 ' HB3' ' CG2' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -56.2 -51.82 66.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.431 ' CD2' ' CG2' ' A' ' 144' ' ' ILE . 3.1 mm? -73.24 -47.0 46.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.5 m -66.92 -37.24 83.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.801 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -67.89 -50.92 53.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.319 -179.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -70.71 -31.32 68.15 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.344 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.14 -39.02 81.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -29.17 64.78 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.448 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.449 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.06 -30.17 70.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.665 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.76 88.98 3.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.03 153.25 78.44 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.63 2.22 . . . . 0.0 112.378 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -147.1 123.48 10.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.485 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -13.27 62.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.332 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -41.58 87.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.879 0.371 . . . . 0.0 110.978 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.8 tp -86.09 -47.94 9.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -74.58 166.37 23.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -91.12 129.94 37.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -102.1 120.65 40.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.31 138.05 68.0 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.63 -44.8 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.449 2.099 . . . . 0.0 112.309 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -105.22 129.04 53.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.9 p -99.0 108.88 21.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -87.31 118.59 26.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.51 125.05 52.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.3 t -98.49 116.18 30.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.962 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.894 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -86.51 -177.51 6.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 110.83 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -112.11 129.69 56.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.7 ptp -88.22 168.75 12.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.99 95.17 2.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -124.59 120.13 31.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.2 tpp -102.26 111.7 24.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.36 126.18 40.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.833 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -167.97 104.16 0.56 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.85 116.86 4.66 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.346 2.031 . . . . 0.0 112.281 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.85 160.68 65.88 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.38 152.67 66.22 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.565 2.176 . . . . 0.0 112.386 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.467 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.5 t -144.07 127.64 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.903 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -110.71 116.8 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.805 0.336 . . . . 0.0 111.353 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.433 HG13 ' CD2' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -106.72 118.33 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.1 p -141.2 142.84 33.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.624 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 1.4 p90 -134.51 170.21 16.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.113 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.624 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 43.63 -96.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.053 0.141 . . . . 0.0 111.167 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.432 ' H ' ' CG ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -128.92 -30.78 2.21 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.483 ' HE3' ' CD1' ' A' ' 22' ' ' PHE . 3.9 ppp? -73.74 169.13 17.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.687 0.28 . . . . 0.0 111.23 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -147.94 161.23 41.74 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.979 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CD1' ' HE3' ' A' ' 20' ' ' MET . 1.3 m-85 -134.11 150.72 51.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.377 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.533 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -121.13 136.36 54.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.122 0.487 . . . . 0.0 111.557 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.535 HG21 ' HA ' ' A' ' 107' ' ' CYS . 1.9 mm -118.19 106.58 20.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.13 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -134.78 166.99 21.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.287 0.565 . . . . 0.0 111.745 -178.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 36' ' ' PHE . 49.1 p-80 -81.33 152.03 27.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.103 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -62.88 154.53 75.66 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.043 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.7 Cg_exo -54.77 138.91 77.5 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.389 2.059 . . . . 0.0 113.312 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.44 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 28.9 p -98.72 174.41 6.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.231 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -93.79 -9.73 36.53 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.59 -30.81 14.77 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -139.62 89.58 2.33 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.274 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.44 -52.27 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.138 0.494 . . . . 0.0 111.174 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.413 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 2.1 p -58.49 -45.21 89.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.162 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 m -57.99 -32.78 68.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.9 0.381 . . . . 0.0 111.339 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.502 ' CD2' ' HA ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -74.51 -48.11 29.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.148 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 34' ' ' SER . 12.0 pt -56.08 -39.15 56.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.265 0.555 . . . . 0.0 110.645 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.3 -50.9 63.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.513 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -69.63 -50.13 47.26 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.887 0.375 . . . . 0.0 111.813 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.432 HD23 ' CE1' ' A' ' 36' ' ' PHE . 53.0 mt -56.19 -44.19 79.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.305 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -78.89 -26.75 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.021 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -52.92 -43.48 66.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.29 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.533 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 14.6 t80 -63.41 -38.4 90.99 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.663 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.663 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 166.31 -177.43 41.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.793 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.56 117.47 19.62 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.639 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.4 m -165.25 -169.93 1.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.687 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 67' ' ' THR . 5.1 p -64.81 144.49 57.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.572 0.701 . . . . 0.0 110.448 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.461 ' CG2' ' HB3' ' A' ' 104' ' ' ALA . 61.0 t -122.18 128.14 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.868 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.659 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 2.1 p -115.44 105.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.355 0.597 . . . . 0.0 111.692 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 111.02 21.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.737 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG12 ' NE ' ' A' ' 113' ' ' ARG . 38.8 t -101.22 92.38 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.498 0.666 . . . . 0.0 110.405 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.18 171.46 20.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.072 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -64.62 130.7 44.62 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 m -68.73 122.05 19.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.411 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 6.5 m -120.45 -47.0 2.36 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.143 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.444 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 2.8 m-85 -129.79 84.89 2.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.362 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -78.21 -35.64 48.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -78.81 -48.49 14.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.45 -51.24 36.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 47.5 Cg_exo -57.13 -42.33 64.62 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.242 . . . . 0.0 113.83 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -45.47 63.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -49.12 19.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -74.46 -26.86 60.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.438 ' HB3' ' CG1' ' A' ' 66' ' ' ILE . 3.1 t0 -99.92 -11.57 20.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.54 25.98 3.49 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.14 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.438 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 4.7 pt -122.76 148.73 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.601 0.239 . . . . 0.0 110.573 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 47' ' ' THR . 10.3 t -77.15 132.87 39.03 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.495 HG21 ' N ' ' A' ' 69' ' ' VAL . 8.0 p -139.71 149.38 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.155 0.502 . . . . 0.0 111.984 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.495 ' N ' HG21 ' A' ' 68' ' ' VAL . 2.8 t -103.3 131.6 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.91 106.63 17.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.585 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.443 ' CH2' ' CG1' ' A' ' 83' ' ' VAL . 4.4 m95 -110.22 103.46 53.86 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.555 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -108.78 -175.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 123.538 2.825 . . . . 0.0 112.882 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.433 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 2.4 t80 -126.4 102.11 7.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.756 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.24 173.02 7.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.776 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -55.02 -24.26 23.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.54 45.17 1.36 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.488 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -85.87 102.66 2.82 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.551 0.176 . . . . 0.0 110.656 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 77' ' ' ALA . 8.2 Cg_endo -50.93 102.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.646 2.23 . . . . 0.0 112.69 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.664 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 52.8 Cg_exo -55.75 -43.26 59.12 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.717 2.278 . . . . 0.0 114.102 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 4.1 Cg_endo -48.72 154.16 3.15 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.361 2.041 . . . . 0.0 113.572 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.437 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -63.68 -19.79 63.22 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.347 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 5.7 tmtp? -50.81 -29.66 12.27 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 120.609 0.242 . . . . 0.0 110.833 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.443 ' CG1' ' CH2' ' A' ' 71' ' ' TRP . 42.1 t -56.56 -46.71 82.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.419 HG13 ' OH ' ' A' ' 151' ' ' TYR . 89.3 t -56.08 -40.37 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.039 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 2.0 mt-10 -58.2 -31.44 67.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.746 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.72 -50.74 63.72 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.498 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.659 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.03 -28.9 69.21 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.419 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.418 ' CD2' ' O ' ' A' ' 120' ' ' LEU . 11.3 mt -64.74 -38.5 91.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.228 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.8 m -66.93 -39.99 87.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.994 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -63.44 -51.3 66.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.874 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.46 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 13.5 p -69.76 -43.42 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -60.82 -34.76 75.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.393 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.2 -47.96 72.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -74.6 -25.59 59.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.46 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 3.3 m-85 -82.02 -34.48 29.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.992 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.1 t -72.26 -46.4 56.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -76.35 -33.36 58.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.35 141.99 41.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.91 159.32 53.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.406 2.071 . . . . 0.0 112.125 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.09 90.75 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -81.44 -83.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.68 0.276 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.663 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.6 m -153.26 113.05 3.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.792 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 23.5 t -108.07 151.21 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.461 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . . . -122.4 140.45 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.27 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.547 HG13 ' H ' ' A' ' 106' ' ' HIS . 2.5 t -139.6 166.79 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.612 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.547 ' H ' HG13 ' A' ' 105' ' ' VAL . 2.0 t60 -67.16 156.27 36.64 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.52 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.535 ' HA ' HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -68.06 105.07 1.93 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' CG1' HD11 ' A' ' 24' ' ' ILE . 29.8 m -75.28 -0.02 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.025 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.72 -8.72 3.17 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.93 -136.32 4.68 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.409 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 13.0 mt -120.9 127.46 51.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.74 -147.42 5.22 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.374 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.49 ' NE ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.24 -20.01 6.32 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.907 0.384 . . . . 0.0 111.89 -178.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.652 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -52.64 -46.56 95.87 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 6.5 Cg_endo -52.1 -48.31 22.31 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.264 1.976 . . . . 0.0 112.73 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.4 ' O ' ' CD2' ' A' ' 120' ' ' LEU . 39.0 t -60.95 -44.47 98.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.917 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.427 HD11 ' CE3' ' A' ' 71' ' ' TRP . 9.4 mt -58.12 -45.31 87.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.212 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.461 HG13 ' CD2' ' A' ' 22' ' ' PHE . 94.9 t -55.0 -55.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.776 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.36 -49.25 74.95 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.147 0.499 . . . . 0.0 110.748 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.609 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 2.7 mm? -53.91 -30.91 48.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.732 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.51 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -69.58 -43.32 73.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.05 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.432 ' CD1' ' HE3' ' A' ' 20' ' ' MET . 0.7 OUTLIER -66.98 -15.63 63.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.757 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.6 mt -57.04 -30.64 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -72.45 -17.02 61.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.424 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.5 m -84.54 11.25 9.09 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 113.79 -99.5 0.98 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.763 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.497 ' HE3' ' CD2' ' A' ' 17' ' ' TYR . 3.0 ptt? -62.45 79.73 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.9 -67.69 0.54 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 5.2 t80 -67.33 -32.05 72.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.959 0.409 . . . . 0.0 111.001 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.37 -52.04 17.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.25 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.538 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 32.3 t0 -68.24 -38.13 81.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.816 0.341 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.502 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -60.04 -49.98 75.54 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.007 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.4 mm -73.67 -37.61 49.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -74.17 -49.6 22.92 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -70.57 -35.8 73.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.583 0.23 . . . . 0.0 110.902 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.4 tt -74.14 -29.26 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.395 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -66.31 -48.44 70.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.477 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -44.94 93.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.443 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -82.81 152.25 25.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.29 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 117.25 14.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.503 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -114.53 163.54 15.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.01 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.409 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -59.15 -164.08 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.485 -0.865 . . . . 0.0 111.173 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.06 98.96 11.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.709 0.755 . . . . 0.0 110.745 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 pp -88.48 109.03 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.074 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -113.45 -77.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.456 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.4 m -100.27 -60.7 1.48 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.79 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.5 tmtt? -53.19 -51.8 60.91 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -56.03 -52.03 65.68 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.04 -45.3 42.56 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.4 m -67.09 -35.0 78.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.629 0.252 . . . . 0.0 111.622 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.79 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -69.51 -50.87 41.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.387 -179.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.433 ' HB3' ' CE1' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -69.47 -32.25 71.04 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.323 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -59.73 -39.55 85.08 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -27.46 63.52 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.585 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.44 ' CD2' HD11 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -66.23 -33.77 76.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.621 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.82 85.9 2.09 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.662 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.93 153.14 63.68 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.618 2.212 . . . . 0.0 112.502 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.31 123.5 10.84 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.427 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -77.98 -30.88 50.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.005 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -62.55 -30.6 71.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.64 -48.0 12.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -71.48 -55.35 8.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.9 122.38 20.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.5 pttp -155.48 164.97 37.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -86.83 112.55 47.94 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.69 176.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.44 2.093 . . . . 0.0 112.22 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.78 115.53 12.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 75.3 p -138.49 157.37 46.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -83.94 105.2 14.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -138.8 -47.31 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.36 -66.42 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -159.73 157.89 30.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 110.957 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.95 120.83 40.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 ttp -83.35 -56.1 3.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.05 169.06 21.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -148.54 131.02 15.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.78 160.82 23.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.957 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -136.13 -63.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -101.41 148.55 35.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.53 126.45 12.82 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.582 2.188 . . . . 0.0 112.237 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.65 139.59 97.12 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.064 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.02 165.16 33.55 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.538 2.159 . . . . 0.0 112.368 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.93 126.83 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.534 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -116.82 136.01 53.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.015 0.436 . . . . 0.0 111.898 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.471 HG13 ' CD2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.8 137.02 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.12 129.3 37.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.245 0.545 . . . . 0.0 111.963 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CE1' ' HE1' ' A' ' 127' ' ' MET . 25.7 t80 -145.57 132.74 20.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.268 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HG2' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 64.08 -103.49 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.204 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.4 14.04 6.07 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.421 ' CE ' ' CD2' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -119.26 169.0 10.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.775 0.322 . . . . 0.0 110.96 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.8 mtm-85 -141.79 164.08 31.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.122 0.486 . . . . 0.0 111.733 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 3.9 m-85 -134.59 150.19 50.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.872 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -126.21 135.49 51.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 111.143 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.424 HD12 ' HB ' ' A' ' 105' ' ' VAL . 10.9 mm -118.33 106.27 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 107' ' ' CYS . 1.2 p -131.07 163.74 26.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.197 0.522 . . . . 0.0 111.756 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.527 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.5 p80 -81.24 152.44 27.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.261 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.38 154.81 70.29 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.802 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.417 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 51.8 Cg_exo -53.89 136.6 66.73 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.32 2.013 . . . . 0.0 113.15 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.53 143.53 28.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.21 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -64.79 -12.78 51.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.338 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -31.31 14.59 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.4 p -139.97 88.8 2.26 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.282 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.89 -52.28 7.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.259 0.552 . . . . 0.0 111.256 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.444 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 2.3 m -56.84 -46.36 81.76 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.624 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -57.58 -31.9 66.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.961 0.41 . . . . 0.0 111.145 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.527 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -74.85 -47.59 29.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.175 -179.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.444 ' CG1' ' O ' ' A' ' 34' ' ' SER . 11.6 pt -55.62 -39.06 52.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.136 0.493 . . . . 0.0 110.605 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -65.18 -52.03 57.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.51 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 2.4 m-20 -67.99 -50.15 57.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.902 0.382 . . . . 0.0 111.935 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.445 ' HG ' ' CD1' ' A' ' 36' ' ' PHE . 74.2 mt -55.84 -45.2 78.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.556 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.8 tttm -77.34 -26.71 52.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.085 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.2 mttt -53.04 -44.99 67.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.217 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.549 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 11.5 t80 -63.57 -38.32 90.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.748 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.659 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 161.05 -177.74 37.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.934 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.67 122.33 27.17 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.569 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 4.1 m -164.54 -171.39 2.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.513 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.491 ' H ' ' CG2' ' A' ' 46' ' ' THR . 1.7 t -65.44 162.22 18.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 91.8 t -138.01 137.99 44.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.538 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 11.2 p -115.23 104.2 16.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.421 0.629 . . . . 0.0 111.002 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.22 110.98 20.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.05 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.553 HG11 ' HD3' ' A' ' 113' ' ' ARG . 6.1 t -105.8 91.26 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.462 0.649 . . . . 0.0 109.704 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 t -157.87 171.29 20.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.911 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -67.61 130.45 43.08 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.83 122.48 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.4 p -120.16 -47.66 2.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.376 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.423 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -130.56 83.34 2.11 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.457 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.17 -36.38 40.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -79.06 -48.55 14.17 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -43.91 -60.22 2.9 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.249 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.61 -34.31 15.35 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.551 2.167 . . . . 0.0 113.871 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.406 HD23 HG13 ' A' ' 68' ' ' VAL . 1.6 mm? -71.13 -45.19 64.08 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -75.1 -29.37 60.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -33.8 33.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -101.31 -12.41 18.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.11 24.19 4.48 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.473 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 64' ' ' ASP . 12.7 mt -96.4 147.47 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.946 0.373 . . . . 0.0 110.835 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 47' ' ' THR . 3.4 m -78.47 132.57 37.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.425 HG22 ' HB ' ' A' ' 48' ' ' VAL . 7.5 p -145.05 152.78 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.337 0.589 . . . . 0.0 112.125 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.83 130.54 54.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.001 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.09 106.84 18.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.082 0.468 . . . . 0.0 111.044 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.5 m95 -109.35 103.9 53.82 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.51 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -105.83 153.95 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.262 2.642 . . . . 0.0 112.94 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' CZ ' ' O ' ' A' ' 77' ' ' ALA . 1.1 t80 -126.24 99.85 6.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.08 173.54 0.62 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.15 -34.02 71.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.969 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.45 52.07 0.84 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.378 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.415 ' O ' ' CZ ' ' A' ' 73' ' ' PHE . . . -103.93 102.98 34.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.484 0.183 . . . . 0.0 111.232 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.456 ' O ' ' CD ' ' A' ' 80' ' ' PRO . 70.9 Cg_exo -50.8 164.31 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.311 2.007 . . . . 0.0 111.89 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -100.28 70.89 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.472 2.781 . . . . 0.0 113.257 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.471 ' O ' HG21 ' A' ' 83' ' ' VAL . 57.4 Cg_endo -69.92 135.68 30.68 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.116 1.877 . . . . 0.0 111.827 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.444 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -66.52 -22.52 71.51 Favored Glycine 0 C--O 1.238 0.386 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.243 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -38.8 63.22 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.647 0.26 . . . . 0.0 111.09 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 80' ' ' PRO . 31.2 m -58.65 -44.4 89.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.492 HG13 ' CE1' ' A' ' 151' ' ' TYR . 0.8 OUTLIER -53.42 -39.41 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.229 0.538 . . . . 0.0 109.591 178.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.63 -31.35 70.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.726 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.04 -50.88 64.5 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.538 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -68.86 -34.76 75.99 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.785 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 mt -55.17 -43.67 74.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.411 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -40.6 82.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.316 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -58.39 -51.35 70.18 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.9 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.2 p -73.9 -36.06 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.878 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 -44.06 64.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.934 0.397 . . . . 0.0 110.597 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.08 -43.6 57.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.951 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -27.62 69.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.263 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.06 -40.71 21.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 111.0 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 7.2 t -67.0 -46.05 75.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -76.1 -33.04 59.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.08 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -109.37 87.99 5.63 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.293 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.27 115.91 4.04 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.584 2.189 . . . . 0.0 112.363 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.15 52.14 19.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 t -101.17 -174.16 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.62 0.247 . . . . 0.0 111.179 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.659 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 3.1 m -112.94 114.12 26.48 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 16.3 t -106.81 151.28 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -121.33 145.7 47.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.643 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.562 HG11 ' CG2' ' A' ' 118' ' ' VAL . 97.5 t -139.86 166.25 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.489 ' N ' HG13 ' A' ' 105' ' ' VAL . 3.0 t60 -67.81 155.43 39.36 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.825 0.345 . . . . 0.0 110.725 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.541 ' N ' ' O ' ' A' ' 25' ' ' THR . 43.7 t -69.36 104.23 2.21 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.495 HG12 ' HG3' ' A' ' 115' ' ' PRO . 3.0 t -75.73 1.39 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.417 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.16 -8.37 1.54 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.73 -121.32 2.62 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 mt -132.12 127.32 35.74 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.13 -154.48 7.55 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.146 -1.025 . . . . 0.0 113.255 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.553 ' HD3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.37 -15.12 7.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.91 0.386 . . . . 0.0 111.943 -178.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.661 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.34 -46.79 97.79 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 10.1 Cg_endo -52.98 -48.1 23.97 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.352 2.035 . . . . 0.0 112.446 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 41.8 t -55.84 -53.23 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.859 0.362 . . . . 0.0 110.479 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.423 HD12 ' CE3' ' A' ' 71' ' ' TRP . 2.7 mt -54.44 -48.76 71.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.773 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.562 ' CG2' HG11 ' A' ' 105' ' ' VAL . 17.0 t -51.28 -49.71 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 111.354 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 123' ' ' ILE . . . -55.91 -45.26 78.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.668 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.527 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -57.54 -30.88 65.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.766 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HB1' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.05 -44.76 62.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.939 0.4 . . . . 0.0 110.597 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.433 HD22 ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -69.63 -15.9 63.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.791 179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.551 HG23 ' CB ' ' A' ' 128' ' ' LYS . 1.3 mt -57.77 -41.72 80.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.871 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.52 -15.81 3.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.83 11.24 4.06 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 117.79 -88.08 0.44 Allowed Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.307 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.532 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.97 79.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.288 0.566 . . . . 0.0 109.662 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.551 ' CB ' HG23 ' A' ' 123' ' ' ILE . 20.9 mttm -62.61 -68.08 0.36 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.005 -177.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.47 ' CD1' ' HB3' ' A' ' 152' ' ' LEU . 7.1 t80 -74.34 -30.47 62.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.229 0.537 . . . . 0.0 110.499 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 7.5 mt-10 -72.57 -47.15 50.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.107 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 127' ' ' MET . 50.8 t0 -68.88 -47.23 66.39 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.349 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.477 ' HB2' HD13 ' A' ' 152' ' ' LEU . . . -59.07 -50.16 75.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.941 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 35.4 mm -72.44 -36.18 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 75.8 mt-30 -74.21 -49.56 22.9 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.471 ' CD2' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.69 -37.5 76.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 110.815 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 3.3 tt -74.44 -28.55 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.464 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 0.9 OUTLIER -69.51 -46.73 65.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.944 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -41.52 91.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.118 0.485 . . . . 0.0 110.027 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -87.14 152.64 22.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.154 179.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.38 117.81 14.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.112 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -114.19 163.66 14.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.234 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -57.95 -163.36 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.946 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.17 100.18 13.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.156 0.478 . . . . 0.0 111.51 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.51 ' O ' HG12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -87.91 109.17 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.482 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.65 -77.52 0.58 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.6 m -100.48 -61.41 1.37 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.778 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 8.8 tmtt? -64.29 -46.39 83.85 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -176.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.432 ' CB ' HG21 ' A' ' 144' ' ' ILE . 0.9 OUTLIER -56.23 -52.13 65.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -176.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -75.35 -37.19 60.81 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.963 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.1 t -71.76 -37.11 70.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.844 0.355 . . . . 0.0 110.968 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.778 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.85 -50.56 64.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.643 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' A' ' 132' ' ' ALA . 0.7 OUTLIER -66.7 -31.64 72.44 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.643 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.82 -37.45 84.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -23.0 55.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.883 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.486 ' CE2' HD11 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -66.22 -43.84 85.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.507 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 48.0 ttt85 -107.0 115.31 60.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.607 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.48 138.41 59.74 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.421 2.081 . . . . 0.0 112.369 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -147.31 123.46 10.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.559 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.19 2.83 29.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.596 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -59.08 -37.07 76.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.71 0.29 . . . . 0.0 110.983 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.54 -29.56 33.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.955 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.3 96.09 4.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -73.67 97.73 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -129.2 162.69 27.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -94.05 103.09 9.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.78 116.78 4.72 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.452 2.101 . . . . 0.0 112.269 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -137.42 120.68 16.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.815 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.3 t -97.04 133.66 41.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.811 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -104.85 122.01 44.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -154.7 128.12 8.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.78 33.28 20.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.883 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.5 p -135.25 142.13 45.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.64 126.58 24.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 35.4 mtm -106.37 125.6 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.8 -39.45 7.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.074 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -149.85 -61.07 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -169.3 -64.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -162.06 114.06 1.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -60.1 127.77 86.37 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.8 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.21 123.34 7.14 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.508 2.139 . . . . 0.0 112.4 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.63 153.93 55.85 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.26 165.14 32.51 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.99 126.85 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -106.89 132.64 52.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.448 . . . . 0.0 111.657 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.521 ' CG1' ' CE2' ' A' ' 135' ' ' PHE . 2.1 t -106.78 124.78 62.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.224 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.6 p -122.32 140.88 52.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 111.823 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.447 ' CD2' HD21 ' A' ' 122' ' ' LEU . 26.5 t80 -155.25 131.04 9.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.7 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm 59.04 -100.24 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.082 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -129.56 14.09 5.98 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.436 ' CE ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -117.06 164.65 14.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 110.949 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -132.72 164.01 27.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.421 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 1.2 m-85 -142.89 146.22 33.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.847 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.527 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -122.66 136.28 54.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 111.259 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.463 HG23 ' HA ' ' A' ' 107' ' ' CYS . 5.6 mm -118.49 106.3 19.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.69 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 107' ' ' CYS . 1.9 p -132.38 164.79 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.057 0.456 . . . . 0.0 111.506 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.509 ' CD2' ' CZ ' ' A' ' 36' ' ' PHE . 31.3 p-80 -81.46 152.12 27.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.074 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -62.8 154.54 74.99 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.978 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.03 134.7 61.07 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.425 2.083 . . . . 0.0 113.068 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -98.5 152.96 18.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.267 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -71.81 -11.41 60.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.53 -31.58 14.49 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -140.08 88.75 2.25 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.135 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -52.38 7.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.184 0.516 . . . . 0.0 111.533 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 1.6 p -57.2 -46.78 82.57 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.635 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.2 m -57.82 -32.27 67.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.881 0.372 . . . . 0.0 111.255 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.509 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -74.67 -47.95 28.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' CG1' ' O ' ' A' ' 34' ' ' SER . 12.0 pt -55.93 -39.03 55.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.207 0.527 . . . . 0.0 110.623 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.83 -52.01 59.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.558 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 3.7 m-20 -68.88 -50.08 52.77 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.929 0.395 . . . . 0.0 111.832 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.432 HD23 ' CE1' ' A' ' 36' ' ' PHE . 53.5 mt -55.92 -45.21 78.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -26.77 48.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.027 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -53.32 -43.36 67.56 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.367 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.527 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 14.0 t80 -63.28 -38.65 92.0 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.689 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.626 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.68 -178.38 40.5 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.821 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.56 117.4 19.51 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.604 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.3 m -165.18 -170.41 1.9 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.806 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 67' ' ' THR . 3.6 t -65.09 159.83 22.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.484 0.659 . . . . 0.0 110.617 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 104' ' ' ALA . 60.0 t -136.27 138.15 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.073 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.551 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 14.9 p -115.55 104.65 17.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.551 0.691 . . . . 0.0 111.211 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -115.13 110.79 20.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.251 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.59 HG11 ' HD3' ' A' ' 113' ' ' ARG . 12.9 t -106.62 91.84 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.366 0.603 . . . . 0.0 109.722 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.32 171.42 20.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.719 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -64.69 130.47 43.71 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.61 121.86 19.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.424 HG21 ' CE1' ' A' ' 56' ' ' TYR . 2.0 m -120.66 -47.38 2.32 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.133 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.429 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 9.0 m-85 -130.33 84.62 2.21 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.483 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -78.33 -36.05 46.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -48.55 14.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.429 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -45.14 -49.99 28.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.153 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 34.2 Cg_exo -60.93 -40.67 50.82 Favored 'Trans proline' 0 N--CA 1.471 0.193 0 C-N-CA 122.646 2.23 . . . . 0.0 113.605 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -45.05 64.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -49.13 20.18 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -76.16 -25.72 55.54 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 2.8 t0 -99.35 -11.48 21.16 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.42 26.85 2.61 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.278 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.422 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 4.2 pt -122.54 148.12 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.688 0.28 . . . . 0.0 110.737 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 47' ' ' THR . 11.0 t -77.83 135.11 37.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.064 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 p -141.59 154.46 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.277 0.561 . . . . 0.0 111.733 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.68 131.28 52.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.145 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -100.8 106.81 18.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.201 0.524 . . . . 0.0 110.193 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.568 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.5 m95 -111.26 104.51 56.24 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -103.21 153.72 0.24 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.204 2.602 . . . . 0.0 112.344 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -122.32 121.43 36.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.008 0.433 . . . . 0.0 110.984 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.5 -161.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.369 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -63.96 -15.76 59.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.223 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.8 -4.72 45.39 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.194 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.96 112.55 46.11 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.952 0.376 . . . . 0.0 111.066 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . 51.6 Cg_exo -55.31 106.1 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.502 2.134 . . . . 0.0 112.482 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 42.2 Cg_exo -57.81 -39.38 87.57 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.017 2.478 . . . . 0.0 114.589 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 2.0 Cg_endo -47.56 154.09 1.87 Allowed 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.142 1.894 . . . . 0.0 113.635 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -64.71 -20.67 66.45 Favored Glycine 0 C--O 1.237 0.34 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.332 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -29.83 16.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.563 0.22 . . . . 0.0 110.936 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.424 HG11 ' CZ2' ' A' ' 71' ' ' TRP . 11.6 t -59.93 -48.23 88.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 1.1 t -53.52 -38.69 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.227 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.45 -31.19 71.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.355 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -63.35 -50.64 69.17 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.551 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.551 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -67.44 -32.64 73.64 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.89 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.423 HD13 ' CE2' ' A' ' 155' ' ' TYR . 13.5 mt -55.93 -48.02 76.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.607 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -41.34 95.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.487 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -57.68 -51.59 68.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.445 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 13.2 p -74.75 -35.82 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.383 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -55.04 -40.95 70.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.963 0.411 . . . . 0.0 110.513 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.28 -46.75 39.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.227 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.3 -37.57 86.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.631 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.425 ' CE1' HG23 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -82.02 -33.49 30.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.763 0.316 . . . . 0.0 111.171 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.04 -46.04 58.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -76.1 -31.5 58.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.273 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -117.35 87.25 23.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.479 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.45 136.35 42.8 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.745 2.297 . . . . 0.0 112.168 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 20' ' ' MET . . . 58.12 58.23 15.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.662 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.421 ' CB ' HG22 ' A' ' 46' ' ' THR . 51.8 p -101.2 -169.98 1.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.808 0.337 . . . . 0.0 111.263 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.626 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -123.46 113.67 19.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.091 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.425 HG23 ' CE1' ' A' ' 95' ' ' PHE . 7.4 t -111.98 151.38 14.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.135 0.493 . . . . 0.0 112.323 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.439 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . . . -118.93 145.34 45.85 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.422 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.537 HG11 ' H ' ' A' ' 106' ' ' HIS . 7.6 t -140.3 167.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.708 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.537 ' H ' HG11 ' A' ' 105' ' ' VAL . 9.8 t60 -66.87 155.49 38.22 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 25' ' ' THR . 10.5 t -69.1 122.5 18.89 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 140' ' ' ARG . 5.1 m -75.75 -0.2 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.475 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.95 -8.78 3.43 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.99 -156.38 6.8 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.5 mt -92.91 127.27 38.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.83 -169.38 16.61 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.223 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.59 ' HD3' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.22 -24.63 5.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.069 0.461 . . . . 0.0 111.407 -179.252 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.486 ' N ' ' CD ' ' A' ' 115' ' ' PRO . . . -54.48 -43.07 97.5 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 114' ' ' ALA . 58.4 Cg_exo -52.35 -48.38 22.07 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.844 1.696 . . . . 0.0 111.67 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.52 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 91.3 t -55.98 -51.14 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.46 ' HA ' ' HG ' ' A' ' 120' ' ' LEU . 8.5 mt -51.97 -45.3 64.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.137 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.479 ' CG2' HG13 ' A' ' 105' ' ' VAL . 15.9 t -51.81 -53.18 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.951 0.405 . . . . 0.0 110.909 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.414 ' HB3' ' CB ' ' A' ' 132' ' ' ALA . . . -53.5 -43.27 68.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.177 0.513 . . . . 0.0 110.519 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.549 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -58.64 -30.83 67.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.529 179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.26 -40.38 71.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.115 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.447 HD21 ' CD2' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -71.59 -16.68 62.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.734 179.026 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.7 mt -57.31 -30.7 36.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.284 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -16.61 62.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.7 m -79.76 -23.34 42.28 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.43 -96.58 0.17 Allowed Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.946 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.5 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 6.1 ptt? -63.87 71.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.61 -67.37 0.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 6.0 t80 -65.88 -32.42 73.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.894 0.378 . . . . 0.0 111.139 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -72.55 -52.43 15.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.259 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 5.2 t0 -67.05 -36.75 82.74 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 110.486 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.536 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -61.07 -50.42 73.36 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.162 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 133' ' ' ILE . 32.9 mm -73.43 -39.3 54.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.569 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -49.97 19.79 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.58 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -68.28 -37.35 80.59 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.581 -179.31 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -74.16 -28.72 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.736 0.303 . . . . 0.0 110.407 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -63.8 -44.92 91.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.399 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -45.1 93.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.668 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 136' ' ' ILE . 2.5 mptt -87.08 151.44 23.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.633 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.475 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.93 116.78 14.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 0.0 110.972 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.14 163.21 15.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.81 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.31 -179.99 0.18 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.307 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.09 99.4 4.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.62 0.71 . . . . 0.0 111.015 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 144' ' ' ILE . 11.3 pt -88.22 109.53 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.763 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -112.95 -76.62 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.628 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.91 -60.93 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.767 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.6 tmtt? -52.49 -51.81 57.6 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.408 ' HG3' ' CG2' ' A' ' 144' ' ' ILE . 1.3 tm0? -60.23 -51.75 68.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.03 -34.77 66.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.9 t -75.29 -40.77 58.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.082 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.767 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -64.03 -50.76 67.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.502 ' HA ' ' HB2' ' A' ' 155' ' ' TYR . 0.8 OUTLIER -69.0 -33.82 74.28 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.932 -179.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.22 -38.03 78.95 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -25.43 55.35 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.551 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.543 ' CE2' HD11 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -66.43 -31.34 72.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.471 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.71 104.33 50.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.427 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.97 146.98 96.06 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.476 2.117 . . . . 0.0 112.579 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -147.27 123.53 10.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.373 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -4.92 46.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.469 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.91 -30.52 67.88 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.8 tt -74.26 -31.03 62.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.912 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.04 -170.65 1.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.91 155.82 16.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -79.39 116.93 19.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -70.25 137.92 86.79 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.841 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.19 174.73 10.96 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.541 2.161 . . . . 0.0 112.269 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -171.56 -54.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.7 t -167.13 168.64 13.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -84.29 176.29 8.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -143.55 134.37 25.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.6 t -140.34 151.09 44.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.962 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -170.47 172.8 5.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.2 -58.55 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.04 108.51 3.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -105.88 128.78 53.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -140.66 -47.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -125.57 138.5 53.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -83.19 133.61 35.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.7 ttm-85 -120.62 131.11 24.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.32 118.3 5.61 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.387 2.058 . . . . 0.0 112.232 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.36 145.85 85.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.78 165.13 33.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.596 2.197 . . . . 0.0 112.265 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.51 126.99 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.776 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -114.37 128.95 56.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.993 0.425 . . . . 0.0 111.698 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.482 HG13 ' CD2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.87 127.66 62.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.509 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.41 147.63 42.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.119 0.485 . . . . 0.0 111.786 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.451 ' CE1' ' HE1' ' A' ' 127' ' ' MET . 26.4 t80 -155.15 117.93 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.642 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 29.2 mmtp 64.28 -95.77 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.408 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.39 13.99 6.07 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.434 ' HE3' ' CD2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -121.67 169.05 11.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.754 0.311 . . . . 0.0 110.886 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -145.62 164.03 33.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 111.697 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 3.0 m-85 -134.29 148.9 50.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.561 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.538 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -122.48 135.77 54.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.21 0.529 . . . . 0.0 111.334 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 107' ' ' CYS . 2.5 mm -118.17 106.58 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.223 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -132.54 165.34 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.286 0.565 . . . . 0.0 111.644 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.52 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.2 p80 -81.1 152.08 28.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -62.83 154.04 77.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.514 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 10.0 Cg_endo -54.38 138.53 73.47 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.64 2.227 . . . . 0.0 113.439 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.441 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -98.93 174.24 6.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.249 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.8 -8.66 30.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.53 -30.67 14.88 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.6 p -139.36 89.62 2.35 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.109 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.441 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.18 -52.18 8.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.19 0.519 . . . . 0.0 111.22 178.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.429 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.6 p -57.8 -45.67 85.75 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.225 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.4 m -57.85 -32.13 67.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.747 0.308 . . . . 0.0 111.276 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -75.3 -47.89 25.75 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.148 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.429 HG12 ' HA ' ' A' ' 34' ' ' SER . 11.6 pt -55.66 -39.03 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.179 0.514 . . . . 0.0 110.761 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.32 -51.83 53.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.543 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.1 m-20 -68.13 -50.12 56.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.838 0.351 . . . . 0.0 111.915 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 36' ' ' PHE . 87.9 mt -55.8 -46.22 78.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.986 0.422 . . . . 0.0 110.42 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -77.05 -26.63 53.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.102 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -53.13 -44.48 67.77 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.532 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.538 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 10.9 t80 -63.56 -38.53 91.48 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.959 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.674 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.93 -178.35 39.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.006 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.53 117.4 19.53 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.613 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.0 OUTLIER -165.19 -169.69 1.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.166 -0.924 . . . . 0.0 108.853 177.416 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 67' ' ' THR . 3.5 p -64.48 146.49 54.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.555 0.693 . . . . 0.0 110.544 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 59.5 t -125.38 132.72 70.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.565 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.663 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 12.9 p -115.41 105.52 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.372 0.606 . . . . 0.0 111.315 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 110.64 20.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.735 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.559 HG11 ' NE ' ' A' ' 113' ' ' ARG . 23.0 t -104.08 90.44 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.635 0.731 . . . . 0.0 109.734 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -158.78 171.62 19.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.352 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 1.8 mm-40 -64.95 130.35 43.07 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.4 t -77.56 122.63 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 p -120.2 -47.87 2.35 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.169 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.8 83.45 2.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.363 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -79.36 -36.77 38.8 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -79.44 -48.65 13.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.405 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -43.95 -51.66 17.18 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 12.6 Cg_exo -71.51 -42.62 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.491 2.127 . . . . 0.0 113.973 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.4 ' CD1' ' CG1' ' A' ' 68' ' ' VAL . 2.9 tp -71.44 -45.19 63.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -56.27 -46.47 79.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -20.45 41.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.436 ' HB3' HG12 ' A' ' 66' ' ' ILE . 72.7 m-20 -101.0 -11.52 19.61 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 42.64 52.78 5.36 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.852 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.436 HG12 ' HB3' ' A' ' 64' ' ' ASP . 4.2 pt -133.01 148.53 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.733 0.302 . . . . 0.0 111.144 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' THR . 73.8 p -78.1 135.21 37.66 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 69' ' ' VAL . 11.2 p -141.75 149.54 19.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.45 ' N ' HG23 ' A' ' 68' ' ' VAL . 2.0 t -103.55 130.22 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -100.72 106.88 18.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.161 0.505 . . . . 0.0 110.474 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.433 ' CH2' ' HA ' ' A' ' 84' ' ' VAL . 4.1 m95 -111.57 103.63 55.28 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.094 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -108.18 175.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 123.64 2.893 . . . . 0.0 112.487 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.472 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 0.4 OUTLIER -126.32 105.55 8.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.844 0.355 . . . . 0.0 110.93 179.256 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -142.56 -173.92 4.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.674 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -56.65 -22.61 35.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.993 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -105.24 41.93 2.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.822 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.407 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -106.31 102.74 42.16 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.442 0.163 . . . . 0.0 110.712 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . 31.6 Cg_exo -59.17 107.27 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.569 2.179 . . . . 0.0 112.554 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.667 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 50.7 Cg_exo -53.93 -43.51 57.52 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.818 2.345 . . . . 0.0 114.171 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 2.8 Cg_endo -47.62 154.03 1.97 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.346 2.03 . . . . 0.0 113.578 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -64.12 -19.81 64.21 Favored Glycine 0 C--O 1.237 0.307 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.402 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.61 -29.73 11.64 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.546 0.173 . . . . 0.0 110.907 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 78' ' ' PRO . 26.1 t -56.12 -48.1 79.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.434 HG13 ' CE2' ' A' ' 151' ' ' TYR . 86.5 t -55.72 -39.22 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.216 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.26 -31.46 69.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.914 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -66.85 -50.84 61.27 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.619 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.663 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.23 -26.89 65.92 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.534 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.3 mt -63.88 -47.2 81.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.319 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -42.09 98.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.298 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -53.91 -51.37 63.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.795 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 92' ' ' LYS . 8.6 p -72.33 -41.73 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.488 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.433 ' N ' HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -54.56 -38.92 67.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 0.0 110.992 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.42 53.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -73.17 -20.53 60.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.909 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.418 ' CD1' ' CG2' ' A' ' 91' ' ' VAL . 1.9 m-85 -82.07 -40.71 21.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.9 t -69.1 -42.73 75.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -75.99 -31.19 58.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.106 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.68 90.78 48.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.327 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.27 137.38 18.92 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.606 2.204 . . . . 0.0 112.363 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.78 57.38 20.19 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.588 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.436 ' CB ' HG23 ' A' ' 46' ' ' THR . 51.5 p -101.22 -168.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.328 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.674 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -120.91 113.44 20.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.053 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 43.8 t -105.46 151.02 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -123.92 139.43 53.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.207 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.584 HG11 ' CG2' ' A' ' 118' ' ' VAL . 45.1 t -140.12 166.71 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.451 ' N ' ' CG1' ' A' ' 105' ' ' VAL . 2.7 t60 -66.97 155.97 37.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.381 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 25' ' ' THR . 49.3 t -68.5 106.94 2.72 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' A' ' 24' ' ' ILE . 34.1 m -75.42 0.09 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.022 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.45 -8.72 2.9 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.37 -139.4 5.31 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.417 HD23 ' HA2' ' A' ' 142' ' ' GLY . 11.7 mt -117.93 127.34 53.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.19 -146.28 4.82 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.349 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.559 ' NE ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.3 -20.94 5.99 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.018 0.437 . . . . 0.0 111.936 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.639 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -51.93 -46.29 92.56 Favored Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.4 Cg_endo -52.59 -48.65 20.82 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.223 1.948 . . . . 0.0 113.274 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.418 ' O ' HD21 ' A' ' 120' ' ' LEU . 39.4 t -62.25 -41.0 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.079 0.466 . . . . 0.0 110.127 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.413 HD11 ' CG2' ' A' ' 51' ' ' VAL . 6.4 mt -59.06 -41.11 87.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.81 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.584 ' CG2' HG11 ' A' ' 105' ' ' VAL . 17.6 t -64.15 -55.53 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.32 -53.07 61.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 110.903 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.728 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 3.1 mm? -55.25 -30.31 59.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.038 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.544 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.56 -50.62 24.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 110.614 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.434 ' CD2' ' HE3' ' A' ' 20' ' ' MET . 0.4 OUTLIER -65.27 -10.09 29.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.586 179.04 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.728 ' HB ' ' O ' ' A' ' 120' ' ' LEU . 1.0 OUTLIER -56.78 -34.26 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.687 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -62.28 -16.56 54.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.908 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.0 m -79.88 11.06 3.53 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 120.27 -98.8 0.71 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.251 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.49 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 1.1 ptt? -62.61 73.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.36 0.6 . . . . 0.0 109.469 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.614 ' HB3' HG22 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.9 -68.03 0.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.536 ' HA ' HD21 ' A' ' 152' ' ' LEU . 5.3 t80 -68.71 -32.68 72.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.946 0.403 . . . . 0.0 111.186 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.26 -49.44 34.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.479 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 39.2 t0 -70.04 -45.6 66.81 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.914 0.387 . . . . 0.0 111.294 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -57.84 -49.72 75.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.649 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 33.5 mm -70.29 -40.81 78.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -74.28 -49.8 21.61 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -67.87 -35.19 78.1 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.937 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.4 tt -74.24 -32.79 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.707 0.289 . . . . 0.0 110.74 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -63.95 -43.05 97.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.714 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -44.69 93.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.46 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -86.21 151.84 23.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.256 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.26 117.11 14.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 110.63 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -114.82 163.66 15.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.417 ' HA2' HD23 ' A' ' 111' ' ' LEU . . . -57.71 -165.83 0.09 OUTLIER Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.42 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.26 99.22 11.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.589 0.695 . . . . 0.0 111.0 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.4 pt -88.45 109.44 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.809 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -113.14 -76.65 0.58 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -99.78 -60.74 1.47 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.837 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.0 tmtt? -52.83 -51.9 59.13 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -56.59 -51.63 67.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.24 -40.94 58.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 m -69.95 -40.53 75.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.933 0.397 . . . . 0.0 111.1 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.837 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -65.46 -50.02 66.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.536 HD21 ' HA ' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -65.02 -38.03 89.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.919 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -55.77 -44.0 77.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -24.31 62.83 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.685 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.469 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -66.28 -32.62 74.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.731 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -106.58 118.46 54.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.06 153.48 72.09 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.61 2.207 . . . . 0.0 112.458 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -138.16 123.39 19.3 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.131 0.491 . . . . 0.0 110.337 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -60.41 -18.9 53.76 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.377 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -39.09 80.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.803 0.335 . . . . 0.0 111.025 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.4 tp -86.05 -35.07 20.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.34 113.98 27.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.94 118.25 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -167.44 133.27 2.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.41 138.03 44.99 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.75 -47.5 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.414 2.076 . . . . 0.0 112.346 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 55.9 94.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.019 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.9 p -143.77 123.12 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -155.15 -51.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.0 tttt 59.94 92.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.0 t -124.66 -44.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.906 -179.97 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -101.85 170.83 7.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 110.924 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -174.06 145.25 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.797 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.48 -39.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.966 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.3 99.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -114.87 129.15 56.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 133.0 47.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.882 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.91 99.01 10.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 111.17 3.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.1 66.32 0.99 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.475 2.117 . . . . 0.0 112.336 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.33 151.82 85.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 57.2 Cg_endo -71.03 165.01 33.77 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.635 2.224 . . . . 0.0 112.443 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.43 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 19.5 t -144.02 127.44 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 10.3 pt-20 -110.07 116.73 32.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.476 HG12 ' CD2' ' A' ' 135' ' ' PHE . 0.6 OUTLIER -108.01 118.7 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.4 p -140.83 145.26 36.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.599 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -136.4 159.93 40.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.734 178.183 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 9.4 ptpt 48.64 -103.79 0.11 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -177.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -120.44 -26.68 5.34 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.141 -0.349 . . . . 0.0 111.643 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.417 ' CE ' HD12 ' A' ' 122' ' ' LEU . 5.6 ppp? -73.84 165.71 24.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.654 0.264 . . . . 0.0 111.316 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -147.6 164.05 34.71 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.088 0.471 . . . . 0.0 111.507 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.436 ' CE1' HG11 ' A' ' 118' ' ' VAL . 1.7 m-85 -137.89 146.5 43.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -119.36 133.61 55.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.988 0.423 . . . . 0.0 110.954 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.466 HG21 ' HA ' ' A' ' 107' ' ' CYS . 2.1 mm -118.17 106.68 20.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.404 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 107' ' ' CYS . 60.4 p -131.61 165.52 23.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.283 0.563 . . . . 0.0 111.876 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.52 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.2 p80 -81.25 152.44 27.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.728 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.42 154.38 72.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.411 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.7 Cg_exo -54.2 137.24 70.3 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.472 2.114 . . . . 0.0 113.264 -177.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.63 145.89 26.4 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.197 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -68.58 -11.13 59.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.26 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.5 -31.71 14.46 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -140.12 88.73 2.24 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.064 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.01 -51.9 8.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.106 0.479 . . . . 0.0 111.515 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.9 m -55.77 -45.48 78.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.438 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -57.81 -36.14 71.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.408 . . . . 0.0 111.321 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -72.92 -47.91 41.58 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 34' ' ' SER . 12.1 pt -55.87 -40.06 60.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 110.882 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.67 -52.1 59.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.497 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.6 OUTLIER -67.62 -50.17 59.36 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.799 0.333 . . . . 0.0 111.807 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' A' ' 36' ' ' PHE . 62.9 mt -55.04 -46.29 75.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.614 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -26.77 52.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.2 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.1 mtmt -53.85 -42.33 68.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.382 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.529 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 16.8 t80 -63.3 -38.48 91.33 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.933 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.634 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.31 -178.59 40.2 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.885 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.64 117.43 19.49 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.61 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.0 OUTLIER -165.18 -170.03 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.732 177.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 67' ' ' THR . 2.5 t -64.58 160.46 19.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.367 0.603 . . . . 0.0 110.502 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.494 ' O ' HG21 ' A' ' 68' ' ' VAL . 57.5 t -138.4 135.74 44.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.226 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 14.6 p -115.62 104.68 17.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.474 0.654 . . . . 0.0 110.974 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 110.86 20.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.724 178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.529 HG13 ' CD ' ' A' ' 113' ' ' ARG . 25.0 t -108.0 91.6 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.592 0.71 . . . . 0.0 110.141 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.77 171.22 20.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.005 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.91 130.32 43.0 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.22 122.49 26.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -120.2 -47.67 2.36 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.227 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -130.63 83.8 2.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.535 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -78.95 -36.22 41.97 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.09 -48.55 14.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.46 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.0 m -45.71 -48.32 38.59 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.46 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 8.4 Cg_exo -73.19 -41.19 1.36 Allowed 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.613 2.209 . . . . 0.0 113.503 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.447 ' CD2' ' CG1' ' A' ' 68' ' ' VAL . 4.0 mm? -65.5 -45.27 84.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.34 -31.06 60.45 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -81.09 -34.22 32.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' CB ' HG12 ' A' ' 66' ' ' ILE . 17.2 m-20 -101.68 -11.53 19.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.54 27.75 3.15 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.294 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.483 HG12 ' CB ' ' A' ' 64' ' ' ASP . 1.1 pt -105.01 148.74 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.775 0.322 . . . . 0.0 111.072 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.7 OUTLIER -77.42 133.34 38.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.494 HG21 ' O ' ' A' ' 48' ' ' VAL . 4.0 p -145.06 149.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.048 0.451 . . . . 0.0 111.796 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.405 ' N ' HG21 ' A' ' 68' ' ' VAL . 2.0 t -103.07 128.96 55.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -100.94 106.71 18.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.097 0.475 . . . . 0.0 111.198 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.449 ' CH2' ' HA ' ' A' ' 84' ' ' VAL . 5.5 m0 -109.72 103.51 53.31 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.188 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -108.23 179.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 123.498 2.798 . . . . 0.0 113.028 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.459 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 1.5 t80 -126.33 105.26 8.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.677 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.52 -174.79 4.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.777 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -56.76 -22.77 38.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.984 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.41 37.7 3.69 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.676 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.406 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -87.64 102.96 3.93 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.4 0.143 . . . . 0.0 110.723 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.52 105.41 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.52 2.147 . . . . 0.0 112.51 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.651 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 29.2 Cg_exo -62.71 -37.39 57.02 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.94 2.427 . . . . 0.0 114.441 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 10.9 Cg_endo -56.48 154.21 31.25 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.875 1.717 . . . . 0.0 113.632 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.77 -20.16 59.31 Favored Glycine 0 C--O 1.236 0.271 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.407 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -29.84 14.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.348 0.118 . . . . 0.0 111.29 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.42 HG13 ' CZ2' ' A' ' 71' ' ' TRP . 35.4 t -55.38 -50.99 61.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.535 HG13 HD11 ' A' ' 120' ' ' LEU . 2.6 t -53.77 -43.4 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.307 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -56.34 -31.21 63.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.876 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.7 -50.4 62.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.651 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -65.14 -33.93 77.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.743 179.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.87 -46.89 84.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.723 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.83 -42.21 99.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.28 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.05 -51.46 69.97 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.757 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.43 HG22 ' CD1' ' A' ' 95' ' ' PHE . 11.2 p -69.7 -35.86 67.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.075 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -56.94 -45.02 83.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.319 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.04 91.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.497 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -24.1 61.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.229 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.43 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.1 m-85 -81.76 -51.86 7.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.793 0.33 . . . . 0.0 111.179 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.4 -40.51 97.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -76.07 -32.94 59.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.213 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.53 90.81 49.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.323 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.78 132.49 14.45 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.539 2.159 . . . . 0.0 112.375 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.5 56.3 25.81 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.584 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.447 ' CB ' HG22 ' A' ' 46' ' ' THR . 1.1 m -101.21 -164.77 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.816 0.341 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.634 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 m -117.88 113.54 21.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.43 ' CG1' ' CE1' ' A' ' 22' ' ' PHE . 38.5 t -110.03 149.73 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.148 0.499 . . . . 0.0 112.243 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.464 ' O ' ' CG1' ' A' ' 48' ' ' VAL . . . -119.11 143.29 47.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.946 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.584 HG11 ' CG2' ' A' ' 118' ' ' VAL . 92.7 t -139.98 166.16 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.511 ' N ' HG13 ' A' ' 105' ' ' VAL . 2.7 t60 -67.36 156.12 37.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.126 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 25' ' ' THR . 48.5 t -68.38 105.52 2.2 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.443 HG12 ' HD3' ' A' ' 115' ' ' PRO . 34.3 m -75.42 0.62 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.185 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.07 -8.55 2.45 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.29 -129.24 3.46 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD21 ' HA2' ' A' ' 142' ' ' GLY . 14.0 mt -127.9 127.42 43.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.59 -150.45 6.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.273 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.529 ' CD ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.47 -19.02 6.52 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.025 0.441 . . . . 0.0 111.775 -178.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.657 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.15 -46.39 97.79 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.1 Cg_endo -52.41 -48.15 23.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.179 1.919 . . . . 0.0 112.428 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.512 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 23.0 t -56.85 -52.04 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 110.341 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.418 ' HB3' ' NE1' ' A' ' 87' ' ' TRP . 8.0 mt -51.88 -48.79 63.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.889 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.584 ' CG2' HG11 ' A' ' 105' ' ' VAL . 17.4 t -54.01 -54.09 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.62 -42.79 64.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.039 0.447 . . . . 0.0 111.17 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.597 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 9.6 mt -64.12 -30.78 71.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.195 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.498 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -69.24 -38.25 78.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.211 0.529 . . . . 0.0 109.748 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.417 HD12 ' CE ' ' A' ' 20' ' ' MET . 6.0 tp -77.26 -15.97 59.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.204 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.636 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 1.7 mt -57.78 -31.74 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.816 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -16.53 63.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.0 m -83.81 11.04 8.13 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 118.08 -99.99 0.83 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.193 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.453 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.9 ptt? -62.48 76.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.52 -67.51 0.55 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -177.09 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 7.5 t80 -67.52 -32.46 73.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.926 0.393 . . . . 0.0 111.102 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -72.03 -52.1 18.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.152 179.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 29.5 t0 -68.7 -41.02 79.74 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.127 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -58.53 -49.03 78.89 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.288 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 133' ' ' ILE . 32.3 mm -72.25 -40.19 65.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.804 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 2.7 mp0 -74.35 -49.6 22.13 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.551 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -66.63 -37.25 84.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.711 0.291 . . . . 0.0 110.525 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.6 tt -74.17 -27.93 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 110.465 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -65.47 -46.28 80.4 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.629 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -45.07 93.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.61 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 136' ' ' ILE . 3.9 mmpt? -86.76 151.97 22.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.196 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.14 116.8 14.11 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.46 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.81 163.79 15.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.133 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.406 ' HA2' HD21 ' A' ' 111' ' ' LEU . . . -54.92 -171.08 0.07 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.86 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.78 100.17 12.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.24 0.52 . . . . 0.0 111.349 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.599 ' O ' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.63 109.73 19.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.825 178.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -113.62 -76.8 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.6 p -99.9 -60.87 1.45 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.786 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 9.7 tmtt? -63.09 -49.81 73.01 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.445 ' CB ' ' HB ' ' A' ' 144' ' ' ILE . 0.8 OUTLIER -55.87 -52.42 64.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.38 -40.53 57.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.8 m -70.72 -33.8 71.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.805 0.336 . . . . 0.0 111.475 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.786 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -70.48 -50.69 35.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.057 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.42 ' HB3' ' CE1' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -64.6 -31.42 72.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.638 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -61.81 -38.68 89.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -26.5 66.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.118 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.472 ' CE2' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.04 -41.49 90.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.936 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.8 86.01 2.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.349 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.18 145.68 84.86 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.687 2.258 . . . . 0.0 112.637 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -147.42 123.43 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.304 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -78.6 -37.99 41.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.968 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -66.77 -29.8 69.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.35 -47.98 83.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.027 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -88.23 -42.6 12.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.007 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -60.02 -57.74 11.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -103.47 165.06 11.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.1 106.64 15.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.15 132.32 22.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.372 2.048 . . . . 0.0 112.318 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -95.15 123.68 38.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.872 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.9 m -160.94 -44.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.966 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 7.2 m170 62.35 155.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.786 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -96.25 -52.54 3.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.2 m -67.0 98.2 0.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.962 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.912 -179.988 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.6 p -153.98 134.8 13.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.772 0.32 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -121.13 137.05 54.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.4 ttt -167.16 168.64 13.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.52 -179.65 8.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.092 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -126.28 -50.5 1.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.5 mtt -139.49 178.65 7.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -167.51 -46.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -137.62 115.69 9.77 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.06 140.74 55.28 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.495 2.13 . . . . 0.0 112.328 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.33 145.29 79.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.014 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.99 164.81 34.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.566 2.177 . . . . 0.0 112.314 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.14 126.84 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.2 pp20? -114.16 129.56 56.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.034 0.445 . . . . 0.0 111.844 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -108.2 120.34 59.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.01 158.1 21.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.156 0.503 . . . . 0.0 111.977 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CE1' ' HE2' ' A' ' 127' ' ' MET . 9.7 t80 -150.06 107.48 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.528 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp 62.9 -83.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.165 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -129.3 14.11 6.12 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.411 ' SD ' ' CE2' ' A' ' 95' ' ' PHE . 24.2 ttp -110.6 162.02 15.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.683 0.278 . . . . 0.0 110.969 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.5 mtt180 -148.53 134.9 19.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.093 0.473 . . . . 0.0 111.623 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 3.6 m-85 -115.34 151.35 34.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.729 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.536 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -124.45 135.93 53.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.113 0.482 . . . . 0.0 111.424 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.441 HD12 ' CG1' ' A' ' 108' ' ' VAL . 15.9 mm -118.34 106.54 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 107' ' ' CYS . 2.2 p -129.84 163.47 26.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.358 0.599 . . . . 0.0 111.896 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.523 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.7 p80 -81.16 152.58 27.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.933 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -62.41 154.6 71.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.968 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.429 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.5 Cg_exo -54.27 138.21 72.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.396 2.064 . . . . 0.0 113.433 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.7 p -98.54 145.49 26.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.217 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -68.47 -12.26 60.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.56 -31.25 14.6 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.3 p -139.81 88.99 2.28 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.172 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.7 -52.3 7.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.175 0.512 . . . . 0.0 111.417 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.426 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 74.9 m -55.95 -45.64 78.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.59 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.2 m -57.65 -33.11 67.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.874 0.369 . . . . 0.0 111.314 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -74.52 -47.71 31.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.426 ' CG1' ' O ' ' A' ' 34' ' ' SER . 11.5 pt -55.81 -39.5 56.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.133 0.492 . . . . 0.0 110.63 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -65.12 -52.16 57.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.46 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.6 OUTLIER -67.68 -50.04 59.69 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 120.803 0.335 . . . . 0.0 111.831 -179.153 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' HG ' ' CD1' ' A' ' 36' ' ' PHE . 76.2 mt -54.95 -46.2 74.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.6 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -77.65 -26.82 50.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.05 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 5.9 mttt -52.4 -43.21 64.63 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.07 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.536 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 12.5 t80 -63.48 -38.49 91.36 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.585 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.678 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.96 -178.54 39.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.078 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.47 117.52 19.77 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.625 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 0.7 OUTLIER -165.2 -169.67 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.973 177.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 67' ' ' THR . 7.8 t -64.37 156.81 28.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.463 0.649 . . . . 0.0 110.51 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 66.5 t -136.78 134.29 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.135 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.611 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 13.1 p -115.66 105.07 17.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.393 0.616 . . . . 0.0 111.49 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -114.77 110.88 20.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.108 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.607 HG11 ' HD3' ' A' ' 113' ' ' ARG . 14.6 t -105.25 91.62 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.468 0.651 . . . . 0.0 109.736 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.63 171.55 20.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.851 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.39 129.97 41.58 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -77.33 122.66 32.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.9 p -119.87 -47.73 2.39 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.063 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.413 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -130.57 83.45 2.12 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.398 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -79.44 -36.84 38.26 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.73 -48.54 13.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.504 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -47.02 -55.39 15.46 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.504 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 64.0 Cg_endo -73.37 -42.79 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.261 1.974 . . . . 0.0 114.204 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.44 ' CD1' ' CG1' ' A' ' 68' ' ' VAL . 27.1 mt -71.66 -45.36 62.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -66.24 -32.1 73.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.68 0.276 . . . . 0.0 111.565 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.23 -30.67 34.14 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.12 -11.46 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 45.52 67.2 1.31 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.804 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.1 mt -136.36 147.69 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.624 0.25 . . . . 0.0 110.84 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' THR . 70.9 p -78.07 128.02 33.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 69' ' ' VAL . 8.3 p -145.23 151.73 14.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.091 0.472 . . . . 0.0 112.1 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.518 ' N ' HG23 ' A' ' 68' ' ' VAL . 2.3 t -103.52 130.69 53.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -101.1 106.85 18.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.04 0.448 . . . . 0.0 111.143 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.489 ' HZ2' ' O ' ' A' ' 83' ' ' VAL . 5.7 m0 -110.89 103.96 55.44 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.367 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -106.21 149.97 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.258 2.639 . . . . 0.0 112.841 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.424 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -126.22 109.99 12.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.906 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.4 174.84 11.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.857 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.43 -34.02 71.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.847 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.84 42.88 1.58 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.307 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.423 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . -112.06 106.43 56.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.445 0.164 . . . . 0.0 111.191 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.592 ' C ' ' HD3' ' A' ' 80' ' ' PRO . 37.6 Cg_endo -66.13 165.35 24.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.255 1.97 . . . . 0.0 111.728 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -102.76 55.87 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.475 2.783 . . . . 0.0 114.353 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.592 ' HD3' ' C ' ' A' ' 78' ' ' PRO . 62.4 Cg_exo -47.99 138.36 21.62 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 121.888 1.725 . . . . 0.0 111.894 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.415 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -66.18 -22.63 70.98 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.675 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -43.25 68.12 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.578 0.228 . . . . 0.0 111.06 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.489 ' O ' ' HZ2' ' A' ' 71' ' ' TRP . 15.2 m -55.12 -43.03 68.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.079 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.449 HG12 ' CE1' ' A' ' 151' ' ' TYR . 0.8 OUTLIER -53.49 -41.08 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -64.96 -31.38 72.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.324 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -66.48 -50.34 63.61 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.611 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -66.87 -30.34 70.48 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.439 HD11 ' CE2' ' A' ' 155' ' ' TYR . 18.2 mt -61.05 -46.71 89.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.339 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -64.05 -40.08 95.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.31 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.67 -51.34 70.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.725 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.439 HG22 ' CD1' ' A' ' 95' ' ' PHE . 14.4 p -71.07 -35.92 60.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.066 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.52 -46.85 76.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.46 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.89 -43.41 83.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.66 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -69.13 -25.71 64.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.439 ' CD1' HG22 ' A' ' 91' ' ' VAL . 1.7 m-85 -76.58 -52.02 10.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.948 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.2 t -59.67 -39.8 85.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.13 -33.08 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.126 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.09 88.23 54.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.304 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.95 128.15 12.09 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.536 2.158 . . . . 0.0 112.194 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.51 57.48 19.35 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.321 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.418 ' CB ' HG22 ' A' ' 46' ' ' THR . 1.5 t -101.03 -163.08 0.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.616 0.246 . . . . 0.0 111.123 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.678 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 m -115.44 113.26 23.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.337 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 25.7 t -110.42 150.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 112.016 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -121.58 142.0 50.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.188 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.607 HG13 ' H ' ' A' ' 106' ' ' HIS . 20.0 t -140.1 166.14 20.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.357 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.607 ' H ' HG13 ' A' ' 105' ' ' VAL . 3.3 t60 -67.17 155.37 38.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.95 0.405 . . . . 0.0 110.81 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.5 ' N ' ' O ' ' A' ' 25' ' ' THR . 34.4 t -69.27 110.33 4.57 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 140' ' ' ARG . 13.2 m -75.6 0.63 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.372 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.04 -8.66 2.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.35 -137.7 4.44 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.427 HD23 ' HA2' ' A' ' 142' ' ' GLY . 4.1 mt -111.49 127.13 55.6 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.69 -162.42 12.52 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 119.952 -1.118 . . . . 0.0 113.522 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.607 ' HD3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.38 -19.88 6.29 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.08 0.467 . . . . 0.0 111.735 -178.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.638 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.43 -46.42 98.06 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 8.0 Cg_endo -52.69 -48.51 21.6 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.948 1.766 . . . . 0.0 112.359 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.587 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 89.4 t -55.87 -53.34 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.444 HD12 ' CD2' ' A' ' 71' ' ' TRP . 10.6 mt -52.28 -45.57 65.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.692 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.469 HG11 ' CE1' ' A' ' 22' ' ' PHE . 13.8 t -51.42 -52.63 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 111.177 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 123' ' ' ILE . . . -54.99 -45.6 75.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.025 0.441 . . . . 0.0 110.436 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 116' ' ' VAL . 1.5 mt -55.16 -30.92 60.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.039 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.493 ' HB1' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.96 -49.19 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' A' ' 122' ' ' LEU . 22.5 tp -67.08 -14.02 62.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.805 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 120' ' ' LEU . 2.1 mt -57.74 -32.41 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.977 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -16.21 63.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.75 -23.45 42.23 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 151.2 -96.46 0.17 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.899 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.504 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.17 73.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -72.07 -67.8 0.51 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -176.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.436 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 5.3 t80 -66.14 -34.58 78.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.931 0.396 . . . . 0.0 111.227 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.27 -52.75 14.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.414 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 25.8 t70 -70.78 -32.65 69.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.716 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.549 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -60.42 -49.98 75.4 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.1 mm -71.04 -41.18 76.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.576 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.86 -50.37 17.28 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.566 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -66.1 -35.82 81.54 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.704 0.287 . . . . 0.0 110.55 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.3 tt -74.24 -40.47 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.677 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.0 ttt-85 -58.6 -36.61 74.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.177 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -59.52 -45.55 91.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.819 0.343 . . . . 0.0 110.747 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.78 151.28 23.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.61 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.466 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.73 116.71 14.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.842 0.353 . . . . 0.0 110.155 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.466 ' HD3' HG23 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -115.39 164.1 14.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.355 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.427 ' HA2' HD23 ' A' ' 111' ' ' LEU . . . -53.39 -172.8 0.05 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.586 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.18 9.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.62 0.71 . . . . 0.0 111.616 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.62 109.75 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.457 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.63 -76.55 0.59 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.67 -60.78 1.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.819 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.9 tmtt? -53.42 -51.74 61.64 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.79 -51.98 66.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.62 -41.31 62.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.9 m -69.74 -41.3 75.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.793 0.33 . . . . 0.0 111.265 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.819 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -62.84 -50.66 70.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.223 -179.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.489 ' CD2' ' CD1' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -67.19 -31.22 71.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.923 -179.401 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -39.56 90.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -23.1 55.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.91 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.515 ' CE2' HD12 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -66.4 -39.56 89.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.72 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.89 124.48 35.27 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.755 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.53 151.75 83.9 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.496 2.131 . . . . 0.0 112.382 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.36 123.48 10.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.525 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -59.41 -22.22 61.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.113 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -59.06 -41.26 87.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.908 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.5 tp -60.05 -46.85 88.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 169.53 5.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -75.05 -49.44 19.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -62.85 115.45 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.99 138.08 49.69 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.35 -178.11 2.4 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.494 2.129 . . . . 0.0 112.273 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -167.15 -65.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.4 p -147.98 161.69 40.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -134.59 -47.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -141.1 163.59 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.8 t -71.19 98.79 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.847 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.77 -37.65 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -106.98 124.14 49.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 30.1 ttm -124.37 123.5 40.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.27 137.79 20.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -106.68 113.96 27.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.0 mmm -132.31 134.74 45.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.16 -37.95 9.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.8 mtm105 -132.3 116.02 15.21 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.09 106.61 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.419 2.079 . . . . 0.0 112.198 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.64 154.5 94.33 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.21 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.37 165.27 31.09 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.651 2.234 . . . . 0.0 112.345 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 t -130.32 126.69 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.795 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.424 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -103.81 122.67 45.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.536 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.501 ' CG1' ' CD2' ' A' ' 135' ' ' PHE . 2.3 t -106.82 134.17 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.317 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 p -132.17 133.63 44.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.171 0.51 . . . . 0.0 112.16 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CE2' ' HG3' ' A' ' 18' ' ' LYS . 41.2 t80 -155.13 141.98 19.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.371 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mmtt 61.97 -103.59 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.932 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -129.84 -1.62 4.75 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.442 ' CE ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -113.34 168.43 9.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.038 0.447 . . . . 0.0 111.478 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -125.9 164.2 21.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.009 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.431 ' CE1' HG11 ' A' ' 103' ' ' VAL . 1.5 m-85 -136.65 137.44 40.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.339 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.535 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -114.88 132.8 56.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.002 0.429 . . . . 0.0 111.134 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.436 HD12 ' HB ' ' A' ' 105' ' ' VAL . 1.2 mm -115.85 106.35 20.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -135.33 167.1 21.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 111.921 -178.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.425 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 3.0 t-80 -81.09 151.53 28.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.689 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -63.42 154.84 77.63 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.83 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.417 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.7 Cg_exo -54.57 140.11 75.59 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.222 1.948 . . . . 0.0 112.954 -178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.465 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 67.8 p -98.61 174.27 6.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -92.52 -13.06 30.35 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.57 -31.04 14.68 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 p -139.72 89.56 2.33 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.49 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.465 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.3 OUTLIER -80.4 -52.19 7.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.106 0.479 . . . . 0.0 111.31 178.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -55.97 -45.38 78.92 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.549 -178.637 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.7 -34.47 69.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.897 0.379 . . . . 0.0 111.354 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.438 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.17 -47.75 33.73 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' CG1' ' O ' ' A' ' 34' ' ' SER . 12.5 pt -55.54 -39.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.155 0.502 . . . . 0.0 110.605 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -65.43 -51.97 56.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.483 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 2.5 m-20 -68.35 -50.2 54.89 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.438 HD21 ' CE1' ' A' ' 36' ' ' PHE . 84.9 mt -55.69 -45.38 77.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.556 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -78.45 -26.63 46.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.102 0.477 . . . . 0.0 110.059 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.3 mttp -52.01 -43.98 63.91 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.283 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.535 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 20.2 t80 -63.31 -38.39 90.98 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.696 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.725 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 166.24 -178.83 40.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.928 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.17 19.23 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.602 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 0.6 OUTLIER -165.22 -169.38 1.62 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.853 177.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 67' ' ' THR . 2.9 t -64.33 143.07 58.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.692 0.758 . . . . 0.0 110.557 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 104' ' ' ALA . 25.4 t -122.23 132.12 71.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.113 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.629 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 9.8 p -115.47 105.25 18.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.181 0.515 . . . . 0.0 111.175 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 110.93 20.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.906 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.476 HG11 ' NE ' ' A' ' 113' ' ' ARG . 44.0 t -103.98 91.74 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.556 0.693 . . . . 0.0 110.493 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.6 t -157.79 171.19 20.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.733 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.74 130.2 42.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -72.36 122.0 23.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 p -120.57 -47.71 2.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.046 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.411 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -130.75 84.24 2.18 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.503 179.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -78.77 -36.51 42.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -79.5 -48.59 13.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.402 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.5 -49.7 24.91 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 9.6 Cg_exo -72.97 -42.46 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.702 2.268 . . . . 0.0 113.731 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -71.39 -45.21 63.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -70.54 -28.9 65.28 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.02 -34.72 32.65 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' CB ' HG12 ' A' ' 66' ' ' ILE . 44.0 m-20 -101.54 -11.37 19.33 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.56 41.56 49.69 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.423 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.463 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 1.1 pt -118.77 148.71 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 122.313 0.245 . . . . 0.0 111.047 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 47' ' ' THR . 21.9 p -77.39 135.03 38.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 69' ' ' VAL . 7.4 p -144.98 149.68 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.073 0.463 . . . . 0.0 112.054 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.472 ' N ' HG23 ' A' ' 68' ' ' VAL . 2.2 t -103.31 131.04 52.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.11 106.55 17.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 111.021 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.453 ' CH2' ' HA ' ' A' ' 84' ' ' VAL . 4.9 m95 -110.53 103.47 54.28 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.199 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -108.58 -176.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.469 2.779 . . . . 0.0 113.042 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -126.27 140.0 52.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.531 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -152.67 172.74 16.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.63 -25.22 37.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.945 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -120.47 59.99 0.53 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.499 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.432 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -85.69 135.56 37.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 122.938 -0.154 . . . . 0.0 110.703 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.427 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . 39.4 Cg_endo -66.31 107.75 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.569 2.18 . . . . 0.0 112.666 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.626 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 24.1 Cg_exo -64.62 -36.62 41.31 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.004 2.469 . . . . 0.0 114.603 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 18.2 Cg_endo -62.06 152.26 76.66 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.823 1.682 . . . . 0.0 113.713 -178.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HZ3' ' A' ' 147' ' ' LYS . . . -66.09 -19.34 67.9 Favored Glycine 0 C--O 1.236 0.263 0 CA-C-N 114.948 -1.024 . . . . 0.0 113.266 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -50.11 -29.4 8.95 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.428 0.156 . . . . 0.0 110.93 -177.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 78' ' ' PRO . 55.3 t -55.36 -47.98 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.453 ' HA ' ' CH2' ' A' ' 71' ' ' TRP . 88.0 t -56.13 -39.8 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.05 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 2.8 mt-10 -58.21 -31.25 67.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.481 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.87 -50.25 67.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.988 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.629 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.04 -26.79 66.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.402 ' CD2' ' HB3' ' A' ' 120' ' ' LEU . 25.9 mt -62.79 -41.44 99.26 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.159 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 t -67.78 -41.72 82.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.026 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -58.98 -51.23 70.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.779 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.459 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 7.8 p -71.81 -41.06 69.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.261 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -55.34 -38.49 68.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.936 0.398 . . . . 0.0 110.706 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.04 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.763 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -29.58 67.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.145 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.459 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 3.3 m-85 -76.78 -52.06 10.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.032 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.3 t -59.8 -36.95 77.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -31.87 59.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.06 94.4 41.59 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.287 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.13 129.09 16.61 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.425 2.083 . . . . 0.0 112.219 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.95 59.46 10.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.292 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.433 ' CB ' HG23 ' A' ' 46' ' ' THR . 83.5 p -101.2 -170.09 1.79 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.927 0.394 . . . . 0.0 111.442 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.725 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.6 m -113.03 113.61 25.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.308 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 76.0 t -104.23 149.98 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.483 ' HB2' ' CG2' ' A' ' 48' ' ' VAL . . . -122.52 140.58 52.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.787 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 49' ' ' VAL . 2.2 t -140.6 166.74 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 2.4 t60 -67.49 156.14 37.35 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.651 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.576 ' N ' ' O ' ' A' ' 25' ' ' THR . 50.4 t -68.41 102.44 1.42 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.381 0.61 . . . . 0.0 112.287 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.432 ' O ' HG21 ' A' ' 108' ' ' VAL . 7.1 p -75.27 -0.02 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.025 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.81 -8.68 3.21 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.424 ' O ' HD21 ' A' ' 111' ' ' LEU . . . -122.3 -134.06 4.39 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 22.3 mt -125.29 127.58 46.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.2 -143.19 3.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.993 -1.099 . . . . 0.0 113.597 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.476 ' NE ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.13 -19.37 6.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.968 0.413 . . . . 0.0 111.794 -178.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.656 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.62 -46.46 85.68 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.0 Cg_endo -51.98 -48.39 21.84 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.46 2.107 . . . . 0.0 112.869 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 120' ' ' LEU . 22.1 t -61.73 -38.51 80.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.932 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.431 HD23 ' CZ3' ' A' ' 71' ' ' TRP . 6.8 mt -64.61 -49.1 72.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.527 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.425 HG13 ' CD1' ' A' ' 22' ' ' PHE . 12.5 t -54.59 -55.4 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.4 78.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.214 0.531 . . . . 0.0 111.091 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.602 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 1.2 mm? -53.92 -30.66 47.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.532 ' HB3' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.24 -47.66 55.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.04 0.447 . . . . 0.0 110.085 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.442 ' CD1' ' CE ' ' A' ' 20' ' ' MET . 14.4 tp -61.58 -16.99 53.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.746 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.9 mt -57.08 -30.81 35.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.494 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.402 ' OE2' ' CG ' ' A' ' 95' ' ' PHE . 3.3 pt-20 -68.14 -17.29 64.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.557 0.218 . . . . 0.0 111.456 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.7 t -84.75 11.04 9.83 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 104.02 -81.69 0.35 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.873 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 51.8 ttp -63.16 66.47 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.665 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -74.63 -67.91 0.59 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -176.239 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.446 ' CD1' HD21 ' A' ' 152' ' ' LEU . 5.1 t80 -71.59 -31.54 67.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.057 0.456 . . . . 0.0 110.806 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -72.53 -47.32 49.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.311 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 10.8 t0 -70.09 -43.77 70.44 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 110.836 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.51 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -58.36 -50.04 75.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.879 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 133' ' ' ILE . 35.0 mm -71.65 -42.38 71.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.904 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -49.33 27.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -68.62 -39.66 80.7 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.189 -0.204 . . . . 0.0 111.016 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.7 OUTLIER -72.62 -27.79 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.318 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -47.18 79.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.949 0.404 . . . . 0.0 110.034 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -45.13 93.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.667 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -86.5 152.54 22.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.346 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.83 117.07 14.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.004 0.43 . . . . 0.0 110.299 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.406 ' HA ' ' CG2' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -114.82 163.29 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.158 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.426 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -58.06 172.47 3.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.197 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.23 99.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.528 0.664 . . . . 0.0 110.447 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.414 ' CG2' ' HG3' ' A' ' 148' ' ' GLN . 2.2 pt -88.31 109.06 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.098 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -113.55 -76.88 0.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.562 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.06 -60.61 1.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.631 ' O ' ' CB ' ' A' ' 151' ' ' TYR . 0.8 OUTLIER -54.76 -51.93 64.14 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.295 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.414 ' HG3' ' CG2' ' A' ' 144' ' ' ILE . 1.1 tm0? -56.35 -51.87 66.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 149' ' ' LEU . 3.4 mm? -75.22 -47.46 28.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.7 m -64.96 -34.82 79.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.733 0.301 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.631 ' CB ' ' O ' ' A' ' 147' ' ' LYS . 6.9 t80 -68.2 -50.95 50.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.281 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.447 ' CD2' ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -72.01 -32.76 67.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.525 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.59 -37.7 79.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -28.24 62.4 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.642 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.521 ' CD2' HD12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -65.88 -34.34 77.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.679 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.02 89.52 4.56 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.28 150.33 87.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.536 2.157 . . . . 0.0 112.363 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.27 123.57 10.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -70.42 -11.96 61.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.339 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.9 -38.71 79.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.817 0.341 . . . . 0.0 111.037 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -38.84 84.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -109.76 -169.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -124.01 111.01 15.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.45 138.06 54.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -86.66 108.58 18.72 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.8 112.35 2.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.404 2.069 . . . . 0.0 112.277 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 4.9 t60 61.72 152.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.6 m -142.79 149.35 38.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -151.33 137.06 17.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 60.69 106.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.3 m -101.9 -64.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.814 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t -163.91 126.13 2.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.36 . . . . 0.0 110.946 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -149.76 150.18 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.84 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.2 mtt 60.64 168.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.64 -67.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -91.21 84.36 5.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.03 161.34 30.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.35 145.44 48.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -74.68 141.05 75.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.28 110.09 3.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.515 2.143 . . . . 0.0 112.336 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.76 148.04 92.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.068 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.29 163.43 39.15 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.526 2.151 . . . . 0.0 112.297 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.05 126.83 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -108.5 126.25 52.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.523 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.513 ' CG1' ' CE2' ' A' ' 135' ' ' PHE . 2.4 t -106.65 129.79 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 p -132.87 139.25 47.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.222 0.534 . . . . 0.0 112.136 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.44 ' CZ ' ' HG3' ' A' ' 18' ' ' LYS . 10.8 t80 -155.12 129.17 8.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.104 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 2.0 mmmp? 63.46 -92.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.198 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.42 -39.06 1.52 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.77 151.66 40.56 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 111.273 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.62 164.24 21.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.067 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 103' ' ' VAL . 2.0 m-85 -136.76 139.16 41.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.646 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -117.77 138.5 52.01 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.118 0.485 . . . . 0.0 111.343 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.518 HG22 ' HA ' ' A' ' 107' ' ' CYS . 2.6 mm -118.22 106.64 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.211 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -131.05 164.29 25.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.476 0.655 . . . . 0.0 112.451 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.532 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.8 p80 -81.74 152.55 26.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.248 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -62.48 154.44 72.75 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.495 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.2 Cg_exo -54.85 139.03 78.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.391 2.061 . . . . 0.0 113.601 -177.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.7 p -98.97 145.94 26.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.977 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -71.3 -10.12 59.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.83 14.74 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 p -139.59 89.43 2.32 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.382 -0.527 . . . . 0.0 112.244 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.38 -52.25 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.177 0.513 . . . . 0.0 111.23 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.434 ' HA ' HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -56.7 -45.19 81.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.321 -178.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.5 m -57.69 -31.91 66.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -75.22 -47.56 27.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.142 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 34' ' ' SER . 11.3 pt -55.44 -38.39 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.227 0.537 . . . . 0.0 110.334 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.43 -51.75 58.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.374 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.507 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.2 m-20 -68.8 -50.29 51.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.918 0.389 . . . . 0.0 111.953 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.455 ' HG ' ' CD1' ' A' ' 36' ' ' PHE . 83.6 mt -56.89 -44.45 82.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.993 0.425 . . . . 0.0 110.303 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -77.19 -26.65 53.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.886 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 2.1 mtmt -52.79 -47.52 67.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.306 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.549 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 11.6 t80 -63.63 -38.5 91.37 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.656 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.655 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 160.03 -177.44 36.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.041 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.62 122.93 28.34 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.579 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 3.8 m -164.52 -171.2 2.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.46 177.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.485 ' H ' ' CG2' ' A' ' 46' ' ' THR . 1.8 t -65.33 149.63 49.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.329 0.585 . . . . 0.0 109.862 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 74.4 t -126.64 135.18 64.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.882 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.624 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 9.3 p -115.46 104.91 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.111 0.482 . . . . 0.0 111.27 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.414 ' CD ' HG23 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -114.74 111.01 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.399 178.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.593 HG11 ' CD ' ' A' ' 113' ' ' ARG . 8.1 t -103.71 90.39 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.451 0.643 . . . . 0.0 109.303 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -158.63 171.87 19.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.953 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -65.06 130.62 44.02 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 m -81.07 122.32 36.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.6 p -120.15 -47.52 2.37 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.663 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.419 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -130.33 83.86 2.16 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -79.4 -36.6 38.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.65 -48.58 13.48 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.435 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.22 -56.65 10.21 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 65.4 Cg_endo -73.17 -42.35 1.0 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.493 2.129 . . . . 0.0 114.182 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.462 ' CD1' ' CG1' ' A' ' 68' ' ' VAL . 28.9 mt -71.19 -45.21 63.89 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.3 -30.83 70.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.817 0.341 . . . . 0.0 111.422 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -81.37 -32.67 32.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 66' ' ' ILE . 18.1 p30 -101.23 -11.35 19.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 61' ' ' LEU . . . 48.11 31.29 8.25 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.284 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 64' ' ' ASP . 5.6 mt -97.42 147.53 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.679 0.276 . . . . 0.0 110.974 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 47' ' ' THR . 50.1 p -78.41 131.14 36.82 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 69' ' ' VAL . 9.1 p -145.36 152.24 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.494 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.3 t -103.63 132.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -100.57 106.79 18.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 109.947 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.459 ' CH2' ' HA ' ' A' ' 84' ' ' VAL . 3.4 m95 -111.72 104.07 55.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.677 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -106.83 88.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 123.573 2.849 . . . . 0.0 112.344 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 1.5 t80 -85.79 95.85 9.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 110.963 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.74 -165.39 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -55.25 -24.74 29.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.112 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -114.68 39.49 2.78 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HB3' ' CD1' ' A' ' 73' ' ' PHE . . . -85.98 155.07 58.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.623 0.249 . . . . 0.0 111.029 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . 57.4 Cg_endo -70.62 109.55 2.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.682 2.255 . . . . 0.0 112.586 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.631 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 32.7 Cg_exo -60.32 -40.17 60.98 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.914 2.409 . . . . 0.0 114.354 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 12.4 Cg_endo -58.06 143.15 96.95 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.936 1.758 . . . . 0.0 113.544 -178.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -66.03 -19.9 68.34 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.179 -0.919 . . . . 0.0 113.04 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -50.73 -29.57 11.72 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.561 0.22 . . . . 0.0 110.763 -178.234 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.415 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 41.4 t -56.79 -48.3 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.459 ' HA ' ' CH2' ' A' ' 71' ' ' TRP . 90.3 t -55.34 -37.47 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.986 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 1.8 mt-10 -60.42 -31.32 70.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.429 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.91 -50.17 69.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.245 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.624 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.56 -27.42 67.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.49 -38.16 90.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.095 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -69.03 -41.42 77.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.803 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -59.53 -51.32 70.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.381 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.466 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 8.5 p -71.74 -35.9 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.909 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -56.23 -47.19 78.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.502 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.31 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.636 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -68.0 -24.28 65.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.077 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.466 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 2.4 m-85 -82.09 -52.04 7.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.167 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.3 t -63.93 -39.87 95.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.992 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.11 -31.72 58.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.226 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.15 89.1 52.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.52 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.64 135.07 14.19 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.594 2.196 . . . . 0.0 112.236 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.95 46.23 89.94 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.468 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 t -101.04 -176.59 3.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.66 0.267 . . . . 0.0 111.118 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.655 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 2.2 m -111.98 114.05 26.71 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 28.0 t -101.94 151.28 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -122.05 141.74 51.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.146 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.482 HG12 ' CG2' ' A' ' 118' ' ' VAL . 2.5 t -140.68 166.95 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 2.3 t60 -67.38 156.51 36.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.639 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.518 ' HA ' HG22 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -68.01 98.79 0.79 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.375 0.607 . . . . 0.0 112.469 -178.042 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.457 ' O ' HG21 ' A' ' 108' ' ' VAL . 7.5 p -75.41 -0.08 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.96 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.66 -8.76 3.13 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.03 -124.71 2.96 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.429 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 13.1 mt -129.11 127.39 41.36 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.86 -144.41 4.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.807 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.593 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.14 -20.56 6.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.033 0.444 . . . . 0.0 111.931 -178.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.671 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -52.11 -44.94 93.63 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 6.4 Cg_endo -51.62 -48.3 22.05 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.524 2.149 . . . . 0.0 113.165 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.42 ' O ' HD23 ' A' ' 120' ' ' LEU . 62.1 t -62.48 -46.45 96.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.02 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.429 HD13 ' CG2' ' A' ' 51' ' ' VAL . 13.4 mt -58.85 -41.89 88.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.973 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.482 ' CG2' HG12 ' A' ' 105' ' ' VAL . 54.0 t -61.63 -55.44 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.609 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.09 -52.51 65.24 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.157 0.504 . . . . 0.0 111.032 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.622 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 4.3 mm? -53.82 -30.82 46.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.668 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.482 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.26 -42.38 65.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.078 0.466 . . . . 0.0 110.115 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.4 tp -67.51 -14.04 62.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 120' ' ' LEU . 2.4 mt -57.25 -30.77 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.031 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.28 -16.87 63.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.6 m -83.93 11.2 8.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.19 -101.58 1.06 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.211 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.455 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.7 ptt? -62.49 77.78 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.65 -67.59 0.54 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.473 ' CD1' HD21 ' A' ' 152' ' ' LEU . 4.1 t80 -66.26 -33.77 76.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.926 0.393 . . . . 0.0 111.187 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.26 -51.67 19.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.294 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 30.0 t0 -70.03 -36.25 74.92 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.841 0.353 . . . . 0.0 111.029 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.537 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -61.31 -50.16 74.09 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.654 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.411 HG21 HD12 ' A' ' 133' ' ' ILE . 27.9 mm -74.31 -37.61 45.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.531 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -74.24 -49.68 22.27 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -69.24 -35.84 76.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.473 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.3 tt -74.0 -27.91 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 0.0 110.227 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -65.14 -52.31 55.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.539 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.86 -45.17 93.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.633 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 136' ' ' ILE . 7.3 mmtt -81.54 152.22 27.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.253 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.83 117.21 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.344 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.411 ' HA ' ' CG2' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -114.64 163.39 15.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.12 -179.649 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -60.15 -163.35 0.14 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.276 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.1 99.28 12.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.427 0.614 . . . . 0.0 110.633 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 144' ' ' ILE . 6.8 pt -88.35 109.26 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.119 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.67 -76.98 0.58 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.605 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.23 -60.69 1.48 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.6 tmtt? -57.35 -51.89 67.59 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.42 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -56.14 -52.09 65.61 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.412 ' CD2' ' N ' ' A' ' 149' ' ' LEU . 3.4 mm? -75.27 -45.55 39.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 56.3 m -66.44 -33.47 75.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.807 0.336 . . . . 0.0 111.147 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.61 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 2.2 t80 -68.68 -50.93 47.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.473 HD21 ' CD1' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -70.25 -34.26 72.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.407 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -36.44 76.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -26.26 60.55 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.71 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.464 ' CD2' HD12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -65.93 -37.58 86.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.451 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.91 85.92 2.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.614 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.01 151.61 67.73 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.609 2.206 . . . . 0.0 112.486 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.33 123.5 10.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.472 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -65.21 -20.68 66.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.208 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -30.37 67.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.82 0.343 . . . . 0.0 110.985 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.2 mt -67.86 -48.03 67.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.12 126.53 46.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.56 -60.58 2.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -63.25 119.11 8.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -94.05 103.5 10.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.9 177.43 4.99 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.437 2.091 . . . . 0.0 112.264 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -141.78 176.12 9.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.7 m -111.82 133.63 53.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -109.39 168.74 9.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -170.73 97.21 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.6 m -124.4 110.94 15.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.996 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.935 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 t -176.11 164.61 2.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.814 0.34 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -97.23 -62.52 1.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.5 ptp -66.26 110.88 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -167.99 -55.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.74 36.56 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.939 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -130.8 120.83 24.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -141.77 88.7 2.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -161.47 80.71 2.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.05 148.82 29.16 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.6 2.2 . . . . 0.0 112.326 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.56 160.78 49.96 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.83 163.67 37.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.577 2.185 . . . . 0.0 112.306 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.4 t -144.26 129.26 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.964 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -111.34 116.6 31.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.868 0.366 . . . . 0.0 111.269 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.438 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -109.05 118.29 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.41 ' CB ' ' HA ' ' A' ' 21' ' ' ARG . 70.3 p -141.24 142.46 33.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HG2' ' A' ' 18' ' ' LYS . 1.2 p90 -136.61 164.48 28.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.413 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.576 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 pttp 50.09 -95.99 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.202 0.201 . . . . 0.0 110.973 -177.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.488 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 t-160 -128.92 -32.36 2.09 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.494 ' HE2' ' CD1' ' A' ' 22' ' ' PHE . 3.8 ppp? -73.65 168.05 20.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.645 0.259 . . . . 0.0 111.329 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.41 ' HA ' ' CB ' ' A' ' 16' ' ' SER . 3.4 mtp180 -146.05 161.54 39.9 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.012 0.434 . . . . 0.0 111.752 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CD1' ' HE2' ' A' ' 20' ' ' MET . 0.9 OUTLIER -135.05 148.78 49.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.555 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.548 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -120.28 135.96 54.83 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.106 0.479 . . . . 0.0 111.206 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 107' ' ' CYS . 2.2 mm -117.98 106.66 20.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.25 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 107' ' ' CYS . 1.3 p -132.62 164.44 26.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.197 0.523 . . . . 0.0 111.819 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.463 ' CD2' ' CZ ' ' A' ' 36' ' ' PHE . 45.4 p-80 -81.31 152.17 27.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.738 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -62.71 154.42 74.65 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.485 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.9 Cg_exo -54.61 140.58 75.86 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.296 1.997 . . . . 0.0 113.2 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.462 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.5 p -98.69 174.38 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.129 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -94.26 -11.4 30.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.66 -30.75 14.76 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.0 p -139.5 89.61 2.34 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.45 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.462 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.27 -52.22 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.19 0.519 . . . . 0.0 111.173 178.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.8 p -56.86 -45.05 82.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.308 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.1 m -57.92 -32.82 68.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.828 0.347 . . . . 0.0 111.288 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.485 ' CD2' ' HA ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -74.8 -47.92 28.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.146 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 34' ' ' SER . 12.1 pt -55.7 -38.93 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.233 0.54 . . . . 0.0 110.655 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -51.9 57.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.46 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -68.7 -50.29 52.07 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.437 HD21 ' CE1' ' A' ' 36' ' ' PHE . 72.4 mt -56.47 -43.64 79.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.437 . . . . 0.0 110.392 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -78.6 -26.73 45.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.077 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 3.7 mttt -53.25 -44.6 68.28 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.374 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.548 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 16.5 t80 -63.52 -38.56 91.6 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.949 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.641 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.32 -178.47 39.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.951 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.64 117.67 19.84 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.605 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 0.8 OUTLIER -164.88 -170.16 1.89 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.966 177.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 67' ' ' THR . 16.8 p -64.94 155.11 35.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.474 0.654 . . . . 0.0 110.788 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 65.6 t -134.0 139.1 49.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.04 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.61 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 3.3 p -115.77 105.37 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.164 0.507 . . . . 0.0 110.936 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.23 110.92 20.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.22 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.555 HG13 ' HD3' ' A' ' 113' ' ' ARG . 10.8 t -105.62 91.38 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.331 0.586 . . . . 0.0 109.914 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 10.4 p -158.01 171.28 20.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.948 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.64 130.48 43.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.59 121.75 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 p -120.77 -47.63 2.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.212 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.426 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.7 m-85 -130.43 84.29 2.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.488 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -78.61 -36.24 44.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -79.1 -48.49 14.24 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.411 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.56 -49.88 24.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 17.2 Cg_exo -68.08 -42.1 6.5 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.574 2.183 . . . . 0.0 113.427 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.414 ' CD2' ' CG1' ' A' ' 68' ' ' VAL . 1.4 mm? -66.19 -45.43 80.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.61 -41.08 55.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -80.92 -27.51 36.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.439 ' HB3' ' CG1' ' A' ' 66' ' ' ILE . 2.7 t0 -101.15 -11.49 19.53 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.45 29.5 1.16 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.522 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.439 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 2.4 pt -117.56 148.06 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.714 0.293 . . . . 0.0 110.982 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 47' ' ' THR . 24.6 p -77.77 135.15 37.96 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 69' ' ' VAL . 9.4 p -143.87 154.91 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.491 ' N ' HG23 ' A' ' 68' ' ' VAL . 3.3 t -103.46 134.18 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -100.82 106.77 18.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.241 0.544 . . . . 0.0 110.319 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.1 m95 -111.96 104.35 55.97 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.091 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -103.79 165.02 0.23 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 123.225 2.617 . . . . 0.0 112.275 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.412 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 2.5 t80 -126.13 122.47 35.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.009 0.433 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -178.11 -167.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.36 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.93 -20.89 40.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.241 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -105.59 27.33 18.4 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.897 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.407 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -110.59 102.73 52.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.643 0.222 . . . . 0.0 110.974 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.68 102.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.633 2.222 . . . . 0.0 112.717 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.659 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 9.7 Cg_endo -53.66 -43.36 58.45 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.773 2.316 . . . . 0.0 113.863 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 4.5 Cg_endo -47.66 148.41 5.86 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.343 2.028 . . . . 0.0 113.49 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.42 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -57.45 -19.78 35.04 Favored Glycine 0 C--O 1.237 0.293 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.399 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -32.0 19.39 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.546 0.173 . . . . 0.0 111.014 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.414 ' HB ' ' CH2' ' A' ' 71' ' ' TRP . 0.0 OUTLIER -55.01 -46.86 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.847 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.475 HG12 ' HG ' ' A' ' 120' ' ' LEU . 79.7 t -55.02 -43.13 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.268 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.27 -31.28 63.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.802 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.94 -50.54 62.02 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.61 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.63 -26.96 65.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.411 ' CD2' ' HB3' ' A' ' 120' ' ' LEU . 18.8 mt -61.34 -50.98 70.74 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.117 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 m -60.53 -41.09 93.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.12 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -56.84 -51.12 70.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.725 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.467 ' CG2' ' CZ ' ' A' ' 95' ' ' PHE . 11.3 p -70.67 -36.66 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.383 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 3.2 tmtt? -64.87 -41.37 95.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 110.71 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.07 -48.07 77.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.36 -26.79 62.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.467 ' CZ ' ' CG2' ' A' ' 91' ' ' VAL . 3.6 m-30 -82.01 -33.91 29.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.885 0.374 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 16.0 t -72.24 -39.44 68.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.067 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -76.16 -33.07 59.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.535 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.56 137.33 26.89 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.679 0.276 . . . . 0.0 111.486 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.58 -166.75 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.547 2.165 . . . . 0.0 112.046 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -46.76 96.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.727 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.437 ' HB3' HG21 ' A' ' 46' ' ' THR . 0.2 OUTLIER -101.1 -160.72 0.81 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.726 0.298 . . . . 0.0 111.017 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.641 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -116.09 113.48 23.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.86 0.362 . . . . 0.0 111.266 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 25.1 t -106.84 151.18 8.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.229 0.538 . . . . 0.0 112.147 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -123.17 139.87 53.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.986 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 49' ' ' VAL . 5.4 t -140.09 166.8 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.458 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 1.7 t60 -66.9 156.1 36.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.391 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.553 ' HA ' HG21 ' A' ' 24' ' ' ILE . 25.5 t -68.3 105.61 2.2 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.433 ' CG1' HD12 ' A' ' 24' ' ' ILE . 35.2 m -75.47 0.25 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.099 178.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.66 -8.77 3.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.53 -135.81 4.39 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.401 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 12.8 mt -120.51 127.29 52.05 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.2 -144.03 3.93 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.822 -1.18 . . . . 0.0 113.671 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.555 ' HD3' HG13 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.19 -25.63 4.84 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.925 0.393 . . . . 0.0 112.005 -178.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.642 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.94 -46.36 87.71 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.1 Cg_endo -52.26 -48.44 21.73 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.29 1.993 . . . . 0.0 112.964 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.401 ' CG1' HD21 ' A' ' 120' ' ' LEU . 59.6 t -61.01 -46.74 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.097 0.475 . . . . 0.0 110.105 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.431 HD11 ' CE3' ' A' ' 71' ' ' TRP . 14.4 mt -59.37 -40.2 85.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.743 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.463 ' CG2' HG11 ' A' ' 105' ' ' VAL . 47.9 t -59.96 -55.65 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.613 0.244 . . . . 0.0 111.629 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.7 -47.13 83.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.609 0.719 . . . . 0.0 110.23 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.606 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 4.5 mm? -54.52 -30.26 53.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.667 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.469 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -70.32 -47.47 60.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 110.164 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.435 ' CD1' ' HE2' ' A' ' 20' ' ' MET . 3.7 mp -63.61 -16.01 59.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.698 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 2.3 mt -57.06 -30.92 35.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.401 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 2.4 pt-20 -73.58 -16.58 61.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.405 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.3 m -85.18 11.03 10.68 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 117.51 -102.65 1.01 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.182 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.495 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 3.6 ptt? -62.42 79.56 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.85 -67.77 0.54 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -176.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.411 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 6.3 t80 -66.81 -32.03 73.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.0 111.054 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.46 -52.05 17.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 29.9 t0 -69.24 -36.21 76.93 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.546 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -61.25 -50.26 73.76 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.812 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.4 mm -74.35 -37.62 45.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.551 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -74.07 -49.71 22.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -70.07 -34.98 73.88 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.666 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.546 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.19 -27.86 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.327 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.18 -48.19 68.7 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.52 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.79 -45.23 92.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.594 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' ILE . 73.7 mmtt -85.51 152.01 23.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.114 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.23 116.81 14.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.055 0.455 . . . . 0.0 110.62 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.12 163.57 15.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.86 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.401 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -57.57 -169.16 0.14 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.496 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.51 99.63 11.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.391 0.596 . . . . 0.0 110.762 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.429 HG23 ' HG3' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -88.05 109.4 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.989 179.189 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -113.16 -76.32 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.4 t -99.75 -60.51 1.52 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.879 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.0 OUTLIER -57.65 -52.65 64.57 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.429 ' HG3' HG23 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -56.88 -51.68 68.12 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.05 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.26 -42.55 62.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.2 m -71.76 -40.76 69.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.785 0.326 . . . . 0.0 111.486 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.879 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -63.75 -50.29 69.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.409 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.45 ' CD2' HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -67.5 -34.07 76.38 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.645 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -55.95 -44.96 78.93 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -27.97 63.63 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.728 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.502 ' CD2' HD12 ' A' ' 123' ' ' ILE . 0.9 OUTLIER -66.73 -25.98 66.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.891 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.87 143.02 26.24 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.673 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.59 152.7 71.9 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.499 2.133 . . . . 0.0 112.352 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -147.31 123.48 10.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.522 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -30.59 61.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.039 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -65.41 -31.24 72.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.5 -35.77 68.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.08 155.83 38.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -77.29 -177.88 4.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 62.85 120.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -92.74 138.1 23.8 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.32 171.41 16.16 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.52 2.147 . . . . 0.0 112.32 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -64.88 113.16 3.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 64.5 p -134.18 148.59 50.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.962 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.31 -43.43 2.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -149.63 -65.01 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 63.0 p -115.63 -38.92 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.953 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m -83.57 174.65 10.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -112.81 -41.44 3.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -31.64 72.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.71 -179.02 3.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -68.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -109.98 144.06 39.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -149.51 115.13 5.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -119.73 90.42 43.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.54 113.92 3.32 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.522 2.148 . . . . 0.0 112.311 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.45 158.19 81.64 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.02 163.55 38.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.613 2.209 . . . . 0.0 112.344 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -144.09 126.84 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.9 pt-20 -102.93 118.5 36.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.364 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.501 ' CG1' ' CD2' ' A' ' 135' ' ' PHE . 18.4 t -106.74 118.53 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.814 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 p -141.24 149.3 41.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.889 0.376 . . . . 0.0 111.957 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.497 ' CD2' ' HE1' ' A' ' 127' ' ' MET . 0.0 OUTLIER -149.57 120.22 7.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.157 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 40.4 mmtt 84.4 -87.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.262 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -129.41 -38.51 1.55 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.417 ' CE ' HD13 ' A' ' 122' ' ' LEU . 4.8 ppp? -73.54 163.8 27.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 111.473 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -145.67 164.05 32.95 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.067 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' CE1' ' CG1' ' A' ' 103' ' ' VAL . 3.0 m-85 -135.67 155.37 50.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.38 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.524 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -125.27 124.75 42.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.315 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.569 HG23 ' HA ' ' A' ' 107' ' ' CYS . 2.0 mm -106.37 106.85 21.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.9 OUTLIER -130.71 165.66 22.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.463 0.649 . . . . 0.0 112.546 -178.407 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.528 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 12.0 p80 -81.61 152.64 27.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.907 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.3 154.35 71.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.4 Cg_exo -54.96 138.36 77.92 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.482 2.121 . . . . 0.0 113.527 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.0 p -98.85 139.57 34.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.929 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -65.65 -10.27 34.57 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.49 -31.14 14.69 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.4 p -139.85 89.04 2.28 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.238 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.75 -52.2 7.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.005 0.431 . . . . 0.0 111.485 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.559 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -55.92 -38.68 70.6 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.187 -178.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -33.71 76.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.913 0.387 . . . . 0.0 111.035 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -76.12 -48.03 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.205 -179.16 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 34' ' ' SER . 0.7 OUTLIER -57.36 -37.18 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.092 0.473 . . . . 0.0 110.458 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -52.14 51.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.189 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.2 m-20 -67.94 -50.06 58.15 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.811 0.339 . . . . 0.0 111.688 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.432 HD22 ' CE1' ' A' ' 36' ' ' PHE . 31.9 mt -56.17 -39.52 72.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.013 0.435 . . . . 0.0 110.418 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -26.74 34.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.085 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -55.11 -43.0 73.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.181 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.524 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 13.5 t80 -63.58 -38.42 91.04 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.621 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.679 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.69 -178.52 39.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.912 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.57 117.93 20.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.596 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.4 m -164.71 -170.66 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.045 177.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 67' ' ' THR . 4.6 t -65.18 158.7 25.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.338 0.59 . . . . 0.0 110.718 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 63.1 t -136.39 136.55 48.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.927 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.654 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 14.8 p -115.87 104.73 17.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.364 0.602 . . . . 0.0 111.288 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -114.58 110.94 20.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.046 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.534 HG11 ' HD3' ' A' ' 113' ' ' ARG . 15.5 t -107.18 91.46 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 121.29 0.567 . . . . 0.0 109.798 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 m -157.81 171.28 20.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.865 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.406 ' CD ' ' N ' ' A' ' 53' ' ' GLU . 2.2 mm-40 -65.26 130.51 43.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.4 t -76.01 122.27 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -120.2 -47.69 2.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.309 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.6 83.54 2.13 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.522 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.43 -36.74 38.47 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -48.54 13.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -45.84 -54.14 17.63 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 8.3 Cg_exo -73.11 -41.97 1.14 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.645 2.23 . . . . 0.0 113.575 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.423 HD22 HG11 ' A' ' 68' ' ' VAL . 1.3 mm? -63.68 -45.34 90.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -75.27 -28.65 59.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -76.41 -37.78 56.58 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -101.74 -11.98 18.71 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.88 24.75 6.53 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.017 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.2 mt -94.47 147.68 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.638 0.256 . . . . 0.0 110.975 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 47' ' ' THR . 23.0 p -78.21 129.21 34.83 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 69' ' ' VAL . 8.5 p -145.08 153.04 14.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 111.977 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.483 ' N ' HG23 ' A' ' 68' ' ' VAL . 2.3 t -103.56 131.36 52.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.09 106.85 18.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.147 0.499 . . . . 0.0 110.849 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.458 ' HZ2' ' O ' ' A' ' 83' ' ' VAL . 4.9 m95 -110.74 103.83 55.11 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -105.82 161.74 0.15 Allowed 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.395 2.73 . . . . 0.0 112.605 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.427 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 0.6 OUTLIER -126.23 95.99 4.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.905 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.96 -160.94 1.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.456 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.02 -23.25 18.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.163 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.82 56.8 0.54 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.729 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.72 102.82 13.51 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.488 0.185 . . . . 0.0 110.94 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.443 ' C ' ' HD2' ' A' ' 80' ' ' PRO . 26.9 Cg_exo -62.35 108.56 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.587 2.191 . . . . 0.0 112.362 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.7 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 41.4 Cg_endo -68.35 -31.22 28.77 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.663 2.242 . . . . 0.0 114.97 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 3.4 Cg_endo -47.9 148.4 6.5 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.8 1.667 . . . . 0.0 113.421 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.27 -21.1 38.73 Favored Glycine 0 C--O 1.237 0.318 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.175 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -51.96 -38.81 57.9 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.599 0.238 . . . . 0.0 110.689 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.458 ' O ' ' HZ2' ' A' ' 71' ' ' TRP . 14.9 t -55.19 -42.93 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.506 HG13 ' CZ ' ' A' ' 151' ' ' TYR . 0.4 OUTLIER -53.24 -42.31 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.301 178.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 84' ' ' VAL . 22.2 mm-40 -62.8 -31.47 72.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.164 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.39 -50.6 69.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.63 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.654 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -66.42 -28.87 68.96 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.872 179.249 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.496 HD13 ' CE2' ' A' ' 155' ' ' TYR . 33.0 mt -62.68 -44.0 97.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.641 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.1 m -66.52 -38.35 86.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.392 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -61.9 -51.47 68.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.988 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.427 HG21 ' CD1' ' A' ' 95' ' ' PHE . 14.3 p -74.36 -37.69 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.353 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -44.21 89.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.387 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.78 -43.77 78.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.523 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -69.93 -23.91 63.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 91' ' ' VAL . 2.1 m-85 -81.76 -52.07 7.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.068 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.5 t -59.51 -37.6 78.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.94 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.99 -33.09 59.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.97 93.2 44.39 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.36 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.89 133.95 20.86 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.504 2.136 . . . . 0.0 112.251 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 59.35 10.97 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.432 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.422 ' CB ' HG22 ' A' ' 46' ' ' THR . 4.4 m -101.1 -163.7 1.04 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.679 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -121.01 113.56 20.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.251 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.457 ' CG1' ' CE1' ' A' ' 22' ' ' PHE . 44.6 t -105.97 150.23 8.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -122.22 135.14 54.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.361 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 24' ' ' ILE . 34.0 m -140.68 167.81 17.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 1.5 t60 -66.87 155.75 37.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.115 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.569 ' HA ' HG23 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -68.46 109.11 3.54 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.396 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.443 ' CG1' HD12 ' A' ' 24' ' ' ILE . 18.7 m -75.79 0.26 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.2 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.48 -8.58 2.84 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.78 -143.37 5.69 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.403 HD21 ' HA2' ' A' ' 142' ' ' GLY . 7.1 mt -115.05 127.27 55.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.99 -144.85 4.23 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.981 -1.104 . . . . 0.0 113.408 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.534 ' HD3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.4 -17.11 7.15 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.646 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -55.18 -47.03 99.51 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.6 Cg_endo -52.49 -48.19 23.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.31 2.006 . . . . 0.0 112.773 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 22.0 t -60.06 -54.15 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.702 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.478 ' HA ' HD12 ' A' ' 120' ' ' LEU . 2.4 mt -52.26 -51.23 59.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.969 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.443 HG11 ' CE1' ' A' ' 22' ' ' PHE . 21.9 t -52.08 -55.19 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.19 -50.18 65.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.333 0.587 . . . . 0.0 111.053 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.597 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 13.5 mt -54.38 -30.55 52.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.977 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.49 ' HB3' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.94 -39.79 69.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.034 0.445 . . . . 0.0 110.004 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.417 HD13 ' CE ' ' A' ' 20' ' ' MET . 3.4 tp -69.45 -15.54 63.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.636 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.597 ' HB ' ' O ' ' A' ' 120' ' ' LEU . 2.4 mt -57.12 -30.6 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.886 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -17.0 64.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.403 ' HB2' HD11 ' A' ' 122' ' ' LEU . 45.0 m -79.79 -23.41 42.17 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.11 -95.79 0.17 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.749 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.497 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 2.7 ptt? -63.84 71.85 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -66.37 -67.52 0.44 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 8.0 t80 -65.69 -33.24 75.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.948 0.404 . . . . 0.0 111.068 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.52 -52.34 16.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.219 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.2 t0 -69.99 -35.91 74.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.857 0.36 . . . . 0.0 110.864 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.54 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -61.36 -50.04 74.5 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.605 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.53 -37.32 43.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.49 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -49.87 21.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.59 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -68.76 -36.96 79.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.668 0.27 . . . . 0.0 110.485 -179.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.6 tt -74.18 -27.85 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.488 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -66.63 -45.79 77.89 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.465 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -45.01 93.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 110.434 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 136' ' ' ILE . 6.2 mptt -86.18 152.12 23.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.107 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 116.57 13.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.11 0.481 . . . . 0.0 110.531 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.13 163.82 15.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.135 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.403 ' HA2' HD21 ' A' ' 111' ' ' LEU . . . -55.64 -170.4 0.09 OUTLIER Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.689 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.93 100.0 12.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.258 0.529 . . . . 0.0 111.303 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 144' ' ' ILE . 14.5 pt -87.75 109.54 19.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.571 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.32 -76.71 0.58 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.0 t -99.65 -60.95 1.43 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.833 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 8.9 tmtt? -62.55 -50.8 69.9 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.407 ' NE2' HG22 ' A' ' 144' ' ' ILE . 1.7 mt-30 -55.61 -51.76 66.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.58 -45.34 53.83 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.2 m -67.42 -37.4 82.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.754 0.311 . . . . 0.0 111.559 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.833 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.67 -50.31 65.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.147 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.481 ' HA ' ' HB2' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -63.85 -34.68 78.49 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.477 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -57.24 -45.22 84.14 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -22.79 62.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.658 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.496 ' CE2' HD13 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -66.5 -36.21 82.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.923 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 125.51 32.86 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.11 153.39 62.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.656 2.237 . . . . 0.0 112.46 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -145.85 123.47 11.82 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.341 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.66 -0.55 38.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.506 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.92 -29.07 66.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.803 0.335 . . . . 0.0 110.959 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mp -80.23 -46.82 15.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.62 92.05 3.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -74.15 90.55 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.01 131.2 55.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.66 119.66 68.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.812 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.35 -175.54 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.386 2.058 . . . . 0.0 112.297 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -140.49 140.85 35.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.4 p -137.22 115.37 11.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -135.99 -63.77 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 -31.92 7.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.0 m -137.37 128.83 28.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.7 t -86.75 -55.2 3.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -85.01 164.78 18.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.78 171.58 8.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.97 105.75 14.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mtp-105 -137.57 126.55 24.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.847 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt -134.34 -46.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.945 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -171.87 156.24 4.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -130.23 145.98 59.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.38 112.14 3.46 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.556 2.17 . . . . 0.0 112.374 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.02 143.03 69.78 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.106 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.02 162.63 40.45 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.518 2.146 . . . . 0.0 112.368 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.5 t -144.2 126.81 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.739 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 mp0 -110.51 129.8 55.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.396 . . . . 0.0 111.503 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.518 HG12 ' CD2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.61 118.89 55.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.95 153.07 29.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.529 . . . . 0.0 112.206 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CE1' ' HE1' ' A' ' 127' ' ' MET . 18.5 t80 -155.16 112.71 3.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.11 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 9.8 mmtm 65.88 -82.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.27 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -129.26 -42.59 1.34 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.457 ' HE1' HD13 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -73.8 149.53 41.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.945 0.402 . . . . 0.0 111.154 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.02 164.19 26.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.528 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 12.2 m-85 -127.59 155.58 43.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.269 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.546 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -125.6 135.88 52.67 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.128 0.489 . . . . 0.0 111.205 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.472 HD11 HG13 ' A' ' 108' ' ' VAL . 21.3 mm -118.23 106.42 19.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.275 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -132.27 163.14 29.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.233 0.539 . . . . 0.0 111.824 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.531 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.0 p80 -81.29 152.41 27.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.026 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -62.52 154.54 72.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.455 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 50.6 Cg_exo -54.38 136.53 69.5 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.369 2.046 . . . . 0.0 113.279 -177.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -98.75 146.57 25.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.041 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -69.39 -10.32 57.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.256 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -31.24 14.61 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 p -139.85 88.97 2.27 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.127 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.79 -52.22 7.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 111.396 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.437 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 1.9 t -56.11 -46.94 78.96 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.596 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -57.67 -32.09 66.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.89 0.376 . . . . 0.0 111.195 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.531 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -75.15 -47.6 27.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.437 ' CG1' ' O ' ' A' ' 34' ' ' SER . 12.1 pt -55.54 -38.78 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.158 0.504 . . . . 0.0 110.573 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -65.74 -51.75 56.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.511 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.505 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 9.4 m-20 -68.52 -50.25 53.53 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD21 ' CE1' ' A' ' 36' ' ' PHE . 75.2 mt -56.45 -44.98 81.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.417 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -77.43 -26.54 51.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.997 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 4.2 mttt -53.12 -46.17 68.64 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.416 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.546 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 14.1 t80 -63.61 -38.52 91.43 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.809 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.668 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.87 -179.31 38.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.01 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.58 117.79 20.07 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.6 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 1.3 m -164.78 -170.29 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.857 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 67' ' ' THR . 2.9 t -64.85 154.02 38.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.43 0.633 . . . . 0.0 110.707 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 57.8 t -131.42 135.39 59.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.992 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.597 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 11.7 p -115.6 105.06 17.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.273 0.559 . . . . 0.0 111.1 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.08 110.79 20.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.69 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.604 HG11 ' HD3' ' A' ' 113' ' ' ARG . 14.5 t -102.26 90.97 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.1 171.59 19.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.737 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -67.1 129.9 41.39 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.43 122.53 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.09 -47.65 2.37 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.448 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.447 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 0.4 OUTLIER -130.63 83.63 2.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.611 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -78.91 -35.73 43.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -78.26 -48.11 16.43 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.447 ' OG1' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -40.88 -60.04 1.83 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.24 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 59' ' ' THR . 33.3 Cg_endo -65.16 -42.43 13.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.436 2.091 . . . . 0.0 113.837 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.419 ' CD1' ' CG1' ' A' ' 68' ' ' VAL . 5.4 mp -71.37 -28.98 64.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.04 -44.6 46.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -81.18 -28.36 35.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.845 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.433 ' CB ' HG12 ' A' ' 66' ' ' ILE . 40.4 m-20 -101.48 -11.61 19.19 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.05 32.44 1.51 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.34 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.433 HG12 ' CB ' ' A' ' 64' ' ' ASP . 1.3 pt -102.56 148.22 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 0.0 111.303 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.2 OUTLIER -78.02 135.36 37.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.498 HG23 ' N ' ' A' ' 69' ' ' VAL . 11.3 p -145.02 152.03 14.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.117 0.484 . . . . 0.0 111.919 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.498 ' N ' HG23 ' A' ' 68' ' ' VAL . 2.2 t -103.23 132.05 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -100.66 106.76 18.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.289 0.566 . . . . 0.0 110.31 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.508 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.5 m95 -112.88 104.64 55.94 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.794 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -103.75 150.11 0.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 123.096 2.531 . . . . 0.0 112.707 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -125.98 96.0 4.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.9 179.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -147.76 -160.2 1.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.533 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.87 -24.08 21.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.794 0.331 . . . . 0.0 111.124 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.86 60.68 0.55 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.537 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.66 104.84 41.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.519 0.2 . . . . 0.0 111.045 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -43.53 101.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.816 2.344 . . . . 0.0 112.891 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.698 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 33.1 Cg_endo -65.97 -34.17 39.4 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.618 2.212 . . . . 0.0 114.733 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 4.2 Cg_endo -48.0 148.04 7.14 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.923 1.749 . . . . 0.0 113.414 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.19 -21.24 69.92 Favored Glycine 0 C--O 1.238 0.351 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.014 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -52.2 -29.98 25.07 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.683 0.278 . . . . 0.0 110.536 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.426 ' CG1' ' CZ2' ' A' ' 71' ' ' TRP . 39.4 t -60.27 -46.49 94.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.489 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 1.2 t -53.47 -38.69 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -65.29 -31.5 72.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.993 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.95 -50.5 70.54 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.332 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.597 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -66.84 -30.29 70.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.199 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.444 HD12 ' CE2' ' A' ' 155' ' ' TYR . 16.3 mt -60.64 -48.03 83.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.558 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -62.81 -42.16 99.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.172 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -55.08 -51.19 67.14 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.558 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.407 HG13 ' HB1' ' A' ' 121' ' ' ALA . 7.1 p -71.4 -35.94 59.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.047 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 1.7 tmtt? -55.85 -45.36 78.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.903 0.382 . . . . 0.0 110.543 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.67 -41.18 75.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.977 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -30.61 69.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.363 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' ' OE2' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -82.13 -37.21 26.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.99 -46.1 58.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.873 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -76.26 -33.02 59.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -115.52 89.87 23.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.08 129.23 11.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.607 2.205 . . . . 0.0 112.228 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.37 56.15 25.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.422 ' CB ' HG22 ' A' ' 46' ' ' THR . 0.4 OUTLIER -101.13 -164.75 1.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 111.066 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.668 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -124.76 113.53 18.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.33 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 42.0 t -104.45 150.5 7.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -123.46 135.9 54.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.098 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.598 HG11 ' H ' ' A' ' 106' ' ' HIS . 8.0 t -134.05 166.42 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -177.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.598 ' H ' HG11 ' A' ' 105' ' ' VAL . 2.0 t60 -67.45 155.72 38.34 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.862 0.363 . . . . 0.0 110.873 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 25' ' ' THR . 42.2 t -69.07 106.08 2.66 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.472 HG13 HD11 ' A' ' 24' ' ' ILE . 2.6 m -75.88 0.57 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.3 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.05 -8.65 2.49 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.69 -140.8 5.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mt -106.56 127.08 53.04 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.65 -158.82 10.21 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.423 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.604 ' HD3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.62 -14.35 7.77 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.375 -0.413 . . . . 0.0 111.861 -178.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.639 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -58.06 -46.93 99.65 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 9.5 Cg_endo -52.52 -48.49 21.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.131 1.888 . . . . 0.0 112.381 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 87.0 t -58.65 -52.44 59.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.232 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.434 HD11 ' CG2' ' A' ' 51' ' ' VAL . 9.4 mt -51.9 -49.08 63.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.732 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.463 ' CG2' HG13 ' A' ' 105' ' ' VAL . 85.7 t -51.46 -49.68 31.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.914 0.388 . . . . 0.0 110.638 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.444 ' O ' HG13 ' A' ' 123' ' ' ILE . . . -54.65 -47.85 73.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.672 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 1.6 mt -55.03 -31.63 61.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.87 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.482 ' HB1' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.24 -51.68 19.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.219 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.457 HD13 ' HE1' ' A' ' 20' ' ' MET . 5.8 tp -68.31 -13.98 62.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.581 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.621 HG22 ' HB3' ' A' ' 128' ' ' LYS . 1.1 mt -58.15 -36.38 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.157 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.403 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 4.5 pt-20 -63.03 -16.04 58.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.77 11.17 3.39 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 116.89 -95.44 0.67 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.79 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.493 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 4.8 ptt? -62.67 75.48 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.621 ' HB3' HG22 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -71.76 -67.59 0.52 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.429 ' CD1' ' HB3' ' A' ' 152' ' ' LEU . 9.8 t80 -68.65 -32.19 71.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.977 0.418 . . . . 0.0 111.165 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.45 -50.56 25.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.301 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.0 t0 -70.09 -40.05 75.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.772 0.32 . . . . 0.0 111.363 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.6 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -61.89 -48.51 80.16 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.005 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 34.6 mm -73.06 -41.23 59.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.494 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -74.73 -50.12 18.58 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.563 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -67.99 -39.75 83.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.594 0.235 . . . . 0.0 110.812 -179.222 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.2 tp -74.54 -28.61 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.774 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 5.8 ttm-85 -64.53 -41.68 96.22 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -41.6 90.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.016 0.436 . . . . 0.0 110.061 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -87.17 151.85 22.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.102 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 116.73 14.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 110.607 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.97 163.5 15.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.209 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -57.06 -166.64 0.07 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.715 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.19 100.0 12.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.298 0.549 . . . . 0.0 111.599 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.421 ' CD1' ' CD2' ' A' ' 149' ' ' LEU . 12.5 pt -87.87 109.46 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.476 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -113.2 -76.64 0.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.9 t -99.8 -61.1 1.41 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.767 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 10.0 tmtt? -65.78 -49.87 66.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -176.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.41 ' CB ' ' CG2' ' A' ' 144' ' ' ILE . 0.9 OUTLIER -56.33 -52.04 66.02 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.308 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.421 ' CD2' ' CD1' ' A' ' 144' ' ' ILE . 0.5 OUTLIER -72.86 -46.6 52.02 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.528 -179.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 81.2 m -62.61 -39.16 92.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.23 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.767 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -62.34 -50.56 71.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.761 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -62.01 -37.1 83.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.501 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -57.08 -37.95 72.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -22.74 58.81 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.646 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.527 ' CE2' HD13 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -66.19 -34.08 77.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.993 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.52 85.86 1.95 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.374 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.29 153.34 71.23 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.814 2.342 . . . . 0.0 112.752 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.1 123.45 10.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.317 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -69.78 -11.16 60.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.4 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -30.98 68.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.767 0.318 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.05 -44.29 12.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -76.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -71.6 175.05 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.97 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.28 110.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -68.9 112.97 13.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.77 -177.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.519 2.146 . . . . 0.0 112.204 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.63 -45.93 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.802 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.5 t -64.36 -32.11 73.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 150.18 26.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -142.6 154.89 44.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -161.98 152.45 17.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.853 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.456 -0.257 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 m -99.52 162.33 13.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.832 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.42 119.0 5.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.09 -46.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.71 108.33 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -63.08 139.47 58.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -151.8 -47.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -83.46 173.49 11.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -134.16 158.33 75.56 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.39 111.76 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.642 2.228 . . . . 0.0 112.31 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.04 155.84 60.68 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.084 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.58 162.47 42.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.496 2.131 . . . . 0.0 112.272 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.426 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 24.6 t -144.13 127.04 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.805 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.17 116.67 31.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.836 0.35 . . . . 0.0 111.46 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.438 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -109.66 118.45 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.1 p -140.96 142.69 34.31 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.518 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -137.37 162.08 34.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.162 178.291 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 3.0 pttp 48.92 -100.65 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.014 0.126 . . . . 0.0 110.76 -177.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.469 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -124.35 -25.68 4.05 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.157 -0.34 . . . . 0.0 111.908 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.426 ' HE1' ' CD2' ' A' ' 22' ' ' PHE . 5.1 ppp? -74.01 165.91 24.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 111.464 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -143.5 156.74 44.71 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.282 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.469 ' CE1' ' CG1' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -137.42 138.39 39.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.299 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD2' ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -115.09 135.53 54.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.051 0.453 . . . . 0.0 111.359 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.469 HD13 ' HB ' ' A' ' 105' ' ' VAL . 1.9 mm -118.23 106.61 20.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 107' ' ' CYS . 1.4 p -131.01 166.55 20.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.606 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.536 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 5.9 p80 -81.25 152.0 27.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.731 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -62.64 153.71 77.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.465 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.1 Cg_exo -54.94 142.37 76.0 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.476 2.118 . . . . 0.0 113.291 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.483 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 6.4 p -98.7 174.35 6.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.158 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -94.95 -12.35 26.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.54 -30.83 14.8 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -139.51 89.77 2.36 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.452 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.23 -52.2 8.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.055 0.455 . . . . 0.0 111.16 178.23 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.433 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.0 m -55.96 -43.51 77.57 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.358 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 m -58.04 -37.38 74.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.878 0.37 . . . . 0.0 111.257 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.536 ' CZ ' ' CE1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -71.21 -48.13 53.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.433 HG12 ' HA ' ' A' ' 34' ' ' SER . 13.7 pt -55.94 -39.63 58.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.183 0.516 . . . . 0.0 110.79 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -62.85 -52.01 64.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.336 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.516 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -69.84 -50.28 44.3 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.884 0.374 . . . . 0.0 111.774 -179.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.432 HD22 ' CE1' ' A' ' 36' ' ' PHE . 48.5 mt -56.27 -43.68 79.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.046 0.451 . . . . 0.0 110.265 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -78.6 -26.83 45.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.098 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -53.0 -43.81 66.75 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.151 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.529 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 13.5 t80 -63.35 -38.52 91.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.671 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.713 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.21 -179.92 39.45 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.803 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.44 117.07 19.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.606 ' CB ' ' O ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -165.42 -169.12 1.51 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.94 177.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 67' ' ' THR . 9.8 t -64.05 154.0 35.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.676 0.75 . . . . 0.0 110.578 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 104' ' ' ALA . 60.3 t -134.2 137.57 51.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.453 -178.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.606 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -115.56 105.18 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.067 0.461 . . . . 0.0 110.445 178.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -113.6 111.0 21.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.637 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.47 HG11 ' CD ' ' A' ' 113' ' ' ARG . 44.0 t -107.9 92.09 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.642 0.734 . . . . 0.0 110.59 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.42 171.15 20.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.453 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.62 130.2 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 m -68.89 121.91 19.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.61 -47.65 2.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.82 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.414 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.8 m-85 -130.74 84.36 2.19 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.213 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -78.55 -35.92 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -78.93 -48.52 14.41 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.403 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.53 -50.92 22.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 32.3 Cg_exo -59.25 -40.37 69.39 Favored 'Trans proline' 0 N--CA 1.471 0.196 0 C-N-CA 122.622 2.215 . . . . 0.0 113.653 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -45.02 64.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -75.2 -49.31 19.83 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -64.7 -35.53 81.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' CB ' HG12 ' A' ' 66' ' ' ILE . 49.1 m-20 -101.22 -11.45 19.5 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.09 24.81 9.49 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.789 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.466 HG12 ' CB ' ' A' ' 64' ' ' ASP . 16.2 pt -110.78 148.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 47' ' ' THR . 6.7 t -77.7 135.1 38.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.075 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 69' ' ' VAL . 7.4 p -145.21 151.91 14.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.052 0.453 . . . . 0.0 111.649 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.447 ' N ' HG23 ' A' ' 68' ' ' VAL . 3.6 t -103.5 133.33 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.97 106.64 17.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.156 0.503 . . . . 0.0 110.478 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.434 ' CH2' ' HA ' ' A' ' 84' ' ' VAL . 4.3 m95 -110.03 103.24 53.16 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.63 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -109.61 -178.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 123.547 2.831 . . . . 0.0 112.82 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -126.45 95.93 4.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.578 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.33 177.78 4.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.32 -25.26 33.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.933 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.02 72.02 0.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.492 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -99.96 102.92 19.27 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.497 0.189 . . . . 0.0 110.791 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . 87.8 Cg_exo -41.57 98.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.85 2.367 . . . . 0.0 112.954 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.668 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 50.8 Cg_exo -54.98 -42.34 70.12 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.009 2.472 . . . . 0.0 114.277 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 2.6 Cg_endo -47.48 144.96 9.41 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.285 1.99 . . . . 0.0 113.609 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -57.35 -19.65 33.8 Favored Glycine 0 C--O 1.236 0.228 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.448 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.82 -29.87 12.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.514 0.157 . . . . 0.0 111.092 -178.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 78' ' ' PRO . 16.1 t -56.33 -48.46 79.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.434 ' HA ' ' CH2' ' A' ' 71' ' ' TRP . 71.4 t -54.19 -40.99 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.092 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.84 -31.47 66.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.456 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -50.32 70.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.274 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.606 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.08 -33.2 75.24 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.554 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 11.1 mt -55.94 -47.75 76.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.4 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -63.0 -39.89 96.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.083 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.56 -51.17 69.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.94 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.456 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 14.7 p -68.79 -42.49 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.639 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 0.8 OUTLIER -53.87 -47.39 71.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 111.038 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -48.08 76.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.826 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -66.12 -26.54 67.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.018 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.456 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 2.4 m-85 -79.27 -51.92 8.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.969 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 t -56.89 -33.71 67.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.047 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.0 -33.06 59.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.046 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.25 84.02 62.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.52 128.23 26.49 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.601 2.201 . . . . 0.0 112.101 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.37 59.8 10.08 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.282 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.416 ' CB ' HG22 ' A' ' 46' ' ' THR . 84.9 p -101.1 -171.26 1.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.308 . . . . 0.0 111.425 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.713 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.1 m -106.21 113.77 27.49 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.324 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.469 ' CG1' ' CE1' ' A' ' 22' ' ' PHE . 44.5 t -111.26 150.86 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.472 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . . . -122.45 142.5 50.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.069 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 106' ' ' HIS . 3.2 t -140.09 167.08 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.727 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.57 ' H ' HG12 ' A' ' 105' ' ' VAL . 3.6 t60 -67.2 155.61 38.37 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.7 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' THR . 26.9 p -68.86 105.18 2.27 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.32 0.581 . . . . 0.0 112.433 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.45 HG13 ' HD3' ' A' ' 115' ' ' PRO . 26.6 m -75.22 0.02 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.919 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.65 -8.79 3.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.424 ' O ' HD22 ' A' ' 111' ' ' LEU . . . -123.74 -134.87 4.39 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.439 ' HA ' ' HA2' ' A' ' 142' ' ' GLY . 7.3 mt -118.83 127.46 53.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.41 -153.97 7.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.63 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.47 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.3 -20.2 6.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.114 0.483 . . . . 0.0 111.669 -178.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.644 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.81 -46.29 86.9 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 6.6 Cg_endo -52.01 -48.5 21.3 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.157 1.905 . . . . 0.0 113.078 -178.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.7 t -60.95 -39.99 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.693 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.405 HD11 ' CG2' ' A' ' 51' ' ' VAL . 9.7 mt -59.5 -55.0 40.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.633 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.449 ' CG2' HG11 ' A' ' 105' ' ' VAL . 55.6 t -52.01 -55.21 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.85 -53.22 51.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.009 0.433 . . . . 0.0 111.31 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.618 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 7.7 mp -54.92 -30.18 57.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.98 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.473 ' HB1' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.27 -47.72 48.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.886 0.374 . . . . 0.0 110.403 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.1 -13.06 57.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.816 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 120' ' ' LEU . 2.1 mt -57.05 -36.37 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.311 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.425 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -63.22 -16.79 61.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.7 m -80.03 7.45 9.05 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 114.39 -99.09 0.92 Allowed Glycine 0 N--CA 1.46 0.246 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.922 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.504 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.6 ptt? -62.56 75.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.3 OUTLIER -73.4 -67.86 0.55 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -176.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.462 ' CD1' HD23 ' A' ' 152' ' ' LEU . 4.4 t80 -66.72 -32.86 74.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.949 0.404 . . . . 0.0 111.162 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.17 -51.86 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.208 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 25.8 t0 -70.12 -40.39 74.9 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.918 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.545 ' O ' ' HB ' ' A' ' 136' ' ' ILE . . . -58.01 -49.17 77.75 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.315 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.7 mm -69.7 -42.56 80.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -49.76 21.84 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -66.27 -34.29 77.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 110.724 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.7 tt -74.27 -33.34 34.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.974 0.416 . . . . 0.0 110.49 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -40.76 96.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.087 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.58 -45.29 92.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.984 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -87.33 151.65 22.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.682 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -73.31 117.25 14.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.896 0.379 . . . . 0.0 110.419 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.469 ' HG2' ' CG1' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -115.36 163.43 15.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.691 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -55.45 -176.05 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.346 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.54 98.81 3.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.692 0.746 . . . . 0.0 110.716 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.3 pp -88.67 109.24 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -113.22 -76.59 0.58 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.214 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.5 m -99.77 -60.62 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.643 ' O ' ' CB ' ' A' ' 151' ' ' TYR . 1.2 tmtt? -48.66 -51.43 28.42 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -55.77 -52.08 65.17 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 149' ' ' LEU . 3.2 mm? -75.66 -45.29 37.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -67.78 -34.37 76.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.361 . . . . 0.0 111.34 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.643 ' CB ' ' O ' ' A' ' 147' ' ' LYS . 1.3 t80 -68.17 -50.8 52.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.3 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 155' ' ' TYR . 0.6 OUTLIER -71.25 -38.92 71.91 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.519 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -36.48 68.0 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -26.35 59.92 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.465 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.555 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -65.82 -29.46 69.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.205 179.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -105.81 121.61 45.26 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.882 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.23 153.06 62.08 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.542 2.161 . . . . 0.0 112.671 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -147.25 123.62 10.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.337 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -75.29 -5.03 42.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.68 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -33.82 71.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 110.938 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.02 -44.31 12.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.94 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.94 132.24 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.888 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -89.7 171.89 9.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.974 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -167.37 134.6 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.853 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -71.32 138.12 84.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.91 170.7 18.22 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.482 2.121 . . . . 0.0 112.34 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -152.15 -65.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.01 110.06 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -111.84 87.31 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 104.62 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.6 m -119.69 134.68 55.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.856 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.641 0.258 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 61.0 Cg_endo -72.99 162.48 40.88 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.505 2.137 . . . . 0.0 112.355 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.433 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.1 t -144.16 126.89 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 pm0 -108.94 121.31 44.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.94 0.4 . . . . 0.0 111.652 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.763 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -106.8 118.66 54.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.7 p -140.63 140.01 34.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.135 0.493 . . . . 0.0 112.156 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CD2' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -138.98 139.4 37.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.746 178.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 11.1 mmmt 65.93 -88.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.295 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -129.46 -39.76 1.47 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.5 ptm -73.61 161.77 29.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 111.565 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 164.22 30.78 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.601 ' CE1' HG11 ' A' ' 103' ' ' VAL . 2.5 m-85 -133.05 154.23 50.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.277 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.073 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -126.32 130.68 51.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.056 0.455 . . . . 0.0 110.939 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.927 HD12 HG13 ' A' ' 108' ' ' VAL . 2.6 mm -114.46 106.58 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -130.86 167.34 19.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.908 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 51.0 p-80 -80.99 152.2 28.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.875 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -62.64 154.29 74.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.512 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 9.6 Cg_endo -54.45 141.76 72.04 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.61 2.206 . . . . 0.0 113.464 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.445 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.2 p -98.98 174.37 6.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.009 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -97.96 -10.43 24.52 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.61 -30.43 14.96 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.7 p -139.19 90.01 2.39 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.373 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -79.99 -52.18 8.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.043 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.446 ' HA ' HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -57.62 -44.02 85.21 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.091 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.3 m -57.93 -33.51 68.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.849 0.357 . . . . 0.0 111.233 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.579 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -73.71 -47.93 35.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.046 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.881 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.6 pt -55.94 -39.53 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.53 . . . . 0.0 110.697 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.12 -52.14 60.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.519 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -68.99 -50.11 51.82 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.863 0.363 . . . . 0.0 111.843 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.579 HD21 ' CE1' ' A' ' 36' ' ' PHE . 41.9 mt -56.52 -44.47 80.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -77.86 -26.67 49.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.081 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -52.9 -45.37 67.5 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.268 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.073 ' CD1' HD21 ' A' ' 23' ' ' LEU . 15.3 t80 -63.51 -38.32 90.69 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.779 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.664 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.63 -177.92 40.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.946 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.63 117.9 20.18 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.755 HG22 ' H ' ' A' ' 47' ' ' THR . 1.7 m -164.9 -170.63 2.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.88 177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.884 ' HA ' HG23 ' A' ' 67' ' ' THR . 2.9 t -64.87 153.36 40.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.507 0.67 . . . . 0.0 110.565 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 104' ' ' ALA . 55.8 t -131.42 133.33 62.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.944 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.051 HG13 HG13 ' A' ' 105' ' ' VAL . 6.4 p -115.57 105.4 18.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.346 0.593 . . . . 0.0 111.279 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -114.22 111.06 20.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.113 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' A' ' 71' ' ' TRP . 10.7 t -104.12 91.59 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.402 0.62 . . . . 0.0 110.093 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.486 ' HG ' ' CE1' ' A' ' 106' ' ' HIS . 1.1 m -157.74 171.3 20.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.552 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.95 130.41 43.29 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.75 122.23 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.4 p -120.23 -47.8 2.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.868 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.455 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -130.74 83.92 2.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.384 178.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -79.11 -37.15 39.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -80.08 -48.42 13.28 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.415 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.19 -53.05 24.53 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -177.594 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.455 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 11.0 Cg_exo -72.58 -42.76 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.412 2.074 . . . . 0.0 113.983 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.706 ' CD1' HG12 ' A' ' 68' ' ' VAL . 2.5 tt -71.53 -45.23 62.94 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.42 -28.7 68.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.473 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.881 ' HB3' HG21 ' A' ' 37' ' ' ILE . 16.1 mttt -80.5 -34.01 36.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.882 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.488 ' HB3' HG22 ' A' ' 37' ' ' ILE . 44.9 p30 -101.25 -11.33 19.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.03 34.62 52.6 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.804 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' A' ' 46' ' ' THR . 6.0 mt -108.61 147.35 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.646 0.26 . . . . 0.0 110.967 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.884 HG23 ' HA ' ' A' ' 47' ' ' THR . 4.4 t -78.41 132.79 37.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.706 HG12 ' CD1' ' A' ' 61' ' ' LEU . 7.4 p -144.99 151.11 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.133 0.492 . . . . 0.0 111.965 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.34 131.93 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -101.21 106.72 17.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.164 0.507 . . . . 0.0 111.09 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.812 ' HB3' HG13 ' A' ' 51' ' ' VAL . 5.2 m0 -110.96 103.93 55.47 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.302 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.447 -1.239 0 C-N-CA 123.321 2.681 . . . . 0.0 112.993 -179.043 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.491 0.186 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.1 m -53.98 -49.05 62.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 151' ' ' TYR . 7.5 t -54.57 -42.87 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.5 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -56.15 -31.53 63.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.99 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -68.49 -50.4 52.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.009 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.799 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -67.8 -28.09 67.3 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 120' ' ' LEU . 11.1 mt -63.5 -43.95 95.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.25 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.2 -41.51 94.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.205 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.1 tm? -59.35 -51.34 70.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.673 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.103 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.6 p -71.36 -35.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.072 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.03 -45.92 86.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.96 86.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.599 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -72.2 -23.9 61.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.157 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -79.28 -52.04 8.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.775 0.322 . . . . 0.0 111.184 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 25.4 t -65.02 -36.82 85.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -76.11 -32.82 59.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.268 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.573 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -123.45 88.58 51.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.526 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.37 130.71 19.03 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.816 2.344 . . . . 0.0 112.063 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.34 57.81 17.82 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.448 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.573 ' OG ' ' HB1' ' A' ' 98' ' ' ALA . 4.7 m -101.08 -164.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.719 0.295 . . . . 0.0 111.212 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.664 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -123.11 113.55 19.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.373 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.601 HG11 ' CE1' ' A' ' 22' ' ' PHE . 24.3 t -107.45 151.06 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.73 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -122.2 139.97 53.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.982 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.051 HG13 HG13 ' A' ' 49' ' ' VAL . 10.8 t -140.09 166.73 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.663 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.0 t60 -66.81 156.35 35.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.516 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.53 ' HA ' HG23 ' A' ' 24' ' ' ILE . 20.8 t -68.13 104.49 1.8 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.927 HG13 HD12 ' A' ' 24' ' ' ILE . 34.5 m -75.56 0.25 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.06 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.4 -8.53 2.73 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.25 -127.49 3.12 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 143' ' ' ALA . 0.0 OUTLIER -128.14 127.27 42.69 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.42 -144.44 4.1 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.607 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.661 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.29 -25.96 4.74 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.163 0.506 . . . . 0.0 112.017 -178.472 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.671 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -50.23 -46.22 83.08 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.838 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.2 Cg_endo -51.72 -48.54 20.92 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.306 2.004 . . . . 0.0 113.275 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 1.041 HG12 HD11 ' A' ' 120' ' ' LEU . 57.9 t -61.68 -46.66 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.818 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.53 ' HA ' HD12 ' A' ' 120' ' ' LEU . 11.6 mt -54.77 -46.55 74.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.847 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.893 ' CG2' HG11 ' A' ' 105' ' ' VAL . 57.6 t -57.37 -55.28 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.726 0.298 . . . . 0.0 111.671 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -52.98 -48.76 67.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.336 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 1.041 HD11 HG12 ' A' ' 116' ' ' VAL . 5.5 mt -59.06 -30.55 68.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.389 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 1.103 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.12 -42.43 66.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.967 0.413 . . . . 0.0 110.227 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.551 HD13 ' OD2' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -70.75 -16.11 62.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.595 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.914 ' CD1' HD21 ' A' ' 152' ' ' LEU . 1.4 mt -57.42 -30.97 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.124 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -15.97 14.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.539 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.87 11.29 5.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.27 -83.79 0.35 Allowed Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.4 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.502 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.9 76.92 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 121.337 0.589 . . . . 0.0 109.534 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.882 ' CB ' HG23 ' A' ' 123' ' ' ILE . 11.3 mttt -62.56 -67.4 0.42 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.088 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.487 ' HD1' HD13 ' A' ' 152' ' ' LEU . 6.1 t80 -73.61 -31.68 63.68 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.069 0.462 . . . . 0.0 110.762 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.3 -46.4 55.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.061 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.551 ' OD2' HD13 ' A' ' 122' ' ' LEU . 47.9 t0 -70.24 -47.19 62.45 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.457 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.84 ' HB3' HD11 ' A' ' 152' ' ' LEU . . . -57.97 -50.06 74.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.821 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.0 mm -70.8 -37.78 70.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -74.37 -49.71 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.763 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -70.19 -35.44 73.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.501 0.191 . . . . 0.0 111.066 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 132' ' ' ALA . 4.2 tt -74.25 -32.7 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.782 0.325 . . . . 0.0 110.662 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -64.93 -43.99 90.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.497 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.82 -44.19 94.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.527 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.05 152.08 22.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.667 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -72.96 117.73 15.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.378 . . . . 0.0 110.33 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.488 ' HG3' HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -114.13 163.9 14.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.433 -179.109 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -56.45 -165.42 0.05 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.039 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.842 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -82.1 99.0 8.95 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.715 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.794 HG23 ' HB3' ' A' ' 148' ' ' GLN . 45.8 mt -88.73 108.88 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.828 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -114.03 -78.09 0.58 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.021 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.6 t -101.32 -61.23 1.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.832 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.7 tmtt? -48.99 -51.54 30.01 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.794 ' HB3' HG23 ' A' ' 144' ' ' ILE . 7.2 tm0? -56.28 -51.51 67.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.433 ' CD2' ' CG2' ' A' ' 144' ' ' ILE . 3.9 mm? -75.19 -37.69 61.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.5 m -73.08 -42.68 62.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.033 0.444 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.832 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -64.0 -50.11 69.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.034 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.914 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -64.28 -38.16 90.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.709 0.29 . . . . 0.0 110.871 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.56 -43.98 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -24.76 57.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.497 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.74 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.9 OUTLIER -66.42 -23.75 66.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.651 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.434 ' HB2' ' HB2' ' A' ' 129' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.217 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.103 0 CA-C-O 120.598 0.237 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.512 ' HB3' HG22 ' A' ' 25' ' ' THR . 61.2 Cg_endo -73.03 162.41 40.99 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.458 2.106 . . . . 0.0 112.479 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.751 HG11 ' HD2' ' A' ' 139' ' ' LYS . 12.7 t -144.07 126.92 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.85 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.7 OUTLIER -108.64 121.96 46.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.576 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.764 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.75 120.6 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.41 ' HB3' ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -116.02 147.03 41.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.195 0.522 . . . . 0.0 111.978 -178.672 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HD2' HD21 ' A' ' 122' ' ' LEU . 20.5 t80 -155.12 127.62 7.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.225 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.45 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 7.2 mmpt? 55.06 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.521 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -129.26 -46.45 1.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.538 ' CE ' HD21 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -73.66 139.84 45.68 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.099 0.476 . . . . 0.0 111.266 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.41 ' HG2' ' HB3' ' A' ' 16' ' ' SER . 1.6 mtt180 -115.35 164.4 14.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.276 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CE1' HG11 ' A' ' 103' ' ' VAL . 1.4 m-85 -131.97 138.39 48.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.562 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.061 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -114.88 133.74 55.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.422 . . . . 0.0 110.962 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.82 HG21 HG12 ' A' ' 108' ' ' VAL . 1.5 mm -115.85 106.52 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.57 HG21 HD23 ' A' ' 40' ' ' LEU . 1.6 p -132.33 162.89 29.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.27 0.557 . . . . 0.0 111.936 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.456 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 43.0 p-80 -81.41 152.13 27.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.937 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -62.74 154.36 75.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.987 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.4 Cg_exo -54.55 140.83 75.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.343 2.029 . . . . 0.0 113.275 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.468 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 32.3 p -98.47 174.33 6.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.161 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -93.37 -11.64 31.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.69 -31.04 14.61 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -139.69 89.65 2.34 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.519 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.636 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.3 OUTLIER -80.38 -52.16 8.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.173 0.511 . . . . 0.0 111.272 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 37' ' ' ILE . 1.1 p -56.79 -45.64 82.03 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.359 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.1 m -57.72 -33.47 68.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.936 0.398 . . . . 0.0 111.439 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.741 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.27 -47.93 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.174 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.83 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.0 pt -55.91 -39.08 55.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.216 0.531 . . . . 0.0 110.696 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -65.21 -51.86 58.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.487 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 4.0 m-20 -68.64 -50.05 54.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.873 0.368 . . . . 0.0 111.906 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.741 HD21 ' CE1' ' A' ' 36' ' ' PHE . 58.7 mt -55.93 -44.84 78.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.871 0.367 . . . . 0.0 110.412 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -78.53 -26.62 45.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.028 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -53.36 -42.8 67.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.406 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.061 ' CD1' HD21 ' A' ' 23' ' ' LEU . 17.9 t80 -63.37 -38.56 91.61 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.241 -0.583 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.654 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.64 -177.71 40.12 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.958 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.54 117.71 19.99 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.738 HG22 ' H ' ' A' ' 47' ' ' THR . 1.7 m -164.8 -170.23 1.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.63 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.738 ' H ' HG22 ' A' ' 46' ' ' THR . 2.9 t -64.7 158.65 24.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.411 0.624 . . . . 0.0 110.443 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 104' ' ' ALA . 59.8 t -136.47 136.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.333 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.11 HG13 HG13 ' A' ' 105' ' ' VAL . 2.4 p -115.64 105.17 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.282 0.563 . . . . 0.0 110.699 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.404 ' HG2' ' CG2' ' A' ' 68' ' ' VAL . 7.4 ptm180 -113.99 110.72 20.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.705 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.8 HG13 ' HB3' ' A' ' 71' ' ' TRP . 18.5 t -105.39 90.94 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.537 0.684 . . . . 0.0 109.817 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 t -158.4 171.77 19.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.582 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -65.51 130.02 41.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 m -74.33 122.39 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.26 -47.6 2.35 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.182 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.413 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.2 m-85 -130.54 84.29 2.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.628 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.433 ' O ' HD23 ' A' ' 61' ' ' LEU . 2.4 m-20 -78.56 -35.87 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -78.84 -48.42 14.76 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.636 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -44.64 -49.82 25.56 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.296 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 8.2 Cg_exo -73.16 -39.44 2.18 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.737 2.291 . . . . 0.0 113.336 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.868 HD21 ' CG1' ' A' ' 68' ' ' VAL . 3.7 mm? -66.95 -45.26 78.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -75.35 -33.34 61.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.83 ' HB3' HG21 ' A' ' 37' ' ' ILE . 5.8 mmtt -81.12 -32.05 33.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' CB ' HG12 ' A' ' 66' ' ' ILE . 71.1 m-20 -101.37 -11.5 19.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 44.6 34.77 3.83 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.051 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.555 HD12 HG21 ' A' ' 48' ' ' VAL . 4.3 pt -114.69 148.82 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.694 0.283 . . . . 0.0 111.001 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 47' ' ' THR . 81.9 p -77.53 135.2 38.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.868 ' CG1' HD21 ' A' ' 61' ' ' LEU . 7.9 p -144.9 151.73 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.084 0.469 . . . . 0.0 111.941 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.539 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.1 t -103.43 132.59 49.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -100.87 106.71 18.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.189 0.519 . . . . 0.0 110.365 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.81 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.0 m95 -111.93 104.07 55.74 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.136 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.447 -1.217 0 C-N-CA 123.599 2.866 . . . . 0.0 112.6 -179.425 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 120.57 0.224 . . . . 0.0 110.818 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.81 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 21.8 t -56.09 -48.0 79.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.734 HG11 ' HG ' ' A' ' 120' ' ' LEU . 94.0 t -55.98 -37.9 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.024 177.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.766 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.0 OUTLIER -59.46 -31.33 69.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.529 178.182 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -66.16 -50.74 62.89 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.23 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.706 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -67.97 -26.98 66.2 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.261 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.796 HD21 ' HB3' ' A' ' 120' ' ' LEU . 18.2 mt -61.05 -41.5 96.71 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.111 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -67.58 -42.54 82.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.872 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.466 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.3 tm? -60.32 -51.48 69.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.772 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.019 HG21 ' HB1' ' A' ' 121' ' ' ALA . 7.3 p -68.42 -43.94 83.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.25 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.441 ' N ' HG13 ' A' ' 91' ' ' VAL . 26.7 mttt -54.7 -40.33 69.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.907 0.384 . . . . 0.0 110.833 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.64 -45.78 77.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.992 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.403 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 2.3 mmtt -74.6 -24.81 58.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.652 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -82.1 -45.53 15.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.747 0.308 . . . . 0.0 111.109 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.92 -37.86 69.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.915 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -76.11 -32.99 59.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.04 88.82 53.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.451 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.24 133.89 13.76 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.58 2.187 . . . . 0.0 112.319 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.2 46.42 34.91 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.45 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.418 ' HB3' HG21 ' A' ' 46' ' ' THR . 0.4 OUTLIER -101.21 -165.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 111.269 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.654 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.0 m -127.42 113.71 16.56 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.199 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.487 HG11 ' CE1' ' A' ' 22' ' ' PHE . 5.4 t -110.65 151.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.737 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -118.97 144.73 46.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.308 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.11 HG13 HG13 ' A' ' 49' ' ' VAL . 3.5 t -140.37 167.08 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.622 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.2 t-80 -66.97 156.34 36.21 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.463 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 25' ' ' THR . 25.6 p -68.19 101.72 1.22 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.471 0.653 . . . . 0.0 112.593 -177.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.82 HG12 HG21 ' A' ' 24' ' ' ILE . 5.4 p -75.55 0.08 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.065 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.46 -8.53 2.8 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.18 -125.84 3.08 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.755 -0.735 . . . . 0.0 111.391 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.858 HD21 ' HB2' ' A' ' 143' ' ' ALA . 0.0 OUTLIER -132.06 127.31 35.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.781 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.58 -142.73 3.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.644 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.742 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.31 -22.06 5.65 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.043 0.449 . . . . 0.0 111.965 -178.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.677 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -49.85 -46.33 80.67 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 5.7 Cg_endo -51.6 -48.38 21.64 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.482 2.121 . . . . 0.0 113.107 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.601 ' O ' HD23 ' A' ' 120' ' ' LEU . 43.5 t -61.1 -42.59 93.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.805 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.726 HD12 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -57.56 -55.07 39.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.687 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.893 ' CG2' HG11 ' A' ' 105' ' ' VAL . 61.1 t -52.93 -55.2 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.618 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -53.01 -53.14 54.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.249 0.547 . . . . 0.0 110.72 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.796 ' HB3' HD21 ' A' ' 88' ' ' LEU . 2.4 mm? -54.34 -30.78 52.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.793 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 1.019 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.21 -48.88 39.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.954 0.406 . . . . 0.0 110.467 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.538 HD21 ' CE ' ' A' ' 20' ' ' MET . 0.3 OUTLIER -62.92 -14.66 49.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.712 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.922 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.3 mt -57.01 -30.86 35.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.832 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -16.65 62.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.574 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.5 m -83.13 11.02 6.95 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.27 -101.85 1.08 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.016 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.476 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.3 ptt? -62.53 78.67 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.922 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.86 -67.65 0.55 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -176.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.64 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.6 t80 -67.42 -32.05 72.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.856 0.36 . . . . 0.0 111.092 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.38 -51.35 20.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.199 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.2 t0 -69.61 -38.36 77.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 111.009 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.618 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -60.36 -49.93 75.61 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.972 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.7 mm -73.56 -38.0 51.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.562 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.09 -49.72 22.71 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.764 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.84 -36.38 75.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.675 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.4 tt -74.29 -27.83 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.775 0.321 . . . . 0.0 110.434 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -49.67 66.65 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.542 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -45.14 93.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.61 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.751 ' HD2' HG11 ' A' ' 13' ' ' VAL . 19.6 mmtm -84.15 152.08 24.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.412 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.703 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.13 117.34 14.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.96 0.41 . . . . 0.0 110.454 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.41 ' HA ' HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -114.43 163.6 15.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.216 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.549 ' HA2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.32 -171.21 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.59 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.858 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -80.63 98.88 7.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.378 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.709 HD12 HD21 ' A' ' 149' ' ' LEU . 2.3 pt -88.71 108.53 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.062 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.89 -77.32 0.58 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.094 -0.643 . . . . 0.0 112.449 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.2 m -100.67 -60.68 1.48 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.754 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.4 tmtt? -54.27 -52.03 62.7 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.582 ' HG3' HG22 ' A' ' 144' ' ' ILE . 8.5 tm0? -56.31 -51.91 66.46 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.709 HD21 HD12 ' A' ' 144' ' ' ILE . 3.2 mm? -75.09 -44.46 47.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.2 m -68.88 -34.9 76.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.718 0.294 . . . . 0.0 111.441 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.754 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 1.8 t80 -68.66 -50.6 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.321 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.769 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -69.36 -33.32 72.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.475 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -57.4 -44.65 84.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -27.52 65.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.596 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.517 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -66.44 -29.22 69.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.832 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.767 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.688 0.28 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 60.3 Cg_endo -72.76 161.14 44.61 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.499 2.132 . . . . 0.0 112.252 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.46 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.3 t -143.98 127.38 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.061 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -105.14 116.63 32.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.031 0.443 . . . . 0.0 111.396 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.709 HG12 ' CE2' ' A' ' 135' ' ' PHE . 21.3 t -107.22 118.31 54.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.5 p -141.59 149.57 40.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.758 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -144.08 153.61 42.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.015 178.482 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 51.08 -97.81 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.406 0.282 . . . . 0.0 110.82 -176.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.429 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 2.6 m80 -124.78 -25.03 4.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.851 ' CE ' HD13 ' A' ' 122' ' ' LEU . 5.5 ppp? -73.8 164.31 26.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.747 0.308 . . . . 0.0 111.269 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -142.54 161.52 37.86 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.015 0.436 . . . . 0.0 111.3 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.819 ' CE1' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -142.99 140.65 31.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.147 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.053 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -114.69 134.59 54.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.107 0.479 . . . . 0.0 111.23 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.944 HD12 HG13 ' A' ' 108' ' ' VAL . 2.1 mm -116.91 106.51 20.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.329 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -133.33 167.26 20.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.183 0.515 . . . . 0.0 111.669 -178.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.475 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 49.7 p-80 -80.92 151.9 28.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.847 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -62.65 154.26 74.82 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.045 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.517 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 53.1 Cg_exo -54.81 140.92 77.89 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.348 2.032 . . . . 0.0 113.376 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.441 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -98.72 174.34 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.125 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -94.41 -10.31 32.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.84 14.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.9 p -139.54 89.62 2.34 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.431 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -80.21 -52.18 8.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.261 0.553 . . . . 0.0 111.196 178.099 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.446 ' O ' HG13 ' A' ' 37' ' ' ILE . 17.2 p -57.56 -46.31 84.09 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.418 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -57.75 -31.96 66.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.823 0.344 . . . . 0.0 111.295 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.637 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.47 -47.78 31.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.619 HD13 ' HB3' ' A' ' 63' ' ' LYS . 11.6 pt -56.84 -39.36 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.191 0.52 . . . . 0.0 110.742 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.26 -52.14 60.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.466 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -68.49 -50.04 55.29 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.82 0.343 . . . . 0.0 111.757 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.637 HD21 ' CE1' ' A' ' 36' ' ' PHE . 25.3 mt -55.81 -45.35 78.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -26.62 49.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.108 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 17.2 mttt -52.88 -44.31 66.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.447 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.053 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.2 t80 -63.36 -38.42 91.07 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.897 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.689 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 167.01 -177.56 41.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.616 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.84 121.08 24.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.846 HG22 ' H ' ' A' ' 47' ' ' THR . 4.2 m -164.72 -171.82 2.43 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.846 ' H ' HG22 ' A' ' 46' ' ' THR . 8.8 t -65.74 166.9 10.11 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.754 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.787 HG13 ' O ' ' A' ' 104' ' ' ALA . 44.0 t -139.84 134.74 37.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.193 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.067 HG13 HG13 ' A' ' 105' ' ' VAL . 3.6 p -115.67 105.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.222 0.534 . . . . 0.0 111.483 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 110.81 20.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.984 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.826 HG13 ' HB3' ' A' ' 71' ' ' TRP . 7.4 t -103.86 91.86 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.453 0.644 . . . . 0.0 109.737 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 t -157.28 171.66 20.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.336 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.42 130.33 43.33 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 72' ' ' PRO . 16.4 t -68.91 121.67 18.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -176.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -120.73 -47.49 2.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.898 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.415 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 3.0 m-85 -130.44 84.47 2.2 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.263 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.52 -36.25 45.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -79.21 -48.58 13.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.66 HG22 ' HG3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -44.81 -48.24 29.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.112 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 59' ' ' THR . 33.6 Cg_exo -60.9 -42.27 38.86 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.551 2.167 . . . . 0.0 113.787 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.818 HD22 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -71.44 -45.75 61.83 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.85 -49.12 18.88 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.66 ' HG3' HG22 ' A' ' 59' ' ' THR . 0.3 OUTLIER -73.61 -28.08 61.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -177.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' CG ' HD11 ' A' ' 66' ' ' ILE . 4.6 t0 -98.49 -11.43 22.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.91 22.39 9.08 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.151 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.706 HD12 HG21 ' A' ' 48' ' ' VAL . 2.7 pt -122.02 148.61 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.626 0.25 . . . . 0.0 110.376 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' THR . 19.5 m -77.43 135.0 38.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.83 0.348 . . . . 0.0 110.192 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.818 HG12 HD22 ' A' ' 61' ' ' LEU . 7.4 p -141.24 150.53 19.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 0.0 111.756 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.443 HG22 ' HG ' ' A' ' 90' ' ' LEU . 3.4 t -103.73 134.42 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.135 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.83 106.69 18.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.19 0.519 . . . . 0.0 110.109 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.826 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.0 m95 -111.43 104.38 56.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.229 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HB3' HG23 ' A' ' 54' ' ' VAL . 43.4 Cg_endo . . . . . 0 N--CA 1.446 -1.3 0 C-N-CA 123.303 2.669 . . . . 0.0 112.433 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.129 0 N-CA-C 111.359 0.133 . . . . 0.0 111.359 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.11 -48.83 78.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.767 HG11 ' CE2' ' A' ' 151' ' ' TYR . 15.7 t -53.81 -41.16 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.218 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -61.07 -31.37 71.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.02 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.28 -50.36 68.2 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.395 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.845 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -70.31 -28.32 65.08 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.969 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.963 HD21 ' HB3' ' A' ' 120' ' ' LEU . 13.8 mt -61.64 -40.63 95.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.15 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.57 -39.93 70.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.132 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.3 tm? -58.03 -51.27 70.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.522 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.103 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.9 p -70.42 -35.83 63.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.666 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -46.34 77.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.381 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.71 85.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.446 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -67.49 -26.96 66.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.814 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.4 m-85 -79.81 -47.23 15.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.008 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.88 -43.3 98.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -33.03 59.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.97 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -118.55 89.38 36.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.32 113.6 3.52 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.597 2.198 . . . . 0.0 112.361 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.32 60.38 7.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.648 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.462 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 18.5 t -101.23 -163.85 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.627 0.251 . . . . 0.0 110.809 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.689 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 2.2 m -112.41 114.09 26.63 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.674 HG11 ' CE1' ' A' ' 22' ' ' PHE . 10.6 t -109.79 151.31 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.787 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -116.02 140.86 48.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.088 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.067 HG13 HG13 ' A' ' 49' ' ' VAL . 3.4 t -140.36 166.35 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.71 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.7 t60 -67.54 156.08 37.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.621 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 25' ' ' THR . 18.7 t -68.51 105.81 2.35 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.944 HG13 HD12 ' A' ' 24' ' ' ILE . 35.7 m -75.51 0.42 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.194 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.22 -8.6 2.61 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.72 -140.49 5.24 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.412 HD22 ' HA2' ' A' ' 142' ' ' GLY . 5.9 mt -114.97 127.34 55.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.64 -146.46 4.81 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.834 -1.174 . . . . 0.0 113.593 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.57 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.34 -21.68 5.75 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.031 0.443 . . . . 0.0 111.877 -178.392 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.887 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -52.8 -46.22 96.79 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.804 ' HD3' HG12 ' A' ' 108' ' ' VAL . 8.3 Cg_endo -52.41 -48.48 21.63 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.237 1.958 . . . . 0.0 112.904 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.807 HG21 ' NE2' ' A' ' 148' ' ' GLN . 57.5 t -60.9 -52.19 64.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.386 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.692 HD12 ' CG2' ' A' ' 49' ' ' VAL . 3.8 mt -51.89 -44.48 63.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.942 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.961 HG22 HG11 ' A' ' 105' ' ' VAL . 4.4 t -58.55 -54.62 30.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.472 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.68 -44.4 66.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 111.34 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.963 ' HB3' HD21 ' A' ' 88' ' ' LEU . 12.5 mt -63.95 -30.73 71.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.383 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 1.103 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -68.67 -37.53 79.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.069 0.462 . . . . 0.0 109.793 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.851 HD13 ' CE ' ' A' ' 20' ' ' MET . 7.6 tp -78.88 -15.68 58.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.256 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.93 HG23 ' CB ' ' A' ' 128' ' ' LYS . 1.8 mt -57.59 -30.86 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.73 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -16.33 64.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.512 ' OG ' HD12 ' A' ' 122' ' ' LEU . 7.1 m -79.54 -23.36 42.91 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 152.95 -96.1 0.16 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.994 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.478 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.2 ptt? -63.2 71.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.93 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.44 -67.62 0.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -176.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.573 ' CD1' HD22 ' A' ' 152' ' ' LEU . 8.6 t80 -66.26 -32.67 74.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.9 0.381 . . . . 0.0 111.128 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.59 -52.22 16.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.634 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 30.0 t0 -70.12 -39.43 75.45 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.821 0.343 . . . . 0.0 110.975 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.674 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -60.45 -50.01 75.29 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.811 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 129' ' ' TYR . 26.1 mm -73.38 -38.69 53.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -74.44 -49.95 20.35 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.709 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.83 -37.09 83.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.31 . . . . 0.0 110.165 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.561 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.23 -27.87 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.437 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -47.93 78.98 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -44.71 93.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.598 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.1 OUTLIER -84.9 152.03 23.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.44 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 116.7 14.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.009 0.433 . . . . 0.0 110.514 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 163.61 15.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.14 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -56.77 -168.8 0.09 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.649 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.21 100.03 12.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.286 0.543 . . . . 0.0 111.516 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.8 HD12 HD21 ' A' ' 149' ' ' LEU . 10.4 pt -87.93 109.52 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.373 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -113.25 -76.87 0.58 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 6.8 p -99.6 -61.01 1.42 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.833 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 11.7 tmtt? -66.48 -48.6 69.36 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.807 ' NE2' HG21 ' A' ' 116' ' ' VAL . 23.5 mm-40 -56.12 -51.84 66.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.8 HD21 HD12 ' A' ' 144' ' ' ILE . 2.0 mm? -74.2 -45.34 48.92 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.766 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.9 m -64.62 -37.31 87.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.795 0.331 . . . . 0.0 111.425 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.833 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -66.41 -50.51 63.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.157 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.859 HD21 HD11 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -61.52 -34.61 75.82 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.171 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.33 -43.4 88.21 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -23.76 65.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.482 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.661 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -66.18 -39.67 89.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.49 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 129' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.956 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.668 0.271 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.891 ' HB3' HG22 ' A' ' 25' ' ' THR . 64.2 Cg_endo -73.14 165.15 33.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.537 2.158 . . . . 0.0 112.339 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.434 HG11 ' HE2' ' A' ' 139' ' ' LYS . 21.2 t -138.78 126.88 28.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.809 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.0 pt-20 -105.96 116.74 32.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.978 0.418 . . . . 0.0 111.559 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.689 HG12 ' CE2' ' A' ' 135' ' ' PHE . 45.3 t -107.82 118.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.06 151.9 42.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 0.0 112.223 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -145.13 151.07 37.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.962 178.306 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.625 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 44.71 -78.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.455 0.702 . . . . 0.0 112.623 -177.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -129.81 -41.58 1.31 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.189 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.624 ' HE1' ' CE2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -73.58 154.22 39.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 112.027 -178.511 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -135.7 164.25 28.29 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.064 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.624 ' CE2' ' HE1' ' A' ' 20' ' ' MET . 7.9 m-85 -139.28 150.08 45.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.052 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -121.24 132.0 54.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.466 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.017 HD12 HG13 ' A' ' 108' ' ' VAL . 2.6 mm -117.27 106.68 20.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.512 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.891 HG22 ' HB3' ' A' ' 12' ' ' PRO . 31.7 p -130.45 167.23 18.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.202 0.525 . . . . 0.0 111.773 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.497 ' CD2' ' CE2' ' A' ' 36' ' ' PHE . 42.1 p-80 -80.89 152.29 28.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.39 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -62.45 153.93 74.66 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.3 Cg_exo -54.71 142.4 73.3 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.393 2.062 . . . . 0.0 113.46 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.484 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.1 p -98.5 174.44 6.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.053 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -94.01 -12.48 28.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.7 -31.02 14.61 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.4 p -139.86 89.81 2.34 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.691 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.651 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.5 OUTLIER -80.23 -52.32 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.212 0.529 . . . . 0.0 111.136 177.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.555 ' O ' HG13 ' A' ' 37' ' ' ILE . 1.5 m -57.45 -36.11 71.0 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.211 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -65.88 -35.48 80.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.919 0.39 . . . . 0.0 110.927 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.638 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -73.94 -47.97 33.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.072 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.588 HD13 ' HB3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -58.62 -37.02 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 110.472 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.48 -51.94 60.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.262 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -69.78 -49.88 48.63 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 111.552 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.699 HD23 HG21 ' A' ' 25' ' ' THR . 27.3 mt -54.96 -44.82 74.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.99 0.424 . . . . 0.0 110.502 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -78.4 -26.76 46.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.181 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 11.9 mttt -54.56 -41.89 70.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.351 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.052 ' CD1' HD21 ' A' ' 23' ' ' LEU . 13.3 t80 -63.58 -38.7 92.13 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.804 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.644 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 168.84 -178.84 41.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.706 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.83 118.36 20.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.804 HG22 ' H ' ' A' ' 47' ' ' THR . 3.3 m -164.7 -171.35 2.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.305 -0.862 . . . . 0.0 108.696 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.804 ' H ' HG22 ' A' ' 46' ' ' THR . 1.6 t -65.52 163.09 16.7 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.064 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.797 HG21 HD12 ' A' ' 66' ' ' ILE . 50.0 t -137.26 133.5 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.082 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.815 HG12 HG22 ' A' ' 105' ' ' VAL . 14.9 p -115.4 105.18 18.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.55 0.69 . . . . 0.0 111.514 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -114.64 110.84 20.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.845 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.791 HG13 ' HB3' ' A' ' 71' ' ' TRP . 14.5 t -105.87 91.83 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.629 0.728 . . . . 0.0 109.936 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.41 172.04 19.3 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.229 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' CD ' ' N ' ' A' ' 53' ' ' GLU . 1.5 mm-40 -64.28 130.33 43.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG12 ' OD1' ' A' ' 70' ' ' ASP . 12.0 m -69.07 121.95 19.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 m -120.53 -47.45 2.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.074 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.425 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 6.7 m-85 -130.41 84.51 2.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.34 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.52 -35.86 45.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -78.97 -48.45 14.47 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.651 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -45.67 -49.79 34.99 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.215 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 44.6 Cg_exo -57.44 -42.22 63.8 Favored 'Trans proline' 0 N--CA 1.471 0.189 0 C-N-CA 122.63 2.22 . . . . 0.0 113.572 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.602 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -71.3 -45.52 62.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.57 -49.1 19.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.588 ' HB3' HD13 ' A' ' 37' ' ' ILE . 11.0 mttt -75.15 -26.72 59.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.464 ' CG ' HD11 ' A' ' 66' ' ' ILE . 2.5 t0 -101.06 -11.39 19.67 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.95 25.53 3.81 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.138 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.797 HD12 HG21 ' A' ' 48' ' ' VAL . 4.2 pt -122.22 148.73 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.649 0.262 . . . . 0.0 110.531 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 47' ' ' THR . 1.3 m -77.29 135.05 38.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.965 0.412 . . . . 0.0 110.233 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.602 HG12 ' CD2' ' A' ' 61' ' ' LEU . 7.1 p -142.56 148.52 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.697 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.476 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.2 t -103.63 131.2 52.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.138 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.491 ' OD1' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -101.1 106.65 17.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.097 0.475 . . . . 0.0 110.651 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.895 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.6 m0 -109.21 103.5 52.62 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.815 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 N--CA 1.446 -1.319 0 C-N-CA 123.553 2.836 . . . . 0.0 112.559 -179.206 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.467 0.175 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.895 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 18.4 t -56.2 -52.34 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.683 HG13 HD13 ' A' ' 120' ' ' LEU . 1.4 t -53.81 -40.01 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.391 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -60.55 -31.34 70.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.955 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -50.29 63.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.284 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.76 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -67.86 -33.75 75.36 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.726 HD21 ' CB ' ' A' ' 120' ' ' LEU . 11.8 mt -59.32 -44.88 92.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.525 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -65.99 -39.91 90.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.203 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.507 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.7 tm? -60.16 -51.23 70.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.623 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.911 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.5 p -72.46 -35.99 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.295 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -56.41 -45.02 80.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.686 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.31 -42.23 72.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.709 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -67.49 -27.15 66.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.446 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 2.7 m-85 -81.97 -52.06 7.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.835 0.35 . . . . 0.0 111.331 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.3 t -57.08 -37.43 71.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.101 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -76.11 -33.05 59.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.339 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.13 84.63 61.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.539 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -66.27 136.75 44.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.714 2.276 . . . . 0.0 111.987 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.58 56.9 22.22 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.46 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.05 -161.8 0.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 111.189 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.644 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 1.5 m -125.36 114.05 18.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.268 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.51 HG11 ' HE1' ' A' ' 22' ' ' PHE . 39.1 t -106.88 151.05 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.789 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -119.0 140.9 49.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.79 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.815 HG22 HG12 ' A' ' 49' ' ' VAL . 99.4 t -139.36 166.37 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.57 ' N ' HG12 ' A' ' 105' ' ' VAL . 2.8 t60 -67.06 156.19 36.72 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.147 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 25' ' ' THR . 44.3 t -68.46 105.68 2.28 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.017 HG13 HD12 ' A' ' 24' ' ' ILE . 34.7 m -75.32 0.28 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.107 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.411 ' HB3' ' SG ' ' A' ' 107' ' ' CYS . . . -60.54 -8.56 2.89 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.08 -138.42 4.87 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mt -114.36 127.4 55.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.9 -156.29 8.71 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.154 -1.022 . . . . 0.0 113.121 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.691 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.31 -17.11 7.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.977 0.417 . . . . 0.0 111.758 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.669 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.67 -46.37 98.33 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.79 ' HD3' HG12 ' A' ' 108' ' ' VAL . 8.6 Cg_endo -52.82 -48.45 21.99 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.059 1.84 . . . . 0.0 112.506 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.638 HG22 ' HG3' ' A' ' 148' ' ' GLN . 59.8 t -56.55 -51.74 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.007 0.432 . . . . 0.0 110.285 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.6 HD12 ' CG2' ' A' ' 49' ' ' VAL . 10.3 mt -52.97 -48.35 67.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.614 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.739 HG22 HG21 ' A' ' 105' ' ' VAL . 41.6 t -51.76 -50.56 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.721 0.296 . . . . 0.0 111.464 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.748 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -52.8 -46.91 67.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.327 0.584 . . . . 0.0 110.484 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.726 ' CB ' HD21 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -57.51 -31.41 66.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.623 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.911 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.28 -44.33 62.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.4 . . . . 0.0 110.517 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.445 ' HA ' HD12 ' A' ' 122' ' ' LEU . 7.3 tp -66.82 -15.84 63.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.656 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 1.04 HD11 HD21 ' A' ' 152' ' ' LEU . 2.5 mt -57.23 -30.53 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.696 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -17.2 63.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.013 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.9 m -79.99 -23.31 41.65 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.13 -96.64 0.17 Allowed Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.778 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.583 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 1.3 ptt? -63.55 72.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.941 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.95 -67.42 0.43 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.506 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 7.0 t80 -67.74 -32.73 73.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.004 0.43 . . . . 0.0 110.959 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.48 -52.11 17.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.252 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 41.6 t0 -69.32 -35.86 76.38 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.748 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -61.63 -50.31 73.05 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.771 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -73.92 -37.99 48.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.537 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -74.08 -49.71 22.82 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.689 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.19 -34.32 72.8 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.72 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.23 -29.86 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 110.473 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.16 -43.23 82.81 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.633 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -45.55 91.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 110.598 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.434 ' HE2' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -87.37 151.41 23.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.223 179.301 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.407 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.7 116.47 14.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.568 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.35 163.67 15.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.074 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.04 -174.86 0.08 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.555 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.4 9.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.56 0.68 . . . . 0.0 111.443 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.801 HD12 HD21 ' A' ' 149' ' ' LEU . 1.6 pt -88.4 109.57 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.543 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -113.13 -76.72 0.58 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.75 -60.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.824 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 10.5 tmtt? -55.94 -52.05 65.51 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.693 ' OE1' HD22 ' A' ' 149' ' ' LEU . 17.6 tm0? -58.3 -51.52 69.43 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.801 HD21 HD12 ' A' ' 144' ' ' ILE . 3.2 mm? -72.02 -41.0 68.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 50.0 m -70.53 -39.69 73.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.779 0.323 . . . . 0.0 111.524 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.824 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.35 -50.97 63.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.228 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.04 HD21 HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -66.87 -31.23 71.69 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.708 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.57 -37.7 87.19 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -23.94 59.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.545 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CB ' HD23 ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.21 -40.63 90.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.286 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.563 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.766 0.317 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.728 ' HB3' HG23 ' A' ' 25' ' ' THR . 58.1 Cg_endo -71.52 160.22 49.07 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.596 2.197 . . . . 0.0 112.378 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.429 HG11 ' CD ' ' A' ' 139' ' ' LYS . 18.5 t -143.26 126.89 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.853 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 5.5 pt-20 -109.38 116.68 32.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.895 0.379 . . . . 0.0 111.618 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.75 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -107.42 118.53 55.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.3 p -140.97 140.53 34.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.106 0.479 . . . . 0.0 112.056 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.475 ' CD2' ' HE1' ' A' ' 127' ' ' MET . 0.0 OUTLIER -141.03 147.56 38.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.701 178.803 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 1.3 mmmp? 64.59 -90.73 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.273 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.51 -45.02 1.21 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.531 ' SD ' HD21 ' A' ' 122' ' ' LEU . 2.7 ppp? -73.68 164.76 26.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 111.728 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -139.2 164.32 30.11 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.475 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.698 ' CE1' HG11 ' A' ' 103' ' ' VAL . 0.3 OUTLIER -134.18 141.63 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.4 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.075 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -114.9 133.86 55.63 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.107 0.48 . . . . 0.0 111.038 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.965 HD12 HG13 ' A' ' 108' ' ' VAL . 1.7 mm -117.92 106.56 20.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.156 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.728 HG23 ' HB3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -134.67 166.83 22.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.15 0.5 . . . . 0.0 111.509 -179.036 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.522 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 7.3 p80 -81.31 151.77 27.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.175 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -63.02 154.42 77.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.023 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.524 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.3 Cg_exo -54.72 139.03 77.17 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.329 2.019 . . . . 0.0 113.245 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.439 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 29.8 p -98.59 174.21 6.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.096 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -92.75 -9.89 39.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.64 -30.85 14.73 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 p -139.79 89.56 2.32 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.244 -0.582 . . . . 0.0 112.357 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.503 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -80.27 -52.27 7.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 0.0 111.169 178.124 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -58.59 -46.09 87.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.352 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.7 m -57.83 -32.45 67.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.841 0.353 . . . . 0.0 111.148 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.687 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.16 -47.99 32.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.114 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.946 HG21 ' HB3' ' A' ' 63' ' ' LYS . 10.8 pt -56.12 -38.84 55.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.55 . . . . 0.0 110.539 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.1 -51.94 61.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.369 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.1 m-20 -69.43 -50.21 47.91 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.866 0.365 . . . . 0.0 111.72 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.687 HD21 ' CE1' ' A' ' 36' ' ' PHE . 57.6 mt -56.12 -44.75 79.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.958 0.408 . . . . 0.0 110.326 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -78.18 -26.67 47.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -52.74 -44.13 66.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.311 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.075 ' CD1' HD21 ' A' ' 23' ' ' LEU . 16.8 t80 -63.45 -38.17 90.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.73 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.72 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.41 -176.96 40.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.943 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.71 118.05 20.33 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.752 HG22 ' H ' ' A' ' 47' ' ' THR . 1.3 m -165.06 -170.27 1.89 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.822 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.752 ' H ' HG22 ' A' ' 46' ' ' THR . 1.5 t -64.91 150.75 47.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.458 0.647 . . . . 0.0 110.122 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.786 HG21 HD12 ' A' ' 66' ' ' ILE . 48.2 t -126.33 133.69 68.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.817 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.039 HG13 HG13 ' A' ' 105' ' ' VAL . 8.5 p -115.24 105.45 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.155 0.502 . . . . 0.0 111.184 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.52 110.9 21.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.755 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.952 HG11 ' HB2' ' A' ' 113' ' ' ARG . 39.6 t -103.28 91.27 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.55 0.691 . . . . 0.0 110.236 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.2 171.43 20.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.05 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.78 130.7 44.51 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -68.55 121.93 18.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.0 p -120.63 -47.38 2.32 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.948 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.43 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 4.2 m-85 -130.23 84.4 2.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.288 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.4 -35.85 46.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -78.84 -48.43 14.74 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.503 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -45.67 -50.26 33.39 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.226 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.43 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 39.4 Cg_exo -61.64 -42.13 34.72 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.543 2.162 . . . . 0.0 113.639 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.91 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -71.32 -45.65 62.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.68 -49.29 18.78 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.946 ' HB3' HG21 ' A' ' 37' ' ' ILE . 10.4 mttt -61.41 -39.4 90.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.89 ' OD2' HG22 ' A' ' 37' ' ' ILE . 45.8 m-20 -101.76 -11.39 19.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 53.2 25.17 24.63 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.771 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.786 HD12 HG21 ' A' ' 48' ' ' VAL . 8.9 pt -107.52 149.08 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.854 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 47' ' ' THR . 63.9 p -77.46 135.44 38.26 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.91 HG12 ' CD2' ' A' ' 61' ' ' LEU . 11.7 p -140.17 150.08 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.464 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.6 t -103.35 132.08 50.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.86 106.65 18.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.172 0.51 . . . . 0.0 110.706 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.768 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.5 m95 -111.25 103.73 55.3 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.498 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo . . . . . 0 N--CA 1.447 -1.222 0 C-N-CA 123.472 2.782 . . . . 0.0 113.008 -179.02 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 2.6 tttt . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 120.341 0.115 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.72 HG12 ' CH2' ' A' ' 71' ' ' TRP . 21.6 t -54.73 -48.17 72.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.828 HG11 ' HG ' ' A' ' 120' ' ' LEU . 78.4 t -59.34 -38.05 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.207 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.748 ' HA ' HD12 ' A' ' 88' ' ' LEU . 8.1 mt-10 -58.16 -31.18 67.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.57 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.07 -50.68 63.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.912 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.827 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -67.1 -27.03 67.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.201 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.804 HD21 ' HB3' ' A' ' 120' ' ' LEU . 26.3 mt -63.42 -39.29 94.1 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.966 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.4 m -66.8 -44.95 79.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.029 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.1 tm? -57.27 -51.41 69.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.483 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.838 HG21 ' HB1' ' A' ' 121' ' ' ALA . 9.0 p -69.77 -35.87 67.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.718 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.65 -45.22 73.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.81 -43.91 74.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.687 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -26.22 65.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.126 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.548 ' HE1' HG21 ' A' ' 103' ' ' VAL . 1.6 m-85 -82.04 -52.0 7.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 111.192 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 15.9 t -67.05 -34.96 78.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.176 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -33.08 59.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.161 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.12 96.3 37.26 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.386 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.94 132.42 23.01 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.457 2.105 . . . . 0.0 112.058 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.04 56.12 27.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.174 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.573 ' OG ' HG21 ' A' ' 46' ' ' THR . 82.5 p -101.07 169.38 8.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 111.232 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.72 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -100.68 113.78 26.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.573 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.698 HG11 ' CE1' ' A' ' 22' ' ' PHE . 24.4 t -107.85 151.29 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.757 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -120.94 140.87 51.25 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.323 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.057 HG11 HG22 ' A' ' 118' ' ' VAL . 3.0 t -140.07 166.54 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.548 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.3 t-80 -67.97 155.84 38.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -68.84 105.61 2.41 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.965 HG13 HD12 ' A' ' 24' ' ' ILE . 32.0 m -75.39 -0.04 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.01 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.77 -8.5 3.06 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.97 -128.77 3.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.543 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.902 HD21 ' HB2' ' A' ' 143' ' ' ALA . 0.1 OUTLIER -132.09 127.4 35.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -171.31 -142.31 3.63 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.397 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.952 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.44 -21.8 5.67 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.994 0.426 . . . . 0.0 111.89 -178.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.661 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.17 -46.8 82.9 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.727 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.5 Cg_endo -52.13 -48.49 21.42 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.296 1.997 . . . . 0.0 112.867 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.747 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.2 t -59.23 -41.79 84.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.674 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.453 HD11 ' CE3' ' A' ' 71' ' ' TRP . 7.1 mt -61.06 -50.08 74.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.737 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 1.057 HG22 HG11 ' A' ' 105' ' ' VAL . 12.0 t -53.76 -55.52 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -60.2 -47.14 87.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.129 0.49 . . . . 0.0 110.839 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.828 ' HG ' HG11 ' A' ' 84' ' ' VAL . 3.3 mm? -54.59 -30.76 55.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.044 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.838 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.33 -49.99 30.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.046 0.45 . . . . 0.0 110.54 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.531 HD21 ' SD ' ' A' ' 20' ' ' MET . 0.3 OUTLIER -62.62 -15.67 52.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.083 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.931 ' CD1' HD21 ' A' ' 152' ' ' LEU . 1.2 mt -57.45 -34.58 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.637 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.31 -15.38 15.65 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.81 11.38 3.28 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 116.99 -85.53 0.39 Allowed Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.158 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.42 78.39 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.892 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -62.37 -67.71 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.531 ' HD1' HD22 ' A' ' 152' ' ' LEU . 6.4 t80 -74.98 -30.52 61.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.122 0.487 . . . . 0.0 110.544 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -72.6 -46.64 53.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.034 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 127' ' ' MET . 51.5 t0 -70.22 -47.3 62.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.381 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.816 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -58.32 -50.32 74.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.871 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 129' ' ' TYR . 32.7 mm -69.54 -37.85 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.46 -49.93 20.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.75 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.61 -34.67 74.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.647 0.261 . . . . 0.0 110.977 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 119' ' ' ALA . 1.8 tt -74.21 -34.05 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.0 110.645 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -63.46 -45.9 88.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -39.79 85.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.023 0.44 . . . . 0.0 110.499 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.429 ' CD ' HG11 ' A' ' 13' ' ' VAL . 14.7 mmtt -87.09 152.27 22.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.68 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.66 117.89 14.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.457 ' HD3' HG23 ' A' ' 136' ' ' ILE . 0.1 OUTLIER -114.28 163.34 15.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.946 -179.081 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -62.26 -156.55 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.329 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.902 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -90.2 98.71 11.93 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.942 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.583 HG22 ' HG3' ' A' ' 148' ' ' GLN . 1.1 pt -88.9 108.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.815 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -113.66 -77.38 0.58 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 119.88 -0.728 . . . . 0.0 112.756 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.49 -60.8 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.728 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -53.21 -51.78 61.02 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.411 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.693 ' HG3' HG22 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -56.84 -52.09 66.47 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.13 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.28 -40.0 59.14 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.3 m -69.47 -42.71 74.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.878 0.37 . . . . 0.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.728 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -63.59 -50.56 68.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.931 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -65.29 -36.51 84.3 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.784 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -55.92 -39.82 72.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.405 ' C ' ' HD2' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -74.13 -24.85 59.5 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.213 178.598 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.663 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -66.17 -39.99 90.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.34 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.413 ' HB2' ' HB2' ' A' ' 129' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.168 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.708 0.29 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 58.7 Cg_endo -72.1 152.03 56.19 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.468 2.112 . . . . 0.0 112.305 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.416 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 19.1 t -144.09 126.94 11.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 mp0 -112.77 116.84 30.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.904 0.383 . . . . 0.0 111.611 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.81 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -106.84 118.33 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.5 p -141.29 143.68 34.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.732 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -133.36 158.8 42.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.248 178.167 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 45.7 -93.16 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.302 0.241 . . . . 0.0 111.384 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -127.04 -29.31 2.8 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.589 ' HE3' HD13 ' A' ' 122' ' ' LEU . 4.3 ppp? -73.65 159.13 33.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.58 0.228 . . . . 0.0 111.183 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -141.63 164.06 31.22 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.143 0.497 . . . . 0.0 111.807 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' HE1' HG11 ' A' ' 103' ' ' VAL . 3.4 m-85 -138.14 144.31 40.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.933 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.056 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -119.39 135.49 54.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.033 0.444 . . . . 0.0 111.002 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.886 HG21 HG22 ' A' ' 108' ' ' VAL . 5.1 mm -118.51 106.69 20.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.64 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.611 HG21 HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -130.36 165.31 22.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.48 0.657 . . . . 0.0 111.943 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.496 ' CD2' ' CE2' ' A' ' 36' ' ' PHE . 35.9 p-80 -81.89 152.58 26.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.941 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -62.42 154.76 70.81 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.1 Cg_exo -54.09 136.65 68.14 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.246 1.964 . . . . 0.0 113.162 -177.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -98.64 147.03 25.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.302 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -68.68 -12.36 61.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.49 -31.41 14.58 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.2 p -139.97 88.81 2.26 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.119 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.5 OUTLIER -80.91 -52.23 7.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.221 0.534 . . . . 0.0 111.359 178.069 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.44 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.7 m -56.44 -46.17 80.44 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.49 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.8 m -57.62 -31.92 66.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.853 0.359 . . . . 0.0 111.286 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.689 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.3 -47.77 26.34 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.81 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.8 pt -55.83 -39.12 54.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.192 0.52 . . . . 0.0 110.648 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.38 -52.08 56.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.46 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.547 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 7.1 m-20 -68.06 -50.12 57.13 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.82 0.343 . . . . 0.0 111.799 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.689 HD21 ' CE1' ' A' ' 36' ' ' PHE . 63.4 mt -55.76 -45.78 78.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.427 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -77.05 -26.64 53.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.119 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 7.0 mttt -53.12 -44.74 67.93 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.288 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.056 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.0 t80 -63.43 -38.56 91.6 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.709 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.702 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.35 -179.57 39.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.038 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.55 117.25 19.31 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 101' ' ' SER . 0.8 OUTLIER -164.9 -169.77 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.892 177.65 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' THR . 9.1 p -64.59 160.08 20.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.455 0.645 . . . . 0.0 110.686 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 104' ' ' ALA . 57.2 t -139.0 137.01 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.078 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.825 HG12 HG22 ' A' ' 105' ' ' VAL . 11.3 p -115.52 104.3 16.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.479 0.657 . . . . 0.0 111.385 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -115.21 111.04 20.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.028 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.794 HG13 ' HB3' ' A' ' 71' ' ' TRP . 11.9 t -106.49 91.48 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.405 0.621 . . . . 0.0 109.914 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.4 p -157.68 171.24 20.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.77 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.403 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 2.2 mm-40 -66.62 130.5 43.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.9 p -73.37 122.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.9 p -120.0 -47.7 2.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.254 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.404 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 1.2 m-85 -130.6 83.67 2.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.467 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.2 -36.61 39.89 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -79.6 -48.58 13.55 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.478 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.56 -56.97 7.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 61.5 Cg_endo -72.99 -34.71 6.11 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.47 2.113 . . . . 0.0 113.811 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.037 HD21 HG11 ' A' ' 68' ' ' VAL . 2.0 mm? -71.1 -45.44 63.68 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.21 -28.91 60.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.81 ' HB3' HG21 ' A' ' 37' ' ' ILE . 3.5 mtpp -78.92 -36.57 41.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.517 ' O ' HG13 ' A' ' 66' ' ' ILE . 1.2 m-20 -101.76 -12.27 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.28 23.95 6.52 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.11 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 64' ' ' ASP . 28.1 mt -93.15 147.38 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.728 0.299 . . . . 0.0 111.029 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 47' ' ' THR . 27.8 m -78.52 129.58 35.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.037 HG11 HD21 ' A' ' 61' ' ' LEU . 6.1 p -145.07 152.46 14.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.261 0.553 . . . . 0.0 111.945 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.76 129.25 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.258 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.0 106.72 18.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.972 0.415 . . . . 0.0 110.946 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 1.008 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 5.2 m0 -107.38 103.55 49.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.626 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo . . . . . 0 N--CA 1.444 -1.397 0 C-N-CA 123.617 2.878 . . . . 0.0 112.439 -179.22 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.675 0.274 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 1.008 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 26.1 t -55.05 -41.55 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.709 HG22 ' CD1' ' A' ' 120' ' ' LEU . 0.5 OUTLIER -53.55 -41.65 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -65.83 -31.21 72.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.504 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -64.08 -50.94 66.37 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.749 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -67.52 -32.85 73.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.696 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.811 HD21 ' HB3' ' A' ' 120' ' ' LEU . 12.0 mt -57.01 -45.67 82.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.467 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -43.13 94.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.493 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.511 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.5 tm? -58.35 -51.66 68.87 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.009 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.886 HG21 ' HB1' ' A' ' 121' ' ' ALA . 13.8 p -70.96 -39.96 75.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.376 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -58.55 -41.02 84.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.924 0.393 . . . . 0.0 110.547 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.75 -48.17 75.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.642 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -71.59 -25.7 62.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.485 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.0 m-85 -75.11 -51.73 12.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.7 t -60.0 -42.26 93.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.788 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -76.09 -33.06 59.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -126.08 92.12 46.55 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.275 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.22 138.29 15.89 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.637 2.225 . . . . 0.0 112.489 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.401 ' HA2' ' CB ' ' A' ' 20' ' ' MET . . . 58.24 56.35 25.69 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.712 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.691 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.8 OUTLIER -101.24 -172.49 2.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 111.176 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.702 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 m -108.29 113.55 26.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.145 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.64 HG11 ' HE1' ' A' ' 22' ' ' PHE . 46.0 t -111.3 149.55 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.183 0.516 . . . . 0.0 112.306 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.858 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -119.96 144.3 47.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.949 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.825 HG22 HG12 ' A' ' 49' ' ' VAL . 96.5 t -140.17 166.32 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.711 0.291 . . . . 0.0 111.6 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.571 ' N ' HG12 ' A' ' 105' ' ' VAL . 1.6 t-80 -67.34 155.74 38.19 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.344 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.465 ' O ' ' CE1' ' A' ' 106' ' ' HIS . 0.2 OUTLIER -68.61 106.59 2.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.413 0.625 . . . . 0.0 112.615 -178.194 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.886 HG22 HG21 ' A' ' 24' ' ' ILE . 28.0 m -75.33 0.53 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.221 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.19 -8.58 2.57 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.07 -124.86 2.87 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 111' ' ' LEU . 8.4 mt -128.15 127.34 42.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.98 -158.17 9.17 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.261 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.626 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.19 -18.81 6.74 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.063 0.459 . . . . 0.0 111.776 -178.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.806 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -52.75 -46.2 96.53 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.687 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.6 Cg_endo -52.78 -48.44 22.01 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.043 1.829 . . . . 0.0 112.509 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.774 HG22 ' HG3' ' A' ' 148' ' ' GLN . 58.5 t -55.95 -51.88 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 0.0 109.94 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.674 HD12 ' CG2' ' A' ' 49' ' ' VAL . 8.8 mt -54.47 -46.2 73.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.583 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 114' ' ' ALA . 17.0 t -51.42 -50.58 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 111.076 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.818 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -54.03 -48.04 70.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.29 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.811 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.2 mt -53.97 -31.32 50.33 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.205 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.886 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.51 -50.61 29.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.716 0.293 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.768 HD23 ' OD2' ' A' ' 131' ' ' ASP . 8.5 tp -66.55 -14.63 62.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.714 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.999 HD11 HD21 ' A' ' 152' ' ' LEU . 2.2 mt -58.49 -30.95 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.063 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -70.49 -16.55 62.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.44 -23.24 40.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.67 -96.96 0.17 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.792 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.647 ' HE3' ' CD2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -63.12 74.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.904 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -70.73 -67.47 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.472 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 6.9 t80 -65.49 -34.86 79.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.933 0.397 . . . . 0.0 111.341 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -71.77 -51.5 22.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.454 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.768 ' OD2' HD23 ' A' ' 122' ' ' LEU . 32.8 t70 -70.14 -32.51 70.53 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.943 0.402 . . . . 0.0 111.06 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.818 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -62.3 -50.16 72.76 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.97 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.478 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 32.9 mm -74.5 -40.32 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.269 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -50.03 19.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.81 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.48 -38.98 88.47 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.29 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -74.43 -27.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.709 0.29 . . . . 0.0 110.877 179.027 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 1.9 ttp85 -65.08 -42.2 94.31 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.797 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -45.43 91.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.888 0.375 . . . . 0.0 110.41 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' ILE . 6.7 mmtt -87.72 151.72 22.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.273 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.36 117.0 14.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.163 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 163.81 14.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.288 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -53.52 -173.61 0.05 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.011 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.417 ' N ' HD22 ' A' ' 111' ' ' LEU . . . -84.13 99.5 10.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.213 0.507 . . . . 0.0 111.473 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 1.09 HD12 HD21 ' A' ' 149' ' ' LEU . 1.8 pt -88.17 109.5 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.407 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -113.13 -76.5 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.313 0.856 . . . . 0.0 113.313 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.7 p -99.63 -60.84 1.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.897 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.3 tmtt? -56.81 -51.87 67.27 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -176.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.774 ' HG3' HG22 ' A' ' 116' ' ' VAL . 9.8 tm0? -56.73 -51.22 69.68 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.09 HD21 HD12 ' A' ' 144' ' ' ILE . 3.9 mm? -72.98 -43.09 62.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 m -70.27 -39.71 74.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.771 0.319 . . . . 0.0 111.661 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.897 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -66.54 -50.91 61.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.999 HD21 HD11 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -66.49 -30.17 70.44 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.413 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.93 -40.12 96.66 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -22.72 61.46 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.58 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.467 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.21 -47.95 72.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.608 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.514 0.197 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.6 ' HB3' HG23 ' A' ' 25' ' ' THR . 37.5 Cg_exo -57.03 161.91 10.0 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.408 2.072 . . . . 0.0 112.126 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.733 HG11 ' CE ' ' A' ' 139' ' ' LYS . 3.7 t -137.74 126.97 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.817 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 11.6 pt-20 -107.42 116.92 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 111.752 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.836 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.7 OUTLIER -108.92 118.53 56.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.499 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.9 p -140.99 147.56 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 111.95 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CD2' ' HG2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -144.04 126.35 15.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.282 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 38.0 mmtt 77.92 -87.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.278 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -129.38 -40.62 1.43 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.631 ' CE ' HD13 ' A' ' 122' ' ' LEU . 2.7 tmm? -73.74 154.41 39.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.884 0.373 . . . . 0.0 111.289 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.11 161.66 35.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.621 ' CE2' ' HE1' ' A' ' 20' ' ' MET . 8.6 m-85 -132.09 145.75 51.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.069 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.3 mm? -117.81 129.21 55.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 110.791 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.871 HD12 HG13 ' A' ' 108' ' ' VAL . 2.1 mm -112.56 106.63 21.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.6 HG23 ' HB3' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -130.89 164.54 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.243 0.544 . . . . 0.0 111.987 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 50.0 p-80 -81.24 152.33 27.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.797 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.6 153.46 77.76 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.521 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 9.6 Cg_endo -54.43 139.58 74.34 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.564 2.176 . . . . 0.0 113.475 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.439 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.6 p -98.86 174.38 6.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.095 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -98.24 -8.08 27.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -30.6 14.91 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 p -139.37 89.73 2.36 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.487 -0.485 . . . . 0.0 112.112 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.448 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.6 OUTLIER -79.99 -52.28 8.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.122 0.487 . . . . 0.0 111.421 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 37' ' ' ILE . 1.2 m -57.62 -45.38 85.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.083 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -32.03 67.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.797 0.332 . . . . 0.0 111.464 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.646 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.57 -48.01 24.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.09 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.915 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.9 pt -55.88 -39.21 55.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.178 0.513 . . . . 0.0 110.746 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.12 -52.08 51.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.58 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.559 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 4.8 m-20 -67.67 -50.14 59.26 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.905 0.384 . . . . 0.0 111.945 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.646 HD21 ' CE1' ' A' ' 36' ' ' PHE . 80.0 mt -55.79 -46.35 78.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.359 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -76.95 -26.71 54.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.083 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 5.3 mttt -52.91 -44.46 66.98 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.069 ' CD1' HD21 ' A' ' 23' ' ' LEU . 15.4 t80 -63.54 -38.62 91.81 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.734 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.692 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.6 -178.82 39.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.991 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.38 19.54 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 47' ' ' THR . 0.9 OUTLIER -165.19 -169.93 1.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.92 177.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.647 ' H ' HG22 ' A' ' 46' ' ' THR . 3.0 t -64.55 152.52 41.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.705 0.764 . . . . 0.0 110.437 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.81 HG22 ' HB3' ' A' ' 104' ' ' ALA . 83.6 t -132.2 136.5 56.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.006 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.062 HG13 HG13 ' A' ' 105' ' ' VAL . 14.9 p -115.66 105.31 18.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.147 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.423 ' HG2' ' CG2' ' A' ' 68' ' ' VAL . 17.1 ptt180 -113.59 110.85 20.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.748 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 113' ' ' ARG . 41.9 t -108.57 91.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.571 0.7 . . . . 0.0 110.327 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.7 p -157.82 171.03 21.02 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.041 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.27 130.25 42.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.689 HG23 ' HB3' ' A' ' 72' ' ' PRO . 17.6 t -70.22 122.19 21.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.5 p -120.51 -47.93 2.31 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.179 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.422 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.3 m-85 -130.77 83.91 2.15 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.623 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.13 -36.78 40.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.65 -48.58 13.5 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.448 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -45.92 -54.3 17.28 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 8.2 Cg_exo -73.1 -35.6 5.07 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.659 2.239 . . . . 0.0 113.653 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.977 HD21 HG11 ' A' ' 68' ' ' VAL . 2.1 mm? -71.03 -45.24 64.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.01 -28.97 60.72 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.915 ' HB3' HG21 ' A' ' 37' ' ' ILE . 5.7 mttp -81.02 -35.09 32.33 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.541 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -101.56 -12.45 18.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.48 25.61 4.6 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.378 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 64' ' ' ASP . 20.8 mt -95.36 147.72 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.672 0.272 . . . . 0.0 111.079 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 47' ' ' THR . 1.8 m -78.16 127.94 33.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.977 HG11 HD21 ' A' ' 61' ' ' LEU . 10.5 p -145.18 153.95 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.151 0.501 . . . . 0.0 112.209 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.7 t -103.33 132.75 48.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -101.08 106.84 18.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.124 0.488 . . . . 0.0 110.931 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.74 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.8 m95 -111.4 103.25 54.8 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.739 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.689 ' HB3' HG23 ' A' ' 54' ' ' VAL . 31.1 Cg_endo . . . . . 0 N--CA 1.446 -1.316 0 C-N-CA 123.62 2.88 . . . . 0.0 112.657 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.283 0.087 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -44.7 63.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.628 HG11 ' HE2' ' A' ' 151' ' ' TYR . 39.4 t -55.33 -43.53 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.344 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.527 ' HA ' HD12 ' A' ' 88' ' ' LEU . 21.0 mm-40 -55.37 -31.62 61.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.263 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -50.07 70.15 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.419 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.754 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.9 -30.3 70.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.897 HD21 ' HB3' ' A' ' 120' ' ' LEU . 22.9 mt -59.6 -48.32 82.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.451 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 m -63.63 -40.45 96.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.189 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.476 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.3 tm? -59.57 -51.26 70.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.616 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.917 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.8 p -69.92 -35.92 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.092 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -48.06 78.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.76 92.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.748 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -26.78 63.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.139 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.462 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.7 m-85 -82.08 -52.0 7.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.229 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.0 t -59.51 -37.95 79.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.25 -33.05 59.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.278 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.09 95.31 39.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.509 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.46 134.12 15.14 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.553 2.169 . . . . 0.0 112.223 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 56.09 27.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.494 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.642 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.9 OUTLIER -101.0 -164.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 0.0 111.248 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.692 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 m -117.74 113.51 21.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.32 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.0 t -108.71 151.03 11.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 111.983 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.81 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.99 141.79 51.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.963 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.062 HG13 HG13 ' A' ' 49' ' ' VAL . 10.1 t -140.3 166.9 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.527 ' N ' HG12 ' A' ' 105' ' ' VAL . 1.5 t-80 -66.76 156.1 36.37 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.441 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.514 ' N ' ' O ' ' A' ' 25' ' ' THR . 49.8 t -68.34 106.05 2.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.314 0.578 . . . . 0.0 112.457 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.871 HG13 HD12 ' A' ' 24' ' ' ILE . 28.8 m -75.2 0.21 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.097 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.65 -8.63 3.03 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.47 -131.31 3.67 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.402 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 14.0 mt -124.42 127.42 47.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.75 -151.49 6.5 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.33 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.808 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.19 -21.26 5.95 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 111.805 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.663 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -51.28 -46.42 89.46 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.751 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.2 Cg_endo -52.02 -48.51 21.24 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.2 1.934 . . . . 0.0 112.978 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.837 HG12 HD11 ' A' ' 120' ' ' LEU . 25.5 t -60.1 -41.09 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.67 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.507 HD12 ' CG2' ' A' ' 49' ' ' VAL . 13.0 mt -60.24 -45.25 93.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.531 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.673 ' CG2' HG11 ' A' ' 105' ' ' VAL . 38.2 t -57.34 -55.14 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.749 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.72 -51.74 59.15 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.264 0.554 . . . . 0.0 110.94 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.897 ' HB3' HD21 ' A' ' 88' ' ' LEU . 6.7 mt -55.27 -30.48 60.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.16 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.917 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.93 -40.08 69.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 110.148 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.631 HD13 ' CE ' ' A' ' 20' ' ' MET . 6.4 tp -71.26 -14.36 62.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 1.001 HD11 HD21 ' A' ' 152' ' ' LEU . 2.8 mt -57.2 -30.7 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.661 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -16.61 63.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.9 p -79.53 -23.39 42.91 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.55 -96.66 0.17 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.805 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.528 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 1.4 ptt? -64.0 72.61 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.941 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.16 -67.61 0.42 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.666 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.596 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.8 t80 -67.73 -32.68 73.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 111.046 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 127' ' ' MET . 12.1 mp0 -72.29 -51.91 18.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.321 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 46.8 t0 -67.12 -39.78 86.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 111.043 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.749 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -59.43 -50.0 75.63 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.203 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 35.6 mm -73.94 -36.28 44.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.645 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.22 -49.51 23.09 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.836 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.37 -36.91 74.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.627 0.251 . . . . 0.0 110.793 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.5 tt -74.22 -28.23 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.815 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 8.0 ttm180 -68.35 -47.92 66.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.818 0.342 . . . . 0.0 110.399 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -59.89 -45.02 93.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.443 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.733 ' CE ' HG11 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -84.7 151.73 24.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.319 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.6 116.48 14.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.063 0.459 . . . . 0.0 110.667 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -115.39 163.47 15.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.844 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.402 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -55.07 -176.78 0.15 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.247 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.05 98.75 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.772 0.786 . . . . 0.0 110.751 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.63 HD12 HD21 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -88.94 109.68 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.972 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -112.88 -76.71 0.58 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.397 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.747 ' O ' HG22 ' A' ' 150' ' ' THR . 4.8 p -99.77 -60.79 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.738 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.8 tmtt? -49.04 -51.44 31.1 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -177.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.543 ' HG3' HG21 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -56.29 -51.67 67.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.244 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.63 HD21 HD12 ' A' ' 144' ' ' ILE . 3.4 mm? -75.27 -39.37 59.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 146' ' ' SER . 12.3 t -74.12 -36.25 64.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.577 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.738 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -70.16 -50.68 37.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.193 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -67.11 -35.08 79.0 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.216 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.1 -43.58 82.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -25.24 65.27 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.336 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.715 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -66.11 -32.53 74.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.373 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.747 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.725 0.297 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HB3' HG23 ' A' ' 25' ' ' THR . 60.8 Cg_endo -73.09 165.2 33.38 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.628 2.219 . . . . 0.0 112.327 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 t -141.07 126.96 19.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.671 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -109.6 116.99 32.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.974 0.416 . . . . 0.0 111.607 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.835 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -107.06 118.6 55.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.603 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.6 p -140.78 144.76 35.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.97 0.414 . . . . 0.0 111.72 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.594 ' CD2' ' HE2' ' A' ' 127' ' ' MET . 0.2 OUTLIER -142.46 122.71 13.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.467 179.222 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 16.0 mmtt 84.12 -88.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.274 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -129.41 -40.46 1.43 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.733 0.302 . . . . 0.0 111.763 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.516 ' HE1' HD12 ' A' ' 122' ' ' LEU . 10.2 ptm -73.77 162.83 28.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.23 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -143.34 164.04 31.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.121 0.486 . . . . 0.0 111.5 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.768 ' CE1' HG11 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -135.35 142.37 45.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.892 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -114.67 136.44 53.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.061 0.458 . . . . 0.0 110.939 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.889 HD13 ' HB ' ' A' ' 105' ' ' VAL . 14.4 mm -118.3 106.46 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.37 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -134.55 165.34 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.218 0.533 . . . . 0.0 112.008 -179.08 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.478 ' CA ' ' HB2' ' A' ' 107' ' ' CYS . 48.6 p-80 -81.4 152.09 27.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.454 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -62.89 154.73 74.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.679 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.5 Cg_exo -54.64 139.93 76.27 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.187 1.925 . . . . 0.0 113.171 -177.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -98.69 174.31 6.47 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.108 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.475 ' H ' HG22 ' A' ' 29' ' ' THR . 3.6 t-20 -93.78 -10.7 33.32 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.84 14.74 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.3 p -139.62 89.73 2.35 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.403 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.457 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.29 -52.22 7.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.077 0.465 . . . . 0.0 111.228 178.139 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.442 ' O ' HG13 ' A' ' 37' ' ' ILE . 2.7 p -57.55 -45.8 84.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.33 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 m -57.72 -31.98 66.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.851 0.357 . . . . 0.0 111.187 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.721 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.39 -47.78 25.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.861 HG21 ' HB3' ' A' ' 63' ' ' LYS . 10.9 pt -55.64 -38.85 51.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 110.609 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.19 -51.4 58.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.486 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.565 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -68.27 -50.19 55.41 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.87 0.367 . . . . 0.0 111.989 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.721 HD21 ' CE1' ' A' ' 36' ' ' PHE . 85.6 mt -55.7 -45.52 77.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.481 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.98 -26.57 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.02 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 12.2 mttt -52.49 -44.56 65.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.358 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.066 ' CD1' HD21 ' A' ' 23' ' ' LEU . 11.0 t80 -63.45 -38.43 91.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.664 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.682 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 162.99 -178.41 38.71 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.921 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.52 19.76 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.676 HG22 ' H ' ' A' ' 47' ' ' THR . 1.3 m -164.9 -170.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.833 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.676 ' H ' HG22 ' A' ' 46' ' ' THR . 2.6 t -64.51 159.64 21.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.355 0.598 . . . . 0.0 110.456 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.791 HG13 ' O ' ' A' ' 104' ' ' ALA . 57.7 t -138.48 138.83 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.322 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.09 HG13 HG13 ' A' ' 105' ' ' VAL . 12.4 p -115.57 104.71 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.261 0.553 . . . . 0.0 110.816 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -114.56 110.79 20.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.322 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.802 HG13 ' HB3' ' A' ' 71' ' ' TRP . 6.3 t -107.17 90.95 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.421 0.629 . . . . 0.0 109.376 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.3 p -158.02 171.38 20.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.938 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -66.45 130.41 43.11 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 m -76.0 122.35 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -120.15 -47.66 2.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.44 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.425 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -130.63 83.88 2.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.708 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.09 -36.54 40.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -79.51 -48.57 13.66 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.437 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.34 -54.13 19.75 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 8.1 Cg_exo -73.26 -34.67 5.82 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.623 2.216 . . . . 0.0 113.48 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.968 HD21 HG11 ' A' ' 68' ' ' VAL . 2.1 mm? -71.09 -45.19 64.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.21 -28.86 60.13 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.861 ' HB3' HG21 ' A' ' 37' ' ' ILE . 5.6 mmtm -79.04 -36.63 40.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' O ' HG13 ' A' ' 66' ' ' ILE . 3.8 m-20 -101.57 -12.4 18.51 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.03 23.95 6.06 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.285 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 64' ' ' ASP . 24.6 mt -92.82 147.38 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 110.927 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' THR . 82.2 p -78.69 129.19 34.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.968 HG11 HD21 ' A' ' 61' ' ' LEU . 5.9 p -145.16 154.44 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.2 0.524 . . . . 0.0 112.123 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.51 HG22 ' HG ' ' A' ' 90' ' ' LEU . 3.2 t -103.75 133.59 47.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.108 178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.99 106.78 18.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.139 0.495 . . . . 0.0 110.396 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.889 ' CH2' HG12 ' A' ' 83' ' ' VAL . 4.4 m95 -111.91 104.27 55.91 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.049 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo . . . . . 0 N--CA 1.448 -1.198 0 C-N-CA 123.162 2.575 . . . . 0.0 112.645 -179.586 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.099 0 CA-C-O 120.503 0.192 . . . . 0.0 110.977 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.889 HG12 ' CH2' ' A' ' 71' ' ' TRP . 40.1 t -56.98 -47.8 82.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 151' ' ' TYR . 54.4 t -55.22 -40.87 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.817 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.582 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.7 mt-10 -57.3 -31.39 65.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.532 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.04 -50.46 68.33 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.257 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.745 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.08 -29.9 70.32 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.437 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 120' ' ' LEU . 8.7 mt -62.46 -38.61 90.47 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.312 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.57 -43.78 79.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.036 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.51 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.4 tm? -60.47 -51.29 70.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.603 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.491 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 10.2 p -69.14 -35.9 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -57.3 -46.38 83.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.756 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.5 84.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -26.58 64.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.241 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.543 ' CE1' HG21 ' A' ' 103' ' ' VAL . 3.8 m-30 -81.99 -50.88 8.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.25 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 51.4 t -59.88 -38.04 81.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.921 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -76.21 -33.09 59.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.96 90.21 50.76 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.425 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.12 135.77 25.71 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.879 2.386 . . . . 0.0 112.231 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.07 55.39 30.91 Favored Glycine 0 C--N 1.329 0.154 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.696 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.577 ' HB2' HG21 ' A' ' 46' ' ' THR . 4.5 m -101.3 -163.46 1.02 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.25 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.682 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.0 m -119.34 113.87 21.48 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.319 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.768 HG11 ' CE1' ' A' ' 22' ' ' PHE . 38.1 t -109.2 151.0 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.791 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -120.65 145.12 47.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.224 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.09 HG13 HG13 ' A' ' 49' ' ' VAL . 4.0 t -140.31 166.78 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.786 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.6 t-80 -67.29 155.52 38.68 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.018 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.55 ' N ' ' O ' ' A' ' 25' ' ' THR . 38.5 t -69.0 98.36 0.95 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.506 0.67 . . . . 0.0 112.37 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.844 HG23 HD12 ' A' ' 24' ' ' ILE . 2.7 t -75.76 1.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.854 -1.067 . . . . 0.0 112.347 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.42 -8.62 1.87 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.86 -120.62 2.55 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.424 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 8.3 mt -126.46 127.29 45.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.91 -154.34 7.47 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.839 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.509 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.25 -17.65 7.06 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.082 0.468 . . . . 0.0 111.834 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.878 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -51.44 -46.21 90.22 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 9.4 Cg_endo -52.11 -48.51 21.27 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.491 2.128 . . . . 0.0 113.303 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.737 ' O ' HD23 ' A' ' 120' ' ' LEU . 24.0 t -61.64 -44.6 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.029 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.785 HD12 ' CG2' ' A' ' 49' ' ' VAL . 2.3 mt -59.66 -46.06 90.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.573 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.654 ' CG2' HG11 ' A' ' 105' ' ' VAL . 97.5 t -56.44 -55.19 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.645 0.26 . . . . 0.0 111.562 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.615 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.76 -48.61 66.65 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.181 0.515 . . . . 0.0 110.835 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 116' ' ' VAL . 3.3 mm? -56.88 -30.87 64.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.588 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.745 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -70.92 -34.23 71.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.4 . . . . 0.0 110.092 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.734 HD23 ' OD2' ' A' ' 131' ' ' ASP . 1.4 tp -75.32 -16.66 60.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.528 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.917 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.9 mt -57.28 -30.66 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.179 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.409 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 10.6 pt-20 -73.81 -16.72 61.14 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.3 t -79.49 -23.29 43.08 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.66 -97.6 0.18 Allowed Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.576 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.594 ' HE2' ' CD2' ' A' ' 17' ' ' TYR . 1.1 ptt? -63.03 73.61 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.917 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.03 -67.58 0.42 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.726 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.592 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.2 t80 -69.33 -32.3 71.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.042 0.448 . . . . 0.0 110.914 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.28 -50.44 27.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.36 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.734 ' OD2' HD23 ' A' ' 122' ' ' LEU . 43.3 t0 -67.59 -37.17 82.19 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.615 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -61.05 -50.2 74.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.991 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 129' ' ' TYR . 24.6 mm -72.8 -38.45 57.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 111.681 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -49.6 22.9 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.835 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.64 -34.11 71.71 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.864 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.9 OUTLIER -74.07 -30.64 27.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.798 0.332 . . . . 0.0 110.393 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -65.42 -48.95 71.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.29 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -59.93 -45.1 93.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.593 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -83.19 151.89 25.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.637 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 117.46 14.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.6 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.482 ' HG3' HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -114.44 163.17 15.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.968 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -61.02 -157.49 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.274 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.43 98.71 11.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.568 0.684 . . . . 0.0 110.461 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.739 HG23 ' CB ' ' A' ' 148' ' ' GLN . 61.4 mt -88.71 109.0 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.058 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -113.87 -77.74 0.58 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.854 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.5 p -101.13 -60.95 1.43 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.831 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.2 tmtt? -48.99 -52.06 27.07 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.739 ' CB ' HG23 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -56.2 -51.82 66.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.431 ' CD2' ' CG2' ' A' ' 144' ' ' ILE . 3.1 mm? -73.24 -47.0 46.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.5 m -66.92 -37.24 83.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.831 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -67.89 -50.92 53.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.319 -179.273 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.835 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -70.71 -31.32 68.15 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.344 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 1.2 tt0 -59.14 -39.02 81.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -29.17 64.78 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.448 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.711 ' HE2' HD12 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -66.06 -30.17 70.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.665 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.743 0.306 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.544 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 56.3 Cg_endo -70.38 152.67 66.22 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.565 2.176 . . . . 0.0 112.386 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.478 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.5 t -144.07 127.64 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.903 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -110.71 116.8 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.805 0.336 . . . . 0.0 111.353 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.787 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -106.72 118.33 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.1 p -141.2 142.84 33.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.643 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 1.4 p90 -134.51 170.21 16.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.113 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 43.63 -96.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.053 0.141 . . . . 0.0 111.167 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.402 ' H ' ' CG ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -128.92 -30.78 2.21 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.76 ' HE1' HD11 ' A' ' 122' ' ' LEU . 3.9 ppp? -73.74 169.13 17.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.687 0.28 . . . . 0.0 111.23 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -147.94 161.23 41.74 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.979 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.839 ' CD2' HG13 ' A' ' 118' ' ' VAL . 1.3 m-85 -134.11 150.72 51.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.377 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -121.13 136.36 54.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.122 0.487 . . . . 0.0 111.557 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.916 HD12 HG13 ' A' ' 108' ' ' VAL . 1.9 mm -118.19 106.58 20.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.13 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -134.78 166.99 21.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.287 0.565 . . . . 0.0 111.745 -178.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 36' ' ' PHE . 49.1 p-80 -81.33 152.03 27.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.103 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -62.88 154.53 75.66 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.043 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.7 Cg_exo -54.77 138.91 77.5 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.389 2.059 . . . . 0.0 113.312 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.44 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 28.9 p -98.72 174.41 6.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.231 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -93.79 -9.73 36.53 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.59 -30.81 14.77 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -139.62 89.58 2.33 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.274 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.44 -52.27 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.138 0.494 . . . . 0.0 111.174 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.433 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.1 p -58.49 -45.21 89.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.162 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 m -57.99 -32.78 68.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.9 0.381 . . . . 0.0 111.339 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.691 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.51 -48.11 29.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.148 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.751 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.0 pt -56.08 -39.15 56.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.265 0.555 . . . . 0.0 110.645 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.3 -50.9 63.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.513 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -69.63 -50.13 47.26 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.887 0.375 . . . . 0.0 111.813 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.691 HD21 ' CE1' ' A' ' 36' ' ' PHE . 53.0 mt -56.19 -44.19 79.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.305 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -78.89 -26.75 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.021 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -52.92 -43.48 66.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.29 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.066 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.6 t80 -63.41 -38.4 90.99 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.663 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.682 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 166.31 -177.43 41.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.793 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.56 117.47 19.62 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.706 HG22 ' H ' ' A' ' 47' ' ' THR . 1.4 m -165.25 -169.93 1.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.687 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.721 ' HA ' HG23 ' A' ' 67' ' ' THR . 5.1 p -64.81 144.49 57.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.572 0.701 . . . . 0.0 110.448 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.956 HG21 HD12 ' A' ' 66' ' ' ILE . 61.0 t -122.18 128.14 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.868 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.041 HG13 HG13 ' A' ' 105' ' ' VAL . 2.1 p -115.44 105.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.355 0.597 . . . . 0.0 111.692 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -113.89 111.02 21.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.737 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.823 HG11 ' HB2' ' A' ' 113' ' ' ARG . 38.8 t -101.22 92.38 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.498 0.666 . . . . 0.0 110.405 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.18 171.46 20.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.072 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -64.62 130.7 44.62 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 m -68.73 122.05 19.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.553 HG22 ' CE1' ' A' ' 56' ' ' TYR . 6.5 m -120.45 -47.0 2.36 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.143 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.553 ' CE1' HG22 ' A' ' 55' ' ' THR . 2.8 m-85 -129.79 84.89 2.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.362 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.411 ' HA ' ' NH2' ' A' ' 50' ' ' ARG . 6.0 p-10 -78.21 -35.64 48.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -78.81 -48.49 14.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.41 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -46.45 -51.24 36.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.111 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 47.5 Cg_exo -57.13 -42.33 64.62 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.242 . . . . 0.0 113.83 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.73 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -71.21 -45.47 63.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -49.12 19.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.751 ' HB3' HG21 ' A' ' 37' ' ' ILE . 28.1 mmtt -74.46 -26.86 60.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.46 ' CG ' HD11 ' A' ' 66' ' ' ILE . 3.1 t0 -99.92 -11.57 20.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.54 25.98 3.49 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.14 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.956 HD12 HG21 ' A' ' 48' ' ' VAL . 4.7 pt -122.76 148.73 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.601 0.239 . . . . 0.0 110.573 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.721 HG23 ' HA ' ' A' ' 47' ' ' THR . 10.3 t -77.15 132.87 39.03 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.73 HG12 ' CD2' ' A' ' 61' ' ' LEU . 8.0 p -139.71 149.38 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.155 0.502 . . . . 0.0 111.984 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.446 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.8 t -103.3 131.6 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.91 106.63 17.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.585 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.888 ' CH2' HG12 ' A' ' 83' ' ' VAL . 4.4 m95 -110.22 103.46 53.86 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.555 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 N--CA 1.445 -1.372 0 C-N-CA 123.538 2.825 . . . . 0.0 112.882 -178.866 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 5.7 tmtp? . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.609 0.242 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.888 HG12 ' CH2' ' A' ' 71' ' ' TRP . 42.1 t -56.56 -46.71 82.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG21 ' NZ ' ' A' ' 147' ' ' LYS . 89.3 t -56.08 -40.37 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.039 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 2.0 mt-10 -58.2 -31.44 67.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.746 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.72 -50.74 63.72 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.498 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.856 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.03 -28.9 69.21 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.419 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.715 HD21 ' HB3' ' A' ' 120' ' ' LEU . 11.3 mt -64.74 -38.5 91.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.228 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.8 m -66.93 -39.99 87.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.994 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.502 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.6 tm? -63.44 -51.3 66.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.874 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.675 HG21 ' HB1' ' A' ' 121' ' ' ALA . 13.5 p -69.76 -43.42 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.457 ' N ' HG13 ' A' ' 91' ' ' VAL . 21.2 mttm -60.82 -34.76 75.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.393 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.2 -47.96 72.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.418 ' HE2' HG21 ' A' ' 67' ' ' THR . 9.4 mptt -74.6 -25.59 59.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.652 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 3.3 m-85 -82.02 -34.48 29.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.992 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.1 t -72.26 -46.4 56.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -76.35 -33.36 58.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.35 141.99 41.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.91 159.32 53.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.406 2.071 . . . . 0.0 112.125 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.09 90.75 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -81.44 -83.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.68 0.276 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.682 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.6 m -153.26 113.05 3.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.792 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.652 HG21 ' HZ ' ' A' ' 95' ' ' PHE . 23.5 t -108.07 151.21 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.694 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.4 140.45 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.27 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.041 HG13 HG13 ' A' ' 49' ' ' VAL . 2.5 t -139.6 166.79 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.612 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.637 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.0 t60 -67.16 156.27 36.64 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.52 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -68.06 105.07 1.93 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.64 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.916 HG13 HD12 ' A' ' 24' ' ' ILE . 29.8 m -75.28 -0.02 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.025 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.72 -8.72 3.17 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.93 -136.32 4.68 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 13.0 mt -120.9 127.46 51.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.74 -147.42 5.22 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.374 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.823 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.24 -20.01 6.32 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.907 0.384 . . . . 0.0 111.89 -178.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.666 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -52.64 -46.56 95.87 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.817 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.5 Cg_endo -52.1 -48.31 22.31 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.264 1.976 . . . . 0.0 112.73 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.68 ' O ' HD23 ' A' ' 120' ' ' LEU . 39.0 t -60.95 -44.47 98.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.917 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.463 HD12 ' CG2' ' A' ' 51' ' ' VAL . 9.4 mt -58.12 -45.31 87.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.212 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.934 ' CG2' HG11 ' A' ' 105' ' ' VAL . 94.9 t -55.0 -55.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.776 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.669 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -56.36 -49.25 74.95 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.147 0.499 . . . . 0.0 110.748 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.715 ' HB3' HD21 ' A' ' 88' ' ' LEU . 2.7 mm? -53.91 -30.91 48.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.732 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.856 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -69.58 -43.32 73.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.05 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.782 HD23 ' OD2' ' A' ' 131' ' ' ASP . 0.7 OUTLIER -66.98 -15.63 63.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.757 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.919 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.6 mt -57.04 -30.64 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -72.45 -17.02 61.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.424 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.5 m -84.54 11.25 9.09 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 113.79 -99.5 0.98 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.763 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.482 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.0 ptt? -62.45 79.73 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.919 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.9 -67.69 0.54 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.619 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.2 t80 -67.33 -32.05 72.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.959 0.409 . . . . 0.0 111.001 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.37 -52.04 17.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.25 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.782 ' OD2' HD23 ' A' ' 122' ' ' LEU . 32.3 t0 -68.24 -38.13 81.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.816 0.341 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.669 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -60.04 -49.98 75.54 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.007 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.4 mm -73.67 -37.61 49.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -74.17 -49.6 22.92 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.787 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.57 -35.8 73.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.583 0.23 . . . . 0.0 110.902 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.4 tt -74.14 -29.26 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.395 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -66.31 -48.44 70.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.477 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -44.94 93.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.443 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -82.81 152.25 25.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.29 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 117.25 14.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.503 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -114.53 163.54 15.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.01 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.416 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -59.15 -164.08 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.485 -0.865 . . . . 0.0 111.173 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.06 98.96 11.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.709 0.755 . . . . 0.0 110.745 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.768 HD13 HD21 ' A' ' 149' ' ' LEU . 1.6 pp -88.48 109.03 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.074 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -113.45 -77.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.456 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.4 m -100.27 -60.7 1.48 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.822 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.5 tmtt? -53.19 -51.8 60.91 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.642 ' HG3' HG22 ' A' ' 144' ' ' ILE . 3.7 tm0? -56.03 -52.03 65.68 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.768 HD21 HD13 ' A' ' 144' ' ' ILE . 3.6 mm? -75.04 -45.3 42.56 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.4 m -67.09 -35.0 78.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.629 0.252 . . . . 0.0 111.622 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.822 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -69.51 -50.87 41.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.387 -179.275 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.831 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -69.47 -32.25 71.04 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.323 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 51.3 tt0 -59.73 -39.55 85.08 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -27.46 63.52 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.585 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.651 ' HE2' HD12 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -66.23 -33.77 76.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.621 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.662 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.634 0.254 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.02 165.16 33.55 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.538 2.159 . . . . 0.0 112.368 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.93 126.83 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.534 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.55 ' HB3' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -116.82 136.01 53.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.015 0.436 . . . . 0.0 111.898 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.682 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.8 137.02 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.12 129.3 37.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.245 0.545 . . . . 0.0 111.963 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.447 ' CE1' ' HE1' ' A' ' 127' ' ' MET . 25.7 t80 -145.57 132.74 20.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.268 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 64.08 -103.49 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.204 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.4 14.04 6.07 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.521 ' HE2' HD21 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -119.26 169.0 10.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.775 0.322 . . . . 0.0 110.96 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.8 mtm-85 -141.79 164.08 31.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.122 0.486 . . . . 0.0 111.733 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.502 ' HE1' HG11 ' A' ' 103' ' ' VAL . 3.9 m-85 -134.59 150.19 50.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.872 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.062 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -126.21 135.49 51.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 111.143 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.846 HD12 HG23 ' A' ' 108' ' ' VAL . 10.9 mm -118.33 106.27 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.554 HG21 HD23 ' A' ' 40' ' ' LEU . 1.2 p -131.07 163.74 26.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.197 0.522 . . . . 0.0 111.756 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.496 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 37.3 p-80 -81.24 152.44 27.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.261 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -62.38 154.81 70.29 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.802 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 51.8 Cg_exo -53.89 136.6 66.73 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.32 2.013 . . . . 0.0 113.15 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.53 143.53 28.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.21 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -64.79 -12.78 51.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.338 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -31.31 14.59 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.4 p -139.97 88.8 2.26 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.282 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.89 -52.28 7.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.259 0.552 . . . . 0.0 111.256 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.466 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.3 m -56.84 -46.36 81.76 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.624 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -57.58 -31.9 66.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.961 0.41 . . . . 0.0 111.145 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.704 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.85 -47.59 29.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.175 -179.205 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.904 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.6 pt -55.62 -39.06 52.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.136 0.493 . . . . 0.0 110.605 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -65.18 -52.03 57.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.51 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.536 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 2.4 m-20 -67.99 -50.15 57.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.902 0.382 . . . . 0.0 111.935 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.704 HD21 ' CE1' ' A' ' 36' ' ' PHE . 74.2 mt -55.84 -45.2 78.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.556 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.8 tttm -77.34 -26.71 52.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.085 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.2 mttt -53.04 -44.99 67.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.217 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.062 ' CD1' HD21 ' A' ' 23' ' ' LEU . 11.5 t80 -63.57 -38.32 90.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.748 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.675 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 161.05 -177.74 37.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.934 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.67 122.33 27.17 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.848 HG22 ' H ' ' A' ' 47' ' ' THR . 4.1 m -164.54 -171.39 2.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.513 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.848 ' H ' HG22 ' A' ' 46' ' ' THR . 1.7 t -65.44 162.22 18.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.816 HG13 ' O ' ' A' ' 104' ' ' ALA . 91.8 t -138.01 137.99 44.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.834 HG12 HG22 ' A' ' 105' ' ' VAL . 11.2 p -115.23 104.2 16.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.421 0.629 . . . . 0.0 111.002 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.22 110.98 20.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.05 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.828 HG13 ' HB3' ' A' ' 71' ' ' TRP . 6.1 t -105.8 91.26 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.462 0.649 . . . . 0.0 109.704 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 t -157.87 171.29 20.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.911 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -67.61 130.45 43.08 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 54' ' ' VAL . 34.7 m -74.83 122.48 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.4 p -120.16 -47.66 2.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.376 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.449 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -130.56 83.34 2.11 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.457 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.17 -36.38 40.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -79.06 -48.55 14.17 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -43.91 -60.22 2.9 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.249 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.61 -34.31 15.35 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.551 2.167 . . . . 0.0 113.871 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.037 HD21 HG11 ' A' ' 68' ' ' VAL . 1.6 mm? -71.13 -45.19 64.08 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -75.1 -29.37 60.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.904 ' HB3' HG21 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -81.09 -33.8 33.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.23 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.539 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -101.31 -12.41 18.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.11 24.19 4.48 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.473 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 64' ' ' ASP . 12.7 mt -96.4 147.47 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.946 0.373 . . . . 0.0 110.835 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 47' ' ' THR . 3.4 m -78.47 132.57 37.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.037 HG11 HD21 ' A' ' 61' ' ' LEU . 7.5 p -145.05 152.78 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.337 0.589 . . . . 0.0 112.125 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.83 130.54 54.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.001 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.09 106.84 18.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.082 0.468 . . . . 0.0 111.044 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.828 ' HB3' HG13 ' A' ' 51' ' ' VAL . 5.5 m95 -109.35 103.9 53.82 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.51 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 N--CA 1.446 -1.266 0 C-N-CA 123.262 2.642 . . . . 0.0 112.94 -179.185 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.647 0.26 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 84' ' ' VAL . 31.2 m -58.65 -44.4 89.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.707 HG22 ' CD1' ' A' ' 120' ' ' LEU . 0.8 OUTLIER -53.42 -39.41 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.229 0.538 . . . . 0.0 109.591 178.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.63 -31.35 70.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.726 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.04 -50.88 64.5 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.712 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -68.86 -34.76 75.99 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.785 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.705 HD21 ' HB3' ' A' ' 120' ' ' LEU . 10.2 mt -55.17 -43.67 74.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.411 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -40.6 82.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.316 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.416 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.2 tm? -58.39 -51.35 70.18 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.9 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.065 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.2 p -73.9 -36.06 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.878 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 -44.06 64.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.934 0.397 . . . . 0.0 110.597 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.08 -43.6 57.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.951 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.721 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.7 OUTLIER -64.74 -27.62 69.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.263 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.06 -40.71 21.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 111.0 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 7.2 t -67.0 -46.05 75.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -76.1 -33.04 59.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.08 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -109.37 87.99 5.63 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.293 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.27 115.91 4.04 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.584 2.189 . . . . 0.0 112.363 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.15 52.14 19.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 t -101.17 -174.16 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.62 0.247 . . . . 0.0 111.179 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.675 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 3.1 m -112.94 114.12 26.48 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.502 HG11 ' HE1' ' A' ' 22' ' ' PHE . 16.3 t -106.81 151.28 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.816 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -121.33 145.7 47.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.643 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.834 HG22 HG12 ' A' ' 49' ' ' VAL . 97.5 t -139.86 166.25 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.659 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.4 t-80 -67.81 155.43 39.36 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.825 0.345 . . . . 0.0 110.725 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.541 ' N ' ' O ' ' A' ' 25' ' ' THR . 43.7 t -69.36 104.23 2.21 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.846 HG23 HD12 ' A' ' 24' ' ' ILE . 3.0 t -75.73 1.39 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.417 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.16 -8.37 1.54 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.73 -121.32 2.62 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 111' ' ' LEU . 7.8 mt -132.12 127.32 35.74 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.13 -154.48 7.55 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.146 -1.025 . . . . 0.0 113.255 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.572 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.37 -15.12 7.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.91 0.386 . . . . 0.0 111.943 -178.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.77 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -53.34 -46.79 97.79 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 10.1 Cg_endo -52.98 -48.1 23.97 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.352 2.035 . . . . 0.0 112.446 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.525 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 41.8 t -55.84 -53.23 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.859 0.362 . . . . 0.0 110.479 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.819 HD12 ' CG2' ' A' ' 49' ' ' VAL . 2.7 mt -54.44 -48.76 71.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.773 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 114' ' ' ALA . 17.0 t -51.28 -49.71 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 111.354 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.706 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -55.91 -45.26 78.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.668 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.785 HD13 ' OH ' ' A' ' 151' ' ' TYR . 0.5 OUTLIER -57.54 -30.88 65.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.766 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 1.065 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.05 -44.76 62.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.939 0.4 . . . . 0.0 110.597 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.723 HD13 ' OD2' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -69.63 -15.9 63.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.791 179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 1.068 HD11 HD21 ' A' ' 152' ' ' LEU . 1.3 mt -57.77 -41.72 80.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.871 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.52 -15.81 3.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.45 ' OG ' HD23 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -80.83 11.24 4.06 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.028 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 117.79 -88.08 0.44 Allowed Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.307 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.532 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.97 79.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.288 0.566 . . . . 0.0 109.662 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.91 ' CB ' HG23 ' A' ' 123' ' ' ILE . 20.9 mttm -62.61 -68.08 0.36 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.005 -177.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 152' ' ' LEU . 7.1 t80 -74.34 -30.47 62.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.229 0.537 . . . . 0.0 110.499 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -72.57 -47.15 50.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.107 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.723 ' OD2' HD13 ' A' ' 122' ' ' LEU . 50.8 t0 -68.88 -47.23 66.39 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.349 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.755 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -59.07 -50.16 75.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.941 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 35.4 mm -72.44 -36.18 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -74.21 -49.56 22.9 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.682 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.69 -37.5 76.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 110.815 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 132' ' ' ALA . 3.3 tt -74.44 -28.55 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.464 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 0.9 OUTLIER -69.51 -46.73 65.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.944 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -41.52 91.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.118 0.485 . . . . 0.0 110.027 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -87.14 152.64 22.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.154 179.118 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.38 117.81 14.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.112 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -114.19 163.66 14.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.234 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -57.95 -163.36 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.946 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.17 100.18 13.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.156 0.478 . . . . 0.0 111.51 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 144' ' ' ILE . 0.1 OUTLIER -87.91 109.17 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.482 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.65 -77.52 0.58 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.544 ' O ' HG22 ' A' ' 150' ' ' THR . 14.6 m -100.48 -61.41 1.37 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 8.8 tmtt? -64.29 -46.39 83.85 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -176.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.485 ' OE1' HG22 ' A' ' 144' ' ' ILE . 1.1 mt-30 -56.23 -52.13 65.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -176.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 149' ' ' LEU . 2.2 mm? -75.35 -37.19 60.81 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.963 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.618 HG22 ' HA ' ' A' ' 147' ' ' LYS . 5.1 t -71.76 -37.11 70.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.844 0.355 . . . . 0.0 110.968 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.799 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.85 -50.56 64.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.643 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.068 HD21 HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -66.7 -31.64 72.44 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.643 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.82 -37.45 84.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -23.0 55.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.883 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.493 ' CB ' HD23 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -66.22 -43.84 85.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.507 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 48.0 ttt85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.607 179.582 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.747 0.308 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.26 165.14 32.51 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.99 126.85 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -106.89 132.64 52.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.448 . . . . 0.0 111.657 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.811 HG12 ' CE2' ' A' ' 135' ' ' PHE . 2.1 t -106.78 124.78 62.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.224 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.6 p -122.32 140.88 52.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 111.823 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.53 ' CB ' HD21 ' A' ' 122' ' ' LEU . 26.5 t80 -155.25 131.04 9.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.7 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm 59.04 -100.24 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.082 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -129.56 14.09 5.98 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.54 ' CE ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -117.06 164.65 14.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 110.949 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -132.72 164.01 27.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.421 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.677 ' CE1' HG13 ' A' ' 118' ' ' VAL . 1.2 m-85 -142.89 146.22 33.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.847 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.035 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -122.66 136.28 54.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 111.259 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.97 HG21 HG22 ' A' ' 108' ' ' VAL . 5.6 mm -118.49 106.3 19.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.69 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.568 HG21 HD23 ' A' ' 40' ' ' LEU . 1.9 p -132.38 164.79 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.057 0.456 . . . . 0.0 111.506 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.509 ' CD2' ' CZ ' ' A' ' 36' ' ' PHE . 31.3 p-80 -81.46 152.12 27.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.074 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -62.8 154.54 74.99 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.978 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 51.2 Cg_exo -54.03 134.7 61.07 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.425 2.083 . . . . 0.0 113.068 -177.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -98.5 152.96 18.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.267 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.81 -11.41 60.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.53 -31.58 14.49 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -140.08 88.75 2.25 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.135 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.527 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -81.07 -52.38 7.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.184 0.516 . . . . 0.0 111.533 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.429 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.6 p -57.2 -46.78 82.57 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.635 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.2 m -57.82 -32.27 67.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.881 0.372 . . . . 0.0 111.255 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.687 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.67 -47.95 28.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.939 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.0 pt -55.93 -39.03 55.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.207 0.527 . . . . 0.0 110.623 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.83 -52.01 59.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.558 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.563 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 3.7 m-20 -68.88 -50.08 52.77 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.929 0.395 . . . . 0.0 111.832 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.687 HD21 ' CE1' ' A' ' 36' ' ' PHE . 53.5 mt -55.92 -45.21 78.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -26.77 48.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.027 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.563 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -53.32 -43.36 67.56 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.367 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.035 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.0 t80 -63.28 -38.65 92.0 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.689 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.647 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.68 -178.38 40.5 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.821 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.56 117.4 19.51 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.775 HG21 ' OG ' ' A' ' 101' ' ' SER . 1.3 m -165.18 -170.41 1.9 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.806 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.684 ' H ' HG22 ' A' ' 46' ' ' THR . 3.6 t -65.09 159.83 22.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.484 0.659 . . . . 0.0 110.617 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.792 HG13 ' O ' ' A' ' 104' ' ' ALA . 60.0 t -136.27 138.15 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.073 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.027 HG13 HG13 ' A' ' 105' ' ' VAL . 14.9 p -115.55 104.65 17.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.551 0.691 . . . . 0.0 111.211 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -115.13 110.79 20.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.251 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.815 HG13 ' HB3' ' A' ' 71' ' ' TRP . 12.9 t -106.62 91.84 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.366 0.603 . . . . 0.0 109.722 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.32 171.42 20.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.719 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -64.69 130.47 43.71 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.61 121.86 19.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -120.66 -47.38 2.32 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.133 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.429 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 9.0 m-85 -130.33 84.62 2.21 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.483 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -78.33 -36.05 46.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -48.55 14.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.615 HG22 ' CD ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -45.14 -49.99 28.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.153 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 34.2 Cg_exo -60.93 -40.67 50.82 Favored 'Trans proline' 0 N--CA 1.471 0.193 0 C-N-CA 122.646 2.23 . . . . 0.0 113.605 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.504 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -71.14 -45.05 64.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -49.13 20.18 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.939 ' HB3' HG21 ' A' ' 37' ' ' ILE . 11.4 mttm -76.16 -25.72 55.54 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.446 ' CG ' HD11 ' A' ' 66' ' ' ILE . 2.8 t0 -99.35 -11.48 21.16 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.42 26.85 2.61 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.278 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.446 HD11 ' CG ' ' A' ' 64' ' ' ASP . 4.2 pt -122.54 148.12 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.688 0.28 . . . . 0.0 110.737 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.53 HG23 ' HA ' ' A' ' 47' ' ' THR . 11.0 t -77.83 135.11 37.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.064 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.504 HG12 ' CD2' ' A' ' 61' ' ' LEU . 3.6 p -141.59 154.46 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.277 0.561 . . . . 0.0 111.733 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.404 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.7 t -103.68 131.28 52.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.145 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -100.8 106.81 18.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.201 0.524 . . . . 0.0 110.193 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.884 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.5 m95 -111.26 104.51 56.24 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.447 -1.239 0 C-N-CA 123.204 2.602 . . . . 0.0 112.344 -179.757 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.563 0.22 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.884 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 11.6 t -59.93 -48.23 88.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.529 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 1.1 t -53.52 -38.69 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.227 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.414 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.2 mt-10 -66.45 -31.19 71.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.355 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -63.35 -50.64 69.17 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.551 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.721 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -67.44 -32.64 73.64 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.89 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.788 HD21 ' HB3' ' A' ' 120' ' ' LEU . 13.5 mt -55.93 -48.02 76.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.607 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -41.34 95.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.487 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.435 ' C ' HD13 ' A' ' 90' ' ' LEU . 1.9 tm? -57.68 -51.59 68.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.875 HG21 ' HB1' ' A' ' 121' ' ' ALA . 13.2 p -74.75 -35.82 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.383 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -55.04 -40.95 70.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.963 0.411 . . . . 0.0 110.513 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.28 -46.75 39.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.227 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -62.3 -37.57 86.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.631 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.441 ' HE1' HG23 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -82.02 -33.49 30.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.763 0.316 . . . . 0.0 111.171 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.04 -46.04 58.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -76.1 -31.5 58.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.273 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -117.35 87.25 23.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.479 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.45 136.35 42.8 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.745 2.297 . . . . 0.0 112.168 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 20' ' ' MET . . . 58.12 58.23 15.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.662 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.775 ' OG ' HG21 ' A' ' 46' ' ' THR . 51.8 p -101.2 -169.98 1.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.808 0.337 . . . . 0.0 111.263 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.647 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -123.46 113.67 19.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.091 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.631 HG11 ' CE1' ' A' ' 22' ' ' PHE . 7.4 t -111.98 151.38 14.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.135 0.493 . . . . 0.0 112.323 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.792 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -118.93 145.34 45.85 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.422 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.027 HG13 HG13 ' A' ' 49' ' ' VAL . 7.6 t -140.3 167.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.708 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.605 ' O ' HG23 ' A' ' 24' ' ' ILE . 9.8 t60 -66.87 155.49 38.22 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.498 ' HB2' ' CA ' ' A' ' 26' ' ' HIS . 10.5 t -69.1 122.5 18.89 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.97 HG22 HG21 ' A' ' 24' ' ' ILE . 5.1 m -75.75 -0.2 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.475 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.95 -8.78 3.43 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.99 -156.38 6.8 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.5 mt -92.91 127.27 38.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.83 -169.38 16.61 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.223 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.637 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.22 -24.63 5.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.069 0.461 . . . . 0.0 111.407 -179.252 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -54.48 -43.07 97.5 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.669 ' HG3' HG12 ' A' ' 108' ' ' VAL . 58.4 Cg_exo -52.35 -48.38 22.07 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.844 1.696 . . . . 0.0 111.67 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 91.3 t -55.98 -51.14 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.701 HD12 ' CG2' ' A' ' 49' ' ' VAL . 8.5 mt -51.97 -45.3 64.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.137 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 114' ' ' ALA . 15.9 t -51.81 -53.18 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.951 0.405 . . . . 0.0 110.909 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.601 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -53.5 -43.27 68.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.177 0.513 . . . . 0.0 110.519 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.788 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -58.64 -30.83 67.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.529 179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.875 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.26 -40.38 71.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.115 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.54 HD11 ' CE ' ' A' ' 20' ' ' MET . 0.2 OUTLIER -71.59 -16.68 62.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.734 179.026 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 1.047 HD11 HD21 ' A' ' 152' ' ' LEU . 2.7 mt -57.31 -30.7 36.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.284 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -16.61 62.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.7 m -79.76 -23.34 42.28 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.43 -96.58 0.17 Allowed Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.946 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.528 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 6.1 ptt? -63.87 71.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.938 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.61 -67.37 0.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 6.0 t80 -65.88 -32.42 73.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.894 0.378 . . . . 0.0 111.139 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -72.55 -52.43 15.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.259 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 5.2 t0 -67.05 -36.75 82.74 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 110.486 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.622 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -61.07 -50.42 73.36 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.162 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.9 mm -73.43 -39.3 54.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.569 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -49.97 19.79 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.811 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.28 -37.35 80.59 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.581 -179.31 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.575 HD11 ' C ' ' A' ' 115' ' ' PRO . 0.6 OUTLIER -74.16 -28.72 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.736 0.303 . . . . 0.0 110.407 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -63.8 -44.92 91.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.399 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -45.1 93.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.668 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 136' ' ' ILE . 2.5 mptt -87.08 151.44 23.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.633 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.484 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.93 116.78 14.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 0.0 110.972 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.14 163.21 15.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.81 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.31 -179.99 0.18 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.307 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.09 99.4 4.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.62 0.71 . . . . 0.0 111.015 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.586 HD12 HD21 ' A' ' 149' ' ' LEU . 11.3 pt -88.22 109.53 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.763 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -112.95 -76.62 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.628 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.558 ' O ' HG22 ' A' ' 150' ' ' THR . 0.3 OUTLIER -99.91 -60.93 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.617 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.794 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.6 tmtt? -52.49 -51.81 57.6 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.453 ' OE1' HD22 ' A' ' 149' ' ' LEU . 1.3 tm0? -60.23 -51.75 68.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.586 HD21 HD12 ' A' ' 144' ' ' ILE . 3.5 mm? -73.03 -34.77 66.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 146' ' ' SER . 3.9 t -75.29 -40.77 58.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.082 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.794 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -64.03 -50.76 67.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.047 HD21 HD11 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -69.0 -33.82 74.28 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.932 -179.352 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.22 -38.03 78.95 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -25.43 55.35 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.551 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.58 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -66.43 -31.34 72.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.471 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.427 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.713 0.292 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.78 165.13 33.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.596 2.197 . . . . 0.0 112.265 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.4 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.7 t -137.51 126.99 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.776 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -114.37 128.95 56.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.993 0.425 . . . . 0.0 111.698 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.721 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.87 127.66 62.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.509 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.41 147.63 42.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.119 0.485 . . . . 0.0 111.786 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.547 ' HD2' HD21 ' A' ' 122' ' ' LEU . 26.4 t80 -155.15 117.93 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.642 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 29.2 mmtp 64.28 -95.77 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.408 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.39 13.99 6.07 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.969 ' HE1' HD21 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -121.67 169.05 11.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.754 0.311 . . . . 0.0 110.886 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -145.62 164.03 33.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 111.697 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.707 ' CE1' HG11 ' A' ' 103' ' ' VAL . 3.0 m-85 -134.29 148.9 50.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.561 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -122.48 135.77 54.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.21 0.529 . . . . 0.0 111.334 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.011 HD12 HG13 ' A' ' 108' ' ' VAL . 2.5 mm -118.17 106.58 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.223 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -132.54 165.34 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.286 0.565 . . . . 0.0 111.644 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.496 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 48.8 p-80 -81.1 152.08 28.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -62.83 154.04 77.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.514 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 10.0 Cg_endo -54.38 138.53 73.47 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.64 2.227 . . . . 0.0 113.439 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.441 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -98.93 174.24 6.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.249 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.8 -8.66 30.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.53 -30.67 14.88 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.6 p -139.36 89.62 2.35 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.109 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.441 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.18 -52.18 8.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.19 0.519 . . . . 0.0 111.22 178.387 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.448 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.6 p -57.8 -45.67 85.75 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.225 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.4 m -57.85 -32.13 67.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.747 0.308 . . . . 0.0 111.276 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.667 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.3 -47.89 25.75 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.148 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.723 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.6 pt -55.66 -39.03 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.179 0.514 . . . . 0.0 110.761 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.32 -51.83 53.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.543 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.559 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.1 m-20 -68.13 -50.12 56.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.838 0.351 . . . . 0.0 111.915 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.667 HD21 ' CE1' ' A' ' 36' ' ' PHE . 87.9 mt -55.8 -46.22 78.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.986 0.422 . . . . 0.0 110.42 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -77.05 -26.63 53.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.102 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -53.13 -44.48 67.77 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.532 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.066 ' CD1' HD21 ' A' ' 23' ' ' LEU . 10.9 t80 -63.56 -38.53 91.48 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.959 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.693 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.93 -178.35 39.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.006 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.53 117.4 19.53 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.831 HG21 ' OG ' ' A' ' 101' ' ' SER . 1.0 OUTLIER -165.19 -169.69 1.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.166 -0.924 . . . . 0.0 108.853 177.416 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.671 ' H ' HG22 ' A' ' 46' ' ' THR . 3.5 p -64.48 146.49 54.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.555 0.693 . . . . 0.0 110.544 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.057 HG22 ' HB3' ' A' ' 104' ' ' ALA . 59.5 t -125.38 132.72 70.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.565 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.822 HG12 HG22 ' A' ' 105' ' ' VAL . 12.9 p -115.41 105.52 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.372 0.606 . . . . 0.0 111.315 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 110.64 20.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.735 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 71' ' ' TRP . 23.0 t -104.08 90.44 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.635 0.731 . . . . 0.0 109.734 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -158.78 171.62 19.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.352 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 1.8 mm-40 -64.95 130.35 43.07 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.58 HG22 ' OD1' ' A' ' 70' ' ' ASP . 16.4 t -77.56 122.63 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 p -120.2 -47.87 2.35 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.169 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.8 83.45 2.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.363 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -79.36 -36.77 38.8 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -79.44 -48.65 13.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.408 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -43.95 -51.66 17.18 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.158 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.408 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 12.6 Cg_exo -71.51 -42.62 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.491 2.127 . . . . 0.0 113.973 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.477 HD11 ' O ' ' A' ' 66' ' ' ILE . 2.9 tp -71.44 -45.19 63.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -56.27 -46.47 79.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.723 ' HB3' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -81.21 -20.45 41.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.547 ' OD2' HG22 ' A' ' 37' ' ' ILE . 72.7 m-20 -101.0 -11.52 19.61 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 42.64 52.78 5.36 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.852 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.536 HD12 HG21 ' A' ' 48' ' ' VAL . 4.2 pt -133.01 148.53 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.733 0.302 . . . . 0.0 111.144 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' THR . 73.8 p -78.1 135.21 37.66 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 48' ' ' VAL . 11.2 p -141.75 149.54 19.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -103.55 130.22 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.58 ' OD1' HG22 ' A' ' 54' ' ' VAL . 4.4 t0 -100.72 106.88 18.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.161 0.505 . . . . 0.0 110.474 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.776 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.1 m95 -111.57 103.63 55.28 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.094 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 N--CA 1.447 -1.246 0 C-N-CA 123.64 2.893 . . . . 0.0 112.487 -179.445 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.395 0.14 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.766 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 26.1 t -56.12 -48.1 79.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.491 HG11 ' CE2' ' A' ' 151' ' ' TYR . 86.5 t -55.72 -39.22 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.216 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.508 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.6 mt-10 -59.26 -31.46 69.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.914 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -66.85 -50.84 61.27 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.619 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.714 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -68.23 -26.89 65.92 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.534 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.634 HD13 ' OH ' ' A' ' 155' ' ' TYR . 15.3 mt -63.88 -47.2 81.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.319 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -42.09 98.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.298 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -53.91 -51.37 63.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.795 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 121' ' ' ALA . 8.6 p -72.33 -41.73 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.488 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.419 ' N ' HG13 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -54.56 -38.92 67.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 0.0 110.992 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.42 53.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 3.6 mmtt -73.17 -20.53 60.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.909 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE1' HG23 ' A' ' 91' ' ' VAL . 1.9 m-85 -82.07 -40.71 21.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.9 t -69.1 -42.73 75.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -75.99 -31.19 58.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.106 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -121.68 90.78 48.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.327 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.27 137.38 18.92 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.606 2.204 . . . . 0.0 112.363 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 20' ' ' MET . . . 58.78 57.38 20.19 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.588 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.831 ' OG ' HG21 ' A' ' 46' ' ' THR . 51.5 p -101.22 -168.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.328 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.693 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -120.91 113.44 20.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.053 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.707 HG11 ' CE1' ' A' ' 22' ' ' PHE . 43.8 t -105.46 151.02 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 1.057 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -123.92 139.43 53.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.207 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.822 HG22 HG12 ' A' ' 49' ' ' VAL . 45.1 t -140.12 166.71 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.623 ' N ' HG12 ' A' ' 105' ' ' VAL . 1.2 t-80 -66.97 155.97 37.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.381 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 25' ' ' THR . 49.3 t -68.5 106.94 2.72 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.011 HG13 HD12 ' A' ' 24' ' ' ILE . 34.1 m -75.42 0.09 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.022 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.45 -8.72 2.9 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.37 -139.4 5.31 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.543 HD22 ' HA2' ' A' ' 142' ' ' GLY . 11.7 mt -117.93 127.34 53.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.19 -146.28 4.82 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.349 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.7 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.3 -20.94 5.99 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.018 0.437 . . . . 0.0 111.936 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.655 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -51.93 -46.29 92.56 Favored Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.785 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.4 Cg_endo -52.59 -48.65 20.82 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.223 1.948 . . . . 0.0 113.274 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.52 ' O ' HD23 ' A' ' 120' ' ' LEU . 39.4 t -62.25 -41.0 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.079 0.466 . . . . 0.0 110.127 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.477 HD22 ' CD1' ' A' ' 87' ' ' TRP . 6.4 mt -59.06 -41.11 87.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.81 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.77 HG22 HG21 ' A' ' 105' ' ' VAL . 17.6 t -64.15 -55.53 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.65 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -60.32 -53.07 61.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 110.903 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.793 HD13 HD12 ' A' ' 123' ' ' ILE . 3.1 mm? -55.25 -30.31 59.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.038 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.714 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.56 -50.62 24.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 110.614 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.969 HD21 ' HE1' ' A' ' 20' ' ' MET . 0.4 OUTLIER -65.27 -10.09 29.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.586 179.04 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 1.007 HG23 ' CB ' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -56.78 -34.26 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.687 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -62.28 -16.56 54.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.908 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.0 m -79.88 11.06 3.53 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 120.27 -98.8 0.71 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.251 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.49 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 1.1 ptt? -62.61 73.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.36 0.6 . . . . 0.0 109.469 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 1.007 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.9 -68.03 0.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.635 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.3 t80 -68.71 -32.68 72.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.946 0.403 . . . . 0.0 111.186 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.26 -49.44 34.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.479 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 39.2 t0 -70.04 -45.6 66.81 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.914 0.387 . . . . 0.0 111.294 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 152' ' ' LEU . . . -57.84 -49.72 75.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.649 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 33.5 mm -70.29 -40.81 78.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -74.28 -49.8 21.61 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.721 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -67.87 -35.19 78.1 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.937 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.4 tt -74.24 -32.79 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.707 0.289 . . . . 0.0 110.74 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -63.95 -43.05 97.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.714 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -44.69 93.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.46 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.42 ' CE ' HG13 ' A' ' 15' ' ' VAL . 6.7 mptt -86.21 151.84 23.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.256 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.26 117.11 14.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 110.63 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -114.82 163.66 15.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.543 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -57.71 -165.83 0.09 OUTLIER Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.42 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.26 99.22 11.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.589 0.695 . . . . 0.0 111.0 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.642 HD12 HD21 ' A' ' 149' ' ' LEU . 1.4 pt -88.45 109.44 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.809 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -113.14 -76.65 0.58 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -99.78 -60.74 1.47 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.864 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.0 tmtt? -52.83 -51.9 59.13 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.455 ' HG3' HG22 ' A' ' 144' ' ' ILE . 7.1 tm0? -56.59 -51.63 67.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.642 HD21 HD12 ' A' ' 144' ' ' ILE . 4.3 mm? -75.24 -40.94 58.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 m -69.95 -40.53 75.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.933 0.397 . . . . 0.0 111.1 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.864 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -65.46 -50.02 66.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.854 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -65.02 -38.03 89.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.919 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -55.77 -44.0 77.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -24.31 62.83 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.685 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.634 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -66.28 -32.62 74.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.731 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.039 -179.861 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.71 0.29 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.855 ' HB3' HG22 ' A' ' 25' ' ' THR . 57.2 Cg_endo -71.03 165.01 33.77 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.635 2.224 . . . . 0.0 112.443 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.742 HG11 ' HD3' ' A' ' 139' ' ' LYS . 19.5 t -144.02 127.44 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 10.3 pt-20 -110.07 116.73 32.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.816 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.6 OUTLIER -108.01 118.7 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.589 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.4 p -140.83 145.26 36.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.715 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -136.4 159.93 40.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.734 178.183 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.622 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 9.4 ptpt 48.64 -103.79 0.11 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -177.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -120.44 -26.68 5.34 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.141 -0.349 . . . . 0.0 111.643 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.752 ' CE ' HD13 ' A' ' 122' ' ' LEU . 5.6 ppp? -73.84 165.71 24.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.654 0.264 . . . . 0.0 111.316 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -147.6 164.05 34.71 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.088 0.471 . . . . 0.0 111.507 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.765 ' CE1' HG13 ' A' ' 118' ' ' VAL . 1.7 m-85 -137.89 146.5 43.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.058 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -119.36 133.61 55.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.988 0.423 . . . . 0.0 110.954 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.043 HD12 HG13 ' A' ' 108' ' ' VAL . 2.1 mm -118.17 106.68 20.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.404 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.855 HG22 ' HB3' ' A' ' 12' ' ' PRO . 60.4 p -131.61 165.52 23.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.283 0.563 . . . . 0.0 111.876 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.488 ' CD2' ' CE2' ' A' ' 36' ' ' PHE . 35.4 p-80 -81.25 152.44 27.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.728 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.42 154.38 72.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.442 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.7 Cg_exo -54.2 137.24 70.3 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.472 2.114 . . . . 0.0 113.264 -177.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.63 145.89 26.4 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.197 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -68.58 -11.13 59.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.26 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.5 -31.71 14.46 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -140.12 88.73 2.24 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.064 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.673 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.5 OUTLIER -81.01 -51.9 8.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.106 0.479 . . . . 0.0 111.515 178.193 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.451 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.9 m -55.77 -45.48 78.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.438 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -57.81 -36.14 71.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.408 . . . . 0.0 111.321 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.645 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -72.92 -47.91 41.58 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.634 HG22 ' OD2' ' A' ' 64' ' ' ASP . 12.1 pt -55.87 -40.06 60.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 110.882 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.67 -52.1 59.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.497 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.54 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.6 OUTLIER -67.62 -50.17 59.36 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.799 0.333 . . . . 0.0 111.807 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.645 HD21 ' CE1' ' A' ' 36' ' ' PHE . 62.9 mt -55.04 -46.29 75.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.614 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -26.77 52.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.2 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.1 mtmt -53.85 -42.33 68.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.382 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.058 ' CD1' HD21 ' A' ' 23' ' ' LEU . 16.8 t80 -63.3 -38.48 91.33 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.933 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.653 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.31 -178.59 40.2 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.885 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.64 117.43 19.49 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.656 HG22 ' H ' ' A' ' 47' ' ' THR . 1.0 OUTLIER -165.18 -170.03 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.732 177.378 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' THR . 2.5 t -64.58 160.46 19.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.367 0.603 . . . . 0.0 110.502 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 104' ' ' ALA . 57.5 t -138.4 135.74 44.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.226 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.872 HG12 HG22 ' A' ' 105' ' ' VAL . 14.6 p -115.62 104.68 17.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.474 0.654 . . . . 0.0 110.974 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 110.86 20.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.724 178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.835 HG11 ' HB2' ' A' ' 113' ' ' ARG . 25.0 t -108.0 91.6 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.592 0.71 . . . . 0.0 110.141 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.77 171.22 20.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.005 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.91 130.32 43.0 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.22 122.49 26.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -120.2 -47.67 2.36 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.227 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -130.63 83.8 2.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.535 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -78.95 -36.22 41.97 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.09 -48.55 14.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.673 HG21 ' HG ' ' A' ' 33' ' ' LEU . 2.0 m -45.71 -48.32 38.59 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.497 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 8.4 Cg_exo -73.19 -41.19 1.36 Allowed 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.613 2.209 . . . . 0.0 113.503 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.85 HD21 ' CG1' ' A' ' 68' ' ' VAL . 4.0 mm? -65.5 -45.27 84.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.34 -31.06 60.45 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.62 ' HB3' HG21 ' A' ' 37' ' ' ILE . 2.2 mmpt? -81.09 -34.22 32.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.634 ' OD2' HG22 ' A' ' 37' ' ' ILE . 17.2 m-20 -101.68 -11.53 19.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.54 27.75 3.15 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.294 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.574 ' CD1' HG21 ' A' ' 48' ' ' VAL . 1.1 pt -105.01 148.74 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.775 0.322 . . . . 0.0 111.072 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.7 OUTLIER -77.42 133.34 38.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.85 ' CG1' HD21 ' A' ' 61' ' ' LEU . 4.0 p -145.06 149.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.048 0.451 . . . . 0.0 111.796 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.584 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.0 t -103.07 128.96 55.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -100.94 106.71 18.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.097 0.475 . . . . 0.0 111.198 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.924 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 5.5 m0 -109.72 103.51 53.31 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.188 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo . . . . . 0 N--CA 1.445 -1.338 0 C-N-CA 123.498 2.798 . . . . 0.0 113.028 -178.86 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.348 0.118 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.924 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 35.4 t -55.38 -50.99 61.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 2.6 t -53.77 -43.4 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.307 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -56.34 -31.21 63.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.876 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.7 -50.4 62.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.757 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -65.14 -33.93 77.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.743 179.134 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.94 HD21 ' HB3' ' A' ' 120' ' ' LEU . 17.8 mt -57.87 -46.89 84.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.723 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.83 -42.21 99.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.28 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.463 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.3 tm? -59.05 -51.46 69.97 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.757 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.986 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.2 p -69.7 -35.86 67.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.075 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -56.94 -45.02 83.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.319 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.04 91.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.497 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.12 -24.1 61.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.229 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.585 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.1 m-85 -81.76 -51.86 7.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.793 0.33 . . . . 0.0 111.179 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.4 -40.51 97.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -76.07 -32.94 59.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.213 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -125.53 90.81 49.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.323 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.78 132.49 14.45 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.539 2.159 . . . . 0.0 112.375 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.5 56.3 25.81 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.584 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.632 ' HB2' HG21 ' A' ' 46' ' ' THR . 1.1 m -101.21 -164.77 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.816 0.341 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.653 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 m -117.88 113.54 21.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.684 HG11 ' CE1' ' A' ' 22' ' ' PHE . 38.5 t -110.03 149.73 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.148 0.499 . . . . 0.0 112.243 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.833 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -119.11 143.29 47.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.946 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.872 HG22 HG12 ' A' ' 49' ' ' VAL . 92.7 t -139.98 166.16 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.579 ' N ' HG12 ' A' ' 105' ' ' VAL . 1.3 t-80 -67.36 156.12 37.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.126 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 25' ' ' THR . 48.5 t -68.38 105.52 2.2 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.043 HG13 HD12 ' A' ' 24' ' ' ILE . 34.3 m -75.42 0.62 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.185 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HB3' ' SG ' ' A' ' 107' ' ' CYS . . . -60.07 -8.55 2.45 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.29 -129.24 3.46 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.0 mt -127.9 127.42 43.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.59 -150.45 6.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.273 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.835 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.47 -19.02 6.52 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.025 0.441 . . . . 0.0 111.775 -178.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.672 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.15 -46.39 97.79 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.741 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.1 Cg_endo -52.41 -48.15 23.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.179 1.919 . . . . 0.0 112.428 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.521 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 23.0 t -56.85 -52.04 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 110.341 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.719 HD12 ' CG2' ' A' ' 49' ' ' VAL . 8.0 mt -51.88 -48.79 63.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.889 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.765 HG13 ' CE1' ' A' ' 22' ' ' PHE . 17.4 t -54.01 -54.09 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.58 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.62 -42.79 64.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.039 0.447 . . . . 0.0 111.17 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.94 ' HB3' HD21 ' A' ' 88' ' ' LEU . 9.6 mt -64.12 -30.78 71.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.195 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.986 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -69.24 -38.25 78.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.211 0.529 . . . . 0.0 109.748 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.752 HD13 ' CE ' ' A' ' 20' ' ' MET . 6.0 tp -77.26 -15.97 59.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.204 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.933 HG23 ' CB ' ' A' ' 128' ' ' LYS . 1.7 mt -57.78 -31.74 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.816 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -16.53 63.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 122' ' ' LEU . 5.0 m -83.81 11.04 8.13 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 118.08 -99.99 0.83 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.193 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.481 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.9 ptt? -62.48 76.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.933 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.52 -67.51 0.55 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -177.09 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.571 ' CD1' HD22 ' A' ' 152' ' ' LEU . 7.5 t80 -67.52 -32.46 73.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.926 0.393 . . . . 0.0 111.102 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -52.1 18.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.152 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 29.5 t0 -68.7 -41.02 79.74 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.127 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.673 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -58.53 -49.03 78.89 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.288 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.3 mm -72.25 -40.19 65.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.804 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -74.35 -49.6 22.13 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.816 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.63 -37.25 84.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.711 0.291 . . . . 0.0 110.525 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.6 tt -74.17 -27.93 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 110.465 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.411 ' HG2' ' NH2' ' A' ' 141' ' ' ARG . 6.2 mtt180 -65.47 -46.28 80.4 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.629 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -45.07 93.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.61 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.742 ' HD3' HG11 ' A' ' 13' ' ' VAL . 3.9 mmpt? -86.76 151.97 22.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.196 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.14 116.8 14.11 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.46 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.411 ' NH2' ' HG2' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -114.81 163.79 15.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.133 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.92 -171.08 0.07 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.86 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.78 100.17 12.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.24 0.52 . . . . 0.0 111.349 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.711 HG22 ' OE1' ' A' ' 148' ' ' GLN . 0.2 OUTLIER -87.63 109.73 19.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.825 178.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -113.62 -76.8 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.6 p -99.9 -60.87 1.45 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.811 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 9.7 tmtt? -63.09 -49.81 73.01 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.711 ' OE1' HG22 ' A' ' 144' ' ' ILE . 0.4 OUTLIER -55.87 -52.42 64.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.424 HD21 HG13 ' A' ' 144' ' ' ILE . 3.9 mm? -75.38 -40.53 57.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.8 m -70.72 -33.8 71.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.805 0.336 . . . . 0.0 111.475 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.811 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -70.48 -50.69 35.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.057 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.895 HD21 HD11 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -64.6 -31.42 72.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.638 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -61.81 -38.68 89.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -26.5 66.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.118 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.491 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -66.04 -41.49 90.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.936 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.349 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.67 0.271 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.99 164.81 34.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.566 2.177 . . . . 0.0 112.314 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.403 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.5 t -144.14 126.84 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.2 pp20? -114.16 129.56 56.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.034 0.445 . . . . 0.0 111.844 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.788 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -108.2 120.34 59.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.866 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.01 158.1 21.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.156 0.503 . . . . 0.0 111.977 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.718 ' CD2' HD11 ' A' ' 122' ' ' LEU . 9.7 t80 -150.06 107.48 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.528 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 4.7 mmtp 62.9 -83.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.165 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -129.3 14.11 6.12 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.869 ' CE ' HD13 ' A' ' 122' ' ' LEU . 24.2 ttp -110.6 162.02 15.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.683 0.278 . . . . 0.0 110.969 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.5 mtt180 -148.53 134.9 19.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.093 0.473 . . . . 0.0 111.623 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.645 ' CE1' HG11 ' A' ' 103' ' ' VAL . 3.6 m-85 -115.34 151.35 34.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.729 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.058 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -124.45 135.93 53.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.113 0.482 . . . . 0.0 111.424 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.842 HD13 ' HB ' ' A' ' 105' ' ' VAL . 15.9 mm -118.34 106.54 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.654 HG21 HD23 ' A' ' 40' ' ' LEU . 2.2 p -129.84 163.47 26.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.358 0.599 . . . . 0.0 111.896 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.484 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 40.0 p-80 -81.16 152.58 27.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.933 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -62.41 154.6 71.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.968 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.452 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.5 Cg_exo -54.27 138.21 72.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.396 2.064 . . . . 0.0 113.433 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.7 p -98.54 145.49 26.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.217 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -68.47 -12.26 60.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.56 -31.25 14.6 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.3 p -139.81 88.99 2.28 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.172 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.432 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.6 OUTLIER -80.7 -52.3 7.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.175 0.512 . . . . 0.0 111.417 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.441 ' HA ' HG12 ' A' ' 37' ' ' ILE . 74.9 m -55.95 -45.64 78.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.59 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.2 m -57.65 -33.11 67.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.874 0.369 . . . . 0.0 111.314 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.677 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.52 -47.71 31.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.698 HD13 ' HB3' ' A' ' 63' ' ' LYS . 11.5 pt -55.81 -39.5 56.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.133 0.492 . . . . 0.0 110.63 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -65.12 -52.16 57.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.46 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.6 OUTLIER -67.68 -50.04 59.69 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 120.803 0.335 . . . . 0.0 111.831 -179.153 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.677 HD21 ' CE1' ' A' ' 36' ' ' PHE . 76.2 mt -54.95 -46.2 74.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.6 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -77.65 -26.82 50.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.05 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 5.9 mttt -52.4 -43.21 64.63 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.07 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.058 ' CD1' HD21 ' A' ' 23' ' ' LEU . 12.5 t80 -63.48 -38.49 91.36 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.585 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.699 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.96 -178.54 39.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.078 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.47 117.52 19.77 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.662 HG21 ' HB3' ' A' ' 101' ' ' SER . 0.7 OUTLIER -165.2 -169.67 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.973 177.673 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.64 ' H ' HG22 ' A' ' 46' ' ' THR . 7.8 t -64.37 156.81 28.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.463 0.649 . . . . 0.0 110.51 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.809 HG13 ' O ' ' A' ' 104' ' ' ALA . 66.5 t -136.78 134.29 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.135 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.941 HG13 HG13 ' A' ' 105' ' ' VAL . 13.1 p -115.66 105.07 17.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.393 0.616 . . . . 0.0 111.49 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.434 ' HD2' HG21 ' A' ' 68' ' ' VAL . 4.8 ptm180 -114.77 110.88 20.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.108 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 71' ' ' TRP . 14.6 t -105.25 91.62 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.468 0.651 . . . . 0.0 109.736 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.63 171.55 20.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.851 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.39 129.97 41.58 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -77.33 122.66 32.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.9 p -119.87 -47.73 2.39 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.063 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.413 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -130.57 83.45 2.12 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.398 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -79.44 -36.84 38.26 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.73 -48.54 13.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.558 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -47.02 -55.39 15.46 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.593 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 64.0 Cg_endo -73.37 -42.79 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.261 1.974 . . . . 0.0 114.204 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.687 ' CD2' HG11 ' A' ' 68' ' ' VAL . 27.1 mt -71.66 -45.36 62.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -66.24 -32.1 73.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.68 0.276 . . . . 0.0 111.565 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.698 ' HB3' HD13 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -81.23 -30.67 34.14 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.259 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.12 -11.46 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 45.52 67.2 1.31 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.804 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.1 mt -136.36 147.69 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.624 0.25 . . . . 0.0 110.84 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 47' ' ' THR . 70.9 p -78.07 128.02 33.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.687 HG11 ' CD2' ' A' ' 61' ' ' LEU . 8.3 p -145.23 151.73 14.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.091 0.472 . . . . 0.0 112.1 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.566 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.3 t -103.52 130.69 53.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -101.1 106.85 18.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.04 0.448 . . . . 0.0 111.143 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.804 ' HB3' HG13 ' A' ' 51' ' ' VAL . 5.7 m0 -110.89 103.96 55.44 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.367 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 N--CA 1.446 -1.277 0 C-N-CA 123.258 2.639 . . . . 0.0 112.841 -179.251 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.578 0.228 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.491 ' O ' ' HZ2' ' A' ' 71' ' ' TRP . 15.2 m -55.12 -43.03 68.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.079 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.721 HG22 ' CD1' ' A' ' 120' ' ' LEU . 0.8 OUTLIER -53.49 -41.08 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -64.96 -31.38 72.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.324 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -66.48 -50.34 63.61 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.826 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -66.87 -30.34 70.48 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.87 HD21 ' HB3' ' A' ' 120' ' ' LEU . 18.2 mt -61.05 -46.71 89.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.339 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -64.05 -40.08 95.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.31 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.506 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.7 tm? -59.67 -51.34 70.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.725 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.059 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.4 p -71.07 -35.92 60.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.066 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.52 -46.85 76.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.46 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.89 -43.41 83.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.66 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -69.13 -25.71 64.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.511 ' CD1' HG22 ' A' ' 91' ' ' VAL . 1.7 m-85 -76.58 -52.02 10.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.948 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.2 t -59.67 -39.8 85.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.13 -33.08 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.126 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.09 88.23 54.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.304 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.95 128.15 12.09 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.536 2.158 . . . . 0.0 112.194 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.51 57.48 19.35 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.321 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.662 ' HB3' HG21 ' A' ' 46' ' ' THR . 1.5 t -101.03 -163.08 0.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.616 0.246 . . . . 0.0 111.123 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.699 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 m -115.44 113.26 23.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.337 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.645 HG11 ' CE1' ' A' ' 22' ' ' PHE . 25.7 t -110.42 150.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 112.016 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.809 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -121.58 142.0 50.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.188 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.941 HG13 HG13 ' A' ' 49' ' ' VAL . 20.0 t -140.1 166.14 20.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.357 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 3.3 t60 -67.17 155.37 38.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.95 0.405 . . . . 0.0 110.81 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.5 ' N ' ' O ' ' A' ' 25' ' ' THR . 34.4 t -69.27 110.33 4.57 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.734 HG13 HD12 ' A' ' 24' ' ' ILE . 13.2 m -75.6 0.63 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.372 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.04 -8.66 2.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.35 -137.7 4.44 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.544 HD22 ' HA2' ' A' ' 142' ' ' GLY . 4.1 mt -111.49 127.13 55.6 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.69 -162.42 12.52 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 119.952 -1.118 . . . . 0.0 113.522 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.668 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.38 -19.88 6.29 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.08 0.467 . . . . 0.0 111.735 -178.79 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.802 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -53.43 -46.42 98.06 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 8.0 Cg_endo -52.69 -48.51 21.6 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.948 1.766 . . . . 0.0 112.359 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.599 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 89.4 t -55.87 -53.34 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.571 HD12 ' CG2' ' A' ' 49' ' ' VAL . 10.6 mt -52.28 -45.57 65.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.692 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 114' ' ' ALA . 13.8 t -51.42 -52.63 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 111.177 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.469 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -54.99 -45.6 75.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.025 0.441 . . . . 0.0 110.436 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.87 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.5 mt -55.16 -30.92 60.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.039 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 1.059 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.96 -49.19 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.869 HD13 ' CE ' ' A' ' 20' ' ' MET . 22.5 tp -67.08 -14.02 62.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.805 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 1.001 ' CD1' HD21 ' A' ' 152' ' ' LEU . 2.1 mt -57.74 -32.41 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.977 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -16.21 63.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.673 ' HB2' HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -79.75 -23.45 42.23 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 151.2 -96.46 0.17 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.899 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.534 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.17 73.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.917 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -72.07 -67.8 0.51 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -176.756 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 5.3 t80 -66.14 -34.58 78.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.931 0.396 . . . . 0.0 111.227 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.27 -52.75 14.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.414 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 25.8 t70 -70.78 -32.65 69.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.716 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -60.42 -49.98 75.4 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 32.1 mm -71.04 -41.18 76.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.576 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.86 -50.37 17.28 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.788 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.1 -35.82 81.54 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.704 0.287 . . . . 0.0 110.55 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.3 tt -74.24 -40.47 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.677 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 52.0 ttt-85 -58.6 -36.61 74.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.177 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -59.52 -45.55 91.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.819 0.343 . . . . 0.0 110.747 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.402 ' CG ' HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -87.78 151.28 23.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.61 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.48 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.73 116.71 14.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.842 0.353 . . . . 0.0 110.155 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.447 ' HD3' HG23 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -115.39 164.1 14.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.355 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.544 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -53.39 -172.8 0.05 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.586 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.18 9.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.62 0.71 . . . . 0.0 111.616 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.458 HD12 ' CD2' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -88.62 109.75 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.457 178.43 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.63 -76.55 0.59 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.67 -60.78 1.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.846 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.9 tmtt? -53.42 -51.74 61.64 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.496 ' HG3' HG22 ' A' ' 116' ' ' VAL . 1.1 tm0? -56.79 -51.98 66.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 149' ' ' LEU . 3.7 mm? -73.62 -41.31 62.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.9 m -69.74 -41.3 75.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.793 0.33 . . . . 0.0 111.265 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.846 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -62.84 -50.66 70.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.223 -179.487 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.001 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -67.19 -31.22 71.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.923 -179.401 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -39.56 90.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -23.1 55.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.91 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.591 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -66.4 -39.56 89.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.72 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.755 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.733 0.302 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HB3' HG23 ' A' ' 25' ' ' THR . 52.7 Cg_endo -69.37 165.27 31.09 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.651 2.234 . . . . 0.0 112.345 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 t -130.32 126.69 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.795 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.425 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -103.81 122.67 45.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.536 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.734 HG12 ' CE2' ' A' ' 135' ' ' PHE . 2.3 t -106.82 134.17 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.317 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 p -132.17 133.63 44.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.171 0.51 . . . . 0.0 112.16 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.655 ' HD2' HD11 ' A' ' 122' ' ' LEU . 41.2 t80 -155.13 141.98 19.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.371 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mmtt 61.97 -103.59 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.932 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -129.84 -1.62 4.75 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.605 ' HE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -113.34 168.43 9.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.038 0.447 . . . . 0.0 111.478 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -125.9 164.2 21.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.009 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.712 ' CE1' HG11 ' A' ' 103' ' ' VAL . 1.5 m-85 -136.65 137.44 40.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.339 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.062 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -114.88 132.8 56.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.002 0.429 . . . . 0.0 111.134 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.81 HG21 HG12 ' A' ' 108' ' ' VAL . 1.2 mm -115.85 106.35 20.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -135.33 167.1 21.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 111.921 -178.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.426 ' CA ' ' HB2' ' A' ' 107' ' ' CYS . 3.0 t-80 -81.09 151.53 28.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.689 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -63.42 154.84 77.63 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.83 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.44 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.7 Cg_exo -54.57 140.11 75.59 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.222 1.948 . . . . 0.0 112.954 -178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.465 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 67.8 p -98.61 174.27 6.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -92.52 -13.06 30.35 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.57 -31.04 14.68 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 p -139.72 89.56 2.33 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.49 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.465 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.3 OUTLIER -80.4 -52.19 7.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.106 0.479 . . . . 0.0 111.31 178.15 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.446 ' HA ' HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -55.97 -45.38 78.92 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.549 -178.637 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.7 -34.47 69.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.897 0.379 . . . . 0.0 111.354 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.637 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.17 -47.75 33.73 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.845 HG22 ' OD2' ' A' ' 64' ' ' ASP . 12.5 pt -55.54 -39.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.155 0.502 . . . . 0.0 110.605 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -65.43 -51.97 56.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.483 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.569 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 2.5 m-20 -68.35 -50.2 54.89 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.637 HD21 ' CE1' ' A' ' 36' ' ' PHE . 84.9 mt -55.69 -45.38 77.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.556 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -78.45 -26.63 46.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.102 0.477 . . . . 0.0 110.059 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.3 mttp -52.01 -43.98 63.91 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.283 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.062 ' CD1' HD21 ' A' ' 23' ' ' LEU . 20.2 t80 -63.31 -38.39 90.98 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.696 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.747 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 166.24 -178.83 40.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.928 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.17 19.23 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.825 HG21 ' OG ' ' A' ' 101' ' ' SER . 0.6 OUTLIER -165.22 -169.38 1.62 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.853 177.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.636 ' H ' HG22 ' A' ' 46' ' ' THR . 2.9 t -64.33 143.07 58.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.692 0.758 . . . . 0.0 110.557 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.789 HG13 ' HB3' ' A' ' 104' ' ' ALA . 25.4 t -122.23 132.12 71.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.113 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.057 HG13 HG13 ' A' ' 105' ' ' VAL . 9.8 p -115.47 105.25 18.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.181 0.515 . . . . 0.0 111.175 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 110.93 20.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.906 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.893 HG11 ' HB2' ' A' ' 113' ' ' ARG . 44.0 t -103.98 91.74 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.556 0.693 . . . . 0.0 110.493 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.6 t -157.79 171.19 20.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.733 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.74 130.2 42.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -72.36 122.0 23.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 p -120.57 -47.71 2.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.046 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.411 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -130.75 84.24 2.18 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.503 179.162 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -78.77 -36.51 42.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -79.5 -48.59 13.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.452 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -44.5 -49.7 24.91 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.416 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 9.6 Cg_exo -72.97 -42.46 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.702 2.268 . . . . 0.0 113.731 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.836 HD12 HG12 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -71.39 -45.21 63.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.653 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -70.54 -28.9 65.28 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.495 ' CB ' HG21 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -81.02 -34.72 32.65 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.332 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.845 ' OD2' HG22 ' A' ' 37' ' ' ILE . 44.0 m-20 -101.54 -11.37 19.33 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.56 41.56 49.69 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.423 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.757 ' CD1' HG21 ' A' ' 48' ' ' VAL . 1.1 pt -118.77 148.71 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 122.313 0.245 . . . . 0.0 111.047 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' THR . 21.9 p -77.39 135.03 38.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.836 HG12 HD12 ' A' ' 61' ' ' LEU . 7.4 p -144.98 149.68 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.073 0.463 . . . . 0.0 112.054 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.453 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.2 t -103.31 131.04 52.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.11 106.55 17.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 111.021 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.857 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.9 m95 -110.53 103.47 54.28 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.199 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 N--CA 1.444 -1.387 0 C-N-CA 123.469 2.779 . . . . 0.0 113.042 -178.73 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.428 0.156 . . . . 0.0 110.93 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.857 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 55.3 t -55.36 -47.98 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.717 HG11 ' HE2' ' A' ' 151' ' ' TYR . 88.0 t -56.13 -39.8 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.05 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.786 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.8 mt-10 -58.21 -31.25 67.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.481 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.87 -50.25 67.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.988 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.859 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -68.04 -26.79 66.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.531 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.896 HD21 ' HB3' ' A' ' 120' ' ' LEU . 25.9 mt -62.79 -41.44 99.26 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.159 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 t -67.78 -41.72 82.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.026 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.453 ' HG ' HG22 ' A' ' 69' ' ' VAL . 1.8 tm? -58.98 -51.23 70.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.779 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.762 HG21 ' HB1' ' A' ' 121' ' ' ALA . 7.8 p -71.81 -41.06 69.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.261 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -55.34 -38.49 68.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.936 0.398 . . . . 0.0 110.706 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.04 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.763 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -29.58 67.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.145 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.501 ' CE1' HG21 ' A' ' 103' ' ' VAL . 3.3 m-85 -76.78 -52.06 10.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.032 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.3 t -59.8 -36.95 77.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -31.87 59.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.06 94.4 41.59 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.287 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.13 129.09 16.61 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.425 2.083 . . . . 0.0 112.219 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.95 59.46 10.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.292 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.825 ' OG ' HG21 ' A' ' 46' ' ' THR . 83.5 p -101.2 -170.09 1.79 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.927 0.394 . . . . 0.0 111.442 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.747 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.6 m -113.03 113.61 25.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.308 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.712 HG11 ' CE1' ' A' ' 22' ' ' PHE . 76.0 t -104.23 149.98 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.789 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -122.52 140.58 52.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.787 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.057 HG13 HG13 ' A' ' 49' ' ' VAL . 2.2 t -140.6 166.74 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.688 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.1 t-80 -67.49 156.14 37.35 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.651 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.576 ' N ' ' O ' ' A' ' 25' ' ' THR . 50.4 t -68.41 102.44 1.42 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.381 0.61 . . . . 0.0 112.287 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.81 HG12 HG21 ' A' ' 24' ' ' ILE . 7.1 p -75.27 -0.02 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.025 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HB3' ' SG ' ' A' ' 107' ' ' CYS . . . -60.81 -8.68 3.21 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.452 ' O ' HD23 ' A' ' 111' ' ' LEU . . . -122.3 -134.06 4.39 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 110' ' ' GLY . 22.3 mt -125.29 127.58 46.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.2 -143.19 3.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.993 -1.099 . . . . 0.0 113.597 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.893 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.13 -19.37 6.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.968 0.413 . . . . 0.0 111.794 -178.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.701 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -50.62 -46.46 85.68 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.0 Cg_endo -51.98 -48.39 21.84 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.46 2.107 . . . . 0.0 112.869 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.595 ' O ' HD23 ' A' ' 120' ' ' LEU . 22.1 t -61.73 -38.51 80.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.932 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.455 HD12 ' CG2' ' A' ' 51' ' ' VAL . 6.8 mt -64.61 -49.1 72.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.527 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 1.017 HG22 HG11 ' A' ' 105' ' ' VAL . 12.5 t -54.59 -55.4 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.742 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -59.23 -49.4 78.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.214 0.531 . . . . 0.0 111.091 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.896 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.2 mm? -53.92 -30.66 47.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.859 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.24 -47.66 55.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.04 0.447 . . . . 0.0 110.085 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.655 HD11 ' HD2' ' A' ' 17' ' ' TYR . 14.4 tp -61.58 -16.99 53.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.746 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.903 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.9 mt -57.08 -30.81 35.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.494 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.402 ' OE2' ' CG ' ' A' ' 95' ' ' PHE . 3.3 pt-20 -68.14 -17.29 64.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.557 0.218 . . . . 0.0 111.456 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.7 t -84.75 11.04 9.83 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 104.02 -81.69 0.35 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.873 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 51.8 ttp -63.16 66.47 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.903 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -74.63 -67.91 0.59 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -176.239 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.6 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.1 t80 -71.59 -31.54 67.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.057 0.456 . . . . 0.0 110.806 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.404 ' HB2' ' HG3' ' A' ' 127' ' ' MET . 1.3 mt-10 -72.53 -47.32 49.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.311 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.687 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 10.8 t0 -70.09 -43.77 70.44 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 110.836 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.742 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -58.36 -50.04 75.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.879 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.0 mm -71.65 -42.38 71.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.904 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -49.33 27.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.734 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -68.62 -39.66 80.7 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.189 -0.204 . . . . 0.0 111.016 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.7 OUTLIER -72.62 -27.79 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.318 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -47.18 79.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.949 0.404 . . . . 0.0 110.034 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -45.13 93.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.667 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -86.5 152.54 22.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.346 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -72.83 117.07 14.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.004 0.43 . . . . 0.0 110.299 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.455 ' HA ' HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -114.82 163.29 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.158 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.461 ' H ' ' HG3' ' A' ' 115' ' ' PRO . . . -58.06 172.47 3.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.197 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.23 99.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.528 0.664 . . . . 0.0 110.447 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.834 HD12 HD21 ' A' ' 149' ' ' LEU . 2.2 pt -88.31 109.06 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.098 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -113.55 -76.88 0.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.562 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.06 -60.61 1.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.631 ' O ' ' CB ' ' A' ' 151' ' ' TYR . 0.8 OUTLIER -54.76 -51.93 64.14 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.295 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.493 ' HG3' HG22 ' A' ' 144' ' ' ILE . 1.1 tm0? -56.35 -51.87 66.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.834 HD21 HD12 ' A' ' 144' ' ' ILE . 3.4 mm? -75.22 -47.46 28.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.7 m -64.96 -34.82 79.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.733 0.301 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.717 ' HE2' HG11 ' A' ' 84' ' ' VAL . 6.9 t80 -68.2 -50.95 50.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.281 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.772 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -72.01 -32.76 67.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.525 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.59 -37.7 79.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -28.24 62.4 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.642 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.556 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -65.88 -34.34 77.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.679 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.763 0.316 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.29 163.43 39.15 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.526 2.151 . . . . 0.0 112.297 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.05 126.83 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -108.5 126.25 52.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.523 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.786 HG12 ' CE2' ' A' ' 135' ' ' PHE . 2.4 t -106.65 129.79 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 p -132.87 139.25 47.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.222 0.534 . . . . 0.0 112.136 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 18' ' ' LYS . 10.8 t80 -155.12 129.17 8.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.104 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 2.0 mmmp? 63.46 -92.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.198 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.42 -39.06 1.52 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.455 ' HE1' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -73.77 151.66 40.56 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 111.273 -179.398 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.62 164.24 21.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.067 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.665 ' CE1' HG11 ' A' ' 103' ' ' VAL . 2.0 m-85 -136.76 139.16 41.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.646 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.078 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -117.77 138.5 52.01 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.118 0.485 . . . . 0.0 111.343 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.772 HG21 HG12 ' A' ' 108' ' ' VAL . 2.6 mm -118.22 106.64 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.211 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -131.05 164.29 25.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.476 0.655 . . . . 0.0 112.451 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 107' ' ' CYS . 46.3 p-80 -81.74 152.55 26.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.248 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -62.48 154.44 72.75 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.2 Cg_exo -54.85 139.03 78.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.391 2.061 . . . . 0.0 113.601 -177.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.7 p -98.97 145.94 26.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.977 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -71.3 -10.12 59.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.83 14.74 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 p -139.59 89.43 2.32 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.382 -0.527 . . . . 0.0 112.244 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.38 -52.25 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.177 0.513 . . . . 0.0 111.23 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.457 ' HA ' HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -56.7 -45.19 81.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.321 -178.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.5 m -57.69 -31.91 66.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.739 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.22 -47.56 27.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.142 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.732 HD13 ' HB3' ' A' ' 63' ' ' LYS . 11.3 pt -55.44 -38.39 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.227 0.537 . . . . 0.0 110.334 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.43 -51.75 58.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.374 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.547 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.2 m-20 -68.8 -50.29 51.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.918 0.389 . . . . 0.0 111.953 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.739 HD21 ' CE1' ' A' ' 36' ' ' PHE . 83.6 mt -56.89 -44.45 82.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.993 0.425 . . . . 0.0 110.303 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -77.19 -26.65 53.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.886 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 2.1 mtmt -52.79 -47.52 67.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.306 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.078 ' CD1' HD21 ' A' ' 23' ' ' LEU . 11.6 t80 -63.63 -38.5 91.37 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.656 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.671 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 160.03 -177.44 36.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.041 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.62 122.93 28.34 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.833 HG22 ' H ' ' A' ' 47' ' ' THR . 3.8 m -164.52 -171.2 2.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.46 177.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.833 ' H ' HG22 ' A' ' 46' ' ' THR . 1.8 t -65.33 149.63 49.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.329 0.585 . . . . 0.0 109.862 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.037 HG22 ' HB3' ' A' ' 104' ' ' ALA . 74.4 t -126.64 135.18 64.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.882 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.032 HG13 HG13 ' A' ' 105' ' ' VAL . 9.3 p -115.46 104.91 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.111 0.482 . . . . 0.0 111.27 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -114.74 111.01 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.399 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.796 HG13 ' HB3' ' A' ' 71' ' ' TRP . 8.1 t -103.71 90.39 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.451 0.643 . . . . 0.0 109.303 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -158.63 171.87 19.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.953 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -65.06 130.62 44.02 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 m -81.07 122.32 36.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.6 p -120.15 -47.52 2.37 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.663 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.419 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -130.33 83.86 2.16 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.581 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -79.4 -36.6 38.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.65 -48.58 13.48 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.454 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.22 -56.65 10.21 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 65.4 Cg_endo -73.17 -42.35 1.0 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.493 2.129 . . . . 0.0 114.182 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.737 HD21 HG11 ' A' ' 68' ' ' VAL . 28.9 mt -71.19 -45.21 63.89 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.3 -30.83 70.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.817 0.341 . . . . 0.0 111.422 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.732 ' HB3' HD13 ' A' ' 37' ' ' ILE . 13.3 mttm -81.37 -32.67 32.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 66' ' ' ILE . 18.1 p30 -101.23 -11.35 19.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 61' ' ' LEU . . . 48.11 31.29 8.25 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.284 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 64' ' ' ASP . 5.6 mt -97.42 147.53 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.679 0.276 . . . . 0.0 110.974 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' THR . 50.1 p -78.41 131.14 36.82 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.737 HG11 HD21 ' A' ' 61' ' ' LEU . 9.1 p -145.36 152.24 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.63 132.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -100.57 106.79 18.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 109.947 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.861 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 3.4 m95 -111.72 104.07 55.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.677 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 N--CA 1.447 -1.216 0 C-N-CA 123.573 2.849 . . . . 0.0 112.344 -179.909 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.561 0.22 . . . . 0.0 110.763 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.861 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 41.4 t -56.79 -48.3 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.737 HG11 ' HE2' ' A' ' 151' ' ' TYR . 90.3 t -55.34 -37.47 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.986 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.838 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.8 mt-10 -60.42 -31.32 70.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.429 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.91 -50.17 69.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.245 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.731 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.56 -27.42 67.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.612 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.838 HD12 ' HA ' ' A' ' 85' ' ' GLU . 37.1 mt -64.49 -38.16 90.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.095 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -69.03 -41.42 77.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.803 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -59.53 -51.32 70.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.381 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.562 HG21 ' HB1' ' A' ' 121' ' ' ALA . 8.5 p -71.74 -35.9 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.909 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -56.23 -47.19 78.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.502 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.31 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.636 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 1.7 mmtp -68.0 -24.28 65.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.077 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.548 ' HE1' HG21 ' A' ' 103' ' ' VAL . 2.4 m-85 -82.09 -52.04 7.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.167 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.3 t -63.93 -39.87 95.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.992 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.11 -31.72 58.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.226 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -124.15 89.1 52.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.52 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.64 135.07 14.19 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.594 2.196 . . . . 0.0 112.236 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 20' ' ' MET . . . 64.95 46.23 89.94 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.468 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 t -101.04 -176.59 3.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.66 0.267 . . . . 0.0 111.118 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.671 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 2.2 m -111.98 114.05 26.71 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.665 HG11 ' CE1' ' A' ' 22' ' ' PHE . 28.0 t -101.94 151.28 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 1.037 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.05 141.74 51.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.146 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.032 HG13 HG13 ' A' ' 49' ' ' VAL . 2.5 t -140.68 166.95 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.78 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.0 OUTLIER -67.38 156.51 36.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.639 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -68.01 98.79 0.79 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.375 0.607 . . . . 0.0 112.469 -178.042 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.772 HG12 HG21 ' A' ' 24' ' ' ILE . 7.5 p -75.41 -0.08 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.96 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.66 -8.76 3.13 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.03 -124.71 2.96 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 143' ' ' ALA . 13.1 mt -129.11 127.39 41.36 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.86 -144.41 4.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.807 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.481 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.14 -20.56 6.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.033 0.444 . . . . 0.0 111.931 -178.487 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.78 ' HB2' ' HB3' ' A' ' 106' ' ' HIS . . . -52.11 -44.94 93.63 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 6.4 Cg_endo -51.62 -48.3 22.05 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.524 2.149 . . . . 0.0 113.165 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 ' CG ' ' A' ' 148' ' ' GLN . 62.1 t -62.48 -46.45 96.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.02 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 49' ' ' VAL . 13.4 mt -58.85 -41.89 88.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.973 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.856 ' CG2' HG11 ' A' ' 105' ' ' VAL . 54.0 t -61.63 -55.44 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.609 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -58.09 -52.51 65.24 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.157 0.504 . . . . 0.0 111.032 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.738 ' HB3' HD21 ' A' ' 88' ' ' LEU . 4.3 mm? -53.82 -30.82 46.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.668 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.731 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.26 -42.38 65.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.078 0.466 . . . . 0.0 110.115 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.455 ' CD1' ' HE1' ' A' ' 20' ' ' MET . 3.4 tp -67.51 -14.04 62.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.928 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.4 mt -57.25 -30.77 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.031 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.28 -16.87 63.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.6 m -83.93 11.2 8.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.19 -101.58 1.06 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.211 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.484 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.7 ptt? -62.49 77.78 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.928 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.65 -67.59 0.54 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.655 ' CD1' HD22 ' A' ' 152' ' ' LEU . 4.1 t80 -66.26 -33.77 76.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.926 0.393 . . . . 0.0 111.187 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.26 -51.67 19.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.294 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 30.0 t0 -70.03 -36.25 74.92 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.841 0.353 . . . . 0.0 111.029 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -61.31 -50.16 74.09 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.654 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.9 mm -74.31 -37.61 45.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.531 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -74.24 -49.68 22.27 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.786 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.24 -35.84 76.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.473 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.3 tt -74.0 -27.91 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 0.0 110.227 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -65.14 -52.31 55.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.539 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.86 -45.17 93.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.633 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 136' ' ' ILE . 7.3 mmtt -81.54 152.22 27.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.253 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.83 117.21 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.344 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.423 ' HA ' ' CG2' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -114.64 163.39 15.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.12 -179.649 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.484 ' H ' ' HG3' ' A' ' 115' ' ' PRO . . . -60.15 -163.35 0.14 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.276 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.457 ' N ' HD22 ' A' ' 111' ' ' LEU . . . -90.1 99.28 12.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.427 0.614 . . . . 0.0 110.633 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.603 HG22 ' HG3' ' A' ' 148' ' ' GLN . 6.8 pt -88.35 109.26 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.119 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.67 -76.98 0.58 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.605 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.23 -60.69 1.48 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.641 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.6 tmtt? -57.35 -51.89 67.59 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.765 ' CG ' HG22 ' A' ' 116' ' ' VAL . 4.3 tm0? -56.14 -52.09 65.61 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 149' ' ' LEU . 3.4 mm? -75.27 -45.55 39.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 56.3 m -66.44 -33.47 75.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.807 0.336 . . . . 0.0 111.147 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.737 ' HE2' HG11 ' A' ' 84' ' ' VAL . 2.2 t80 -68.68 -50.93 47.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.735 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -70.25 -34.26 72.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.407 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -36.44 76.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -26.26 60.55 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.71 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.728 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -65.93 -37.58 86.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.451 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.614 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.534 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.81 0.338 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.588 ' HB3' HG22 ' A' ' 25' ' ' THR . 54.6 Cg_endo -69.83 163.67 37.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.577 2.185 . . . . 0.0 112.306 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.461 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.4 t -144.26 129.26 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.964 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -111.34 116.6 31.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.868 0.366 . . . . 0.0 111.269 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.804 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -109.05 118.29 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' A' ' 21' ' ' ARG . 70.3 p -141.24 142.46 33.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.616 ' CD2' ' HE1' ' A' ' 127' ' ' MET . 1.2 p90 -136.61 164.48 28.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.413 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.584 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 pttp 50.09 -95.99 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.202 0.201 . . . . 0.0 110.973 -177.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.491 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 t-160 -128.92 -32.36 2.09 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.859 ' HE1' HD11 ' A' ' 122' ' ' LEU . 3.8 ppp? -73.65 168.05 20.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.645 0.259 . . . . 0.0 111.329 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HA ' ' CB ' ' A' ' 16' ' ' SER . 3.4 mtp180 -146.05 161.54 39.9 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.012 0.434 . . . . 0.0 111.752 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.86 ' CD2' HG13 ' A' ' 118' ' ' VAL . 0.9 OUTLIER -135.05 148.78 49.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.555 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.08 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -120.28 135.96 54.83 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.106 0.479 . . . . 0.0 111.206 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.918 HD12 HG13 ' A' ' 108' ' ' VAL . 2.2 mm -117.98 106.66 20.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.25 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 12' ' ' PRO . 1.3 p -132.62 164.44 26.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.197 0.523 . . . . 0.0 111.819 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.463 ' CD2' ' CZ ' ' A' ' 36' ' ' PHE . 45.4 p-80 -81.31 152.17 27.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.738 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -62.71 154.42 74.65 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.492 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.9 Cg_exo -54.61 140.58 75.86 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.296 1.997 . . . . 0.0 113.2 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.462 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.5 p -98.69 174.38 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.129 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -94.26 -11.4 30.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.66 -30.75 14.76 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.0 p -139.5 89.61 2.34 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.45 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.604 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -80.27 -52.22 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.19 0.519 . . . . 0.0 111.173 178.212 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.438 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.8 p -56.86 -45.05 82.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.308 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.1 m -57.92 -32.82 68.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.828 0.347 . . . . 0.0 111.288 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.749 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.8 -47.92 28.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.146 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.825 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.1 pt -55.7 -38.93 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.233 0.54 . . . . 0.0 110.655 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -51.9 57.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.46 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.554 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -68.7 -50.29 52.07 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.749 HD21 ' CE1' ' A' ' 36' ' ' PHE . 72.4 mt -56.47 -43.64 79.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.437 . . . . 0.0 110.392 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -78.6 -26.73 45.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.077 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 3.7 mttt -53.25 -44.6 68.28 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.374 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.08 ' CD1' HD21 ' A' ' 23' ' ' LEU . 16.5 t80 -63.52 -38.56 91.6 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.949 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.663 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.32 -178.47 39.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.951 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.64 117.67 19.84 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.652 HG22 ' H ' ' A' ' 47' ' ' THR . 0.8 OUTLIER -164.88 -170.16 1.89 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.966 177.324 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.652 ' H ' HG22 ' A' ' 46' ' ' THR . 16.8 p -64.94 155.11 35.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.474 0.654 . . . . 0.0 110.788 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.054 HG22 ' HB3' ' A' ' 104' ' ' ALA . 65.6 t -134.0 139.1 49.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.04 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.022 HG13 HG13 ' A' ' 105' ' ' VAL . 3.3 p -115.77 105.37 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.164 0.507 . . . . 0.0 110.936 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.23 110.92 20.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.22 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.82 HG13 ' HB3' ' A' ' 71' ' ' TRP . 10.8 t -105.62 91.38 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.331 0.586 . . . . 0.0 109.914 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 10.4 p -158.01 171.28 20.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.948 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.64 130.48 43.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.59 121.75 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 p -120.77 -47.63 2.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.212 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.426 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.7 m-85 -130.43 84.29 2.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.488 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -78.61 -36.24 44.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -79.1 -48.49 14.24 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.63 HG22 ' HD2' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -44.56 -49.88 24.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.426 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 17.2 Cg_exo -68.08 -42.1 6.5 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.574 2.183 . . . . 0.0 113.427 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.737 HD21 HG12 ' A' ' 68' ' ' VAL . 1.4 mm? -66.19 -45.43 80.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.61 -41.08 55.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.825 ' HB3' HG21 ' A' ' 37' ' ' ILE . 18.1 mttt -80.92 -27.51 36.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HB3' ' CG1' ' A' ' 66' ' ' ILE . 2.7 t0 -101.15 -11.49 19.53 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.45 29.5 1.16 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.522 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.434 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 2.4 pt -117.56 148.06 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.714 0.293 . . . . 0.0 110.982 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' THR . 24.6 p -77.77 135.15 37.96 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.737 HG12 HD21 ' A' ' 61' ' ' LEU . 9.4 p -143.87 154.91 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.46 134.18 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -100.82 106.77 18.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.241 0.544 . . . . 0.0 110.319 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.82 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.1 m95 -111.96 104.35 55.97 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.091 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.446 -1.292 0 C-N-CA 123.225 2.617 . . . . 0.0 112.275 -179.725 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.392 0.139 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.429 ' HB ' ' CH2' ' A' ' 71' ' ' TRP . 0.0 OUTLIER -55.01 -46.86 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.847 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' A' ' 151' ' ' TYR . 79.7 t -55.02 -43.13 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.268 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.64 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.3 mt-10 -56.27 -31.28 63.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.802 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.94 -50.54 62.02 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.827 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -68.63 -26.96 65.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.816 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.828 HD21 ' HB3' ' A' ' 120' ' ' LEU . 18.8 mt -61.34 -50.98 70.74 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.117 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 m -60.53 -41.09 93.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.12 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.503 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.9 tm? -56.84 -51.12 70.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.725 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.803 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.3 p -70.67 -36.66 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.383 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 3.2 tmtt? -64.87 -41.37 95.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 110.71 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.07 -48.07 77.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.36 -26.79 62.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.743 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 3.6 m-30 -82.01 -33.91 29.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.885 0.374 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 16.0 t -72.24 -39.44 68.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.067 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -76.16 -33.07 59.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.535 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.56 137.33 26.89 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.679 0.276 . . . . 0.0 111.486 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.58 -166.75 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.547 2.165 . . . . 0.0 112.046 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 20' ' ' MET . . . -46.76 96.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.727 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.528 ' HB3' HG21 ' A' ' 46' ' ' THR . 0.2 OUTLIER -101.1 -160.72 0.81 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.726 0.298 . . . . 0.0 111.017 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.663 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -116.09 113.48 23.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.86 0.362 . . . . 0.0 111.266 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.743 HG21 ' HZ ' ' A' ' 95' ' ' PHE . 25.1 t -106.84 151.18 8.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.229 0.538 . . . . 0.0 112.147 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 1.054 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -123.17 139.87 53.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.986 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.022 HG13 HG13 ' A' ' 49' ' ' VAL . 5.4 t -140.09 166.8 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 0.7 OUTLIER -66.9 156.1 36.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.391 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.519 ' HA ' HG23 ' A' ' 24' ' ' ILE . 25.5 t -68.3 105.61 2.2 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.918 HG13 HD12 ' A' ' 24' ' ' ILE . 35.2 m -75.47 0.25 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.099 178.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.66 -8.77 3.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.53 -135.81 4.39 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.432 HD22 ' HA2' ' A' ' 142' ' ' GLY . 12.8 mt -120.51 127.29 52.05 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.2 -144.03 3.93 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.822 -1.18 . . . . 0.0 113.671 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.567 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.19 -25.63 4.84 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.925 0.393 . . . . 0.0 112.005 -178.457 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.748 ' HB2' ' HB3' ' A' ' 106' ' ' HIS . . . -50.94 -46.36 87.71 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.825 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.1 Cg_endo -52.26 -48.44 21.73 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.29 1.993 . . . . 0.0 112.964 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.836 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.6 t -61.01 -46.74 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.097 0.475 . . . . 0.0 110.105 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 49' ' ' VAL . 14.4 mt -59.37 -40.2 85.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.743 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.86 HG13 ' CD2' ' A' ' 22' ' ' PHE . 47.9 t -59.96 -55.65 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.613 0.244 . . . . 0.0 111.629 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.589 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -57.7 -47.13 83.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.609 0.719 . . . . 0.0 110.23 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.836 HD23 ' O ' ' A' ' 116' ' ' VAL . 4.5 mm? -54.52 -30.26 53.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.667 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.827 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -70.32 -47.47 60.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 110.164 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.859 HD11 ' HE1' ' A' ' 20' ' ' MET . 3.7 mp -63.61 -16.01 59.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.698 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.919 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.3 mt -57.06 -30.92 35.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.401 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 2.4 pt-20 -73.58 -16.58 61.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.405 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.3 m -85.18 11.03 10.68 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 117.51 -102.65 1.01 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.182 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.616 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 3.6 ptt? -62.42 79.56 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.919 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.85 -67.77 0.54 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -176.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.663 ' CD1' HD22 ' A' ' 152' ' ' LEU . 6.3 t80 -66.81 -32.03 73.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.0 111.054 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.46 -52.05 17.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.685 ' OD2' HD23 ' A' ' 122' ' ' LEU . 29.9 t0 -69.24 -36.21 76.93 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.589 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -61.25 -50.26 73.76 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.812 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.4 mm -74.35 -37.62 45.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.551 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -74.07 -49.71 22.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.804 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.07 -34.98 73.88 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.666 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.19 -27.86 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.327 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.18 -48.19 68.7 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.52 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.79 -45.23 92.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.594 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' ILE . 73.7 mmtt -85.51 152.01 23.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.114 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.23 116.81 14.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.055 0.455 . . . . 0.0 110.62 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.503 ' HG3' HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -115.12 163.57 15.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.86 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.432 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -57.57 -169.16 0.14 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.496 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.51 99.63 11.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.391 0.596 . . . . 0.0 110.762 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.519 HG22 ' HG3' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -88.05 109.4 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.989 179.189 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -113.16 -76.32 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.4 t -99.75 -60.51 1.52 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.904 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.0 OUTLIER -57.65 -52.65 64.57 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.761 ' HG3' HG22 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -56.88 -51.68 68.12 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.05 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 149' ' ' LEU . 3.6 mm? -73.26 -42.55 62.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.2 m -71.76 -40.76 69.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.785 0.326 . . . . 0.0 111.486 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.904 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -63.75 -50.29 69.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.409 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.8 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -67.5 -34.07 76.38 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.645 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -55.95 -44.96 78.93 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -27.97 63.63 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.728 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.61 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.9 OUTLIER -66.73 -25.98 66.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.891 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.673 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.447 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.673 0.273 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 59.7 Cg_endo -72.02 163.55 38.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.613 2.209 . . . . 0.0 112.344 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -144.09 126.84 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.9 pt-20 -102.93 118.5 36.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.364 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.705 HG12 ' CE2' ' A' ' 135' ' ' PHE . 18.4 t -106.74 118.53 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.814 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 p -141.24 149.3 41.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.889 0.376 . . . . 0.0 111.957 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.692 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -149.57 120.22 7.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.157 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.514 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 40.4 mmtt 84.4 -87.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.262 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -129.41 -38.51 1.55 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.74 ' CE ' HD13 ' A' ' 122' ' ' LEU . 4.8 ppp? -73.54 163.8 27.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 111.473 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -145.67 164.05 32.95 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.067 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.782 ' CE1' HG11 ' A' ' 103' ' ' VAL . 3.0 m-85 -135.67 155.37 50.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.38 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.058 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -125.27 124.75 42.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.315 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.866 HD13 HG23 ' A' ' 105' ' ' VAL . 2.0 mm -106.37 106.85 21.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.541 HG21 HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -130.71 165.66 22.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.463 0.649 . . . . 0.0 112.546 -178.407 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.484 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 45.6 p-80 -81.61 152.64 27.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.907 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.3 154.35 71.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.449 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.4 Cg_exo -54.96 138.36 77.92 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.482 2.121 . . . . 0.0 113.527 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.0 p -98.85 139.57 34.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.929 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.65 -10.27 34.57 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.49 -31.14 14.69 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.4 p -139.85 89.04 2.28 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.238 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.75 -52.2 7.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.005 0.431 . . . . 0.0 111.485 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.575 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -55.92 -38.68 70.6 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.187 -178.79 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -33.71 76.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.913 0.387 . . . . 0.0 111.035 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.674 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -76.12 -48.03 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.205 -179.16 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.821 HG21 ' CB ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -57.36 -37.18 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.092 0.473 . . . . 0.0 110.458 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -52.14 51.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.189 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.2 m-20 -67.94 -50.06 58.15 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.811 0.339 . . . . 0.0 111.688 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.674 HD21 ' CE1' ' A' ' 36' ' ' PHE . 31.9 mt -56.17 -39.52 72.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.013 0.435 . . . . 0.0 110.418 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -26.74 34.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.085 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -55.11 -43.0 73.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.181 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.058 ' CD1' HD21 ' A' ' 23' ' ' LEU . 13.5 t80 -63.58 -38.42 91.04 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.621 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.7 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.69 -178.52 39.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.912 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.57 117.93 20.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.726 HG22 ' H ' ' A' ' 47' ' ' THR . 1.4 m -164.71 -170.66 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.045 177.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.726 ' H ' HG22 ' A' ' 46' ' ' THR . 4.6 t -65.18 158.7 25.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.338 0.59 . . . . 0.0 110.718 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.042 HG22 ' HB3' ' A' ' 104' ' ' ALA . 63.1 t -136.39 136.55 48.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.927 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.003 HG12 HG12 ' A' ' 105' ' ' VAL . 14.8 p -115.87 104.73 17.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.364 0.602 . . . . 0.0 111.288 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -114.58 110.94 20.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.046 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.8 HG13 ' HB3' ' A' ' 71' ' ' TRP . 15.5 t -107.18 91.46 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 121.29 0.567 . . . . 0.0 109.798 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 m -157.81 171.28 20.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.865 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.406 ' CD ' ' N ' ' A' ' 53' ' ' GLU . 2.2 mm-40 -65.26 130.51 43.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' A' ' 70' ' ' ASP . 18.4 t -76.01 122.27 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -120.2 -47.69 2.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.309 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.6 83.54 2.13 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.522 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.43 -36.74 38.47 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -48.54 13.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -45.84 -54.14 17.63 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 8.3 Cg_exo -73.11 -41.97 1.14 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.645 2.23 . . . . 0.0 113.575 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.065 HD21 HG11 ' A' ' 68' ' ' VAL . 1.3 mm? -63.68 -45.34 90.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -75.27 -28.65 59.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.821 ' CB ' HG21 ' A' ' 37' ' ' ILE . 34.7 mttm -76.41 -37.78 56.58 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.735 ' HB3' HG22 ' A' ' 37' ' ' ILE . 56.3 p30 -101.74 -11.98 18.71 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.88 24.75 6.53 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.017 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 64' ' ' ASP . 9.2 mt -94.47 147.68 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.638 0.256 . . . . 0.0 110.975 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 47' ' ' THR . 23.0 p -78.21 129.21 34.83 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.065 HG11 HD21 ' A' ' 61' ' ' LEU . 8.5 p -145.08 153.04 14.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 111.977 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.463 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.3 t -103.56 131.36 52.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -101.09 106.85 18.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.147 0.499 . . . . 0.0 110.849 -178.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.909 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.9 m95 -110.74 103.83 55.11 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.445 -1.339 0 C-N-CA 123.395 2.73 . . . . 0.0 112.605 -179.396 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 tttt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.599 0.238 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.909 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 14.9 t -55.19 -42.93 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.597 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 0.4 OUTLIER -53.24 -42.31 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.301 178.327 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 88' ' ' LEU . 22.2 mm-40 -62.8 -31.47 72.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.164 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.39 -50.6 69.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.63 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.807 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.2 OUTLIER -66.42 -28.87 68.96 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.872 179.249 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.958 HD21 ' HB3' ' A' ' 120' ' ' LEU . 33.0 mt -62.68 -44.0 97.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.641 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.1 m -66.52 -38.35 86.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.392 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.401 ' HG ' HG22 ' A' ' 69' ' ' VAL . 1.4 tm? -61.9 -51.47 68.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.988 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.032 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.3 p -74.36 -37.69 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.353 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -44.21 89.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.387 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.78 -43.77 78.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.523 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -69.93 -23.91 63.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -81.76 -52.07 7.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.068 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.5 t -59.51 -37.6 78.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.94 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.99 -33.09 59.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.97 93.2 44.39 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.36 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.89 133.95 20.86 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.504 2.136 . . . . 0.0 112.251 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 59.35 10.97 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.432 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.423 ' HB2' HG21 ' A' ' 46' ' ' THR . 4.4 m -101.1 -163.7 1.04 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.7 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -121.01 113.56 20.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.251 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.782 HG11 ' CE1' ' A' ' 22' ' ' PHE . 44.6 t -105.97 150.23 8.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 1.042 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.22 135.14 54.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.361 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.003 HG12 HG12 ' A' ' 49' ' ' VAL . 34.0 m -140.68 167.81 17.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.741 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.5 t60 -66.87 155.75 37.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.115 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.571 ' HA ' HG23 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -68.46 109.11 3.54 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.396 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.8 HG13 ' CD1' ' A' ' 24' ' ' ILE . 18.7 m -75.79 0.26 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.2 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.48 -8.58 2.84 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.78 -143.37 5.69 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.493 HD22 ' HA2' ' A' ' 142' ' ' GLY . 7.1 mt -115.05 127.27 55.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.99 -144.85 4.23 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.981 -1.104 . . . . 0.0 113.408 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.483 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.4 -17.11 7.15 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.799 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -55.18 -47.03 99.51 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.763 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.6 Cg_endo -52.49 -48.19 23.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.31 2.006 . . . . 0.0 112.773 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.749 HG12 HD11 ' A' ' 120' ' ' LEU . 22.0 t -60.06 -54.15 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.702 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.812 HD12 ' CG2' ' A' ' 49' ' ' VAL . 2.4 mt -52.26 -51.23 59.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.969 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.874 HG22 HG11 ' A' ' 105' ' ' VAL . 21.9 t -52.08 -55.19 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' A' ' 136' ' ' ILE . . . -53.19 -50.18 65.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.333 0.587 . . . . 0.0 111.053 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.958 ' HB3' HD21 ' A' ' 88' ' ' LEU . 13.5 mt -54.38 -30.55 52.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.977 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 1.032 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.94 -39.79 69.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.034 0.445 . . . . 0.0 110.004 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.74 HD13 ' CE ' ' A' ' 20' ' ' MET . 3.4 tp -69.45 -15.54 63.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.636 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.943 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.4 mt -57.12 -30.6 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.886 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -17.0 64.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.0 m -79.79 -23.41 42.17 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.11 -95.79 0.17 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.749 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.492 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 2.7 ptt? -63.84 71.85 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.943 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.37 -67.52 0.44 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.871 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.557 ' CD1' HD22 ' A' ' 152' ' ' LEU . 8.0 t80 -65.69 -33.24 75.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.948 0.404 . . . . 0.0 111.068 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.52 -52.34 16.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.219 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.623 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.2 t0 -69.99 -35.91 74.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.857 0.36 . . . . 0.0 110.864 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.649 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -61.36 -50.04 74.5 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.605 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 28.1 mm -74.53 -37.32 43.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.49 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -49.87 21.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.705 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.76 -36.96 79.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.668 0.27 . . . . 0.0 110.485 -179.528 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.6 tt -74.18 -27.85 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.488 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 4.4 ttt-85 -66.63 -45.79 77.89 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.465 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -45.01 93.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 110.434 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.477 ' HE2' HG22 ' A' ' 15' ' ' VAL . 6.2 mptt -86.18 152.12 23.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.107 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 116.57 13.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.11 0.481 . . . . 0.0 110.531 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.13 163.82 15.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.135 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.493 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -55.64 -170.4 0.09 OUTLIER Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.689 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.93 100.0 12.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.258 0.529 . . . . 0.0 111.303 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.847 HD12 HD21 ' A' ' 149' ' ' LEU . 14.5 pt -87.75 109.54 19.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.571 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.32 -76.71 0.58 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.0 t -99.65 -60.95 1.43 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.858 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 8.9 tmtt? -62.55 -50.8 69.9 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.544 ' CG ' HG22 ' A' ' 144' ' ' ILE . 0.6 OUTLIER -55.61 -51.76 66.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.031 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.847 HD21 HD12 ' A' ' 144' ' ' ILE . 4.2 mm? -73.58 -45.34 53.83 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.2 m -67.42 -37.4 82.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.754 0.311 . . . . 0.0 111.559 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.858 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.67 -50.31 65.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.147 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -63.85 -34.68 78.49 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.477 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -57.24 -45.22 84.14 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -22.79 62.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.658 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.677 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -66.5 -36.21 82.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.923 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.671 0.272 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.02 162.63 40.45 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.518 2.146 . . . . 0.0 112.368 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.406 HG11 ' HG3' ' A' ' 139' ' ' LYS . 17.5 t -144.2 126.81 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.739 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 mp0 -110.51 129.8 55.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.396 . . . . 0.0 111.503 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.852 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.61 118.89 55.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.95 153.07 29.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.529 . . . . 0.0 112.206 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.514 ' CD2' HD11 ' A' ' 122' ' ' LEU . 18.5 t80 -155.16 112.71 3.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.11 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 9.8 mmtm 65.88 -82.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.27 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -129.26 -42.59 1.34 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.864 ' CE ' HD13 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -73.8 149.53 41.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.945 0.402 . . . . 0.0 111.154 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.02 164.19 26.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.528 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.473 ' C ' HD22 ' A' ' 23' ' ' LEU . 12.2 m-85 -127.59 155.58 43.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.269 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.061 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -125.6 135.88 52.67 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.128 0.489 . . . . 0.0 111.205 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.87 HD13 ' HB ' ' A' ' 105' ' ' VAL . 21.3 mm -118.23 106.42 19.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.275 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -132.27 163.14 29.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.233 0.539 . . . . 0.0 111.824 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.471 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 42.9 p-80 -81.29 152.41 27.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.026 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -62.52 154.54 72.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 50.6 Cg_exo -54.38 136.53 69.5 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.369 2.046 . . . . 0.0 113.279 -177.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -98.75 146.57 25.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.041 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -69.39 -10.32 57.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.256 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -31.24 14.61 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 p -139.85 88.97 2.27 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.127 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.79 -52.22 7.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 111.396 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.454 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.9 t -56.11 -46.94 78.96 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.596 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -57.67 -32.09 66.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.89 0.376 . . . . 0.0 111.195 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.734 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.15 -47.6 27.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.165 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.868 HG22 ' OD2' ' A' ' 64' ' ' ASP . 12.1 pt -55.54 -38.78 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.158 0.504 . . . . 0.0 110.573 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -65.74 -51.75 56.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.511 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 9.4 m-20 -68.52 -50.25 53.53 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.734 HD21 ' CE1' ' A' ' 36' ' ' PHE . 75.2 mt -56.45 -44.98 81.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.417 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -77.43 -26.54 51.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.997 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 4.2 mttt -53.12 -46.17 68.64 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.416 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.061 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.1 t80 -63.61 -38.52 91.43 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.809 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.69 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.87 -179.31 38.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.01 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.58 117.79 20.07 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 47' ' ' THR . 1.3 m -164.78 -170.29 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.857 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.704 ' H ' HG22 ' A' ' 46' ' ' THR . 2.9 t -64.85 154.02 38.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.43 0.633 . . . . 0.0 110.707 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.05 HG22 ' HB3' ' A' ' 104' ' ' ALA . 57.8 t -131.42 135.39 59.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.992 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.91 HG13 HG13 ' A' ' 105' ' ' VAL . 11.7 p -115.6 105.06 17.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.273 0.559 . . . . 0.0 111.1 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.08 110.79 20.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.69 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.8 HG13 ' HB3' ' A' ' 71' ' ' TRP . 14.5 t -102.26 90.97 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.1 171.59 19.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.737 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -67.1 129.9 41.39 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -78.43 122.53 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.09 -47.65 2.37 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.448 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.476 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 0.4 OUTLIER -130.63 83.63 2.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.611 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.574 ' O ' HD13 ' A' ' 61' ' ' LEU . 2.8 p30 -78.91 -35.73 43.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -78.26 -48.11 16.43 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -40.88 -60.04 1.83 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.24 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 59' ' ' THR . 33.3 Cg_endo -65.16 -42.43 13.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.436 2.091 . . . . 0.0 113.837 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.065 HD11 HG11 ' A' ' 68' ' ' VAL . 5.4 mp -71.37 -28.98 64.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.04 -44.6 46.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.759 ' CB ' HG21 ' A' ' 37' ' ' ILE . 1.6 mttp -81.18 -28.36 35.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.845 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.868 ' OD2' HG22 ' A' ' 37' ' ' ILE . 40.4 m-20 -101.48 -11.61 19.19 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.05 32.44 1.51 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.34 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.454 HG12 ' CB ' ' A' ' 64' ' ' ASP . 1.3 pt -102.56 148.22 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 0.0 111.303 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.2 OUTLIER -78.02 135.36 37.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.065 HG11 HD11 ' A' ' 61' ' ' LEU . 11.3 p -145.02 152.03 14.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.117 0.484 . . . . 0.0 111.919 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.23 132.05 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -100.66 106.76 18.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.289 0.566 . . . . 0.0 110.31 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.972 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.5 m95 -112.88 104.64 55.94 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.794 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.448 -1.2 0 C-N-CA 123.096 2.531 . . . . 0.0 112.707 -179.479 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.683 0.278 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.972 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 39.4 t -60.27 -46.49 94.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.519 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 1.2 t -53.47 -38.69 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 88' ' ' LEU . 14.7 mm-40 -65.29 -31.5 72.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.993 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.95 -50.5 70.54 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.332 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.819 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -66.84 -30.29 70.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.199 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.86 HD21 ' HB3' ' A' ' 120' ' ' LEU . 16.3 mt -60.64 -48.03 83.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.558 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -62.81 -42.16 99.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.172 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -55.08 -51.19 67.14 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.558 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.999 HG21 ' HB1' ' A' ' 121' ' ' ALA . 7.1 p -71.4 -35.94 59.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.047 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 1.7 tmtt? -55.85 -45.36 78.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.903 0.382 . . . . 0.0 110.543 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.67 -41.18 75.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.977 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.673 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.92 -30.61 69.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.363 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' ' OE2' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -82.13 -37.21 26.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.99 -46.1 58.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.873 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -76.26 -33.02 59.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -115.52 89.87 23.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.08 129.23 11.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.607 2.205 . . . . 0.0 112.228 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.37 56.15 25.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.451 ' HB3' HG21 ' A' ' 46' ' ' THR . 0.4 OUTLIER -101.13 -164.75 1.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 111.066 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.69 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -124.76 113.53 18.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.33 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 42.0 t -104.45 150.5 7.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 1.05 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -123.46 135.9 54.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.098 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.926 HG21 HG22 ' A' ' 118' ' ' VAL . 8.0 t -134.05 166.42 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -177.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.74 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 0.8 OUTLIER -67.45 155.72 38.34 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.862 0.363 . . . . 0.0 110.873 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 25' ' ' THR . 42.2 t -69.07 106.08 2.66 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.829 HG12 ' HD3' ' A' ' 115' ' ' PRO . 2.6 m -75.88 0.57 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.3 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.05 -8.65 2.49 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.69 -140.8 5.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mt -106.56 127.08 53.04 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.65 -158.82 10.21 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.423 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.541 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.62 -14.35 7.77 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.375 -0.413 . . . . 0.0 111.861 -178.546 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.856 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -58.06 -46.93 99.65 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.829 ' HD3' HG12 ' A' ' 108' ' ' VAL . 9.5 Cg_endo -52.52 -48.49 21.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.131 1.888 . . . . 0.0 112.381 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.826 HG21 ' NE2' ' A' ' 148' ' ' GLN . 87.0 t -58.65 -52.44 59.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.232 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 51' ' ' VAL . 9.4 mt -51.9 -49.08 63.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.732 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.926 HG22 HG21 ' A' ' 105' ' ' VAL . 85.7 t -51.46 -49.68 31.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.914 0.388 . . . . 0.0 110.638 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.699 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -54.65 -47.85 73.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.672 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.86 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.6 mt -55.03 -31.63 61.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.87 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.999 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.24 -51.68 19.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.219 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.864 HD13 ' CE ' ' A' ' 20' ' ' MET . 5.8 tp -68.31 -13.98 62.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.581 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 1.071 HD11 HD21 ' A' ' 152' ' ' LEU . 1.1 mt -58.15 -36.38 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.157 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.403 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 4.5 pt-20 -63.03 -16.04 58.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.626 ' HB2' HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -79.77 11.17 3.39 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 116.89 -95.44 0.67 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.79 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.493 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 4.8 ptt? -62.67 75.48 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.946 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -71.76 -67.59 0.52 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 9.8 t80 -68.65 -32.19 71.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.977 0.418 . . . . 0.0 111.165 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.45 -50.56 25.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.301 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.0 t0 -70.09 -40.05 75.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.772 0.32 . . . . 0.0 111.363 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.7 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -61.89 -48.51 80.16 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.005 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 34.6 mm -73.06 -41.23 59.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.494 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -74.73 -50.12 18.58 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.852 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -67.99 -39.75 83.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.594 0.235 . . . . 0.0 110.812 -179.222 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.2 tp -74.54 -28.61 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.774 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 5.8 ttm-85 -64.53 -41.68 96.22 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -41.6 90.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.016 0.436 . . . . 0.0 110.061 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.494 ' HE2' HG13 ' A' ' 15' ' ' VAL . 5.6 mptt -87.17 151.85 22.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.102 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 116.73 14.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 110.607 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.474 ' HD2' HG23 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -114.97 163.5 15.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.209 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -57.06 -166.64 0.07 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.715 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.19 100.0 12.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.298 0.549 . . . . 0.0 111.599 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.945 HD12 ' CD2' ' A' ' 149' ' ' LEU . 12.5 pt -87.87 109.46 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.476 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -113.2 -76.64 0.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.9 t -99.8 -61.1 1.41 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.793 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 10.0 tmtt? -65.78 -49.87 66.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -176.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.826 ' NE2' HG21 ' A' ' 116' ' ' VAL . 2.0 mm100 -56.33 -52.04 66.02 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.945 ' CD2' HD12 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -72.86 -46.6 52.02 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.528 -179.639 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 81.2 m -62.61 -39.16 92.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.23 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.793 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -62.34 -50.56 71.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.761 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.071 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -62.01 -37.1 83.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.501 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -57.08 -37.95 72.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -22.74 58.81 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.646 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.544 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.19 -34.08 77.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.993 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.374 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.657 0.265 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.662 ' HB3' HG22 ' A' ' 25' ' ' THR . 56.4 Cg_endo -70.58 162.47 42.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.496 2.131 . . . . 0.0 112.272 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.522 HG11 ' HD2' ' A' ' 139' ' ' LYS . 24.6 t -144.13 127.04 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.805 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.17 116.67 31.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.836 0.35 . . . . 0.0 111.46 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.803 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -109.66 118.45 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.1 p -140.96 142.69 34.31 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.59 ' HE1' HD11 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -137.37 162.08 34.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.162 178.291 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 3.0 pttp 48.92 -100.65 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.014 0.126 . . . . 0.0 110.76 -177.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.452 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -124.35 -25.68 4.05 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.157 -0.34 . . . . 0.0 111.908 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.728 ' HE3' HD13 ' A' ' 122' ' ' LEU . 5.1 ppp? -74.01 165.91 24.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 111.464 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -143.5 156.74 44.71 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.282 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.721 ' CE1' HG11 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -137.42 138.39 39.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.299 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.06 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -115.09 135.53 54.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.051 0.453 . . . . 0.0 111.359 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.816 HD12 HG13 ' A' ' 108' ' ' VAL . 1.9 mm -118.23 106.61 20.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 12' ' ' PRO . 1.4 p -131.01 166.55 20.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.606 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.536 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 5.9 p80 -81.25 152.0 27.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.731 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -62.64 153.71 77.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.1 Cg_exo -54.94 142.37 76.0 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.476 2.118 . . . . 0.0 113.291 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.483 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 6.4 p -98.7 174.35 6.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.158 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.95 -12.35 26.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.54 -30.83 14.8 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -139.51 89.77 2.36 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.452 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.23 -52.2 8.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.055 0.455 . . . . 0.0 111.16 178.23 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.456 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.0 m -55.96 -43.51 77.57 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.358 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 m -58.04 -37.38 74.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.878 0.37 . . . . 0.0 111.257 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.674 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.21 -48.13 53.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.933 HG21 ' HB3' ' A' ' 63' ' ' LYS . 13.7 pt -55.94 -39.63 58.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.183 0.516 . . . . 0.0 110.79 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -62.85 -52.01 64.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.336 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -69.84 -50.28 44.3 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.884 0.374 . . . . 0.0 111.774 -179.272 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.674 HD21 ' CE1' ' A' ' 36' ' ' PHE . 48.5 mt -56.27 -43.68 79.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.046 0.451 . . . . 0.0 110.265 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -78.6 -26.83 45.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.098 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -53.0 -43.81 66.75 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.151 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.06 ' CD1' HD21 ' A' ' 23' ' ' LEU . 13.5 t80 -63.35 -38.52 91.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.671 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.735 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.21 -179.92 39.45 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.803 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.44 117.07 19.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.927 HG21 ' OG ' ' A' ' 101' ' ' SER . 0.4 OUTLIER -165.42 -169.12 1.51 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.94 177.869 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.709 ' HA ' HG23 ' A' ' 67' ' ' THR . 9.8 t -64.05 154.0 35.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.676 0.75 . . . . 0.0 110.578 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 104' ' ' ALA . 60.3 t -134.2 137.57 51.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.453 -178.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.02 HG13 HG13 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -115.56 105.18 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.067 0.461 . . . . 0.0 110.445 178.687 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -113.6 111.0 21.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.637 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.885 HG11 ' HB2' ' A' ' 113' ' ' ARG . 44.0 t -107.9 92.09 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.642 0.734 . . . . 0.0 110.59 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.42 171.15 20.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.453 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.62 130.2 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.612 HG13 ' HB3' ' A' ' 72' ' ' PRO . 9.3 m -68.89 121.91 19.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.61 -47.65 2.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.82 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.414 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.8 m-85 -130.74 84.36 2.19 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.213 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -78.55 -35.92 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -78.93 -48.52 14.41 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.88 HG22 ' HD3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -44.53 -50.92 22.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.223 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 32.3 Cg_exo -59.25 -40.37 69.39 Favored 'Trans proline' 0 N--CA 1.471 0.196 0 C-N-CA 122.622 2.215 . . . . 0.0 113.653 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.766 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -71.09 -45.02 64.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.614 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -75.2 -49.31 19.83 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.933 ' HB3' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -64.7 -35.53 81.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.405 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.911 ' OD2' HG22 ' A' ' 37' ' ' ILE . 49.1 m-20 -101.22 -11.45 19.5 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.09 24.81 9.49 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.789 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.464 HG12 ' CB ' ' A' ' 64' ' ' ASP . 16.2 pt -110.78 148.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.763 HG21 ' HD2' ' A' ' 94' ' ' LYS . 6.7 t -77.7 135.1 38.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.075 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.766 HG12 ' CD2' ' A' ' 61' ' ' LEU . 7.4 p -145.21 151.91 14.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.052 0.453 . . . . 0.0 111.649 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.608 HG22 ' HG ' ' A' ' 90' ' ' LEU . 3.6 t -103.5 133.33 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.97 106.64 17.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.156 0.503 . . . . 0.0 110.478 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.736 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.3 m95 -110.03 103.24 53.16 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.63 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HB3' HG13 ' A' ' 54' ' ' VAL . 24.8 Cg_endo . . . . . 0 N--CA 1.446 -1.32 0 C-N-CA 123.547 2.831 . . . . 0.0 112.82 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.398 0.142 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.714 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 16.1 t -56.33 -48.46 79.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.897 HG11 HD22 ' A' ' 120' ' ' LEU . 71.4 t -54.19 -40.99 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.092 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.751 ' HA ' HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -57.84 -31.47 66.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.456 178.338 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -50.32 70.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.274 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.616 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.08 -33.2 75.24 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.554 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.858 HD21 ' HB3' ' A' ' 120' ' ' LEU . 11.1 mt -55.94 -47.75 76.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.4 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -63.0 -39.89 96.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.083 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.608 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.8 tm? -61.56 -51.17 69.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.94 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.73 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.7 p -68.79 -42.49 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.639 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.438 ' N ' HG13 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -53.87 -47.39 71.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 111.038 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -48.08 76.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.826 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.763 ' HD2' HG21 ' A' ' 67' ' ' THR . 21.3 mmtt -66.12 -26.54 67.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.018 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 103' ' ' VAL . 2.4 m-85 -79.27 -51.92 8.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.969 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 t -56.89 -33.71 67.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.047 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.0 -33.06 59.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.046 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.25 84.02 62.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.52 128.23 26.49 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.601 2.201 . . . . 0.0 112.101 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.37 59.8 10.08 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.282 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.927 ' OG ' HG21 ' A' ' 46' ' ' THR . 84.9 p -101.1 -171.26 1.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.308 . . . . 0.0 111.425 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.735 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.1 m -106.21 113.77 27.49 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.324 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.721 HG11 ' CE1' ' A' ' 22' ' ' PHE . 44.5 t -111.26 150.86 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -122.45 142.5 50.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.069 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.02 HG13 HG13 ' A' ' 49' ' ' VAL . 3.2 t -140.09 167.08 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.727 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.7 t-80 -67.2 155.61 38.37 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.7 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' THR . 26.9 p -68.86 105.18 2.27 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.32 0.581 . . . . 0.0 112.433 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.844 HG12 ' HD3' ' A' ' 115' ' ' PRO . 26.6 m -75.22 0.02 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.919 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.65 -8.79 3.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.419 ' O ' HD23 ' A' ' 111' ' ' LEU . . . -123.74 -134.87 4.39 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.48 ' HA ' ' HA2' ' A' ' 142' ' ' GLY . 7.3 mt -118.83 127.46 53.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.41 -153.97 7.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.63 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.885 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.3 -20.2 6.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.114 0.483 . . . . 0.0 111.669 -178.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.661 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.81 -46.29 86.9 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.844 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.6 Cg_endo -52.01 -48.5 21.3 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.157 1.905 . . . . 0.0 113.078 -178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.614 ' O ' HD13 ' A' ' 120' ' ' LEU . 11.7 t -60.95 -39.99 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.693 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.503 HD12 ' CG2' ' A' ' 49' ' ' VAL . 9.7 mt -59.5 -55.0 40.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.633 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.854 ' CG2' HG11 ' A' ' 105' ' ' VAL . 55.6 t -52.01 -55.21 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.725 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -52.85 -53.22 51.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.009 0.433 . . . . 0.0 111.31 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.897 HD22 HG11 ' A' ' 84' ' ' VAL . 7.7 mp -54.92 -30.18 57.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.98 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.73 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.27 -47.72 48.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.886 0.374 . . . . 0.0 110.403 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.728 HD13 ' HE3' ' A' ' 20' ' ' MET . 12.6 tp -65.1 -13.06 57.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.816 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.928 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.1 mt -57.05 -36.37 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.311 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.425 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -63.22 -16.79 61.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.7 m -80.03 7.45 9.05 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 114.39 -99.09 0.92 Allowed Glycine 0 N--CA 1.46 0.246 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.922 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.571 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 3.6 ptt? -62.56 75.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.928 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -73.4 -67.86 0.55 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -176.6 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.666 ' CD1' HD22 ' A' ' 152' ' ' LEU . 4.4 t80 -66.72 -32.86 74.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.949 0.404 . . . . 0.0 111.162 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.17 -51.86 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.208 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 25.8 t0 -70.12 -40.39 74.9 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.918 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.725 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -58.01 -49.17 77.75 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.315 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.7 mm -69.7 -42.56 80.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -49.76 21.84 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.803 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.27 -34.29 77.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 110.724 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.7 tt -74.27 -33.34 34.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.974 0.416 . . . . 0.0 110.49 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -40.76 96.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.087 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.58 -45.29 92.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.984 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.522 ' HD2' HG11 ' A' ' 13' ' ' VAL . 68.5 mmtt -87.33 151.65 22.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.419 ' C ' ' HD2' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -73.31 117.25 14.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.896 0.379 . . . . 0.0 110.419 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.467 ' HG2' ' CG1' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -115.36 163.43 15.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.691 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -55.45 -176.05 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.346 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.54 98.81 3.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.692 0.746 . . . . 0.0 110.716 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.457 HG21 ' HG3' ' A' ' 148' ' ' GLN . 1.3 pp -88.67 109.24 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -113.22 -76.59 0.58 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.214 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.757 ' O ' HG22 ' A' ' 150' ' ' THR . 36.5 m -99.77 -60.62 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.643 ' O ' ' CB ' ' A' ' 151' ' ' TYR . 1.2 tmtt? -48.66 -51.43 28.42 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.457 ' HG3' HG21 ' A' ' 144' ' ' ILE . 1.9 tm0? -55.77 -52.08 65.17 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.576 ' N ' HD22 ' A' ' 149' ' ' LEU . 3.2 mm? -75.66 -45.29 37.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 146' ' ' SER . 6.5 t -67.78 -34.37 76.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.361 . . . . 0.0 111.34 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.643 ' CB ' ' O ' ' A' ' 147' ' ' LYS . 1.3 t80 -68.17 -50.8 52.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.3 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.825 HD21 HD11 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -71.25 -38.92 71.91 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.519 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -36.48 68.0 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -26.35 59.92 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.465 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.631 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -65.82 -29.46 69.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.205 179.595 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.882 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -96.31 -51.36 4.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.26 35.86 1.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.83 143.17 50.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.59 156.35 39.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.142 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.53 178.27 7.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 60.74 157.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.57 96.66 3.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.602 HH21 HG21 ' A' ' 29' ' ' THR . 11.3 mtt85 -79.45 147.88 69.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.01 137.12 62.05 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.547 2.164 . . . . 0.0 112.339 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.86 143.6 54.07 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.021 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 61.0 Cg_endo -72.99 162.48 40.88 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.505 2.137 . . . . 0.0 112.355 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.433 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.1 t -144.16 126.89 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 pm0 -108.94 121.31 44.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.94 0.4 . . . . 0.0 111.652 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.763 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -106.8 118.66 54.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.7 p -140.63 140.01 34.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.135 0.493 . . . . 0.0 112.156 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CD2' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -138.98 139.4 37.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.746 178.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 11.1 mmmt 65.93 -88.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.295 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -129.46 -39.76 1.47 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.5 ptm -73.61 161.77 29.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 111.565 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 164.22 30.78 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.601 ' CE1' HG11 ' A' ' 103' ' ' VAL . 2.5 m-85 -133.05 154.23 50.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.277 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.073 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -126.32 130.68 51.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.056 0.455 . . . . 0.0 110.939 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.927 HD12 HG13 ' A' ' 108' ' ' VAL . 2.6 mm -114.46 106.58 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -130.86 167.34 19.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.908 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 51.0 p-80 -80.99 152.2 28.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.875 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -62.64 154.29 74.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.512 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 9.6 Cg_endo -54.45 141.76 72.04 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.61 2.206 . . . . 0.0 113.464 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.602 HG21 HH21 ' A' ' 9' ' ' ARG . 1.2 p -98.98 174.37 6.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.009 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -97.96 -10.43 24.52 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.61 -30.43 14.96 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.7 p -139.19 90.01 2.39 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.373 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -79.99 -52.18 8.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.043 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.446 ' HA ' HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -57.62 -44.02 85.21 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.091 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.3 m -57.93 -33.51 68.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.849 0.357 . . . . 0.0 111.233 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.579 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -73.71 -47.93 35.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.046 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.881 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.6 pt -55.94 -39.53 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.53 . . . . 0.0 110.697 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.12 -52.14 60.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.519 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -68.99 -50.11 51.82 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.863 0.363 . . . . 0.0 111.843 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.579 HD21 ' CE1' ' A' ' 36' ' ' PHE . 41.9 mt -56.52 -44.47 80.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -77.86 -26.67 49.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.081 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -52.9 -45.37 67.5 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.268 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.073 ' CD1' HD21 ' A' ' 23' ' ' LEU . 15.3 t80 -63.51 -38.32 90.69 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.779 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.664 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.63 -177.92 40.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.946 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.63 117.9 20.18 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.755 HG22 ' H ' ' A' ' 47' ' ' THR . 1.7 m -164.9 -170.63 2.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.88 177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.884 ' HA ' HG23 ' A' ' 67' ' ' THR . 2.9 t -64.87 153.36 40.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.507 0.67 . . . . 0.0 110.565 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 104' ' ' ALA . 55.8 t -131.42 133.33 62.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.944 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.051 HG13 HG13 ' A' ' 105' ' ' VAL . 6.4 p -115.57 105.4 18.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.346 0.593 . . . . 0.0 111.279 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -114.22 111.06 20.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.113 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' A' ' 71' ' ' TRP . 10.7 t -104.12 91.59 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.402 0.62 . . . . 0.0 110.093 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.486 ' HG ' ' CE1' ' A' ' 106' ' ' HIS . 1.1 m -157.74 171.3 20.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.552 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.95 130.41 43.29 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.75 122.23 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.4 p -120.23 -47.8 2.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.868 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.455 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -130.74 83.92 2.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.384 178.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -79.11 -37.15 39.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -80.08 -48.42 13.28 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.415 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.19 -53.05 24.53 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -177.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.455 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 11.0 Cg_exo -72.58 -42.76 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.412 2.074 . . . . 0.0 113.983 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.706 ' CD1' HG12 ' A' ' 68' ' ' VAL . 2.5 tt -71.53 -45.23 62.94 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.42 -28.7 68.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.473 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.881 ' HB3' HG21 ' A' ' 37' ' ' ILE . 16.1 mttt -80.5 -34.01 36.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.882 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.488 ' HB3' HG22 ' A' ' 37' ' ' ILE . 44.9 p30 -101.25 -11.33 19.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.03 34.62 52.6 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.804 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' A' ' 46' ' ' THR . 6.0 mt -108.61 147.35 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.646 0.26 . . . . 0.0 110.967 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.884 HG23 ' HA ' ' A' ' 47' ' ' THR . 4.4 t -78.41 132.79 37.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.706 HG12 ' CD1' ' A' ' 61' ' ' LEU . 7.4 p -144.99 151.11 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.133 0.492 . . . . 0.0 111.965 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.34 131.93 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -101.21 106.72 17.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.164 0.507 . . . . 0.0 111.09 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.812 ' HB3' HG13 ' A' ' 51' ' ' VAL . 5.2 m0 -110.96 103.93 55.47 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.302 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -106.13 164.6 0.14 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.321 2.681 . . . . 0.0 112.993 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.422 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 8.3 t80 -126.21 95.93 4.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.665 ' H ' ' HB2' ' A' ' 77' ' ' ALA . 7.7 p-10 -125.33 -171.41 2.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -54.96 -27.27 42.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.044 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -114.68 41.25 2.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.529 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.665 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -85.95 119.42 71.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.43 0.157 . . . . 0.0 110.911 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.579 ' HG2' HG11 ' A' ' 83' ' ' VAL . 18.9 Cg_endo -59.98 108.13 0.46 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.543 2.162 . . . . 0.0 112.541 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.638 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 82.3 Cg_endo -78.3 -23.68 8.59 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.683 2.255 . . . . 0.0 115.442 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.889 ' O ' HG22 ' A' ' 83' ' ' VAL . 32.8 Cg_endo -65.52 152.34 82.14 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.368 1.379 . . . . 0.0 113.284 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.427 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -56.65 -20.71 32.77 Favored Glycine 0 C--O 1.236 0.234 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.334 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.74 -34.08 37.6 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.491 0.186 . . . . 0.0 110.972 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 80' ' ' PRO . 1.1 m -53.98 -49.05 62.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 151' ' ' TYR . 7.5 t -54.57 -42.87 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.5 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -56.15 -31.53 63.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.99 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -68.49 -50.4 52.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.009 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.799 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -67.8 -28.09 67.3 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 120' ' ' LEU . 11.1 mt -63.5 -43.95 95.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.25 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.2 -41.51 94.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.205 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.1 tm? -59.35 -51.34 70.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.673 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.103 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.6 p -71.36 -35.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.072 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.03 -45.92 86.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.96 86.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.599 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -72.2 -23.9 61.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.157 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -79.28 -52.04 8.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.775 0.322 . . . . 0.0 111.184 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 25.4 t -65.02 -36.82 85.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -76.11 -32.82 59.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.268 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.573 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -123.45 88.58 51.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.526 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.37 130.71 19.03 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.816 2.344 . . . . 0.0 112.063 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.34 57.81 17.82 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.448 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.573 ' OG ' ' HB1' ' A' ' 98' ' ' ALA . 4.7 m -101.08 -164.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.719 0.295 . . . . 0.0 111.212 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.664 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -123.11 113.55 19.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.373 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.601 HG11 ' CE1' ' A' ' 22' ' ' PHE . 24.3 t -107.45 151.06 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.73 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -122.2 139.97 53.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.982 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.051 HG13 HG13 ' A' ' 49' ' ' VAL . 10.8 t -140.09 166.73 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.663 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.0 t60 -66.81 156.35 35.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.516 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.53 ' HA ' HG23 ' A' ' 24' ' ' ILE . 20.8 t -68.13 104.49 1.8 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.927 HG13 HD12 ' A' ' 24' ' ' ILE . 34.5 m -75.56 0.25 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.06 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.4 -8.53 2.73 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.25 -127.49 3.12 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 143' ' ' ALA . 0.0 OUTLIER -128.14 127.27 42.69 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.42 -144.44 4.1 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.607 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.661 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.29 -25.96 4.74 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.163 0.506 . . . . 0.0 112.017 -178.472 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.671 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -50.23 -46.22 83.08 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.838 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.2 Cg_endo -51.72 -48.54 20.92 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.306 2.004 . . . . 0.0 113.275 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 1.041 HG12 HD11 ' A' ' 120' ' ' LEU . 57.9 t -61.68 -46.66 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.818 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.53 ' HA ' HD12 ' A' ' 120' ' ' LEU . 11.6 mt -54.77 -46.55 74.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.847 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.893 ' CG2' HG11 ' A' ' 105' ' ' VAL . 57.6 t -57.37 -55.28 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.726 0.298 . . . . 0.0 111.671 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -52.98 -48.76 67.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.336 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 1.041 HD11 HG12 ' A' ' 116' ' ' VAL . 5.5 mt -59.06 -30.55 68.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.389 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 1.103 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.12 -42.43 66.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.967 0.413 . . . . 0.0 110.227 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.551 HD13 ' OD2' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -70.75 -16.11 62.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.595 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.914 ' CD1' HD21 ' A' ' 152' ' ' LEU . 1.4 mt -57.42 -30.97 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.124 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -15.97 14.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.539 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.87 11.29 5.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.27 -83.79 0.35 Allowed Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.4 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.502 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.9 76.92 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 121.337 0.589 . . . . 0.0 109.534 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.882 ' CB ' HG23 ' A' ' 123' ' ' ILE . 11.3 mttt -62.56 -67.4 0.42 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.088 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.487 ' HD1' HD13 ' A' ' 152' ' ' LEU . 6.1 t80 -73.61 -31.68 63.68 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.069 0.462 . . . . 0.0 110.762 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.3 -46.4 55.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.061 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.551 ' OD2' HD13 ' A' ' 122' ' ' LEU . 47.9 t0 -70.24 -47.19 62.45 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.457 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.84 ' HB3' HD11 ' A' ' 152' ' ' LEU . . . -57.97 -50.06 74.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.821 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.0 mm -70.8 -37.78 70.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -74.37 -49.71 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.763 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -70.19 -35.44 73.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.501 0.191 . . . . 0.0 111.066 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 132' ' ' ALA . 4.2 tt -74.25 -32.7 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.782 0.325 . . . . 0.0 110.662 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -64.93 -43.99 90.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.497 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.82 -44.19 94.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.527 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.05 152.08 22.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.667 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -72.96 117.73 15.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.378 . . . . 0.0 110.33 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.488 ' HG3' HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -114.13 163.9 14.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.433 -179.109 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -56.45 -165.42 0.05 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.039 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.842 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -82.1 99.0 8.95 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.715 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.794 HG23 ' HB3' ' A' ' 148' ' ' GLN . 45.8 mt -88.73 108.88 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.828 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -114.03 -78.09 0.58 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.021 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.6 t -101.32 -61.23 1.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.832 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.7 tmtt? -48.99 -51.54 30.01 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.794 ' HB3' HG23 ' A' ' 144' ' ' ILE . 7.2 tm0? -56.28 -51.51 67.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.433 ' CD2' ' CG2' ' A' ' 144' ' ' ILE . 3.9 mm? -75.19 -37.69 61.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.5 m -73.08 -42.68 62.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.033 0.444 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.832 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -64.0 -50.11 69.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.034 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.914 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -64.28 -38.16 90.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.709 0.29 . . . . 0.0 110.871 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.56 -43.98 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -24.76 57.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.497 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.74 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.9 OUTLIER -66.42 -23.75 66.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.651 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.434 ' HB2' ' HB2' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -106.8 126.92 29.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.217 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.09 153.42 62.73 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.556 2.171 . . . . 0.0 112.202 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -146.88 123.5 11.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.028 0.442 . . . . 0.0 110.574 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.97 -26.85 68.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.052 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -58.94 -30.38 67.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.829 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.99 -28.34 24.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -96.23 40.45 1.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -97.83 102.54 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -112.23 128.12 56.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.6 136.55 32.85 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.24 -62.11 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.44 2.093 . . . . 0.0 112.265 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -86.69 114.12 23.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.1 p -149.61 179.21 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.45 145.97 51.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -131.88 138.97 48.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.7 m -143.17 -52.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.5 p -139.04 153.42 48.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.369 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -77.18 148.34 35.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.1 mmt -135.46 140.19 44.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.37 132.89 16.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 ptm85 -150.0 149.94 31.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.94 109.11 8.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.974 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -117.74 -40.31 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.696 ' HE ' HG21 ' A' ' 29' ' ' THR . 4.0 mpt_? -132.92 150.99 77.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.961 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.91 145.86 30.96 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.655 2.237 . . . . 0.0 112.424 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.3 143.63 65.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.012 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.512 ' HB3' HG22 ' A' ' 25' ' ' THR . 61.2 Cg_endo -73.03 162.41 40.99 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.458 2.106 . . . . 0.0 112.479 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.751 HG11 ' HD2' ' A' ' 139' ' ' LYS . 12.7 t -144.07 126.92 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.85 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.7 OUTLIER -108.64 121.96 46.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.576 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.764 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.75 120.6 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.41 ' HB3' ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -116.02 147.03 41.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.195 0.522 . . . . 0.0 111.978 -178.672 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HD2' HD21 ' A' ' 122' ' ' LEU . 20.5 t80 -155.12 127.62 7.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.225 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.45 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 7.2 mmpt? 55.06 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.521 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -129.26 -46.45 1.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.538 ' CE ' HD21 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -73.66 139.84 45.68 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.099 0.476 . . . . 0.0 111.266 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.41 ' HG2' ' HB3' ' A' ' 16' ' ' SER . 1.6 mtt180 -115.35 164.4 14.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.276 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CE1' HG11 ' A' ' 103' ' ' VAL . 1.4 m-85 -131.97 138.39 48.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.562 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.061 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -114.88 133.74 55.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.422 . . . . 0.0 110.962 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.82 HG21 HG12 ' A' ' 108' ' ' VAL . 1.5 mm -115.85 106.52 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.57 HG21 HD23 ' A' ' 40' ' ' LEU . 1.6 p -132.33 162.89 29.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.27 0.557 . . . . 0.0 111.936 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.456 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 43.0 p-80 -81.41 152.13 27.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.937 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -62.74 154.36 75.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.987 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.4 Cg_exo -54.55 140.83 75.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.343 2.029 . . . . 0.0 113.275 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.696 HG21 ' HE ' ' A' ' 9' ' ' ARG . 32.3 p -98.47 174.33 6.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.161 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -93.37 -11.64 31.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.69 -31.04 14.61 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -139.69 89.65 2.34 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.519 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.636 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.3 OUTLIER -80.38 -52.16 8.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.173 0.511 . . . . 0.0 111.272 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 37' ' ' ILE . 1.1 p -56.79 -45.64 82.03 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.359 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.1 m -57.72 -33.47 68.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.936 0.398 . . . . 0.0 111.439 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.741 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.27 -47.93 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.174 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.83 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.0 pt -55.91 -39.08 55.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.216 0.531 . . . . 0.0 110.696 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -65.21 -51.86 58.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.487 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 4.0 m-20 -68.64 -50.05 54.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.873 0.368 . . . . 0.0 111.906 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.741 HD21 ' CE1' ' A' ' 36' ' ' PHE . 58.7 mt -55.93 -44.84 78.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.871 0.367 . . . . 0.0 110.412 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -78.53 -26.62 45.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.028 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -53.36 -42.8 67.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.406 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.061 ' CD1' HD21 ' A' ' 23' ' ' LEU . 17.9 t80 -63.37 -38.56 91.61 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.241 -0.583 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.654 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.64 -177.71 40.12 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.958 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.54 117.71 19.99 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.738 HG22 ' H ' ' A' ' 47' ' ' THR . 1.7 m -164.8 -170.23 1.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.63 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.738 ' H ' HG22 ' A' ' 46' ' ' THR . 2.9 t -64.7 158.65 24.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.411 0.624 . . . . 0.0 110.443 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 104' ' ' ALA . 59.8 t -136.47 136.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.333 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.11 HG13 HG13 ' A' ' 105' ' ' VAL . 2.4 p -115.64 105.17 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.282 0.563 . . . . 0.0 110.699 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.404 ' HG2' ' CG2' ' A' ' 68' ' ' VAL . 7.4 ptm180 -113.99 110.72 20.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.705 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.8 HG13 ' HB3' ' A' ' 71' ' ' TRP . 18.5 t -105.39 90.94 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.537 0.684 . . . . 0.0 109.817 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 t -158.4 171.77 19.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.582 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -65.51 130.02 41.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 m -74.33 122.39 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.26 -47.6 2.35 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.182 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.413 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.2 m-85 -130.54 84.29 2.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.628 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.433 ' O ' HD23 ' A' ' 61' ' ' LEU . 2.4 m-20 -78.56 -35.87 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -78.84 -48.42 14.76 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.636 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -44.64 -49.82 25.56 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.296 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 8.2 Cg_exo -73.16 -39.44 2.18 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.737 2.291 . . . . 0.0 113.336 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.868 HD21 ' CG1' ' A' ' 68' ' ' VAL . 3.7 mm? -66.95 -45.26 78.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -75.35 -33.34 61.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.83 ' HB3' HG21 ' A' ' 37' ' ' ILE . 5.8 mmtt -81.12 -32.05 33.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' CB ' HG12 ' A' ' 66' ' ' ILE . 71.1 m-20 -101.37 -11.5 19.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 44.6 34.77 3.83 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.051 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.555 HD12 HG21 ' A' ' 48' ' ' VAL . 4.3 pt -114.69 148.82 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.694 0.283 . . . . 0.0 111.001 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 47' ' ' THR . 81.9 p -77.53 135.2 38.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.868 ' CG1' HD21 ' A' ' 61' ' ' LEU . 7.9 p -144.9 151.73 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.084 0.469 . . . . 0.0 111.941 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.539 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.1 t -103.43 132.59 49.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -100.87 106.71 18.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.189 0.519 . . . . 0.0 110.365 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.81 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.0 m95 -111.93 104.07 55.74 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.136 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -106.85 169.5 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 123.599 2.866 . . . . 0.0 112.6 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 9.0 t80 -126.11 95.96 4.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.752 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.43 -173.99 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.833 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -57.48 -26.96 62.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.97 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.19 64.9 0.53 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.26 106.87 28.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.345 0.117 . . . . 0.0 110.903 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.444 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . 72.8 Cg_exo -40.16 97.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.945 2.43 . . . . 0.0 113.024 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.69 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 52.9 Cg_exo -55.92 -42.05 70.9 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.107 2.538 . . . . 0.0 114.339 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 2.7 Cg_endo -47.67 151.72 3.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.303 2.002 . . . . 0.0 113.507 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.564 ' HA2' ' HZ1' ' A' ' 147' ' ' LYS . . . -65.97 -19.7 68.02 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.362 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -50.52 -29.74 11.31 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 120.57 0.224 . . . . 0.0 110.818 -178.131 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.81 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 21.8 t -56.09 -48.0 79.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.734 HG11 ' HG ' ' A' ' 120' ' ' LEU . 94.0 t -55.98 -37.9 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.024 177.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.766 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.0 OUTLIER -59.46 -31.33 69.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.529 178.182 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -66.16 -50.74 62.89 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.23 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.706 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -67.97 -26.98 66.2 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.261 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.796 HD21 ' HB3' ' A' ' 120' ' ' LEU . 18.2 mt -61.05 -41.5 96.71 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.111 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -67.58 -42.54 82.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.872 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.466 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.3 tm? -60.32 -51.48 69.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.772 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.019 HG21 ' HB1' ' A' ' 121' ' ' ALA . 7.3 p -68.42 -43.94 83.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.25 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.441 ' N ' HG13 ' A' ' 91' ' ' VAL . 26.7 mttt -54.7 -40.33 69.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.907 0.384 . . . . 0.0 110.833 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.64 -45.78 77.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.992 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.403 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 2.3 mmtt -74.6 -24.81 58.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.652 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -82.1 -45.53 15.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.747 0.308 . . . . 0.0 111.109 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.92 -37.86 69.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.915 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -76.11 -32.99 59.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.04 88.82 53.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.451 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.24 133.89 13.76 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.58 2.187 . . . . 0.0 112.319 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.2 46.42 34.91 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.45 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.418 ' HB3' HG21 ' A' ' 46' ' ' THR . 0.4 OUTLIER -101.21 -165.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 111.269 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.654 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.0 m -127.42 113.71 16.56 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.199 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.487 HG11 ' CE1' ' A' ' 22' ' ' PHE . 5.4 t -110.65 151.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.737 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -118.97 144.73 46.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.308 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.11 HG13 HG13 ' A' ' 49' ' ' VAL . 3.5 t -140.37 167.08 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.622 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.2 t-80 -66.97 156.34 36.21 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.463 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 25' ' ' THR . 25.6 p -68.19 101.72 1.22 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.471 0.653 . . . . 0.0 112.593 -177.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.82 HG12 HG21 ' A' ' 24' ' ' ILE . 5.4 p -75.55 0.08 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.065 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.46 -8.53 2.8 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.18 -125.84 3.08 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.755 -0.735 . . . . 0.0 111.391 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.858 HD21 ' HB2' ' A' ' 143' ' ' ALA . 0.0 OUTLIER -132.06 127.31 35.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.58 -142.73 3.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.644 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.742 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.31 -22.06 5.65 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.043 0.449 . . . . 0.0 111.965 -178.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.677 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -49.85 -46.33 80.67 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 5.7 Cg_endo -51.6 -48.38 21.64 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.482 2.121 . . . . 0.0 113.107 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.601 ' O ' HD23 ' A' ' 120' ' ' LEU . 43.5 t -61.1 -42.59 93.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.805 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.726 HD12 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -57.56 -55.07 39.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.687 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.893 ' CG2' HG11 ' A' ' 105' ' ' VAL . 61.1 t -52.93 -55.2 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.618 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -53.01 -53.14 54.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.249 0.547 . . . . 0.0 110.72 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.796 ' HB3' HD21 ' A' ' 88' ' ' LEU . 2.4 mm? -54.34 -30.78 52.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.793 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 1.019 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.21 -48.88 39.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.954 0.406 . . . . 0.0 110.467 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.538 HD21 ' CE ' ' A' ' 20' ' ' MET . 0.3 OUTLIER -62.92 -14.66 49.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.712 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.922 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.3 mt -57.01 -30.86 35.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.832 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -16.65 62.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.574 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.5 m -83.13 11.02 6.95 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.27 -101.85 1.08 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.016 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.476 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.3 ptt? -62.53 78.67 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.922 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.86 -67.65 0.55 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -176.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.64 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.6 t80 -67.42 -32.05 72.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.856 0.36 . . . . 0.0 111.092 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.38 -51.35 20.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.199 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.2 t0 -69.61 -38.36 77.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 111.009 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.618 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -60.36 -49.93 75.61 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.972 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.7 mm -73.56 -38.0 51.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.562 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.09 -49.72 22.71 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.764 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.84 -36.38 75.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.675 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.4 tt -74.29 -27.83 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.775 0.321 . . . . 0.0 110.434 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -49.67 66.65 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.542 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -45.14 93.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.61 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.751 ' HD2' HG11 ' A' ' 13' ' ' VAL . 19.6 mmtm -84.15 152.08 24.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.412 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.703 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.13 117.34 14.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.96 0.41 . . . . 0.0 110.454 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.41 ' HA ' HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -114.43 163.6 15.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.216 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.549 ' HA2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.32 -171.21 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.59 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.858 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -80.63 98.88 7.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.378 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.709 HD12 HD21 ' A' ' 149' ' ' LEU . 2.3 pt -88.71 108.53 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.062 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.89 -77.32 0.58 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.094 -0.643 . . . . 0.0 112.449 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.2 m -100.67 -60.68 1.48 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.754 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.4 tmtt? -54.27 -52.03 62.7 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.582 ' HG3' HG22 ' A' ' 144' ' ' ILE . 8.5 tm0? -56.31 -51.91 66.46 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.709 HD21 HD12 ' A' ' 144' ' ' ILE . 3.2 mm? -75.09 -44.46 47.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.2 m -68.88 -34.9 76.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.718 0.294 . . . . 0.0 111.441 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.754 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 1.8 t80 -68.66 -50.6 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.321 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.769 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -69.36 -33.32 72.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.475 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -57.4 -44.65 84.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -27.52 65.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.596 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.517 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -66.44 -29.22 69.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.832 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.73 114.6 61.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.767 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.7 153.15 76.76 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.531 2.154 . . . . 0.0 112.506 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -147.16 123.62 11.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.502 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.08 3.32 23.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.675 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -58.89 -29.12 66.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.77 0.319 . . . . 0.0 110.983 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mt -65.45 -39.25 91.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.819 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -99.98 177.66 5.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.813 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 2.4 p90 -120.88 -56.01 1.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? 59.29 110.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.08 103.88 11.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.51 62.63 3.65 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.447 2.098 . . . . 0.0 112.19 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.51 112.72 22.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 p -137.52 156.04 48.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -76.72 -46.75 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.42 166.16 12.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 24.5 m -115.57 143.56 45.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.833 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 p -81.92 -53.94 5.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -113.33 129.72 56.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.1 ttm -61.54 128.88 38.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.952 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.06 -45.76 3.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.079 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.96 155.32 38.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.61 156.14 35.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.814 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -82.0 -73.08 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.09 143.56 27.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.857 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.49 96.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.489 2.126 . . . . 0.0 112.324 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.38 148.47 83.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 60.3 Cg_endo -72.76 161.14 44.61 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.499 2.132 . . . . 0.0 112.252 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.46 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.3 t -143.98 127.38 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.061 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -105.14 116.63 32.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.031 0.443 . . . . 0.0 111.396 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.709 HG12 ' CE2' ' A' ' 135' ' ' PHE . 21.3 t -107.22 118.31 54.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.5 p -141.59 149.57 40.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.758 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -144.08 153.61 42.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.015 178.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 51.08 -97.81 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.406 0.282 . . . . 0.0 110.82 -176.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.429 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 2.6 m80 -124.78 -25.03 4.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.851 ' CE ' HD13 ' A' ' 122' ' ' LEU . 5.5 ppp? -73.8 164.31 26.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.747 0.308 . . . . 0.0 111.269 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -142.54 161.52 37.86 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.015 0.436 . . . . 0.0 111.3 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.819 ' CE1' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -142.99 140.65 31.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.147 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.053 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -114.69 134.59 54.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.107 0.479 . . . . 0.0 111.23 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.944 HD12 HG13 ' A' ' 108' ' ' VAL . 2.1 mm -116.91 106.51 20.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.329 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -133.33 167.26 20.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.183 0.515 . . . . 0.0 111.669 -178.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.475 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 49.7 p-80 -80.92 151.9 28.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.847 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -62.65 154.26 74.82 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.045 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.517 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 53.1 Cg_exo -54.81 140.92 77.89 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.348 2.032 . . . . 0.0 113.376 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.441 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -98.72 174.34 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.125 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -94.41 -10.31 32.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.84 14.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.9 p -139.54 89.62 2.34 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.431 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -80.21 -52.18 8.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.261 0.553 . . . . 0.0 111.196 178.099 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.446 ' O ' HG13 ' A' ' 37' ' ' ILE . 17.2 p -57.56 -46.31 84.09 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.418 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -57.75 -31.96 66.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.823 0.344 . . . . 0.0 111.295 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.637 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.47 -47.78 31.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.619 HD13 ' HB3' ' A' ' 63' ' ' LYS . 11.6 pt -56.84 -39.36 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.191 0.52 . . . . 0.0 110.742 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.26 -52.14 60.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.466 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -68.49 -50.04 55.29 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.82 0.343 . . . . 0.0 111.757 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.637 HD21 ' CE1' ' A' ' 36' ' ' PHE . 25.3 mt -55.81 -45.35 78.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -26.62 49.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.108 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 17.2 mttt -52.88 -44.31 66.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.447 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.053 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.2 t80 -63.36 -38.42 91.07 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.897 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.689 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 167.01 -177.56 41.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.616 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.84 121.08 24.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.846 HG22 ' H ' ' A' ' 47' ' ' THR . 4.2 m -164.72 -171.82 2.43 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.846 ' H ' HG22 ' A' ' 46' ' ' THR . 8.8 t -65.74 166.9 10.11 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.754 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.787 HG13 ' O ' ' A' ' 104' ' ' ALA . 44.0 t -139.84 134.74 37.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.193 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.067 HG13 HG13 ' A' ' 105' ' ' VAL . 3.6 p -115.67 105.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.222 0.534 . . . . 0.0 111.483 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 110.81 20.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.984 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.826 HG13 ' HB3' ' A' ' 71' ' ' TRP . 7.4 t -103.86 91.86 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.453 0.644 . . . . 0.0 109.737 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 t -157.28 171.66 20.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.336 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.42 130.33 43.33 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 72' ' ' PRO . 16.4 t -68.91 121.67 18.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -176.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -120.73 -47.49 2.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.898 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.415 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 3.0 m-85 -130.44 84.47 2.2 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.263 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.52 -36.25 45.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -79.21 -48.58 13.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.66 HG22 ' HG3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -44.81 -48.24 29.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.112 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 59' ' ' THR . 33.6 Cg_exo -60.9 -42.27 38.86 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.551 2.167 . . . . 0.0 113.787 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.818 HD22 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -71.44 -45.75 61.83 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.85 -49.12 18.88 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.66 ' HG3' HG22 ' A' ' 59' ' ' THR . 0.3 OUTLIER -73.61 -28.08 61.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -177.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' CG ' HD11 ' A' ' 66' ' ' ILE . 4.6 t0 -98.49 -11.43 22.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.91 22.39 9.08 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.151 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.706 HD12 HG21 ' A' ' 48' ' ' VAL . 2.7 pt -122.02 148.61 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.626 0.25 . . . . 0.0 110.376 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' THR . 19.5 m -77.43 135.0 38.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.83 0.348 . . . . 0.0 110.192 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.818 HG12 HD22 ' A' ' 61' ' ' LEU . 7.4 p -141.24 150.53 19.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 0.0 111.756 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.443 HG22 ' HG ' ' A' ' 90' ' ' LEU . 3.4 t -103.73 134.42 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.135 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.83 106.69 18.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.19 0.519 . . . . 0.0 110.109 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.826 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.0 m95 -111.43 104.38 56.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.229 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HB3' HG23 ' A' ' 54' ' ' VAL . 43.4 Cg_endo -104.56 138.57 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 123.303 2.669 . . . . 0.0 112.433 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.42 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -114.97 95.96 5.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.894 0.378 . . . . 0.0 110.913 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.59 ' H ' ' HB2' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -145.31 -162.15 1.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.542 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -55.04 -23.5 20.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.121 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -115.52 49.36 0.86 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.599 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.59 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -115.41 102.93 54.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.476 0.179 . . . . 0.0 110.944 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.434 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 93.0 Cg_exo -43.32 99.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.774 2.316 . . . . 0.0 112.918 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.692 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 52.9 Cg_exo -55.83 -41.43 77.4 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.985 2.457 . . . . 0.0 114.256 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.763 ' O ' HG22 ' A' ' 83' ' ' VAL . 2.4 Cg_endo -47.46 153.97 1.81 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.275 1.983 . . . . 0.0 113.609 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.33 -20.22 67.24 Favored Glycine 0 C--O 1.237 0.284 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.527 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.3 -33.18 27.82 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.359 0.133 . . . . 0.0 111.359 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -56.11 -48.83 78.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.767 HG11 ' CE2' ' A' ' 151' ' ' TYR . 15.7 t -53.81 -41.16 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.218 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -61.07 -31.37 71.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.02 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.28 -50.36 68.2 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.395 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.845 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -70.31 -28.32 65.08 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.969 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.963 HD21 ' HB3' ' A' ' 120' ' ' LEU . 13.8 mt -61.64 -40.63 95.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.15 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.57 -39.93 70.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.132 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.3 tm? -58.03 -51.27 70.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.522 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.103 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.9 p -70.42 -35.83 63.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.666 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -46.34 77.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.381 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.71 85.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.446 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -67.49 -26.96 66.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.814 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.4 m-85 -79.81 -47.23 15.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.008 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.88 -43.3 98.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -33.03 59.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.97 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -118.55 89.38 36.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.32 113.6 3.52 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.597 2.198 . . . . 0.0 112.361 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.32 60.38 7.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.648 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.462 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 18.5 t -101.23 -163.85 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.627 0.251 . . . . 0.0 110.809 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.689 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 2.2 m -112.41 114.09 26.63 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.674 HG11 ' CE1' ' A' ' 22' ' ' PHE . 10.6 t -109.79 151.31 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.787 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -116.02 140.86 48.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.088 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.067 HG13 HG13 ' A' ' 49' ' ' VAL . 3.4 t -140.36 166.35 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.71 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.7 t60 -67.54 156.08 37.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.621 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 25' ' ' THR . 18.7 t -68.51 105.81 2.35 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.944 HG13 HD12 ' A' ' 24' ' ' ILE . 35.7 m -75.51 0.42 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.194 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.22 -8.6 2.61 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.72 -140.49 5.24 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.412 HD22 ' HA2' ' A' ' 142' ' ' GLY . 5.9 mt -114.97 127.34 55.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.64 -146.46 4.81 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.834 -1.174 . . . . 0.0 113.593 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.57 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.34 -21.68 5.75 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.031 0.443 . . . . 0.0 111.877 -178.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.887 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -52.8 -46.22 96.79 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.804 ' HD3' HG12 ' A' ' 108' ' ' VAL . 8.3 Cg_endo -52.41 -48.48 21.63 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.237 1.958 . . . . 0.0 112.904 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.807 HG21 ' NE2' ' A' ' 148' ' ' GLN . 57.5 t -60.9 -52.19 64.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.386 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.692 HD12 ' CG2' ' A' ' 49' ' ' VAL . 3.8 mt -51.89 -44.48 63.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.942 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.961 HG22 HG11 ' A' ' 105' ' ' VAL . 4.4 t -58.55 -54.62 30.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.472 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.68 -44.4 66.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 111.34 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.963 ' HB3' HD21 ' A' ' 88' ' ' LEU . 12.5 mt -63.95 -30.73 71.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.383 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 1.103 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -68.67 -37.53 79.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.069 0.462 . . . . 0.0 109.793 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.851 HD13 ' CE ' ' A' ' 20' ' ' MET . 7.6 tp -78.88 -15.68 58.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.256 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.93 HG23 ' CB ' ' A' ' 128' ' ' LYS . 1.8 mt -57.59 -30.86 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.73 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -16.33 64.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.512 ' OG ' HD12 ' A' ' 122' ' ' LEU . 7.1 m -79.54 -23.36 42.91 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 152.95 -96.1 0.16 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.994 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.478 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.2 ptt? -63.2 71.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.93 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.44 -67.62 0.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -176.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.573 ' CD1' HD22 ' A' ' 152' ' ' LEU . 8.6 t80 -66.26 -32.67 74.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.9 0.381 . . . . 0.0 111.128 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.59 -52.22 16.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.634 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 30.0 t0 -70.12 -39.43 75.45 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.821 0.343 . . . . 0.0 110.975 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.674 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -60.45 -50.01 75.29 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.811 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 129' ' ' TYR . 26.1 mm -73.38 -38.69 53.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -74.44 -49.95 20.35 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.709 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.83 -37.09 83.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.31 . . . . 0.0 110.165 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.561 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.23 -27.87 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.437 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -47.93 78.98 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -44.71 93.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.598 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.1 OUTLIER -84.9 152.03 23.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.44 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 116.7 14.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.009 0.433 . . . . 0.0 110.514 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 163.61 15.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.14 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -56.77 -168.8 0.09 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.649 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.21 100.03 12.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.286 0.543 . . . . 0.0 111.516 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.8 HD12 HD21 ' A' ' 149' ' ' LEU . 10.4 pt -87.93 109.52 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.373 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -113.25 -76.87 0.58 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 6.8 p -99.6 -61.01 1.42 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.833 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 11.7 tmtt? -66.48 -48.6 69.36 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.807 ' NE2' HG21 ' A' ' 116' ' ' VAL . 23.5 mm-40 -56.12 -51.84 66.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.8 HD21 HD12 ' A' ' 144' ' ' ILE . 2.0 mm? -74.2 -45.34 48.92 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.766 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.9 m -64.62 -37.31 87.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.795 0.331 . . . . 0.0 111.425 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.833 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -66.41 -50.51 63.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.157 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.859 HD21 HD11 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -61.52 -34.61 75.82 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.171 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.33 -43.4 88.21 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -23.76 65.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.482 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.661 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -66.18 -39.67 89.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.49 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 129' ' ' TYR . 0.0 OUTLIER -106.7 141.03 21.97 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.956 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.08 153.42 62.79 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.656 2.238 . . . . 0.0 112.34 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.56 123.45 11.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.526 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.83 -12.58 61.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.508 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -28.12 65.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.763 0.316 . . . . 0.0 110.967 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.681 ' O ' HD23 ' A' ' 161' ' ' LEU . 2.2 tt -75.04 -31.56 61.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -177.9 6.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -108.9 -66.33 1.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -66.61 121.96 16.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -94.03 138.05 22.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.801 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.85 -48.5 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.492 2.128 . . . . 0.0 112.36 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -177.6 37.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.948 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.8 p -134.64 116.56 15.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -86.99 127.67 35.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -148.46 -47.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.9 m -120.39 -62.08 1.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.54 116.34 14.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.815 0.34 . . . . 0.0 110.898 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -119.45 114.96 23.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.87 103.49 10.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -121.63 140.5 52.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.138 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -132.2 -65.92 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 mmt -112.89 130.78 55.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.906 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -163.75 31.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 ptt-85 -175.89 112.34 0.26 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.3 109.85 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.499 2.133 . . . . 0.0 112.37 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.07 57.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.053 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.891 ' HB3' HG22 ' A' ' 25' ' ' THR . 64.2 Cg_endo -73.14 165.15 33.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.537 2.158 . . . . 0.0 112.339 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.434 HG11 ' HE2' ' A' ' 139' ' ' LYS . 21.2 t -138.78 126.88 28.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.809 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.0 pt-20 -105.96 116.74 32.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.978 0.418 . . . . 0.0 111.559 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.689 HG12 ' CE2' ' A' ' 135' ' ' PHE . 45.3 t -107.82 118.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.06 151.9 42.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 0.0 112.223 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -145.13 151.07 37.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.962 178.306 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.625 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 44.71 -78.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.455 0.702 . . . . 0.0 112.623 -177.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -129.81 -41.58 1.31 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.189 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.624 ' HE1' ' CE2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -73.58 154.22 39.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 112.027 -178.511 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -135.7 164.25 28.29 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.064 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.624 ' CE2' ' HE1' ' A' ' 20' ' ' MET . 7.9 m-85 -139.28 150.08 45.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.052 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -121.24 132.0 54.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.466 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.017 HD12 HG13 ' A' ' 108' ' ' VAL . 2.6 mm -117.27 106.68 20.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.512 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.891 HG22 ' HB3' ' A' ' 12' ' ' PRO . 31.7 p -130.45 167.23 18.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.202 0.525 . . . . 0.0 111.773 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.497 ' CD2' ' CE2' ' A' ' 36' ' ' PHE . 42.1 p-80 -80.89 152.29 28.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.39 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -62.45 153.93 74.66 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.3 Cg_exo -54.71 142.4 73.3 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.393 2.062 . . . . 0.0 113.46 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.484 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.1 p -98.5 174.44 6.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.053 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -94.01 -12.48 28.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.7 -31.02 14.61 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.4 p -139.86 89.81 2.34 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.691 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.651 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.5 OUTLIER -80.23 -52.32 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.212 0.529 . . . . 0.0 111.136 177.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.555 ' O ' HG13 ' A' ' 37' ' ' ILE . 1.5 m -57.45 -36.11 71.0 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.211 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -65.88 -35.48 80.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.919 0.39 . . . . 0.0 110.927 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.638 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -73.94 -47.97 33.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.072 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.588 HD13 ' HB3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -58.62 -37.02 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 110.472 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.48 -51.94 60.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.262 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -69.78 -49.88 48.63 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 111.552 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.699 HD23 HG21 ' A' ' 25' ' ' THR . 27.3 mt -54.96 -44.82 74.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.99 0.424 . . . . 0.0 110.502 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -78.4 -26.76 46.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.181 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 11.9 mttt -54.56 -41.89 70.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.351 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.052 ' CD1' HD21 ' A' ' 23' ' ' LEU . 13.3 t80 -63.58 -38.7 92.13 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.804 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.644 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 168.84 -178.84 41.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.706 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.83 118.36 20.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.804 HG22 ' H ' ' A' ' 47' ' ' THR . 3.3 m -164.7 -171.35 2.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.305 -0.862 . . . . 0.0 108.696 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.804 ' H ' HG22 ' A' ' 46' ' ' THR . 1.6 t -65.52 163.09 16.7 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.064 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.797 HG21 HD12 ' A' ' 66' ' ' ILE . 50.0 t -137.26 133.5 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.082 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.815 HG12 HG22 ' A' ' 105' ' ' VAL . 14.9 p -115.4 105.18 18.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.55 0.69 . . . . 0.0 111.514 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -114.64 110.84 20.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.845 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.791 HG13 ' HB3' ' A' ' 71' ' ' TRP . 14.5 t -105.87 91.83 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.629 0.728 . . . . 0.0 109.936 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.41 172.04 19.3 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.229 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' CD ' ' N ' ' A' ' 53' ' ' GLU . 1.5 mm-40 -64.28 130.33 43.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.491 HG12 ' OD1' ' A' ' 70' ' ' ASP . 12.0 m -69.07 121.95 19.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 m -120.53 -47.45 2.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.074 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.425 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 6.7 m-85 -130.41 84.51 2.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.34 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.52 -35.86 45.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -78.97 -48.45 14.47 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.651 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -45.67 -49.79 34.99 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.215 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 44.6 Cg_exo -57.44 -42.22 63.8 Favored 'Trans proline' 0 N--CA 1.471 0.189 0 C-N-CA 122.63 2.22 . . . . 0.0 113.572 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.602 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -71.3 -45.52 62.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.57 -49.1 19.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.588 ' HB3' HD13 ' A' ' 37' ' ' ILE . 11.0 mttt -75.15 -26.72 59.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.464 ' CG ' HD11 ' A' ' 66' ' ' ILE . 2.5 t0 -101.06 -11.39 19.67 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.95 25.53 3.81 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.138 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.797 HD12 HG21 ' A' ' 48' ' ' VAL . 4.2 pt -122.22 148.73 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.649 0.262 . . . . 0.0 110.531 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 47' ' ' THR . 1.3 m -77.29 135.05 38.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.965 0.412 . . . . 0.0 110.233 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.602 HG12 ' CD2' ' A' ' 61' ' ' LEU . 7.1 p -142.56 148.52 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.697 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.476 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.2 t -103.63 131.2 52.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.138 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' OD1' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -101.1 106.65 17.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.097 0.475 . . . . 0.0 110.651 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.895 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.6 m0 -109.21 103.5 52.62 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.815 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -108.46 171.22 0.09 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.553 2.836 . . . . 0.0 112.559 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.445 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -126.34 139.99 52.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.768 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.429 ' H ' ' HB2' ' A' ' 77' ' ' ALA . 12.4 p30 178.85 -175.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.692 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -54.86 -24.25 22.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.927 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.7 41.34 2.26 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.511 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -102.81 102.82 29.31 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.489 0.185 . . . . 0.0 110.922 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.598 ' O ' HG21 ' A' ' 83' ' ' VAL . 89.2 Cg_exo -47.02 101.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.676 2.251 . . . . 0.0 112.775 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.696 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 27.1 Cg_exo -63.27 -36.91 53.94 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.88 2.386 . . . . 0.0 114.677 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.696 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 9.5 Cg_endo -53.36 154.09 15.7 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.948 1.765 . . . . 0.0 113.697 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -59.68 -20.09 51.08 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.462 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.15 -29.63 14.24 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.467 0.175 . . . . 0.0 111.081 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.895 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 18.4 t -56.2 -52.34 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.683 HG13 HD13 ' A' ' 120' ' ' LEU . 1.4 t -53.81 -40.01 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.391 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -60.55 -31.34 70.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.955 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -50.29 63.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.284 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.76 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -67.86 -33.75 75.36 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.726 HD21 ' CB ' ' A' ' 120' ' ' LEU . 11.8 mt -59.32 -44.88 92.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.525 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -65.99 -39.91 90.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.203 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.507 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.7 tm? -60.16 -51.23 70.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.623 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.911 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.5 p -72.46 -35.99 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.295 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -56.41 -45.02 80.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.686 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.31 -42.23 72.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.709 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -67.49 -27.15 66.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.446 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 2.7 m-85 -81.97 -52.06 7.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.835 0.35 . . . . 0.0 111.331 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.3 t -57.08 -37.43 71.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.101 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -76.11 -33.05 59.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.339 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.13 84.63 61.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.539 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -66.27 136.75 44.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.714 2.276 . . . . 0.0 111.987 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.58 56.9 22.22 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.46 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.05 -161.8 0.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 111.189 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.644 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 1.5 m -125.36 114.05 18.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.268 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.51 HG11 ' HE1' ' A' ' 22' ' ' PHE . 39.1 t -106.88 151.05 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.789 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -119.0 140.9 49.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.79 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.815 HG22 HG12 ' A' ' 49' ' ' VAL . 99.4 t -139.36 166.37 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.57 ' N ' HG12 ' A' ' 105' ' ' VAL . 2.8 t60 -67.06 156.19 36.72 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.147 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 25' ' ' THR . 44.3 t -68.46 105.68 2.28 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.017 HG13 HD12 ' A' ' 24' ' ' ILE . 34.7 m -75.32 0.28 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.107 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.411 ' HB3' ' SG ' ' A' ' 107' ' ' CYS . . . -60.54 -8.56 2.89 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.08 -138.42 4.87 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mt -114.36 127.4 55.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.9 -156.29 8.71 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.154 -1.022 . . . . 0.0 113.121 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.691 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.31 -17.11 7.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.977 0.417 . . . . 0.0 111.758 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.669 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.67 -46.37 98.33 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.79 ' HD3' HG12 ' A' ' 108' ' ' VAL . 8.6 Cg_endo -52.82 -48.45 21.99 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.059 1.84 . . . . 0.0 112.506 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.638 HG22 ' HG3' ' A' ' 148' ' ' GLN . 59.8 t -56.55 -51.74 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.007 0.432 . . . . 0.0 110.285 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.6 HD12 ' CG2' ' A' ' 49' ' ' VAL . 10.3 mt -52.97 -48.35 67.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.614 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.739 HG22 HG21 ' A' ' 105' ' ' VAL . 41.6 t -51.76 -50.56 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.721 0.296 . . . . 0.0 111.464 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.748 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -52.8 -46.91 67.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.327 0.584 . . . . 0.0 110.484 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.726 ' CB ' HD21 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -57.51 -31.41 66.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.623 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.911 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.28 -44.33 62.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.4 . . . . 0.0 110.517 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.445 ' HA ' HD12 ' A' ' 122' ' ' LEU . 7.3 tp -66.82 -15.84 63.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.656 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 1.04 HD11 HD21 ' A' ' 152' ' ' LEU . 2.5 mt -57.23 -30.53 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.696 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -17.2 63.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.013 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.9 m -79.99 -23.31 41.65 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.13 -96.64 0.17 Allowed Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.778 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.583 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 1.3 ptt? -63.55 72.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.941 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.95 -67.42 0.43 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.506 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 7.0 t80 -67.74 -32.73 73.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.004 0.43 . . . . 0.0 110.959 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.48 -52.11 17.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.252 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 41.6 t0 -69.32 -35.86 76.38 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.748 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -61.63 -50.31 73.05 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.771 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -73.92 -37.99 48.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.537 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -74.08 -49.71 22.82 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.689 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.19 -34.32 72.8 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.72 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.23 -29.86 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 110.473 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.16 -43.23 82.81 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.633 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -45.55 91.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 110.598 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.434 ' HE2' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -87.37 151.41 23.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.223 179.301 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.407 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.7 116.47 14.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.568 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.35 163.67 15.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.074 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.04 -174.86 0.08 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.555 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.4 9.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.56 0.68 . . . . 0.0 111.443 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.801 HD12 HD21 ' A' ' 149' ' ' LEU . 1.6 pt -88.4 109.57 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.543 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -113.13 -76.72 0.58 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.75 -60.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.824 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 10.5 tmtt? -55.94 -52.05 65.51 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.693 ' OE1' HD22 ' A' ' 149' ' ' LEU . 17.6 tm0? -58.3 -51.52 69.43 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.801 HD21 HD12 ' A' ' 144' ' ' ILE . 3.2 mm? -72.02 -41.0 68.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 50.0 m -70.53 -39.69 73.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.779 0.323 . . . . 0.0 111.524 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.824 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.35 -50.97 63.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.228 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.04 HD21 HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -66.87 -31.23 71.69 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.708 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.57 -37.7 87.19 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -23.94 59.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.545 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CB ' HD23 ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.21 -40.63 90.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.286 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.9 88.21 3.45 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.563 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.68 153.08 79.73 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.669 2.246 . . . . 0.0 112.521 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -147.24 123.47 10.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.477 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -57.99 -32.6 68.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.035 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.3 -30.8 69.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.95 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.38 -41.41 76.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.38 92.73 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -74.11 156.04 37.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -138.18 132.63 32.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.56 138.1 44.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.446 ' HG3' ' CE1' ' A' ' 169' ' ' HIS . 42.9 Cg_endo -67.58 158.74 55.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.495 2.13 . . . . 0.0 112.29 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.462 ' H ' ' CD2' ' A' ' 167' ' ' HIS . 15.1 p80 -75.62 -37.4 59.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.977 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -143.03 147.1 34.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.446 ' CE1' ' HG3' ' A' ' 166' ' ' PRO . 1.7 m-70 -116.71 154.95 29.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -101.24 -33.49 10.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.85 175.94 9.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.879 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -107.32 98.72 8.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.878 0.371 . . . . 0.0 110.894 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -115.37 -39.82 3.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -150.07 -60.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.906 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.17 110.81 3.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -76.33 -37.9 56.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -167.69 162.79 14.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -156.15 159.63 39.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.0 133.96 9.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.771 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.16 90.94 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.357 2.038 . . . . 0.0 112.364 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.33 153.71 95.62 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.011 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.728 ' HB3' HG23 ' A' ' 25' ' ' THR . 58.1 Cg_endo -71.52 160.22 49.07 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.596 2.197 . . . . 0.0 112.378 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.429 HG11 ' CD ' ' A' ' 139' ' ' LYS . 18.5 t -143.26 126.89 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.853 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 5.5 pt-20 -109.38 116.68 32.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.895 0.379 . . . . 0.0 111.618 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.75 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -107.42 118.53 55.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.3 p -140.97 140.53 34.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.106 0.479 . . . . 0.0 112.056 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' CD2' ' HE1' ' A' ' 127' ' ' MET . 0.0 OUTLIER -141.03 147.56 38.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.701 178.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 1.3 mmmp? 64.59 -90.73 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.273 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.51 -45.02 1.21 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.531 ' SD ' HD21 ' A' ' 122' ' ' LEU . 2.7 ppp? -73.68 164.76 26.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 111.728 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -139.2 164.32 30.11 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.475 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.698 ' CE1' HG11 ' A' ' 103' ' ' VAL . 0.3 OUTLIER -134.18 141.63 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.4 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.075 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -114.9 133.86 55.63 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.107 0.48 . . . . 0.0 111.038 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.965 HD12 HG13 ' A' ' 108' ' ' VAL . 1.7 mm -117.92 106.56 20.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.156 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.728 HG23 ' HB3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -134.67 166.83 22.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.15 0.5 . . . . 0.0 111.509 -179.036 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.522 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 7.3 p80 -81.31 151.77 27.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.175 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -63.02 154.42 77.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.023 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.524 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.3 Cg_exo -54.72 139.03 77.17 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.329 2.019 . . . . 0.0 113.245 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.439 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 29.8 p -98.59 174.21 6.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.096 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -92.75 -9.89 39.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.64 -30.85 14.73 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 p -139.79 89.56 2.32 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.244 -0.582 . . . . 0.0 112.357 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.503 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -80.27 -52.27 7.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 0.0 111.169 178.124 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -58.59 -46.09 87.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.352 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.7 m -57.83 -32.45 67.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.841 0.353 . . . . 0.0 111.148 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.687 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.16 -47.99 32.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.114 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.946 HG21 ' HB3' ' A' ' 63' ' ' LYS . 10.8 pt -56.12 -38.84 55.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.55 . . . . 0.0 110.539 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.1 -51.94 61.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.369 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.1 m-20 -69.43 -50.21 47.91 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.866 0.365 . . . . 0.0 111.72 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.687 HD21 ' CE1' ' A' ' 36' ' ' PHE . 57.6 mt -56.12 -44.75 79.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.958 0.408 . . . . 0.0 110.326 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -78.18 -26.67 47.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -52.74 -44.13 66.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.311 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.075 ' CD1' HD21 ' A' ' 23' ' ' LEU . 16.8 t80 -63.45 -38.17 90.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.73 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.72 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.41 -176.96 40.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.943 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.71 118.05 20.33 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.752 HG22 ' H ' ' A' ' 47' ' ' THR . 1.3 m -165.06 -170.27 1.89 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.822 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.752 ' H ' HG22 ' A' ' 46' ' ' THR . 1.5 t -64.91 150.75 47.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.458 0.647 . . . . 0.0 110.122 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.786 HG21 HD12 ' A' ' 66' ' ' ILE . 48.2 t -126.33 133.69 68.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.817 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.039 HG13 HG13 ' A' ' 105' ' ' VAL . 8.5 p -115.24 105.45 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.155 0.502 . . . . 0.0 111.184 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.52 110.9 21.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.755 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.952 HG11 ' HB2' ' A' ' 113' ' ' ARG . 39.6 t -103.28 91.27 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.55 0.691 . . . . 0.0 110.236 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.2 171.43 20.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.05 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.78 130.7 44.51 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -68.55 121.93 18.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.0 p -120.63 -47.38 2.32 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.948 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.43 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 4.2 m-85 -130.23 84.4 2.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.288 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.4 -35.85 46.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -78.84 -48.43 14.74 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.503 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -45.67 -50.26 33.39 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.226 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.43 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 39.4 Cg_exo -61.64 -42.13 34.72 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.543 2.162 . . . . 0.0 113.639 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.91 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -71.32 -45.65 62.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.68 -49.29 18.78 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.946 ' HB3' HG21 ' A' ' 37' ' ' ILE . 10.4 mttt -61.41 -39.4 90.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.89 ' OD2' HG22 ' A' ' 37' ' ' ILE . 45.8 m-20 -101.76 -11.39 19.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 53.2 25.17 24.63 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.771 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.786 HD12 HG21 ' A' ' 48' ' ' VAL . 8.9 pt -107.52 149.08 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.854 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 47' ' ' THR . 63.9 p -77.46 135.44 38.26 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.91 HG12 ' CD2' ' A' ' 61' ' ' LEU . 11.7 p -140.17 150.08 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.464 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.6 t -103.35 132.08 50.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.86 106.65 18.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.172 0.51 . . . . 0.0 110.706 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.768 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.5 m95 -111.25 103.73 55.3 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.498 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -107.43 178.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.472 2.782 . . . . 0.0 113.008 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.425 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -126.27 120.48 30.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.686 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.34 -176.28 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -54.9 -24.82 25.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.843 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.42 88.19 0.2 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.441 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.437 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -85.71 124.65 70.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 O-C-N 122.91 -0.17 . . . . 0.0 110.749 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.71 101.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.68 2.253 . . . . 0.0 112.582 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.666 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 51.3 Cg_exo -55.05 -44.06 53.27 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.813 2.342 . . . . 0.0 114.021 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 5.0 Cg_endo -49.27 147.94 11.05 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.277 1.985 . . . . 0.0 113.465 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.591 ' HA2' ' HZ2' ' A' ' 147' ' ' LYS . . . -66.1 -19.32 67.91 Favored Glycine 0 C--N 1.33 0.208 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.103 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 2.6 tttt -50.23 -29.53 9.67 Favored 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 123.457 0.151 . . . . 0.0 111.146 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.72 HG12 ' CH2' ' A' ' 71' ' ' TRP . 21.6 t -54.73 -48.17 72.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.828 HG11 ' HG ' ' A' ' 120' ' ' LEU . 78.4 t -59.34 -38.05 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.207 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.748 ' HA ' HD12 ' A' ' 88' ' ' LEU . 8.1 mt-10 -58.16 -31.18 67.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.57 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.07 -50.68 63.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.912 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.827 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -67.1 -27.03 67.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.201 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.804 HD21 ' HB3' ' A' ' 120' ' ' LEU . 26.3 mt -63.42 -39.29 94.1 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.966 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.4 m -66.8 -44.95 79.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.029 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.1 tm? -57.27 -51.41 69.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.483 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.838 HG21 ' HB1' ' A' ' 121' ' ' ALA . 9.0 p -69.77 -35.87 67.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.718 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.65 -45.22 73.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.81 -43.91 74.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.687 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -26.22 65.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.126 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.548 ' HE1' HG21 ' A' ' 103' ' ' VAL . 1.6 m-85 -82.04 -52.0 7.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 111.192 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 15.9 t -67.05 -34.96 78.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.176 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -33.08 59.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.161 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.12 96.3 37.26 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.386 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.94 132.42 23.01 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.457 2.105 . . . . 0.0 112.058 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.04 56.12 27.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.174 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.573 ' OG ' HG21 ' A' ' 46' ' ' THR . 82.5 p -101.07 169.38 8.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 111.232 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.72 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -100.68 113.78 26.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.573 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.698 HG11 ' CE1' ' A' ' 22' ' ' PHE . 24.4 t -107.85 151.29 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.757 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -120.94 140.87 51.25 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.323 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.057 HG11 HG22 ' A' ' 118' ' ' VAL . 3.0 t -140.07 166.54 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.548 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.3 t-80 -67.97 155.84 38.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -68.84 105.61 2.41 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.965 HG13 HD12 ' A' ' 24' ' ' ILE . 32.0 m -75.39 -0.04 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.01 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.77 -8.5 3.06 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.97 -128.77 3.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.543 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.902 HD21 ' HB2' ' A' ' 143' ' ' ALA . 0.1 OUTLIER -132.09 127.4 35.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -171.31 -142.31 3.63 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.397 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.952 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.44 -21.8 5.67 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.994 0.426 . . . . 0.0 111.89 -178.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.661 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.17 -46.8 82.9 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.727 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.5 Cg_endo -52.13 -48.49 21.42 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.296 1.997 . . . . 0.0 112.867 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.747 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.2 t -59.23 -41.79 84.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.674 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.453 HD11 ' CE3' ' A' ' 71' ' ' TRP . 7.1 mt -61.06 -50.08 74.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.737 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 1.057 HG22 HG11 ' A' ' 105' ' ' VAL . 12.0 t -53.76 -55.52 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -60.2 -47.14 87.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.129 0.49 . . . . 0.0 110.839 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.828 ' HG ' HG11 ' A' ' 84' ' ' VAL . 3.3 mm? -54.59 -30.76 55.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.044 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.838 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.33 -49.99 30.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.046 0.45 . . . . 0.0 110.54 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.531 HD21 ' SD ' ' A' ' 20' ' ' MET . 0.3 OUTLIER -62.62 -15.67 52.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.083 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.931 ' CD1' HD21 ' A' ' 152' ' ' LEU . 1.2 mt -57.45 -34.58 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.637 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.31 -15.38 15.65 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.81 11.38 3.28 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 116.99 -85.53 0.39 Allowed Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.158 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.42 78.39 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.892 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -62.37 -67.71 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.531 ' HD1' HD22 ' A' ' 152' ' ' LEU . 6.4 t80 -74.98 -30.52 61.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.122 0.487 . . . . 0.0 110.544 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -72.6 -46.64 53.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.034 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 127' ' ' MET . 51.5 t0 -70.22 -47.3 62.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.381 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.816 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -58.32 -50.32 74.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.871 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 129' ' ' TYR . 32.7 mm -69.54 -37.85 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.46 -49.93 20.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.75 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.61 -34.67 74.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.647 0.261 . . . . 0.0 110.977 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 119' ' ' ALA . 1.8 tt -74.21 -34.05 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.0 110.645 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -63.46 -45.9 88.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -39.79 85.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.023 0.44 . . . . 0.0 110.499 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.429 ' CD ' HG11 ' A' ' 13' ' ' VAL . 14.7 mmtt -87.09 152.27 22.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.68 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.66 117.89 14.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.457 ' HD3' HG23 ' A' ' 136' ' ' ILE . 0.1 OUTLIER -114.28 163.34 15.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.946 -179.081 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -62.26 -156.55 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.329 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.902 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -90.2 98.71 11.93 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.942 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.583 HG22 ' HG3' ' A' ' 148' ' ' GLN . 1.1 pt -88.9 108.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.815 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -113.66 -77.38 0.58 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 119.88 -0.728 . . . . 0.0 112.756 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.49 -60.8 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.728 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -53.21 -51.78 61.02 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.411 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.693 ' HG3' HG22 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -56.84 -52.09 66.47 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.13 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.28 -40.0 59.14 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.3 m -69.47 -42.71 74.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.878 0.37 . . . . 0.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.728 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -63.59 -50.56 68.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.931 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -65.29 -36.51 84.3 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.784 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -55.92 -39.82 72.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.405 ' C ' ' HD2' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -74.13 -24.85 59.5 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.213 178.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.663 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -66.17 -39.99 90.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.34 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.413 ' HB2' ' HB2' ' A' ' 129' ' ' TYR . 0.0 OUTLIER -106.97 113.91 62.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.168 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.05 153.31 26.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.57 2.18 . . . . 0.0 112.063 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -141.21 123.27 15.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.118 0.485 . . . . 0.0 110.45 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -71.6 -21.0 61.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.17 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -61.27 -36.8 81.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.09 -48.06 8.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.181 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -171.9 3.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.16 160.62 27.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.34 124.67 10.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -89.6 106.96 15.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.41 177.11 4.91 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.439 2.093 . . . . 0.0 112.286 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -157.04 130.44 7.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.5 m -147.54 158.66 44.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.19 -38.8 3.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.402 ' HD3' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -139.9 -53.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.402 HG22 ' HD3' ' A' ' 170' ' ' LYS . 3.9 t -151.28 -48.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 46.0 mtt85 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.904 179.901 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.3 p -98.34 120.24 38.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -91.9 -64.31 1.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.9 mtt 60.55 92.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.93 124.39 24.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.067 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -98.12 106.14 18.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.8 mmt -142.66 123.92 14.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -105.04 105.84 16.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.95 101.98 1.44 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.63 98.36 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.345 2.03 . . . . 0.0 112.428 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.31 151.48 53.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.014 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 58.7 Cg_endo -72.1 152.03 56.19 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.468 2.112 . . . . 0.0 112.305 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.416 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 19.1 t -144.09 126.94 11.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 mp0 -112.77 116.84 30.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.904 0.383 . . . . 0.0 111.611 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.81 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -106.84 118.33 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.5 p -141.29 143.68 34.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.732 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -133.36 158.8 42.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.248 178.167 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 45.7 -93.16 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.302 0.241 . . . . 0.0 111.384 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -127.04 -29.31 2.8 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.589 ' HE3' HD13 ' A' ' 122' ' ' LEU . 4.3 ppp? -73.65 159.13 33.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.58 0.228 . . . . 0.0 111.183 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -141.63 164.06 31.22 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.143 0.497 . . . . 0.0 111.807 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' HE1' HG11 ' A' ' 103' ' ' VAL . 3.4 m-85 -138.14 144.31 40.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.933 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.056 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -119.39 135.49 54.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.033 0.444 . . . . 0.0 111.002 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.886 HG21 HG22 ' A' ' 108' ' ' VAL . 5.1 mm -118.51 106.69 20.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.64 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.611 HG21 HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -130.36 165.31 22.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.48 0.657 . . . . 0.0 111.943 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.496 ' CD2' ' CE2' ' A' ' 36' ' ' PHE . 35.9 p-80 -81.89 152.58 26.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.941 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -62.42 154.76 70.81 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.1 Cg_exo -54.09 136.65 68.14 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.246 1.964 . . . . 0.0 113.162 -177.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -98.64 147.03 25.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.302 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -68.68 -12.36 61.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.49 -31.41 14.58 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.2 p -139.97 88.81 2.26 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.119 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.5 OUTLIER -80.91 -52.23 7.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.221 0.534 . . . . 0.0 111.359 178.069 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.44 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.7 m -56.44 -46.17 80.44 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.49 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.8 m -57.62 -31.92 66.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.853 0.359 . . . . 0.0 111.286 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.689 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.3 -47.77 26.34 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.81 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.8 pt -55.83 -39.12 54.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.192 0.52 . . . . 0.0 110.648 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.38 -52.08 56.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.46 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.547 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 7.1 m-20 -68.06 -50.12 57.13 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.82 0.343 . . . . 0.0 111.799 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.689 HD21 ' CE1' ' A' ' 36' ' ' PHE . 63.4 mt -55.76 -45.78 78.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.427 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -77.05 -26.64 53.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.119 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 7.0 mttt -53.12 -44.74 67.93 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.288 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.056 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.0 t80 -63.43 -38.56 91.6 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.709 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.702 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.35 -179.57 39.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.038 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.55 117.25 19.31 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 101' ' ' SER . 0.8 OUTLIER -164.9 -169.77 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.892 177.65 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' THR . 9.1 p -64.59 160.08 20.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.455 0.645 . . . . 0.0 110.686 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 104' ' ' ALA . 57.2 t -139.0 137.01 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.078 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.825 HG12 HG22 ' A' ' 105' ' ' VAL . 11.3 p -115.52 104.3 16.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.479 0.657 . . . . 0.0 111.385 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -115.21 111.04 20.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.028 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.794 HG13 ' HB3' ' A' ' 71' ' ' TRP . 11.9 t -106.49 91.48 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.405 0.621 . . . . 0.0 109.914 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.4 p -157.68 171.24 20.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.77 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.403 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 2.2 mm-40 -66.62 130.5 43.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 54' ' ' VAL . 14.9 p -73.37 122.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.9 p -120.0 -47.7 2.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.254 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.404 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 1.2 m-85 -130.6 83.67 2.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.467 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.2 -36.61 39.89 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -79.6 -48.58 13.55 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.478 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.56 -56.97 7.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 61.5 Cg_endo -72.99 -34.71 6.11 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.47 2.113 . . . . 0.0 113.811 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.037 HD21 HG11 ' A' ' 68' ' ' VAL . 2.0 mm? -71.1 -45.44 63.68 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.21 -28.91 60.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.81 ' HB3' HG21 ' A' ' 37' ' ' ILE . 3.5 mtpp -78.92 -36.57 41.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.517 ' O ' HG13 ' A' ' 66' ' ' ILE . 1.2 m-20 -101.76 -12.27 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.28 23.95 6.52 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.11 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 64' ' ' ASP . 28.1 mt -93.15 147.38 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.728 0.299 . . . . 0.0 111.029 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 47' ' ' THR . 27.8 m -78.52 129.58 35.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.037 HG11 HD21 ' A' ' 61' ' ' LEU . 6.1 p -145.07 152.46 14.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.261 0.553 . . . . 0.0 111.945 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.76 129.25 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.258 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.0 106.72 18.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.972 0.415 . . . . 0.0 110.946 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 1.008 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 5.2 m0 -107.38 103.55 49.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.626 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -107.96 -163.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 123.617 2.878 . . . . 0.0 112.439 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -119.51 95.78 4.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.888 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -176.97 -99.57 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -76.22 -34.05 59.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.078 0.466 . . . . 0.0 110.509 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.08 76.63 0.39 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.781 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -85.74 154.75 58.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 0.0 111.541 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.497 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 35.1 Cg_exo -61.9 -40.69 42.23 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.971 2.448 . . . . 0.0 113.768 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 87.6 Cg_exo -40.24 -55.18 1.92 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.629 2.219 . . . . 0.0 113.915 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 79' ' ' PRO . 18.0 Cg_endo -59.37 135.09 62.85 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.671 1.581 . . . . 0.0 111.823 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.481 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -67.07 -33.63 84.11 Favored Glycine 0 C--O 1.239 0.418 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.612 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 -45.46 69.16 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.675 0.274 . . . . 0.0 111.165 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 1.008 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 26.1 t -55.05 -41.55 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.709 HG22 ' CD1' ' A' ' 120' ' ' LEU . 0.5 OUTLIER -53.55 -41.65 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -65.83 -31.21 72.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.504 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -64.08 -50.94 66.37 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.749 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -67.52 -32.85 73.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.696 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.811 HD21 ' HB3' ' A' ' 120' ' ' LEU . 12.0 mt -57.01 -45.67 82.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.467 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -43.13 94.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.493 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.511 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.5 tm? -58.35 -51.66 68.87 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.009 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.886 HG21 ' HB1' ' A' ' 121' ' ' ALA . 13.8 p -70.96 -39.96 75.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.376 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -58.55 -41.02 84.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.924 0.393 . . . . 0.0 110.547 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.75 -48.17 75.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.642 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -71.59 -25.7 62.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.485 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.0 m-85 -75.11 -51.73 12.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.7 t -60.0 -42.26 93.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.788 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -76.09 -33.06 59.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -126.08 92.12 46.55 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.275 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.22 138.29 15.89 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.637 2.225 . . . . 0.0 112.489 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.401 ' HA2' ' CB ' ' A' ' 20' ' ' MET . . . 58.24 56.35 25.69 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.712 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.691 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.8 OUTLIER -101.24 -172.49 2.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 111.176 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.702 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 m -108.29 113.55 26.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.145 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.64 HG11 ' HE1' ' A' ' 22' ' ' PHE . 46.0 t -111.3 149.55 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.183 0.516 . . . . 0.0 112.306 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.858 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -119.96 144.3 47.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.949 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.825 HG22 HG12 ' A' ' 49' ' ' VAL . 96.5 t -140.17 166.32 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.711 0.291 . . . . 0.0 111.6 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.571 ' N ' HG12 ' A' ' 105' ' ' VAL . 1.6 t-80 -67.34 155.74 38.19 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.344 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.465 ' O ' ' CE1' ' A' ' 106' ' ' HIS . 0.2 OUTLIER -68.61 106.59 2.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.413 0.625 . . . . 0.0 112.615 -178.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.886 HG22 HG21 ' A' ' 24' ' ' ILE . 28.0 m -75.33 0.53 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.221 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.19 -8.58 2.57 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.07 -124.86 2.87 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 111' ' ' LEU . 8.4 mt -128.15 127.34 42.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.98 -158.17 9.17 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.261 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.626 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.19 -18.81 6.74 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.063 0.459 . . . . 0.0 111.776 -178.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.806 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -52.75 -46.2 96.53 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.687 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.6 Cg_endo -52.78 -48.44 22.01 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.043 1.829 . . . . 0.0 112.509 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.774 HG22 ' HG3' ' A' ' 148' ' ' GLN . 58.5 t -55.95 -51.88 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 0.0 109.94 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.674 HD12 ' CG2' ' A' ' 49' ' ' VAL . 8.8 mt -54.47 -46.2 73.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.583 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 114' ' ' ALA . 17.0 t -51.42 -50.58 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 111.076 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.818 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -54.03 -48.04 70.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.29 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.811 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.2 mt -53.97 -31.32 50.33 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.205 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.886 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.51 -50.61 29.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.716 0.293 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.768 HD23 ' OD2' ' A' ' 131' ' ' ASP . 8.5 tp -66.55 -14.63 62.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.714 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.999 HD11 HD21 ' A' ' 152' ' ' LEU . 2.2 mt -58.49 -30.95 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.063 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -70.49 -16.55 62.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.44 -23.24 40.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.67 -96.96 0.17 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.792 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.647 ' HE3' ' CD2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -63.12 74.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.904 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -70.73 -67.47 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.472 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 6.9 t80 -65.49 -34.86 79.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.933 0.397 . . . . 0.0 111.341 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -71.77 -51.5 22.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.454 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.768 ' OD2' HD23 ' A' ' 122' ' ' LEU . 32.8 t70 -70.14 -32.51 70.53 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.943 0.402 . . . . 0.0 111.06 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.818 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -62.3 -50.16 72.76 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.97 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.478 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 32.9 mm -74.5 -40.32 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.269 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -50.03 19.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.81 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.48 -38.98 88.47 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.29 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -74.43 -27.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.709 0.29 . . . . 0.0 110.877 179.027 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 1.9 ttp85 -65.08 -42.2 94.31 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.797 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -45.43 91.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.888 0.375 . . . . 0.0 110.41 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' ILE . 6.7 mmtt -87.72 151.72 22.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.273 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.36 117.0 14.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.163 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 163.81 14.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.288 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -53.52 -173.61 0.05 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.011 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.417 ' N ' HD22 ' A' ' 111' ' ' LEU . . . -84.13 99.5 10.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.213 0.507 . . . . 0.0 111.473 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 1.09 HD12 HD21 ' A' ' 149' ' ' LEU . 1.8 pt -88.17 109.5 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.407 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -113.13 -76.5 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.313 0.856 . . . . 0.0 113.313 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.7 p -99.63 -60.84 1.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.897 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.3 tmtt? -56.81 -51.87 67.27 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -176.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.774 ' HG3' HG22 ' A' ' 116' ' ' VAL . 9.8 tm0? -56.73 -51.22 69.68 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.09 HD21 HD12 ' A' ' 144' ' ' ILE . 3.9 mm? -72.98 -43.09 62.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 m -70.27 -39.71 74.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.771 0.319 . . . . 0.0 111.661 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.897 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -66.54 -50.91 61.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.999 HD21 HD11 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -66.49 -30.17 70.44 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.413 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.93 -40.12 96.66 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -22.72 61.46 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.58 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.467 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.21 -47.95 72.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.608 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.98 97.07 16.45 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.42 133.01 33.12 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.37 2.046 . . . . 0.0 112.189 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -147.15 123.58 11.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.67 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -77.99 -2.83 38.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.422 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -58.88 -31.08 68.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.876 0.37 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.25 -36.86 78.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -102.54 30.34 4.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -101.09 -62.8 1.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.63 136.89 36.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.8 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.36 129.81 94.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.817 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.29 -44.27 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.486 2.124 . . . . 0.0 112.304 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -75.92 -40.63 53.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.7 m -71.11 128.48 36.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -92.44 123.47 35.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.29 107.6 12.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.922 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.4 p -96.06 137.32 35.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.194 -0.907 . . . . 0.0 110.902 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -162.67 90.06 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 110.937 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -108.25 109.26 20.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.35 -47.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.82 108.6 18.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.073 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.18 -48.18 3.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.824 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 36.2 mtm -115.71 164.41 14.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -127.45 -45.3 1.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.2 130.59 49.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.36 122.91 12.06 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.412 2.075 . . . . 0.0 112.292 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . . . -81.52 129.01 67.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.028 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.6 ' HB3' HG23 ' A' ' 25' ' ' THR . 37.5 Cg_exo -57.03 161.91 10.0 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.408 2.072 . . . . 0.0 112.126 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.733 HG11 ' CE ' ' A' ' 139' ' ' LYS . 3.7 t -137.74 126.97 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.817 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 11.6 pt-20 -107.42 116.92 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 111.752 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.836 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.7 OUTLIER -108.92 118.53 56.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.499 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.9 p -140.99 147.56 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 111.95 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CD2' ' HG2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -144.04 126.35 15.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.282 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 38.0 mmtt 77.92 -87.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.278 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -129.38 -40.62 1.43 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.631 ' CE ' HD13 ' A' ' 122' ' ' LEU . 2.7 tmm? -73.74 154.41 39.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.884 0.373 . . . . 0.0 111.289 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.11 161.66 35.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.621 ' CE2' ' HE1' ' A' ' 20' ' ' MET . 8.6 m-85 -132.09 145.75 51.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.069 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.3 mm? -117.81 129.21 55.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 110.791 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.871 HD12 HG13 ' A' ' 108' ' ' VAL . 2.1 mm -112.56 106.63 21.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.6 HG23 ' HB3' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -130.89 164.54 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.243 0.544 . . . . 0.0 111.987 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 50.0 p-80 -81.24 152.33 27.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.797 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.6 153.46 77.76 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.521 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 9.6 Cg_endo -54.43 139.58 74.34 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.564 2.176 . . . . 0.0 113.475 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.439 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.6 p -98.86 174.38 6.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.095 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -98.24 -8.08 27.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -30.6 14.91 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 p -139.37 89.73 2.36 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.487 -0.485 . . . . 0.0 112.112 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.448 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.6 OUTLIER -79.99 -52.28 8.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.122 0.487 . . . . 0.0 111.421 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 37' ' ' ILE . 1.2 m -57.62 -45.38 85.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.083 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -32.03 67.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.797 0.332 . . . . 0.0 111.464 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.646 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.57 -48.01 24.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.09 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.915 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.9 pt -55.88 -39.21 55.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.178 0.513 . . . . 0.0 110.746 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.12 -52.08 51.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.58 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.559 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 4.8 m-20 -67.67 -50.14 59.26 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.905 0.384 . . . . 0.0 111.945 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.646 HD21 ' CE1' ' A' ' 36' ' ' PHE . 80.0 mt -55.79 -46.35 78.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.359 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -76.95 -26.71 54.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.083 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 5.3 mttt -52.91 -44.46 66.98 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.069 ' CD1' HD21 ' A' ' 23' ' ' LEU . 15.4 t80 -63.54 -38.62 91.81 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.734 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.692 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.6 -178.82 39.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.991 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.38 19.54 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 47' ' ' THR . 0.9 OUTLIER -165.19 -169.93 1.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.92 177.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.647 ' H ' HG22 ' A' ' 46' ' ' THR . 3.0 t -64.55 152.52 41.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.705 0.764 . . . . 0.0 110.437 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.81 HG22 ' HB3' ' A' ' 104' ' ' ALA . 83.6 t -132.2 136.5 56.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.006 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.062 HG13 HG13 ' A' ' 105' ' ' VAL . 14.9 p -115.66 105.31 18.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.147 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.423 ' HG2' ' CG2' ' A' ' 68' ' ' VAL . 17.1 ptt180 -113.59 110.85 20.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.748 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 113' ' ' ARG . 41.9 t -108.57 91.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.571 0.7 . . . . 0.0 110.327 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.7 p -157.82 171.03 21.02 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.041 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.27 130.25 42.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.689 HG23 ' HB3' ' A' ' 72' ' ' PRO . 17.6 t -70.22 122.19 21.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.5 p -120.51 -47.93 2.31 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.179 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.422 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.3 m-85 -130.77 83.91 2.15 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.623 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.13 -36.78 40.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.65 -48.58 13.5 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.448 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -45.92 -54.3 17.28 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 8.2 Cg_exo -73.1 -35.6 5.07 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.659 2.239 . . . . 0.0 113.653 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.977 HD21 HG11 ' A' ' 68' ' ' VAL . 2.1 mm? -71.03 -45.24 64.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.01 -28.97 60.72 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.915 ' HB3' HG21 ' A' ' 37' ' ' ILE . 5.7 mttp -81.02 -35.09 32.33 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.541 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -101.56 -12.45 18.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.48 25.61 4.6 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.378 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 64' ' ' ASP . 20.8 mt -95.36 147.72 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.672 0.272 . . . . 0.0 111.079 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 47' ' ' THR . 1.8 m -78.16 127.94 33.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.977 HG11 HD21 ' A' ' 61' ' ' LEU . 10.5 p -145.18 153.95 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.151 0.501 . . . . 0.0 112.209 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.7 t -103.33 132.75 48.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -101.08 106.84 18.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.124 0.488 . . . . 0.0 110.931 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.74 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.8 m95 -111.4 103.25 54.8 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.739 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.689 ' HB3' HG23 ' A' ' 54' ' ' VAL . 31.1 Cg_endo -109.45 -177.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.62 2.88 . . . . 0.0 112.657 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -126.41 122.22 34.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.848 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.16 -164.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.442 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -20.99 50.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.951 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -102.22 20.9 43.41 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.911 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -107.46 102.71 45.58 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.718 0.259 . . . . 0.0 110.711 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.688 ' HB2' HG13 ' A' ' 83' ' ' VAL . 17.6 Cg_exo -67.14 109.42 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.745 2.297 . . . . 0.0 112.502 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 52.5 Cg_exo -53.02 -45.53 40.45 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.692 2.261 . . . . 0.0 113.852 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.745 ' O ' HG22 ' A' ' 83' ' ' VAL . 8.0 Cg_endo -51.39 154.09 9.06 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.422 2.081 . . . . 0.0 113.662 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.73 -19.55 58.51 Favored Glycine 0 C--O 1.235 0.216 0 CA-C-N 114.979 -1.01 . . . . 0.0 113.52 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -50.85 -35.68 33.78 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.623 0.211 . . . . 0.0 111.009 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -54.04 -44.7 63.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.628 HG11 ' HE2' ' A' ' 151' ' ' TYR . 39.4 t -55.33 -43.53 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.344 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.527 ' HA ' HD12 ' A' ' 88' ' ' LEU . 21.0 mm-40 -55.37 -31.62 61.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.263 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -50.07 70.15 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.419 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.754 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.9 -30.3 70.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.897 HD21 ' HB3' ' A' ' 120' ' ' LEU . 22.9 mt -59.6 -48.32 82.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.451 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 m -63.63 -40.45 96.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.189 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.476 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.3 tm? -59.57 -51.26 70.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.616 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.917 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.8 p -69.92 -35.92 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.092 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -48.06 78.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.76 92.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.748 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -26.78 63.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.139 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.462 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.7 m-85 -82.08 -52.0 7.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.229 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.0 t -59.51 -37.95 79.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.25 -33.05 59.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.278 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.09 95.31 39.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.509 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.46 134.12 15.14 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.553 2.169 . . . . 0.0 112.223 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 56.09 27.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.494 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.642 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.9 OUTLIER -101.0 -164.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 0.0 111.248 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.692 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 m -117.74 113.51 21.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.32 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.0 t -108.71 151.03 11.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 111.983 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.81 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.99 141.79 51.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.963 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.062 HG13 HG13 ' A' ' 49' ' ' VAL . 10.1 t -140.3 166.9 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.527 ' N ' HG12 ' A' ' 105' ' ' VAL . 1.5 t-80 -66.76 156.1 36.37 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.441 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.514 ' N ' ' O ' ' A' ' 25' ' ' THR . 49.8 t -68.34 106.05 2.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.314 0.578 . . . . 0.0 112.457 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.871 HG13 HD12 ' A' ' 24' ' ' ILE . 28.8 m -75.2 0.21 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.097 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.65 -8.63 3.03 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.47 -131.31 3.67 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.402 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 14.0 mt -124.42 127.42 47.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.75 -151.49 6.5 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.33 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.808 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.19 -21.26 5.95 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 111.805 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.663 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -51.28 -46.42 89.46 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.751 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.2 Cg_endo -52.02 -48.51 21.24 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.2 1.934 . . . . 0.0 112.978 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.837 HG12 HD11 ' A' ' 120' ' ' LEU . 25.5 t -60.1 -41.09 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.67 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.507 HD12 ' CG2' ' A' ' 49' ' ' VAL . 13.0 mt -60.24 -45.25 93.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.531 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.673 ' CG2' HG11 ' A' ' 105' ' ' VAL . 38.2 t -57.34 -55.14 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.749 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.72 -51.74 59.15 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.264 0.554 . . . . 0.0 110.94 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.897 ' HB3' HD21 ' A' ' 88' ' ' LEU . 6.7 mt -55.27 -30.48 60.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.16 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.917 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.93 -40.08 69.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 110.148 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.631 HD13 ' CE ' ' A' ' 20' ' ' MET . 6.4 tp -71.26 -14.36 62.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 1.001 HD11 HD21 ' A' ' 152' ' ' LEU . 2.8 mt -57.2 -30.7 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.661 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -16.61 63.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.9 p -79.53 -23.39 42.91 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.55 -96.66 0.17 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.805 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.528 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 1.4 ptt? -64.0 72.61 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.941 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.16 -67.61 0.42 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.666 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.596 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.8 t80 -67.73 -32.68 73.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 111.046 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 127' ' ' MET . 12.1 mp0 -72.29 -51.91 18.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.321 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 46.8 t0 -67.12 -39.78 86.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 111.043 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.749 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -59.43 -50.0 75.63 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.203 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 35.6 mm -73.94 -36.28 44.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.645 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.22 -49.51 23.09 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.836 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.37 -36.91 74.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.627 0.251 . . . . 0.0 110.793 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.5 tt -74.22 -28.23 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.815 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 8.0 ttm180 -68.35 -47.92 66.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.818 0.342 . . . . 0.0 110.399 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -59.89 -45.02 93.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.443 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.733 ' CE ' HG11 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -84.7 151.73 24.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.319 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.6 116.48 14.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.063 0.459 . . . . 0.0 110.667 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -115.39 163.47 15.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.844 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.402 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -55.07 -176.78 0.15 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.247 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.05 98.75 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.772 0.786 . . . . 0.0 110.751 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.63 HD12 HD21 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -88.94 109.68 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.972 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -112.88 -76.71 0.58 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.397 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.747 ' O ' HG22 ' A' ' 150' ' ' THR . 4.8 p -99.77 -60.79 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.738 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.8 tmtt? -49.04 -51.44 31.1 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -177.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.543 ' HG3' HG21 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -56.29 -51.67 67.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.244 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.63 HD21 HD12 ' A' ' 144' ' ' ILE . 3.4 mm? -75.27 -39.37 59.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 146' ' ' SER . 12.3 t -74.12 -36.25 64.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.577 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.738 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -70.16 -50.68 37.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.193 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -67.11 -35.08 79.0 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.216 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.1 -43.58 82.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -25.24 65.27 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.336 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.715 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -66.11 -32.53 74.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.373 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.54 91.77 6.33 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.747 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.46 153.29 78.87 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.663 2.242 . . . . 0.0 112.585 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -146.98 123.56 11.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.44 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -53.72 -23.94 13.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.347 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -58.8 -27.86 65.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.016 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.17 -48.02 74.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.42 -169.49 1.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -115.47 156.25 26.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.983 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? 60.08 164.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -83.52 109.63 19.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.28 111.15 2.42 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.425 2.083 . . . . 0.0 112.325 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -90.78 -42.48 10.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.955 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.9 m -95.53 139.06 32.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.91 176.57 5.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.52 89.12 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.4 p -81.71 -46.38 14.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.951 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.947 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -104.94 -31.83 9.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -133.64 155.79 49.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -129.46 147.13 51.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.47 160.61 30.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.097 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -56.14 3.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.824 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.71 149.26 28.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -104.68 145.73 29.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -141.17 147.06 45.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.81 115.02 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.516 2.144 . . . . 0.0 112.31 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.6 145.76 40.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HB3' HG23 ' A' ' 25' ' ' THR . 60.8 Cg_endo -73.09 165.2 33.38 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.628 2.219 . . . . 0.0 112.327 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 t -141.07 126.96 19.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.671 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -109.6 116.99 32.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.974 0.416 . . . . 0.0 111.607 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.835 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -107.06 118.6 55.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.603 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.6 p -140.78 144.76 35.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.97 0.414 . . . . 0.0 111.72 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.594 ' CD2' ' HE2' ' A' ' 127' ' ' MET . 0.2 OUTLIER -142.46 122.71 13.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.467 179.222 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 16.0 mmtt 84.12 -88.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.274 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -129.41 -40.46 1.43 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.733 0.302 . . . . 0.0 111.763 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.516 ' HE1' HD12 ' A' ' 122' ' ' LEU . 10.2 ptm -73.77 162.83 28.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.23 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -143.34 164.04 31.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.121 0.486 . . . . 0.0 111.5 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.768 ' CE1' HG11 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -135.35 142.37 45.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.892 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -114.67 136.44 53.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.061 0.458 . . . . 0.0 110.939 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.889 HD13 ' HB ' ' A' ' 105' ' ' VAL . 14.4 mm -118.3 106.46 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.37 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -134.55 165.34 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.218 0.533 . . . . 0.0 112.008 -179.08 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.478 ' CA ' ' HB2' ' A' ' 107' ' ' CYS . 48.6 p-80 -81.4 152.09 27.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.454 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -62.89 154.73 74.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.679 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.5 Cg_exo -54.64 139.93 76.27 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.187 1.925 . . . . 0.0 113.171 -177.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -98.69 174.31 6.47 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.108 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.475 ' H ' HG22 ' A' ' 29' ' ' THR . 3.6 t-20 -93.78 -10.7 33.32 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.84 14.74 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.3 p -139.62 89.73 2.35 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.403 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.457 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.29 -52.22 7.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.077 0.465 . . . . 0.0 111.228 178.139 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.442 ' O ' HG13 ' A' ' 37' ' ' ILE . 2.7 p -57.55 -45.8 84.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.33 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 m -57.72 -31.98 66.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.851 0.357 . . . . 0.0 111.187 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.721 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.39 -47.78 25.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.861 HG21 ' HB3' ' A' ' 63' ' ' LYS . 10.9 pt -55.64 -38.85 51.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 110.609 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.19 -51.4 58.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.486 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.565 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -68.27 -50.19 55.41 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.87 0.367 . . . . 0.0 111.989 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.721 HD21 ' CE1' ' A' ' 36' ' ' PHE . 85.6 mt -55.7 -45.52 77.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.481 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.98 -26.57 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.02 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 12.2 mttt -52.49 -44.56 65.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.358 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.066 ' CD1' HD21 ' A' ' 23' ' ' LEU . 11.0 t80 -63.45 -38.43 91.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.664 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.682 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 162.99 -178.41 38.71 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.921 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.52 19.76 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.676 HG22 ' H ' ' A' ' 47' ' ' THR . 1.3 m -164.9 -170.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.833 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.676 ' H ' HG22 ' A' ' 46' ' ' THR . 2.6 t -64.51 159.64 21.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.355 0.598 . . . . 0.0 110.456 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.791 HG13 ' O ' ' A' ' 104' ' ' ALA . 57.7 t -138.48 138.83 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.322 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.09 HG13 HG13 ' A' ' 105' ' ' VAL . 12.4 p -115.57 104.71 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.261 0.553 . . . . 0.0 110.816 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -114.56 110.79 20.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.322 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.802 HG13 ' HB3' ' A' ' 71' ' ' TRP . 6.3 t -107.17 90.95 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.421 0.629 . . . . 0.0 109.376 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.3 p -158.02 171.38 20.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.938 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -66.45 130.41 43.11 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 m -76.0 122.35 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -120.15 -47.66 2.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.44 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.425 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -130.63 83.88 2.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.708 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.09 -36.54 40.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -79.51 -48.57 13.66 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.437 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.34 -54.13 19.75 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 8.1 Cg_exo -73.26 -34.67 5.82 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.623 2.216 . . . . 0.0 113.48 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.968 HD21 HG11 ' A' ' 68' ' ' VAL . 2.1 mm? -71.09 -45.19 64.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.21 -28.86 60.13 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.861 ' HB3' HG21 ' A' ' 37' ' ' ILE . 5.6 mmtm -79.04 -36.63 40.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' O ' HG13 ' A' ' 66' ' ' ILE . 3.8 m-20 -101.57 -12.4 18.51 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.03 23.95 6.06 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.285 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 64' ' ' ASP . 24.6 mt -92.82 147.38 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 110.927 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' THR . 82.2 p -78.69 129.19 34.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.968 HG11 HD21 ' A' ' 61' ' ' LEU . 5.9 p -145.16 154.44 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.2 0.524 . . . . 0.0 112.123 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.51 HG22 ' HG ' ' A' ' 90' ' ' LEU . 3.2 t -103.75 133.59 47.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.108 178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.99 106.78 18.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.139 0.495 . . . . 0.0 110.396 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.889 ' CH2' HG12 ' A' ' 83' ' ' VAL . 4.4 m95 -111.91 104.27 55.91 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.049 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -104.08 160.43 0.22 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.162 2.575 . . . . 0.0 112.645 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.444 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 15.9 t80 -126.25 95.99 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.833 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.1 -175.99 3.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.703 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.83 -24.08 21.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.049 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.46 75.61 0.39 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.584 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 73' ' ' PHE . . . -85.97 148.91 49.25 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.497 0.189 . . . . 0.0 110.901 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.691 ' HG2' HG21 ' A' ' 83' ' ' VAL . 65.9 Cg_endo -73.72 109.64 2.9 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.637 2.225 . . . . 0.0 112.597 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.648 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 26.5 Cg_exo -63.44 -37.76 46.81 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.895 2.397 . . . . 0.0 114.492 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 18.3 Cg_endo -61.49 144.89 98.26 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.934 1.756 . . . . 0.0 113.596 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.428 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -66.1 -19.8 68.37 Favored Glycine 0 C--O 1.236 0.275 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.088 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -50.58 -29.52 11.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.503 0.192 . . . . 0.0 110.977 -178.141 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.889 HG12 ' CH2' ' A' ' 71' ' ' TRP . 40.1 t -56.98 -47.8 82.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 151' ' ' TYR . 54.4 t -55.22 -40.87 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.817 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.582 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.7 mt-10 -57.3 -31.39 65.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.532 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.04 -50.46 68.33 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.257 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.745 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.08 -29.9 70.32 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.437 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 120' ' ' LEU . 8.7 mt -62.46 -38.61 90.47 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.312 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.57 -43.78 79.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.036 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.51 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.4 tm? -60.47 -51.29 70.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.603 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.491 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 10.2 p -69.14 -35.9 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -57.3 -46.38 83.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.756 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.5 84.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -26.58 64.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.241 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.543 ' CE1' HG21 ' A' ' 103' ' ' VAL . 3.8 m-30 -81.99 -50.88 8.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.25 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 51.4 t -59.88 -38.04 81.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.921 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -76.21 -33.09 59.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.96 90.21 50.76 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.425 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.12 135.77 25.71 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.879 2.386 . . . . 0.0 112.231 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.07 55.39 30.91 Favored Glycine 0 C--N 1.329 0.154 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.696 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.577 ' HB2' HG21 ' A' ' 46' ' ' THR . 4.5 m -101.3 -163.46 1.02 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.25 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.682 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.0 m -119.34 113.87 21.48 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.319 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.768 HG11 ' CE1' ' A' ' 22' ' ' PHE . 38.1 t -109.2 151.0 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.791 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -120.65 145.12 47.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.224 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.09 HG13 HG13 ' A' ' 49' ' ' VAL . 4.0 t -140.31 166.78 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.786 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.6 t-80 -67.29 155.52 38.68 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.018 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.55 ' N ' ' O ' ' A' ' 25' ' ' THR . 38.5 t -69.0 98.36 0.95 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.506 0.67 . . . . 0.0 112.37 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.844 HG23 HD12 ' A' ' 24' ' ' ILE . 2.7 t -75.76 1.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.854 -1.067 . . . . 0.0 112.347 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.42 -8.62 1.87 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.86 -120.62 2.55 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.424 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 8.3 mt -126.46 127.29 45.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.91 -154.34 7.47 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.839 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.509 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.25 -17.65 7.06 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.082 0.468 . . . . 0.0 111.834 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.878 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -51.44 -46.21 90.22 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 9.4 Cg_endo -52.11 -48.51 21.27 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.491 2.128 . . . . 0.0 113.303 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.737 ' O ' HD23 ' A' ' 120' ' ' LEU . 24.0 t -61.64 -44.6 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.029 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.785 HD12 ' CG2' ' A' ' 49' ' ' VAL . 2.3 mt -59.66 -46.06 90.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.573 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.654 ' CG2' HG11 ' A' ' 105' ' ' VAL . 97.5 t -56.44 -55.19 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.645 0.26 . . . . 0.0 111.562 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.615 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.76 -48.61 66.65 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.181 0.515 . . . . 0.0 110.835 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 116' ' ' VAL . 3.3 mm? -56.88 -30.87 64.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.588 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.745 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -70.92 -34.23 71.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.4 . . . . 0.0 110.092 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.734 HD23 ' OD2' ' A' ' 131' ' ' ASP . 1.4 tp -75.32 -16.66 60.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.528 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.917 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.9 mt -57.28 -30.66 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.179 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.409 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 10.6 pt-20 -73.81 -16.72 61.14 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.3 t -79.49 -23.29 43.08 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.66 -97.6 0.18 Allowed Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.576 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.594 ' HE2' ' CD2' ' A' ' 17' ' ' TYR . 1.1 ptt? -63.03 73.61 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.917 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.03 -67.58 0.42 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.592 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.2 t80 -69.33 -32.3 71.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.042 0.448 . . . . 0.0 110.914 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.28 -50.44 27.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.36 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.734 ' OD2' HD23 ' A' ' 122' ' ' LEU . 43.3 t0 -67.59 -37.17 82.19 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.615 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -61.05 -50.2 74.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.991 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 129' ' ' TYR . 24.6 mm -72.8 -38.45 57.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 111.681 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -49.6 22.9 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.835 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.64 -34.11 71.71 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.864 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.9 OUTLIER -74.07 -30.64 27.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.798 0.332 . . . . 0.0 110.393 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -65.42 -48.95 71.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.29 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -59.93 -45.1 93.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.593 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -83.19 151.89 25.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.637 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 117.46 14.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.6 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.482 ' HG3' HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -114.44 163.17 15.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.968 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -61.02 -157.49 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.274 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.43 98.71 11.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.568 0.684 . . . . 0.0 110.461 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.739 HG23 ' CB ' ' A' ' 148' ' ' GLN . 61.4 mt -88.71 109.0 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.058 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -113.87 -77.74 0.58 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.854 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.5 p -101.13 -60.95 1.43 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.831 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.2 tmtt? -48.99 -52.06 27.07 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.739 ' CB ' HG23 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -56.2 -51.82 66.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.431 ' CD2' ' CG2' ' A' ' 144' ' ' ILE . 3.1 mm? -73.24 -47.0 46.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.5 m -66.92 -37.24 83.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.831 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -67.89 -50.92 53.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.319 -179.273 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.835 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -70.71 -31.32 68.15 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.344 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 1.2 tt0 -59.14 -39.02 81.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -29.17 64.78 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.448 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.711 ' HE2' HD12 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -66.06 -30.17 70.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.665 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.76 88.98 3.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.03 153.25 78.44 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.63 2.22 . . . . 0.0 112.378 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -147.1 123.48 10.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.485 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -13.27 62.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.332 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -41.58 87.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.879 0.371 . . . . 0.0 110.978 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.8 tp -86.09 -47.94 9.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -74.58 166.37 23.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -91.12 129.94 37.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -102.1 120.65 40.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.31 138.05 68.0 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.63 -44.8 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.449 2.099 . . . . 0.0 112.309 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -105.22 129.04 53.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.9 p -99.0 108.88 21.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -87.31 118.59 26.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.51 125.05 52.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 171' ' ' THR . 8.3 t -98.49 116.18 30.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.962 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.894 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -86.51 -177.51 6.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 110.83 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -112.11 129.69 56.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.7 ptp -88.22 168.75 12.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.99 95.17 2.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -124.59 120.13 31.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.2 tpp -102.26 111.7 24.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.36 126.18 40.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.833 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -167.97 104.16 0.56 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 49.4 Cg_endo -68.85 116.86 4.66 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.346 2.031 . . . . 0.0 112.281 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -80.85 160.68 65.88 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.544 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 56.3 Cg_endo -70.38 152.67 66.22 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.565 2.176 . . . . 0.0 112.386 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.478 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.5 t -144.07 127.64 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.903 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -110.71 116.8 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.805 0.336 . . . . 0.0 111.353 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.787 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -106.72 118.33 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.1 p -141.2 142.84 33.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.643 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 1.4 p90 -134.51 170.21 16.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.113 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 43.63 -96.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.053 0.141 . . . . 0.0 111.167 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.402 ' H ' ' CG ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -128.92 -30.78 2.21 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.76 ' HE1' HD11 ' A' ' 122' ' ' LEU . 3.9 ppp? -73.74 169.13 17.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.687 0.28 . . . . 0.0 111.23 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -147.94 161.23 41.74 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.979 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.839 ' CD2' HG13 ' A' ' 118' ' ' VAL . 1.3 m-85 -134.11 150.72 51.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.377 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -121.13 136.36 54.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.122 0.487 . . . . 0.0 111.557 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.916 HD12 HG13 ' A' ' 108' ' ' VAL . 1.9 mm -118.19 106.58 20.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.13 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -134.78 166.99 21.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.287 0.565 . . . . 0.0 111.745 -178.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 36' ' ' PHE . 49.1 p-80 -81.33 152.03 27.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.103 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -62.88 154.53 75.66 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.043 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.7 Cg_exo -54.77 138.91 77.5 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.389 2.059 . . . . 0.0 113.312 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.44 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 28.9 p -98.72 174.41 6.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.231 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -93.79 -9.73 36.53 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.59 -30.81 14.77 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -139.62 89.58 2.33 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.274 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.44 -52.27 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.138 0.494 . . . . 0.0 111.174 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.433 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.1 p -58.49 -45.21 89.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.162 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 m -57.99 -32.78 68.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.9 0.381 . . . . 0.0 111.339 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.691 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.51 -48.11 29.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.148 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.751 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.0 pt -56.08 -39.15 56.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.265 0.555 . . . . 0.0 110.645 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.3 -50.9 63.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.513 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -69.63 -50.13 47.26 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.887 0.375 . . . . 0.0 111.813 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.691 HD21 ' CE1' ' A' ' 36' ' ' PHE . 53.0 mt -56.19 -44.19 79.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.305 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -78.89 -26.75 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.021 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -52.92 -43.48 66.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.29 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.066 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.6 t80 -63.41 -38.4 90.99 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.663 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.682 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 166.31 -177.43 41.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.793 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.56 117.47 19.62 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.706 HG22 ' H ' ' A' ' 47' ' ' THR . 1.4 m -165.25 -169.93 1.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.687 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.721 ' HA ' HG23 ' A' ' 67' ' ' THR . 5.1 p -64.81 144.49 57.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.572 0.701 . . . . 0.0 110.448 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.956 HG21 HD12 ' A' ' 66' ' ' ILE . 61.0 t -122.18 128.14 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.868 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.041 HG13 HG13 ' A' ' 105' ' ' VAL . 2.1 p -115.44 105.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.355 0.597 . . . . 0.0 111.692 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -113.89 111.02 21.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.737 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.823 HG11 ' HB2' ' A' ' 113' ' ' ARG . 38.8 t -101.22 92.38 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.498 0.666 . . . . 0.0 110.405 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.18 171.46 20.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.072 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -64.62 130.7 44.62 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 m -68.73 122.05 19.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.553 HG22 ' CE1' ' A' ' 56' ' ' TYR . 6.5 m -120.45 -47.0 2.36 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.143 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.553 ' CE1' HG22 ' A' ' 55' ' ' THR . 2.8 m-85 -129.79 84.89 2.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.362 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.411 ' HA ' ' NH2' ' A' ' 50' ' ' ARG . 6.0 p-10 -78.21 -35.64 48.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -78.81 -48.49 14.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.41 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -46.45 -51.24 36.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.111 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 47.5 Cg_exo -57.13 -42.33 64.62 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.242 . . . . 0.0 113.83 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.73 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -71.21 -45.47 63.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -49.12 19.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.751 ' HB3' HG21 ' A' ' 37' ' ' ILE . 28.1 mmtt -74.46 -26.86 60.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.46 ' CG ' HD11 ' A' ' 66' ' ' ILE . 3.1 t0 -99.92 -11.57 20.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.54 25.98 3.49 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.14 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.956 HD12 HG21 ' A' ' 48' ' ' VAL . 4.7 pt -122.76 148.73 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.601 0.239 . . . . 0.0 110.573 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.721 HG23 ' HA ' ' A' ' 47' ' ' THR . 10.3 t -77.15 132.87 39.03 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.73 HG12 ' CD2' ' A' ' 61' ' ' LEU . 8.0 p -139.71 149.38 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.155 0.502 . . . . 0.0 111.984 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.446 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.8 t -103.3 131.6 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.91 106.63 17.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.585 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.888 ' CH2' HG12 ' A' ' 83' ' ' VAL . 4.4 m95 -110.22 103.46 53.86 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.555 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -108.78 -175.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 123.538 2.825 . . . . 0.0 112.882 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.434 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 2.4 t80 -126.4 102.11 7.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.756 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.24 173.02 7.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.776 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -55.02 -24.26 23.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.54 45.17 1.36 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.488 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.45 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . . . -85.87 102.66 2.82 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.551 0.176 . . . . 0.0 110.656 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.551 ' O ' HG21 ' A' ' 83' ' ' VAL . 8.2 Cg_endo -50.93 102.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.646 2.23 . . . . 0.0 112.69 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.687 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 52.8 Cg_exo -55.75 -43.26 59.12 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.717 2.278 . . . . 0.0 114.102 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.687 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 4.1 Cg_endo -48.72 154.16 3.15 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.361 2.041 . . . . 0.0 113.572 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -63.68 -19.79 63.22 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.347 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 5.7 tmtp? -50.81 -29.66 12.27 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 120.609 0.242 . . . . 0.0 110.833 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.888 HG12 ' CH2' ' A' ' 71' ' ' TRP . 42.1 t -56.56 -46.71 82.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG21 ' NZ ' ' A' ' 147' ' ' LYS . 89.3 t -56.08 -40.37 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.039 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 2.0 mt-10 -58.2 -31.44 67.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.746 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.72 -50.74 63.72 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.498 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.856 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.03 -28.9 69.21 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.419 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.715 HD21 ' HB3' ' A' ' 120' ' ' LEU . 11.3 mt -64.74 -38.5 91.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.228 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.8 m -66.93 -39.99 87.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.994 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.502 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.6 tm? -63.44 -51.3 66.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.874 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.675 HG21 ' HB1' ' A' ' 121' ' ' ALA . 13.5 p -69.76 -43.42 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.457 ' N ' HG13 ' A' ' 91' ' ' VAL . 21.2 mttm -60.82 -34.76 75.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.393 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.2 -47.96 72.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.418 ' HE2' HG21 ' A' ' 67' ' ' THR . 9.4 mptt -74.6 -25.59 59.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.652 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 3.3 m-85 -82.02 -34.48 29.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.992 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.1 t -72.26 -46.4 56.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -76.35 -33.36 58.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.35 141.99 41.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.91 159.32 53.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.406 2.071 . . . . 0.0 112.125 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.09 90.75 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -81.44 -83.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.68 0.276 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.682 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.6 m -153.26 113.05 3.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.792 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.652 HG21 ' HZ ' ' A' ' 95' ' ' PHE . 23.5 t -108.07 151.21 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.694 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.4 140.45 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.27 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.041 HG13 HG13 ' A' ' 49' ' ' VAL . 2.5 t -139.6 166.79 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.612 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.637 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.0 t60 -67.16 156.27 36.64 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.52 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -68.06 105.07 1.93 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.64 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.916 HG13 HD12 ' A' ' 24' ' ' ILE . 29.8 m -75.28 -0.02 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.025 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 10' ' ' PRO . . . -60.72 -8.72 3.17 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.93 -136.32 4.68 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 13.0 mt -120.9 127.46 51.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.74 -147.42 5.22 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.374 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.823 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.24 -20.01 6.32 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.907 0.384 . . . . 0.0 111.89 -178.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.666 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -52.64 -46.56 95.87 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.817 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.5 Cg_endo -52.1 -48.31 22.31 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.264 1.976 . . . . 0.0 112.73 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.68 ' O ' HD23 ' A' ' 120' ' ' LEU . 39.0 t -60.95 -44.47 98.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.917 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.463 HD12 ' CG2' ' A' ' 51' ' ' VAL . 9.4 mt -58.12 -45.31 87.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.212 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.934 ' CG2' HG11 ' A' ' 105' ' ' VAL . 94.9 t -55.0 -55.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.776 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.669 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -56.36 -49.25 74.95 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.147 0.499 . . . . 0.0 110.748 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.715 ' HB3' HD21 ' A' ' 88' ' ' LEU . 2.7 mm? -53.91 -30.91 48.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.732 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.856 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -69.58 -43.32 73.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.05 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.782 HD23 ' OD2' ' A' ' 131' ' ' ASP . 0.7 OUTLIER -66.98 -15.63 63.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.757 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.919 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.6 mt -57.04 -30.64 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -72.45 -17.02 61.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.424 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.5 m -84.54 11.25 9.09 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 113.79 -99.5 0.98 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.763 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.482 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.0 ptt? -62.45 79.73 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.919 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.9 -67.69 0.54 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.619 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.2 t80 -67.33 -32.05 72.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.959 0.409 . . . . 0.0 111.001 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.37 -52.04 17.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.25 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.782 ' OD2' HD23 ' A' ' 122' ' ' LEU . 32.3 t0 -68.24 -38.13 81.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.816 0.341 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.669 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -60.04 -49.98 75.54 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.007 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.4 mm -73.67 -37.61 49.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -74.17 -49.6 22.92 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.787 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.57 -35.8 73.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.583 0.23 . . . . 0.0 110.902 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.4 tt -74.14 -29.26 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.395 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -66.31 -48.44 70.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.477 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -44.94 93.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.443 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -82.81 152.25 25.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.29 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 117.25 14.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.503 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -114.53 163.54 15.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.01 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.416 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -59.15 -164.08 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.485 -0.865 . . . . 0.0 111.173 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.06 98.96 11.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.709 0.755 . . . . 0.0 110.745 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.768 HD13 HD21 ' A' ' 149' ' ' LEU . 1.6 pp -88.48 109.03 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.074 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -113.45 -77.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.456 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.4 m -100.27 -60.7 1.48 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.822 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.5 tmtt? -53.19 -51.8 60.91 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.642 ' HG3' HG22 ' A' ' 144' ' ' ILE . 3.7 tm0? -56.03 -52.03 65.68 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.768 HD21 HD13 ' A' ' 144' ' ' ILE . 3.6 mm? -75.04 -45.3 42.56 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.4 m -67.09 -35.0 78.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.629 0.252 . . . . 0.0 111.622 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.822 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -69.51 -50.87 41.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.387 -179.275 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.831 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -69.47 -32.25 71.04 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.323 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 51.3 tt0 -59.73 -39.55 85.08 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -27.46 63.52 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.585 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.651 ' HE2' HD12 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -66.23 -33.77 76.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.621 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.82 85.9 2.09 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.662 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.93 153.14 63.68 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.618 2.212 . . . . 0.0 112.502 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.31 123.5 10.84 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.427 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -77.98 -30.88 50.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.005 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -62.55 -30.6 71.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.64 -48.0 12.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -71.48 -55.35 8.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.9 122.38 20.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.5 pttp -155.48 164.97 37.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -86.83 112.55 47.94 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.69 176.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.44 2.093 . . . . 0.0 112.22 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.78 115.53 12.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 75.3 p -138.49 157.37 46.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -83.94 105.2 14.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -138.8 -47.31 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.36 -66.42 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -159.73 157.89 30.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 110.957 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.95 120.83 40.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 ttp -83.35 -56.1 3.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.05 169.06 21.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -148.54 131.02 15.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.78 160.82 23.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.957 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -136.13 -63.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -101.41 148.55 35.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.53 126.45 12.82 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.582 2.188 . . . . 0.0 112.237 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.65 139.59 97.12 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.064 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.02 165.16 33.55 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.538 2.159 . . . . 0.0 112.368 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.93 126.83 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.534 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.55 ' HB3' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -116.82 136.01 53.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.015 0.436 . . . . 0.0 111.898 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.682 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.8 137.02 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.12 129.3 37.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.245 0.545 . . . . 0.0 111.963 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.447 ' CE1' ' HE1' ' A' ' 127' ' ' MET . 25.7 t80 -145.57 132.74 20.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.268 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 64.08 -103.49 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.204 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.4 14.04 6.07 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.521 ' HE2' HD21 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -119.26 169.0 10.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.775 0.322 . . . . 0.0 110.96 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.8 mtm-85 -141.79 164.08 31.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.122 0.486 . . . . 0.0 111.733 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.502 ' HE1' HG11 ' A' ' 103' ' ' VAL . 3.9 m-85 -134.59 150.19 50.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.872 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.062 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -126.21 135.49 51.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 111.143 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.846 HD12 HG23 ' A' ' 108' ' ' VAL . 10.9 mm -118.33 106.27 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.554 HG21 HD23 ' A' ' 40' ' ' LEU . 1.2 p -131.07 163.74 26.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.197 0.522 . . . . 0.0 111.756 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.496 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 37.3 p-80 -81.24 152.44 27.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.261 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -62.38 154.81 70.29 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.802 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 51.8 Cg_exo -53.89 136.6 66.73 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.32 2.013 . . . . 0.0 113.15 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.53 143.53 28.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.21 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -64.79 -12.78 51.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.338 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -31.31 14.59 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.4 p -139.97 88.8 2.26 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.282 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.89 -52.28 7.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.259 0.552 . . . . 0.0 111.256 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.466 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.3 m -56.84 -46.36 81.76 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.624 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -57.58 -31.9 66.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.961 0.41 . . . . 0.0 111.145 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.704 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.85 -47.59 29.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.175 -179.205 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.904 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.6 pt -55.62 -39.06 52.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.136 0.493 . . . . 0.0 110.605 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -65.18 -52.03 57.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.51 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.536 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 2.4 m-20 -67.99 -50.15 57.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.902 0.382 . . . . 0.0 111.935 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.704 HD21 ' CE1' ' A' ' 36' ' ' PHE . 74.2 mt -55.84 -45.2 78.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.556 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.8 tttm -77.34 -26.71 52.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.085 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.2 mttt -53.04 -44.99 67.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.217 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.062 ' CD1' HD21 ' A' ' 23' ' ' LEU . 11.5 t80 -63.57 -38.32 90.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.748 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.675 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 161.05 -177.74 37.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.934 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.67 122.33 27.17 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.848 HG22 ' H ' ' A' ' 47' ' ' THR . 4.1 m -164.54 -171.39 2.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.513 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.848 ' H ' HG22 ' A' ' 46' ' ' THR . 1.7 t -65.44 162.22 18.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.816 HG13 ' O ' ' A' ' 104' ' ' ALA . 91.8 t -138.01 137.99 44.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.834 HG12 HG22 ' A' ' 105' ' ' VAL . 11.2 p -115.23 104.2 16.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.421 0.629 . . . . 0.0 111.002 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.22 110.98 20.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.05 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.828 HG13 ' HB3' ' A' ' 71' ' ' TRP . 6.1 t -105.8 91.26 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.462 0.649 . . . . 0.0 109.704 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 t -157.87 171.29 20.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.911 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -67.61 130.45 43.08 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 54' ' ' VAL . 34.7 m -74.83 122.48 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.4 p -120.16 -47.66 2.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.376 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.449 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -130.56 83.34 2.11 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.457 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.17 -36.38 40.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -79.06 -48.55 14.17 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -43.91 -60.22 2.9 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.249 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.61 -34.31 15.35 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.551 2.167 . . . . 0.0 113.871 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.037 HD21 HG11 ' A' ' 68' ' ' VAL . 1.6 mm? -71.13 -45.19 64.08 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -75.1 -29.37 60.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.904 ' HB3' HG21 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -81.09 -33.8 33.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.23 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.539 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -101.31 -12.41 18.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.11 24.19 4.48 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.473 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 64' ' ' ASP . 12.7 mt -96.4 147.47 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.946 0.373 . . . . 0.0 110.835 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 47' ' ' THR . 3.4 m -78.47 132.57 37.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.037 HG11 HD21 ' A' ' 61' ' ' LEU . 7.5 p -145.05 152.78 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.337 0.589 . . . . 0.0 112.125 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.83 130.54 54.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.001 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.09 106.84 18.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.082 0.468 . . . . 0.0 111.044 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.828 ' HB3' HG13 ' A' ' 51' ' ' VAL . 5.5 m95 -109.35 103.9 53.82 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.51 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -105.83 153.95 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.262 2.642 . . . . 0.0 112.94 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' CZ ' ' O ' ' A' ' 77' ' ' ALA . 1.1 t80 -126.24 99.85 6.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.08 173.54 0.62 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.15 -34.02 71.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.969 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.45 52.07 0.84 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.378 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.415 ' O ' ' CZ ' ' A' ' 73' ' ' PHE . . . -103.93 102.98 34.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.484 0.183 . . . . 0.0 111.232 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.456 ' O ' ' CD ' ' A' ' 80' ' ' PRO . 70.9 Cg_exo -50.8 164.31 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.311 2.007 . . . . 0.0 111.89 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -100.28 70.89 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.472 2.781 . . . . 0.0 113.257 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.866 ' O ' HG22 ' A' ' 83' ' ' VAL . 57.4 Cg_endo -69.92 135.68 30.68 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.116 1.877 . . . . 0.0 111.827 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.469 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -66.52 -22.52 71.51 Favored Glycine 0 C--O 1.238 0.386 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.243 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -38.8 63.22 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.647 0.26 . . . . 0.0 111.09 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 80' ' ' PRO . 31.2 m -58.65 -44.4 89.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.707 HG22 ' CD1' ' A' ' 120' ' ' LEU . 0.8 OUTLIER -53.42 -39.41 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.229 0.538 . . . . 0.0 109.591 178.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.63 -31.35 70.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.726 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.04 -50.88 64.5 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.712 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -68.86 -34.76 75.99 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.785 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.705 HD21 ' HB3' ' A' ' 120' ' ' LEU . 10.2 mt -55.17 -43.67 74.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.411 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -40.6 82.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.316 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.416 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.2 tm? -58.39 -51.35 70.18 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.9 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.065 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.2 p -73.9 -36.06 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.878 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 -44.06 64.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.934 0.397 . . . . 0.0 110.597 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.08 -43.6 57.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.951 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.721 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.7 OUTLIER -64.74 -27.62 69.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.263 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.06 -40.71 21.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 111.0 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 7.2 t -67.0 -46.05 75.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -76.1 -33.04 59.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.08 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -109.37 87.99 5.63 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.293 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.27 115.91 4.04 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.584 2.189 . . . . 0.0 112.363 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.15 52.14 19.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 t -101.17 -174.16 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.62 0.247 . . . . 0.0 111.179 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.675 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 3.1 m -112.94 114.12 26.48 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.502 HG11 ' HE1' ' A' ' 22' ' ' PHE . 16.3 t -106.81 151.28 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.816 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -121.33 145.7 47.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.643 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.834 HG22 HG12 ' A' ' 49' ' ' VAL . 97.5 t -139.86 166.25 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.659 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.4 t-80 -67.81 155.43 39.36 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.825 0.345 . . . . 0.0 110.725 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.541 ' N ' ' O ' ' A' ' 25' ' ' THR . 43.7 t -69.36 104.23 2.21 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.846 HG23 HD12 ' A' ' 24' ' ' ILE . 3.0 t -75.73 1.39 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.417 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.16 -8.37 1.54 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.73 -121.32 2.62 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 111' ' ' LEU . 7.8 mt -132.12 127.32 35.74 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.13 -154.48 7.55 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.146 -1.025 . . . . 0.0 113.255 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.572 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.37 -15.12 7.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.91 0.386 . . . . 0.0 111.943 -178.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.77 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -53.34 -46.79 97.79 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 10.1 Cg_endo -52.98 -48.1 23.97 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.352 2.035 . . . . 0.0 112.446 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.525 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 41.8 t -55.84 -53.23 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.859 0.362 . . . . 0.0 110.479 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.819 HD12 ' CG2' ' A' ' 49' ' ' VAL . 2.7 mt -54.44 -48.76 71.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.773 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 114' ' ' ALA . 17.0 t -51.28 -49.71 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 111.354 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.706 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -55.91 -45.26 78.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.668 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.785 HD13 ' OH ' ' A' ' 151' ' ' TYR . 0.5 OUTLIER -57.54 -30.88 65.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.766 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 1.065 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.05 -44.76 62.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.939 0.4 . . . . 0.0 110.597 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.723 HD13 ' OD2' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -69.63 -15.9 63.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.791 179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 1.068 HD11 HD21 ' A' ' 152' ' ' LEU . 1.3 mt -57.77 -41.72 80.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.871 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.52 -15.81 3.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.45 ' OG ' HD23 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -80.83 11.24 4.06 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.028 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 117.79 -88.08 0.44 Allowed Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.307 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.532 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.97 79.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.288 0.566 . . . . 0.0 109.662 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.91 ' CB ' HG23 ' A' ' 123' ' ' ILE . 20.9 mttm -62.61 -68.08 0.36 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.005 -177.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 152' ' ' LEU . 7.1 t80 -74.34 -30.47 62.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.229 0.537 . . . . 0.0 110.499 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -72.57 -47.15 50.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.107 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.723 ' OD2' HD13 ' A' ' 122' ' ' LEU . 50.8 t0 -68.88 -47.23 66.39 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.349 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.755 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -59.07 -50.16 75.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.941 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 35.4 mm -72.44 -36.18 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -74.21 -49.56 22.9 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.682 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.69 -37.5 76.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 110.815 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 132' ' ' ALA . 3.3 tt -74.44 -28.55 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.464 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 0.9 OUTLIER -69.51 -46.73 65.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.944 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -41.52 91.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.118 0.485 . . . . 0.0 110.027 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -87.14 152.64 22.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.154 179.118 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.38 117.81 14.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.112 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -114.19 163.66 14.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.234 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -57.95 -163.36 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.946 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.17 100.18 13.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.156 0.478 . . . . 0.0 111.51 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 144' ' ' ILE . 0.1 OUTLIER -87.91 109.17 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.482 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.65 -77.52 0.58 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.544 ' O ' HG22 ' A' ' 150' ' ' THR . 14.6 m -100.48 -61.41 1.37 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 8.8 tmtt? -64.29 -46.39 83.85 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -176.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.485 ' OE1' HG22 ' A' ' 144' ' ' ILE . 1.1 mt-30 -56.23 -52.13 65.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -176.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 149' ' ' LEU . 2.2 mm? -75.35 -37.19 60.81 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.963 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.618 HG22 ' HA ' ' A' ' 147' ' ' LYS . 5.1 t -71.76 -37.11 70.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.844 0.355 . . . . 0.0 110.968 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.799 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.85 -50.56 64.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.643 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.068 HD21 HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -66.7 -31.64 72.44 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.643 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.82 -37.45 84.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -23.0 55.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.883 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.493 ' CB ' HD23 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -66.22 -43.84 85.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.507 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 48.0 ttt85 -107.0 115.31 60.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.607 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.48 138.41 59.74 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.421 2.081 . . . . 0.0 112.369 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -147.31 123.46 10.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.559 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.19 2.83 29.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.596 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -59.08 -37.07 76.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.71 0.29 . . . . 0.0 110.983 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.557 HD12 ' HD2' ' A' ' 162' ' ' ARG . 0.6 OUTLIER -81.54 -29.56 33.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.955 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.557 ' HD2' HD12 ' A' ' 161' ' ' LEU . 0.4 OUTLIER -122.3 96.09 4.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -73.67 97.73 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -129.2 162.69 27.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -94.05 103.09 9.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.78 116.78 4.72 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.452 2.101 . . . . 0.0 112.269 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -137.42 120.68 16.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.815 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.3 t -97.04 133.66 41.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.811 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -104.85 122.01 44.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -154.7 128.12 8.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.78 33.28 20.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.883 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.5 p -135.25 142.13 45.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.64 126.58 24.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 35.4 mtm -106.37 125.6 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.8 -39.45 7.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.074 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -149.85 -61.07 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -169.3 -64.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -162.06 114.06 1.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -60.1 127.77 86.37 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.8 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HB3' ' CB ' ' A' ' 109' ' ' ALA . 72.3 Cg_endo -76.21 123.34 7.14 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.508 2.139 . . . . 0.0 112.4 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.63 153.93 55.85 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.26 165.14 32.51 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.99 126.85 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -106.89 132.64 52.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.448 . . . . 0.0 111.657 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.811 HG12 ' CE2' ' A' ' 135' ' ' PHE . 2.1 t -106.78 124.78 62.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.224 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.6 p -122.32 140.88 52.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 111.823 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.53 ' CB ' HD21 ' A' ' 122' ' ' LEU . 26.5 t80 -155.25 131.04 9.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.7 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm 59.04 -100.24 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.082 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -129.56 14.09 5.98 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.54 ' CE ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -117.06 164.65 14.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 110.949 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -132.72 164.01 27.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.421 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.677 ' CE1' HG13 ' A' ' 118' ' ' VAL . 1.2 m-85 -142.89 146.22 33.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.847 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.035 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -122.66 136.28 54.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 111.259 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.97 HG21 HG22 ' A' ' 108' ' ' VAL . 5.6 mm -118.49 106.3 19.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.69 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.568 HG21 HD23 ' A' ' 40' ' ' LEU . 1.9 p -132.38 164.79 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.057 0.456 . . . . 0.0 111.506 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.509 ' CD2' ' CZ ' ' A' ' 36' ' ' PHE . 31.3 p-80 -81.46 152.12 27.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.074 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -62.8 154.54 74.99 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.978 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 51.2 Cg_exo -54.03 134.7 61.07 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.425 2.083 . . . . 0.0 113.068 -177.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -98.5 152.96 18.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.267 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.81 -11.41 60.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.53 -31.58 14.49 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -140.08 88.75 2.25 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.135 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.527 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -81.07 -52.38 7.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.184 0.516 . . . . 0.0 111.533 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.429 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.6 p -57.2 -46.78 82.57 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.635 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.2 m -57.82 -32.27 67.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.881 0.372 . . . . 0.0 111.255 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.687 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.67 -47.95 28.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.939 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.0 pt -55.93 -39.03 55.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.207 0.527 . . . . 0.0 110.623 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.83 -52.01 59.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.558 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.563 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 3.7 m-20 -68.88 -50.08 52.77 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.929 0.395 . . . . 0.0 111.832 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.687 HD21 ' CE1' ' A' ' 36' ' ' PHE . 53.5 mt -55.92 -45.21 78.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -26.77 48.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.027 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.563 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -53.32 -43.36 67.56 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.367 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.035 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.0 t80 -63.28 -38.65 92.0 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.689 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.647 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.68 -178.38 40.5 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.821 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.56 117.4 19.51 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.775 HG21 ' OG ' ' A' ' 101' ' ' SER . 1.3 m -165.18 -170.41 1.9 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.806 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.684 ' H ' HG22 ' A' ' 46' ' ' THR . 3.6 t -65.09 159.83 22.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.484 0.659 . . . . 0.0 110.617 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.792 HG13 ' O ' ' A' ' 104' ' ' ALA . 60.0 t -136.27 138.15 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.073 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.027 HG13 HG13 ' A' ' 105' ' ' VAL . 14.9 p -115.55 104.65 17.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.551 0.691 . . . . 0.0 111.211 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -115.13 110.79 20.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.251 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.815 HG13 ' HB3' ' A' ' 71' ' ' TRP . 12.9 t -106.62 91.84 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.366 0.603 . . . . 0.0 109.722 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.32 171.42 20.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.719 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -64.69 130.47 43.71 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.61 121.86 19.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -120.66 -47.38 2.32 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.133 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.429 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 9.0 m-85 -130.33 84.62 2.21 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.483 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -78.33 -36.05 46.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -48.55 14.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.615 HG22 ' CD ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -45.14 -49.99 28.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.153 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 34.2 Cg_exo -60.93 -40.67 50.82 Favored 'Trans proline' 0 N--CA 1.471 0.193 0 C-N-CA 122.646 2.23 . . . . 0.0 113.605 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.504 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -71.14 -45.05 64.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -49.13 20.18 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.939 ' HB3' HG21 ' A' ' 37' ' ' ILE . 11.4 mttm -76.16 -25.72 55.54 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.446 ' CG ' HD11 ' A' ' 66' ' ' ILE . 2.8 t0 -99.35 -11.48 21.16 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.42 26.85 2.61 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.278 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.446 HD11 ' CG ' ' A' ' 64' ' ' ASP . 4.2 pt -122.54 148.12 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.688 0.28 . . . . 0.0 110.737 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.53 HG23 ' HA ' ' A' ' 47' ' ' THR . 11.0 t -77.83 135.11 37.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.064 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.504 HG12 ' CD2' ' A' ' 61' ' ' LEU . 3.6 p -141.59 154.46 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.277 0.561 . . . . 0.0 111.733 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.404 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.7 t -103.68 131.28 52.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.145 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -100.8 106.81 18.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.201 0.524 . . . . 0.0 110.193 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.884 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.5 m95 -111.26 104.51 56.24 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 48.9 Cg_endo -103.21 153.72 0.24 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.204 2.602 . . . . 0.0 112.344 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -122.32 121.43 36.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.008 0.433 . . . . 0.0 110.984 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' A' ' 77' ' ' ALA . 0.5 OUTLIER 175.5 -161.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.369 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -63.96 -15.76 59.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.223 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.8 -4.72 45.39 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.194 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.434 ' HB3' ' H ' ' A' ' 74' ' ' ASP . . . -85.96 112.55 46.11 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.952 0.376 . . . . 0.0 111.066 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.643 ' O ' HG21 ' A' ' 83' ' ' VAL . 51.6 Cg_exo -55.31 106.1 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.502 2.134 . . . . 0.0 112.482 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.7 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 42.2 Cg_exo -57.81 -39.38 87.57 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.017 2.478 . . . . 0.0 114.589 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 2.0 Cg_endo -47.56 154.09 1.87 Allowed 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.142 1.894 . . . . 0.0 113.635 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.423 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -64.71 -20.67 66.45 Favored Glycine 0 C--O 1.237 0.34 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.332 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -29.83 16.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.563 0.22 . . . . 0.0 110.936 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.884 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 11.6 t -59.93 -48.23 88.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.529 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 1.1 t -53.52 -38.69 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.227 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.414 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.2 mt-10 -66.45 -31.19 71.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.355 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -63.35 -50.64 69.17 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.551 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.721 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -67.44 -32.64 73.64 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.89 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.788 HD21 ' HB3' ' A' ' 120' ' ' LEU . 13.5 mt -55.93 -48.02 76.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.607 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -41.34 95.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.487 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.435 ' C ' HD13 ' A' ' 90' ' ' LEU . 1.9 tm? -57.68 -51.59 68.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.875 HG21 ' HB1' ' A' ' 121' ' ' ALA . 13.2 p -74.75 -35.82 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.383 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -55.04 -40.95 70.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.963 0.411 . . . . 0.0 110.513 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.28 -46.75 39.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.227 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -62.3 -37.57 86.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.631 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.441 ' HE1' HG23 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -82.02 -33.49 30.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.763 0.316 . . . . 0.0 111.171 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.04 -46.04 58.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -76.1 -31.5 58.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.273 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -117.35 87.25 23.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.479 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.45 136.35 42.8 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.745 2.297 . . . . 0.0 112.168 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 20' ' ' MET . . . 58.12 58.23 15.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.662 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.775 ' OG ' HG21 ' A' ' 46' ' ' THR . 51.8 p -101.2 -169.98 1.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.808 0.337 . . . . 0.0 111.263 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.647 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -123.46 113.67 19.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.091 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.631 HG11 ' CE1' ' A' ' 22' ' ' PHE . 7.4 t -111.98 151.38 14.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.135 0.493 . . . . 0.0 112.323 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.792 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -118.93 145.34 45.85 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.422 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.027 HG13 HG13 ' A' ' 49' ' ' VAL . 7.6 t -140.3 167.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.708 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.605 ' O ' HG23 ' A' ' 24' ' ' ILE . 9.8 t60 -66.87 155.49 38.22 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.498 ' HB2' ' CA ' ' A' ' 26' ' ' HIS . 10.5 t -69.1 122.5 18.89 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.97 HG22 HG21 ' A' ' 24' ' ' ILE . 5.1 m -75.75 -0.2 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.475 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' A' ' 10' ' ' PRO . . . -60.95 -8.78 3.43 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.99 -156.38 6.8 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.5 mt -92.91 127.27 38.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.83 -169.38 16.61 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.223 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.637 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.22 -24.63 5.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.069 0.461 . . . . 0.0 111.407 -179.252 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -54.48 -43.07 97.5 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.669 ' HG3' HG12 ' A' ' 108' ' ' VAL . 58.4 Cg_exo -52.35 -48.38 22.07 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.844 1.696 . . . . 0.0 111.67 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 91.3 t -55.98 -51.14 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.701 HD12 ' CG2' ' A' ' 49' ' ' VAL . 8.5 mt -51.97 -45.3 64.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.137 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 114' ' ' ALA . 15.9 t -51.81 -53.18 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.951 0.405 . . . . 0.0 110.909 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.601 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -53.5 -43.27 68.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.177 0.513 . . . . 0.0 110.519 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.788 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -58.64 -30.83 67.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.529 179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.875 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.26 -40.38 71.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.115 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.54 HD11 ' CE ' ' A' ' 20' ' ' MET . 0.2 OUTLIER -71.59 -16.68 62.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.734 179.026 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 1.047 HD11 HD21 ' A' ' 152' ' ' LEU . 2.7 mt -57.31 -30.7 36.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.284 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -16.61 62.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.7 m -79.76 -23.34 42.28 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.43 -96.58 0.17 Allowed Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.946 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.528 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 6.1 ptt? -63.87 71.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.938 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.61 -67.37 0.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 6.0 t80 -65.88 -32.42 73.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.894 0.378 . . . . 0.0 111.139 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -72.55 -52.43 15.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.259 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 5.2 t0 -67.05 -36.75 82.74 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 110.486 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.622 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -61.07 -50.42 73.36 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.162 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.9 mm -73.43 -39.3 54.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.569 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -49.97 19.79 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.811 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.28 -37.35 80.59 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.581 -179.31 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.575 HD11 ' C ' ' A' ' 115' ' ' PRO . 0.6 OUTLIER -74.16 -28.72 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.736 0.303 . . . . 0.0 110.407 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -63.8 -44.92 91.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.399 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -45.1 93.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.668 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 136' ' ' ILE . 2.5 mptt -87.08 151.44 23.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.633 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.484 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.93 116.78 14.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 0.0 110.972 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.14 163.21 15.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.81 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.31 -179.99 0.18 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.307 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.09 99.4 4.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.62 0.71 . . . . 0.0 111.015 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.586 HD12 HD21 ' A' ' 149' ' ' LEU . 11.3 pt -88.22 109.53 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.763 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -112.95 -76.62 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.628 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.558 ' O ' HG22 ' A' ' 150' ' ' THR . 0.3 OUTLIER -99.91 -60.93 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.794 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.6 tmtt? -52.49 -51.81 57.6 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.453 ' OE1' HD22 ' A' ' 149' ' ' LEU . 1.3 tm0? -60.23 -51.75 68.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.586 HD21 HD12 ' A' ' 144' ' ' ILE . 3.5 mm? -73.03 -34.77 66.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 146' ' ' SER . 3.9 t -75.29 -40.77 58.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.082 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.794 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -64.03 -50.76 67.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.047 HD21 HD11 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -69.0 -33.82 74.28 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.932 -179.352 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.22 -38.03 78.95 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -25.43 55.35 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.551 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.58 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -66.43 -31.34 72.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.471 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 157' ' ' PRO . 0.0 OUTLIER -106.71 104.33 50.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.427 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 156' ' ' ARG . 24.6 Cg_endo -61.97 146.98 96.06 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.476 2.117 . . . . 0.0 112.579 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -147.27 123.53 10.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.373 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -4.92 46.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.469 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.91 -30.52 67.88 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.8 tt -74.26 -31.03 62.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.912 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.04 -170.65 1.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.91 155.82 16.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -79.39 116.93 19.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -70.25 137.92 86.79 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.841 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.19 174.73 10.96 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.541 2.161 . . . . 0.0 112.269 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -171.56 -54.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.7 t -167.13 168.64 13.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -84.29 176.29 8.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -143.55 134.37 25.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.6 t -140.34 151.09 44.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.962 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -170.47 172.8 5.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.2 -58.55 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.04 108.51 3.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -105.88 128.78 53.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -140.66 -47.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -125.57 138.5 53.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -83.19 133.61 35.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.7 ttm-85 -120.62 131.11 24.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.32 118.3 5.61 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.387 2.058 . . . . 0.0 112.232 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.36 145.85 85.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.78 165.13 33.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.596 2.197 . . . . 0.0 112.265 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.4 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.7 t -137.51 126.99 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.776 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -114.37 128.95 56.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.993 0.425 . . . . 0.0 111.698 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.721 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.87 127.66 62.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.509 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.41 147.63 42.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.119 0.485 . . . . 0.0 111.786 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.547 ' HD2' HD21 ' A' ' 122' ' ' LEU . 26.4 t80 -155.15 117.93 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.642 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 29.2 mmtp 64.28 -95.77 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.408 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.39 13.99 6.07 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.969 ' HE1' HD21 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -121.67 169.05 11.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.754 0.311 . . . . 0.0 110.886 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -145.62 164.03 33.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 111.697 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.707 ' CE1' HG11 ' A' ' 103' ' ' VAL . 3.0 m-85 -134.29 148.9 50.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.561 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -122.48 135.77 54.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.21 0.529 . . . . 0.0 111.334 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.011 HD12 HG13 ' A' ' 108' ' ' VAL . 2.5 mm -118.17 106.58 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.223 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -132.54 165.34 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.286 0.565 . . . . 0.0 111.644 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.496 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 48.8 p-80 -81.1 152.08 28.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -62.83 154.04 77.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.514 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 10.0 Cg_endo -54.38 138.53 73.47 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.64 2.227 . . . . 0.0 113.439 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.441 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -98.93 174.24 6.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.249 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.8 -8.66 30.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.53 -30.67 14.88 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.6 p -139.36 89.62 2.35 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.109 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.441 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.18 -52.18 8.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.19 0.519 . . . . 0.0 111.22 178.387 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.448 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.6 p -57.8 -45.67 85.75 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.225 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.4 m -57.85 -32.13 67.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.747 0.308 . . . . 0.0 111.276 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.667 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.3 -47.89 25.75 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.148 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.723 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.6 pt -55.66 -39.03 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.179 0.514 . . . . 0.0 110.761 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.32 -51.83 53.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.543 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.559 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.1 m-20 -68.13 -50.12 56.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.838 0.351 . . . . 0.0 111.915 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.667 HD21 ' CE1' ' A' ' 36' ' ' PHE . 87.9 mt -55.8 -46.22 78.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.986 0.422 . . . . 0.0 110.42 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -77.05 -26.63 53.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.102 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -53.13 -44.48 67.77 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.532 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.066 ' CD1' HD21 ' A' ' 23' ' ' LEU . 10.9 t80 -63.56 -38.53 91.48 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.959 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.693 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.93 -178.35 39.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.006 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.53 117.4 19.53 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.831 HG21 ' OG ' ' A' ' 101' ' ' SER . 1.0 OUTLIER -165.19 -169.69 1.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.166 -0.924 . . . . 0.0 108.853 177.416 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.671 ' H ' HG22 ' A' ' 46' ' ' THR . 3.5 p -64.48 146.49 54.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.555 0.693 . . . . 0.0 110.544 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.057 HG22 ' HB3' ' A' ' 104' ' ' ALA . 59.5 t -125.38 132.72 70.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.565 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.822 HG12 HG22 ' A' ' 105' ' ' VAL . 12.9 p -115.41 105.52 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.372 0.606 . . . . 0.0 111.315 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 110.64 20.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.735 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 71' ' ' TRP . 23.0 t -104.08 90.44 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.635 0.731 . . . . 0.0 109.734 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -158.78 171.62 19.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.352 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 1.8 mm-40 -64.95 130.35 43.07 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.58 HG22 ' OD1' ' A' ' 70' ' ' ASP . 16.4 t -77.56 122.63 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 p -120.2 -47.87 2.35 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.169 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.8 83.45 2.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.363 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -79.36 -36.77 38.8 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -79.44 -48.65 13.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.408 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -43.95 -51.66 17.18 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.158 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.408 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 12.6 Cg_exo -71.51 -42.62 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.491 2.127 . . . . 0.0 113.973 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.477 HD11 ' O ' ' A' ' 66' ' ' ILE . 2.9 tp -71.44 -45.19 63.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -56.27 -46.47 79.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.723 ' HB3' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -81.21 -20.45 41.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.547 ' OD2' HG22 ' A' ' 37' ' ' ILE . 72.7 m-20 -101.0 -11.52 19.61 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 42.64 52.78 5.36 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.852 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.536 HD12 HG21 ' A' ' 48' ' ' VAL . 4.2 pt -133.01 148.53 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.733 0.302 . . . . 0.0 111.144 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' THR . 73.8 p -78.1 135.21 37.66 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 48' ' ' VAL . 11.2 p -141.75 149.54 19.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -103.55 130.22 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.58 ' OD1' HG22 ' A' ' 54' ' ' VAL . 4.4 t0 -100.72 106.88 18.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.161 0.505 . . . . 0.0 110.474 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.776 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.1 m95 -111.57 103.63 55.28 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.094 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -108.18 175.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 123.64 2.893 . . . . 0.0 112.487 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.482 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 0.4 OUTLIER -126.32 105.55 8.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.844 0.355 . . . . 0.0 110.93 179.256 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -142.56 -173.92 4.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.674 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -56.65 -22.61 35.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.993 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -105.24 41.93 2.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.822 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.31 102.74 42.16 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.442 0.163 . . . . 0.0 110.712 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.512 ' O ' HG21 ' A' ' 83' ' ' VAL . 31.6 Cg_exo -59.17 107.27 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.569 2.179 . . . . 0.0 112.554 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.689 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 50.7 Cg_exo -53.93 -43.51 57.52 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.818 2.345 . . . . 0.0 114.171 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 2.8 Cg_endo -47.62 154.03 1.97 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.346 2.03 . . . . 0.0 113.578 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -64.12 -19.81 64.21 Favored Glycine 0 C--O 1.237 0.307 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.402 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.61 -29.73 11.64 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.546 0.173 . . . . 0.0 110.907 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.766 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 26.1 t -56.12 -48.1 79.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.491 HG11 ' CE2' ' A' ' 151' ' ' TYR . 86.5 t -55.72 -39.22 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.216 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.508 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.6 mt-10 -59.26 -31.46 69.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.914 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -66.85 -50.84 61.27 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.619 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.714 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -68.23 -26.89 65.92 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.534 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.634 HD13 ' OH ' ' A' ' 155' ' ' TYR . 15.3 mt -63.88 -47.2 81.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.319 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -42.09 98.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.298 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -53.91 -51.37 63.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.795 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 121' ' ' ALA . 8.6 p -72.33 -41.73 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.488 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.419 ' N ' HG13 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -54.56 -38.92 67.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 0.0 110.992 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.42 53.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 3.6 mmtt -73.17 -20.53 60.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.909 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE1' HG23 ' A' ' 91' ' ' VAL . 1.9 m-85 -82.07 -40.71 21.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.9 t -69.1 -42.73 75.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -75.99 -31.19 58.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.106 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -121.68 90.78 48.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.327 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.27 137.38 18.92 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.606 2.204 . . . . 0.0 112.363 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 20' ' ' MET . . . 58.78 57.38 20.19 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.588 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.831 ' OG ' HG21 ' A' ' 46' ' ' THR . 51.5 p -101.22 -168.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.328 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.693 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -120.91 113.44 20.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.053 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.707 HG11 ' CE1' ' A' ' 22' ' ' PHE . 43.8 t -105.46 151.02 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.057 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -123.92 139.43 53.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.207 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.822 HG22 HG12 ' A' ' 49' ' ' VAL . 45.1 t -140.12 166.71 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.623 ' N ' HG12 ' A' ' 105' ' ' VAL . 1.2 t-80 -66.97 155.97 37.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.381 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 25' ' ' THR . 49.3 t -68.5 106.94 2.72 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.011 HG13 HD12 ' A' ' 24' ' ' ILE . 34.1 m -75.42 0.09 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.022 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.45 -8.72 2.9 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.37 -139.4 5.31 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.543 HD22 ' HA2' ' A' ' 142' ' ' GLY . 11.7 mt -117.93 127.34 53.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.19 -146.28 4.82 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.349 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.7 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.3 -20.94 5.99 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.018 0.437 . . . . 0.0 111.936 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.655 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -51.93 -46.29 92.56 Favored Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.785 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.4 Cg_endo -52.59 -48.65 20.82 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.223 1.948 . . . . 0.0 113.274 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.52 ' O ' HD23 ' A' ' 120' ' ' LEU . 39.4 t -62.25 -41.0 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.079 0.466 . . . . 0.0 110.127 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.477 HD22 ' CD1' ' A' ' 87' ' ' TRP . 6.4 mt -59.06 -41.11 87.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.81 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.77 HG22 HG21 ' A' ' 105' ' ' VAL . 17.6 t -64.15 -55.53 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.65 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -60.32 -53.07 61.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 110.903 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.793 HD13 HD12 ' A' ' 123' ' ' ILE . 3.1 mm? -55.25 -30.31 59.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.038 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.714 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.56 -50.62 24.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 110.614 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.969 HD21 ' HE1' ' A' ' 20' ' ' MET . 0.4 OUTLIER -65.27 -10.09 29.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.586 179.04 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 1.007 HG23 ' CB ' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -56.78 -34.26 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.687 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -62.28 -16.56 54.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.908 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.0 m -79.88 11.06 3.53 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 120.27 -98.8 0.71 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.251 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.49 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 1.1 ptt? -62.61 73.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.36 0.6 . . . . 0.0 109.469 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 1.007 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.9 -68.03 0.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.635 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.3 t80 -68.71 -32.68 72.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.946 0.403 . . . . 0.0 111.186 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.26 -49.44 34.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.479 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 39.2 t0 -70.04 -45.6 66.81 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.914 0.387 . . . . 0.0 111.294 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 152' ' ' LEU . . . -57.84 -49.72 75.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.649 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 33.5 mm -70.29 -40.81 78.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -74.28 -49.8 21.61 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.721 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -67.87 -35.19 78.1 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.937 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.4 tt -74.24 -32.79 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.707 0.289 . . . . 0.0 110.74 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -63.95 -43.05 97.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.714 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -44.69 93.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.46 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.42 ' CE ' HG13 ' A' ' 15' ' ' VAL . 6.7 mptt -86.21 151.84 23.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.256 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.26 117.11 14.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 110.63 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -114.82 163.66 15.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.543 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -57.71 -165.83 0.09 OUTLIER Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.42 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.26 99.22 11.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.589 0.695 . . . . 0.0 111.0 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.642 HD12 HD21 ' A' ' 149' ' ' LEU . 1.4 pt -88.45 109.44 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.809 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -113.14 -76.65 0.58 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -99.78 -60.74 1.47 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.864 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.0 tmtt? -52.83 -51.9 59.13 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.455 ' HG3' HG22 ' A' ' 144' ' ' ILE . 7.1 tm0? -56.59 -51.63 67.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.642 HD21 HD12 ' A' ' 144' ' ' ILE . 4.3 mm? -75.24 -40.94 58.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 m -69.95 -40.53 75.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.933 0.397 . . . . 0.0 111.1 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.864 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -65.46 -50.02 66.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.854 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -65.02 -38.03 89.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.919 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -55.77 -44.0 77.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -24.31 62.83 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.685 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.634 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -66.28 -32.62 74.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.731 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -106.58 118.46 54.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.06 153.48 72.09 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.61 2.207 . . . . 0.0 112.458 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -138.16 123.39 19.3 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.131 0.491 . . . . 0.0 110.337 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -60.41 -18.9 53.76 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.377 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -39.09 80.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.803 0.335 . . . . 0.0 111.025 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.4 tp -86.05 -35.07 20.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.34 113.98 27.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.94 118.25 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -167.44 133.27 2.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.41 138.03 44.99 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.75 -47.5 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.414 2.076 . . . . 0.0 112.346 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 55.9 94.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.019 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.9 p -143.77 123.12 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -155.15 -51.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.0 tttt 59.94 92.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.0 t -124.66 -44.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.906 -179.97 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -101.85 170.83 7.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 110.924 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -174.06 145.25 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.797 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.48 -39.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.966 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.3 99.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -114.87 129.15 56.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 133.0 47.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.882 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.91 99.01 10.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 111.17 3.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.1 66.32 0.99 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.475 2.117 . . . . 0.0 112.336 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.33 151.82 85.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.855 ' HB3' HG22 ' A' ' 25' ' ' THR . 57.2 Cg_endo -71.03 165.01 33.77 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.635 2.224 . . . . 0.0 112.443 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.742 HG11 ' HD3' ' A' ' 139' ' ' LYS . 19.5 t -144.02 127.44 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 10.3 pt-20 -110.07 116.73 32.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.816 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.6 OUTLIER -108.01 118.7 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.589 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.4 p -140.83 145.26 36.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.715 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -136.4 159.93 40.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.734 178.183 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.622 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 9.4 ptpt 48.64 -103.79 0.11 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -177.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -120.44 -26.68 5.34 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.141 -0.349 . . . . 0.0 111.643 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.752 ' CE ' HD13 ' A' ' 122' ' ' LEU . 5.6 ppp? -73.84 165.71 24.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.654 0.264 . . . . 0.0 111.316 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -147.6 164.05 34.71 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.088 0.471 . . . . 0.0 111.507 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.765 ' CE1' HG13 ' A' ' 118' ' ' VAL . 1.7 m-85 -137.89 146.5 43.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.058 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -119.36 133.61 55.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.988 0.423 . . . . 0.0 110.954 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.043 HD12 HG13 ' A' ' 108' ' ' VAL . 2.1 mm -118.17 106.68 20.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.404 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.855 HG22 ' HB3' ' A' ' 12' ' ' PRO . 60.4 p -131.61 165.52 23.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.283 0.563 . . . . 0.0 111.876 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.488 ' CD2' ' CE2' ' A' ' 36' ' ' PHE . 35.4 p-80 -81.25 152.44 27.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.728 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.42 154.38 72.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.442 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.7 Cg_exo -54.2 137.24 70.3 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.472 2.114 . . . . 0.0 113.264 -177.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.63 145.89 26.4 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.197 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -68.58 -11.13 59.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.26 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.5 -31.71 14.46 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -140.12 88.73 2.24 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.064 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.673 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.5 OUTLIER -81.01 -51.9 8.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.106 0.479 . . . . 0.0 111.515 178.193 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.451 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.9 m -55.77 -45.48 78.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.438 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -57.81 -36.14 71.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.408 . . . . 0.0 111.321 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.645 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -72.92 -47.91 41.58 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.634 HG22 ' OD2' ' A' ' 64' ' ' ASP . 12.1 pt -55.87 -40.06 60.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 110.882 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.67 -52.1 59.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.497 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.54 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.6 OUTLIER -67.62 -50.17 59.36 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.799 0.333 . . . . 0.0 111.807 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.645 HD21 ' CE1' ' A' ' 36' ' ' PHE . 62.9 mt -55.04 -46.29 75.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.614 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -26.77 52.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.2 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.1 mtmt -53.85 -42.33 68.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.382 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.058 ' CD1' HD21 ' A' ' 23' ' ' LEU . 16.8 t80 -63.3 -38.48 91.33 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.933 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.653 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.31 -178.59 40.2 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.885 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.64 117.43 19.49 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.656 HG22 ' H ' ' A' ' 47' ' ' THR . 1.0 OUTLIER -165.18 -170.03 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.732 177.378 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' THR . 2.5 t -64.58 160.46 19.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.367 0.603 . . . . 0.0 110.502 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 104' ' ' ALA . 57.5 t -138.4 135.74 44.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.226 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.872 HG12 HG22 ' A' ' 105' ' ' VAL . 14.6 p -115.62 104.68 17.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.474 0.654 . . . . 0.0 110.974 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 110.86 20.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.724 178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.835 HG11 ' HB2' ' A' ' 113' ' ' ARG . 25.0 t -108.0 91.6 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.592 0.71 . . . . 0.0 110.141 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.77 171.22 20.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.005 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.91 130.32 43.0 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.22 122.49 26.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -120.2 -47.67 2.36 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.227 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -130.63 83.8 2.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.535 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -78.95 -36.22 41.97 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.09 -48.55 14.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.673 HG21 ' HG ' ' A' ' 33' ' ' LEU . 2.0 m -45.71 -48.32 38.59 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.497 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 8.4 Cg_exo -73.19 -41.19 1.36 Allowed 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.613 2.209 . . . . 0.0 113.503 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.85 HD21 ' CG1' ' A' ' 68' ' ' VAL . 4.0 mm? -65.5 -45.27 84.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.34 -31.06 60.45 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.62 ' HB3' HG21 ' A' ' 37' ' ' ILE . 2.2 mmpt? -81.09 -34.22 32.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.634 ' OD2' HG22 ' A' ' 37' ' ' ILE . 17.2 m-20 -101.68 -11.53 19.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.54 27.75 3.15 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.294 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.574 HD12 HG21 ' A' ' 48' ' ' VAL . 1.1 pt -105.01 148.74 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.775 0.322 . . . . 0.0 111.072 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.7 OUTLIER -77.42 133.34 38.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.85 ' CG1' HD21 ' A' ' 61' ' ' LEU . 4.0 p -145.06 149.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.048 0.451 . . . . 0.0 111.796 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.584 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.0 t -103.07 128.96 55.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -100.94 106.71 18.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.097 0.475 . . . . 0.0 111.198 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.924 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 5.5 m0 -109.72 103.51 53.31 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.188 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -108.23 179.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 123.498 2.798 . . . . 0.0 113.028 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.462 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 1.5 t80 -126.33 105.26 8.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.677 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.52 -174.79 4.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.777 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -56.76 -22.77 38.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.984 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.41 37.7 3.69 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.676 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.411 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . . . -87.64 102.96 3.93 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.4 0.143 . . . . 0.0 110.723 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.473 ' O ' HG21 ' A' ' 83' ' ' VAL . 12.6 Cg_endo -56.52 105.41 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.52 2.147 . . . . 0.0 112.51 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.676 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 29.2 Cg_exo -62.71 -37.39 57.02 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.94 2.427 . . . . 0.0 114.441 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 10.9 Cg_endo -56.48 154.21 31.25 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.875 1.717 . . . . 0.0 113.632 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.77 -20.16 59.31 Favored Glycine 0 C--O 1.236 0.271 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.407 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -29.84 14.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.348 0.118 . . . . 0.0 111.29 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.924 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 35.4 t -55.38 -50.99 61.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 2.6 t -53.77 -43.4 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.307 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -56.34 -31.21 63.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.876 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.7 -50.4 62.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.757 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -65.14 -33.93 77.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.743 179.134 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.94 HD21 ' HB3' ' A' ' 120' ' ' LEU . 17.8 mt -57.87 -46.89 84.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.723 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.83 -42.21 99.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.28 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.463 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.3 tm? -59.05 -51.46 69.97 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.757 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.986 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.2 p -69.7 -35.86 67.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.075 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -56.94 -45.02 83.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.319 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.04 91.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.497 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.12 -24.1 61.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.229 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.585 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.1 m-85 -81.76 -51.86 7.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.793 0.33 . . . . 0.0 111.179 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.4 -40.51 97.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -76.07 -32.94 59.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.213 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -125.53 90.81 49.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.323 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.78 132.49 14.45 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.539 2.159 . . . . 0.0 112.375 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.5 56.3 25.81 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.584 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.632 ' HB2' HG21 ' A' ' 46' ' ' THR . 1.1 m -101.21 -164.77 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.816 0.341 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.653 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 m -117.88 113.54 21.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.684 HG11 ' CE1' ' A' ' 22' ' ' PHE . 38.5 t -110.03 149.73 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.148 0.499 . . . . 0.0 112.243 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.833 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -119.11 143.29 47.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.946 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.872 HG22 HG12 ' A' ' 49' ' ' VAL . 92.7 t -139.98 166.16 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.579 ' N ' HG12 ' A' ' 105' ' ' VAL . 1.3 t-80 -67.36 156.12 37.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.126 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 25' ' ' THR . 48.5 t -68.38 105.52 2.2 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.043 HG13 HD12 ' A' ' 24' ' ' ILE . 34.3 m -75.42 0.62 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.185 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HB3' ' SG ' ' A' ' 107' ' ' CYS . . . -60.07 -8.55 2.45 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.29 -129.24 3.46 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.0 mt -127.9 127.42 43.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.59 -150.45 6.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.273 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.835 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.47 -19.02 6.52 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.025 0.441 . . . . 0.0 111.775 -178.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.672 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.15 -46.39 97.79 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.741 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.1 Cg_endo -52.41 -48.15 23.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.179 1.919 . . . . 0.0 112.428 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.521 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 23.0 t -56.85 -52.04 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 110.341 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.719 HD12 ' CG2' ' A' ' 49' ' ' VAL . 8.0 mt -51.88 -48.79 63.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.889 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.765 HG13 ' CE1' ' A' ' 22' ' ' PHE . 17.4 t -54.01 -54.09 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.58 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.62 -42.79 64.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.039 0.447 . . . . 0.0 111.17 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.94 ' HB3' HD21 ' A' ' 88' ' ' LEU . 9.6 mt -64.12 -30.78 71.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.195 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.986 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -69.24 -38.25 78.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.211 0.529 . . . . 0.0 109.748 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.752 HD13 ' CE ' ' A' ' 20' ' ' MET . 6.0 tp -77.26 -15.97 59.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.204 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.933 HG23 ' CB ' ' A' ' 128' ' ' LYS . 1.7 mt -57.78 -31.74 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.816 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -16.53 63.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 122' ' ' LEU . 5.0 m -83.81 11.04 8.13 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 118.08 -99.99 0.83 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.193 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.481 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.9 ptt? -62.48 76.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.933 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.52 -67.51 0.55 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -177.09 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.571 ' CD1' HD22 ' A' ' 152' ' ' LEU . 7.5 t80 -67.52 -32.46 73.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.926 0.393 . . . . 0.0 111.102 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -52.1 18.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.152 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 29.5 t0 -68.7 -41.02 79.74 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.127 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.673 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -58.53 -49.03 78.89 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.288 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.3 mm -72.25 -40.19 65.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.804 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -74.35 -49.6 22.13 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.816 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.63 -37.25 84.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.711 0.291 . . . . 0.0 110.525 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.6 tt -74.17 -27.93 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 110.465 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.411 ' HG2' ' NH2' ' A' ' 141' ' ' ARG . 6.2 mtt180 -65.47 -46.28 80.4 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.629 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -45.07 93.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.61 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.742 ' HD3' HG11 ' A' ' 13' ' ' VAL . 3.9 mmpt? -86.76 151.97 22.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.196 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.14 116.8 14.11 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.46 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.411 ' NH2' ' HG2' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -114.81 163.79 15.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.133 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.92 -171.08 0.07 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.86 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.78 100.17 12.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.24 0.52 . . . . 0.0 111.349 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.711 HG22 ' OE1' ' A' ' 148' ' ' GLN . 0.2 OUTLIER -87.63 109.73 19.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.825 178.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -113.62 -76.8 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.6 p -99.9 -60.87 1.45 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.811 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 9.7 tmtt? -63.09 -49.81 73.01 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.711 ' OE1' HG22 ' A' ' 144' ' ' ILE . 0.4 OUTLIER -55.87 -52.42 64.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.424 HD21 HG13 ' A' ' 144' ' ' ILE . 3.9 mm? -75.38 -40.53 57.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.8 m -70.72 -33.8 71.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.805 0.336 . . . . 0.0 111.475 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.811 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -70.48 -50.69 35.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.057 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.895 HD21 HD11 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -64.6 -31.42 72.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.638 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -61.81 -38.68 89.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -26.5 66.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.118 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.491 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -66.04 -41.49 90.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.936 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.8 86.01 2.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.349 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.18 145.68 84.86 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.687 2.258 . . . . 0.0 112.637 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -147.42 123.43 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.304 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -78.6 -37.99 41.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.968 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -66.77 -29.8 69.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.35 -47.98 83.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.027 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -88.23 -42.6 12.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.007 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -60.02 -57.74 11.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -103.47 165.06 11.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.1 106.64 15.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.15 132.32 22.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.372 2.048 . . . . 0.0 112.318 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -95.15 123.68 38.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.872 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.9 m -160.94 -44.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.966 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 7.2 m170 62.35 155.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.786 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -96.25 -52.54 3.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.2 m -67.0 98.2 0.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.962 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.912 -179.988 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.6 p -153.98 134.8 13.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.772 0.32 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -121.13 137.05 54.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.4 ttt -167.16 168.64 13.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.52 -179.65 8.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.092 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -126.28 -50.5 1.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.5 mtt -139.49 178.65 7.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -167.51 -46.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -137.62 115.69 9.77 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.06 140.74 55.28 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.495 2.13 . . . . 0.0 112.328 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.33 145.29 79.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.014 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.99 164.81 34.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.566 2.177 . . . . 0.0 112.314 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.403 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.5 t -144.14 126.84 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.2 pp20? -114.16 129.56 56.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.034 0.445 . . . . 0.0 111.844 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.788 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -108.2 120.34 59.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.01 158.1 21.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.156 0.503 . . . . 0.0 111.977 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.718 ' CD2' HD11 ' A' ' 122' ' ' LEU . 9.7 t80 -150.06 107.48 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.528 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 4.7 mmtp 62.9 -83.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.165 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -129.3 14.11 6.12 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.869 ' CE ' HD13 ' A' ' 122' ' ' LEU . 24.2 ttp -110.6 162.02 15.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.683 0.278 . . . . 0.0 110.969 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.5 mtt180 -148.53 134.9 19.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.093 0.473 . . . . 0.0 111.623 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.645 ' CE1' HG11 ' A' ' 103' ' ' VAL . 3.6 m-85 -115.34 151.35 34.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.729 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.058 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -124.45 135.93 53.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.113 0.482 . . . . 0.0 111.424 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.842 HD13 ' HB ' ' A' ' 105' ' ' VAL . 15.9 mm -118.34 106.54 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.654 HG21 HD23 ' A' ' 40' ' ' LEU . 2.2 p -129.84 163.47 26.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.358 0.599 . . . . 0.0 111.896 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.484 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 40.0 p-80 -81.16 152.58 27.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.933 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -62.41 154.6 71.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.968 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.452 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.5 Cg_exo -54.27 138.21 72.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.396 2.064 . . . . 0.0 113.433 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.7 p -98.54 145.49 26.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.217 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -68.47 -12.26 60.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.56 -31.25 14.6 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.3 p -139.81 88.99 2.28 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.172 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.432 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.6 OUTLIER -80.7 -52.3 7.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.175 0.512 . . . . 0.0 111.417 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.441 ' HA ' HG12 ' A' ' 37' ' ' ILE . 74.9 m -55.95 -45.64 78.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.59 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.2 m -57.65 -33.11 67.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.874 0.369 . . . . 0.0 111.314 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.677 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.52 -47.71 31.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.698 HD13 ' HB3' ' A' ' 63' ' ' LYS . 11.5 pt -55.81 -39.5 56.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.133 0.492 . . . . 0.0 110.63 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -65.12 -52.16 57.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.46 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.6 OUTLIER -67.68 -50.04 59.69 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 120.803 0.335 . . . . 0.0 111.831 -179.153 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.677 HD21 ' CE1' ' A' ' 36' ' ' PHE . 76.2 mt -54.95 -46.2 74.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.6 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -77.65 -26.82 50.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.05 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 5.9 mttt -52.4 -43.21 64.63 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.07 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.058 ' CD1' HD21 ' A' ' 23' ' ' LEU . 12.5 t80 -63.48 -38.49 91.36 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.585 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.699 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.96 -178.54 39.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.078 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.47 117.52 19.77 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.662 HG21 ' HB3' ' A' ' 101' ' ' SER . 0.7 OUTLIER -165.2 -169.67 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.973 177.673 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.64 ' H ' HG22 ' A' ' 46' ' ' THR . 7.8 t -64.37 156.81 28.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.463 0.649 . . . . 0.0 110.51 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.809 HG13 ' O ' ' A' ' 104' ' ' ALA . 66.5 t -136.78 134.29 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.135 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.941 HG13 HG13 ' A' ' 105' ' ' VAL . 13.1 p -115.66 105.07 17.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.393 0.616 . . . . 0.0 111.49 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.434 ' HD2' HG21 ' A' ' 68' ' ' VAL . 4.8 ptm180 -114.77 110.88 20.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.108 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 71' ' ' TRP . 14.6 t -105.25 91.62 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.468 0.651 . . . . 0.0 109.736 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.63 171.55 20.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.851 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.39 129.97 41.58 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -77.33 122.66 32.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.9 p -119.87 -47.73 2.39 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.063 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.413 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -130.57 83.45 2.12 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.398 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -79.44 -36.84 38.26 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.73 -48.54 13.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.558 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -47.02 -55.39 15.46 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.593 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 64.0 Cg_endo -73.37 -42.79 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.261 1.974 . . . . 0.0 114.204 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.687 ' CD2' HG11 ' A' ' 68' ' ' VAL . 27.1 mt -71.66 -45.36 62.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -66.24 -32.1 73.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.68 0.276 . . . . 0.0 111.565 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.698 ' HB3' HD13 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -81.23 -30.67 34.14 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.259 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.12 -11.46 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 45.52 67.2 1.31 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.804 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.1 mt -136.36 147.69 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.624 0.25 . . . . 0.0 110.84 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 47' ' ' THR . 70.9 p -78.07 128.02 33.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.687 HG11 ' CD2' ' A' ' 61' ' ' LEU . 8.3 p -145.23 151.73 14.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.091 0.472 . . . . 0.0 112.1 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.566 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.3 t -103.52 130.69 53.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -101.1 106.85 18.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.04 0.448 . . . . 0.0 111.143 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.804 ' HB3' HG13 ' A' ' 51' ' ' VAL . 5.7 m0 -110.89 103.96 55.44 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.367 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -106.21 149.97 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.258 2.639 . . . . 0.0 112.841 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.424 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -126.22 109.99 12.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.906 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.4 174.84 11.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.857 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.43 -34.02 71.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.847 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.84 42.88 1.58 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.307 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.423 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . -112.06 106.43 56.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.445 0.164 . . . . 0.0 111.191 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.633 ' C ' ' HD3' ' A' ' 80' ' ' PRO . 37.6 Cg_endo -66.13 165.35 24.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.255 1.97 . . . . 0.0 111.728 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -102.76 55.87 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.475 2.783 . . . . 0.0 114.353 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.891 ' O ' HG22 ' A' ' 83' ' ' VAL . 62.4 Cg_exo -47.99 138.36 21.62 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 121.888 1.725 . . . . 0.0 111.894 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -66.18 -22.63 70.98 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.675 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -43.25 68.12 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.578 0.228 . . . . 0.0 111.06 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.891 HG22 ' O ' ' A' ' 80' ' ' PRO . 15.2 m -55.12 -43.03 68.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.079 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.721 HG22 ' CD1' ' A' ' 120' ' ' LEU . 0.8 OUTLIER -53.49 -41.08 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -64.96 -31.38 72.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.324 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -66.48 -50.34 63.61 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.826 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -66.87 -30.34 70.48 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.87 HD21 ' HB3' ' A' ' 120' ' ' LEU . 18.2 mt -61.05 -46.71 89.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.339 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -64.05 -40.08 95.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.31 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.506 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.7 tm? -59.67 -51.34 70.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.725 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.059 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.4 p -71.07 -35.92 60.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.066 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.52 -46.85 76.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.46 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.89 -43.41 83.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.66 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -69.13 -25.71 64.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.511 ' CD1' HG22 ' A' ' 91' ' ' VAL . 1.7 m-85 -76.58 -52.02 10.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.948 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.2 t -59.67 -39.8 85.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.13 -33.08 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.126 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.09 88.23 54.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.304 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.95 128.15 12.09 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.536 2.158 . . . . 0.0 112.194 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.51 57.48 19.35 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.321 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.662 ' HB3' HG21 ' A' ' 46' ' ' THR . 1.5 t -101.03 -163.08 0.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.616 0.246 . . . . 0.0 111.123 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.699 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 m -115.44 113.26 23.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.337 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.645 HG11 ' CE1' ' A' ' 22' ' ' PHE . 25.7 t -110.42 150.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 112.016 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.809 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -121.58 142.0 50.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.188 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.941 HG13 HG13 ' A' ' 49' ' ' VAL . 20.0 t -140.1 166.14 20.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.357 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 3.3 t60 -67.17 155.37 38.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.95 0.405 . . . . 0.0 110.81 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.5 ' N ' ' O ' ' A' ' 25' ' ' THR . 34.4 t -69.27 110.33 4.57 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.734 HG13 HD12 ' A' ' 24' ' ' ILE . 13.2 m -75.6 0.63 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.372 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.04 -8.66 2.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.35 -137.7 4.44 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.544 HD22 ' HA2' ' A' ' 142' ' ' GLY . 4.1 mt -111.49 127.13 55.6 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.69 -162.42 12.52 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 119.952 -1.118 . . . . 0.0 113.522 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.668 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.38 -19.88 6.29 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.08 0.467 . . . . 0.0 111.735 -178.79 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.802 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -53.43 -46.42 98.06 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 8.0 Cg_endo -52.69 -48.51 21.6 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.948 1.766 . . . . 0.0 112.359 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.599 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 89.4 t -55.87 -53.34 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.571 HD12 ' CG2' ' A' ' 49' ' ' VAL . 10.6 mt -52.28 -45.57 65.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.692 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 114' ' ' ALA . 13.8 t -51.42 -52.63 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 111.177 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.469 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -54.99 -45.6 75.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.025 0.441 . . . . 0.0 110.436 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.87 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.5 mt -55.16 -30.92 60.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.039 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 1.059 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.96 -49.19 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.869 HD13 ' CE ' ' A' ' 20' ' ' MET . 22.5 tp -67.08 -14.02 62.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.805 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 1.001 ' CD1' HD21 ' A' ' 152' ' ' LEU . 2.1 mt -57.74 -32.41 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.977 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -16.21 63.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.673 ' HB2' HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -79.75 -23.45 42.23 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 151.2 -96.46 0.17 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.899 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.534 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.17 73.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.917 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -72.07 -67.8 0.51 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -176.756 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 5.3 t80 -66.14 -34.58 78.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.931 0.396 . . . . 0.0 111.227 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.27 -52.75 14.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.414 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 25.8 t70 -70.78 -32.65 69.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.716 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -60.42 -49.98 75.4 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 32.1 mm -71.04 -41.18 76.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.576 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.86 -50.37 17.28 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.788 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.1 -35.82 81.54 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.704 0.287 . . . . 0.0 110.55 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.3 tt -74.24 -40.47 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.677 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 52.0 ttt-85 -58.6 -36.61 74.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.177 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -59.52 -45.55 91.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.819 0.343 . . . . 0.0 110.747 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.402 ' CG ' HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -87.78 151.28 23.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.61 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.48 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.73 116.71 14.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.842 0.353 . . . . 0.0 110.155 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.447 ' HD3' HG23 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -115.39 164.1 14.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.355 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.544 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -53.39 -172.8 0.05 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.586 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.18 9.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.62 0.71 . . . . 0.0 111.616 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.458 HD12 ' CD2' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -88.62 109.75 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.457 178.43 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.63 -76.55 0.59 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.67 -60.78 1.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.846 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.9 tmtt? -53.42 -51.74 61.64 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.496 ' HG3' HG22 ' A' ' 116' ' ' VAL . 1.1 tm0? -56.79 -51.98 66.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 149' ' ' LEU . 3.7 mm? -73.62 -41.31 62.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.9 m -69.74 -41.3 75.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.793 0.33 . . . . 0.0 111.265 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.846 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -62.84 -50.66 70.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.223 -179.487 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.001 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -67.19 -31.22 71.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.923 -179.401 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -39.56 90.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -23.1 55.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.91 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.591 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -66.4 -39.56 89.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.72 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.89 124.48 35.27 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.755 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.53 151.75 83.9 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.496 2.131 . . . . 0.0 112.382 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.36 123.48 10.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.525 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -59.41 -22.22 61.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.113 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -59.06 -41.26 87.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.908 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.5 tp -60.05 -46.85 88.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 169.53 5.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -75.05 -49.44 19.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -62.85 115.45 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.99 138.08 49.69 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.35 -178.11 2.4 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.494 2.129 . . . . 0.0 112.273 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -167.15 -65.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.4 p -147.98 161.69 40.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -134.59 -47.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -141.1 163.59 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 171' ' ' THR . 9.8 t -71.19 98.79 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.847 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.77 -37.65 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -106.98 124.14 49.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 30.1 ttm -124.37 123.5 40.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.27 137.79 20.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -106.68 113.96 27.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.0 mmm -132.31 134.74 45.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.16 -37.95 9.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.8 mtm105 -132.3 116.02 15.21 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.09 106.61 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.419 2.079 . . . . 0.0 112.198 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.64 154.5 94.33 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.21 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HB3' HG23 ' A' ' 25' ' ' THR . 52.7 Cg_endo -69.37 165.27 31.09 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.651 2.234 . . . . 0.0 112.345 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 t -130.32 126.69 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.795 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.425 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -103.81 122.67 45.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.536 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.734 HG12 ' CE2' ' A' ' 135' ' ' PHE . 2.3 t -106.82 134.17 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.317 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 p -132.17 133.63 44.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.171 0.51 . . . . 0.0 112.16 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.655 ' HD2' HD11 ' A' ' 122' ' ' LEU . 41.2 t80 -155.13 141.98 19.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.371 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mmtt 61.97 -103.59 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.932 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -129.84 -1.62 4.75 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.605 ' HE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -113.34 168.43 9.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.038 0.447 . . . . 0.0 111.478 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -125.9 164.2 21.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.009 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.712 ' CE1' HG11 ' A' ' 103' ' ' VAL . 1.5 m-85 -136.65 137.44 40.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.339 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.062 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -114.88 132.8 56.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.002 0.429 . . . . 0.0 111.134 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.81 HG21 HG12 ' A' ' 108' ' ' VAL . 1.2 mm -115.85 106.35 20.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -135.33 167.1 21.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 111.921 -178.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.426 ' CA ' ' HB2' ' A' ' 107' ' ' CYS . 3.0 t-80 -81.09 151.53 28.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.689 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -63.42 154.84 77.63 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.83 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.44 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.7 Cg_exo -54.57 140.11 75.59 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.222 1.948 . . . . 0.0 112.954 -178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.465 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 67.8 p -98.61 174.27 6.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -92.52 -13.06 30.35 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.57 -31.04 14.68 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 p -139.72 89.56 2.33 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.49 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.465 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.3 OUTLIER -80.4 -52.19 7.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.106 0.479 . . . . 0.0 111.31 178.15 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.446 ' HA ' HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -55.97 -45.38 78.92 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.549 -178.637 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.7 -34.47 69.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.897 0.379 . . . . 0.0 111.354 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.637 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.17 -47.75 33.73 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.845 HG22 ' OD2' ' A' ' 64' ' ' ASP . 12.5 pt -55.54 -39.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.155 0.502 . . . . 0.0 110.605 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -65.43 -51.97 56.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.483 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.569 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 2.5 m-20 -68.35 -50.2 54.89 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.637 HD21 ' CE1' ' A' ' 36' ' ' PHE . 84.9 mt -55.69 -45.38 77.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.556 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -78.45 -26.63 46.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.102 0.477 . . . . 0.0 110.059 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.3 mttp -52.01 -43.98 63.91 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.283 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.062 ' CD1' HD21 ' A' ' 23' ' ' LEU . 20.2 t80 -63.31 -38.39 90.98 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.696 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.747 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 166.24 -178.83 40.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.928 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.17 19.23 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.825 HG21 ' OG ' ' A' ' 101' ' ' SER . 0.6 OUTLIER -165.22 -169.38 1.62 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.853 177.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.636 ' H ' HG22 ' A' ' 46' ' ' THR . 2.9 t -64.33 143.07 58.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.692 0.758 . . . . 0.0 110.557 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.789 HG13 ' HB3' ' A' ' 104' ' ' ALA . 25.4 t -122.23 132.12 71.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.113 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.057 HG13 HG13 ' A' ' 105' ' ' VAL . 9.8 p -115.47 105.25 18.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.181 0.515 . . . . 0.0 111.175 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 110.93 20.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.906 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.893 HG11 ' HB2' ' A' ' 113' ' ' ARG . 44.0 t -103.98 91.74 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.556 0.693 . . . . 0.0 110.493 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.6 t -157.79 171.19 20.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.733 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.74 130.2 42.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -72.36 122.0 23.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 p -120.57 -47.71 2.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.046 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.411 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -130.75 84.24 2.18 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.503 179.162 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -78.77 -36.51 42.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -79.5 -48.59 13.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.452 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -44.5 -49.7 24.91 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.416 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 9.6 Cg_exo -72.97 -42.46 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.702 2.268 . . . . 0.0 113.731 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.836 HD12 HG12 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -71.39 -45.21 63.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.653 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -70.54 -28.9 65.28 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.495 ' CB ' HG21 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -81.02 -34.72 32.65 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.332 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.845 ' OD2' HG22 ' A' ' 37' ' ' ILE . 44.0 m-20 -101.54 -11.37 19.33 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.56 41.56 49.69 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.423 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.757 ' CD1' HG21 ' A' ' 48' ' ' VAL . 1.1 pt -118.77 148.71 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 122.313 0.245 . . . . 0.0 111.047 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' THR . 21.9 p -77.39 135.03 38.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.836 HG12 HD12 ' A' ' 61' ' ' LEU . 7.4 p -144.98 149.68 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.073 0.463 . . . . 0.0 112.054 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.453 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.2 t -103.31 131.04 52.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.11 106.55 17.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 111.021 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.857 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.9 m95 -110.53 103.47 54.28 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.199 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -108.58 -176.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.469 2.779 . . . . 0.0 113.042 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -126.27 140.0 52.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.531 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -152.67 172.74 16.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.63 -25.22 37.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.945 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -120.47 59.99 0.53 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.499 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.417 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -85.69 135.56 37.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 122.938 -0.154 . . . . 0.0 110.703 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.718 ' HG2' HG21 ' A' ' 83' ' ' VAL . 39.4 Cg_endo -66.31 107.75 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.569 2.18 . . . . 0.0 112.666 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.656 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 24.1 Cg_exo -64.62 -36.62 41.31 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.004 2.469 . . . . 0.0 114.603 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 18.2 Cg_endo -62.06 152.26 76.66 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.823 1.682 . . . . 0.0 113.713 -178.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.445 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -66.09 -19.34 67.9 Favored Glycine 0 C--O 1.236 0.263 0 CA-C-N 114.948 -1.024 . . . . 0.0 113.266 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -50.11 -29.4 8.95 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.428 0.156 . . . . 0.0 110.93 -177.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.857 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 55.3 t -55.36 -47.98 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.717 HG11 ' HE2' ' A' ' 151' ' ' TYR . 88.0 t -56.13 -39.8 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.05 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.786 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.8 mt-10 -58.21 -31.25 67.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.481 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.87 -50.25 67.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.988 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.859 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -68.04 -26.79 66.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.531 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.896 HD21 ' HB3' ' A' ' 120' ' ' LEU . 25.9 mt -62.79 -41.44 99.26 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.159 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 t -67.78 -41.72 82.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.026 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.453 ' HG ' HG22 ' A' ' 69' ' ' VAL . 1.8 tm? -58.98 -51.23 70.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.779 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.762 HG21 ' HB1' ' A' ' 121' ' ' ALA . 7.8 p -71.81 -41.06 69.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.261 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -55.34 -38.49 68.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.936 0.398 . . . . 0.0 110.706 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.04 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.763 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -29.58 67.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.145 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.501 ' CE1' HG21 ' A' ' 103' ' ' VAL . 3.3 m-85 -76.78 -52.06 10.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.032 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.3 t -59.8 -36.95 77.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -31.87 59.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.06 94.4 41.59 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.287 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.13 129.09 16.61 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.425 2.083 . . . . 0.0 112.219 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.95 59.46 10.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.292 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.825 ' OG ' HG21 ' A' ' 46' ' ' THR . 83.5 p -101.2 -170.09 1.79 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.927 0.394 . . . . 0.0 111.442 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.747 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.6 m -113.03 113.61 25.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.308 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.712 HG11 ' CE1' ' A' ' 22' ' ' PHE . 76.0 t -104.23 149.98 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.789 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -122.52 140.58 52.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.787 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.057 HG13 HG13 ' A' ' 49' ' ' VAL . 2.2 t -140.6 166.74 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.688 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.1 t-80 -67.49 156.14 37.35 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.651 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.576 ' N ' ' O ' ' A' ' 25' ' ' THR . 50.4 t -68.41 102.44 1.42 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.381 0.61 . . . . 0.0 112.287 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.81 HG12 HG21 ' A' ' 24' ' ' ILE . 7.1 p -75.27 -0.02 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.025 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HB3' ' SG ' ' A' ' 107' ' ' CYS . . . -60.81 -8.68 3.21 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.452 ' O ' HD23 ' A' ' 111' ' ' LEU . . . -122.3 -134.06 4.39 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 110' ' ' GLY . 22.3 mt -125.29 127.58 46.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.2 -143.19 3.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.993 -1.099 . . . . 0.0 113.597 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.893 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.13 -19.37 6.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.968 0.413 . . . . 0.0 111.794 -178.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.701 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -50.62 -46.46 85.68 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.0 Cg_endo -51.98 -48.39 21.84 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.46 2.107 . . . . 0.0 112.869 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.595 ' O ' HD23 ' A' ' 120' ' ' LEU . 22.1 t -61.73 -38.51 80.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.932 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.455 HD12 ' CG2' ' A' ' 51' ' ' VAL . 6.8 mt -64.61 -49.1 72.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.527 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 1.017 HG22 HG11 ' A' ' 105' ' ' VAL . 12.5 t -54.59 -55.4 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.742 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -59.23 -49.4 78.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.214 0.531 . . . . 0.0 111.091 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.896 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.2 mm? -53.92 -30.66 47.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.859 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.24 -47.66 55.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.04 0.447 . . . . 0.0 110.085 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.655 HD11 ' HD2' ' A' ' 17' ' ' TYR . 14.4 tp -61.58 -16.99 53.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.746 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.903 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.9 mt -57.08 -30.81 35.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.494 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.402 ' OE2' ' CG ' ' A' ' 95' ' ' PHE . 3.3 pt-20 -68.14 -17.29 64.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.557 0.218 . . . . 0.0 111.456 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.7 t -84.75 11.04 9.83 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 104.02 -81.69 0.35 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.873 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 51.8 ttp -63.16 66.47 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.903 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -74.63 -67.91 0.59 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -176.239 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.6 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.1 t80 -71.59 -31.54 67.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.057 0.456 . . . . 0.0 110.806 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.404 ' HB2' ' HG3' ' A' ' 127' ' ' MET . 1.3 mt-10 -72.53 -47.32 49.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.311 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.687 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 10.8 t0 -70.09 -43.77 70.44 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 110.836 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.742 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -58.36 -50.04 75.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.879 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.0 mm -71.65 -42.38 71.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.904 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -49.33 27.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.734 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -68.62 -39.66 80.7 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.189 -0.204 . . . . 0.0 111.016 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.7 OUTLIER -72.62 -27.79 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.318 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -47.18 79.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.949 0.404 . . . . 0.0 110.034 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -45.13 93.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.667 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -86.5 152.54 22.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.346 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -72.83 117.07 14.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.004 0.43 . . . . 0.0 110.299 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.455 ' HA ' HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -114.82 163.29 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.158 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.461 ' H ' ' HG3' ' A' ' 115' ' ' PRO . . . -58.06 172.47 3.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.197 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.23 99.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.528 0.664 . . . . 0.0 110.447 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.834 HD12 HD21 ' A' ' 149' ' ' LEU . 2.2 pt -88.31 109.06 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.098 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -113.55 -76.88 0.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.562 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.06 -60.61 1.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.631 ' O ' ' CB ' ' A' ' 151' ' ' TYR . 0.8 OUTLIER -54.76 -51.93 64.14 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.295 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.493 ' HG3' HG22 ' A' ' 144' ' ' ILE . 1.1 tm0? -56.35 -51.87 66.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.834 HD21 HD12 ' A' ' 144' ' ' ILE . 3.4 mm? -75.22 -47.46 28.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.7 m -64.96 -34.82 79.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.733 0.301 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.717 ' HE2' HG11 ' A' ' 84' ' ' VAL . 6.9 t80 -68.2 -50.95 50.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.281 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.772 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -72.01 -32.76 67.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.525 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.59 -37.7 79.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -28.24 62.4 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.642 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.556 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -65.88 -34.34 77.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.679 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.02 89.52 4.56 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.28 150.33 87.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.536 2.157 . . . . 0.0 112.363 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.27 123.57 10.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -70.42 -11.96 61.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.339 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.9 -38.71 79.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.817 0.341 . . . . 0.0 111.037 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -38.84 84.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -109.76 -169.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -124.01 111.01 15.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.45 138.06 54.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -86.66 108.58 18.72 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.8 112.35 2.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.404 2.069 . . . . 0.0 112.277 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 4.9 t60 61.72 152.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.6 m -142.79 149.35 38.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -151.33 137.06 17.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 60.69 106.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.3 m -101.9 -64.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.814 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t -163.91 126.13 2.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.36 . . . . 0.0 110.946 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -149.76 150.18 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.84 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.2 mtt 60.64 168.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.64 -67.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -91.21 84.36 5.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.03 161.34 30.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.35 145.44 48.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -74.68 141.05 75.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.28 110.09 3.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.515 2.143 . . . . 0.0 112.336 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.76 148.04 92.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.068 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.29 163.43 39.15 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.526 2.151 . . . . 0.0 112.297 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.05 126.83 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -108.5 126.25 52.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.523 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.786 HG12 ' CE2' ' A' ' 135' ' ' PHE . 2.4 t -106.65 129.79 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 p -132.87 139.25 47.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.222 0.534 . . . . 0.0 112.136 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 18' ' ' LYS . 10.8 t80 -155.12 129.17 8.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.104 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 2.0 mmmp? 63.46 -92.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.198 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.42 -39.06 1.52 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.455 ' HE1' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -73.77 151.66 40.56 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 111.273 -179.398 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.62 164.24 21.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.067 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.665 ' CE1' HG11 ' A' ' 103' ' ' VAL . 2.0 m-85 -136.76 139.16 41.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.646 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.078 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -117.77 138.5 52.01 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.118 0.485 . . . . 0.0 111.343 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.772 HG21 HG12 ' A' ' 108' ' ' VAL . 2.6 mm -118.22 106.64 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.211 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -131.05 164.29 25.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.476 0.655 . . . . 0.0 112.451 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 107' ' ' CYS . 46.3 p-80 -81.74 152.55 26.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.248 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -62.48 154.44 72.75 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.2 Cg_exo -54.85 139.03 78.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.391 2.061 . . . . 0.0 113.601 -177.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.7 p -98.97 145.94 26.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.977 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -71.3 -10.12 59.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.83 14.74 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 p -139.59 89.43 2.32 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.382 -0.527 . . . . 0.0 112.244 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.38 -52.25 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.177 0.513 . . . . 0.0 111.23 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.457 ' HA ' HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -56.7 -45.19 81.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.321 -178.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.5 m -57.69 -31.91 66.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.739 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.22 -47.56 27.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.142 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.732 HD13 ' HB3' ' A' ' 63' ' ' LYS . 11.3 pt -55.44 -38.39 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.227 0.537 . . . . 0.0 110.334 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.43 -51.75 58.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.374 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.547 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.2 m-20 -68.8 -50.29 51.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.918 0.389 . . . . 0.0 111.953 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.739 HD21 ' CE1' ' A' ' 36' ' ' PHE . 83.6 mt -56.89 -44.45 82.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.993 0.425 . . . . 0.0 110.303 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -77.19 -26.65 53.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.886 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 2.1 mtmt -52.79 -47.52 67.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.306 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.078 ' CD1' HD21 ' A' ' 23' ' ' LEU . 11.6 t80 -63.63 -38.5 91.37 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.656 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.671 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 160.03 -177.44 36.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.041 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.62 122.93 28.34 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.833 HG22 ' H ' ' A' ' 47' ' ' THR . 3.8 m -164.52 -171.2 2.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.46 177.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.833 ' H ' HG22 ' A' ' 46' ' ' THR . 1.8 t -65.33 149.63 49.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.329 0.585 . . . . 0.0 109.862 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.037 HG22 ' HB3' ' A' ' 104' ' ' ALA . 74.4 t -126.64 135.18 64.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.882 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.032 HG13 HG13 ' A' ' 105' ' ' VAL . 9.3 p -115.46 104.91 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.111 0.482 . . . . 0.0 111.27 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -114.74 111.01 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.399 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.796 HG13 ' HB3' ' A' ' 71' ' ' TRP . 8.1 t -103.71 90.39 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.451 0.643 . . . . 0.0 109.303 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -158.63 171.87 19.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.953 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -65.06 130.62 44.02 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 m -81.07 122.32 36.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.6 p -120.15 -47.52 2.37 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.663 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.419 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -130.33 83.86 2.16 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.581 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -79.4 -36.6 38.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.65 -48.58 13.48 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.454 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.22 -56.65 10.21 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 65.4 Cg_endo -73.17 -42.35 1.0 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.493 2.129 . . . . 0.0 114.182 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.737 HD21 HG11 ' A' ' 68' ' ' VAL . 28.9 mt -71.19 -45.21 63.89 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.3 -30.83 70.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.817 0.341 . . . . 0.0 111.422 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.732 ' HB3' HD13 ' A' ' 37' ' ' ILE . 13.3 mttm -81.37 -32.67 32.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 66' ' ' ILE . 18.1 p30 -101.23 -11.35 19.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 61' ' ' LEU . . . 48.11 31.29 8.25 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.284 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 64' ' ' ASP . 5.6 mt -97.42 147.53 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.679 0.276 . . . . 0.0 110.974 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' THR . 50.1 p -78.41 131.14 36.82 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.737 HG11 HD21 ' A' ' 61' ' ' LEU . 9.1 p -145.36 152.24 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.63 132.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -100.57 106.79 18.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 109.947 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.861 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 3.4 m95 -111.72 104.07 55.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.677 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -106.83 88.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 123.573 2.849 . . . . 0.0 112.344 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.632 ' CD1' ' HB1' ' A' ' 77' ' ' ALA . 1.5 t80 -85.79 95.85 9.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 110.963 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.74 -165.39 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -55.25 -24.74 29.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.112 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -114.68 39.49 2.78 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.632 ' HB1' ' CD1' ' A' ' 73' ' ' PHE . . . -85.98 155.07 58.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.623 0.249 . . . . 0.0 111.029 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.798 ' HG2' HG21 ' A' ' 83' ' ' VAL . 57.4 Cg_endo -70.62 109.55 2.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.682 2.255 . . . . 0.0 112.586 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 32.7 Cg_exo -60.32 -40.17 60.98 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.914 2.409 . . . . 0.0 114.354 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 12.4 Cg_endo -58.06 143.15 96.95 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.936 1.758 . . . . 0.0 113.544 -178.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -66.03 -19.9 68.34 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.179 -0.919 . . . . 0.0 113.04 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -50.73 -29.57 11.72 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.561 0.22 . . . . 0.0 110.763 -178.234 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.861 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 41.4 t -56.79 -48.3 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.737 HG11 ' HE2' ' A' ' 151' ' ' TYR . 90.3 t -55.34 -37.47 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.986 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.838 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.8 mt-10 -60.42 -31.32 70.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.429 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.91 -50.17 69.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.245 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.731 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.56 -27.42 67.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.612 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.838 HD12 ' HA ' ' A' ' 85' ' ' GLU . 37.1 mt -64.49 -38.16 90.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.095 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -69.03 -41.42 77.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.803 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -59.53 -51.32 70.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.381 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.562 HG21 ' HB1' ' A' ' 121' ' ' ALA . 8.5 p -71.74 -35.9 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.909 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -56.23 -47.19 78.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.502 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.31 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.636 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 1.7 mmtp -68.0 -24.28 65.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.077 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.548 ' HE1' HG21 ' A' ' 103' ' ' VAL . 2.4 m-85 -82.09 -52.04 7.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.167 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.3 t -63.93 -39.87 95.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.992 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.11 -31.72 58.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.226 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -124.15 89.1 52.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.52 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.64 135.07 14.19 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.594 2.196 . . . . 0.0 112.236 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 20' ' ' MET . . . 64.95 46.23 89.94 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.468 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 t -101.04 -176.59 3.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.66 0.267 . . . . 0.0 111.118 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.671 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 2.2 m -111.98 114.05 26.71 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.665 HG11 ' CE1' ' A' ' 22' ' ' PHE . 28.0 t -101.94 151.28 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.037 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.05 141.74 51.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.146 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.032 HG13 HG13 ' A' ' 49' ' ' VAL . 2.5 t -140.68 166.95 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.78 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.0 OUTLIER -67.38 156.51 36.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.639 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -68.01 98.79 0.79 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.375 0.607 . . . . 0.0 112.469 -178.042 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.772 HG12 HG21 ' A' ' 24' ' ' ILE . 7.5 p -75.41 -0.08 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.96 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.66 -8.76 3.13 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.03 -124.71 2.96 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 143' ' ' ALA . 13.1 mt -129.11 127.39 41.36 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.86 -144.41 4.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.807 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.481 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.14 -20.56 6.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.033 0.444 . . . . 0.0 111.931 -178.487 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.78 ' HB2' ' HB3' ' A' ' 106' ' ' HIS . . . -52.11 -44.94 93.63 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 6.4 Cg_endo -51.62 -48.3 22.05 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.524 2.149 . . . . 0.0 113.165 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 ' CG ' ' A' ' 148' ' ' GLN . 62.1 t -62.48 -46.45 96.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.02 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 49' ' ' VAL . 13.4 mt -58.85 -41.89 88.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.973 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.856 ' CG2' HG11 ' A' ' 105' ' ' VAL . 54.0 t -61.63 -55.44 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.609 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -58.09 -52.51 65.24 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.157 0.504 . . . . 0.0 111.032 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.738 ' HB3' HD21 ' A' ' 88' ' ' LEU . 4.3 mm? -53.82 -30.82 46.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.668 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.731 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.26 -42.38 65.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.078 0.466 . . . . 0.0 110.115 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.455 ' CD1' ' HE1' ' A' ' 20' ' ' MET . 3.4 tp -67.51 -14.04 62.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.928 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.4 mt -57.25 -30.77 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.031 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.28 -16.87 63.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.6 m -83.93 11.2 8.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.19 -101.58 1.06 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.211 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.484 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.7 ptt? -62.49 77.78 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.928 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.65 -67.59 0.54 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.655 ' CD1' HD22 ' A' ' 152' ' ' LEU . 4.1 t80 -66.26 -33.77 76.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.926 0.393 . . . . 0.0 111.187 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.26 -51.67 19.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.294 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 30.0 t0 -70.03 -36.25 74.92 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.841 0.353 . . . . 0.0 111.029 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -61.31 -50.16 74.09 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.654 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.9 mm -74.31 -37.61 45.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.531 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -74.24 -49.68 22.27 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.786 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.24 -35.84 76.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.473 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.3 tt -74.0 -27.91 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 0.0 110.227 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -65.14 -52.31 55.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.539 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.86 -45.17 93.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.633 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 136' ' ' ILE . 7.3 mmtt -81.54 152.22 27.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.253 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.83 117.21 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.344 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.423 ' HA ' ' CG2' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -114.64 163.39 15.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.12 -179.649 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.484 ' H ' ' HG3' ' A' ' 115' ' ' PRO . . . -60.15 -163.35 0.14 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.276 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.457 ' N ' HD22 ' A' ' 111' ' ' LEU . . . -90.1 99.28 12.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.427 0.614 . . . . 0.0 110.633 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.603 HG22 ' HG3' ' A' ' 148' ' ' GLN . 6.8 pt -88.35 109.26 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.119 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.67 -76.98 0.58 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.605 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.23 -60.69 1.48 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.641 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.6 tmtt? -57.35 -51.89 67.59 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.765 ' CG ' HG22 ' A' ' 116' ' ' VAL . 4.3 tm0? -56.14 -52.09 65.61 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 149' ' ' LEU . 3.4 mm? -75.27 -45.55 39.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 56.3 m -66.44 -33.47 75.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.807 0.336 . . . . 0.0 111.147 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.737 ' HE2' HG11 ' A' ' 84' ' ' VAL . 2.2 t80 -68.68 -50.93 47.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.735 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -70.25 -34.26 72.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.407 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -36.44 76.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -26.26 60.55 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.71 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.728 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -65.93 -37.58 86.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.451 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.91 85.92 2.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.614 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.01 151.61 67.73 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.609 2.206 . . . . 0.0 112.486 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.33 123.5 10.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.472 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -65.21 -20.68 66.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.208 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -30.37 67.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.82 0.343 . . . . 0.0 110.985 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.2 mt -67.86 -48.03 67.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.12 126.53 46.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.56 -60.58 2.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -63.25 119.11 8.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -94.05 103.5 10.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.9 177.43 4.99 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.437 2.091 . . . . 0.0 112.264 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -141.78 176.12 9.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.7 m -111.82 133.63 53.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -109.39 168.74 9.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -170.73 97.21 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.6 m -124.4 110.94 15.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.996 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.935 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 t -176.11 164.61 2.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.814 0.34 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -97.23 -62.52 1.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.5 ptp -66.26 110.88 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -167.99 -55.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.74 36.56 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.939 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -130.8 120.83 24.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -141.77 88.7 2.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -161.47 80.71 2.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.05 148.82 29.16 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.6 2.2 . . . . 0.0 112.326 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.534 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -86.56 160.78 49.96 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.588 ' HB3' HG22 ' A' ' 25' ' ' THR . 54.6 Cg_endo -69.83 163.67 37.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.577 2.185 . . . . 0.0 112.306 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.461 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.4 t -144.26 129.26 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.964 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -111.34 116.6 31.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.868 0.366 . . . . 0.0 111.269 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.804 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -109.05 118.29 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' A' ' 21' ' ' ARG . 70.3 p -141.24 142.46 33.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.616 ' CD2' ' HE1' ' A' ' 127' ' ' MET . 1.2 p90 -136.61 164.48 28.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.413 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.584 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 pttp 50.09 -95.99 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.202 0.201 . . . . 0.0 110.973 -177.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.491 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 t-160 -128.92 -32.36 2.09 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.859 ' HE1' HD11 ' A' ' 122' ' ' LEU . 3.8 ppp? -73.65 168.05 20.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.645 0.259 . . . . 0.0 111.329 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HA ' ' CB ' ' A' ' 16' ' ' SER . 3.4 mtp180 -146.05 161.54 39.9 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.012 0.434 . . . . 0.0 111.752 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.86 ' CD2' HG13 ' A' ' 118' ' ' VAL . 0.9 OUTLIER -135.05 148.78 49.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.555 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.08 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -120.28 135.96 54.83 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.106 0.479 . . . . 0.0 111.206 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.918 HD12 HG13 ' A' ' 108' ' ' VAL . 2.2 mm -117.98 106.66 20.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.25 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 12' ' ' PRO . 1.3 p -132.62 164.44 26.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.197 0.523 . . . . 0.0 111.819 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.463 ' CD2' ' CZ ' ' A' ' 36' ' ' PHE . 45.4 p-80 -81.31 152.17 27.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.738 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -62.71 154.42 74.65 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.492 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.9 Cg_exo -54.61 140.58 75.86 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.296 1.997 . . . . 0.0 113.2 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.462 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.5 p -98.69 174.38 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.129 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -94.26 -11.4 30.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.66 -30.75 14.76 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.0 p -139.5 89.61 2.34 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.45 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.604 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -80.27 -52.22 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.19 0.519 . . . . 0.0 111.173 178.212 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.438 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.8 p -56.86 -45.05 82.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.308 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.1 m -57.92 -32.82 68.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.828 0.347 . . . . 0.0 111.288 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.749 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.8 -47.92 28.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.146 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.825 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.1 pt -55.7 -38.93 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.233 0.54 . . . . 0.0 110.655 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -51.9 57.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.46 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.554 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -68.7 -50.29 52.07 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.749 HD21 ' CE1' ' A' ' 36' ' ' PHE . 72.4 mt -56.47 -43.64 79.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.437 . . . . 0.0 110.392 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -78.6 -26.73 45.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.077 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 3.7 mttt -53.25 -44.6 68.28 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.374 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.08 ' CD1' HD21 ' A' ' 23' ' ' LEU . 16.5 t80 -63.52 -38.56 91.6 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.949 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.663 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.32 -178.47 39.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.951 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.64 117.67 19.84 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.652 HG22 ' H ' ' A' ' 47' ' ' THR . 0.8 OUTLIER -164.88 -170.16 1.89 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.966 177.324 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.652 ' H ' HG22 ' A' ' 46' ' ' THR . 16.8 p -64.94 155.11 35.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.474 0.654 . . . . 0.0 110.788 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.054 HG22 ' HB3' ' A' ' 104' ' ' ALA . 65.6 t -134.0 139.1 49.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.04 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.022 HG13 HG13 ' A' ' 105' ' ' VAL . 3.3 p -115.77 105.37 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.164 0.507 . . . . 0.0 110.936 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.23 110.92 20.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.22 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.82 HG13 ' HB3' ' A' ' 71' ' ' TRP . 10.8 t -105.62 91.38 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.331 0.586 . . . . 0.0 109.914 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 10.4 p -158.01 171.28 20.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.948 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.64 130.48 43.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.59 121.75 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 p -120.77 -47.63 2.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.212 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.426 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.7 m-85 -130.43 84.29 2.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.488 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -78.61 -36.24 44.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -79.1 -48.49 14.24 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.63 HG22 ' HD2' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -44.56 -49.88 24.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 17.2 Cg_exo -68.08 -42.1 6.5 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.574 2.183 . . . . 0.0 113.427 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.737 HD21 HG12 ' A' ' 68' ' ' VAL . 1.4 mm? -66.19 -45.43 80.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.61 -41.08 55.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.825 ' HB3' HG21 ' A' ' 37' ' ' ILE . 18.1 mttt -80.92 -27.51 36.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HB3' ' CG1' ' A' ' 66' ' ' ILE . 2.7 t0 -101.15 -11.49 19.53 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.45 29.5 1.16 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.522 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.434 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 2.4 pt -117.56 148.06 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.714 0.293 . . . . 0.0 110.982 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' THR . 24.6 p -77.77 135.15 37.96 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.737 HG12 HD21 ' A' ' 61' ' ' LEU . 9.4 p -143.87 154.91 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.46 134.18 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -100.82 106.77 18.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.241 0.544 . . . . 0.0 110.319 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.82 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.1 m95 -111.96 104.35 55.97 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.091 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -103.79 165.02 0.23 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 123.225 2.617 . . . . 0.0 112.275 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.425 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 2.5 t80 -126.13 122.47 35.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.009 0.433 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -178.11 -167.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.36 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.93 -20.89 40.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.241 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -105.59 27.33 18.4 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.897 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -110.59 102.73 52.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.643 0.222 . . . . 0.0 110.974 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.667 ' HB2' HG13 ' A' ' 83' ' ' VAL . 76.4 Cg_exo -50.68 102.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.633 2.222 . . . . 0.0 112.717 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.68 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 9.7 Cg_endo -53.66 -43.36 58.45 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.773 2.316 . . . . 0.0 113.863 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.81 ' O ' HG22 ' A' ' 83' ' ' VAL . 4.5 Cg_endo -47.66 148.41 5.86 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.343 2.028 . . . . 0.0 113.49 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.448 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -57.45 -19.78 35.04 Favored Glycine 0 C--O 1.237 0.293 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.399 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -32.0 19.39 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.546 0.173 . . . . 0.0 111.014 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -55.01 -46.86 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.847 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' A' ' 151' ' ' TYR . 79.7 t -55.02 -43.13 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.268 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.64 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.3 mt-10 -56.27 -31.28 63.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.802 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.94 -50.54 62.02 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.827 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -68.63 -26.96 65.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.828 HD21 ' HB3' ' A' ' 120' ' ' LEU . 18.8 mt -61.34 -50.98 70.74 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.117 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 m -60.53 -41.09 93.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.12 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.503 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.9 tm? -56.84 -51.12 70.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.725 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.803 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.3 p -70.67 -36.66 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.383 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 3.2 tmtt? -64.87 -41.37 95.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 110.71 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.07 -48.07 77.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.36 -26.79 62.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.743 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 3.6 m-30 -82.01 -33.91 29.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.885 0.374 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 16.0 t -72.24 -39.44 68.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.067 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -76.16 -33.07 59.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.535 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.56 137.33 26.89 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.679 0.276 . . . . 0.0 111.486 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.58 -166.75 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.547 2.165 . . . . 0.0 112.046 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 20' ' ' MET . . . -46.76 96.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.727 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.528 ' HB3' HG21 ' A' ' 46' ' ' THR . 0.2 OUTLIER -101.1 -160.72 0.81 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.726 0.298 . . . . 0.0 111.017 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.663 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -116.09 113.48 23.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.86 0.362 . . . . 0.0 111.266 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.743 HG21 ' HZ ' ' A' ' 95' ' ' PHE . 25.1 t -106.84 151.18 8.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.229 0.538 . . . . 0.0 112.147 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.054 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -123.17 139.87 53.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.986 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.022 HG13 HG13 ' A' ' 49' ' ' VAL . 5.4 t -140.09 166.8 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 0.7 OUTLIER -66.9 156.1 36.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.391 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.519 ' HA ' HG23 ' A' ' 24' ' ' ILE . 25.5 t -68.3 105.61 2.2 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.918 HG13 HD12 ' A' ' 24' ' ' ILE . 35.2 m -75.47 0.25 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.099 178.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.66 -8.77 3.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.53 -135.81 4.39 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.432 HD22 ' HA2' ' A' ' 142' ' ' GLY . 12.8 mt -120.51 127.29 52.05 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.2 -144.03 3.93 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.822 -1.18 . . . . 0.0 113.671 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.567 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.19 -25.63 4.84 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.925 0.393 . . . . 0.0 112.005 -178.457 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.748 ' HB2' ' HB3' ' A' ' 106' ' ' HIS . . . -50.94 -46.36 87.71 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.825 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.1 Cg_endo -52.26 -48.44 21.73 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.29 1.993 . . . . 0.0 112.964 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.836 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.6 t -61.01 -46.74 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.097 0.475 . . . . 0.0 110.105 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 49' ' ' VAL . 14.4 mt -59.37 -40.2 85.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.743 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.86 HG13 ' CD2' ' A' ' 22' ' ' PHE . 47.9 t -59.96 -55.65 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.613 0.244 . . . . 0.0 111.629 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.589 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -57.7 -47.13 83.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.609 0.719 . . . . 0.0 110.23 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.836 HD23 ' O ' ' A' ' 116' ' ' VAL . 4.5 mm? -54.52 -30.26 53.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.667 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.827 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -70.32 -47.47 60.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 110.164 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.859 HD11 ' HE1' ' A' ' 20' ' ' MET . 3.7 mp -63.61 -16.01 59.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.698 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.919 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.3 mt -57.06 -30.92 35.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.401 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 2.4 pt-20 -73.58 -16.58 61.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.405 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.3 m -85.18 11.03 10.68 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 117.51 -102.65 1.01 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.182 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.616 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 3.6 ptt? -62.42 79.56 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.919 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.85 -67.77 0.54 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -176.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.663 ' CD1' HD22 ' A' ' 152' ' ' LEU . 6.3 t80 -66.81 -32.03 73.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.0 111.054 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.46 -52.05 17.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.685 ' OD2' HD23 ' A' ' 122' ' ' LEU . 29.9 t0 -69.24 -36.21 76.93 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.589 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -61.25 -50.26 73.76 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.812 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.4 mm -74.35 -37.62 45.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.551 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -74.07 -49.71 22.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.804 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.07 -34.98 73.88 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.666 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.19 -27.86 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.327 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.18 -48.19 68.7 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.52 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.79 -45.23 92.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.594 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' ILE . 73.7 mmtt -85.51 152.01 23.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.114 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.23 116.81 14.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.055 0.455 . . . . 0.0 110.62 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.503 ' HG3' HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -115.12 163.57 15.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.86 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.432 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -57.57 -169.16 0.14 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.496 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.51 99.63 11.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.391 0.596 . . . . 0.0 110.762 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.519 HG22 ' HG3' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -88.05 109.4 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.989 179.189 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -113.16 -76.32 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.4 t -99.75 -60.51 1.52 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.904 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.0 OUTLIER -57.65 -52.65 64.57 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.761 ' HG3' HG22 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -56.88 -51.68 68.12 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.05 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 149' ' ' LEU . 3.6 mm? -73.26 -42.55 62.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.2 m -71.76 -40.76 69.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.785 0.326 . . . . 0.0 111.486 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.904 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -63.75 -50.29 69.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.409 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.8 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -67.5 -34.07 76.38 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.645 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -55.95 -44.96 78.93 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -27.97 63.63 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.728 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.61 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.9 OUTLIER -66.73 -25.98 66.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.891 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.87 143.02 26.24 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.673 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.59 152.7 71.9 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.499 2.133 . . . . 0.0 112.352 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -147.31 123.48 10.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.522 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -30.59 61.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.039 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -65.41 -31.24 72.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.5 -35.77 68.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.08 155.83 38.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -77.29 -177.88 4.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 62.85 120.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -92.74 138.1 23.8 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.32 171.41 16.16 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.52 2.147 . . . . 0.0 112.32 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -64.88 113.16 3.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 64.5 p -134.18 148.59 50.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.962 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.31 -43.43 2.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -149.63 -65.01 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 63.0 p -115.63 -38.92 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.953 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m -83.57 174.65 10.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -112.81 -41.44 3.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -31.64 72.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.71 -179.02 3.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -68.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -109.98 144.06 39.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -149.51 115.13 5.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -119.73 90.42 43.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.54 113.92 3.32 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.522 2.148 . . . . 0.0 112.311 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.447 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -76.45 158.19 81.64 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 59.7 Cg_endo -72.02 163.55 38.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.613 2.209 . . . . 0.0 112.344 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -144.09 126.84 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.9 pt-20 -102.93 118.5 36.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.364 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.705 HG12 ' CE2' ' A' ' 135' ' ' PHE . 18.4 t -106.74 118.53 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.814 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 p -141.24 149.3 41.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.889 0.376 . . . . 0.0 111.957 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.692 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -149.57 120.22 7.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.157 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.514 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 40.4 mmtt 84.4 -87.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.262 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -129.41 -38.51 1.55 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.74 ' CE ' HD13 ' A' ' 122' ' ' LEU . 4.8 ppp? -73.54 163.8 27.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 111.473 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -145.67 164.05 32.95 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.067 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.782 ' CE1' HG11 ' A' ' 103' ' ' VAL . 3.0 m-85 -135.67 155.37 50.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.38 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.058 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -125.27 124.75 42.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.315 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.866 HD13 HG23 ' A' ' 105' ' ' VAL . 2.0 mm -106.37 106.85 21.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.541 HG21 HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -130.71 165.66 22.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.463 0.649 . . . . 0.0 112.546 -178.407 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.484 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 45.6 p-80 -81.61 152.64 27.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.907 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.3 154.35 71.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.449 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.4 Cg_exo -54.96 138.36 77.92 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.482 2.121 . . . . 0.0 113.527 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.0 p -98.85 139.57 34.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.929 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.65 -10.27 34.57 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.49 -31.14 14.69 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.4 p -139.85 89.04 2.28 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.238 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.75 -52.2 7.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.005 0.431 . . . . 0.0 111.485 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.575 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -55.92 -38.68 70.6 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.187 -178.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -33.71 76.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.913 0.387 . . . . 0.0 111.035 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.674 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -76.12 -48.03 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.205 -179.16 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.821 HG21 ' CB ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -57.36 -37.18 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.092 0.473 . . . . 0.0 110.458 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -52.14 51.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.189 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.2 m-20 -67.94 -50.06 58.15 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.811 0.339 . . . . 0.0 111.688 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.674 HD21 ' CE1' ' A' ' 36' ' ' PHE . 31.9 mt -56.17 -39.52 72.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.013 0.435 . . . . 0.0 110.418 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -26.74 34.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.085 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -55.11 -43.0 73.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.181 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.058 ' CD1' HD21 ' A' ' 23' ' ' LEU . 13.5 t80 -63.58 -38.42 91.04 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.621 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.7 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.69 -178.52 39.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.912 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.57 117.93 20.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.726 HG22 ' H ' ' A' ' 47' ' ' THR . 1.4 m -164.71 -170.66 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.045 177.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.726 ' H ' HG22 ' A' ' 46' ' ' THR . 4.6 t -65.18 158.7 25.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.338 0.59 . . . . 0.0 110.718 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.042 HG22 ' HB3' ' A' ' 104' ' ' ALA . 63.1 t -136.39 136.55 48.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.927 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.003 HG12 HG12 ' A' ' 105' ' ' VAL . 14.8 p -115.87 104.73 17.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.364 0.602 . . . . 0.0 111.288 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -114.58 110.94 20.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.046 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.8 HG13 ' HB3' ' A' ' 71' ' ' TRP . 15.5 t -107.18 91.46 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 121.29 0.567 . . . . 0.0 109.798 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 m -157.81 171.28 20.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.865 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.406 ' CD ' ' N ' ' A' ' 53' ' ' GLU . 2.2 mm-40 -65.26 130.51 43.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' A' ' 70' ' ' ASP . 18.4 t -76.01 122.27 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -120.2 -47.69 2.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.309 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.6 83.54 2.13 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.522 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.43 -36.74 38.47 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -48.54 13.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -45.84 -54.14 17.63 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 8.3 Cg_exo -73.11 -41.97 1.14 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.645 2.23 . . . . 0.0 113.575 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.065 HD21 HG11 ' A' ' 68' ' ' VAL . 1.3 mm? -63.68 -45.34 90.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -75.27 -28.65 59.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.821 ' CB ' HG21 ' A' ' 37' ' ' ILE . 34.7 mttm -76.41 -37.78 56.58 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.735 ' HB3' HG22 ' A' ' 37' ' ' ILE . 56.3 p30 -101.74 -11.98 18.71 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.88 24.75 6.53 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.017 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 64' ' ' ASP . 9.2 mt -94.47 147.68 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.638 0.256 . . . . 0.0 110.975 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 47' ' ' THR . 23.0 p -78.21 129.21 34.83 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.065 HG11 HD21 ' A' ' 61' ' ' LEU . 8.5 p -145.08 153.04 14.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 111.977 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.463 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.3 t -103.56 131.36 52.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -101.09 106.85 18.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.147 0.499 . . . . 0.0 110.849 -178.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.909 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.9 m95 -110.74 103.83 55.11 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -105.82 161.74 0.15 Allowed 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.395 2.73 . . . . 0.0 112.605 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.443 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 0.6 OUTLIER -126.23 95.99 4.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.905 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.96 -160.94 1.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.456 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.02 -23.25 18.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.163 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.82 56.8 0.54 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.729 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.72 102.82 13.51 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.488 0.185 . . . . 0.0 110.94 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.754 ' O ' HG21 ' A' ' 83' ' ' VAL . 26.9 Cg_exo -62.35 108.56 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.587 2.191 . . . . 0.0 112.362 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.732 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 41.4 Cg_endo -68.35 -31.22 28.77 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.663 2.242 . . . . 0.0 114.97 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.732 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 3.4 Cg_endo -47.9 148.4 6.5 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.8 1.667 . . . . 0.0 113.421 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.417 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -57.27 -21.1 38.73 Favored Glycine 0 C--O 1.237 0.318 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.175 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -51.96 -38.81 57.9 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.599 0.238 . . . . 0.0 110.689 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.909 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 14.9 t -55.19 -42.93 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.597 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 0.4 OUTLIER -53.24 -42.31 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.301 178.327 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 88' ' ' LEU . 22.2 mm-40 -62.8 -31.47 72.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.164 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.39 -50.6 69.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.63 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.807 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.2 OUTLIER -66.42 -28.87 68.96 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.872 179.249 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.958 HD21 ' HB3' ' A' ' 120' ' ' LEU . 33.0 mt -62.68 -44.0 97.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.641 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.1 m -66.52 -38.35 86.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.392 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.401 ' HG ' HG22 ' A' ' 69' ' ' VAL . 1.4 tm? -61.9 -51.47 68.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.988 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.032 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.3 p -74.36 -37.69 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.353 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -44.21 89.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.387 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.78 -43.77 78.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.523 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -69.93 -23.91 63.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -81.76 -52.07 7.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.068 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.5 t -59.51 -37.6 78.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.94 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.99 -33.09 59.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.97 93.2 44.39 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.36 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.89 133.95 20.86 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.504 2.136 . . . . 0.0 112.251 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 59.35 10.97 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.432 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.423 ' HB2' HG21 ' A' ' 46' ' ' THR . 4.4 m -101.1 -163.7 1.04 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.7 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -121.01 113.56 20.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.251 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.782 HG11 ' CE1' ' A' ' 22' ' ' PHE . 44.6 t -105.97 150.23 8.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.042 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.22 135.14 54.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.361 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.003 HG12 HG12 ' A' ' 49' ' ' VAL . 34.0 m -140.68 167.81 17.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.741 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.5 t60 -66.87 155.75 37.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.115 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.571 ' HA ' HG23 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -68.46 109.11 3.54 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.396 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.8 HG13 ' CD1' ' A' ' 24' ' ' ILE . 18.7 m -75.79 0.26 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.2 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.48 -8.58 2.84 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.78 -143.37 5.69 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.493 HD22 ' HA2' ' A' ' 142' ' ' GLY . 7.1 mt -115.05 127.27 55.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.99 -144.85 4.23 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.981 -1.104 . . . . 0.0 113.408 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.483 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.4 -17.11 7.15 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.799 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -55.18 -47.03 99.51 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.763 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.6 Cg_endo -52.49 -48.19 23.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.31 2.006 . . . . 0.0 112.773 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.749 HG12 HD11 ' A' ' 120' ' ' LEU . 22.0 t -60.06 -54.15 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.702 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.812 HD12 ' CG2' ' A' ' 49' ' ' VAL . 2.4 mt -52.26 -51.23 59.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.969 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.874 HG22 HG11 ' A' ' 105' ' ' VAL . 21.9 t -52.08 -55.19 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' A' ' 136' ' ' ILE . . . -53.19 -50.18 65.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.333 0.587 . . . . 0.0 111.053 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.958 ' HB3' HD21 ' A' ' 88' ' ' LEU . 13.5 mt -54.38 -30.55 52.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.977 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 1.032 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.94 -39.79 69.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.034 0.445 . . . . 0.0 110.004 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.74 HD13 ' CE ' ' A' ' 20' ' ' MET . 3.4 tp -69.45 -15.54 63.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.636 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.943 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.4 mt -57.12 -30.6 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.886 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -17.0 64.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.0 m -79.79 -23.41 42.17 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.11 -95.79 0.17 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.749 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.492 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 2.7 ptt? -63.84 71.85 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.943 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.37 -67.52 0.44 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.557 ' CD1' HD22 ' A' ' 152' ' ' LEU . 8.0 t80 -65.69 -33.24 75.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.948 0.404 . . . . 0.0 111.068 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.52 -52.34 16.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.219 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.623 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.2 t0 -69.99 -35.91 74.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.857 0.36 . . . . 0.0 110.864 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.649 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -61.36 -50.04 74.5 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.605 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 28.1 mm -74.53 -37.32 43.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.49 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -49.87 21.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.705 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.76 -36.96 79.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.668 0.27 . . . . 0.0 110.485 -179.528 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.6 tt -74.18 -27.85 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.488 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 4.4 ttt-85 -66.63 -45.79 77.89 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.465 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -45.01 93.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 110.434 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.477 ' HE2' HG22 ' A' ' 15' ' ' VAL . 6.2 mptt -86.18 152.12 23.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.107 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 116.57 13.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.11 0.481 . . . . 0.0 110.531 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.13 163.82 15.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.135 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.493 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -55.64 -170.4 0.09 OUTLIER Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.689 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.93 100.0 12.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.258 0.529 . . . . 0.0 111.303 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.847 HD12 HD21 ' A' ' 149' ' ' LEU . 14.5 pt -87.75 109.54 19.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.571 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.32 -76.71 0.58 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.0 t -99.65 -60.95 1.43 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.858 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 8.9 tmtt? -62.55 -50.8 69.9 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.544 ' CG ' HG22 ' A' ' 144' ' ' ILE . 0.6 OUTLIER -55.61 -51.76 66.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.031 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.847 HD21 HD12 ' A' ' 144' ' ' ILE . 4.2 mm? -73.58 -45.34 53.83 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.2 m -67.42 -37.4 82.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.754 0.311 . . . . 0.0 111.559 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.858 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.67 -50.31 65.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.147 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -63.85 -34.68 78.49 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.477 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -57.24 -45.22 84.14 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -22.79 62.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.658 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.677 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -66.5 -36.21 82.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.923 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 125.51 32.86 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.11 153.39 62.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.656 2.237 . . . . 0.0 112.46 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -145.85 123.47 11.82 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.341 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.66 -0.55 38.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.506 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.92 -29.07 66.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.803 0.335 . . . . 0.0 110.959 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mp -80.23 -46.82 15.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.62 92.05 3.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -74.15 90.55 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.01 131.2 55.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.66 119.66 68.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.812 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.35 -175.54 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.386 2.058 . . . . 0.0 112.297 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -140.49 140.85 35.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.4 p -137.22 115.37 11.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -135.99 -63.77 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 -31.92 7.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.0 m -137.37 128.83 28.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.7 t -86.75 -55.2 3.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -85.01 164.78 18.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.78 171.58 8.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.97 105.75 14.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mtp-105 -137.57 126.55 24.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.847 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt -134.34 -46.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.945 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -171.87 156.24 4.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -130.23 145.98 59.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.38 112.14 3.46 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.556 2.17 . . . . 0.0 112.374 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.02 143.03 69.78 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.106 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.02 162.63 40.45 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.518 2.146 . . . . 0.0 112.368 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.406 HG11 ' HG3' ' A' ' 139' ' ' LYS . 17.5 t -144.2 126.81 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.739 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 mp0 -110.51 129.8 55.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.396 . . . . 0.0 111.503 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.852 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.61 118.89 55.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.95 153.07 29.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.529 . . . . 0.0 112.206 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.514 ' CD2' HD11 ' A' ' 122' ' ' LEU . 18.5 t80 -155.16 112.71 3.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.11 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 9.8 mmtm 65.88 -82.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.27 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -129.26 -42.59 1.34 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.864 ' CE ' HD13 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -73.8 149.53 41.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.945 0.402 . . . . 0.0 111.154 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.02 164.19 26.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.528 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.473 ' C ' HD22 ' A' ' 23' ' ' LEU . 12.2 m-85 -127.59 155.58 43.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.269 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.061 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -125.6 135.88 52.67 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.128 0.489 . . . . 0.0 111.205 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.87 HD13 ' HB ' ' A' ' 105' ' ' VAL . 21.3 mm -118.23 106.42 19.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.275 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -132.27 163.14 29.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.233 0.539 . . . . 0.0 111.824 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.471 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 42.9 p-80 -81.29 152.41 27.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.026 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -62.52 154.54 72.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 50.6 Cg_exo -54.38 136.53 69.5 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.369 2.046 . . . . 0.0 113.279 -177.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -98.75 146.57 25.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.041 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -69.39 -10.32 57.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.256 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -31.24 14.61 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 p -139.85 88.97 2.27 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.127 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.79 -52.22 7.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 111.396 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.454 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.9 t -56.11 -46.94 78.96 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.596 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -57.67 -32.09 66.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.89 0.376 . . . . 0.0 111.195 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.734 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.15 -47.6 27.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.165 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.868 HG22 ' OD2' ' A' ' 64' ' ' ASP . 12.1 pt -55.54 -38.78 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.158 0.504 . . . . 0.0 110.573 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -65.74 -51.75 56.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.511 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 9.4 m-20 -68.52 -50.25 53.53 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.734 HD21 ' CE1' ' A' ' 36' ' ' PHE . 75.2 mt -56.45 -44.98 81.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.417 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -77.43 -26.54 51.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.997 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 4.2 mttt -53.12 -46.17 68.64 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.416 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.061 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.1 t80 -63.61 -38.52 91.43 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.809 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.69 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.87 -179.31 38.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.01 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.58 117.79 20.07 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 47' ' ' THR . 1.3 m -164.78 -170.29 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.857 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.704 ' H ' HG22 ' A' ' 46' ' ' THR . 2.9 t -64.85 154.02 38.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.43 0.633 . . . . 0.0 110.707 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.05 HG22 ' HB3' ' A' ' 104' ' ' ALA . 57.8 t -131.42 135.39 59.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.992 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.91 HG13 HG13 ' A' ' 105' ' ' VAL . 11.7 p -115.6 105.06 17.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.273 0.559 . . . . 0.0 111.1 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.08 110.79 20.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.69 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.8 HG13 ' HB3' ' A' ' 71' ' ' TRP . 14.5 t -102.26 90.97 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.1 171.59 19.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.737 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -67.1 129.9 41.39 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -78.43 122.53 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.09 -47.65 2.37 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.448 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.476 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 0.4 OUTLIER -130.63 83.63 2.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.611 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.574 ' O ' HD13 ' A' ' 61' ' ' LEU . 2.8 p30 -78.91 -35.73 43.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -78.26 -48.11 16.43 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -40.88 -60.04 1.83 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.24 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 59' ' ' THR . 33.3 Cg_endo -65.16 -42.43 13.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.436 2.091 . . . . 0.0 113.837 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.065 HD11 HG11 ' A' ' 68' ' ' VAL . 5.4 mp -71.37 -28.98 64.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.04 -44.6 46.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.759 ' CB ' HG21 ' A' ' 37' ' ' ILE . 1.6 mttp -81.18 -28.36 35.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.845 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.868 ' OD2' HG22 ' A' ' 37' ' ' ILE . 40.4 m-20 -101.48 -11.61 19.19 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.05 32.44 1.51 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.34 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.454 HG12 ' CB ' ' A' ' 64' ' ' ASP . 1.3 pt -102.56 148.22 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 0.0 111.303 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.2 OUTLIER -78.02 135.36 37.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.065 HG11 HD11 ' A' ' 61' ' ' LEU . 11.3 p -145.02 152.03 14.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.117 0.484 . . . . 0.0 111.919 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.23 132.05 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -100.66 106.76 18.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.289 0.566 . . . . 0.0 110.31 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.972 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.5 m95 -112.88 104.64 55.94 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.794 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -103.75 150.11 0.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 123.096 2.531 . . . . 0.0 112.707 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -125.98 96.0 4.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.9 179.791 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.586 ' H ' ' HB2' ' A' ' 77' ' ' ALA . 1.3 t0 -147.76 -160.2 1.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.533 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.87 -24.08 21.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.794 0.331 . . . . 0.0 111.124 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.86 60.68 0.55 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.537 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -120.66 104.84 41.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.519 0.2 . . . . 0.0 111.045 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.592 ' HB2' HG21 ' A' ' 83' ' ' VAL . 98.0 Cg_exo -43.53 101.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.816 2.344 . . . . 0.0 112.891 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.721 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 33.1 Cg_endo -65.97 -34.17 39.4 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.618 2.212 . . . . 0.0 114.733 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.721 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 4.2 Cg_endo -48.0 148.04 7.14 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.923 1.749 . . . . 0.0 113.414 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.407 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -66.19 -21.24 69.92 Favored Glycine 0 C--O 1.238 0.351 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.014 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -52.2 -29.98 25.07 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.683 0.278 . . . . 0.0 110.536 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.972 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 39.4 t -60.27 -46.49 94.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.519 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 1.2 t -53.47 -38.69 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 88' ' ' LEU . 14.7 mm-40 -65.29 -31.5 72.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.993 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.95 -50.5 70.54 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.332 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.819 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -66.84 -30.29 70.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.199 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.86 HD21 ' HB3' ' A' ' 120' ' ' LEU . 16.3 mt -60.64 -48.03 83.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.558 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -62.81 -42.16 99.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.172 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -55.08 -51.19 67.14 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.558 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.999 HG21 ' HB1' ' A' ' 121' ' ' ALA . 7.1 p -71.4 -35.94 59.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.047 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 1.7 tmtt? -55.85 -45.36 78.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.903 0.382 . . . . 0.0 110.543 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.67 -41.18 75.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.977 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.673 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.92 -30.61 69.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.363 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' ' OE2' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -82.13 -37.21 26.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.99 -46.1 58.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.873 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -76.26 -33.02 59.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -115.52 89.87 23.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.08 129.23 11.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.607 2.205 . . . . 0.0 112.228 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.37 56.15 25.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.451 ' HB3' HG21 ' A' ' 46' ' ' THR . 0.4 OUTLIER -101.13 -164.75 1.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 111.066 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.69 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -124.76 113.53 18.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.33 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 42.0 t -104.45 150.5 7.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.05 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -123.46 135.9 54.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.098 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.926 HG21 HG22 ' A' ' 118' ' ' VAL . 8.0 t -134.05 166.42 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -177.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.74 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 0.8 OUTLIER -67.45 155.72 38.34 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.862 0.363 . . . . 0.0 110.873 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 25' ' ' THR . 42.2 t -69.07 106.08 2.66 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.829 HG12 ' HD3' ' A' ' 115' ' ' PRO . 2.6 m -75.88 0.57 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.3 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.05 -8.65 2.49 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.69 -140.8 5.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mt -106.56 127.08 53.04 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.65 -158.82 10.21 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.423 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.541 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.62 -14.35 7.77 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.375 -0.413 . . . . 0.0 111.861 -178.546 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.856 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -58.06 -46.93 99.65 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.829 ' HD3' HG12 ' A' ' 108' ' ' VAL . 9.5 Cg_endo -52.52 -48.49 21.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.131 1.888 . . . . 0.0 112.381 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.826 HG21 ' NE2' ' A' ' 148' ' ' GLN . 87.0 t -58.65 -52.44 59.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.232 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 51' ' ' VAL . 9.4 mt -51.9 -49.08 63.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.732 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.926 HG22 HG21 ' A' ' 105' ' ' VAL . 85.7 t -51.46 -49.68 31.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.914 0.388 . . . . 0.0 110.638 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.699 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -54.65 -47.85 73.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.672 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.86 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.6 mt -55.03 -31.63 61.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.87 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.999 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.24 -51.68 19.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.219 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.864 HD13 ' CE ' ' A' ' 20' ' ' MET . 5.8 tp -68.31 -13.98 62.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.581 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 1.071 HD11 HD21 ' A' ' 152' ' ' LEU . 1.1 mt -58.15 -36.38 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.157 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.403 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 4.5 pt-20 -63.03 -16.04 58.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.626 ' HB2' HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -79.77 11.17 3.39 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 116.89 -95.44 0.67 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.79 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.493 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 4.8 ptt? -62.67 75.48 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.946 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -71.76 -67.59 0.52 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 9.8 t80 -68.65 -32.19 71.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.977 0.418 . . . . 0.0 111.165 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.45 -50.56 25.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.301 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.0 t0 -70.09 -40.05 75.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.772 0.32 . . . . 0.0 111.363 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.7 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -61.89 -48.51 80.16 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.005 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 34.6 mm -73.06 -41.23 59.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.494 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -74.73 -50.12 18.58 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.852 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -67.99 -39.75 83.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.594 0.235 . . . . 0.0 110.812 -179.222 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.2 tp -74.54 -28.61 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.774 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 5.8 ttm-85 -64.53 -41.68 96.22 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -41.6 90.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.016 0.436 . . . . 0.0 110.061 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.494 ' HE2' HG13 ' A' ' 15' ' ' VAL . 5.6 mptt -87.17 151.85 22.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.102 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 116.73 14.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 110.607 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.474 ' HD2' HG23 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -114.97 163.5 15.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.209 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -57.06 -166.64 0.07 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.715 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.19 100.0 12.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.298 0.549 . . . . 0.0 111.599 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.945 HD12 ' CD2' ' A' ' 149' ' ' LEU . 12.5 pt -87.87 109.46 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.476 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -113.2 -76.64 0.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.9 t -99.8 -61.1 1.41 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.793 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 10.0 tmtt? -65.78 -49.87 66.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -176.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.826 ' NE2' HG21 ' A' ' 116' ' ' VAL . 2.0 mm100 -56.33 -52.04 66.02 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.945 ' CD2' HD12 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -72.86 -46.6 52.02 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.528 -179.639 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 81.2 m -62.61 -39.16 92.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.23 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.793 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -62.34 -50.56 71.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.761 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.071 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -62.01 -37.1 83.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.501 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -57.08 -37.95 72.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -22.74 58.81 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.646 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.544 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.19 -34.08 77.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.993 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.52 85.86 1.95 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.374 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.29 153.34 71.23 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.814 2.342 . . . . 0.0 112.752 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.1 123.45 10.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.317 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -69.78 -11.16 60.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.4 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -30.98 68.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.767 0.318 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.05 -44.29 12.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -76.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -71.6 175.05 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.97 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.28 110.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -68.9 112.97 13.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.77 -177.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.519 2.146 . . . . 0.0 112.204 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.63 -45.93 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.802 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.5 t -64.36 -32.11 73.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 150.18 26.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 171' ' ' THR . 2.3 mtmp? -142.6 154.89 44.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 170' ' ' LYS . 0.8 OUTLIER -161.98 152.45 17.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.853 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.456 -0.257 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 m -99.52 162.33 13.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.832 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.42 119.0 5.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.09 -46.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.71 108.33 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -63.08 139.47 58.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -151.8 -47.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -83.46 173.49 11.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -134.16 158.33 75.56 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.39 111.76 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.642 2.228 . . . . 0.0 112.31 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.04 155.84 60.68 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.084 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.662 ' HB3' HG22 ' A' ' 25' ' ' THR . 56.4 Cg_endo -70.58 162.47 42.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.496 2.131 . . . . 0.0 112.272 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.522 HG11 ' HD2' ' A' ' 139' ' ' LYS . 24.6 t -144.13 127.04 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.805 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.17 116.67 31.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.836 0.35 . . . . 0.0 111.46 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.803 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -109.66 118.45 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.1 p -140.96 142.69 34.31 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.59 ' HE1' HD11 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -137.37 162.08 34.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.162 178.291 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 3.0 pttp 48.92 -100.65 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.014 0.126 . . . . 0.0 110.76 -177.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.452 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -124.35 -25.68 4.05 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.157 -0.34 . . . . 0.0 111.908 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.728 ' HE3' HD13 ' A' ' 122' ' ' LEU . 5.1 ppp? -74.01 165.91 24.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 111.464 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -143.5 156.74 44.71 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.282 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.721 ' CE1' HG11 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -137.42 138.39 39.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.299 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.06 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -115.09 135.53 54.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.051 0.453 . . . . 0.0 111.359 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.816 HD12 HG13 ' A' ' 108' ' ' VAL . 1.9 mm -118.23 106.61 20.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 12' ' ' PRO . 1.4 p -131.01 166.55 20.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.606 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.536 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 5.9 p80 -81.25 152.0 27.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.731 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -62.64 153.71 77.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.1 Cg_exo -54.94 142.37 76.0 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.476 2.118 . . . . 0.0 113.291 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.483 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 6.4 p -98.7 174.35 6.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.158 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.95 -12.35 26.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.54 -30.83 14.8 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -139.51 89.77 2.36 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.452 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.23 -52.2 8.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.055 0.455 . . . . 0.0 111.16 178.23 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.456 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.0 m -55.96 -43.51 77.57 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.358 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 m -58.04 -37.38 74.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.878 0.37 . . . . 0.0 111.257 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.674 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.21 -48.13 53.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.933 HG21 ' HB3' ' A' ' 63' ' ' LYS . 13.7 pt -55.94 -39.63 58.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.183 0.516 . . . . 0.0 110.79 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -62.85 -52.01 64.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.336 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -69.84 -50.28 44.3 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.884 0.374 . . . . 0.0 111.774 -179.272 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.674 HD21 ' CE1' ' A' ' 36' ' ' PHE . 48.5 mt -56.27 -43.68 79.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.046 0.451 . . . . 0.0 110.265 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -78.6 -26.83 45.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.098 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -53.0 -43.81 66.75 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.151 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.06 ' CD1' HD21 ' A' ' 23' ' ' LEU . 13.5 t80 -63.35 -38.52 91.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.671 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.735 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.21 -179.92 39.45 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.803 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.44 117.07 19.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.927 HG21 ' OG ' ' A' ' 101' ' ' SER . 0.4 OUTLIER -165.42 -169.12 1.51 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.94 177.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.709 ' HA ' HG23 ' A' ' 67' ' ' THR . 9.8 t -64.05 154.0 35.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.676 0.75 . . . . 0.0 110.578 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 104' ' ' ALA . 60.3 t -134.2 137.57 51.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.453 -178.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.02 HG13 HG13 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -115.56 105.18 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.067 0.461 . . . . 0.0 110.445 178.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -113.6 111.0 21.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.637 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.885 HG11 ' HB2' ' A' ' 113' ' ' ARG . 44.0 t -107.9 92.09 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.642 0.734 . . . . 0.0 110.59 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.42 171.15 20.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.453 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.62 130.2 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.612 HG13 ' HB3' ' A' ' 72' ' ' PRO . 9.3 m -68.89 121.91 19.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.61 -47.65 2.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.82 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.414 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.8 m-85 -130.74 84.36 2.19 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.213 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -78.55 -35.92 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -78.93 -48.52 14.41 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.88 HG22 ' HD3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -44.53 -50.92 22.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.223 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 32.3 Cg_exo -59.25 -40.37 69.39 Favored 'Trans proline' 0 N--CA 1.471 0.196 0 C-N-CA 122.622 2.215 . . . . 0.0 113.653 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.766 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -71.09 -45.02 64.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.614 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -75.2 -49.31 19.83 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.933 ' HB3' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -64.7 -35.53 81.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.405 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.911 ' OD2' HG22 ' A' ' 37' ' ' ILE . 49.1 m-20 -101.22 -11.45 19.5 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.09 24.81 9.49 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.789 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.464 HG12 ' CB ' ' A' ' 64' ' ' ASP . 16.2 pt -110.78 148.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.763 HG21 ' HD2' ' A' ' 94' ' ' LYS . 6.7 t -77.7 135.1 38.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.075 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.766 HG12 ' CD2' ' A' ' 61' ' ' LEU . 7.4 p -145.21 151.91 14.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.052 0.453 . . . . 0.0 111.649 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.608 HG22 ' HG ' ' A' ' 90' ' ' LEU . 3.6 t -103.5 133.33 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.97 106.64 17.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.156 0.503 . . . . 0.0 110.478 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.736 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.3 m95 -110.03 103.24 53.16 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.63 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HB3' HG13 ' A' ' 54' ' ' VAL . 24.8 Cg_endo -109.61 -178.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 123.547 2.831 . . . . 0.0 112.82 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -126.45 95.93 4.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.578 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.33 177.78 4.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.32 -25.26 33.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.933 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.02 72.02 0.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.492 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.96 102.92 19.27 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.497 0.189 . . . . 0.0 110.791 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.526 ' O ' HG21 ' A' ' 83' ' ' VAL . 87.8 Cg_exo -41.57 98.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.85 2.367 . . . . 0.0 112.954 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.686 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 50.8 Cg_exo -54.98 -42.34 70.12 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.009 2.472 . . . . 0.0 114.277 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 2.6 Cg_endo -47.48 144.96 9.41 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.285 1.99 . . . . 0.0 113.609 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -57.35 -19.65 33.8 Favored Glycine 0 C--O 1.236 0.228 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.448 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.82 -29.87 12.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.514 0.157 . . . . 0.0 111.092 -178.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.714 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 16.1 t -56.33 -48.46 79.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.897 HG11 HD22 ' A' ' 120' ' ' LEU . 71.4 t -54.19 -40.99 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.092 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.751 ' HA ' HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -57.84 -31.47 66.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.456 178.338 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -50.32 70.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.274 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.616 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.08 -33.2 75.24 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.554 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.858 HD21 ' HB3' ' A' ' 120' ' ' LEU . 11.1 mt -55.94 -47.75 76.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.4 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -63.0 -39.89 96.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.083 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.608 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.8 tm? -61.56 -51.17 69.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.94 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.73 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.7 p -68.79 -42.49 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.639 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.438 ' N ' HG13 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -53.87 -47.39 71.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 111.038 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -48.08 76.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.826 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.763 ' HD2' HG21 ' A' ' 67' ' ' THR . 21.3 mmtt -66.12 -26.54 67.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.018 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 103' ' ' VAL . 2.4 m-85 -79.27 -51.92 8.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.969 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 t -56.89 -33.71 67.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.047 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.0 -33.06 59.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.046 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.25 84.02 62.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.52 128.23 26.49 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.601 2.201 . . . . 0.0 112.101 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.37 59.8 10.08 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.282 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.927 ' OG ' HG21 ' A' ' 46' ' ' THR . 84.9 p -101.1 -171.26 1.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.308 . . . . 0.0 111.425 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.735 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.1 m -106.21 113.77 27.49 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.324 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.721 HG11 ' CE1' ' A' ' 22' ' ' PHE . 44.5 t -111.26 150.86 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -122.45 142.5 50.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.069 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.02 HG13 HG13 ' A' ' 49' ' ' VAL . 3.2 t -140.09 167.08 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.727 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.7 t-80 -67.2 155.61 38.37 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.7 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' THR . 26.9 p -68.86 105.18 2.27 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.32 0.581 . . . . 0.0 112.433 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.844 HG12 ' HD3' ' A' ' 115' ' ' PRO . 26.6 m -75.22 0.02 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.919 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.65 -8.79 3.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.419 ' O ' HD23 ' A' ' 111' ' ' LEU . . . -123.74 -134.87 4.39 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.48 ' HA ' ' HA2' ' A' ' 142' ' ' GLY . 7.3 mt -118.83 127.46 53.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.41 -153.97 7.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.63 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.885 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.3 -20.2 6.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.114 0.483 . . . . 0.0 111.669 -178.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.661 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.81 -46.29 86.9 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.844 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.6 Cg_endo -52.01 -48.5 21.3 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.157 1.905 . . . . 0.0 113.078 -178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.614 ' O ' HD13 ' A' ' 120' ' ' LEU . 11.7 t -60.95 -39.99 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.693 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.503 HD12 ' CG2' ' A' ' 49' ' ' VAL . 9.7 mt -59.5 -55.0 40.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.633 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.854 ' CG2' HG11 ' A' ' 105' ' ' VAL . 55.6 t -52.01 -55.21 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.725 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -52.85 -53.22 51.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.009 0.433 . . . . 0.0 111.31 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.897 HD22 HG11 ' A' ' 84' ' ' VAL . 7.7 mp -54.92 -30.18 57.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.98 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.73 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.27 -47.72 48.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.886 0.374 . . . . 0.0 110.403 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.728 HD13 ' HE3' ' A' ' 20' ' ' MET . 12.6 tp -65.1 -13.06 57.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.816 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.928 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.1 mt -57.05 -36.37 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.311 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.425 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -63.22 -16.79 61.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.7 m -80.03 7.45 9.05 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 114.39 -99.09 0.92 Allowed Glycine 0 N--CA 1.46 0.246 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.922 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.571 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 3.6 ptt? -62.56 75.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.928 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -73.4 -67.86 0.55 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -176.6 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.666 ' CD1' HD22 ' A' ' 152' ' ' LEU . 4.4 t80 -66.72 -32.86 74.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.949 0.404 . . . . 0.0 111.162 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.17 -51.86 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.208 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 25.8 t0 -70.12 -40.39 74.9 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.918 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.725 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -58.01 -49.17 77.75 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.315 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.7 mm -69.7 -42.56 80.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -49.76 21.84 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.803 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.27 -34.29 77.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 110.724 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.7 tt -74.27 -33.34 34.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.974 0.416 . . . . 0.0 110.49 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -40.76 96.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.087 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.58 -45.29 92.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.984 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.522 ' HD2' HG11 ' A' ' 13' ' ' VAL . 68.5 mmtt -87.33 151.65 22.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.419 ' C ' ' HD2' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -73.31 117.25 14.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.896 0.379 . . . . 0.0 110.419 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.467 ' HG2' ' CG1' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -115.36 163.43 15.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.691 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -55.45 -176.05 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.346 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.54 98.81 3.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.692 0.746 . . . . 0.0 110.716 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.457 HG21 ' HG3' ' A' ' 148' ' ' GLN . 1.3 pp -88.67 109.24 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -113.22 -76.59 0.58 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.214 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.757 ' O ' HG22 ' A' ' 150' ' ' THR . 36.5 m -99.77 -60.62 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.643 ' O ' ' CB ' ' A' ' 151' ' ' TYR . 1.2 tmtt? -48.66 -51.43 28.42 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.457 ' HG3' HG21 ' A' ' 144' ' ' ILE . 1.9 tm0? -55.77 -52.08 65.17 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.576 ' N ' HD22 ' A' ' 149' ' ' LEU . 3.2 mm? -75.66 -45.29 37.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 146' ' ' SER . 6.5 t -67.78 -34.37 76.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.361 . . . . 0.0 111.34 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.643 ' CB ' ' O ' ' A' ' 147' ' ' LYS . 1.3 t80 -68.17 -50.8 52.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.3 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.825 HD21 HD11 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -71.25 -38.92 71.91 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.519 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -36.48 68.0 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -26.35 59.92 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.465 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.631 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -65.82 -29.46 69.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.205 179.595 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -105.81 121.61 45.26 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.882 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.23 153.06 62.08 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.542 2.161 . . . . 0.0 112.671 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -147.25 123.62 10.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.337 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -75.29 -5.03 42.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.68 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -33.82 71.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 110.938 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.02 -44.31 12.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.94 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.94 132.24 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.888 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -89.7 171.89 9.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.974 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -167.37 134.6 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.853 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -71.32 138.12 84.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.91 170.7 18.22 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.482 2.121 . . . . 0.0 112.34 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -152.15 -65.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.01 110.06 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -111.84 87.31 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 104.62 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.6 m -119.69 134.68 55.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.856 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.641 0.258 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 61.0 Cg_endo -72.99 162.48 40.88 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.505 2.137 . . . . 0.0 112.355 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.433 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.1 t -144.16 126.89 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 pm0 -108.94 121.31 44.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.94 0.4 . . . . 0.0 111.652 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.763 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -106.8 118.66 54.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.7 p -140.63 140.01 34.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.135 0.493 . . . . 0.0 112.156 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CD2' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -138.98 139.4 37.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.746 178.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 11.1 mmmt 65.93 -88.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.295 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -129.46 -39.76 1.47 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.5 ptm -73.61 161.77 29.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 111.565 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 164.22 30.78 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.601 ' CE1' HG11 ' A' ' 103' ' ' VAL . 2.5 m-85 -133.05 154.23 50.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.277 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.073 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -126.32 130.68 51.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.056 0.455 . . . . 0.0 110.939 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.927 HD12 HG13 ' A' ' 108' ' ' VAL . 2.6 mm -114.46 106.58 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -130.86 167.34 19.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.908 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 51.0 p-80 -80.99 152.2 28.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.875 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -62.64 154.29 74.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.512 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 9.6 Cg_endo -54.45 141.76 72.04 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.61 2.206 . . . . 0.0 113.464 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.445 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.2 p -98.98 174.37 6.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.009 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -97.96 -10.43 24.52 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.61 -30.43 14.96 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.7 p -139.19 90.01 2.39 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.373 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -79.99 -52.18 8.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.043 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.446 ' HA ' HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -57.62 -44.02 85.21 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.091 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.3 m -57.93 -33.51 68.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.849 0.357 . . . . 0.0 111.233 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.579 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -73.71 -47.93 35.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.046 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.881 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.6 pt -55.94 -39.53 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.53 . . . . 0.0 110.697 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.12 -52.14 60.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.519 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -68.99 -50.11 51.82 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.863 0.363 . . . . 0.0 111.843 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.579 HD21 ' CE1' ' A' ' 36' ' ' PHE . 41.9 mt -56.52 -44.47 80.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -77.86 -26.67 49.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.081 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -52.9 -45.37 67.5 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.268 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.073 ' CD1' HD21 ' A' ' 23' ' ' LEU . 15.3 t80 -63.51 -38.32 90.69 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.779 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.664 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.63 -177.92 40.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.946 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.63 117.9 20.18 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.755 HG22 ' H ' ' A' ' 47' ' ' THR . 1.7 m -164.9 -170.63 2.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.88 177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.884 ' HA ' HG23 ' A' ' 67' ' ' THR . 2.9 t -64.87 153.36 40.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.507 0.67 . . . . 0.0 110.565 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 104' ' ' ALA . 55.8 t -131.42 133.33 62.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.944 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.051 HG13 HG13 ' A' ' 105' ' ' VAL . 6.4 p -115.57 105.4 18.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.346 0.593 . . . . 0.0 111.279 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -114.22 111.06 20.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.113 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' A' ' 71' ' ' TRP . 10.7 t -104.12 91.59 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.402 0.62 . . . . 0.0 110.093 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.502 ' HG ' ' CE1' ' A' ' 106' ' ' HIS . 1.1 m -157.74 171.3 20.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.552 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.95 130.41 43.29 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.75 122.23 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.4 p -120.23 -47.8 2.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.868 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.455 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -130.74 83.92 2.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.384 178.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -79.11 -37.15 39.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -80.08 -48.42 13.28 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.415 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.19 -53.05 24.53 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -177.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.455 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 11.0 Cg_exo -72.58 -42.76 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.412 2.074 . . . . 0.0 113.983 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.706 ' CD1' HG12 ' A' ' 68' ' ' VAL . 2.5 tt -71.53 -45.23 62.94 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.42 -28.7 68.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.473 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.881 ' HB3' HG21 ' A' ' 37' ' ' ILE . 16.1 mttt -80.5 -34.01 36.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.882 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.488 ' HB3' HG22 ' A' ' 37' ' ' ILE . 44.9 p30 -101.25 -11.33 19.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.03 34.62 52.6 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.804 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' A' ' 46' ' ' THR . 6.0 mt -108.61 147.35 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.646 0.26 . . . . 0.0 110.967 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.884 HG23 ' HA ' ' A' ' 47' ' ' THR . 4.4 t -78.41 132.79 37.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.706 HG12 ' CD1' ' A' ' 61' ' ' LEU . 7.4 p -144.99 151.11 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.133 0.492 . . . . 0.0 111.965 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.34 131.93 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -101.21 106.72 17.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.164 0.507 . . . . 0.0 111.09 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.812 ' HB3' HG13 ' A' ' 51' ' ' VAL . 5.2 m0 -110.96 103.93 55.47 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.302 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.447 -1.239 0 C-N-CA 123.321 2.681 . . . . 0.0 112.993 -179.043 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.491 0.186 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.1 m -53.98 -49.05 62.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 151' ' ' TYR . 7.5 t -54.57 -42.87 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.5 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -56.15 -31.53 63.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.99 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -68.49 -50.4 52.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.009 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.799 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -67.8 -28.09 67.3 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 120' ' ' LEU . 11.1 mt -63.5 -43.95 95.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.25 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.2 -41.51 94.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.205 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.1 tm? -59.35 -51.34 70.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.673 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.103 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.6 p -71.36 -35.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.072 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.03 -45.92 86.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.96 86.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.599 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -72.2 -23.9 61.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.157 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -79.28 -52.04 8.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.775 0.322 . . . . 0.0 111.184 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 25.4 t -65.02 -36.82 85.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -76.11 -32.82 59.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.268 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.573 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -123.45 88.58 51.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.526 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.37 130.71 19.03 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.816 2.344 . . . . 0.0 112.063 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.34 57.81 17.82 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.448 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.573 ' OG ' ' HB1' ' A' ' 98' ' ' ALA . 4.7 m -101.08 -164.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.719 0.295 . . . . 0.0 111.212 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.664 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -123.11 113.55 19.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.373 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.601 HG11 ' CE1' ' A' ' 22' ' ' PHE . 24.3 t -107.45 151.06 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.73 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -122.2 139.97 53.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.982 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.051 HG13 HG13 ' A' ' 49' ' ' VAL . 10.8 t -140.09 166.73 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.663 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.0 t60 -66.81 156.35 35.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.516 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.53 ' HA ' HG23 ' A' ' 24' ' ' ILE . 20.8 t -68.13 104.49 1.8 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.927 HG13 HD12 ' A' ' 24' ' ' ILE . 34.5 m -75.56 0.25 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.06 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.4 -8.53 2.73 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.25 -127.49 3.12 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 143' ' ' ALA . 0.0 OUTLIER -128.14 127.27 42.69 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.42 -144.44 4.1 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.607 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.661 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.29 -25.96 4.74 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.163 0.506 . . . . 0.0 112.017 -178.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.671 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -50.23 -46.22 83.08 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.838 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.2 Cg_endo -51.72 -48.54 20.92 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.306 2.004 . . . . 0.0 113.275 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 1.041 HG12 HD11 ' A' ' 120' ' ' LEU . 57.9 t -61.68 -46.66 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.818 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.53 ' HA ' HD12 ' A' ' 120' ' ' LEU . 11.6 mt -54.77 -46.55 74.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.847 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.893 ' CG2' HG11 ' A' ' 105' ' ' VAL . 57.6 t -57.37 -55.28 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.726 0.298 . . . . 0.0 111.671 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -52.98 -48.76 67.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.336 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 1.041 HD11 HG12 ' A' ' 116' ' ' VAL . 5.5 mt -59.06 -30.55 68.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.389 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 1.103 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.12 -42.43 66.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.967 0.413 . . . . 0.0 110.227 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.551 HD13 ' OD2' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -70.75 -16.11 62.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.595 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.914 ' CD1' HD21 ' A' ' 152' ' ' LEU . 1.4 mt -57.42 -30.97 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.124 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -15.97 14.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.539 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.87 11.29 5.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.27 -83.79 0.35 Allowed Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.4 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.502 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.9 76.92 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 121.337 0.589 . . . . 0.0 109.534 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.882 ' CB ' HG23 ' A' ' 123' ' ' ILE . 11.3 mttt -62.56 -67.4 0.42 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.088 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.487 ' HD1' HD13 ' A' ' 152' ' ' LEU . 6.1 t80 -73.61 -31.68 63.68 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.069 0.462 . . . . 0.0 110.762 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.3 -46.4 55.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.061 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.551 ' OD2' HD13 ' A' ' 122' ' ' LEU . 47.9 t0 -70.24 -47.19 62.45 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.457 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.84 ' HB3' HD11 ' A' ' 152' ' ' LEU . . . -57.97 -50.06 74.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.821 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.0 mm -70.8 -37.78 70.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -74.37 -49.71 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.763 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -70.19 -35.44 73.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.501 0.191 . . . . 0.0 111.066 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 132' ' ' ALA . 4.2 tt -74.25 -32.7 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.782 0.325 . . . . 0.0 110.662 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -64.93 -43.99 90.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.497 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.82 -44.19 94.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.527 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.05 152.08 22.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.667 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -72.96 117.73 15.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.378 . . . . 0.0 110.33 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.488 ' HG3' HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -114.13 163.9 14.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.433 -179.109 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -56.45 -165.42 0.05 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.039 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.842 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -82.1 99.0 8.95 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.715 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.794 HG23 ' HB3' ' A' ' 148' ' ' GLN . 45.8 mt -88.73 108.88 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.828 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -114.03 -78.09 0.58 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.021 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.6 t -101.32 -61.23 1.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.832 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.7 tmtt? -48.99 -51.54 30.01 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.794 ' HB3' HG23 ' A' ' 144' ' ' ILE . 7.2 tm0? -56.28 -51.51 67.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.433 ' CD2' ' CG2' ' A' ' 144' ' ' ILE . 3.9 mm? -75.19 -37.69 61.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.5 m -73.08 -42.68 62.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.033 0.444 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.832 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -64.0 -50.11 69.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.034 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.914 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -64.28 -38.16 90.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.709 0.29 . . . . 0.0 110.871 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.56 -43.98 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -24.76 57.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.497 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.74 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.9 OUTLIER -66.42 -23.75 66.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.651 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.434 ' HB2' ' HB2' ' A' ' 129' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.217 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.103 0 CA-C-O 120.598 0.237 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.512 ' HB3' HG22 ' A' ' 25' ' ' THR . 61.2 Cg_endo -73.03 162.41 40.99 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.458 2.106 . . . . 0.0 112.479 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.751 HG11 ' HD2' ' A' ' 139' ' ' LYS . 12.7 t -144.07 126.92 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.85 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.7 OUTLIER -108.64 121.96 46.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.576 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.764 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.75 120.6 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.41 ' HB3' ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -116.02 147.03 41.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.195 0.522 . . . . 0.0 111.978 -178.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HD2' HD21 ' A' ' 122' ' ' LEU . 20.5 t80 -155.12 127.62 7.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.225 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.45 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 7.2 mmpt? 55.06 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.521 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -129.26 -46.45 1.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.538 ' CE ' HD21 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -73.66 139.84 45.68 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.099 0.476 . . . . 0.0 111.266 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.41 ' HG2' ' HB3' ' A' ' 16' ' ' SER . 1.6 mtt180 -115.35 164.4 14.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.276 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CE1' HG11 ' A' ' 103' ' ' VAL . 1.4 m-85 -131.97 138.39 48.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.562 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.061 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -114.88 133.74 55.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.422 . . . . 0.0 110.962 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.82 HG21 HG12 ' A' ' 108' ' ' VAL . 1.5 mm -115.85 106.52 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.57 HG21 HD23 ' A' ' 40' ' ' LEU . 1.6 p -132.33 162.89 29.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.27 0.557 . . . . 0.0 111.936 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.535 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.7 p80 -81.41 152.13 27.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.937 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -62.74 154.36 75.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.987 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.4 Cg_exo -54.55 140.83 75.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.343 2.029 . . . . 0.0 113.275 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.468 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 32.3 p -98.47 174.33 6.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.161 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -93.37 -11.64 31.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.69 -31.04 14.61 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -139.69 89.65 2.34 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.519 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.636 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.3 OUTLIER -80.38 -52.16 8.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.173 0.511 . . . . 0.0 111.272 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 37' ' ' ILE . 1.1 p -56.79 -45.64 82.03 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.359 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.1 m -57.72 -33.47 68.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.936 0.398 . . . . 0.0 111.439 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.741 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.27 -47.93 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.174 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.83 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.0 pt -55.91 -39.08 55.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.216 0.531 . . . . 0.0 110.696 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -65.21 -51.86 58.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.487 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 4.0 m-20 -68.64 -50.05 54.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.873 0.368 . . . . 0.0 111.906 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.741 HD21 ' CE1' ' A' ' 36' ' ' PHE . 58.7 mt -55.93 -44.84 78.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.871 0.367 . . . . 0.0 110.412 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -78.53 -26.62 45.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.028 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -53.36 -42.8 67.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.406 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.061 ' CD1' HD21 ' A' ' 23' ' ' LEU . 17.9 t80 -63.37 -38.56 91.61 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.241 -0.583 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.654 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.64 -177.71 40.12 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.958 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.54 117.71 19.99 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.738 HG22 ' H ' ' A' ' 47' ' ' THR . 1.7 m -164.8 -170.23 1.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.63 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.738 ' H ' HG22 ' A' ' 46' ' ' THR . 2.9 t -64.7 158.65 24.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.411 0.624 . . . . 0.0 110.443 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 104' ' ' ALA . 59.8 t -136.47 136.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.333 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.11 HG13 HG13 ' A' ' 105' ' ' VAL . 2.4 p -115.64 105.17 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.282 0.563 . . . . 0.0 110.699 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.404 ' HG2' ' CG2' ' A' ' 68' ' ' VAL . 7.4 ptm180 -113.99 110.72 20.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.705 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.8 HG13 ' HB3' ' A' ' 71' ' ' TRP . 18.5 t -105.39 90.94 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.537 0.684 . . . . 0.0 109.817 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 t -158.4 171.77 19.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.582 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -65.51 130.02 41.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 m -74.33 122.39 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.26 -47.6 2.35 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.182 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.413 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.2 m-85 -130.54 84.29 2.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.628 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.433 ' O ' HD23 ' A' ' 61' ' ' LEU . 2.4 m-20 -78.56 -35.87 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -78.84 -48.42 14.76 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.636 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -44.64 -49.82 25.56 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 8.2 Cg_exo -73.16 -39.44 2.18 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.737 2.291 . . . . 0.0 113.336 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.868 HD21 ' CG1' ' A' ' 68' ' ' VAL . 3.7 mm? -66.95 -45.26 78.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -75.35 -33.34 61.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.83 ' HB3' HG21 ' A' ' 37' ' ' ILE . 5.8 mmtt -81.12 -32.05 33.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' CB ' HG12 ' A' ' 66' ' ' ILE . 71.1 m-20 -101.37 -11.5 19.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 44.6 34.77 3.83 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.051 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.555 HD12 HG21 ' A' ' 48' ' ' VAL . 4.3 pt -114.69 148.82 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.694 0.283 . . . . 0.0 111.001 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 47' ' ' THR . 81.9 p -77.53 135.2 38.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.868 ' CG1' HD21 ' A' ' 61' ' ' LEU . 7.9 p -144.9 151.73 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.084 0.469 . . . . 0.0 111.941 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.539 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.1 t -103.43 132.59 49.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -100.87 106.71 18.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.189 0.519 . . . . 0.0 110.365 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.81 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.0 m95 -111.93 104.07 55.74 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.136 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.447 -1.217 0 C-N-CA 123.599 2.866 . . . . 0.0 112.6 -179.425 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 120.57 0.224 . . . . 0.0 110.818 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.81 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 21.8 t -56.09 -48.0 79.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.734 HG11 ' HG ' ' A' ' 120' ' ' LEU . 94.0 t -55.98 -37.9 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.024 177.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.766 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.0 OUTLIER -59.46 -31.33 69.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.529 178.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -66.16 -50.74 62.89 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.23 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.706 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -67.97 -26.98 66.2 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.796 HD21 ' HB3' ' A' ' 120' ' ' LEU . 18.2 mt -61.05 -41.5 96.71 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.111 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -67.58 -42.54 82.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.872 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.466 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.3 tm? -60.32 -51.48 69.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.772 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.019 HG21 ' HB1' ' A' ' 121' ' ' ALA . 7.3 p -68.42 -43.94 83.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.25 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.441 ' N ' HG13 ' A' ' 91' ' ' VAL . 26.7 mttt -54.7 -40.33 69.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.907 0.384 . . . . 0.0 110.833 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.64 -45.78 77.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.992 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.403 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 2.3 mmtt -74.6 -24.81 58.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.652 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -82.1 -45.53 15.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.747 0.308 . . . . 0.0 111.109 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.92 -37.86 69.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.915 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -76.11 -32.99 59.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.04 88.82 53.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.451 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.24 133.89 13.76 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.58 2.187 . . . . 0.0 112.319 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.2 46.42 34.91 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.45 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.418 ' HB3' HG21 ' A' ' 46' ' ' THR . 0.4 OUTLIER -101.21 -165.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 111.269 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.654 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.0 m -127.42 113.71 16.56 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.199 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.487 HG11 ' CE1' ' A' ' 22' ' ' PHE . 5.4 t -110.65 151.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.737 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -118.97 144.73 46.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.308 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.11 HG13 HG13 ' A' ' 49' ' ' VAL . 3.5 t -140.37 167.08 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.622 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.6 t60 -66.97 156.34 36.21 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.463 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 25' ' ' THR . 25.6 p -68.19 101.72 1.22 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.471 0.653 . . . . 0.0 112.593 -177.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.82 HG12 HG21 ' A' ' 24' ' ' ILE . 5.4 p -75.55 0.08 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.065 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.46 -8.53 2.8 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.18 -125.84 3.08 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.755 -0.735 . . . . 0.0 111.391 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.858 HD21 ' HB2' ' A' ' 143' ' ' ALA . 0.0 OUTLIER -132.06 127.31 35.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.58 -142.73 3.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.644 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.742 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.31 -22.06 5.65 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.043 0.449 . . . . 0.0 111.965 -178.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.677 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -49.85 -46.33 80.67 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 5.7 Cg_endo -51.6 -48.38 21.64 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.482 2.121 . . . . 0.0 113.107 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.601 ' O ' HD23 ' A' ' 120' ' ' LEU . 43.5 t -61.1 -42.59 93.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.805 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.726 HD12 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -57.56 -55.07 39.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.687 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.893 ' CG2' HG11 ' A' ' 105' ' ' VAL . 61.1 t -52.93 -55.2 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.618 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -53.01 -53.14 54.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.249 0.547 . . . . 0.0 110.72 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.796 ' HB3' HD21 ' A' ' 88' ' ' LEU . 2.4 mm? -54.34 -30.78 52.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.793 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 1.019 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.21 -48.88 39.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.954 0.406 . . . . 0.0 110.467 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.538 HD21 ' CE ' ' A' ' 20' ' ' MET . 0.3 OUTLIER -62.92 -14.66 49.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.712 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.922 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.3 mt -57.01 -30.86 35.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.832 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -16.65 62.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.574 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.5 m -83.13 11.02 6.95 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.27 -101.85 1.08 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.016 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.476 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.3 ptt? -62.53 78.67 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.922 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.86 -67.65 0.55 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -176.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.64 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.6 t80 -67.42 -32.05 72.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.856 0.36 . . . . 0.0 111.092 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.38 -51.35 20.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.199 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.2 t0 -69.61 -38.36 77.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 111.009 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.618 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -60.36 -49.93 75.61 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.972 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.7 mm -73.56 -38.0 51.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.562 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.09 -49.72 22.71 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.764 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.84 -36.38 75.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.675 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.4 tt -74.29 -27.83 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.775 0.321 . . . . 0.0 110.434 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -49.67 66.65 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.542 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -45.14 93.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.61 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.751 ' HD2' HG11 ' A' ' 13' ' ' VAL . 19.6 mmtm -84.15 152.08 24.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.412 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.703 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.13 117.34 14.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.96 0.41 . . . . 0.0 110.454 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.41 ' HA ' HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -114.43 163.6 15.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.216 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.549 ' HA2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.32 -171.21 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.59 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.858 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -80.63 98.88 7.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.378 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.709 HD12 HD21 ' A' ' 149' ' ' LEU . 2.3 pt -88.71 108.53 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.062 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.89 -77.32 0.58 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.094 -0.643 . . . . 0.0 112.449 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.2 m -100.67 -60.68 1.48 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.754 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.4 tmtt? -54.27 -52.03 62.7 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.582 ' HG3' HG22 ' A' ' 144' ' ' ILE . 8.5 tm0? -56.31 -51.91 66.46 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.709 HD21 HD12 ' A' ' 144' ' ' ILE . 3.2 mm? -75.09 -44.46 47.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.2 m -68.88 -34.9 76.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.718 0.294 . . . . 0.0 111.441 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.754 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 1.8 t80 -68.66 -50.6 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.321 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.769 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -69.36 -33.32 72.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.475 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -57.4 -44.65 84.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -27.52 65.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.596 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.517 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -66.44 -29.22 69.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.832 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.767 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.688 0.28 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 60.3 Cg_endo -72.76 161.14 44.61 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.499 2.132 . . . . 0.0 112.252 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.46 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.3 t -143.98 127.38 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.061 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -105.14 116.63 32.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.031 0.443 . . . . 0.0 111.396 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.709 HG12 ' CE2' ' A' ' 135' ' ' PHE . 21.3 t -107.22 118.31 54.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.5 p -141.59 149.57 40.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.758 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -144.08 153.61 42.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.015 178.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 51.08 -97.81 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.406 0.282 . . . . 0.0 110.82 -176.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.429 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 2.6 m80 -124.78 -25.03 4.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.851 ' CE ' HD13 ' A' ' 122' ' ' LEU . 5.5 ppp? -73.8 164.31 26.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.747 0.308 . . . . 0.0 111.269 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -142.54 161.52 37.86 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.015 0.436 . . . . 0.0 111.3 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.819 ' CE1' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -142.99 140.65 31.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.147 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.053 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -114.69 134.59 54.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.107 0.479 . . . . 0.0 111.23 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.944 HD12 HG13 ' A' ' 108' ' ' VAL . 2.1 mm -116.91 106.51 20.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.329 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -133.33 167.26 20.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.183 0.515 . . . . 0.0 111.669 -178.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.6 p80 -80.92 151.9 28.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.847 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.65 154.26 74.82 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.045 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.517 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 53.1 Cg_exo -54.81 140.92 77.89 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.348 2.032 . . . . 0.0 113.376 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.441 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -98.72 174.34 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.125 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -94.41 -10.31 32.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.84 14.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.9 p -139.54 89.62 2.34 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.431 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -80.21 -52.18 8.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.261 0.553 . . . . 0.0 111.196 178.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.446 ' O ' HG13 ' A' ' 37' ' ' ILE . 17.2 p -57.56 -46.31 84.09 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.418 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -57.75 -31.96 66.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.823 0.344 . . . . 0.0 111.295 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.637 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.47 -47.78 31.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.619 HD13 ' HB3' ' A' ' 63' ' ' LYS . 11.6 pt -56.84 -39.36 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.191 0.52 . . . . 0.0 110.742 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.26 -52.14 60.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.466 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -68.49 -50.04 55.29 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.82 0.343 . . . . 0.0 111.757 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.637 HD21 ' CE1' ' A' ' 36' ' ' PHE . 25.3 mt -55.81 -45.35 78.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -26.62 49.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.108 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 17.2 mttt -52.88 -44.31 66.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.447 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.053 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.2 t80 -63.36 -38.42 91.07 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.897 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.689 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 167.01 -177.56 41.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.616 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.84 121.08 24.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.846 HG22 ' H ' ' A' ' 47' ' ' THR . 4.2 m -164.72 -171.82 2.43 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.846 ' H ' HG22 ' A' ' 46' ' ' THR . 8.8 t -65.74 166.9 10.11 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.754 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.787 HG13 ' O ' ' A' ' 104' ' ' ALA . 44.0 t -139.84 134.74 37.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.193 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.067 HG13 HG13 ' A' ' 105' ' ' VAL . 3.6 p -115.67 105.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.222 0.534 . . . . 0.0 111.483 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 110.81 20.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.984 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.826 HG13 ' HB3' ' A' ' 71' ' ' TRP . 7.4 t -103.86 91.86 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.453 0.644 . . . . 0.0 109.737 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 t -157.28 171.66 20.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.336 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.42 130.33 43.33 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 72' ' ' PRO . 16.4 t -68.91 121.67 18.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -176.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -120.73 -47.49 2.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.898 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.415 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 3.0 m-85 -130.44 84.47 2.2 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.263 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.52 -36.25 45.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -79.21 -48.58 13.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.66 HG22 ' HG3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -44.81 -48.24 29.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 59' ' ' THR . 33.6 Cg_exo -60.9 -42.27 38.86 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.551 2.167 . . . . 0.0 113.787 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.818 HD22 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -71.44 -45.75 61.83 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.85 -49.12 18.88 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.66 ' HG3' HG22 ' A' ' 59' ' ' THR . 0.3 OUTLIER -73.61 -28.08 61.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -177.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' CG ' HD11 ' A' ' 66' ' ' ILE . 4.6 t0 -98.49 -11.43 22.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.91 22.39 9.08 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.151 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.706 HD12 HG21 ' A' ' 48' ' ' VAL . 2.7 pt -122.02 148.61 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.626 0.25 . . . . 0.0 110.376 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' THR . 19.5 m -77.43 135.0 38.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.83 0.348 . . . . 0.0 110.192 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.818 HG12 HD22 ' A' ' 61' ' ' LEU . 7.4 p -141.24 150.53 19.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 0.0 111.756 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.443 HG22 ' HG ' ' A' ' 90' ' ' LEU . 3.4 t -103.73 134.42 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.135 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.83 106.69 18.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.19 0.519 . . . . 0.0 110.109 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.826 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.0 m95 -111.43 104.38 56.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.229 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HB3' HG23 ' A' ' 54' ' ' VAL . 43.4 Cg_endo . . . . . 0 N--CA 1.446 -1.3 0 C-N-CA 123.303 2.669 . . . . 0.0 112.433 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.129 0 N-CA-C 111.359 0.133 . . . . 0.0 111.359 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.11 -48.83 78.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.767 HG11 ' CE2' ' A' ' 151' ' ' TYR . 15.7 t -53.81 -41.16 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.218 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -61.07 -31.37 71.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.02 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.28 -50.36 68.2 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.395 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.845 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -70.31 -28.32 65.08 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.969 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.963 HD21 ' HB3' ' A' ' 120' ' ' LEU . 13.8 mt -61.64 -40.63 95.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.15 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.57 -39.93 70.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.132 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.3 tm? -58.03 -51.27 70.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.522 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.103 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.9 p -70.42 -35.83 63.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.666 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -46.34 77.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.381 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.71 85.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.446 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -67.49 -26.96 66.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.814 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.4 m-85 -79.81 -47.23 15.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.008 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.88 -43.3 98.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -33.03 59.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.97 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -118.55 89.38 36.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.32 113.6 3.52 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.597 2.198 . . . . 0.0 112.361 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.32 60.38 7.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.648 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.462 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 18.5 t -101.23 -163.85 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.627 0.251 . . . . 0.0 110.809 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.689 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 2.2 m -112.41 114.09 26.63 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.674 HG11 ' CE1' ' A' ' 22' ' ' PHE . 10.6 t -109.79 151.31 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.787 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -116.02 140.86 48.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.088 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.067 HG13 HG13 ' A' ' 49' ' ' VAL . 3.4 t -140.36 166.35 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.71 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.7 t60 -67.54 156.08 37.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.621 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 25' ' ' THR . 18.7 t -68.51 105.81 2.35 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.944 HG13 HD12 ' A' ' 24' ' ' ILE . 35.7 m -75.51 0.42 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.194 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.22 -8.6 2.61 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.72 -140.49 5.24 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.412 HD22 ' HA2' ' A' ' 142' ' ' GLY . 5.9 mt -114.97 127.34 55.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.64 -146.46 4.81 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.834 -1.174 . . . . 0.0 113.593 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.57 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.34 -21.68 5.75 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.031 0.443 . . . . 0.0 111.877 -178.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.887 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -52.8 -46.22 96.79 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.804 ' HD3' HG12 ' A' ' 108' ' ' VAL . 8.3 Cg_endo -52.41 -48.48 21.63 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.237 1.958 . . . . 0.0 112.904 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.807 HG21 ' NE2' ' A' ' 148' ' ' GLN . 57.5 t -60.9 -52.19 64.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.386 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.692 HD12 ' CG2' ' A' ' 49' ' ' VAL . 3.8 mt -51.89 -44.48 63.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.942 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.961 HG22 HG11 ' A' ' 105' ' ' VAL . 4.4 t -58.55 -54.62 30.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.472 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.68 -44.4 66.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 111.34 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.963 ' HB3' HD21 ' A' ' 88' ' ' LEU . 12.5 mt -63.95 -30.73 71.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.383 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 1.103 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -68.67 -37.53 79.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.069 0.462 . . . . 0.0 109.793 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.851 HD13 ' CE ' ' A' ' 20' ' ' MET . 7.6 tp -78.88 -15.68 58.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.256 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.93 HG23 ' CB ' ' A' ' 128' ' ' LYS . 1.8 mt -57.59 -30.86 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.73 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -16.33 64.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.512 ' OG ' HD12 ' A' ' 122' ' ' LEU . 7.1 m -79.54 -23.36 42.91 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 152.95 -96.1 0.16 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.994 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.478 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.2 ptt? -63.2 71.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.93 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.44 -67.62 0.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -176.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.573 ' CD1' HD22 ' A' ' 152' ' ' LEU . 8.6 t80 -66.26 -32.67 74.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.9 0.381 . . . . 0.0 111.128 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.59 -52.22 16.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.634 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 30.0 t0 -70.12 -39.43 75.45 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.821 0.343 . . . . 0.0 110.975 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.674 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -60.45 -50.01 75.29 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.811 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 129' ' ' TYR . 26.1 mm -73.38 -38.69 53.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -74.44 -49.95 20.35 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.709 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.83 -37.09 83.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.31 . . . . 0.0 110.165 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.561 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.23 -27.87 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.437 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -47.93 78.98 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -44.71 93.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.598 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.1 OUTLIER -84.9 152.03 23.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.44 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 116.7 14.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.009 0.433 . . . . 0.0 110.514 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 163.61 15.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.14 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -56.77 -168.8 0.09 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.649 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.21 100.03 12.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.286 0.543 . . . . 0.0 111.516 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.8 HD12 HD21 ' A' ' 149' ' ' LEU . 10.4 pt -87.93 109.52 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.373 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -113.25 -76.87 0.58 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 6.8 p -99.6 -61.01 1.42 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.833 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 11.7 tmtt? -66.48 -48.6 69.36 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.807 ' NE2' HG21 ' A' ' 116' ' ' VAL . 23.5 mm-40 -56.12 -51.84 66.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.8 HD21 HD12 ' A' ' 144' ' ' ILE . 2.0 mm? -74.2 -45.34 48.92 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.766 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.9 m -64.62 -37.31 87.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.795 0.331 . . . . 0.0 111.425 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.833 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -66.41 -50.51 63.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.157 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.859 HD21 HD11 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -61.52 -34.61 75.82 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.171 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.33 -43.4 88.21 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -23.76 65.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.482 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.661 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -66.18 -39.67 89.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.49 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 129' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.956 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.668 0.271 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.891 ' HB3' HG22 ' A' ' 25' ' ' THR . 64.2 Cg_endo -73.14 165.15 33.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.537 2.158 . . . . 0.0 112.339 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.434 HG11 ' HE2' ' A' ' 139' ' ' LYS . 21.2 t -138.78 126.88 28.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.809 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.0 pt-20 -105.96 116.74 32.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.978 0.418 . . . . 0.0 111.559 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.689 HG12 ' CE2' ' A' ' 135' ' ' PHE . 45.3 t -107.82 118.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.06 151.9 42.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 0.0 112.223 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -145.13 151.07 37.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.962 178.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.625 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 44.71 -78.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.455 0.702 . . . . 0.0 112.623 -177.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -129.81 -41.58 1.31 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.624 ' HE1' ' CE2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -73.58 154.22 39.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 112.027 -178.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -135.7 164.25 28.29 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.064 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.624 ' CE2' ' HE1' ' A' ' 20' ' ' MET . 7.9 m-85 -139.28 150.08 45.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.052 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -121.24 132.0 54.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.466 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.017 HD12 HG13 ' A' ' 108' ' ' VAL . 2.6 mm -117.27 106.68 20.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.512 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.891 HG22 ' HB3' ' A' ' 12' ' ' PRO . 31.7 p -130.45 167.23 18.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.202 0.525 . . . . 0.0 111.773 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.497 ' CD2' ' CE2' ' A' ' 36' ' ' PHE . 42.1 p-80 -80.89 152.29 28.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.39 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -62.45 153.93 74.66 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.3 Cg_exo -54.71 142.4 73.3 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.393 2.062 . . . . 0.0 113.46 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.484 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.1 p -98.5 174.44 6.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.053 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -94.01 -12.48 28.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.7 -31.02 14.61 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.4 p -139.86 89.81 2.34 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.691 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.651 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.5 OUTLIER -80.23 -52.32 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.212 0.529 . . . . 0.0 111.136 177.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.555 ' O ' HG13 ' A' ' 37' ' ' ILE . 1.5 m -57.45 -36.11 71.0 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.211 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -65.88 -35.48 80.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.919 0.39 . . . . 0.0 110.927 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.638 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -73.94 -47.97 33.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.072 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.588 HD13 ' HB3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -58.62 -37.02 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 110.472 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.48 -51.94 60.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.262 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -69.78 -49.88 48.63 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 111.552 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.699 HD23 HG21 ' A' ' 25' ' ' THR . 27.3 mt -54.96 -44.82 74.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.99 0.424 . . . . 0.0 110.502 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -78.4 -26.76 46.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.181 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 11.9 mttt -54.56 -41.89 70.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.351 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.052 ' CD1' HD21 ' A' ' 23' ' ' LEU . 13.3 t80 -63.58 -38.7 92.13 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.804 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.644 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 168.84 -178.84 41.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.706 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.83 118.36 20.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.804 HG22 ' H ' ' A' ' 47' ' ' THR . 3.3 m -164.7 -171.35 2.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.305 -0.862 . . . . 0.0 108.696 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.804 ' H ' HG22 ' A' ' 46' ' ' THR . 1.6 t -65.52 163.09 16.7 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.064 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.797 HG21 HD12 ' A' ' 66' ' ' ILE . 50.0 t -137.26 133.5 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.082 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.815 HG12 HG22 ' A' ' 105' ' ' VAL . 14.9 p -115.4 105.18 18.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.55 0.69 . . . . 0.0 111.514 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -114.64 110.84 20.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.845 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.791 HG13 ' HB3' ' A' ' 71' ' ' TRP . 14.5 t -105.87 91.83 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.629 0.728 . . . . 0.0 109.936 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.41 172.04 19.3 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.229 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' CD ' ' N ' ' A' ' 53' ' ' GLU . 1.5 mm-40 -64.28 130.33 43.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG12 ' OD1' ' A' ' 70' ' ' ASP . 12.0 m -69.07 121.95 19.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 m -120.53 -47.45 2.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.074 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.425 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 6.7 m-85 -130.41 84.51 2.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.34 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.52 -35.86 45.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -78.97 -48.45 14.47 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.651 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -45.67 -49.79 34.99 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.215 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 44.6 Cg_exo -57.44 -42.22 63.8 Favored 'Trans proline' 0 N--CA 1.471 0.189 0 C-N-CA 122.63 2.22 . . . . 0.0 113.572 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.602 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -71.3 -45.52 62.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.57 -49.1 19.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.588 ' HB3' HD13 ' A' ' 37' ' ' ILE . 11.0 mttt -75.15 -26.72 59.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.464 ' CG ' HD11 ' A' ' 66' ' ' ILE . 2.5 t0 -101.06 -11.39 19.67 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.95 25.53 3.81 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.138 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.797 HD12 HG21 ' A' ' 48' ' ' VAL . 4.2 pt -122.22 148.73 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.649 0.262 . . . . 0.0 110.531 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 47' ' ' THR . 1.3 m -77.29 135.05 38.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.965 0.412 . . . . 0.0 110.233 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.602 HG12 ' CD2' ' A' ' 61' ' ' LEU . 7.1 p -142.56 148.52 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.697 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.476 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.2 t -103.63 131.2 52.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.138 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.491 ' OD1' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -101.1 106.65 17.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.097 0.475 . . . . 0.0 110.651 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.895 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.6 m0 -109.21 103.5 52.62 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.815 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 N--CA 1.446 -1.319 0 C-N-CA 123.553 2.836 . . . . 0.0 112.559 -179.206 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.467 0.175 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.895 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 18.4 t -56.2 -52.34 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.683 HG13 HD13 ' A' ' 120' ' ' LEU . 1.4 t -53.81 -40.01 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.391 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -60.55 -31.34 70.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.955 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -50.29 63.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.284 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.76 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -67.86 -33.75 75.36 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.726 HD21 ' CB ' ' A' ' 120' ' ' LEU . 11.8 mt -59.32 -44.88 92.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.525 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -65.99 -39.91 90.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.203 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.507 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.7 tm? -60.16 -51.23 70.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.623 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.911 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.5 p -72.46 -35.99 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.295 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -56.41 -45.02 80.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.686 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.31 -42.23 72.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.709 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -67.49 -27.15 66.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.446 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 2.7 m-85 -81.97 -52.06 7.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.835 0.35 . . . . 0.0 111.331 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.3 t -57.08 -37.43 71.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.101 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -76.11 -33.05 59.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.339 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.13 84.63 61.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.539 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -66.27 136.75 44.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.714 2.276 . . . . 0.0 111.987 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.58 56.9 22.22 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.46 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.05 -161.8 0.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 111.189 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.644 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 1.5 m -125.36 114.05 18.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.268 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.51 HG11 ' HE1' ' A' ' 22' ' ' PHE . 39.1 t -106.88 151.05 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.789 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -119.0 140.9 49.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.79 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.815 HG22 HG12 ' A' ' 49' ' ' VAL . 99.4 t -139.36 166.37 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.57 ' N ' HG12 ' A' ' 105' ' ' VAL . 2.8 t60 -67.06 156.19 36.72 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.147 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 25' ' ' THR . 44.3 t -68.46 105.68 2.28 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.017 HG13 HD12 ' A' ' 24' ' ' ILE . 34.7 m -75.32 0.28 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.107 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.411 ' HB3' ' SG ' ' A' ' 107' ' ' CYS . . . -60.54 -8.56 2.89 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.08 -138.42 4.87 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mt -114.36 127.4 55.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.9 -156.29 8.71 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.154 -1.022 . . . . 0.0 113.121 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.691 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.31 -17.11 7.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.977 0.417 . . . . 0.0 111.758 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.669 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.67 -46.37 98.33 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.79 ' HD3' HG12 ' A' ' 108' ' ' VAL . 8.6 Cg_endo -52.82 -48.45 21.99 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.059 1.84 . . . . 0.0 112.506 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.638 HG22 ' HG3' ' A' ' 148' ' ' GLN . 59.8 t -56.55 -51.74 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.007 0.432 . . . . 0.0 110.285 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.6 HD12 ' CG2' ' A' ' 49' ' ' VAL . 10.3 mt -52.97 -48.35 67.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.614 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.739 HG22 HG21 ' A' ' 105' ' ' VAL . 41.6 t -51.76 -50.56 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.721 0.296 . . . . 0.0 111.464 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.748 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -52.8 -46.91 67.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.327 0.584 . . . . 0.0 110.484 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.726 ' CB ' HD21 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -57.51 -31.41 66.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.623 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.911 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.28 -44.33 62.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.4 . . . . 0.0 110.517 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.445 ' HA ' HD12 ' A' ' 122' ' ' LEU . 7.3 tp -66.82 -15.84 63.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.656 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 1.04 HD11 HD21 ' A' ' 152' ' ' LEU . 2.5 mt -57.23 -30.53 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.696 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -17.2 63.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.013 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.9 m -79.99 -23.31 41.65 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.13 -96.64 0.17 Allowed Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.778 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.583 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 1.3 ptt? -63.55 72.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.941 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.95 -67.42 0.43 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.506 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 7.0 t80 -67.74 -32.73 73.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.004 0.43 . . . . 0.0 110.959 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.48 -52.11 17.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.252 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 41.6 t0 -69.32 -35.86 76.38 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.748 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -61.63 -50.31 73.05 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.771 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -73.92 -37.99 48.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.537 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -74.08 -49.71 22.82 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.689 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.19 -34.32 72.8 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.72 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.23 -29.86 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 110.473 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.16 -43.23 82.81 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.633 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -45.55 91.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 110.598 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.434 ' HE2' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -87.37 151.41 23.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.223 179.301 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.407 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.7 116.47 14.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.568 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.35 163.67 15.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.074 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.04 -174.86 0.08 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.555 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.4 9.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.56 0.68 . . . . 0.0 111.443 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.801 HD12 HD21 ' A' ' 149' ' ' LEU . 1.6 pt -88.4 109.57 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.543 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -113.13 -76.72 0.58 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.75 -60.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.824 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 10.5 tmtt? -55.94 -52.05 65.51 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.693 ' OE1' HD22 ' A' ' 149' ' ' LEU . 17.6 tm0? -58.3 -51.52 69.43 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.801 HD21 HD12 ' A' ' 144' ' ' ILE . 3.2 mm? -72.02 -41.0 68.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 50.0 m -70.53 -39.69 73.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.779 0.323 . . . . 0.0 111.524 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.824 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.35 -50.97 63.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.228 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.04 HD21 HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -66.87 -31.23 71.69 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.708 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.57 -37.7 87.19 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -23.94 59.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.545 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CB ' HD23 ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.21 -40.63 90.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.286 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.563 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.766 0.317 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.728 ' HB3' HG23 ' A' ' 25' ' ' THR . 58.1 Cg_endo -71.52 160.22 49.07 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.596 2.197 . . . . 0.0 112.378 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.429 HG11 ' CD ' ' A' ' 139' ' ' LYS . 18.5 t -143.26 126.89 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.853 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 5.5 pt-20 -109.38 116.68 32.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.895 0.379 . . . . 0.0 111.618 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.75 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -107.42 118.53 55.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.3 p -140.97 140.53 34.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.106 0.479 . . . . 0.0 112.056 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.475 ' CD2' ' HE1' ' A' ' 127' ' ' MET . 0.0 OUTLIER -141.03 147.56 38.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.701 178.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 1.3 mmmp? 64.59 -90.73 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.273 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.51 -45.02 1.21 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.531 ' SD ' HD21 ' A' ' 122' ' ' LEU . 2.7 ppp? -73.68 164.76 26.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 111.728 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -139.2 164.32 30.11 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.475 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.698 ' CE1' HG11 ' A' ' 103' ' ' VAL . 0.3 OUTLIER -134.18 141.63 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.4 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.075 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -114.9 133.86 55.63 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.107 0.48 . . . . 0.0 111.038 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.965 HD12 HG13 ' A' ' 108' ' ' VAL . 1.7 mm -117.92 106.56 20.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.156 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.728 HG23 ' HB3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -134.67 166.83 22.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.15 0.5 . . . . 0.0 111.509 -179.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.522 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 7.3 p80 -81.31 151.77 27.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.175 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -63.02 154.42 77.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.023 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.524 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.3 Cg_exo -54.72 139.03 77.17 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.329 2.019 . . . . 0.0 113.245 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.439 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 29.8 p -98.59 174.21 6.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.096 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -92.75 -9.89 39.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.64 -30.85 14.73 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 p -139.79 89.56 2.32 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.244 -0.582 . . . . 0.0 112.357 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.503 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -80.27 -52.27 7.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 0.0 111.169 178.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -58.59 -46.09 87.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.352 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.7 m -57.83 -32.45 67.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.841 0.353 . . . . 0.0 111.148 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.687 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.16 -47.99 32.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.114 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.946 HG21 ' HB3' ' A' ' 63' ' ' LYS . 10.8 pt -56.12 -38.84 55.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.55 . . . . 0.0 110.539 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.1 -51.94 61.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.369 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.1 m-20 -69.43 -50.21 47.91 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.866 0.365 . . . . 0.0 111.72 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.687 HD21 ' CE1' ' A' ' 36' ' ' PHE . 57.6 mt -56.12 -44.75 79.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.958 0.408 . . . . 0.0 110.326 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -78.18 -26.67 47.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -52.74 -44.13 66.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.311 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.075 ' CD1' HD21 ' A' ' 23' ' ' LEU . 16.8 t80 -63.45 -38.17 90.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.73 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.72 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.41 -176.96 40.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.943 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.71 118.05 20.33 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.752 HG22 ' H ' ' A' ' 47' ' ' THR . 1.3 m -165.06 -170.27 1.89 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.822 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.752 ' H ' HG22 ' A' ' 46' ' ' THR . 1.5 t -64.91 150.75 47.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.458 0.647 . . . . 0.0 110.122 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.786 HG21 HD12 ' A' ' 66' ' ' ILE . 48.2 t -126.33 133.69 68.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.817 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.039 HG13 HG13 ' A' ' 105' ' ' VAL . 8.5 p -115.24 105.45 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.155 0.502 . . . . 0.0 111.184 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.52 110.9 21.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.755 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.952 HG11 ' HB2' ' A' ' 113' ' ' ARG . 39.6 t -103.28 91.27 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.55 0.691 . . . . 0.0 110.236 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.2 171.43 20.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.05 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.78 130.7 44.51 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -68.55 121.93 18.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.0 p -120.63 -47.38 2.32 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.948 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.43 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 4.2 m-85 -130.23 84.4 2.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.288 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.4 -35.85 46.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -78.84 -48.43 14.74 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.503 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -45.67 -50.26 33.39 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.43 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 39.4 Cg_exo -61.64 -42.13 34.72 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.543 2.162 . . . . 0.0 113.639 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.91 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -71.32 -45.65 62.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.68 -49.29 18.78 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.946 ' HB3' HG21 ' A' ' 37' ' ' ILE . 10.4 mttt -61.41 -39.4 90.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.89 ' OD2' HG22 ' A' ' 37' ' ' ILE . 45.8 m-20 -101.76 -11.39 19.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 53.2 25.17 24.63 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.771 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.786 HD12 HG21 ' A' ' 48' ' ' VAL . 8.9 pt -107.52 149.08 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.854 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 47' ' ' THR . 63.9 p -77.46 135.44 38.26 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.91 HG12 ' CD2' ' A' ' 61' ' ' LEU . 11.7 p -140.17 150.08 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.464 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.6 t -103.35 132.08 50.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.86 106.65 18.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.172 0.51 . . . . 0.0 110.706 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.768 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.5 m95 -111.25 103.73 55.3 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.498 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo . . . . . 0 N--CA 1.447 -1.222 0 C-N-CA 123.472 2.782 . . . . 0.0 113.008 -179.02 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 2.6 tttt . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 120.341 0.115 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.72 HG12 ' CH2' ' A' ' 71' ' ' TRP . 21.6 t -54.73 -48.17 72.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.828 HG11 ' HG ' ' A' ' 120' ' ' LEU . 78.4 t -59.34 -38.05 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.207 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.748 ' HA ' HD12 ' A' ' 88' ' ' LEU . 8.1 mt-10 -58.16 -31.18 67.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.57 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.07 -50.68 63.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.912 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.827 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -67.1 -27.03 67.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.804 HD21 ' HB3' ' A' ' 120' ' ' LEU . 26.3 mt -63.42 -39.29 94.1 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.966 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.4 m -66.8 -44.95 79.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.029 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.1 tm? -57.27 -51.41 69.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.483 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.838 HG21 ' HB1' ' A' ' 121' ' ' ALA . 9.0 p -69.77 -35.87 67.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.718 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.65 -45.22 73.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.81 -43.91 74.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.687 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -26.22 65.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.126 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.548 ' HE1' HG21 ' A' ' 103' ' ' VAL . 1.6 m-85 -82.04 -52.0 7.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 111.192 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 15.9 t -67.05 -34.96 78.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.176 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -33.08 59.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.161 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.12 96.3 37.26 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.386 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.94 132.42 23.01 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.457 2.105 . . . . 0.0 112.058 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.04 56.12 27.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.174 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.573 ' OG ' HG21 ' A' ' 46' ' ' THR . 82.5 p -101.07 169.38 8.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 111.232 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.72 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -100.68 113.78 26.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.573 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.698 HG11 ' CE1' ' A' ' 22' ' ' PHE . 24.4 t -107.85 151.29 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.757 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -120.94 140.87 51.25 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.323 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.057 HG11 HG22 ' A' ' 118' ' ' VAL . 3.0 t -140.07 166.54 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.548 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.7 t60 -67.97 155.84 38.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -68.84 105.61 2.41 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.965 HG13 HD12 ' A' ' 24' ' ' ILE . 32.0 m -75.39 -0.04 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.01 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.77 -8.5 3.06 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.97 -128.77 3.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.543 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.902 HD21 ' HB2' ' A' ' 143' ' ' ALA . 0.1 OUTLIER -132.09 127.4 35.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -171.31 -142.31 3.63 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.397 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.952 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.44 -21.8 5.67 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.994 0.426 . . . . 0.0 111.89 -178.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.661 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.17 -46.8 82.9 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.727 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.5 Cg_endo -52.13 -48.49 21.42 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.296 1.997 . . . . 0.0 112.867 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.747 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.2 t -59.23 -41.79 84.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.674 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.453 HD11 ' CE3' ' A' ' 71' ' ' TRP . 7.1 mt -61.06 -50.08 74.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.737 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 1.057 HG22 HG11 ' A' ' 105' ' ' VAL . 12.0 t -53.76 -55.52 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -60.2 -47.14 87.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.129 0.49 . . . . 0.0 110.839 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.828 ' HG ' HG11 ' A' ' 84' ' ' VAL . 3.3 mm? -54.59 -30.76 55.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.044 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.838 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.33 -49.99 30.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.046 0.45 . . . . 0.0 110.54 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.531 HD21 ' SD ' ' A' ' 20' ' ' MET . 0.3 OUTLIER -62.62 -15.67 52.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.083 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.931 ' CD1' HD21 ' A' ' 152' ' ' LEU . 1.2 mt -57.45 -34.58 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.637 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.31 -15.38 15.65 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.81 11.38 3.28 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 116.99 -85.53 0.39 Allowed Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.158 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.42 78.39 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.892 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -62.37 -67.71 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.531 ' HD1' HD22 ' A' ' 152' ' ' LEU . 6.4 t80 -74.98 -30.52 61.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.122 0.487 . . . . 0.0 110.544 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -72.6 -46.64 53.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.034 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 127' ' ' MET . 51.5 t0 -70.22 -47.3 62.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.381 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.816 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -58.32 -50.32 74.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.871 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 129' ' ' TYR . 32.7 mm -69.54 -37.85 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.46 -49.93 20.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.75 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.61 -34.67 74.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.647 0.261 . . . . 0.0 110.977 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 119' ' ' ALA . 1.8 tt -74.21 -34.05 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.0 110.645 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -63.46 -45.9 88.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -39.79 85.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.023 0.44 . . . . 0.0 110.499 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.429 ' CD ' HG11 ' A' ' 13' ' ' VAL . 14.7 mmtt -87.09 152.27 22.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.68 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.66 117.89 14.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.457 ' HD3' HG23 ' A' ' 136' ' ' ILE . 0.1 OUTLIER -114.28 163.34 15.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.946 -179.081 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -62.26 -156.55 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.329 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.902 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -90.2 98.71 11.93 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.942 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.583 HG22 ' HG3' ' A' ' 148' ' ' GLN . 1.1 pt -88.9 108.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.815 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -113.66 -77.38 0.58 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 119.88 -0.728 . . . . 0.0 112.756 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.49 -60.8 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.728 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -53.21 -51.78 61.02 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.693 ' HG3' HG22 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -56.84 -52.09 66.47 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.28 -40.0 59.14 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.3 m -69.47 -42.71 74.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.878 0.37 . . . . 0.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.728 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -63.59 -50.56 68.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.931 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -65.29 -36.51 84.3 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.784 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -55.92 -39.82 72.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.405 ' C ' ' HD2' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -74.13 -24.85 59.5 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.213 178.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.663 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -66.17 -39.99 90.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.34 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.413 ' HB2' ' HB2' ' A' ' 129' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.168 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.708 0.29 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 58.7 Cg_endo -72.1 152.03 56.19 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.468 2.112 . . . . 0.0 112.305 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.416 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 19.1 t -144.09 126.94 11.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 mp0 -112.77 116.84 30.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.904 0.383 . . . . 0.0 111.611 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.81 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -106.84 118.33 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.5 p -141.29 143.68 34.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.732 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -133.36 158.8 42.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.248 178.167 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 45.7 -93.16 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.302 0.241 . . . . 0.0 111.384 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -127.04 -29.31 2.8 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.589 ' HE3' HD13 ' A' ' 122' ' ' LEU . 4.3 ppp? -73.65 159.13 33.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.58 0.228 . . . . 0.0 111.183 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -141.63 164.06 31.22 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.143 0.497 . . . . 0.0 111.807 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' HE1' HG11 ' A' ' 103' ' ' VAL . 3.4 m-85 -138.14 144.31 40.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.933 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.056 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -119.39 135.49 54.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.033 0.444 . . . . 0.0 111.002 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.886 HG21 HG22 ' A' ' 108' ' ' VAL . 5.1 mm -118.51 106.69 20.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.64 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.611 HG21 HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -130.36 165.31 22.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.48 0.657 . . . . 0.0 111.943 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.525 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.4 p80 -81.89 152.58 26.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.941 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -62.42 154.76 70.81 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.1 Cg_exo -54.09 136.65 68.14 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.246 1.964 . . . . 0.0 113.162 -177.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -98.64 147.03 25.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.302 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -68.68 -12.36 61.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.49 -31.41 14.58 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.2 p -139.97 88.81 2.26 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.119 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.5 OUTLIER -80.91 -52.23 7.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.221 0.534 . . . . 0.0 111.359 178.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.44 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.7 m -56.44 -46.17 80.44 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.49 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.8 m -57.62 -31.92 66.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.853 0.359 . . . . 0.0 111.286 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.689 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.3 -47.77 26.34 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.81 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.8 pt -55.83 -39.12 54.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.192 0.52 . . . . 0.0 110.648 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.38 -52.08 56.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.46 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.547 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 7.1 m-20 -68.06 -50.12 57.13 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.82 0.343 . . . . 0.0 111.799 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.689 HD21 ' CE1' ' A' ' 36' ' ' PHE . 63.4 mt -55.76 -45.78 78.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.427 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -77.05 -26.64 53.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.119 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 7.0 mttt -53.12 -44.74 67.93 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.288 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.056 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.0 t80 -63.43 -38.56 91.6 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.709 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.702 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.35 -179.57 39.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.038 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.55 117.25 19.31 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 101' ' ' SER . 0.8 OUTLIER -164.9 -169.77 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.892 177.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' THR . 9.1 p -64.59 160.08 20.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.455 0.645 . . . . 0.0 110.686 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 104' ' ' ALA . 57.2 t -139.0 137.01 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.078 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.825 HG12 HG22 ' A' ' 105' ' ' VAL . 11.3 p -115.52 104.3 16.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.479 0.657 . . . . 0.0 111.385 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -115.21 111.04 20.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.028 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.794 HG13 ' HB3' ' A' ' 71' ' ' TRP . 11.9 t -106.49 91.48 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.405 0.621 . . . . 0.0 109.914 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.4 p -157.68 171.24 20.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.77 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.403 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 2.2 mm-40 -66.62 130.5 43.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.9 p -73.37 122.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.9 p -120.0 -47.7 2.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.254 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.404 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 1.2 m-85 -130.6 83.67 2.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.467 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.2 -36.61 39.89 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -79.6 -48.58 13.55 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.478 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.56 -56.97 7.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 61.5 Cg_endo -72.99 -34.71 6.11 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.47 2.113 . . . . 0.0 113.811 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.037 HD21 HG11 ' A' ' 68' ' ' VAL . 2.0 mm? -71.1 -45.44 63.68 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.21 -28.91 60.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.81 ' HB3' HG21 ' A' ' 37' ' ' ILE . 3.5 mtpp -78.92 -36.57 41.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.517 ' O ' HG13 ' A' ' 66' ' ' ILE . 1.2 m-20 -101.76 -12.27 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.28 23.95 6.52 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.11 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 64' ' ' ASP . 28.1 mt -93.15 147.38 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.728 0.299 . . . . 0.0 111.029 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 47' ' ' THR . 27.8 m -78.52 129.58 35.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.037 HG11 HD21 ' A' ' 61' ' ' LEU . 6.1 p -145.07 152.46 14.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.261 0.553 . . . . 0.0 111.945 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.76 129.25 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.258 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.0 106.72 18.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.972 0.415 . . . . 0.0 110.946 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 1.008 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 5.2 m0 -107.38 103.55 49.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.626 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo . . . . . 0 N--CA 1.444 -1.397 0 C-N-CA 123.617 2.878 . . . . 0.0 112.439 -179.22 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.675 0.274 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 1.008 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 26.1 t -55.05 -41.55 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.709 HG22 ' CD1' ' A' ' 120' ' ' LEU . 0.5 OUTLIER -53.55 -41.65 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -65.83 -31.21 72.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.504 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -64.08 -50.94 66.37 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.749 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -67.52 -32.85 73.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.696 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.811 HD21 ' HB3' ' A' ' 120' ' ' LEU . 12.0 mt -57.01 -45.67 82.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.467 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -43.13 94.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.493 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.511 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.5 tm? -58.35 -51.66 68.87 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.009 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.886 HG21 ' HB1' ' A' ' 121' ' ' ALA . 13.8 p -70.96 -39.96 75.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.376 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -58.55 -41.02 84.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.924 0.393 . . . . 0.0 110.547 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.75 -48.17 75.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.642 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -71.59 -25.7 62.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.485 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.0 m-85 -75.11 -51.73 12.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.7 t -60.0 -42.26 93.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.788 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -76.09 -33.06 59.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -126.08 92.12 46.55 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.275 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.22 138.29 15.89 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.637 2.225 . . . . 0.0 112.489 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.401 ' HA2' ' CB ' ' A' ' 20' ' ' MET . . . 58.24 56.35 25.69 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.712 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.691 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.8 OUTLIER -101.24 -172.49 2.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 111.176 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.702 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 m -108.29 113.55 26.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.145 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.64 HG11 ' HE1' ' A' ' 22' ' ' PHE . 46.0 t -111.3 149.55 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.183 0.516 . . . . 0.0 112.306 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.858 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -119.96 144.3 47.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.949 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.825 HG22 HG12 ' A' ' 49' ' ' VAL . 96.5 t -140.17 166.32 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.711 0.291 . . . . 0.0 111.6 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.571 ' N ' HG12 ' A' ' 105' ' ' VAL . 3.2 t60 -67.34 155.74 38.19 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.344 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 26' ' ' HIS . 0.2 OUTLIER -68.61 106.59 2.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.413 0.625 . . . . 0.0 112.615 -178.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.886 HG22 HG21 ' A' ' 24' ' ' ILE . 28.0 m -75.33 0.53 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.221 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.19 -8.58 2.57 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.07 -124.86 2.87 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 111' ' ' LEU . 8.4 mt -128.15 127.34 42.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.98 -158.17 9.17 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.261 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.626 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.19 -18.81 6.74 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.063 0.459 . . . . 0.0 111.776 -178.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.806 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -52.75 -46.2 96.53 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.687 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.6 Cg_endo -52.78 -48.44 22.01 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.043 1.829 . . . . 0.0 112.509 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.774 HG22 ' HG3' ' A' ' 148' ' ' GLN . 58.5 t -55.95 -51.88 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 0.0 109.94 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.674 HD12 ' CG2' ' A' ' 49' ' ' VAL . 8.8 mt -54.47 -46.2 73.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.583 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 114' ' ' ALA . 17.0 t -51.42 -50.58 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 111.076 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.818 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -54.03 -48.04 70.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.29 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.811 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.2 mt -53.97 -31.32 50.33 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.205 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.886 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.51 -50.61 29.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.716 0.293 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.768 HD23 ' OD2' ' A' ' 131' ' ' ASP . 8.5 tp -66.55 -14.63 62.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.714 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.999 HD11 HD21 ' A' ' 152' ' ' LEU . 2.2 mt -58.49 -30.95 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.063 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -70.49 -16.55 62.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.44 -23.24 40.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.67 -96.96 0.17 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.792 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.647 ' HE3' ' CD2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -63.12 74.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.904 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -70.73 -67.47 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.472 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 6.9 t80 -65.49 -34.86 79.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.933 0.397 . . . . 0.0 111.341 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -71.77 -51.5 22.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.454 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.768 ' OD2' HD23 ' A' ' 122' ' ' LEU . 32.8 t70 -70.14 -32.51 70.53 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.943 0.402 . . . . 0.0 111.06 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.818 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -62.3 -50.16 72.76 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.97 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.478 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 32.9 mm -74.5 -40.32 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.269 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -50.03 19.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.81 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.48 -38.98 88.47 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.29 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -74.43 -27.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.709 0.29 . . . . 0.0 110.877 179.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 1.9 ttp85 -65.08 -42.2 94.31 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.797 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -45.43 91.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.888 0.375 . . . . 0.0 110.41 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' ILE . 6.7 mmtt -87.72 151.72 22.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.273 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.36 117.0 14.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.163 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 163.81 14.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.288 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -53.52 -173.61 0.05 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.011 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.417 ' N ' HD22 ' A' ' 111' ' ' LEU . . . -84.13 99.5 10.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.213 0.507 . . . . 0.0 111.473 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 1.09 HD12 HD21 ' A' ' 149' ' ' LEU . 1.8 pt -88.17 109.5 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.407 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -113.13 -76.5 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.313 0.856 . . . . 0.0 113.313 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.7 p -99.63 -60.84 1.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.897 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.3 tmtt? -56.81 -51.87 67.27 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -176.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.774 ' HG3' HG22 ' A' ' 116' ' ' VAL . 9.8 tm0? -56.73 -51.22 69.68 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.09 HD21 HD12 ' A' ' 144' ' ' ILE . 3.9 mm? -72.98 -43.09 62.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 m -70.27 -39.71 74.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.771 0.319 . . . . 0.0 111.661 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.897 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -66.54 -50.91 61.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.999 HD21 HD11 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -66.49 -30.17 70.44 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.413 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.93 -40.12 96.66 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -22.72 61.46 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.58 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.467 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.21 -47.95 72.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.608 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.514 0.197 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.6 ' HB3' HG23 ' A' ' 25' ' ' THR . 37.5 Cg_exo -57.03 161.91 10.0 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.408 2.072 . . . . 0.0 112.126 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.733 HG11 ' CE ' ' A' ' 139' ' ' LYS . 3.7 t -137.74 126.97 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.817 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 11.6 pt-20 -107.42 116.92 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 111.752 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.836 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.7 OUTLIER -108.92 118.53 56.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.499 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.9 p -140.99 147.56 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 111.95 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CD2' ' HG2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -144.04 126.35 15.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.282 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 38.0 mmtt 77.92 -87.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.278 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -129.38 -40.62 1.43 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.631 ' CE ' HD13 ' A' ' 122' ' ' LEU . 2.7 tmm? -73.74 154.41 39.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.884 0.373 . . . . 0.0 111.289 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.11 161.66 35.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.621 ' CE2' ' HE1' ' A' ' 20' ' ' MET . 8.6 m-85 -132.09 145.75 51.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.069 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.3 mm? -117.81 129.21 55.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 110.791 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.871 HD12 HG13 ' A' ' 108' ' ' VAL . 2.1 mm -112.56 106.63 21.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.6 HG23 ' HB3' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -130.89 164.54 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.243 0.544 . . . . 0.0 111.987 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.519 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.4 p80 -81.24 152.33 27.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.797 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.6 153.46 77.76 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.521 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 9.6 Cg_endo -54.43 139.58 74.34 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.564 2.176 . . . . 0.0 113.475 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.439 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.6 p -98.86 174.38 6.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.095 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -98.24 -8.08 27.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -30.6 14.91 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 p -139.37 89.73 2.36 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.487 -0.485 . . . . 0.0 112.112 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.448 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.6 OUTLIER -79.99 -52.28 8.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.122 0.487 . . . . 0.0 111.421 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 37' ' ' ILE . 1.2 m -57.62 -45.38 85.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.083 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -32.03 67.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.797 0.332 . . . . 0.0 111.464 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.646 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.57 -48.01 24.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.915 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.9 pt -55.88 -39.21 55.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.178 0.513 . . . . 0.0 110.746 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.12 -52.08 51.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.58 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.559 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 4.8 m-20 -67.67 -50.14 59.26 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.905 0.384 . . . . 0.0 111.945 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.646 HD21 ' CE1' ' A' ' 36' ' ' PHE . 80.0 mt -55.79 -46.35 78.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.359 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -76.95 -26.71 54.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.083 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 5.3 mttt -52.91 -44.46 66.98 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.069 ' CD1' HD21 ' A' ' 23' ' ' LEU . 15.4 t80 -63.54 -38.62 91.81 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.734 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.692 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.6 -178.82 39.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.991 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.38 19.54 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 47' ' ' THR . 0.9 OUTLIER -165.19 -169.93 1.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.92 177.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.647 ' H ' HG22 ' A' ' 46' ' ' THR . 3.0 t -64.55 152.52 41.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.705 0.764 . . . . 0.0 110.437 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.81 HG22 ' HB3' ' A' ' 104' ' ' ALA . 83.6 t -132.2 136.5 56.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.006 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.062 HG13 HG13 ' A' ' 105' ' ' VAL . 14.9 p -115.66 105.31 18.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.147 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.423 ' HG2' ' CG2' ' A' ' 68' ' ' VAL . 17.1 ptt180 -113.59 110.85 20.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.748 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 113' ' ' ARG . 41.9 t -108.57 91.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.571 0.7 . . . . 0.0 110.327 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.7 p -157.82 171.03 21.02 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.041 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.27 130.25 42.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.689 HG23 ' HB3' ' A' ' 72' ' ' PRO . 17.6 t -70.22 122.19 21.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.5 p -120.51 -47.93 2.31 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.179 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.422 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.3 m-85 -130.77 83.91 2.15 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.623 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.13 -36.78 40.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.65 -48.58 13.5 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.448 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -45.92 -54.3 17.28 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 8.2 Cg_exo -73.1 -35.6 5.07 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.659 2.239 . . . . 0.0 113.653 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.977 HD21 HG11 ' A' ' 68' ' ' VAL . 2.1 mm? -71.03 -45.24 64.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.01 -28.97 60.72 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.915 ' HB3' HG21 ' A' ' 37' ' ' ILE . 5.7 mttp -81.02 -35.09 32.33 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.541 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -101.56 -12.45 18.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.48 25.61 4.6 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.378 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 64' ' ' ASP . 20.8 mt -95.36 147.72 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.672 0.272 . . . . 0.0 111.079 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 47' ' ' THR . 1.8 m -78.16 127.94 33.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.977 HG11 HD21 ' A' ' 61' ' ' LEU . 10.5 p -145.18 153.95 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.151 0.501 . . . . 0.0 112.209 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.7 t -103.33 132.75 48.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -101.08 106.84 18.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.124 0.488 . . . . 0.0 110.931 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.74 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.8 m95 -111.4 103.25 54.8 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.739 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.689 ' HB3' HG23 ' A' ' 54' ' ' VAL . 31.1 Cg_endo . . . . . 0 N--CA 1.446 -1.316 0 C-N-CA 123.62 2.88 . . . . 0.0 112.657 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.283 0.087 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -44.7 63.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.628 HG11 ' HE2' ' A' ' 151' ' ' TYR . 39.4 t -55.33 -43.53 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.344 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.527 ' HA ' HD12 ' A' ' 88' ' ' LEU . 21.0 mm-40 -55.37 -31.62 61.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.263 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -50.07 70.15 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.419 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.754 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.9 -30.3 70.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.897 HD21 ' HB3' ' A' ' 120' ' ' LEU . 22.9 mt -59.6 -48.32 82.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.451 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 m -63.63 -40.45 96.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.189 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.476 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.3 tm? -59.57 -51.26 70.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.616 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.917 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.8 p -69.92 -35.92 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.092 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -48.06 78.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.76 92.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.748 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -26.78 63.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.139 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.462 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.7 m-85 -82.08 -52.0 7.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.229 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.0 t -59.51 -37.95 79.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.25 -33.05 59.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.278 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.09 95.31 39.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.509 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.46 134.12 15.14 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.553 2.169 . . . . 0.0 112.223 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 56.09 27.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.494 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.642 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.9 OUTLIER -101.0 -164.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 0.0 111.248 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.692 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 m -117.74 113.51 21.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.32 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.0 t -108.71 151.03 11.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 111.983 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.81 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.99 141.79 51.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.963 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.062 HG13 HG13 ' A' ' 49' ' ' VAL . 10.1 t -140.3 166.9 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.527 ' N ' HG12 ' A' ' 105' ' ' VAL . 3.1 t60 -66.76 156.1 36.37 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.441 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.514 ' N ' ' O ' ' A' ' 25' ' ' THR . 49.8 t -68.34 106.05 2.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.314 0.578 . . . . 0.0 112.457 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.871 HG13 HD12 ' A' ' 24' ' ' ILE . 28.8 m -75.2 0.21 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.097 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.65 -8.63 3.03 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.47 -131.31 3.67 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.402 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 14.0 mt -124.42 127.42 47.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.75 -151.49 6.5 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.33 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.808 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.19 -21.26 5.95 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 111.805 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.663 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -51.28 -46.42 89.46 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.751 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.2 Cg_endo -52.02 -48.51 21.24 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.2 1.934 . . . . 0.0 112.978 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.837 HG12 HD11 ' A' ' 120' ' ' LEU . 25.5 t -60.1 -41.09 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.67 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.507 HD12 ' CG2' ' A' ' 49' ' ' VAL . 13.0 mt -60.24 -45.25 93.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.531 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.673 ' CG2' HG11 ' A' ' 105' ' ' VAL . 38.2 t -57.34 -55.14 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.749 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.72 -51.74 59.15 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.264 0.554 . . . . 0.0 110.94 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.897 ' HB3' HD21 ' A' ' 88' ' ' LEU . 6.7 mt -55.27 -30.48 60.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.16 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.917 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.93 -40.08 69.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 110.148 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.631 HD13 ' CE ' ' A' ' 20' ' ' MET . 6.4 tp -71.26 -14.36 62.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 1.001 HD11 HD21 ' A' ' 152' ' ' LEU . 2.8 mt -57.2 -30.7 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.661 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -16.61 63.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.9 p -79.53 -23.39 42.91 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.55 -96.66 0.17 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.805 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.528 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 1.4 ptt? -64.0 72.61 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.941 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.16 -67.61 0.42 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.596 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.8 t80 -67.73 -32.68 73.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 111.046 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 127' ' ' MET . 12.1 mp0 -72.29 -51.91 18.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.321 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 46.8 t0 -67.12 -39.78 86.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 111.043 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.749 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -59.43 -50.0 75.63 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.203 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 35.6 mm -73.94 -36.28 44.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.645 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.22 -49.51 23.09 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.836 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.37 -36.91 74.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.627 0.251 . . . . 0.0 110.793 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.5 tt -74.22 -28.23 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.815 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 8.0 ttm180 -68.35 -47.92 66.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.818 0.342 . . . . 0.0 110.399 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -59.89 -45.02 93.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.443 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.733 ' CE ' HG11 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -84.7 151.73 24.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.319 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.6 116.48 14.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.063 0.459 . . . . 0.0 110.667 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -115.39 163.47 15.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.844 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.402 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -55.07 -176.78 0.15 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.247 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.05 98.75 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.772 0.786 . . . . 0.0 110.751 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.63 HD12 HD21 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -88.94 109.68 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.972 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -112.88 -76.71 0.58 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.397 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.747 ' O ' HG22 ' A' ' 150' ' ' THR . 4.8 p -99.77 -60.79 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.738 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.8 tmtt? -49.04 -51.44 31.1 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -177.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.543 ' HG3' HG21 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -56.29 -51.67 67.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.63 HD21 HD12 ' A' ' 144' ' ' ILE . 3.4 mm? -75.27 -39.37 59.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 146' ' ' SER . 12.3 t -74.12 -36.25 64.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.577 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.738 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -70.16 -50.68 37.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.193 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -67.11 -35.08 79.0 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.216 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.1 -43.58 82.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -25.24 65.27 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.336 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.715 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -66.11 -32.53 74.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.373 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.747 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.725 0.297 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HB3' HG23 ' A' ' 25' ' ' THR . 60.8 Cg_endo -73.09 165.2 33.38 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.628 2.219 . . . . 0.0 112.327 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 t -141.07 126.96 19.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.671 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -109.6 116.99 32.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.974 0.416 . . . . 0.0 111.607 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.835 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -107.06 118.6 55.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.603 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.6 p -140.78 144.76 35.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.97 0.414 . . . . 0.0 111.72 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.594 ' CD2' ' HE2' ' A' ' 127' ' ' MET . 0.2 OUTLIER -142.46 122.71 13.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.467 179.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 16.0 mmtt 84.12 -88.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.274 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -129.41 -40.46 1.43 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.733 0.302 . . . . 0.0 111.763 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.516 ' HE1' HD12 ' A' ' 122' ' ' LEU . 10.2 ptm -73.77 162.83 28.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.23 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -143.34 164.04 31.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.121 0.486 . . . . 0.0 111.5 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.768 ' CE1' HG11 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -135.35 142.37 45.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.892 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -114.67 136.44 53.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.061 0.458 . . . . 0.0 110.939 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.889 HD13 ' HB ' ' A' ' 105' ' ' VAL . 14.4 mm -118.3 106.46 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.37 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -134.55 165.34 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.218 0.533 . . . . 0.0 112.008 -179.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.478 ' CA ' ' HB2' ' A' ' 107' ' ' CYS . 48.6 p-80 -81.4 152.09 27.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.454 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -62.89 154.73 74.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.679 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.5 Cg_exo -54.64 139.93 76.27 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.187 1.925 . . . . 0.0 113.171 -177.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -98.69 174.31 6.47 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.108 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.475 ' H ' HG22 ' A' ' 29' ' ' THR . 3.6 t-20 -93.78 -10.7 33.32 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.84 14.74 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.3 p -139.62 89.73 2.35 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.403 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.457 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.29 -52.22 7.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.077 0.465 . . . . 0.0 111.228 178.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.442 ' O ' HG13 ' A' ' 37' ' ' ILE . 2.7 p -57.55 -45.8 84.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.33 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 m -57.72 -31.98 66.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.851 0.357 . . . . 0.0 111.187 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.721 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.39 -47.78 25.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.861 HG21 ' HB3' ' A' ' 63' ' ' LYS . 10.9 pt -55.64 -38.85 51.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 110.609 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.19 -51.4 58.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.486 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.565 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -68.27 -50.19 55.41 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.87 0.367 . . . . 0.0 111.989 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.721 HD21 ' CE1' ' A' ' 36' ' ' PHE . 85.6 mt -55.7 -45.52 77.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.481 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.98 -26.57 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.02 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 12.2 mttt -52.49 -44.56 65.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.358 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.066 ' CD1' HD21 ' A' ' 23' ' ' LEU . 11.0 t80 -63.45 -38.43 91.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.664 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.682 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 162.99 -178.41 38.71 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.921 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.52 19.76 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.676 HG22 ' H ' ' A' ' 47' ' ' THR . 1.3 m -164.9 -170.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.833 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.676 ' H ' HG22 ' A' ' 46' ' ' THR . 2.6 t -64.51 159.64 21.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.355 0.598 . . . . 0.0 110.456 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.791 HG13 ' O ' ' A' ' 104' ' ' ALA . 57.7 t -138.48 138.83 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.322 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.09 HG13 HG13 ' A' ' 105' ' ' VAL . 12.4 p -115.57 104.71 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.261 0.553 . . . . 0.0 110.816 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -114.56 110.79 20.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.322 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.802 HG13 ' HB3' ' A' ' 71' ' ' TRP . 6.3 t -107.17 90.95 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.421 0.629 . . . . 0.0 109.376 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.3 p -158.02 171.38 20.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.938 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -66.45 130.41 43.11 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 m -76.0 122.35 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -120.15 -47.66 2.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.44 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.425 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -130.63 83.88 2.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.708 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.09 -36.54 40.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -79.51 -48.57 13.66 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.437 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.34 -54.13 19.75 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 8.1 Cg_exo -73.26 -34.67 5.82 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.623 2.216 . . . . 0.0 113.48 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.968 HD21 HG11 ' A' ' 68' ' ' VAL . 2.1 mm? -71.09 -45.19 64.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.21 -28.86 60.13 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.861 ' HB3' HG21 ' A' ' 37' ' ' ILE . 5.6 mmtm -79.04 -36.63 40.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' O ' HG13 ' A' ' 66' ' ' ILE . 3.8 m-20 -101.57 -12.4 18.51 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.03 23.95 6.06 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.285 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 64' ' ' ASP . 24.6 mt -92.82 147.38 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 110.927 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' THR . 82.2 p -78.69 129.19 34.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.968 HG11 HD21 ' A' ' 61' ' ' LEU . 5.9 p -145.16 154.44 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.2 0.524 . . . . 0.0 112.123 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.51 HG22 ' HG ' ' A' ' 90' ' ' LEU . 3.2 t -103.75 133.59 47.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.108 178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.99 106.78 18.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.139 0.495 . . . . 0.0 110.396 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.889 ' CH2' HG12 ' A' ' 83' ' ' VAL . 4.4 m95 -111.91 104.27 55.91 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.049 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo . . . . . 0 N--CA 1.448 -1.198 0 C-N-CA 123.162 2.575 . . . . 0.0 112.645 -179.586 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.099 0 CA-C-O 120.503 0.192 . . . . 0.0 110.977 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.889 HG12 ' CH2' ' A' ' 71' ' ' TRP . 40.1 t -56.98 -47.8 82.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 151' ' ' TYR . 54.4 t -55.22 -40.87 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.817 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.582 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.7 mt-10 -57.3 -31.39 65.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.532 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.04 -50.46 68.33 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.257 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.745 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.08 -29.9 70.32 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 120' ' ' LEU . 8.7 mt -62.46 -38.61 90.47 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.312 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.57 -43.78 79.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.036 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.51 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.4 tm? -60.47 -51.29 70.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.603 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.491 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 10.2 p -69.14 -35.9 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -57.3 -46.38 83.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.756 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.5 84.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -26.58 64.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.241 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.543 ' CE1' HG21 ' A' ' 103' ' ' VAL . 3.8 m-30 -81.99 -50.88 8.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.25 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 51.4 t -59.88 -38.04 81.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.921 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -76.21 -33.09 59.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.96 90.21 50.76 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.425 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.12 135.77 25.71 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.879 2.386 . . . . 0.0 112.231 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.07 55.39 30.91 Favored Glycine 0 C--N 1.329 0.154 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.696 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.577 ' HB2' HG21 ' A' ' 46' ' ' THR . 4.5 m -101.3 -163.46 1.02 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.25 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.682 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.0 m -119.34 113.87 21.48 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.319 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.768 HG11 ' CE1' ' A' ' 22' ' ' PHE . 38.1 t -109.2 151.0 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.791 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -120.65 145.12 47.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.224 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.09 HG13 HG13 ' A' ' 49' ' ' VAL . 4.0 t -140.31 166.78 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.786 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 3.4 t60 -67.29 155.52 38.68 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.018 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.55 ' N ' ' O ' ' A' ' 25' ' ' THR . 38.5 t -69.0 98.36 0.95 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.506 0.67 . . . . 0.0 112.37 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.844 HG23 HD12 ' A' ' 24' ' ' ILE . 2.7 t -75.76 1.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.854 -1.067 . . . . 0.0 112.347 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.42 -8.62 1.87 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.86 -120.62 2.55 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.424 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 8.3 mt -126.46 127.29 45.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.91 -154.34 7.47 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.839 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.509 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.25 -17.65 7.06 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.082 0.468 . . . . 0.0 111.834 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.878 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -51.44 -46.21 90.22 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 9.4 Cg_endo -52.11 -48.51 21.27 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.491 2.128 . . . . 0.0 113.303 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.737 ' O ' HD23 ' A' ' 120' ' ' LEU . 24.0 t -61.64 -44.6 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.029 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.785 HD12 ' CG2' ' A' ' 49' ' ' VAL . 2.3 mt -59.66 -46.06 90.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.573 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.654 ' CG2' HG11 ' A' ' 105' ' ' VAL . 97.5 t -56.44 -55.19 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.645 0.26 . . . . 0.0 111.562 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.615 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.76 -48.61 66.65 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.181 0.515 . . . . 0.0 110.835 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 116' ' ' VAL . 3.3 mm? -56.88 -30.87 64.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.588 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.745 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -70.92 -34.23 71.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.4 . . . . 0.0 110.092 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.734 HD23 ' OD2' ' A' ' 131' ' ' ASP . 1.4 tp -75.32 -16.66 60.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.528 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.917 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.9 mt -57.28 -30.66 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.179 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.409 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 10.6 pt-20 -73.81 -16.72 61.14 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.3 t -79.49 -23.29 43.08 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.66 -97.6 0.18 Allowed Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.576 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.594 ' HE2' ' CD2' ' A' ' 17' ' ' TYR . 1.1 ptt? -63.03 73.61 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.917 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.03 -67.58 0.42 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.592 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.2 t80 -69.33 -32.3 71.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.042 0.448 . . . . 0.0 110.914 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.28 -50.44 27.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.36 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.734 ' OD2' HD23 ' A' ' 122' ' ' LEU . 43.3 t0 -67.59 -37.17 82.19 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.615 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -61.05 -50.2 74.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.991 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 129' ' ' TYR . 24.6 mm -72.8 -38.45 57.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 111.681 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -49.6 22.9 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.835 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.64 -34.11 71.71 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.864 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.9 OUTLIER -74.07 -30.64 27.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.798 0.332 . . . . 0.0 110.393 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -65.42 -48.95 71.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.29 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -59.93 -45.1 93.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.593 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -83.19 151.89 25.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.637 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 117.46 14.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.6 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.482 ' HG3' HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -114.44 163.17 15.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.968 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -61.02 -157.49 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.274 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.43 98.71 11.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.568 0.684 . . . . 0.0 110.461 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.739 HG23 ' CB ' ' A' ' 148' ' ' GLN . 61.4 mt -88.71 109.0 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.058 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -113.87 -77.74 0.58 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.854 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.5 p -101.13 -60.95 1.43 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.831 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.2 tmtt? -48.99 -52.06 27.07 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.739 ' CB ' HG23 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -56.2 -51.82 66.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.431 ' CD2' ' CG2' ' A' ' 144' ' ' ILE . 3.1 mm? -73.24 -47.0 46.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.5 m -66.92 -37.24 83.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.831 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -67.89 -50.92 53.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.319 -179.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.835 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -70.71 -31.32 68.15 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.344 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 1.2 tt0 -59.14 -39.02 81.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -29.17 64.78 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.448 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.711 ' HE2' HD12 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -66.06 -30.17 70.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.665 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.743 0.306 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.544 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 56.3 Cg_endo -70.38 152.67 66.22 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.565 2.176 . . . . 0.0 112.386 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.478 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.5 t -144.07 127.64 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.903 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -110.71 116.8 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.805 0.336 . . . . 0.0 111.353 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.787 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -106.72 118.33 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.1 p -141.2 142.84 33.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.643 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 1.4 p90 -134.51 170.21 16.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.113 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 43.63 -96.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.053 0.141 . . . . 0.0 111.167 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.402 ' H ' ' CG ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -128.92 -30.78 2.21 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.76 ' HE1' HD11 ' A' ' 122' ' ' LEU . 3.9 ppp? -73.74 169.13 17.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.687 0.28 . . . . 0.0 111.23 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -147.94 161.23 41.74 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.979 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.839 ' CD2' HG13 ' A' ' 118' ' ' VAL . 1.3 m-85 -134.11 150.72 51.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.377 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -121.13 136.36 54.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.122 0.487 . . . . 0.0 111.557 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.916 HD12 HG13 ' A' ' 108' ' ' VAL . 1.9 mm -118.19 106.58 20.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.13 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -134.78 166.99 21.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.287 0.565 . . . . 0.0 111.745 -178.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 36' ' ' PHE . 49.1 p-80 -81.33 152.03 27.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.103 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -62.88 154.53 75.66 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.043 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.7 Cg_exo -54.77 138.91 77.5 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.389 2.059 . . . . 0.0 113.312 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.44 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 28.9 p -98.72 174.41 6.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.231 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -93.79 -9.73 36.53 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.59 -30.81 14.77 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -139.62 89.58 2.33 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.274 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.44 -52.27 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.138 0.494 . . . . 0.0 111.174 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.433 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.1 p -58.49 -45.21 89.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.162 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 m -57.99 -32.78 68.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.9 0.381 . . . . 0.0 111.339 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.691 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.51 -48.11 29.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.148 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.751 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.0 pt -56.08 -39.15 56.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.265 0.555 . . . . 0.0 110.645 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.3 -50.9 63.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.513 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -69.63 -50.13 47.26 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.887 0.375 . . . . 0.0 111.813 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.691 HD21 ' CE1' ' A' ' 36' ' ' PHE . 53.0 mt -56.19 -44.19 79.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.305 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -78.89 -26.75 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.021 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -52.92 -43.48 66.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.29 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.066 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.6 t80 -63.41 -38.4 90.99 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.663 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.682 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 166.31 -177.43 41.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.793 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.56 117.47 19.62 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.706 HG22 ' H ' ' A' ' 47' ' ' THR . 1.4 m -165.25 -169.93 1.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.687 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.721 ' HA ' HG23 ' A' ' 67' ' ' THR . 5.1 p -64.81 144.49 57.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.572 0.701 . . . . 0.0 110.448 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.956 HG21 HD12 ' A' ' 66' ' ' ILE . 61.0 t -122.18 128.14 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.868 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.041 HG13 HG13 ' A' ' 105' ' ' VAL . 2.1 p -115.44 105.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.355 0.597 . . . . 0.0 111.692 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -113.89 111.02 21.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.737 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.823 HG11 ' HB2' ' A' ' 113' ' ' ARG . 38.8 t -101.22 92.38 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.498 0.666 . . . . 0.0 110.405 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.18 171.46 20.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.072 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -64.62 130.7 44.62 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 m -68.73 122.05 19.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.553 HG22 ' CE1' ' A' ' 56' ' ' TYR . 6.5 m -120.45 -47.0 2.36 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.143 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.553 ' CE1' HG22 ' A' ' 55' ' ' THR . 2.8 m-85 -129.79 84.89 2.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.362 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.411 ' HA ' ' NH2' ' A' ' 50' ' ' ARG . 6.0 p-10 -78.21 -35.64 48.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -78.81 -48.49 14.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.41 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -46.45 -51.24 36.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 47.5 Cg_exo -57.13 -42.33 64.62 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.242 . . . . 0.0 113.83 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.73 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -71.21 -45.47 63.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -49.12 19.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.751 ' HB3' HG21 ' A' ' 37' ' ' ILE . 28.1 mmtt -74.46 -26.86 60.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.46 ' CG ' HD11 ' A' ' 66' ' ' ILE . 3.1 t0 -99.92 -11.57 20.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.54 25.98 3.49 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.14 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.956 HD12 HG21 ' A' ' 48' ' ' VAL . 4.7 pt -122.76 148.73 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.601 0.239 . . . . 0.0 110.573 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.721 HG23 ' HA ' ' A' ' 47' ' ' THR . 10.3 t -77.15 132.87 39.03 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.73 HG12 ' CD2' ' A' ' 61' ' ' LEU . 8.0 p -139.71 149.38 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.155 0.502 . . . . 0.0 111.984 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.446 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.8 t -103.3 131.6 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.91 106.63 17.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.585 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.888 ' CH2' HG12 ' A' ' 83' ' ' VAL . 4.4 m95 -110.22 103.46 53.86 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.555 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 N--CA 1.445 -1.372 0 C-N-CA 123.538 2.825 . . . . 0.0 112.882 -178.866 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 5.7 tmtp? . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.609 0.242 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.888 HG12 ' CH2' ' A' ' 71' ' ' TRP . 42.1 t -56.56 -46.71 82.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG21 ' NZ ' ' A' ' 147' ' ' LYS . 89.3 t -56.08 -40.37 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.039 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 2.0 mt-10 -58.2 -31.44 67.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.746 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.72 -50.74 63.72 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.498 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.856 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.03 -28.9 69.21 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.715 HD21 ' HB3' ' A' ' 120' ' ' LEU . 11.3 mt -64.74 -38.5 91.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.228 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.8 m -66.93 -39.99 87.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.994 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.502 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.6 tm? -63.44 -51.3 66.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.874 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.675 HG21 ' HB1' ' A' ' 121' ' ' ALA . 13.5 p -69.76 -43.42 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.457 ' N ' HG13 ' A' ' 91' ' ' VAL . 21.2 mttm -60.82 -34.76 75.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.393 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.2 -47.96 72.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.418 ' HE2' HG21 ' A' ' 67' ' ' THR . 9.4 mptt -74.6 -25.59 59.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.652 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 3.3 m-85 -82.02 -34.48 29.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.992 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.1 t -72.26 -46.4 56.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -76.35 -33.36 58.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.35 141.99 41.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.91 159.32 53.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.406 2.071 . . . . 0.0 112.125 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.09 90.75 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -81.44 -83.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.68 0.276 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.682 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.6 m -153.26 113.05 3.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.792 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.652 HG21 ' HZ ' ' A' ' 95' ' ' PHE . 23.5 t -108.07 151.21 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.694 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.4 140.45 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.27 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.041 HG13 HG13 ' A' ' 49' ' ' VAL . 2.5 t -139.6 166.79 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.612 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.637 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.0 t60 -67.16 156.27 36.64 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.52 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -68.06 105.07 1.93 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.916 HG13 HD12 ' A' ' 24' ' ' ILE . 29.8 m -75.28 -0.02 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.025 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.72 -8.72 3.17 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.93 -136.32 4.68 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 13.0 mt -120.9 127.46 51.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.74 -147.42 5.22 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.374 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.823 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.24 -20.01 6.32 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.907 0.384 . . . . 0.0 111.89 -178.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.666 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -52.64 -46.56 95.87 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.817 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.5 Cg_endo -52.1 -48.31 22.31 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.264 1.976 . . . . 0.0 112.73 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.68 ' O ' HD23 ' A' ' 120' ' ' LEU . 39.0 t -60.95 -44.47 98.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.917 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.463 HD12 ' CG2' ' A' ' 51' ' ' VAL . 9.4 mt -58.12 -45.31 87.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.212 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.934 ' CG2' HG11 ' A' ' 105' ' ' VAL . 94.9 t -55.0 -55.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.776 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.669 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -56.36 -49.25 74.95 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.147 0.499 . . . . 0.0 110.748 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.715 ' HB3' HD21 ' A' ' 88' ' ' LEU . 2.7 mm? -53.91 -30.91 48.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.732 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.856 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -69.58 -43.32 73.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.05 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.782 HD23 ' OD2' ' A' ' 131' ' ' ASP . 0.7 OUTLIER -66.98 -15.63 63.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.757 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.919 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.6 mt -57.04 -30.64 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -72.45 -17.02 61.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.424 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.5 m -84.54 11.25 9.09 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 113.79 -99.5 0.98 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.763 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.482 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.0 ptt? -62.45 79.73 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.919 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.9 -67.69 0.54 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.619 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.2 t80 -67.33 -32.05 72.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.959 0.409 . . . . 0.0 111.001 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.37 -52.04 17.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.25 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.782 ' OD2' HD23 ' A' ' 122' ' ' LEU . 32.3 t0 -68.24 -38.13 81.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.816 0.341 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.669 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -60.04 -49.98 75.54 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.007 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.4 mm -73.67 -37.61 49.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -74.17 -49.6 22.92 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.787 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.57 -35.8 73.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.583 0.23 . . . . 0.0 110.902 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.4 tt -74.14 -29.26 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.395 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -66.31 -48.44 70.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.477 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -44.94 93.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.443 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -82.81 152.25 25.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.29 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 117.25 14.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.503 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -114.53 163.54 15.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.01 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.416 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -59.15 -164.08 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.485 -0.865 . . . . 0.0 111.173 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.06 98.96 11.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.709 0.755 . . . . 0.0 110.745 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.768 HD13 HD21 ' A' ' 149' ' ' LEU . 1.6 pp -88.48 109.03 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.074 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -113.45 -77.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.456 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.4 m -100.27 -60.7 1.48 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.822 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.5 tmtt? -53.19 -51.8 60.91 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.642 ' HG3' HG22 ' A' ' 144' ' ' ILE . 3.7 tm0? -56.03 -52.03 65.68 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.768 HD21 HD13 ' A' ' 144' ' ' ILE . 3.6 mm? -75.04 -45.3 42.56 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.4 m -67.09 -35.0 78.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.629 0.252 . . . . 0.0 111.622 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.822 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -69.51 -50.87 41.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.387 -179.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.831 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -69.47 -32.25 71.04 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.323 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 51.3 tt0 -59.73 -39.55 85.08 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -27.46 63.52 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.585 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.651 ' HE2' HD12 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -66.23 -33.77 76.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.621 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.662 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.634 0.254 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.02 165.16 33.55 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.538 2.159 . . . . 0.0 112.368 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.93 126.83 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.534 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.55 ' HB3' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -116.82 136.01 53.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.015 0.436 . . . . 0.0 111.898 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.682 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.8 137.02 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.12 129.3 37.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.245 0.545 . . . . 0.0 111.963 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.447 ' CE1' ' HE1' ' A' ' 127' ' ' MET . 25.7 t80 -145.57 132.74 20.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.268 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 64.08 -103.49 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.204 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.4 14.04 6.07 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.521 ' HE2' HD21 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -119.26 169.0 10.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.775 0.322 . . . . 0.0 110.96 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.8 mtm-85 -141.79 164.08 31.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.122 0.486 . . . . 0.0 111.733 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.502 ' HE1' HG11 ' A' ' 103' ' ' VAL . 3.9 m-85 -134.59 150.19 50.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.872 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.062 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -126.21 135.49 51.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 111.143 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.846 HD12 HG23 ' A' ' 108' ' ' VAL . 10.9 mm -118.33 106.27 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.554 HG21 HD23 ' A' ' 40' ' ' LEU . 1.2 p -131.07 163.74 26.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.197 0.522 . . . . 0.0 111.756 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.527 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.5 p80 -81.24 152.44 27.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.261 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.38 154.81 70.29 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.802 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 51.8 Cg_exo -53.89 136.6 66.73 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.32 2.013 . . . . 0.0 113.15 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.53 143.53 28.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.21 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -64.79 -12.78 51.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.338 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -31.31 14.59 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.4 p -139.97 88.8 2.26 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.282 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.89 -52.28 7.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.259 0.552 . . . . 0.0 111.256 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.466 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.3 m -56.84 -46.36 81.76 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.624 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -57.58 -31.9 66.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.961 0.41 . . . . 0.0 111.145 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.704 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.85 -47.59 29.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.175 -179.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.904 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.6 pt -55.62 -39.06 52.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.136 0.493 . . . . 0.0 110.605 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -65.18 -52.03 57.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.51 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.536 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 2.4 m-20 -67.99 -50.15 57.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.902 0.382 . . . . 0.0 111.935 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.704 HD21 ' CE1' ' A' ' 36' ' ' PHE . 74.2 mt -55.84 -45.2 78.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.556 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.8 tttm -77.34 -26.71 52.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.085 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.2 mttt -53.04 -44.99 67.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.217 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.062 ' CD1' HD21 ' A' ' 23' ' ' LEU . 11.5 t80 -63.57 -38.32 90.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.748 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.675 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 161.05 -177.74 37.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.934 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.67 122.33 27.17 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.848 HG22 ' H ' ' A' ' 47' ' ' THR . 4.1 m -164.54 -171.39 2.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.513 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.848 ' H ' HG22 ' A' ' 46' ' ' THR . 1.7 t -65.44 162.22 18.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.816 HG13 ' O ' ' A' ' 104' ' ' ALA . 91.8 t -138.01 137.99 44.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.834 HG12 HG22 ' A' ' 105' ' ' VAL . 11.2 p -115.23 104.2 16.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.421 0.629 . . . . 0.0 111.002 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.22 110.98 20.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.05 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.828 HG13 ' HB3' ' A' ' 71' ' ' TRP . 6.1 t -105.8 91.26 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.462 0.649 . . . . 0.0 109.704 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 t -157.87 171.29 20.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.911 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -67.61 130.45 43.08 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 54' ' ' VAL . 34.7 m -74.83 122.48 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.4 p -120.16 -47.66 2.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.376 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.449 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -130.56 83.34 2.11 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.457 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.17 -36.38 40.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -79.06 -48.55 14.17 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -43.91 -60.22 2.9 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.61 -34.31 15.35 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.551 2.167 . . . . 0.0 113.871 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.037 HD21 HG11 ' A' ' 68' ' ' VAL . 1.6 mm? -71.13 -45.19 64.08 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -75.1 -29.37 60.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.904 ' HB3' HG21 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -81.09 -33.8 33.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.23 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.539 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -101.31 -12.41 18.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.11 24.19 4.48 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.473 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 64' ' ' ASP . 12.7 mt -96.4 147.47 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.946 0.373 . . . . 0.0 110.835 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 47' ' ' THR . 3.4 m -78.47 132.57 37.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.037 HG11 HD21 ' A' ' 61' ' ' LEU . 7.5 p -145.05 152.78 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.337 0.589 . . . . 0.0 112.125 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.83 130.54 54.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.001 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.09 106.84 18.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.082 0.468 . . . . 0.0 111.044 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.828 ' HB3' HG13 ' A' ' 51' ' ' VAL . 5.5 m95 -109.35 103.9 53.82 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.51 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 N--CA 1.446 -1.266 0 C-N-CA 123.262 2.642 . . . . 0.0 112.94 -179.185 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.647 0.26 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 84' ' ' VAL . 31.2 m -58.65 -44.4 89.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.707 HG22 ' CD1' ' A' ' 120' ' ' LEU . 0.8 OUTLIER -53.42 -39.41 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.229 0.538 . . . . 0.0 109.591 178.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.63 -31.35 70.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.726 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.04 -50.88 64.5 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.712 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -68.86 -34.76 75.99 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.785 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.705 HD21 ' HB3' ' A' ' 120' ' ' LEU . 10.2 mt -55.17 -43.67 74.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.411 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -40.6 82.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.316 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.416 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.2 tm? -58.39 -51.35 70.18 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.9 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.065 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.2 p -73.9 -36.06 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.878 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 -44.06 64.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.934 0.397 . . . . 0.0 110.597 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.08 -43.6 57.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.951 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.721 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.7 OUTLIER -64.74 -27.62 69.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.263 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.06 -40.71 21.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 111.0 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 7.2 t -67.0 -46.05 75.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -76.1 -33.04 59.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.08 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -109.37 87.99 5.63 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.293 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.27 115.91 4.04 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.584 2.189 . . . . 0.0 112.363 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.15 52.14 19.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 t -101.17 -174.16 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.62 0.247 . . . . 0.0 111.179 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.675 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 3.1 m -112.94 114.12 26.48 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.502 HG11 ' HE1' ' A' ' 22' ' ' PHE . 16.3 t -106.81 151.28 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.816 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -121.33 145.7 47.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.643 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.834 HG22 HG12 ' A' ' 49' ' ' VAL . 97.5 t -139.86 166.25 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.659 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 3.0 t60 -67.81 155.43 39.36 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.825 0.345 . . . . 0.0 110.725 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.541 ' N ' ' O ' ' A' ' 25' ' ' THR . 43.7 t -69.36 104.23 2.21 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.846 HG23 HD12 ' A' ' 24' ' ' ILE . 3.0 t -75.73 1.39 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.417 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.16 -8.37 1.54 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.73 -121.32 2.62 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 111' ' ' LEU . 7.8 mt -132.12 127.32 35.74 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.13 -154.48 7.55 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.146 -1.025 . . . . 0.0 113.255 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.572 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.37 -15.12 7.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.91 0.386 . . . . 0.0 111.943 -178.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.77 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -53.34 -46.79 97.79 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 10.1 Cg_endo -52.98 -48.1 23.97 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.352 2.035 . . . . 0.0 112.446 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.525 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 41.8 t -55.84 -53.23 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.859 0.362 . . . . 0.0 110.479 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.819 HD12 ' CG2' ' A' ' 49' ' ' VAL . 2.7 mt -54.44 -48.76 71.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.773 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 114' ' ' ALA . 17.0 t -51.28 -49.71 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 111.354 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.706 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -55.91 -45.26 78.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.668 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.785 HD13 ' OH ' ' A' ' 151' ' ' TYR . 0.5 OUTLIER -57.54 -30.88 65.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.766 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 1.065 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.05 -44.76 62.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.939 0.4 . . . . 0.0 110.597 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.723 HD13 ' OD2' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -69.63 -15.9 63.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.791 179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 1.068 HD11 HD21 ' A' ' 152' ' ' LEU . 1.3 mt -57.77 -41.72 80.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.871 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.52 -15.81 3.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.45 ' OG ' HD23 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -80.83 11.24 4.06 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 117.79 -88.08 0.44 Allowed Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.307 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.532 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.97 79.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.288 0.566 . . . . 0.0 109.662 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.91 ' CB ' HG23 ' A' ' 123' ' ' ILE . 20.9 mttm -62.61 -68.08 0.36 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.005 -177.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 152' ' ' LEU . 7.1 t80 -74.34 -30.47 62.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.229 0.537 . . . . 0.0 110.499 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -72.57 -47.15 50.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.107 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.723 ' OD2' HD13 ' A' ' 122' ' ' LEU . 50.8 t0 -68.88 -47.23 66.39 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.349 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.755 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -59.07 -50.16 75.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.941 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 35.4 mm -72.44 -36.18 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -74.21 -49.56 22.9 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.682 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.69 -37.5 76.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 110.815 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 132' ' ' ALA . 3.3 tt -74.44 -28.55 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.464 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 0.9 OUTLIER -69.51 -46.73 65.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.944 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -41.52 91.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.118 0.485 . . . . 0.0 110.027 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -87.14 152.64 22.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.154 179.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.38 117.81 14.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.112 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -114.19 163.66 14.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.234 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -57.95 -163.36 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.946 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.17 100.18 13.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.156 0.478 . . . . 0.0 111.51 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.637 HG22 ' NE2' ' A' ' 148' ' ' GLN . 0.1 OUTLIER -87.91 109.17 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.482 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.65 -77.52 0.58 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.544 ' O ' HG22 ' A' ' 150' ' ' THR . 14.6 m -100.48 -61.41 1.37 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 8.8 tmtt? -64.29 -46.39 83.85 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -176.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.637 ' NE2' HG22 ' A' ' 144' ' ' ILE . 0.9 OUTLIER -56.23 -52.13 65.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -176.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 149' ' ' LEU . 2.2 mm? -75.35 -37.19 60.81 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.963 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.618 HG22 ' HA ' ' A' ' 147' ' ' LYS . 5.1 t -71.76 -37.11 70.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.844 0.355 . . . . 0.0 110.968 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.799 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.85 -50.56 64.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.643 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.068 HD21 HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -66.7 -31.64 72.44 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.643 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.82 -37.45 84.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -23.0 55.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.883 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.493 ' CB ' HD23 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -66.22 -43.84 85.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.507 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 48.0 ttt85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.607 179.582 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.747 0.308 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.26 165.14 32.51 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.99 126.85 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -106.89 132.64 52.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.448 . . . . 0.0 111.657 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.811 HG12 ' CE2' ' A' ' 135' ' ' PHE . 2.1 t -106.78 124.78 62.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.224 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.6 p -122.32 140.88 52.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 111.823 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.53 ' CB ' HD21 ' A' ' 122' ' ' LEU . 26.5 t80 -155.25 131.04 9.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.7 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm 59.04 -100.24 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.082 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -129.56 14.09 5.98 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.54 ' CE ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -117.06 164.65 14.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 110.949 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -132.72 164.01 27.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.421 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.677 ' CE1' HG13 ' A' ' 118' ' ' VAL . 1.2 m-85 -142.89 146.22 33.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.847 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.035 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -122.66 136.28 54.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 111.259 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.97 HG21 HG22 ' A' ' 108' ' ' VAL . 5.6 mm -118.49 106.3 19.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.69 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.568 HG21 HD23 ' A' ' 40' ' ' LEU . 1.9 p -132.38 164.79 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.057 0.456 . . . . 0.0 111.506 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.509 ' CD2' ' CZ ' ' A' ' 36' ' ' PHE . 31.3 p-80 -81.46 152.12 27.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.074 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -62.8 154.54 74.99 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.978 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 51.2 Cg_exo -54.03 134.7 61.07 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.425 2.083 . . . . 0.0 113.068 -177.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -98.5 152.96 18.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.267 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -71.81 -11.41 60.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.53 -31.58 14.49 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -140.08 88.75 2.25 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.135 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.527 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -81.07 -52.38 7.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.184 0.516 . . . . 0.0 111.533 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.429 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.6 p -57.2 -46.78 82.57 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.635 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.2 m -57.82 -32.27 67.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.881 0.372 . . . . 0.0 111.255 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.687 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.67 -47.95 28.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.939 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.0 pt -55.93 -39.03 55.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.207 0.527 . . . . 0.0 110.623 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.83 -52.01 59.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.558 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.563 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 3.7 m-20 -68.88 -50.08 52.77 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.929 0.395 . . . . 0.0 111.832 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.687 HD21 ' CE1' ' A' ' 36' ' ' PHE . 53.5 mt -55.92 -45.21 78.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -26.77 48.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.027 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.563 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -53.32 -43.36 67.56 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.367 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.035 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.0 t80 -63.28 -38.65 92.0 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.689 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.647 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.68 -178.38 40.5 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.821 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.56 117.4 19.51 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.775 HG21 ' OG ' ' A' ' 101' ' ' SER . 1.3 m -165.18 -170.41 1.9 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.806 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.684 ' H ' HG22 ' A' ' 46' ' ' THR . 3.6 t -65.09 159.83 22.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.484 0.659 . . . . 0.0 110.617 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.792 HG13 ' O ' ' A' ' 104' ' ' ALA . 60.0 t -136.27 138.15 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.073 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.027 HG13 HG13 ' A' ' 105' ' ' VAL . 14.9 p -115.55 104.65 17.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.551 0.691 . . . . 0.0 111.211 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -115.13 110.79 20.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.251 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.815 HG13 ' HB3' ' A' ' 71' ' ' TRP . 12.9 t -106.62 91.84 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.366 0.603 . . . . 0.0 109.722 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.32 171.42 20.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.719 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -64.69 130.47 43.71 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.61 121.86 19.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -120.66 -47.38 2.32 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.133 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.429 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 9.0 m-85 -130.33 84.62 2.21 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.483 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -78.33 -36.05 46.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -48.55 14.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.615 HG22 ' CD ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -45.14 -49.99 28.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 34.2 Cg_exo -60.93 -40.67 50.82 Favored 'Trans proline' 0 N--CA 1.471 0.193 0 C-N-CA 122.646 2.23 . . . . 0.0 113.605 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.504 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -71.14 -45.05 64.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -49.13 20.18 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.939 ' HB3' HG21 ' A' ' 37' ' ' ILE . 11.4 mttm -76.16 -25.72 55.54 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.446 ' CG ' HD11 ' A' ' 66' ' ' ILE . 2.8 t0 -99.35 -11.48 21.16 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.42 26.85 2.61 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.278 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.446 HD11 ' CG ' ' A' ' 64' ' ' ASP . 4.2 pt -122.54 148.12 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.688 0.28 . . . . 0.0 110.737 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.53 HG23 ' HA ' ' A' ' 47' ' ' THR . 11.0 t -77.83 135.11 37.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.064 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.504 HG12 ' CD2' ' A' ' 61' ' ' LEU . 3.6 p -141.59 154.46 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.277 0.561 . . . . 0.0 111.733 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.404 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.7 t -103.68 131.28 52.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.145 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -100.8 106.81 18.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.201 0.524 . . . . 0.0 110.193 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.884 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.5 m95 -111.26 104.51 56.24 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.447 -1.239 0 C-N-CA 123.204 2.602 . . . . 0.0 112.344 -179.757 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.563 0.22 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.884 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 11.6 t -59.93 -48.23 88.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.529 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 1.1 t -53.52 -38.69 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.227 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.414 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.2 mt-10 -66.45 -31.19 71.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.355 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -63.35 -50.64 69.17 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.551 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.721 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -67.44 -32.64 73.64 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.89 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.788 HD21 ' HB3' ' A' ' 120' ' ' LEU . 13.5 mt -55.93 -48.02 76.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.607 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -41.34 95.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.487 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.435 ' C ' HD13 ' A' ' 90' ' ' LEU . 1.9 tm? -57.68 -51.59 68.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.875 HG21 ' HB1' ' A' ' 121' ' ' ALA . 13.2 p -74.75 -35.82 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.383 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -55.04 -40.95 70.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.963 0.411 . . . . 0.0 110.513 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.28 -46.75 39.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.227 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -62.3 -37.57 86.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.631 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.441 ' HE1' HG23 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -82.02 -33.49 30.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.763 0.316 . . . . 0.0 111.171 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.04 -46.04 58.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -76.1 -31.5 58.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.273 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -117.35 87.25 23.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.479 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.45 136.35 42.8 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.745 2.297 . . . . 0.0 112.168 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 20' ' ' MET . . . 58.12 58.23 15.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.662 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.775 ' OG ' HG21 ' A' ' 46' ' ' THR . 51.8 p -101.2 -169.98 1.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.808 0.337 . . . . 0.0 111.263 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.647 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -123.46 113.67 19.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.091 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.631 HG11 ' CE1' ' A' ' 22' ' ' PHE . 7.4 t -111.98 151.38 14.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.135 0.493 . . . . 0.0 112.323 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.792 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -118.93 145.34 45.85 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.422 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.027 HG13 HG13 ' A' ' 49' ' ' VAL . 7.6 t -140.3 167.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.708 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.605 ' O ' HG23 ' A' ' 24' ' ' ILE . 9.8 t60 -66.87 155.49 38.22 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.498 ' HB2' ' CA ' ' A' ' 26' ' ' HIS . 10.5 t -69.1 122.5 18.89 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.97 HG22 HG21 ' A' ' 24' ' ' ILE . 5.1 m -75.75 -0.2 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.475 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.95 -8.78 3.43 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.99 -156.38 6.8 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.5 mt -92.91 127.27 38.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.83 -169.38 16.61 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.223 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.637 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.22 -24.63 5.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.069 0.461 . . . . 0.0 111.407 -179.252 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -54.48 -43.07 97.5 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.669 ' HG3' HG12 ' A' ' 108' ' ' VAL . 58.4 Cg_exo -52.35 -48.38 22.07 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.844 1.696 . . . . 0.0 111.67 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 91.3 t -55.98 -51.14 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.701 HD12 ' CG2' ' A' ' 49' ' ' VAL . 8.5 mt -51.97 -45.3 64.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.137 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 114' ' ' ALA . 15.9 t -51.81 -53.18 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.951 0.405 . . . . 0.0 110.909 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.601 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -53.5 -43.27 68.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.177 0.513 . . . . 0.0 110.519 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.788 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -58.64 -30.83 67.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.529 179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.875 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.26 -40.38 71.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.115 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.54 HD11 ' CE ' ' A' ' 20' ' ' MET . 0.2 OUTLIER -71.59 -16.68 62.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.734 179.026 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 1.047 HD11 HD21 ' A' ' 152' ' ' LEU . 2.7 mt -57.31 -30.7 36.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.284 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -16.61 62.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.7 m -79.76 -23.34 42.28 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.43 -96.58 0.17 Allowed Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.946 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.528 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 6.1 ptt? -63.87 71.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.938 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.61 -67.37 0.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 6.0 t80 -65.88 -32.42 73.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.894 0.378 . . . . 0.0 111.139 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -72.55 -52.43 15.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.259 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 5.2 t0 -67.05 -36.75 82.74 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 110.486 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.622 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -61.07 -50.42 73.36 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.162 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.9 mm -73.43 -39.3 54.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.569 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -49.97 19.79 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.811 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.28 -37.35 80.59 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.581 -179.31 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.575 HD11 ' C ' ' A' ' 115' ' ' PRO . 0.6 OUTLIER -74.16 -28.72 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.736 0.303 . . . . 0.0 110.407 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -63.8 -44.92 91.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.399 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -45.1 93.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.668 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 136' ' ' ILE . 2.5 mptt -87.08 151.44 23.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.633 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.484 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.93 116.78 14.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 0.0 110.972 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.14 163.21 15.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.81 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.31 -179.99 0.18 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.307 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.09 99.4 4.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.62 0.71 . . . . 0.0 111.015 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.586 HD12 HD21 ' A' ' 149' ' ' LEU . 11.3 pt -88.22 109.53 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.763 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -112.95 -76.62 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.628 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.558 ' O ' HG22 ' A' ' 150' ' ' THR . 0.3 OUTLIER -99.91 -60.93 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.794 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.6 tmtt? -52.49 -51.81 57.6 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.453 ' OE1' HD22 ' A' ' 149' ' ' LEU . 1.3 tm0? -60.23 -51.75 68.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.586 HD21 HD12 ' A' ' 144' ' ' ILE . 3.5 mm? -73.03 -34.77 66.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 146' ' ' SER . 3.9 t -75.29 -40.77 58.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.082 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.794 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -64.03 -50.76 67.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.047 HD21 HD11 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -69.0 -33.82 74.28 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.932 -179.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.22 -38.03 78.95 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -25.43 55.35 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.551 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.58 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -66.43 -31.34 72.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.471 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.427 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.713 0.292 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.78 165.13 33.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.596 2.197 . . . . 0.0 112.265 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.4 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.7 t -137.51 126.99 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.776 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -114.37 128.95 56.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.993 0.425 . . . . 0.0 111.698 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.721 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.87 127.66 62.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.509 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.41 147.63 42.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.119 0.485 . . . . 0.0 111.786 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.547 ' HD2' HD21 ' A' ' 122' ' ' LEU . 26.4 t80 -155.15 117.93 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.642 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 29.2 mmtp 64.28 -95.77 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.408 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.39 13.99 6.07 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.969 ' HE1' HD21 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -121.67 169.05 11.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.754 0.311 . . . . 0.0 110.886 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -145.62 164.03 33.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 111.697 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.707 ' CE1' HG11 ' A' ' 103' ' ' VAL . 3.0 m-85 -134.29 148.9 50.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.561 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -122.48 135.77 54.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.21 0.529 . . . . 0.0 111.334 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.011 HD12 HG13 ' A' ' 108' ' ' VAL . 2.5 mm -118.17 106.58 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.223 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -132.54 165.34 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.286 0.565 . . . . 0.0 111.644 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.52 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.2 p80 -81.1 152.08 28.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -62.83 154.04 77.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.514 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 10.0 Cg_endo -54.38 138.53 73.47 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.64 2.227 . . . . 0.0 113.439 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.441 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -98.93 174.24 6.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.249 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.8 -8.66 30.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.53 -30.67 14.88 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.6 p -139.36 89.62 2.35 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.109 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.441 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.18 -52.18 8.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.19 0.519 . . . . 0.0 111.22 178.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.448 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.6 p -57.8 -45.67 85.75 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.225 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.4 m -57.85 -32.13 67.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.747 0.308 . . . . 0.0 111.276 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.667 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.3 -47.89 25.75 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.148 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.723 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.6 pt -55.66 -39.03 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.179 0.514 . . . . 0.0 110.761 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.32 -51.83 53.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.543 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.559 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.1 m-20 -68.13 -50.12 56.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.838 0.351 . . . . 0.0 111.915 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.667 HD21 ' CE1' ' A' ' 36' ' ' PHE . 87.9 mt -55.8 -46.22 78.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.986 0.422 . . . . 0.0 110.42 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -77.05 -26.63 53.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.102 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -53.13 -44.48 67.77 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.532 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.066 ' CD1' HD21 ' A' ' 23' ' ' LEU . 10.9 t80 -63.56 -38.53 91.48 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.959 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.693 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.93 -178.35 39.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.006 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.53 117.4 19.53 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.831 HG21 ' OG ' ' A' ' 101' ' ' SER . 1.0 OUTLIER -165.19 -169.69 1.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.166 -0.924 . . . . 0.0 108.853 177.416 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.671 ' H ' HG22 ' A' ' 46' ' ' THR . 3.5 p -64.48 146.49 54.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.555 0.693 . . . . 0.0 110.544 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.057 HG22 ' HB3' ' A' ' 104' ' ' ALA . 59.5 t -125.38 132.72 70.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.565 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.822 HG12 HG22 ' A' ' 105' ' ' VAL . 12.9 p -115.41 105.52 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.372 0.606 . . . . 0.0 111.315 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 110.64 20.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.735 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 71' ' ' TRP . 23.0 t -104.08 90.44 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.635 0.731 . . . . 0.0 109.734 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -158.78 171.62 19.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.352 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 1.8 mm-40 -64.95 130.35 43.07 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.58 HG22 ' OD1' ' A' ' 70' ' ' ASP . 16.4 t -77.56 122.63 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 p -120.2 -47.87 2.35 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.169 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.8 83.45 2.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.363 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -79.36 -36.77 38.8 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -79.44 -48.65 13.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.408 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -43.95 -51.66 17.18 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.408 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 12.6 Cg_exo -71.51 -42.62 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.491 2.127 . . . . 0.0 113.973 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.477 HD11 ' O ' ' A' ' 66' ' ' ILE . 2.9 tp -71.44 -45.19 63.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -56.27 -46.47 79.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.723 ' HB3' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -81.21 -20.45 41.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.547 ' OD2' HG22 ' A' ' 37' ' ' ILE . 72.7 m-20 -101.0 -11.52 19.61 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 42.64 52.78 5.36 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.852 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.536 HD12 HG21 ' A' ' 48' ' ' VAL . 4.2 pt -133.01 148.53 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.733 0.302 . . . . 0.0 111.144 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' THR . 73.8 p -78.1 135.21 37.66 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 48' ' ' VAL . 11.2 p -141.75 149.54 19.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -103.55 130.22 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.58 ' OD1' HG22 ' A' ' 54' ' ' VAL . 4.4 t0 -100.72 106.88 18.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.161 0.505 . . . . 0.0 110.474 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.776 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.1 m95 -111.57 103.63 55.28 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.094 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 N--CA 1.447 -1.246 0 C-N-CA 123.64 2.893 . . . . 0.0 112.487 -179.445 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.395 0.14 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.766 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 26.1 t -56.12 -48.1 79.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.491 HG11 ' CE2' ' A' ' 151' ' ' TYR . 86.5 t -55.72 -39.22 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.216 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.508 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.6 mt-10 -59.26 -31.46 69.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.914 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -66.85 -50.84 61.27 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.619 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.714 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -68.23 -26.89 65.92 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.534 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.634 HD13 ' OH ' ' A' ' 155' ' ' TYR . 15.3 mt -63.88 -47.2 81.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.319 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -42.09 98.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.298 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -53.91 -51.37 63.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.795 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 121' ' ' ALA . 8.6 p -72.33 -41.73 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.488 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.419 ' N ' HG13 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -54.56 -38.92 67.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 0.0 110.992 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.42 53.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 3.6 mmtt -73.17 -20.53 60.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.909 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE1' HG23 ' A' ' 91' ' ' VAL . 1.9 m-85 -82.07 -40.71 21.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.9 t -69.1 -42.73 75.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -75.99 -31.19 58.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.106 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -121.68 90.78 48.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.327 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.27 137.38 18.92 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.606 2.204 . . . . 0.0 112.363 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 20' ' ' MET . . . 58.78 57.38 20.19 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.588 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.831 ' OG ' HG21 ' A' ' 46' ' ' THR . 51.5 p -101.22 -168.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.328 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.693 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -120.91 113.44 20.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.053 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.707 HG11 ' CE1' ' A' ' 22' ' ' PHE . 43.8 t -105.46 151.02 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 1.057 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -123.92 139.43 53.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.207 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.822 HG22 HG12 ' A' ' 49' ' ' VAL . 45.1 t -140.12 166.71 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.623 ' N ' HG12 ' A' ' 105' ' ' VAL . 2.7 t60 -66.97 155.97 37.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.381 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 25' ' ' THR . 49.3 t -68.5 106.94 2.72 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.011 HG13 HD12 ' A' ' 24' ' ' ILE . 34.1 m -75.42 0.09 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.022 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.45 -8.72 2.9 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.37 -139.4 5.31 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.543 HD22 ' HA2' ' A' ' 142' ' ' GLY . 11.7 mt -117.93 127.34 53.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.19 -146.28 4.82 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.349 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.7 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.3 -20.94 5.99 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.018 0.437 . . . . 0.0 111.936 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.655 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -51.93 -46.29 92.56 Favored Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.785 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.4 Cg_endo -52.59 -48.65 20.82 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.223 1.948 . . . . 0.0 113.274 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.52 ' O ' HD23 ' A' ' 120' ' ' LEU . 39.4 t -62.25 -41.0 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.079 0.466 . . . . 0.0 110.127 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.477 HD22 ' CD1' ' A' ' 87' ' ' TRP . 6.4 mt -59.06 -41.11 87.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.81 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.77 HG22 HG21 ' A' ' 105' ' ' VAL . 17.6 t -64.15 -55.53 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.65 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -60.32 -53.07 61.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 110.903 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.793 HD13 HD12 ' A' ' 123' ' ' ILE . 3.1 mm? -55.25 -30.31 59.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.038 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.714 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.56 -50.62 24.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 110.614 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.969 HD21 ' HE1' ' A' ' 20' ' ' MET . 0.4 OUTLIER -65.27 -10.09 29.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.586 179.04 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 1.007 HG23 ' CB ' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -56.78 -34.26 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.687 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -62.28 -16.56 54.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.908 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.0 m -79.88 11.06 3.53 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 120.27 -98.8 0.71 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.251 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.49 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 1.1 ptt? -62.61 73.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.36 0.6 . . . . 0.0 109.469 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 1.007 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.9 -68.03 0.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.635 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.3 t80 -68.71 -32.68 72.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.946 0.403 . . . . 0.0 111.186 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.26 -49.44 34.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.479 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 39.2 t0 -70.04 -45.6 66.81 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.914 0.387 . . . . 0.0 111.294 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 152' ' ' LEU . . . -57.84 -49.72 75.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.649 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 33.5 mm -70.29 -40.81 78.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -74.28 -49.8 21.61 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.721 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -67.87 -35.19 78.1 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.937 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.4 tt -74.24 -32.79 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.707 0.289 . . . . 0.0 110.74 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -63.95 -43.05 97.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.714 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -44.69 93.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.46 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.42 ' CE ' HG13 ' A' ' 15' ' ' VAL . 6.7 mptt -86.21 151.84 23.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.256 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.26 117.11 14.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 110.63 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -114.82 163.66 15.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.543 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -57.71 -165.83 0.09 OUTLIER Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.42 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.26 99.22 11.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.589 0.695 . . . . 0.0 111.0 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.642 HD12 HD21 ' A' ' 149' ' ' LEU . 1.4 pt -88.45 109.44 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.809 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -113.14 -76.65 0.58 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -99.78 -60.74 1.47 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.864 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.0 tmtt? -52.83 -51.9 59.13 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.455 ' HG3' HG22 ' A' ' 144' ' ' ILE . 7.1 tm0? -56.59 -51.63 67.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.642 HD21 HD12 ' A' ' 144' ' ' ILE . 4.3 mm? -75.24 -40.94 58.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 m -69.95 -40.53 75.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.933 0.397 . . . . 0.0 111.1 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.864 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -65.46 -50.02 66.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.854 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -65.02 -38.03 89.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.919 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -55.77 -44.0 77.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -24.31 62.83 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.685 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.634 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -66.28 -32.62 74.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.731 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.039 -179.861 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.71 0.29 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.855 ' HB3' HG22 ' A' ' 25' ' ' THR . 57.2 Cg_endo -71.03 165.01 33.77 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.635 2.224 . . . . 0.0 112.443 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.742 HG11 ' HD3' ' A' ' 139' ' ' LYS . 19.5 t -144.02 127.44 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 10.3 pt-20 -110.07 116.73 32.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.816 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.6 OUTLIER -108.01 118.7 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.4 p -140.83 145.26 36.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.715 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -136.4 159.93 40.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.734 178.183 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.622 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 9.4 ptpt 48.64 -103.79 0.11 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -177.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -120.44 -26.68 5.34 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.141 -0.349 . . . . 0.0 111.643 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.752 ' CE ' HD13 ' A' ' 122' ' ' LEU . 5.6 ppp? -73.84 165.71 24.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.654 0.264 . . . . 0.0 111.316 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -147.6 164.05 34.71 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.088 0.471 . . . . 0.0 111.507 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.765 ' CE1' HG13 ' A' ' 118' ' ' VAL . 1.7 m-85 -137.89 146.5 43.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.058 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -119.36 133.61 55.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.988 0.423 . . . . 0.0 110.954 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.043 HD12 HG13 ' A' ' 108' ' ' VAL . 2.1 mm -118.17 106.68 20.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.404 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.855 HG22 ' HB3' ' A' ' 12' ' ' PRO . 60.4 p -131.61 165.52 23.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.283 0.563 . . . . 0.0 111.876 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.52 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.2 p80 -81.25 152.44 27.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.728 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.42 154.38 72.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.442 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.7 Cg_exo -54.2 137.24 70.3 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.472 2.114 . . . . 0.0 113.264 -177.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.63 145.89 26.4 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.197 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -68.58 -11.13 59.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.26 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.5 -31.71 14.46 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -140.12 88.73 2.24 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.064 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.673 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.5 OUTLIER -81.01 -51.9 8.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.106 0.479 . . . . 0.0 111.515 178.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.451 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.9 m -55.77 -45.48 78.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.438 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -57.81 -36.14 71.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.408 . . . . 0.0 111.321 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.645 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -72.92 -47.91 41.58 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.634 HG22 ' OD2' ' A' ' 64' ' ' ASP . 12.1 pt -55.87 -40.06 60.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 110.882 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.67 -52.1 59.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.497 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.54 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.6 OUTLIER -67.62 -50.17 59.36 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.799 0.333 . . . . 0.0 111.807 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.645 HD21 ' CE1' ' A' ' 36' ' ' PHE . 62.9 mt -55.04 -46.29 75.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.614 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -26.77 52.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.2 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.1 mtmt -53.85 -42.33 68.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.382 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.058 ' CD1' HD21 ' A' ' 23' ' ' LEU . 16.8 t80 -63.3 -38.48 91.33 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.933 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.653 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.31 -178.59 40.2 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.885 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.64 117.43 19.49 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.656 HG22 ' H ' ' A' ' 47' ' ' THR . 1.0 OUTLIER -165.18 -170.03 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.732 177.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' THR . 2.5 t -64.58 160.46 19.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.367 0.603 . . . . 0.0 110.502 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 104' ' ' ALA . 57.5 t -138.4 135.74 44.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.226 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.872 HG12 HG22 ' A' ' 105' ' ' VAL . 14.6 p -115.62 104.68 17.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.474 0.654 . . . . 0.0 110.974 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 110.86 20.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.724 178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.835 HG11 ' HB2' ' A' ' 113' ' ' ARG . 25.0 t -108.0 91.6 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.592 0.71 . . . . 0.0 110.141 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.77 171.22 20.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.005 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.91 130.32 43.0 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.22 122.49 26.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -120.2 -47.67 2.36 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.227 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -130.63 83.8 2.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.535 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -78.95 -36.22 41.97 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.09 -48.55 14.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.673 HG21 ' HG ' ' A' ' 33' ' ' LEU . 2.0 m -45.71 -48.32 38.59 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.497 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 8.4 Cg_exo -73.19 -41.19 1.36 Allowed 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.613 2.209 . . . . 0.0 113.503 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.85 HD21 ' CG1' ' A' ' 68' ' ' VAL . 4.0 mm? -65.5 -45.27 84.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.34 -31.06 60.45 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.62 ' HB3' HG21 ' A' ' 37' ' ' ILE . 2.2 mmpt? -81.09 -34.22 32.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.634 ' OD2' HG22 ' A' ' 37' ' ' ILE . 17.2 m-20 -101.68 -11.53 19.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.54 27.75 3.15 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.294 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.574 ' CD1' HG21 ' A' ' 48' ' ' VAL . 1.1 pt -105.01 148.74 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.775 0.322 . . . . 0.0 111.072 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.7 OUTLIER -77.42 133.34 38.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.85 ' CG1' HD21 ' A' ' 61' ' ' LEU . 4.0 p -145.06 149.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.048 0.451 . . . . 0.0 111.796 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.584 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.0 t -103.07 128.96 55.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -100.94 106.71 18.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.097 0.475 . . . . 0.0 111.198 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.924 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 5.5 m0 -109.72 103.51 53.31 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.188 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo . . . . . 0 N--CA 1.445 -1.338 0 C-N-CA 123.498 2.798 . . . . 0.0 113.028 -178.86 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.348 0.118 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.924 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 35.4 t -55.38 -50.99 61.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 2.6 t -53.77 -43.4 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.307 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -56.34 -31.21 63.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.876 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.7 -50.4 62.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.757 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -65.14 -33.93 77.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.743 179.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.94 HD21 ' HB3' ' A' ' 120' ' ' LEU . 17.8 mt -57.87 -46.89 84.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.723 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.83 -42.21 99.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.28 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.463 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.3 tm? -59.05 -51.46 69.97 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.757 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.986 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.2 p -69.7 -35.86 67.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.075 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -56.94 -45.02 83.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.319 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.04 91.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.497 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.12 -24.1 61.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.229 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.585 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.1 m-85 -81.76 -51.86 7.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.793 0.33 . . . . 0.0 111.179 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.4 -40.51 97.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -76.07 -32.94 59.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.213 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -125.53 90.81 49.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.323 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.78 132.49 14.45 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.539 2.159 . . . . 0.0 112.375 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.5 56.3 25.81 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.584 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.632 ' HB2' HG21 ' A' ' 46' ' ' THR . 1.1 m -101.21 -164.77 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.816 0.341 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.653 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 m -117.88 113.54 21.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.684 HG11 ' CE1' ' A' ' 22' ' ' PHE . 38.5 t -110.03 149.73 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.148 0.499 . . . . 0.0 112.243 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.833 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -119.11 143.29 47.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.946 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.872 HG22 HG12 ' A' ' 49' ' ' VAL . 92.7 t -139.98 166.16 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.579 ' N ' HG12 ' A' ' 105' ' ' VAL . 2.7 t60 -67.36 156.12 37.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.126 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 25' ' ' THR . 48.5 t -68.38 105.52 2.2 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.043 HG13 HD12 ' A' ' 24' ' ' ILE . 34.3 m -75.42 0.62 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.185 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HB3' ' SG ' ' A' ' 107' ' ' CYS . . . -60.07 -8.55 2.45 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.29 -129.24 3.46 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.0 mt -127.9 127.42 43.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.59 -150.45 6.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.273 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.835 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.47 -19.02 6.52 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.025 0.441 . . . . 0.0 111.775 -178.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.672 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.15 -46.39 97.79 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.741 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.1 Cg_endo -52.41 -48.15 23.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.179 1.919 . . . . 0.0 112.428 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.521 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 23.0 t -56.85 -52.04 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 110.341 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.719 HD12 ' CG2' ' A' ' 49' ' ' VAL . 8.0 mt -51.88 -48.79 63.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.889 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.765 HG13 ' CE1' ' A' ' 22' ' ' PHE . 17.4 t -54.01 -54.09 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.58 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.62 -42.79 64.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.039 0.447 . . . . 0.0 111.17 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.94 ' HB3' HD21 ' A' ' 88' ' ' LEU . 9.6 mt -64.12 -30.78 71.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.195 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.986 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -69.24 -38.25 78.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.211 0.529 . . . . 0.0 109.748 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.752 HD13 ' CE ' ' A' ' 20' ' ' MET . 6.0 tp -77.26 -15.97 59.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.204 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.933 HG23 ' CB ' ' A' ' 128' ' ' LYS . 1.7 mt -57.78 -31.74 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.816 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -16.53 63.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 122' ' ' LEU . 5.0 m -83.81 11.04 8.13 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 118.08 -99.99 0.83 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.193 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.481 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.9 ptt? -62.48 76.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.933 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.52 -67.51 0.55 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -177.09 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.571 ' CD1' HD22 ' A' ' 152' ' ' LEU . 7.5 t80 -67.52 -32.46 73.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.926 0.393 . . . . 0.0 111.102 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -52.1 18.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.152 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 29.5 t0 -68.7 -41.02 79.74 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.127 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.673 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -58.53 -49.03 78.89 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.288 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.3 mm -72.25 -40.19 65.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.804 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -74.35 -49.6 22.13 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.816 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.63 -37.25 84.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.711 0.291 . . . . 0.0 110.525 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.6 tt -74.17 -27.93 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 110.465 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.411 ' HG2' ' NH2' ' A' ' 141' ' ' ARG . 6.2 mtt180 -65.47 -46.28 80.4 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.629 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -45.07 93.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.61 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.742 ' HD3' HG11 ' A' ' 13' ' ' VAL . 3.9 mmpt? -86.76 151.97 22.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.196 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.14 116.8 14.11 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.46 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.411 ' NH2' ' HG2' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -114.81 163.79 15.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.133 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.92 -171.08 0.07 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.86 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.78 100.17 12.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.24 0.52 . . . . 0.0 111.349 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.861 HG22 ' NE2' ' A' ' 148' ' ' GLN . 0.2 OUTLIER -87.63 109.73 19.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.825 178.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -113.62 -76.8 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.6 p -99.9 -60.87 1.45 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.811 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 9.7 tmtt? -63.09 -49.81 73.01 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.861 ' NE2' HG22 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -55.87 -52.42 64.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.424 HD21 HG13 ' A' ' 144' ' ' ILE . 3.9 mm? -75.38 -40.53 57.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.8 m -70.72 -33.8 71.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.805 0.336 . . . . 0.0 111.475 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.811 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -70.48 -50.69 35.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.057 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.895 HD21 HD11 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -64.6 -31.42 72.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.638 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -61.81 -38.68 89.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -26.5 66.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.118 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.491 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -66.04 -41.49 90.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.936 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.349 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.67 0.271 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.99 164.81 34.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.566 2.177 . . . . 0.0 112.314 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.403 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.5 t -144.14 126.84 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.2 pp20? -114.16 129.56 56.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.034 0.445 . . . . 0.0 111.844 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.788 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -108.2 120.34 59.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.01 158.1 21.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.156 0.503 . . . . 0.0 111.977 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.718 ' CD2' HD11 ' A' ' 122' ' ' LEU . 9.7 t80 -150.06 107.48 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.528 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 4.7 mmtp 62.9 -83.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.165 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -129.3 14.11 6.12 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.869 ' CE ' HD13 ' A' ' 122' ' ' LEU . 24.2 ttp -110.6 162.02 15.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.683 0.278 . . . . 0.0 110.969 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.5 mtt180 -148.53 134.9 19.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.093 0.473 . . . . 0.0 111.623 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.645 ' CE1' HG11 ' A' ' 103' ' ' VAL . 3.6 m-85 -115.34 151.35 34.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.729 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.058 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -124.45 135.93 53.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.113 0.482 . . . . 0.0 111.424 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.842 HD13 ' HB ' ' A' ' 105' ' ' VAL . 15.9 mm -118.34 106.54 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.654 HG21 HD23 ' A' ' 40' ' ' LEU . 2.2 p -129.84 163.47 26.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.358 0.599 . . . . 0.0 111.896 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.523 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.7 p80 -81.16 152.58 27.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.933 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -62.41 154.6 71.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.968 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.452 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.5 Cg_exo -54.27 138.21 72.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.396 2.064 . . . . 0.0 113.433 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.7 p -98.54 145.49 26.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.217 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -68.47 -12.26 60.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.56 -31.25 14.6 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.3 p -139.81 88.99 2.28 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.172 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.432 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.6 OUTLIER -80.7 -52.3 7.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.175 0.512 . . . . 0.0 111.417 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.441 ' HA ' HG12 ' A' ' 37' ' ' ILE . 74.9 m -55.95 -45.64 78.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.59 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.2 m -57.65 -33.11 67.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.874 0.369 . . . . 0.0 111.314 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.677 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.52 -47.71 31.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.698 HD13 ' HB3' ' A' ' 63' ' ' LYS . 11.5 pt -55.81 -39.5 56.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.133 0.492 . . . . 0.0 110.63 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -65.12 -52.16 57.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.46 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.6 OUTLIER -67.68 -50.04 59.69 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 120.803 0.335 . . . . 0.0 111.831 -179.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.677 HD21 ' CE1' ' A' ' 36' ' ' PHE . 76.2 mt -54.95 -46.2 74.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.6 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -77.65 -26.82 50.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.05 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 5.9 mttt -52.4 -43.21 64.63 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.07 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.058 ' CD1' HD21 ' A' ' 23' ' ' LEU . 12.5 t80 -63.48 -38.49 91.36 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.585 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.699 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.96 -178.54 39.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.078 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.47 117.52 19.77 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.662 HG21 ' HB3' ' A' ' 101' ' ' SER . 0.7 OUTLIER -165.2 -169.67 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.973 177.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.64 ' H ' HG22 ' A' ' 46' ' ' THR . 7.8 t -64.37 156.81 28.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.463 0.649 . . . . 0.0 110.51 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.809 HG13 ' O ' ' A' ' 104' ' ' ALA . 66.5 t -136.78 134.29 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.135 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.941 HG13 HG13 ' A' ' 105' ' ' VAL . 13.1 p -115.66 105.07 17.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.393 0.616 . . . . 0.0 111.49 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.434 ' HD2' HG21 ' A' ' 68' ' ' VAL . 4.8 ptm180 -114.77 110.88 20.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.108 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 71' ' ' TRP . 14.6 t -105.25 91.62 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.468 0.651 . . . . 0.0 109.736 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.63 171.55 20.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.851 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.39 129.97 41.58 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -77.33 122.66 32.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.9 p -119.87 -47.73 2.39 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.063 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.413 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -130.57 83.45 2.12 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.398 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -79.44 -36.84 38.26 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.73 -48.54 13.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.558 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -47.02 -55.39 15.46 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 64.0 Cg_endo -73.37 -42.79 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.261 1.974 . . . . 0.0 114.204 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.687 ' CD2' HG11 ' A' ' 68' ' ' VAL . 27.1 mt -71.66 -45.36 62.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -66.24 -32.1 73.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.68 0.276 . . . . 0.0 111.565 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.698 ' HB3' HD13 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -81.23 -30.67 34.14 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.12 -11.46 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 45.52 67.2 1.31 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.804 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.1 mt -136.36 147.69 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.624 0.25 . . . . 0.0 110.84 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 47' ' ' THR . 70.9 p -78.07 128.02 33.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.687 HG11 ' CD2' ' A' ' 61' ' ' LEU . 8.3 p -145.23 151.73 14.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.091 0.472 . . . . 0.0 112.1 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.566 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.3 t -103.52 130.69 53.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -101.1 106.85 18.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.04 0.448 . . . . 0.0 111.143 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.804 ' HB3' HG13 ' A' ' 51' ' ' VAL . 5.7 m0 -110.89 103.96 55.44 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.367 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 N--CA 1.446 -1.277 0 C-N-CA 123.258 2.639 . . . . 0.0 112.841 -179.251 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.578 0.228 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.491 ' O ' ' HZ2' ' A' ' 71' ' ' TRP . 15.2 m -55.12 -43.03 68.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.079 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.721 HG22 ' CD1' ' A' ' 120' ' ' LEU . 0.8 OUTLIER -53.49 -41.08 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -64.96 -31.38 72.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.324 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -66.48 -50.34 63.61 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.826 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -66.87 -30.34 70.48 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.87 HD21 ' HB3' ' A' ' 120' ' ' LEU . 18.2 mt -61.05 -46.71 89.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.339 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -64.05 -40.08 95.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.31 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.506 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.7 tm? -59.67 -51.34 70.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.725 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.059 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.4 p -71.07 -35.92 60.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.066 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.52 -46.85 76.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.46 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.89 -43.41 83.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.66 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -69.13 -25.71 64.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.511 ' CD1' HG22 ' A' ' 91' ' ' VAL . 1.7 m-85 -76.58 -52.02 10.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.948 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.2 t -59.67 -39.8 85.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.13 -33.08 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.126 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.09 88.23 54.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.304 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.95 128.15 12.09 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.536 2.158 . . . . 0.0 112.194 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.51 57.48 19.35 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.321 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.662 ' HB3' HG21 ' A' ' 46' ' ' THR . 1.5 t -101.03 -163.08 0.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.616 0.246 . . . . 0.0 111.123 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.699 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 m -115.44 113.26 23.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.337 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.645 HG11 ' CE1' ' A' ' 22' ' ' PHE . 25.7 t -110.42 150.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 112.016 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.809 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -121.58 142.0 50.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.188 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.941 HG13 HG13 ' A' ' 49' ' ' VAL . 20.0 t -140.1 166.14 20.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.357 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 3.3 t60 -67.17 155.37 38.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.95 0.405 . . . . 0.0 110.81 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.5 ' N ' ' O ' ' A' ' 25' ' ' THR . 34.4 t -69.27 110.33 4.57 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.734 HG13 HD12 ' A' ' 24' ' ' ILE . 13.2 m -75.6 0.63 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.372 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.04 -8.66 2.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.35 -137.7 4.44 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.544 HD22 ' HA2' ' A' ' 142' ' ' GLY . 4.1 mt -111.49 127.13 55.6 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.69 -162.42 12.52 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 119.952 -1.118 . . . . 0.0 113.522 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.668 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.38 -19.88 6.29 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.08 0.467 . . . . 0.0 111.735 -178.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.802 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -53.43 -46.42 98.06 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 8.0 Cg_endo -52.69 -48.51 21.6 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.948 1.766 . . . . 0.0 112.359 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.599 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 89.4 t -55.87 -53.34 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.571 HD12 ' CG2' ' A' ' 49' ' ' VAL . 10.6 mt -52.28 -45.57 65.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.692 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 114' ' ' ALA . 13.8 t -51.42 -52.63 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 111.177 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.469 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -54.99 -45.6 75.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.025 0.441 . . . . 0.0 110.436 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.87 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.5 mt -55.16 -30.92 60.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.039 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 1.059 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.96 -49.19 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.869 HD13 ' CE ' ' A' ' 20' ' ' MET . 22.5 tp -67.08 -14.02 62.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.805 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 1.001 ' CD1' HD21 ' A' ' 152' ' ' LEU . 2.1 mt -57.74 -32.41 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.977 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -16.21 63.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.673 ' HB2' HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -79.75 -23.45 42.23 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 151.2 -96.46 0.17 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.899 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.534 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.17 73.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.917 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -72.07 -67.8 0.51 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -176.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 5.3 t80 -66.14 -34.58 78.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.931 0.396 . . . . 0.0 111.227 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.27 -52.75 14.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.414 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 25.8 t70 -70.78 -32.65 69.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.716 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -60.42 -49.98 75.4 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 32.1 mm -71.04 -41.18 76.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.576 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.86 -50.37 17.28 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.788 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.1 -35.82 81.54 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.704 0.287 . . . . 0.0 110.55 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.3 tt -74.24 -40.47 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.677 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 52.0 ttt-85 -58.6 -36.61 74.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.177 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -59.52 -45.55 91.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.819 0.343 . . . . 0.0 110.747 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.402 ' CG ' HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -87.78 151.28 23.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.61 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.48 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.73 116.71 14.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.842 0.353 . . . . 0.0 110.155 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.447 ' HD3' HG23 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -115.39 164.1 14.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.355 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.544 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -53.39 -172.8 0.05 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.586 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.18 9.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.62 0.71 . . . . 0.0 111.616 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.458 HD12 ' CD2' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -88.62 109.75 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.457 178.43 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.63 -76.55 0.59 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.67 -60.78 1.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.846 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.9 tmtt? -53.42 -51.74 61.64 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.496 ' HG3' HG22 ' A' ' 116' ' ' VAL . 1.1 tm0? -56.79 -51.98 66.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 149' ' ' LEU . 3.7 mm? -73.62 -41.31 62.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.9 m -69.74 -41.3 75.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.793 0.33 . . . . 0.0 111.265 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.846 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -62.84 -50.66 70.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.223 -179.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.001 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -67.19 -31.22 71.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.923 -179.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -39.56 90.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -23.1 55.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.91 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.591 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -66.4 -39.56 89.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.72 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.755 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.733 0.302 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HB3' HG23 ' A' ' 25' ' ' THR . 52.7 Cg_endo -69.37 165.27 31.09 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.651 2.234 . . . . 0.0 112.345 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 t -130.32 126.69 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.795 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.425 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -103.81 122.67 45.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.536 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.734 HG12 ' CE2' ' A' ' 135' ' ' PHE . 2.3 t -106.82 134.17 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.317 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 p -132.17 133.63 44.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.171 0.51 . . . . 0.0 112.16 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.655 ' HD2' HD11 ' A' ' 122' ' ' LEU . 41.2 t80 -155.13 141.98 19.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.371 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mmtt 61.97 -103.59 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.932 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -129.84 -1.62 4.75 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.605 ' HE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -113.34 168.43 9.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.038 0.447 . . . . 0.0 111.478 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -125.9 164.2 21.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.009 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.712 ' CE1' HG11 ' A' ' 103' ' ' VAL . 1.5 m-85 -136.65 137.44 40.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.339 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.062 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -114.88 132.8 56.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.002 0.429 . . . . 0.0 111.134 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.81 HG21 HG12 ' A' ' 108' ' ' VAL . 1.2 mm -115.85 106.35 20.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -135.33 167.1 21.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 111.921 -178.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.426 ' CA ' ' HB2' ' A' ' 107' ' ' CYS . 3.0 t-80 -81.09 151.53 28.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.689 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -63.42 154.84 77.63 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.83 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.44 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.7 Cg_exo -54.57 140.11 75.59 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.222 1.948 . . . . 0.0 112.954 -178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.465 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 67.8 p -98.61 174.27 6.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -92.52 -13.06 30.35 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.57 -31.04 14.68 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 p -139.72 89.56 2.33 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.49 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.465 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.3 OUTLIER -80.4 -52.19 7.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.106 0.479 . . . . 0.0 111.31 178.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.446 ' HA ' HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -55.97 -45.38 78.92 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.549 -178.637 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.7 -34.47 69.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.897 0.379 . . . . 0.0 111.354 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.637 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.17 -47.75 33.73 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.845 HG22 ' OD2' ' A' ' 64' ' ' ASP . 12.5 pt -55.54 -39.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.155 0.502 . . . . 0.0 110.605 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -65.43 -51.97 56.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.483 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.569 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 2.5 m-20 -68.35 -50.2 54.89 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.637 HD21 ' CE1' ' A' ' 36' ' ' PHE . 84.9 mt -55.69 -45.38 77.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.556 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -78.45 -26.63 46.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.102 0.477 . . . . 0.0 110.059 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.3 mttp -52.01 -43.98 63.91 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.283 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.062 ' CD1' HD21 ' A' ' 23' ' ' LEU . 20.2 t80 -63.31 -38.39 90.98 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.696 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.747 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 166.24 -178.83 40.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.928 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.17 19.23 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.825 HG21 ' OG ' ' A' ' 101' ' ' SER . 0.6 OUTLIER -165.22 -169.38 1.62 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.853 177.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.636 ' H ' HG22 ' A' ' 46' ' ' THR . 2.9 t -64.33 143.07 58.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.692 0.758 . . . . 0.0 110.557 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.789 HG13 ' HB3' ' A' ' 104' ' ' ALA . 25.4 t -122.23 132.12 71.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.113 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.057 HG13 HG13 ' A' ' 105' ' ' VAL . 9.8 p -115.47 105.25 18.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.181 0.515 . . . . 0.0 111.175 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 110.93 20.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.906 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.893 HG11 ' HB2' ' A' ' 113' ' ' ARG . 44.0 t -103.98 91.74 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.556 0.693 . . . . 0.0 110.493 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.6 t -157.79 171.19 20.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.733 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.74 130.2 42.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -72.36 122.0 23.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 p -120.57 -47.71 2.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.046 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.411 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -130.75 84.24 2.18 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.503 179.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -78.77 -36.51 42.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -79.5 -48.59 13.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.452 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -44.5 -49.7 24.91 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.416 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 9.6 Cg_exo -72.97 -42.46 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.702 2.268 . . . . 0.0 113.731 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.836 HD12 HG12 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -71.39 -45.21 63.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -70.54 -28.9 65.28 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.495 ' CB ' HG21 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -81.02 -34.72 32.65 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.845 ' OD2' HG22 ' A' ' 37' ' ' ILE . 44.0 m-20 -101.54 -11.37 19.33 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.56 41.56 49.69 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.423 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.757 ' CD1' HG21 ' A' ' 48' ' ' VAL . 1.1 pt -118.77 148.71 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 122.313 0.245 . . . . 0.0 111.047 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' THR . 21.9 p -77.39 135.03 38.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.836 HG12 HD12 ' A' ' 61' ' ' LEU . 7.4 p -144.98 149.68 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.073 0.463 . . . . 0.0 112.054 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.453 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.2 t -103.31 131.04 52.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.11 106.55 17.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 111.021 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.857 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.9 m95 -110.53 103.47 54.28 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.199 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 N--CA 1.444 -1.387 0 C-N-CA 123.469 2.779 . . . . 0.0 113.042 -178.73 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.428 0.156 . . . . 0.0 110.93 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.857 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 55.3 t -55.36 -47.98 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.717 HG11 ' HE2' ' A' ' 151' ' ' TYR . 88.0 t -56.13 -39.8 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.05 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.786 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.8 mt-10 -58.21 -31.25 67.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.481 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.87 -50.25 67.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.988 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.859 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -68.04 -26.79 66.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.896 HD21 ' HB3' ' A' ' 120' ' ' LEU . 25.9 mt -62.79 -41.44 99.26 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.159 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 t -67.78 -41.72 82.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.026 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.453 ' HG ' HG22 ' A' ' 69' ' ' VAL . 1.8 tm? -58.98 -51.23 70.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.779 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.762 HG21 ' HB1' ' A' ' 121' ' ' ALA . 7.8 p -71.81 -41.06 69.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.261 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -55.34 -38.49 68.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.936 0.398 . . . . 0.0 110.706 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.04 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.763 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -29.58 67.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.145 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.501 ' CE1' HG21 ' A' ' 103' ' ' VAL . 3.3 m-85 -76.78 -52.06 10.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.032 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.3 t -59.8 -36.95 77.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -31.87 59.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.06 94.4 41.59 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.287 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.13 129.09 16.61 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.425 2.083 . . . . 0.0 112.219 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.95 59.46 10.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.292 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.825 ' OG ' HG21 ' A' ' 46' ' ' THR . 83.5 p -101.2 -170.09 1.79 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.927 0.394 . . . . 0.0 111.442 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.747 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.6 m -113.03 113.61 25.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.308 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.712 HG11 ' CE1' ' A' ' 22' ' ' PHE . 76.0 t -104.23 149.98 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.789 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -122.52 140.58 52.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.787 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.057 HG13 HG13 ' A' ' 49' ' ' VAL . 2.2 t -140.6 166.74 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.688 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.4 t60 -67.49 156.14 37.35 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.651 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.576 ' N ' ' O ' ' A' ' 25' ' ' THR . 50.4 t -68.41 102.44 1.42 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.381 0.61 . . . . 0.0 112.287 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.81 HG12 HG21 ' A' ' 24' ' ' ILE . 7.1 p -75.27 -0.02 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.025 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HB3' ' SG ' ' A' ' 107' ' ' CYS . . . -60.81 -8.68 3.21 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.452 ' O ' HD23 ' A' ' 111' ' ' LEU . . . -122.3 -134.06 4.39 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 110' ' ' GLY . 22.3 mt -125.29 127.58 46.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.2 -143.19 3.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.993 -1.099 . . . . 0.0 113.597 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.893 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.13 -19.37 6.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.968 0.413 . . . . 0.0 111.794 -178.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.701 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -50.62 -46.46 85.68 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.0 Cg_endo -51.98 -48.39 21.84 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.46 2.107 . . . . 0.0 112.869 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.595 ' O ' HD23 ' A' ' 120' ' ' LEU . 22.1 t -61.73 -38.51 80.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.932 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.455 HD12 ' CG2' ' A' ' 51' ' ' VAL . 6.8 mt -64.61 -49.1 72.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.527 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 1.017 HG22 HG11 ' A' ' 105' ' ' VAL . 12.5 t -54.59 -55.4 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.742 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -59.23 -49.4 78.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.214 0.531 . . . . 0.0 111.091 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.896 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.2 mm? -53.92 -30.66 47.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.859 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.24 -47.66 55.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.04 0.447 . . . . 0.0 110.085 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.655 HD11 ' HD2' ' A' ' 17' ' ' TYR . 14.4 tp -61.58 -16.99 53.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.746 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.903 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.9 mt -57.08 -30.81 35.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.494 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.402 ' OE2' ' CG ' ' A' ' 95' ' ' PHE . 3.3 pt-20 -68.14 -17.29 64.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.557 0.218 . . . . 0.0 111.456 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.7 t -84.75 11.04 9.83 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 104.02 -81.69 0.35 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.873 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 51.8 ttp -63.16 66.47 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.903 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -74.63 -67.91 0.59 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -176.239 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.6 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.1 t80 -71.59 -31.54 67.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.057 0.456 . . . . 0.0 110.806 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.404 ' HB2' ' HG3' ' A' ' 127' ' ' MET . 1.3 mt-10 -72.53 -47.32 49.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.311 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.687 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 10.8 t0 -70.09 -43.77 70.44 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 110.836 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.742 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -58.36 -50.04 75.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.879 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.0 mm -71.65 -42.38 71.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.904 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -49.33 27.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.734 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -68.62 -39.66 80.7 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.189 -0.204 . . . . 0.0 111.016 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.7 OUTLIER -72.62 -27.79 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.318 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -47.18 79.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.949 0.404 . . . . 0.0 110.034 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -45.13 93.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.667 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -86.5 152.54 22.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.346 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -72.83 117.07 14.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.004 0.43 . . . . 0.0 110.299 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.455 ' HA ' HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -114.82 163.29 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.158 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.461 ' H ' ' HG3' ' A' ' 115' ' ' PRO . . . -58.06 172.47 3.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.197 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.23 99.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.528 0.664 . . . . 0.0 110.447 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.834 HD12 HD21 ' A' ' 149' ' ' LEU . 2.2 pt -88.31 109.06 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.098 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -113.55 -76.88 0.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.562 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.06 -60.61 1.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.631 ' O ' ' CB ' ' A' ' 151' ' ' TYR . 0.8 OUTLIER -54.76 -51.93 64.14 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.295 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.493 ' HG3' HG22 ' A' ' 144' ' ' ILE . 1.1 tm0? -56.35 -51.87 66.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.834 HD21 HD12 ' A' ' 144' ' ' ILE . 3.4 mm? -75.22 -47.46 28.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.7 m -64.96 -34.82 79.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.733 0.301 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.717 ' HE2' HG11 ' A' ' 84' ' ' VAL . 6.9 t80 -68.2 -50.95 50.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.281 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.772 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -72.01 -32.76 67.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.525 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.59 -37.7 79.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -28.24 62.4 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.642 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.556 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -65.88 -34.34 77.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.679 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.763 0.316 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.29 163.43 39.15 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.526 2.151 . . . . 0.0 112.297 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.05 126.83 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -108.5 126.25 52.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.523 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.786 HG12 ' CE2' ' A' ' 135' ' ' PHE . 2.4 t -106.65 129.79 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 p -132.87 139.25 47.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.222 0.534 . . . . 0.0 112.136 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 18' ' ' LYS . 10.8 t80 -155.12 129.17 8.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.104 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 2.0 mmmp? 63.46 -92.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.198 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.42 -39.06 1.52 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.455 ' HE1' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -73.77 151.66 40.56 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 111.273 -179.398 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.62 164.24 21.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.067 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.665 ' CE1' HG11 ' A' ' 103' ' ' VAL . 2.0 m-85 -136.76 139.16 41.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.646 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.078 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -117.77 138.5 52.01 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.118 0.485 . . . . 0.0 111.343 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.772 HG21 HG12 ' A' ' 108' ' ' VAL . 2.6 mm -118.22 106.64 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.211 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -131.05 164.29 25.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.476 0.655 . . . . 0.0 112.451 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.532 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.8 p80 -81.74 152.55 26.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.248 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -62.48 154.44 72.75 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.2 Cg_exo -54.85 139.03 78.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.391 2.061 . . . . 0.0 113.601 -177.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.7 p -98.97 145.94 26.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.977 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -71.3 -10.12 59.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.83 14.74 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 p -139.59 89.43 2.32 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.382 -0.527 . . . . 0.0 112.244 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.38 -52.25 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.177 0.513 . . . . 0.0 111.23 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.457 ' HA ' HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -56.7 -45.19 81.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.321 -178.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.5 m -57.69 -31.91 66.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.739 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.22 -47.56 27.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.142 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.732 HD13 ' HB3' ' A' ' 63' ' ' LYS . 11.3 pt -55.44 -38.39 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.227 0.537 . . . . 0.0 110.334 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.43 -51.75 58.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.374 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.547 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.2 m-20 -68.8 -50.29 51.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.918 0.389 . . . . 0.0 111.953 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.739 HD21 ' CE1' ' A' ' 36' ' ' PHE . 83.6 mt -56.89 -44.45 82.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.993 0.425 . . . . 0.0 110.303 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -77.19 -26.65 53.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.886 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 2.1 mtmt -52.79 -47.52 67.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.306 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.078 ' CD1' HD21 ' A' ' 23' ' ' LEU . 11.6 t80 -63.63 -38.5 91.37 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.656 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.671 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 160.03 -177.44 36.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.041 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.62 122.93 28.34 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.833 HG22 ' H ' ' A' ' 47' ' ' THR . 3.8 m -164.52 -171.2 2.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.46 177.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.833 ' H ' HG22 ' A' ' 46' ' ' THR . 1.8 t -65.33 149.63 49.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.329 0.585 . . . . 0.0 109.862 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.037 HG22 ' HB3' ' A' ' 104' ' ' ALA . 74.4 t -126.64 135.18 64.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.882 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.032 HG13 HG13 ' A' ' 105' ' ' VAL . 9.3 p -115.46 104.91 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.111 0.482 . . . . 0.0 111.27 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -114.74 111.01 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.399 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.796 HG13 ' HB3' ' A' ' 71' ' ' TRP . 8.1 t -103.71 90.39 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.451 0.643 . . . . 0.0 109.303 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -158.63 171.87 19.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.953 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -65.06 130.62 44.02 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 m -81.07 122.32 36.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.6 p -120.15 -47.52 2.37 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.663 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.419 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -130.33 83.86 2.16 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -79.4 -36.6 38.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.65 -48.58 13.48 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.454 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.22 -56.65 10.21 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 65.4 Cg_endo -73.17 -42.35 1.0 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.493 2.129 . . . . 0.0 114.182 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.737 HD21 HG11 ' A' ' 68' ' ' VAL . 28.9 mt -71.19 -45.21 63.89 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.3 -30.83 70.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.817 0.341 . . . . 0.0 111.422 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.732 ' HB3' HD13 ' A' ' 37' ' ' ILE . 13.3 mttm -81.37 -32.67 32.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 66' ' ' ILE . 18.1 p30 -101.23 -11.35 19.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 61' ' ' LEU . . . 48.11 31.29 8.25 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.284 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 64' ' ' ASP . 5.6 mt -97.42 147.53 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.679 0.276 . . . . 0.0 110.974 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' THR . 50.1 p -78.41 131.14 36.82 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.737 HG11 HD21 ' A' ' 61' ' ' LEU . 9.1 p -145.36 152.24 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.63 132.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -100.57 106.79 18.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 109.947 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.861 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 3.4 m95 -111.72 104.07 55.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.677 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 N--CA 1.447 -1.216 0 C-N-CA 123.573 2.849 . . . . 0.0 112.344 -179.909 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.561 0.22 . . . . 0.0 110.763 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.861 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 41.4 t -56.79 -48.3 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.737 HG11 ' HE2' ' A' ' 151' ' ' TYR . 90.3 t -55.34 -37.47 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.986 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.838 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.8 mt-10 -60.42 -31.32 70.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.429 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.91 -50.17 69.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.245 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.731 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.56 -27.42 67.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.838 HD12 ' HA ' ' A' ' 85' ' ' GLU . 37.1 mt -64.49 -38.16 90.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.095 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -69.03 -41.42 77.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.803 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -59.53 -51.32 70.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.381 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.562 HG21 ' HB1' ' A' ' 121' ' ' ALA . 8.5 p -71.74 -35.9 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.909 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -56.23 -47.19 78.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.502 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.31 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.636 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 1.7 mmtp -68.0 -24.28 65.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.077 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.548 ' HE1' HG21 ' A' ' 103' ' ' VAL . 2.4 m-85 -82.09 -52.04 7.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.167 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.3 t -63.93 -39.87 95.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.992 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.11 -31.72 58.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.226 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -124.15 89.1 52.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.52 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.64 135.07 14.19 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.594 2.196 . . . . 0.0 112.236 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 20' ' ' MET . . . 64.95 46.23 89.94 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.468 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 t -101.04 -176.59 3.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.66 0.267 . . . . 0.0 111.118 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.671 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 2.2 m -111.98 114.05 26.71 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.665 HG11 ' CE1' ' A' ' 22' ' ' PHE . 28.0 t -101.94 151.28 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 1.037 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.05 141.74 51.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.146 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.032 HG13 HG13 ' A' ' 49' ' ' VAL . 2.5 t -140.68 166.95 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.78 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.3 t60 -67.38 156.51 36.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.639 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -68.01 98.79 0.79 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.375 0.607 . . . . 0.0 112.469 -178.042 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.772 HG12 HG21 ' A' ' 24' ' ' ILE . 7.5 p -75.41 -0.08 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.96 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.66 -8.76 3.13 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.03 -124.71 2.96 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 143' ' ' ALA . 13.1 mt -129.11 127.39 41.36 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.86 -144.41 4.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.807 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.481 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.14 -20.56 6.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.033 0.444 . . . . 0.0 111.931 -178.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.78 ' HB2' ' HB3' ' A' ' 106' ' ' HIS . . . -52.11 -44.94 93.63 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 6.4 Cg_endo -51.62 -48.3 22.05 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.524 2.149 . . . . 0.0 113.165 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 ' CG ' ' A' ' 148' ' ' GLN . 62.1 t -62.48 -46.45 96.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.02 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 49' ' ' VAL . 13.4 mt -58.85 -41.89 88.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.973 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.856 ' CG2' HG11 ' A' ' 105' ' ' VAL . 54.0 t -61.63 -55.44 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.609 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -58.09 -52.51 65.24 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.157 0.504 . . . . 0.0 111.032 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.738 ' HB3' HD21 ' A' ' 88' ' ' LEU . 4.3 mm? -53.82 -30.82 46.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.668 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.731 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.26 -42.38 65.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.078 0.466 . . . . 0.0 110.115 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.455 ' CD1' ' HE1' ' A' ' 20' ' ' MET . 3.4 tp -67.51 -14.04 62.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.928 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.4 mt -57.25 -30.77 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.031 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.28 -16.87 63.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.6 m -83.93 11.2 8.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.19 -101.58 1.06 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.211 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.484 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.7 ptt? -62.49 77.78 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.928 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.65 -67.59 0.54 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.655 ' CD1' HD22 ' A' ' 152' ' ' LEU . 4.1 t80 -66.26 -33.77 76.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.926 0.393 . . . . 0.0 111.187 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.26 -51.67 19.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.294 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 30.0 t0 -70.03 -36.25 74.92 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.841 0.353 . . . . 0.0 111.029 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -61.31 -50.16 74.09 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.654 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.9 mm -74.31 -37.61 45.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.531 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -74.24 -49.68 22.27 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.786 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.24 -35.84 76.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.473 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.3 tt -74.0 -27.91 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 0.0 110.227 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -65.14 -52.31 55.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.539 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.86 -45.17 93.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.633 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 136' ' ' ILE . 7.3 mmtt -81.54 152.22 27.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.253 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.83 117.21 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.344 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.423 ' HA ' ' CG2' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -114.64 163.39 15.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.12 -179.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.484 ' H ' ' HG3' ' A' ' 115' ' ' PRO . . . -60.15 -163.35 0.14 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.276 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.457 ' N ' HD22 ' A' ' 111' ' ' LEU . . . -90.1 99.28 12.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.427 0.614 . . . . 0.0 110.633 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.603 HG22 ' HG3' ' A' ' 148' ' ' GLN . 6.8 pt -88.35 109.26 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.119 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.67 -76.98 0.58 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.605 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.23 -60.69 1.48 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.641 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.6 tmtt? -57.35 -51.89 67.59 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.765 ' CG ' HG22 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -56.14 -52.09 65.61 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 149' ' ' LEU . 3.4 mm? -75.27 -45.55 39.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 56.3 m -66.44 -33.47 75.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.807 0.336 . . . . 0.0 111.147 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.737 ' HE2' HG11 ' A' ' 84' ' ' VAL . 2.2 t80 -68.68 -50.93 47.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.735 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -70.25 -34.26 72.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.407 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -36.44 76.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -26.26 60.55 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.71 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.728 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -65.93 -37.58 86.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.451 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.614 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.534 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.81 0.338 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.588 ' HB3' HG22 ' A' ' 25' ' ' THR . 54.6 Cg_endo -69.83 163.67 37.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.577 2.185 . . . . 0.0 112.306 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.461 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.4 t -144.26 129.26 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.964 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -111.34 116.6 31.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.868 0.366 . . . . 0.0 111.269 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.804 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -109.05 118.29 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' A' ' 21' ' ' ARG . 70.3 p -141.24 142.46 33.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.616 ' CD2' ' HE1' ' A' ' 127' ' ' MET . 1.2 p90 -136.61 164.48 28.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.413 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.584 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 pttp 50.09 -95.99 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.202 0.201 . . . . 0.0 110.973 -177.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.491 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 t-160 -128.92 -32.36 2.09 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.859 ' HE1' HD11 ' A' ' 122' ' ' LEU . 3.8 ppp? -73.65 168.05 20.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.645 0.259 . . . . 0.0 111.329 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HA ' ' CB ' ' A' ' 16' ' ' SER . 3.4 mtp180 -146.05 161.54 39.9 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.012 0.434 . . . . 0.0 111.752 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.86 ' CD2' HG13 ' A' ' 118' ' ' VAL . 0.9 OUTLIER -135.05 148.78 49.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.555 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.08 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -120.28 135.96 54.83 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.106 0.479 . . . . 0.0 111.206 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.918 HD12 HG13 ' A' ' 108' ' ' VAL . 2.2 mm -117.98 106.66 20.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.25 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 12' ' ' PRO . 1.3 p -132.62 164.44 26.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.197 0.523 . . . . 0.0 111.819 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.463 ' CD2' ' CZ ' ' A' ' 36' ' ' PHE . 45.4 p-80 -81.31 152.17 27.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.738 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -62.71 154.42 74.65 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.492 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.9 Cg_exo -54.61 140.58 75.86 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.296 1.997 . . . . 0.0 113.2 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.462 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.5 p -98.69 174.38 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.129 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -94.26 -11.4 30.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.66 -30.75 14.76 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.0 p -139.5 89.61 2.34 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.45 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.604 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -80.27 -52.22 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.19 0.519 . . . . 0.0 111.173 178.212 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.438 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.8 p -56.86 -45.05 82.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.308 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.1 m -57.92 -32.82 68.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.828 0.347 . . . . 0.0 111.288 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.749 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.8 -47.92 28.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.146 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.825 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.1 pt -55.7 -38.93 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.233 0.54 . . . . 0.0 110.655 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -51.9 57.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.46 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.554 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -68.7 -50.29 52.07 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.749 HD21 ' CE1' ' A' ' 36' ' ' PHE . 72.4 mt -56.47 -43.64 79.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.437 . . . . 0.0 110.392 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -78.6 -26.73 45.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.077 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 3.7 mttt -53.25 -44.6 68.28 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.374 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.08 ' CD1' HD21 ' A' ' 23' ' ' LEU . 16.5 t80 -63.52 -38.56 91.6 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.949 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.663 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.32 -178.47 39.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.951 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.64 117.67 19.84 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.652 HG22 ' H ' ' A' ' 47' ' ' THR . 0.8 OUTLIER -164.88 -170.16 1.89 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.966 177.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.652 ' H ' HG22 ' A' ' 46' ' ' THR . 16.8 p -64.94 155.11 35.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.474 0.654 . . . . 0.0 110.788 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.054 HG22 ' HB3' ' A' ' 104' ' ' ALA . 65.6 t -134.0 139.1 49.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.04 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.022 HG13 HG13 ' A' ' 105' ' ' VAL . 3.3 p -115.77 105.37 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.164 0.507 . . . . 0.0 110.936 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.23 110.92 20.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.22 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.82 HG13 ' HB3' ' A' ' 71' ' ' TRP . 10.8 t -105.62 91.38 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.331 0.586 . . . . 0.0 109.914 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 10.4 p -158.01 171.28 20.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.948 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.64 130.48 43.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.59 121.75 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 p -120.77 -47.63 2.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.212 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.426 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.7 m-85 -130.43 84.29 2.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.488 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -78.61 -36.24 44.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -79.1 -48.49 14.24 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.63 HG22 ' HD2' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -44.56 -49.88 24.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.426 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 17.2 Cg_exo -68.08 -42.1 6.5 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.574 2.183 . . . . 0.0 113.427 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.737 HD21 HG12 ' A' ' 68' ' ' VAL . 1.4 mm? -66.19 -45.43 80.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.61 -41.08 55.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.825 ' HB3' HG21 ' A' ' 37' ' ' ILE . 18.1 mttt -80.92 -27.51 36.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HB3' ' CG1' ' A' ' 66' ' ' ILE . 2.7 t0 -101.15 -11.49 19.53 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.45 29.5 1.16 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.522 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.434 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 2.4 pt -117.56 148.06 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.714 0.293 . . . . 0.0 110.982 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' THR . 24.6 p -77.77 135.15 37.96 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.737 HG12 HD21 ' A' ' 61' ' ' LEU . 9.4 p -143.87 154.91 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.46 134.18 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -100.82 106.77 18.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.241 0.544 . . . . 0.0 110.319 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.82 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.1 m95 -111.96 104.35 55.97 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.091 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.446 -1.292 0 C-N-CA 123.225 2.617 . . . . 0.0 112.275 -179.725 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.392 0.139 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.429 ' HB ' ' CH2' ' A' ' 71' ' ' TRP . 0.0 OUTLIER -55.01 -46.86 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' A' ' 151' ' ' TYR . 79.7 t -55.02 -43.13 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.268 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.64 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.3 mt-10 -56.27 -31.28 63.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.802 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.94 -50.54 62.02 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.827 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -68.63 -26.96 65.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.828 HD21 ' HB3' ' A' ' 120' ' ' LEU . 18.8 mt -61.34 -50.98 70.74 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.117 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 m -60.53 -41.09 93.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.12 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.503 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.9 tm? -56.84 -51.12 70.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.725 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.803 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.3 p -70.67 -36.66 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.383 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 3.2 tmtt? -64.87 -41.37 95.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 110.71 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.07 -48.07 77.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.36 -26.79 62.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.743 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 3.6 m-30 -82.01 -33.91 29.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.885 0.374 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 16.0 t -72.24 -39.44 68.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.067 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -76.16 -33.07 59.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.535 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.56 137.33 26.89 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.679 0.276 . . . . 0.0 111.486 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.58 -166.75 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.547 2.165 . . . . 0.0 112.046 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 20' ' ' MET . . . -46.76 96.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.727 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.528 ' HB3' HG21 ' A' ' 46' ' ' THR . 0.2 OUTLIER -101.1 -160.72 0.81 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.726 0.298 . . . . 0.0 111.017 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.663 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -116.09 113.48 23.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.86 0.362 . . . . 0.0 111.266 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.743 HG21 ' HZ ' ' A' ' 95' ' ' PHE . 25.1 t -106.84 151.18 8.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.229 0.538 . . . . 0.0 112.147 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 1.054 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -123.17 139.87 53.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.986 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.022 HG13 HG13 ' A' ' 49' ' ' VAL . 5.4 t -140.09 166.8 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.7 t60 -66.9 156.1 36.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.391 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.519 ' HA ' HG23 ' A' ' 24' ' ' ILE . 25.5 t -68.3 105.61 2.2 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.918 HG13 HD12 ' A' ' 24' ' ' ILE . 35.2 m -75.47 0.25 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.099 178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.66 -8.77 3.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.53 -135.81 4.39 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.432 HD22 ' HA2' ' A' ' 142' ' ' GLY . 12.8 mt -120.51 127.29 52.05 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.2 -144.03 3.93 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.822 -1.18 . . . . 0.0 113.671 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.567 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.19 -25.63 4.84 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.925 0.393 . . . . 0.0 112.005 -178.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.748 ' HB2' ' HB3' ' A' ' 106' ' ' HIS . . . -50.94 -46.36 87.71 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.825 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.1 Cg_endo -52.26 -48.44 21.73 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.29 1.993 . . . . 0.0 112.964 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.836 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.6 t -61.01 -46.74 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.097 0.475 . . . . 0.0 110.105 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 49' ' ' VAL . 14.4 mt -59.37 -40.2 85.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.743 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.86 HG13 ' CD2' ' A' ' 22' ' ' PHE . 47.9 t -59.96 -55.65 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.613 0.244 . . . . 0.0 111.629 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.589 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -57.7 -47.13 83.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.609 0.719 . . . . 0.0 110.23 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.836 HD23 ' O ' ' A' ' 116' ' ' VAL . 4.5 mm? -54.52 -30.26 53.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.667 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.827 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -70.32 -47.47 60.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 110.164 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.859 HD11 ' HE1' ' A' ' 20' ' ' MET . 3.7 mp -63.61 -16.01 59.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.698 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.919 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.3 mt -57.06 -30.92 35.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.401 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 2.4 pt-20 -73.58 -16.58 61.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.405 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.3 m -85.18 11.03 10.68 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 117.51 -102.65 1.01 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.182 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.616 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 3.6 ptt? -62.42 79.56 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.919 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.85 -67.77 0.54 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -176.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.663 ' CD1' HD22 ' A' ' 152' ' ' LEU . 6.3 t80 -66.81 -32.03 73.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.0 111.054 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.46 -52.05 17.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.685 ' OD2' HD23 ' A' ' 122' ' ' LEU . 29.9 t0 -69.24 -36.21 76.93 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.589 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -61.25 -50.26 73.76 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.812 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.4 mm -74.35 -37.62 45.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.551 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -74.07 -49.71 22.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.804 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.07 -34.98 73.88 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.666 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.19 -27.86 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.327 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.18 -48.19 68.7 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.52 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.79 -45.23 92.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.594 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' ILE . 73.7 mmtt -85.51 152.01 23.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.114 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.23 116.81 14.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.055 0.455 . . . . 0.0 110.62 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.503 ' HG3' HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -115.12 163.57 15.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.86 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.432 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -57.57 -169.16 0.14 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.496 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.51 99.63 11.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.391 0.596 . . . . 0.0 110.762 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.519 HG22 ' HG3' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -88.05 109.4 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.989 179.189 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -113.16 -76.32 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.4 t -99.75 -60.51 1.52 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.904 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.0 OUTLIER -57.65 -52.65 64.57 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.761 ' HG3' HG22 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -56.88 -51.68 68.12 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.05 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 149' ' ' LEU . 3.6 mm? -73.26 -42.55 62.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.2 m -71.76 -40.76 69.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.785 0.326 . . . . 0.0 111.486 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.904 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -63.75 -50.29 69.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.409 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.8 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -67.5 -34.07 76.38 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.645 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -55.95 -44.96 78.93 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -27.97 63.63 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.728 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.61 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.9 OUTLIER -66.73 -25.98 66.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.891 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.673 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.447 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.673 0.273 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 59.7 Cg_endo -72.02 163.55 38.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.613 2.209 . . . . 0.0 112.344 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -144.09 126.84 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.9 pt-20 -102.93 118.5 36.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.364 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.705 HG12 ' CE2' ' A' ' 135' ' ' PHE . 18.4 t -106.74 118.53 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.814 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 p -141.24 149.3 41.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.889 0.376 . . . . 0.0 111.957 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.692 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -149.57 120.22 7.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.157 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.514 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 40.4 mmtt 84.4 -87.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.262 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -129.41 -38.51 1.55 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.74 ' CE ' HD13 ' A' ' 122' ' ' LEU . 4.8 ppp? -73.54 163.8 27.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 111.473 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -145.67 164.05 32.95 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.067 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.782 ' CE1' HG11 ' A' ' 103' ' ' VAL . 3.0 m-85 -135.67 155.37 50.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.38 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.058 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -125.27 124.75 42.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.315 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.866 HD13 HG23 ' A' ' 105' ' ' VAL . 2.0 mm -106.37 106.85 21.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.541 HG21 HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -130.71 165.66 22.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.463 0.649 . . . . 0.0 112.546 -178.407 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.528 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 12.0 p80 -81.61 152.64 27.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.907 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.3 154.35 71.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.449 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.4 Cg_exo -54.96 138.36 77.92 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.482 2.121 . . . . 0.0 113.527 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.0 p -98.85 139.57 34.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.929 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -65.65 -10.27 34.57 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.49 -31.14 14.69 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.4 p -139.85 89.04 2.28 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.238 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.75 -52.2 7.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.005 0.431 . . . . 0.0 111.485 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.575 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -55.92 -38.68 70.6 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.187 -178.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -33.71 76.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.913 0.387 . . . . 0.0 111.035 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.674 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -76.12 -48.03 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.205 -179.16 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.821 HG21 ' CB ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -57.36 -37.18 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.092 0.473 . . . . 0.0 110.458 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -52.14 51.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.189 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.2 m-20 -67.94 -50.06 58.15 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.811 0.339 . . . . 0.0 111.688 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.674 HD21 ' CE1' ' A' ' 36' ' ' PHE . 31.9 mt -56.17 -39.52 72.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.013 0.435 . . . . 0.0 110.418 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -26.74 34.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.085 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -55.11 -43.0 73.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.181 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.058 ' CD1' HD21 ' A' ' 23' ' ' LEU . 13.5 t80 -63.58 -38.42 91.04 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.621 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.7 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.69 -178.52 39.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.912 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.57 117.93 20.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.726 HG22 ' H ' ' A' ' 47' ' ' THR . 1.4 m -164.71 -170.66 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.045 177.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.726 ' H ' HG22 ' A' ' 46' ' ' THR . 4.6 t -65.18 158.7 25.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.338 0.59 . . . . 0.0 110.718 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.042 HG22 ' HB3' ' A' ' 104' ' ' ALA . 63.1 t -136.39 136.55 48.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.927 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.003 HG12 HG12 ' A' ' 105' ' ' VAL . 14.8 p -115.87 104.73 17.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.364 0.602 . . . . 0.0 111.288 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -114.58 110.94 20.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.046 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.8 HG13 ' HB3' ' A' ' 71' ' ' TRP . 15.5 t -107.18 91.46 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 121.29 0.567 . . . . 0.0 109.798 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 m -157.81 171.28 20.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.865 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.406 ' CD ' ' N ' ' A' ' 53' ' ' GLU . 2.2 mm-40 -65.26 130.51 43.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' A' ' 70' ' ' ASP . 18.4 t -76.01 122.27 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -120.2 -47.69 2.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.309 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.6 83.54 2.13 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.522 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.43 -36.74 38.47 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -48.54 13.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -45.84 -54.14 17.63 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 8.3 Cg_exo -73.11 -41.97 1.14 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.645 2.23 . . . . 0.0 113.575 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.065 HD21 HG11 ' A' ' 68' ' ' VAL . 1.3 mm? -63.68 -45.34 90.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -75.27 -28.65 59.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.821 ' CB ' HG21 ' A' ' 37' ' ' ILE . 34.7 mttm -76.41 -37.78 56.58 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.735 ' HB3' HG22 ' A' ' 37' ' ' ILE . 56.3 p30 -101.74 -11.98 18.71 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.88 24.75 6.53 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.017 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 64' ' ' ASP . 9.2 mt -94.47 147.68 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.638 0.256 . . . . 0.0 110.975 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 47' ' ' THR . 23.0 p -78.21 129.21 34.83 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.065 HG11 HD21 ' A' ' 61' ' ' LEU . 8.5 p -145.08 153.04 14.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 111.977 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.463 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.3 t -103.56 131.36 52.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -101.09 106.85 18.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.147 0.499 . . . . 0.0 110.849 -178.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.909 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.9 m95 -110.74 103.83 55.11 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.445 -1.339 0 C-N-CA 123.395 2.73 . . . . 0.0 112.605 -179.396 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 tttt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.599 0.238 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.909 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 14.9 t -55.19 -42.93 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.597 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 0.4 OUTLIER -53.24 -42.31 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.301 178.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 88' ' ' LEU . 22.2 mm-40 -62.8 -31.47 72.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.164 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.39 -50.6 69.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.63 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.807 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.2 OUTLIER -66.42 -28.87 68.96 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.872 179.249 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.958 HD21 ' HB3' ' A' ' 120' ' ' LEU . 33.0 mt -62.68 -44.0 97.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.641 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.1 m -66.52 -38.35 86.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.392 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.401 ' HG ' HG22 ' A' ' 69' ' ' VAL . 1.4 tm? -61.9 -51.47 68.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.988 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.032 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.3 p -74.36 -37.69 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.353 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -44.21 89.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.387 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.78 -43.77 78.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.523 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -69.93 -23.91 63.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -81.76 -52.07 7.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.068 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.5 t -59.51 -37.6 78.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.94 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.99 -33.09 59.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.97 93.2 44.39 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.36 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.89 133.95 20.86 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.504 2.136 . . . . 0.0 112.251 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 59.35 10.97 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.432 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.423 ' HB2' HG21 ' A' ' 46' ' ' THR . 4.4 m -101.1 -163.7 1.04 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.7 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -121.01 113.56 20.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.251 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.782 HG11 ' CE1' ' A' ' 22' ' ' PHE . 44.6 t -105.97 150.23 8.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 1.042 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.22 135.14 54.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.361 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.003 HG12 HG12 ' A' ' 49' ' ' VAL . 34.0 m -140.68 167.81 17.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.741 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.5 t60 -66.87 155.75 37.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.115 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.571 ' HA ' HG23 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -68.46 109.11 3.54 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.396 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.8 HG13 ' CD1' ' A' ' 24' ' ' ILE . 18.7 m -75.79 0.26 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.2 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.48 -8.58 2.84 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.78 -143.37 5.69 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.493 HD22 ' HA2' ' A' ' 142' ' ' GLY . 7.1 mt -115.05 127.27 55.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.99 -144.85 4.23 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.981 -1.104 . . . . 0.0 113.408 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.483 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.4 -17.11 7.15 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.799 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -55.18 -47.03 99.51 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.763 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.6 Cg_endo -52.49 -48.19 23.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.31 2.006 . . . . 0.0 112.773 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.749 HG12 HD11 ' A' ' 120' ' ' LEU . 22.0 t -60.06 -54.15 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.702 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.812 HD12 ' CG2' ' A' ' 49' ' ' VAL . 2.4 mt -52.26 -51.23 59.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.969 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.874 HG22 HG11 ' A' ' 105' ' ' VAL . 21.9 t -52.08 -55.19 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' A' ' 136' ' ' ILE . . . -53.19 -50.18 65.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.333 0.587 . . . . 0.0 111.053 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.958 ' HB3' HD21 ' A' ' 88' ' ' LEU . 13.5 mt -54.38 -30.55 52.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.977 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 1.032 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.94 -39.79 69.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.034 0.445 . . . . 0.0 110.004 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.74 HD13 ' CE ' ' A' ' 20' ' ' MET . 3.4 tp -69.45 -15.54 63.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.636 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.943 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.4 mt -57.12 -30.6 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.886 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -17.0 64.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.0 m -79.79 -23.41 42.17 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.11 -95.79 0.17 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.749 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.492 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 2.7 ptt? -63.84 71.85 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.943 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.37 -67.52 0.44 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.557 ' CD1' HD22 ' A' ' 152' ' ' LEU . 8.0 t80 -65.69 -33.24 75.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.948 0.404 . . . . 0.0 111.068 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.52 -52.34 16.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.219 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.623 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.2 t0 -69.99 -35.91 74.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.857 0.36 . . . . 0.0 110.864 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.649 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -61.36 -50.04 74.5 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.605 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 28.1 mm -74.53 -37.32 43.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.49 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -49.87 21.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.705 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.76 -36.96 79.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.668 0.27 . . . . 0.0 110.485 -179.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.6 tt -74.18 -27.85 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.488 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 4.4 ttt-85 -66.63 -45.79 77.89 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.465 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -45.01 93.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 110.434 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.477 ' HE2' HG22 ' A' ' 15' ' ' VAL . 6.2 mptt -86.18 152.12 23.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.107 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 116.57 13.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.11 0.481 . . . . 0.0 110.531 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.13 163.82 15.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.135 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.493 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -55.64 -170.4 0.09 OUTLIER Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.689 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.93 100.0 12.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.258 0.529 . . . . 0.0 111.303 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.847 HD12 HD21 ' A' ' 149' ' ' LEU . 14.5 pt -87.75 109.54 19.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.571 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.32 -76.71 0.58 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.0 t -99.65 -60.95 1.43 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.858 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 8.9 tmtt? -62.55 -50.8 69.9 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.644 ' NE2' HG22 ' A' ' 144' ' ' ILE . 1.7 mt-30 -55.61 -51.76 66.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.847 HD21 HD12 ' A' ' 144' ' ' ILE . 4.2 mm? -73.58 -45.34 53.83 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.2 m -67.42 -37.4 82.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.754 0.311 . . . . 0.0 111.559 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.858 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.67 -50.31 65.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.147 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -63.85 -34.68 78.49 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.477 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -57.24 -45.22 84.14 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -22.79 62.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.658 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.677 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -66.5 -36.21 82.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.923 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.671 0.272 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.02 162.63 40.45 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.518 2.146 . . . . 0.0 112.368 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.406 HG11 ' HG3' ' A' ' 139' ' ' LYS . 17.5 t -144.2 126.81 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.739 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 mp0 -110.51 129.8 55.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.396 . . . . 0.0 111.503 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.852 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.61 118.89 55.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.95 153.07 29.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.529 . . . . 0.0 112.206 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.514 ' CD2' HD11 ' A' ' 122' ' ' LEU . 18.5 t80 -155.16 112.71 3.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.11 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 9.8 mmtm 65.88 -82.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.27 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -129.26 -42.59 1.34 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.864 ' CE ' HD13 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -73.8 149.53 41.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.945 0.402 . . . . 0.0 111.154 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.02 164.19 26.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.528 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.473 ' C ' HD22 ' A' ' 23' ' ' LEU . 12.2 m-85 -127.59 155.58 43.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.269 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.061 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -125.6 135.88 52.67 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.128 0.489 . . . . 0.0 111.205 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.87 HD13 ' HB ' ' A' ' 105' ' ' VAL . 21.3 mm -118.23 106.42 19.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.275 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -132.27 163.14 29.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.233 0.539 . . . . 0.0 111.824 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.531 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.0 p80 -81.29 152.41 27.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.026 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -62.52 154.54 72.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 50.6 Cg_exo -54.38 136.53 69.5 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.369 2.046 . . . . 0.0 113.279 -177.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -98.75 146.57 25.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.041 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -69.39 -10.32 57.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.256 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -31.24 14.61 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 p -139.85 88.97 2.27 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.127 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.79 -52.22 7.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 111.396 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.454 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.9 t -56.11 -46.94 78.96 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.596 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -57.67 -32.09 66.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.89 0.376 . . . . 0.0 111.195 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.734 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.15 -47.6 27.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.868 HG22 ' OD2' ' A' ' 64' ' ' ASP . 12.1 pt -55.54 -38.78 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.158 0.504 . . . . 0.0 110.573 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -65.74 -51.75 56.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.511 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 9.4 m-20 -68.52 -50.25 53.53 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.734 HD21 ' CE1' ' A' ' 36' ' ' PHE . 75.2 mt -56.45 -44.98 81.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.417 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -77.43 -26.54 51.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.997 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 4.2 mttt -53.12 -46.17 68.64 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.416 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.061 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.1 t80 -63.61 -38.52 91.43 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.809 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.69 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.87 -179.31 38.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.01 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.58 117.79 20.07 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 47' ' ' THR . 1.3 m -164.78 -170.29 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.857 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.704 ' H ' HG22 ' A' ' 46' ' ' THR . 2.9 t -64.85 154.02 38.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.43 0.633 . . . . 0.0 110.707 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.05 HG22 ' HB3' ' A' ' 104' ' ' ALA . 57.8 t -131.42 135.39 59.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.992 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.91 HG13 HG13 ' A' ' 105' ' ' VAL . 11.7 p -115.6 105.06 17.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.273 0.559 . . . . 0.0 111.1 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.08 110.79 20.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.69 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.8 HG13 ' HB3' ' A' ' 71' ' ' TRP . 14.5 t -102.26 90.97 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.1 171.59 19.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.737 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -67.1 129.9 41.39 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -78.43 122.53 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.09 -47.65 2.37 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.448 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.476 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 0.4 OUTLIER -130.63 83.63 2.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.611 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.574 ' O ' HD13 ' A' ' 61' ' ' LEU . 2.8 p30 -78.91 -35.73 43.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -78.26 -48.11 16.43 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -40.88 -60.04 1.83 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 59' ' ' THR . 33.3 Cg_endo -65.16 -42.43 13.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.436 2.091 . . . . 0.0 113.837 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.065 HD11 HG11 ' A' ' 68' ' ' VAL . 5.4 mp -71.37 -28.98 64.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.04 -44.6 46.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.759 ' CB ' HG21 ' A' ' 37' ' ' ILE . 1.6 mttp -81.18 -28.36 35.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.845 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.868 ' OD2' HG22 ' A' ' 37' ' ' ILE . 40.4 m-20 -101.48 -11.61 19.19 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.05 32.44 1.51 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.34 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.454 HG12 ' CB ' ' A' ' 64' ' ' ASP . 1.3 pt -102.56 148.22 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 0.0 111.303 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.2 OUTLIER -78.02 135.36 37.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.065 HG11 HD11 ' A' ' 61' ' ' LEU . 11.3 p -145.02 152.03 14.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.117 0.484 . . . . 0.0 111.919 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.23 132.05 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -100.66 106.76 18.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.289 0.566 . . . . 0.0 110.31 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.972 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.5 m95 -112.88 104.64 55.94 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.794 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.448 -1.2 0 C-N-CA 123.096 2.531 . . . . 0.0 112.707 -179.479 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.683 0.278 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.972 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 39.4 t -60.27 -46.49 94.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.519 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 1.2 t -53.47 -38.69 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 88' ' ' LEU . 14.7 mm-40 -65.29 -31.5 72.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.993 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.95 -50.5 70.54 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.332 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.819 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -66.84 -30.29 70.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.199 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.86 HD21 ' HB3' ' A' ' 120' ' ' LEU . 16.3 mt -60.64 -48.03 83.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.558 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -62.81 -42.16 99.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.172 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -55.08 -51.19 67.14 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.558 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.999 HG21 ' HB1' ' A' ' 121' ' ' ALA . 7.1 p -71.4 -35.94 59.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.047 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 1.7 tmtt? -55.85 -45.36 78.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.903 0.382 . . . . 0.0 110.543 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.67 -41.18 75.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.977 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.673 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.92 -30.61 69.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.363 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' ' OE2' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -82.13 -37.21 26.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.99 -46.1 58.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.873 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -76.26 -33.02 59.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -115.52 89.87 23.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.08 129.23 11.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.607 2.205 . . . . 0.0 112.228 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.37 56.15 25.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.451 ' HB3' HG21 ' A' ' 46' ' ' THR . 0.4 OUTLIER -101.13 -164.75 1.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 111.066 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.69 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -124.76 113.53 18.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.33 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 42.0 t -104.45 150.5 7.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 1.05 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -123.46 135.9 54.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.098 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.926 HG21 HG22 ' A' ' 118' ' ' VAL . 8.0 t -134.05 166.42 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -177.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.74 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.0 t60 -67.45 155.72 38.34 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.862 0.363 . . . . 0.0 110.873 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 25' ' ' THR . 42.2 t -69.07 106.08 2.66 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.829 HG12 ' HD3' ' A' ' 115' ' ' PRO . 2.6 m -75.88 0.57 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.3 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.05 -8.65 2.49 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.69 -140.8 5.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mt -106.56 127.08 53.04 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.65 -158.82 10.21 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.423 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.541 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.62 -14.35 7.77 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.375 -0.413 . . . . 0.0 111.861 -178.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.856 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -58.06 -46.93 99.65 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.829 ' HD3' HG12 ' A' ' 108' ' ' VAL . 9.5 Cg_endo -52.52 -48.49 21.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.131 1.888 . . . . 0.0 112.381 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.82 HG21 ' CD ' ' A' ' 148' ' ' GLN . 87.0 t -58.65 -52.44 59.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.232 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 51' ' ' VAL . 9.4 mt -51.9 -49.08 63.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.732 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.926 HG22 HG21 ' A' ' 105' ' ' VAL . 85.7 t -51.46 -49.68 31.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.914 0.388 . . . . 0.0 110.638 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.699 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -54.65 -47.85 73.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.672 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.86 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.6 mt -55.03 -31.63 61.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.87 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.999 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.24 -51.68 19.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.219 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.864 HD13 ' CE ' ' A' ' 20' ' ' MET . 5.8 tp -68.31 -13.98 62.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.581 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 1.071 HD11 HD21 ' A' ' 152' ' ' LEU . 1.1 mt -58.15 -36.38 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.157 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.403 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 4.5 pt-20 -63.03 -16.04 58.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.626 ' HB2' HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -79.77 11.17 3.39 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 116.89 -95.44 0.67 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.79 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.493 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 4.8 ptt? -62.67 75.48 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.946 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -71.76 -67.59 0.52 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 9.8 t80 -68.65 -32.19 71.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.977 0.418 . . . . 0.0 111.165 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.45 -50.56 25.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.301 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.0 t0 -70.09 -40.05 75.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.772 0.32 . . . . 0.0 111.363 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.7 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -61.89 -48.51 80.16 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.005 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 34.6 mm -73.06 -41.23 59.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.494 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -74.73 -50.12 18.58 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.852 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -67.99 -39.75 83.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.594 0.235 . . . . 0.0 110.812 -179.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.2 tp -74.54 -28.61 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.774 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 5.8 ttm-85 -64.53 -41.68 96.22 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -41.6 90.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.016 0.436 . . . . 0.0 110.061 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.494 ' HE2' HG13 ' A' ' 15' ' ' VAL . 5.6 mptt -87.17 151.85 22.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.102 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 116.73 14.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 110.607 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.474 ' HD2' HG23 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -114.97 163.5 15.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.209 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -57.06 -166.64 0.07 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.715 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.19 100.0 12.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.298 0.549 . . . . 0.0 111.599 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.945 HD12 ' CD2' ' A' ' 149' ' ' LEU . 12.5 pt -87.87 109.46 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.476 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -113.2 -76.64 0.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.9 t -99.8 -61.1 1.41 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.793 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 10.0 tmtt? -65.78 -49.87 66.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -176.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.82 ' CD ' HG21 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -56.33 -52.04 66.02 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.308 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.945 ' CD2' HD12 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -72.86 -46.6 52.02 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.528 -179.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 81.2 m -62.61 -39.16 92.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.23 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.793 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -62.34 -50.56 71.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.761 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.071 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -62.01 -37.1 83.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.501 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -57.08 -37.95 72.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -22.74 58.81 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.646 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.544 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.19 -34.08 77.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.993 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.374 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.657 0.265 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.662 ' HB3' HG22 ' A' ' 25' ' ' THR . 56.4 Cg_endo -70.58 162.47 42.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.496 2.131 . . . . 0.0 112.272 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.522 HG11 ' HD2' ' A' ' 139' ' ' LYS . 24.6 t -144.13 127.04 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.805 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.17 116.67 31.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.836 0.35 . . . . 0.0 111.46 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.803 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -109.66 118.45 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.1 p -140.96 142.69 34.31 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.59 ' HE1' HD11 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -137.37 162.08 34.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.162 178.291 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 3.0 pttp 48.92 -100.65 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.014 0.126 . . . . 0.0 110.76 -177.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.452 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -124.35 -25.68 4.05 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.157 -0.34 . . . . 0.0 111.908 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.728 ' HE3' HD13 ' A' ' 122' ' ' LEU . 5.1 ppp? -74.01 165.91 24.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 111.464 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -143.5 156.74 44.71 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.282 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.721 ' CE1' HG11 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -137.42 138.39 39.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.299 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.06 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -115.09 135.53 54.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.051 0.453 . . . . 0.0 111.359 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.816 HD12 HG13 ' A' ' 108' ' ' VAL . 1.9 mm -118.23 106.61 20.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 12' ' ' PRO . 1.4 p -131.01 166.55 20.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.606 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.536 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 5.9 p80 -81.25 152.0 27.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.731 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -62.64 153.71 77.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.1 Cg_exo -54.94 142.37 76.0 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.476 2.118 . . . . 0.0 113.291 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.483 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 6.4 p -98.7 174.35 6.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.158 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -94.95 -12.35 26.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.54 -30.83 14.8 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -139.51 89.77 2.36 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.452 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.23 -52.2 8.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.055 0.455 . . . . 0.0 111.16 178.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.456 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.0 m -55.96 -43.51 77.57 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.358 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 m -58.04 -37.38 74.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.878 0.37 . . . . 0.0 111.257 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.674 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.21 -48.13 53.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.933 HG21 ' HB3' ' A' ' 63' ' ' LYS . 13.7 pt -55.94 -39.63 58.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.183 0.516 . . . . 0.0 110.79 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -62.85 -52.01 64.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.336 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -69.84 -50.28 44.3 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.884 0.374 . . . . 0.0 111.774 -179.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.674 HD21 ' CE1' ' A' ' 36' ' ' PHE . 48.5 mt -56.27 -43.68 79.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.046 0.451 . . . . 0.0 110.265 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -78.6 -26.83 45.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.098 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -53.0 -43.81 66.75 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.151 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.06 ' CD1' HD21 ' A' ' 23' ' ' LEU . 13.5 t80 -63.35 -38.52 91.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.671 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.735 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.21 -179.92 39.45 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.803 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.44 117.07 19.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.927 HG21 ' OG ' ' A' ' 101' ' ' SER . 0.4 OUTLIER -165.42 -169.12 1.51 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.94 177.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.709 ' HA ' HG23 ' A' ' 67' ' ' THR . 9.8 t -64.05 154.0 35.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.676 0.75 . . . . 0.0 110.578 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 104' ' ' ALA . 60.3 t -134.2 137.57 51.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.453 -178.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.02 HG13 HG13 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -115.56 105.18 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.067 0.461 . . . . 0.0 110.445 178.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -113.6 111.0 21.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.637 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.885 HG11 ' HB2' ' A' ' 113' ' ' ARG . 44.0 t -107.9 92.09 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.642 0.734 . . . . 0.0 110.59 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.42 171.15 20.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.453 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.62 130.2 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.612 HG13 ' HB3' ' A' ' 72' ' ' PRO . 9.3 m -68.89 121.91 19.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.61 -47.65 2.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.82 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.414 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.8 m-85 -130.74 84.36 2.19 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.213 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -78.55 -35.92 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -78.93 -48.52 14.41 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.88 HG22 ' HD3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -44.53 -50.92 22.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 32.3 Cg_exo -59.25 -40.37 69.39 Favored 'Trans proline' 0 N--CA 1.471 0.196 0 C-N-CA 122.622 2.215 . . . . 0.0 113.653 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.766 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -71.09 -45.02 64.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -75.2 -49.31 19.83 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.933 ' HB3' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -64.7 -35.53 81.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.911 ' OD2' HG22 ' A' ' 37' ' ' ILE . 49.1 m-20 -101.22 -11.45 19.5 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.09 24.81 9.49 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.789 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.464 HG12 ' CB ' ' A' ' 64' ' ' ASP . 16.2 pt -110.78 148.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.763 HG21 ' HD2' ' A' ' 94' ' ' LYS . 6.7 t -77.7 135.1 38.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.075 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.766 HG12 ' CD2' ' A' ' 61' ' ' LEU . 7.4 p -145.21 151.91 14.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.052 0.453 . . . . 0.0 111.649 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.608 HG22 ' HG ' ' A' ' 90' ' ' LEU . 3.6 t -103.5 133.33 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.97 106.64 17.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.156 0.503 . . . . 0.0 110.478 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.736 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.3 m95 -110.03 103.24 53.16 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.63 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HB3' HG13 ' A' ' 54' ' ' VAL . 24.8 Cg_endo . . . . . 0 N--CA 1.446 -1.32 0 C-N-CA 123.547 2.831 . . . . 0.0 112.82 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.398 0.142 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.714 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 16.1 t -56.33 -48.46 79.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.897 HG11 HD22 ' A' ' 120' ' ' LEU . 71.4 t -54.19 -40.99 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.092 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.751 ' HA ' HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -57.84 -31.47 66.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.456 178.338 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -50.32 70.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.274 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.616 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.08 -33.2 75.24 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.858 HD21 ' HB3' ' A' ' 120' ' ' LEU . 11.1 mt -55.94 -47.75 76.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.4 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -63.0 -39.89 96.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.083 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.608 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.8 tm? -61.56 -51.17 69.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.94 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.73 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.7 p -68.79 -42.49 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.639 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.438 ' N ' HG13 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -53.87 -47.39 71.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 111.038 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -48.08 76.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.826 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.763 ' HD2' HG21 ' A' ' 67' ' ' THR . 21.3 mmtt -66.12 -26.54 67.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.018 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 103' ' ' VAL . 2.4 m-85 -79.27 -51.92 8.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.969 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 t -56.89 -33.71 67.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.047 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.0 -33.06 59.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.046 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.25 84.02 62.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.52 128.23 26.49 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.601 2.201 . . . . 0.0 112.101 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.37 59.8 10.08 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.282 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.927 ' OG ' HG21 ' A' ' 46' ' ' THR . 84.9 p -101.1 -171.26 1.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.308 . . . . 0.0 111.425 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.735 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.1 m -106.21 113.77 27.49 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.324 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.721 HG11 ' CE1' ' A' ' 22' ' ' PHE . 44.5 t -111.26 150.86 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -122.45 142.5 50.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.069 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.02 HG13 HG13 ' A' ' 49' ' ' VAL . 3.2 t -140.09 167.08 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.727 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 3.6 t60 -67.2 155.61 38.37 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.7 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' THR . 26.9 p -68.86 105.18 2.27 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.32 0.581 . . . . 0.0 112.433 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.844 HG12 ' HD3' ' A' ' 115' ' ' PRO . 26.6 m -75.22 0.02 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.919 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.65 -8.79 3.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.419 ' O ' HD23 ' A' ' 111' ' ' LEU . . . -123.74 -134.87 4.39 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.48 ' HA ' ' HA2' ' A' ' 142' ' ' GLY . 7.3 mt -118.83 127.46 53.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.41 -153.97 7.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.63 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.885 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.3 -20.2 6.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.114 0.483 . . . . 0.0 111.669 -178.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.661 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.81 -46.29 86.9 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.844 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.6 Cg_endo -52.01 -48.5 21.3 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.157 1.905 . . . . 0.0 113.078 -178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.614 ' O ' HD13 ' A' ' 120' ' ' LEU . 11.7 t -60.95 -39.99 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.693 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.503 HD12 ' CG2' ' A' ' 49' ' ' VAL . 9.7 mt -59.5 -55.0 40.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.633 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.854 ' CG2' HG11 ' A' ' 105' ' ' VAL . 55.6 t -52.01 -55.21 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.725 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -52.85 -53.22 51.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.009 0.433 . . . . 0.0 111.31 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.897 HD22 HG11 ' A' ' 84' ' ' VAL . 7.7 mp -54.92 -30.18 57.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.98 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.73 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.27 -47.72 48.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.886 0.374 . . . . 0.0 110.403 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.728 HD13 ' HE3' ' A' ' 20' ' ' MET . 12.6 tp -65.1 -13.06 57.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.816 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.928 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.1 mt -57.05 -36.37 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.311 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.425 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -63.22 -16.79 61.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.7 m -80.03 7.45 9.05 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 114.39 -99.09 0.92 Allowed Glycine 0 N--CA 1.46 0.246 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.922 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.571 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 3.6 ptt? -62.56 75.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.928 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -73.4 -67.86 0.55 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -176.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.666 ' CD1' HD22 ' A' ' 152' ' ' LEU . 4.4 t80 -66.72 -32.86 74.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.949 0.404 . . . . 0.0 111.162 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.17 -51.86 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.208 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 25.8 t0 -70.12 -40.39 74.9 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.918 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.725 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -58.01 -49.17 77.75 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.315 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.7 mm -69.7 -42.56 80.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -49.76 21.84 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.803 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.27 -34.29 77.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 110.724 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.7 tt -74.27 -33.34 34.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.974 0.416 . . . . 0.0 110.49 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -40.76 96.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.087 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.58 -45.29 92.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.984 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.522 ' HD2' HG11 ' A' ' 13' ' ' VAL . 68.5 mmtt -87.33 151.65 22.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.419 ' C ' ' HD2' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -73.31 117.25 14.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.896 0.379 . . . . 0.0 110.419 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.467 ' HG2' ' CG1' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -115.36 163.43 15.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.691 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -55.45 -176.05 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.346 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.54 98.81 3.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.692 0.746 . . . . 0.0 110.716 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.457 HG21 ' HG3' ' A' ' 148' ' ' GLN . 1.3 pp -88.67 109.24 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -113.22 -76.59 0.58 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.214 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.757 ' O ' HG22 ' A' ' 150' ' ' THR . 36.5 m -99.77 -60.62 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.643 ' O ' ' CB ' ' A' ' 151' ' ' TYR . 1.2 tmtt? -48.66 -51.43 28.42 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.457 ' HG3' HG21 ' A' ' 144' ' ' ILE . 1.9 tm0? -55.77 -52.08 65.17 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.576 ' N ' HD22 ' A' ' 149' ' ' LEU . 3.2 mm? -75.66 -45.29 37.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 146' ' ' SER . 6.5 t -67.78 -34.37 76.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.361 . . . . 0.0 111.34 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.643 ' CB ' ' O ' ' A' ' 147' ' ' LYS . 1.3 t80 -68.17 -50.8 52.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.3 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.825 HD21 HD11 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -71.25 -38.92 71.91 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.519 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -36.48 68.0 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -26.35 59.92 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.465 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.631 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -65.82 -29.46 69.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.205 179.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.882 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -96.31 -51.36 4.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -142.26 35.86 1.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.83 143.17 50.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.59 156.35 39.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.142 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.53 178.27 7.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 60.74 157.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.57 96.66 3.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.602 HH21 HG21 ' A' ' 29' ' ' THR . 11.3 mtt85 -79.45 147.88 69.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.01 137.12 62.05 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.547 2.164 . . . . 0.0 112.339 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.86 143.6 54.07 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.021 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 61.0 Cg_endo -72.99 162.48 40.88 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.505 2.137 . . . . 0.0 112.355 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.433 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.1 t -144.16 126.89 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 pm0 -108.94 121.31 44.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.94 0.4 . . . . 0.0 111.652 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.763 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -106.8 118.66 54.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.7 p -140.63 140.01 34.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.135 0.493 . . . . 0.0 112.156 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CD2' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -138.98 139.4 37.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.746 178.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 11.1 mmmt 65.93 -88.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.295 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -129.46 -39.76 1.47 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.5 ptm -73.61 161.77 29.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 111.565 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 164.22 30.78 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.601 ' CE1' HG11 ' A' ' 103' ' ' VAL . 2.5 m-85 -133.05 154.23 50.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.277 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.073 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -126.32 130.68 51.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.056 0.455 . . . . 0.0 110.939 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.927 HD12 HG13 ' A' ' 108' ' ' VAL . 2.6 mm -114.46 106.58 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -130.86 167.34 19.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.908 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 51.0 p-80 -80.99 152.2 28.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.875 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -62.64 154.29 74.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.512 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 9.6 Cg_endo -54.45 141.76 72.04 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.61 2.206 . . . . 0.0 113.464 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.602 HG21 HH21 ' A' ' 9' ' ' ARG . 1.2 p -98.98 174.37 6.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.009 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -97.96 -10.43 24.52 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.61 -30.43 14.96 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.7 p -139.19 90.01 2.39 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.373 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -79.99 -52.18 8.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.043 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.446 ' HA ' HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -57.62 -44.02 85.21 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.091 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.3 m -57.93 -33.51 68.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.849 0.357 . . . . 0.0 111.233 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.579 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -73.71 -47.93 35.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.046 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.881 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.6 pt -55.94 -39.53 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.53 . . . . 0.0 110.697 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.12 -52.14 60.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.519 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -68.99 -50.11 51.82 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.863 0.363 . . . . 0.0 111.843 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.579 HD21 ' CE1' ' A' ' 36' ' ' PHE . 41.9 mt -56.52 -44.47 80.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -77.86 -26.67 49.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.081 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -52.9 -45.37 67.5 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.268 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.073 ' CD1' HD21 ' A' ' 23' ' ' LEU . 15.3 t80 -63.51 -38.32 90.69 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.779 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.664 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.63 -177.92 40.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.946 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.63 117.9 20.18 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.755 HG22 ' H ' ' A' ' 47' ' ' THR . 1.7 m -164.9 -170.63 2.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.88 177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.884 ' HA ' HG23 ' A' ' 67' ' ' THR . 2.9 t -64.87 153.36 40.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.507 0.67 . . . . 0.0 110.565 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 104' ' ' ALA . 55.8 t -131.42 133.33 62.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.944 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.051 HG13 HG13 ' A' ' 105' ' ' VAL . 6.4 p -115.57 105.4 18.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.346 0.593 . . . . 0.0 111.279 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -114.22 111.06 20.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.113 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' A' ' 71' ' ' TRP . 10.7 t -104.12 91.59 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.402 0.62 . . . . 0.0 110.093 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.502 ' HG ' ' CE1' ' A' ' 106' ' ' HIS . 1.1 m -157.74 171.3 20.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.552 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.95 130.41 43.29 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.75 122.23 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.4 p -120.23 -47.8 2.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.868 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.455 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -130.74 83.92 2.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.384 178.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -79.11 -37.15 39.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -80.08 -48.42 13.28 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.415 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.19 -53.05 24.53 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -177.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.455 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 11.0 Cg_exo -72.58 -42.76 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.412 2.074 . . . . 0.0 113.983 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.706 ' CD1' HG12 ' A' ' 68' ' ' VAL . 2.5 tt -71.53 -45.23 62.94 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.42 -28.7 68.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.473 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.881 ' HB3' HG21 ' A' ' 37' ' ' ILE . 16.1 mttt -80.5 -34.01 36.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.882 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.488 ' HB3' HG22 ' A' ' 37' ' ' ILE . 44.9 p30 -101.25 -11.33 19.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.03 34.62 52.6 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.804 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' A' ' 46' ' ' THR . 6.0 mt -108.61 147.35 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.646 0.26 . . . . 0.0 110.967 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.884 HG23 ' HA ' ' A' ' 47' ' ' THR . 4.4 t -78.41 132.79 37.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.706 HG12 ' CD1' ' A' ' 61' ' ' LEU . 7.4 p -144.99 151.11 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.133 0.492 . . . . 0.0 111.965 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.34 131.93 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -101.21 106.72 17.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.164 0.507 . . . . 0.0 111.09 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.812 ' HB3' HG13 ' A' ' 51' ' ' VAL . 5.2 m0 -110.96 103.93 55.47 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.302 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -106.13 164.6 0.14 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.321 2.681 . . . . 0.0 112.993 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.422 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 8.3 t80 -126.21 95.93 4.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.665 ' H ' ' HB2' ' A' ' 77' ' ' ALA . 7.7 p-10 -125.33 -171.41 2.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -54.96 -27.27 42.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.044 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -114.68 41.25 2.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.529 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.665 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -85.95 119.42 71.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.43 0.157 . . . . 0.0 110.911 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.579 ' HG2' HG11 ' A' ' 83' ' ' VAL . 18.9 Cg_endo -59.98 108.13 0.46 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.543 2.162 . . . . 0.0 112.541 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.638 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 82.3 Cg_endo -78.3 -23.68 8.59 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.683 2.255 . . . . 0.0 115.442 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.889 ' O ' HG22 ' A' ' 83' ' ' VAL . 32.8 Cg_endo -65.52 152.34 82.14 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.368 1.379 . . . . 0.0 113.284 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.427 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -56.65 -20.71 32.77 Favored Glycine 0 C--O 1.236 0.234 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.334 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.74 -34.08 37.6 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.491 0.186 . . . . 0.0 110.972 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 80' ' ' PRO . 1.1 m -53.98 -49.05 62.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 151' ' ' TYR . 7.5 t -54.57 -42.87 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.5 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -56.15 -31.53 63.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.99 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -68.49 -50.4 52.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.009 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.799 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -67.8 -28.09 67.3 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 120' ' ' LEU . 11.1 mt -63.5 -43.95 95.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.25 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.2 -41.51 94.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.205 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.1 tm? -59.35 -51.34 70.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.673 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.103 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.6 p -71.36 -35.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.072 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.03 -45.92 86.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.96 86.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.599 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -72.2 -23.9 61.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.157 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -79.28 -52.04 8.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.775 0.322 . . . . 0.0 111.184 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 25.4 t -65.02 -36.82 85.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -76.11 -32.82 59.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.268 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.573 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -123.45 88.58 51.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.526 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.37 130.71 19.03 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.816 2.344 . . . . 0.0 112.063 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.34 57.81 17.82 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.448 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.573 ' OG ' ' HB1' ' A' ' 98' ' ' ALA . 4.7 m -101.08 -164.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.719 0.295 . . . . 0.0 111.212 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.664 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -123.11 113.55 19.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.373 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.601 HG11 ' CE1' ' A' ' 22' ' ' PHE . 24.3 t -107.45 151.06 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.73 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -122.2 139.97 53.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.982 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.051 HG13 HG13 ' A' ' 49' ' ' VAL . 10.8 t -140.09 166.73 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.663 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.0 t60 -66.81 156.35 35.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.516 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.53 ' HA ' HG23 ' A' ' 24' ' ' ILE . 20.8 t -68.13 104.49 1.8 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.927 HG13 HD12 ' A' ' 24' ' ' ILE . 34.5 m -75.56 0.25 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.06 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.4 -8.53 2.73 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.25 -127.49 3.12 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 143' ' ' ALA . 0.0 OUTLIER -128.14 127.27 42.69 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.42 -144.44 4.1 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.607 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.661 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.29 -25.96 4.74 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.163 0.506 . . . . 0.0 112.017 -178.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.671 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -50.23 -46.22 83.08 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.838 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.2 Cg_endo -51.72 -48.54 20.92 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.306 2.004 . . . . 0.0 113.275 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 1.041 HG12 HD11 ' A' ' 120' ' ' LEU . 57.9 t -61.68 -46.66 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.818 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.53 ' HA ' HD12 ' A' ' 120' ' ' LEU . 11.6 mt -54.77 -46.55 74.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.847 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.893 ' CG2' HG11 ' A' ' 105' ' ' VAL . 57.6 t -57.37 -55.28 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.726 0.298 . . . . 0.0 111.671 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -52.98 -48.76 67.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.336 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 1.041 HD11 HG12 ' A' ' 116' ' ' VAL . 5.5 mt -59.06 -30.55 68.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.389 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 1.103 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.12 -42.43 66.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.967 0.413 . . . . 0.0 110.227 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.551 HD13 ' OD2' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -70.75 -16.11 62.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.595 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.914 ' CD1' HD21 ' A' ' 152' ' ' LEU . 1.4 mt -57.42 -30.97 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.124 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -15.97 14.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.539 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.87 11.29 5.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.27 -83.79 0.35 Allowed Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.4 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.502 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.9 76.92 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 121.337 0.589 . . . . 0.0 109.534 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.882 ' CB ' HG23 ' A' ' 123' ' ' ILE . 11.3 mttt -62.56 -67.4 0.42 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.088 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.487 ' HD1' HD13 ' A' ' 152' ' ' LEU . 6.1 t80 -73.61 -31.68 63.68 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.069 0.462 . . . . 0.0 110.762 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.3 -46.4 55.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.061 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.551 ' OD2' HD13 ' A' ' 122' ' ' LEU . 47.9 t0 -70.24 -47.19 62.45 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.457 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.84 ' HB3' HD11 ' A' ' 152' ' ' LEU . . . -57.97 -50.06 74.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.821 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.0 mm -70.8 -37.78 70.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -74.37 -49.71 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.763 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -70.19 -35.44 73.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.501 0.191 . . . . 0.0 111.066 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 132' ' ' ALA . 4.2 tt -74.25 -32.7 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.782 0.325 . . . . 0.0 110.662 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -64.93 -43.99 90.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.497 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.82 -44.19 94.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.527 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.05 152.08 22.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.667 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -72.96 117.73 15.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.378 . . . . 0.0 110.33 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.488 ' HG3' HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -114.13 163.9 14.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.433 -179.109 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -56.45 -165.42 0.05 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.039 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.842 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -82.1 99.0 8.95 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.715 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.794 HG23 ' HB3' ' A' ' 148' ' ' GLN . 45.8 mt -88.73 108.88 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.828 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -114.03 -78.09 0.58 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.021 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.6 t -101.32 -61.23 1.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.832 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.7 tmtt? -48.99 -51.54 30.01 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.794 ' HB3' HG23 ' A' ' 144' ' ' ILE . 7.2 tm0? -56.28 -51.51 67.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.433 ' CD2' ' CG2' ' A' ' 144' ' ' ILE . 3.9 mm? -75.19 -37.69 61.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.5 m -73.08 -42.68 62.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.033 0.444 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.832 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -64.0 -50.11 69.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.034 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.914 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -64.28 -38.16 90.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.709 0.29 . . . . 0.0 110.871 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.56 -43.98 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -24.76 57.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.497 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.74 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.9 OUTLIER -66.42 -23.75 66.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.651 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.434 ' HB2' ' HB2' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -106.8 126.92 29.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.217 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.09 153.42 62.73 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.556 2.171 . . . . 0.0 112.202 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -146.88 123.5 11.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.028 0.442 . . . . 0.0 110.574 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.97 -26.85 68.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.052 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -58.94 -30.38 67.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.829 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.99 -28.34 24.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -96.23 40.45 1.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -97.83 102.54 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -112.23 128.12 56.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.6 136.55 32.85 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.24 -62.11 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.44 2.093 . . . . 0.0 112.265 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -86.69 114.12 23.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.1 p -149.61 179.21 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.45 145.97 51.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -131.88 138.97 48.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.7 m -143.17 -52.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.5 p -139.04 153.42 48.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.369 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -77.18 148.34 35.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.1 mmt -135.46 140.19 44.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.37 132.89 16.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 ptm85 -150.0 149.94 31.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.94 109.11 8.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.974 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -117.74 -40.31 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.696 ' HE ' HG21 ' A' ' 29' ' ' THR . 4.0 mpt_? -132.92 150.99 77.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.961 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.91 145.86 30.96 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.655 2.237 . . . . 0.0 112.424 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.3 143.63 65.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.012 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.512 ' HB3' HG22 ' A' ' 25' ' ' THR . 61.2 Cg_endo -73.03 162.41 40.99 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.458 2.106 . . . . 0.0 112.479 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.751 HG11 ' HD2' ' A' ' 139' ' ' LYS . 12.7 t -144.07 126.92 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.85 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.7 OUTLIER -108.64 121.96 46.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.576 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.764 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.75 120.6 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.41 ' HB3' ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -116.02 147.03 41.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.195 0.522 . . . . 0.0 111.978 -178.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HD2' HD21 ' A' ' 122' ' ' LEU . 20.5 t80 -155.12 127.62 7.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.225 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.45 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 7.2 mmpt? 55.06 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.521 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -129.26 -46.45 1.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.538 ' CE ' HD21 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -73.66 139.84 45.68 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.099 0.476 . . . . 0.0 111.266 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.41 ' HG2' ' HB3' ' A' ' 16' ' ' SER . 1.6 mtt180 -115.35 164.4 14.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.276 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CE1' HG11 ' A' ' 103' ' ' VAL . 1.4 m-85 -131.97 138.39 48.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.562 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.061 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -114.88 133.74 55.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.422 . . . . 0.0 110.962 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.82 HG21 HG12 ' A' ' 108' ' ' VAL . 1.5 mm -115.85 106.52 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.57 HG21 HD23 ' A' ' 40' ' ' LEU . 1.6 p -132.33 162.89 29.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.27 0.557 . . . . 0.0 111.936 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.535 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.7 p80 -81.41 152.13 27.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.937 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -62.74 154.36 75.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.987 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.4 Cg_exo -54.55 140.83 75.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.343 2.029 . . . . 0.0 113.275 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.696 HG21 ' HE ' ' A' ' 9' ' ' ARG . 32.3 p -98.47 174.33 6.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.161 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -93.37 -11.64 31.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.69 -31.04 14.61 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -139.69 89.65 2.34 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.519 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.636 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.3 OUTLIER -80.38 -52.16 8.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.173 0.511 . . . . 0.0 111.272 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 37' ' ' ILE . 1.1 p -56.79 -45.64 82.03 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.359 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.1 m -57.72 -33.47 68.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.936 0.398 . . . . 0.0 111.439 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.741 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.27 -47.93 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.174 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.83 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.0 pt -55.91 -39.08 55.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.216 0.531 . . . . 0.0 110.696 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -65.21 -51.86 58.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.487 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 4.0 m-20 -68.64 -50.05 54.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.873 0.368 . . . . 0.0 111.906 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.741 HD21 ' CE1' ' A' ' 36' ' ' PHE . 58.7 mt -55.93 -44.84 78.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.871 0.367 . . . . 0.0 110.412 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -78.53 -26.62 45.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.028 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -53.36 -42.8 67.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.406 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.061 ' CD1' HD21 ' A' ' 23' ' ' LEU . 17.9 t80 -63.37 -38.56 91.61 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.241 -0.583 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.654 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.64 -177.71 40.12 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.958 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.54 117.71 19.99 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.738 HG22 ' H ' ' A' ' 47' ' ' THR . 1.7 m -164.8 -170.23 1.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.63 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.738 ' H ' HG22 ' A' ' 46' ' ' THR . 2.9 t -64.7 158.65 24.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.411 0.624 . . . . 0.0 110.443 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 104' ' ' ALA . 59.8 t -136.47 136.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.333 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.11 HG13 HG13 ' A' ' 105' ' ' VAL . 2.4 p -115.64 105.17 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.282 0.563 . . . . 0.0 110.699 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.404 ' HG2' ' CG2' ' A' ' 68' ' ' VAL . 7.4 ptm180 -113.99 110.72 20.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.705 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.8 HG13 ' HB3' ' A' ' 71' ' ' TRP . 18.5 t -105.39 90.94 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.537 0.684 . . . . 0.0 109.817 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 t -158.4 171.77 19.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.582 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -65.51 130.02 41.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 m -74.33 122.39 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.26 -47.6 2.35 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.182 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.413 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.2 m-85 -130.54 84.29 2.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.628 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.433 ' O ' HD23 ' A' ' 61' ' ' LEU . 2.4 m-20 -78.56 -35.87 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -78.84 -48.42 14.76 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.636 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -44.64 -49.82 25.56 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 8.2 Cg_exo -73.16 -39.44 2.18 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.737 2.291 . . . . 0.0 113.336 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.868 HD21 ' CG1' ' A' ' 68' ' ' VAL . 3.7 mm? -66.95 -45.26 78.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -75.35 -33.34 61.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.83 ' HB3' HG21 ' A' ' 37' ' ' ILE . 5.8 mmtt -81.12 -32.05 33.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' CB ' HG12 ' A' ' 66' ' ' ILE . 71.1 m-20 -101.37 -11.5 19.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 44.6 34.77 3.83 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.051 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.555 HD12 HG21 ' A' ' 48' ' ' VAL . 4.3 pt -114.69 148.82 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.694 0.283 . . . . 0.0 111.001 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 47' ' ' THR . 81.9 p -77.53 135.2 38.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.868 ' CG1' HD21 ' A' ' 61' ' ' LEU . 7.9 p -144.9 151.73 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.084 0.469 . . . . 0.0 111.941 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.539 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.1 t -103.43 132.59 49.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -100.87 106.71 18.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.189 0.519 . . . . 0.0 110.365 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.81 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.0 m95 -111.93 104.07 55.74 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.136 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -106.85 169.5 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 123.599 2.866 . . . . 0.0 112.6 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 9.0 t80 -126.11 95.96 4.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.752 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.43 -173.99 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.833 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -57.48 -26.96 62.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.97 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.19 64.9 0.53 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.26 106.87 28.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.345 0.117 . . . . 0.0 110.903 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.444 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . 72.8 Cg_exo -40.16 97.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.945 2.43 . . . . 0.0 113.024 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.69 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 52.9 Cg_exo -55.92 -42.05 70.9 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.107 2.538 . . . . 0.0 114.339 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 2.7 Cg_endo -47.67 151.72 3.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.303 2.002 . . . . 0.0 113.507 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.564 ' HA2' ' HZ1' ' A' ' 147' ' ' LYS . . . -65.97 -19.7 68.02 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.362 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -50.52 -29.74 11.31 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 120.57 0.224 . . . . 0.0 110.818 -178.131 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.81 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 21.8 t -56.09 -48.0 79.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.734 HG11 ' HG ' ' A' ' 120' ' ' LEU . 94.0 t -55.98 -37.9 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.024 177.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.766 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.0 OUTLIER -59.46 -31.33 69.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.529 178.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -66.16 -50.74 62.89 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.23 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.706 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -67.97 -26.98 66.2 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.796 HD21 ' HB3' ' A' ' 120' ' ' LEU . 18.2 mt -61.05 -41.5 96.71 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.111 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -67.58 -42.54 82.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.872 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.466 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.3 tm? -60.32 -51.48 69.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.772 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.019 HG21 ' HB1' ' A' ' 121' ' ' ALA . 7.3 p -68.42 -43.94 83.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.25 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.441 ' N ' HG13 ' A' ' 91' ' ' VAL . 26.7 mttt -54.7 -40.33 69.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.907 0.384 . . . . 0.0 110.833 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.64 -45.78 77.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.992 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.403 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 2.3 mmtt -74.6 -24.81 58.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.652 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -82.1 -45.53 15.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.747 0.308 . . . . 0.0 111.109 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.92 -37.86 69.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.915 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -76.11 -32.99 59.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.04 88.82 53.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.451 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.24 133.89 13.76 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.58 2.187 . . . . 0.0 112.319 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.2 46.42 34.91 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.45 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.418 ' HB3' HG21 ' A' ' 46' ' ' THR . 0.4 OUTLIER -101.21 -165.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 111.269 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.654 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.0 m -127.42 113.71 16.56 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.199 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.487 HG11 ' CE1' ' A' ' 22' ' ' PHE . 5.4 t -110.65 151.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.737 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -118.97 144.73 46.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.308 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.11 HG13 HG13 ' A' ' 49' ' ' VAL . 3.5 t -140.37 167.08 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.622 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.6 t60 -66.97 156.34 36.21 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.463 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 25' ' ' THR . 25.6 p -68.19 101.72 1.22 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.471 0.653 . . . . 0.0 112.593 -177.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.82 HG12 HG21 ' A' ' 24' ' ' ILE . 5.4 p -75.55 0.08 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.065 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.46 -8.53 2.8 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.18 -125.84 3.08 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.755 -0.735 . . . . 0.0 111.391 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.858 HD21 ' HB2' ' A' ' 143' ' ' ALA . 0.0 OUTLIER -132.06 127.31 35.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.58 -142.73 3.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.644 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.742 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.31 -22.06 5.65 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.043 0.449 . . . . 0.0 111.965 -178.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.677 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -49.85 -46.33 80.67 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 5.7 Cg_endo -51.6 -48.38 21.64 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.482 2.121 . . . . 0.0 113.107 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.601 ' O ' HD23 ' A' ' 120' ' ' LEU . 43.5 t -61.1 -42.59 93.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.805 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.726 HD12 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -57.56 -55.07 39.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.687 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.893 ' CG2' HG11 ' A' ' 105' ' ' VAL . 61.1 t -52.93 -55.2 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.618 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -53.01 -53.14 54.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.249 0.547 . . . . 0.0 110.72 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.796 ' HB3' HD21 ' A' ' 88' ' ' LEU . 2.4 mm? -54.34 -30.78 52.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.793 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 1.019 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.21 -48.88 39.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.954 0.406 . . . . 0.0 110.467 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.538 HD21 ' CE ' ' A' ' 20' ' ' MET . 0.3 OUTLIER -62.92 -14.66 49.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.712 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.922 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.3 mt -57.01 -30.86 35.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.832 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -16.65 62.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.574 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.5 m -83.13 11.02 6.95 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.27 -101.85 1.08 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.016 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.476 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.3 ptt? -62.53 78.67 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.922 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.86 -67.65 0.55 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -176.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.64 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.6 t80 -67.42 -32.05 72.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.856 0.36 . . . . 0.0 111.092 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.38 -51.35 20.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.199 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.2 t0 -69.61 -38.36 77.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 111.009 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.618 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -60.36 -49.93 75.61 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.972 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.7 mm -73.56 -38.0 51.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.562 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.09 -49.72 22.71 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.764 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.84 -36.38 75.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.675 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.4 tt -74.29 -27.83 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.775 0.321 . . . . 0.0 110.434 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -49.67 66.65 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.542 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -45.14 93.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.61 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.751 ' HD2' HG11 ' A' ' 13' ' ' VAL . 19.6 mmtm -84.15 152.08 24.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.412 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.703 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.13 117.34 14.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.96 0.41 . . . . 0.0 110.454 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.41 ' HA ' HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -114.43 163.6 15.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.216 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.549 ' HA2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.32 -171.21 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.59 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.858 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -80.63 98.88 7.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.378 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.709 HD12 HD21 ' A' ' 149' ' ' LEU . 2.3 pt -88.71 108.53 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.062 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.89 -77.32 0.58 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.094 -0.643 . . . . 0.0 112.449 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.2 m -100.67 -60.68 1.48 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.754 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.4 tmtt? -54.27 -52.03 62.7 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.582 ' HG3' HG22 ' A' ' 144' ' ' ILE . 8.5 tm0? -56.31 -51.91 66.46 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.709 HD21 HD12 ' A' ' 144' ' ' ILE . 3.2 mm? -75.09 -44.46 47.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.2 m -68.88 -34.9 76.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.718 0.294 . . . . 0.0 111.441 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.754 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 1.8 t80 -68.66 -50.6 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.321 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.769 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -69.36 -33.32 72.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.475 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -57.4 -44.65 84.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -27.52 65.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.596 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.517 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -66.44 -29.22 69.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.832 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.73 114.6 61.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.767 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.7 153.15 76.76 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.531 2.154 . . . . 0.0 112.506 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -147.16 123.62 11.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.502 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.08 3.32 23.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.675 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -58.89 -29.12 66.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.77 0.319 . . . . 0.0 110.983 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mt -65.45 -39.25 91.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.819 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -99.98 177.66 5.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.813 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 2.4 p90 -120.88 -56.01 1.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? 59.29 110.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.08 103.88 11.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.51 62.63 3.65 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.447 2.098 . . . . 0.0 112.19 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.51 112.72 22.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 p -137.52 156.04 48.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -76.72 -46.75 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.42 166.16 12.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 24.5 m -115.57 143.56 45.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.833 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 p -81.92 -53.94 5.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -113.33 129.72 56.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.1 ttm -61.54 128.88 38.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.952 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.06 -45.76 3.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.079 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.96 155.32 38.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.61 156.14 35.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.814 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -82.0 -73.08 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.09 143.56 27.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.857 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.49 96.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.489 2.126 . . . . 0.0 112.324 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.38 148.47 83.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 60.3 Cg_endo -72.76 161.14 44.61 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.499 2.132 . . . . 0.0 112.252 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.46 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.3 t -143.98 127.38 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.061 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -105.14 116.63 32.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.031 0.443 . . . . 0.0 111.396 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.709 HG12 ' CE2' ' A' ' 135' ' ' PHE . 21.3 t -107.22 118.31 54.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.5 p -141.59 149.57 40.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.758 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -144.08 153.61 42.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.015 178.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 51.08 -97.81 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.406 0.282 . . . . 0.0 110.82 -176.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.429 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 2.6 m80 -124.78 -25.03 4.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.851 ' CE ' HD13 ' A' ' 122' ' ' LEU . 5.5 ppp? -73.8 164.31 26.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.747 0.308 . . . . 0.0 111.269 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -142.54 161.52 37.86 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.015 0.436 . . . . 0.0 111.3 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.819 ' CE1' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -142.99 140.65 31.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.147 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.053 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -114.69 134.59 54.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.107 0.479 . . . . 0.0 111.23 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.944 HD12 HG13 ' A' ' 108' ' ' VAL . 2.1 mm -116.91 106.51 20.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.329 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -133.33 167.26 20.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.183 0.515 . . . . 0.0 111.669 -178.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.6 p80 -80.92 151.9 28.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.847 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.65 154.26 74.82 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.045 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.517 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 53.1 Cg_exo -54.81 140.92 77.89 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.348 2.032 . . . . 0.0 113.376 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.441 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -98.72 174.34 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.125 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -94.41 -10.31 32.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.84 14.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.9 p -139.54 89.62 2.34 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.431 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -80.21 -52.18 8.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.261 0.553 . . . . 0.0 111.196 178.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.446 ' O ' HG13 ' A' ' 37' ' ' ILE . 17.2 p -57.56 -46.31 84.09 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.418 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -57.75 -31.96 66.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.823 0.344 . . . . 0.0 111.295 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.637 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.47 -47.78 31.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.619 HD13 ' HB3' ' A' ' 63' ' ' LYS . 11.6 pt -56.84 -39.36 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.191 0.52 . . . . 0.0 110.742 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.26 -52.14 60.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.466 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -68.49 -50.04 55.29 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.82 0.343 . . . . 0.0 111.757 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.637 HD21 ' CE1' ' A' ' 36' ' ' PHE . 25.3 mt -55.81 -45.35 78.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -26.62 49.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.108 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 17.2 mttt -52.88 -44.31 66.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.447 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.053 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.2 t80 -63.36 -38.42 91.07 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.897 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.689 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 167.01 -177.56 41.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.616 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.84 121.08 24.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.846 HG22 ' H ' ' A' ' 47' ' ' THR . 4.2 m -164.72 -171.82 2.43 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.846 ' H ' HG22 ' A' ' 46' ' ' THR . 8.8 t -65.74 166.9 10.11 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.754 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.787 HG13 ' O ' ' A' ' 104' ' ' ALA . 44.0 t -139.84 134.74 37.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.193 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.067 HG13 HG13 ' A' ' 105' ' ' VAL . 3.6 p -115.67 105.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.222 0.534 . . . . 0.0 111.483 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 110.81 20.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.984 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.826 HG13 ' HB3' ' A' ' 71' ' ' TRP . 7.4 t -103.86 91.86 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.453 0.644 . . . . 0.0 109.737 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 t -157.28 171.66 20.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.336 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.42 130.33 43.33 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 72' ' ' PRO . 16.4 t -68.91 121.67 18.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -176.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -120.73 -47.49 2.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.898 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.415 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 3.0 m-85 -130.44 84.47 2.2 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.263 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.52 -36.25 45.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -79.21 -48.58 13.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.66 HG22 ' HG3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -44.81 -48.24 29.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 59' ' ' THR . 33.6 Cg_exo -60.9 -42.27 38.86 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.551 2.167 . . . . 0.0 113.787 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.818 HD22 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -71.44 -45.75 61.83 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.85 -49.12 18.88 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.66 ' HG3' HG22 ' A' ' 59' ' ' THR . 0.3 OUTLIER -73.61 -28.08 61.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -177.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' CG ' HD11 ' A' ' 66' ' ' ILE . 4.6 t0 -98.49 -11.43 22.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.91 22.39 9.08 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.151 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.706 HD12 HG21 ' A' ' 48' ' ' VAL . 2.7 pt -122.02 148.61 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.626 0.25 . . . . 0.0 110.376 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' THR . 19.5 m -77.43 135.0 38.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.83 0.348 . . . . 0.0 110.192 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.818 HG12 HD22 ' A' ' 61' ' ' LEU . 7.4 p -141.24 150.53 19.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 0.0 111.756 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.443 HG22 ' HG ' ' A' ' 90' ' ' LEU . 3.4 t -103.73 134.42 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.135 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.83 106.69 18.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.19 0.519 . . . . 0.0 110.109 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.826 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.0 m95 -111.43 104.38 56.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.229 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HB3' HG23 ' A' ' 54' ' ' VAL . 43.4 Cg_endo -104.56 138.57 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 123.303 2.669 . . . . 0.0 112.433 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.42 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -114.97 95.96 5.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.894 0.378 . . . . 0.0 110.913 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.59 ' H ' ' HB2' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -145.31 -162.15 1.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.542 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -55.04 -23.5 20.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.121 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -115.52 49.36 0.86 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.599 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.59 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -115.41 102.93 54.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.476 0.179 . . . . 0.0 110.944 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.434 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 93.0 Cg_exo -43.32 99.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.774 2.316 . . . . 0.0 112.918 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.692 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 52.9 Cg_exo -55.83 -41.43 77.4 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.985 2.457 . . . . 0.0 114.256 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.763 ' O ' HG22 ' A' ' 83' ' ' VAL . 2.4 Cg_endo -47.46 153.97 1.81 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.275 1.983 . . . . 0.0 113.609 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.33 -20.22 67.24 Favored Glycine 0 C--O 1.237 0.284 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.527 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.3 -33.18 27.82 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.359 0.133 . . . . 0.0 111.359 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -56.11 -48.83 78.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.767 HG11 ' CE2' ' A' ' 151' ' ' TYR . 15.7 t -53.81 -41.16 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.218 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -61.07 -31.37 71.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.02 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.28 -50.36 68.2 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.395 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.845 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -70.31 -28.32 65.08 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.969 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.963 HD21 ' HB3' ' A' ' 120' ' ' LEU . 13.8 mt -61.64 -40.63 95.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.15 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.57 -39.93 70.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.132 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.3 tm? -58.03 -51.27 70.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.522 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.103 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.9 p -70.42 -35.83 63.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.666 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -46.34 77.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.381 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.71 85.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.446 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -67.49 -26.96 66.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.814 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.4 m-85 -79.81 -47.23 15.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.008 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.88 -43.3 98.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -33.03 59.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.97 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -118.55 89.38 36.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.32 113.6 3.52 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.597 2.198 . . . . 0.0 112.361 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.32 60.38 7.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.648 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.462 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 18.5 t -101.23 -163.85 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.627 0.251 . . . . 0.0 110.809 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.689 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 2.2 m -112.41 114.09 26.63 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.674 HG11 ' CE1' ' A' ' 22' ' ' PHE . 10.6 t -109.79 151.31 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.787 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -116.02 140.86 48.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.088 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.067 HG13 HG13 ' A' ' 49' ' ' VAL . 3.4 t -140.36 166.35 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.71 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.7 t60 -67.54 156.08 37.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.621 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 25' ' ' THR . 18.7 t -68.51 105.81 2.35 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.944 HG13 HD12 ' A' ' 24' ' ' ILE . 35.7 m -75.51 0.42 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.194 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.22 -8.6 2.61 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.72 -140.49 5.24 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.412 HD22 ' HA2' ' A' ' 142' ' ' GLY . 5.9 mt -114.97 127.34 55.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.64 -146.46 4.81 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.834 -1.174 . . . . 0.0 113.593 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.57 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.34 -21.68 5.75 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.031 0.443 . . . . 0.0 111.877 -178.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.887 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -52.8 -46.22 96.79 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.804 ' HD3' HG12 ' A' ' 108' ' ' VAL . 8.3 Cg_endo -52.41 -48.48 21.63 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.237 1.958 . . . . 0.0 112.904 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.807 HG21 ' NE2' ' A' ' 148' ' ' GLN . 57.5 t -60.9 -52.19 64.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.386 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.692 HD12 ' CG2' ' A' ' 49' ' ' VAL . 3.8 mt -51.89 -44.48 63.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.942 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.961 HG22 HG11 ' A' ' 105' ' ' VAL . 4.4 t -58.55 -54.62 30.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.472 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.68 -44.4 66.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 111.34 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.963 ' HB3' HD21 ' A' ' 88' ' ' LEU . 12.5 mt -63.95 -30.73 71.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.383 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 1.103 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -68.67 -37.53 79.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.069 0.462 . . . . 0.0 109.793 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.851 HD13 ' CE ' ' A' ' 20' ' ' MET . 7.6 tp -78.88 -15.68 58.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.256 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.93 HG23 ' CB ' ' A' ' 128' ' ' LYS . 1.8 mt -57.59 -30.86 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.73 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -16.33 64.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.512 ' OG ' HD12 ' A' ' 122' ' ' LEU . 7.1 m -79.54 -23.36 42.91 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 152.95 -96.1 0.16 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.994 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.478 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.2 ptt? -63.2 71.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.93 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.44 -67.62 0.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -176.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.573 ' CD1' HD22 ' A' ' 152' ' ' LEU . 8.6 t80 -66.26 -32.67 74.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.9 0.381 . . . . 0.0 111.128 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.59 -52.22 16.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.634 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 30.0 t0 -70.12 -39.43 75.45 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.821 0.343 . . . . 0.0 110.975 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.674 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -60.45 -50.01 75.29 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.811 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 129' ' ' TYR . 26.1 mm -73.38 -38.69 53.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -74.44 -49.95 20.35 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.709 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.83 -37.09 83.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.31 . . . . 0.0 110.165 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.561 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.23 -27.87 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.437 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -47.93 78.98 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -44.71 93.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.598 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.1 OUTLIER -84.9 152.03 23.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.44 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 116.7 14.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.009 0.433 . . . . 0.0 110.514 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 163.61 15.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.14 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -56.77 -168.8 0.09 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.649 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.21 100.03 12.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.286 0.543 . . . . 0.0 111.516 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.8 HD12 HD21 ' A' ' 149' ' ' LEU . 10.4 pt -87.93 109.52 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.373 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -113.25 -76.87 0.58 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 6.8 p -99.6 -61.01 1.42 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.833 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 11.7 tmtt? -66.48 -48.6 69.36 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.807 ' NE2' HG21 ' A' ' 116' ' ' VAL . 23.5 mm-40 -56.12 -51.84 66.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.8 HD21 HD12 ' A' ' 144' ' ' ILE . 2.0 mm? -74.2 -45.34 48.92 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.766 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.9 m -64.62 -37.31 87.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.795 0.331 . . . . 0.0 111.425 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.833 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -66.41 -50.51 63.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.157 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.859 HD21 HD11 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -61.52 -34.61 75.82 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.171 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.33 -43.4 88.21 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -23.76 65.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.482 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.661 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -66.18 -39.67 89.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.49 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 129' ' ' TYR . 0.0 OUTLIER -106.7 141.03 21.97 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.956 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.08 153.42 62.79 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.656 2.238 . . . . 0.0 112.34 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.56 123.45 11.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.526 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.83 -12.58 61.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.508 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -28.12 65.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.763 0.316 . . . . 0.0 110.967 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.681 ' O ' HD23 ' A' ' 161' ' ' LEU . 2.2 tt -75.04 -31.56 61.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -177.9 6.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -108.9 -66.33 1.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -66.61 121.96 16.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -94.03 138.05 22.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.801 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.85 -48.5 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.492 2.128 . . . . 0.0 112.36 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -177.6 37.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.948 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.8 p -134.64 116.56 15.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -86.99 127.67 35.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -148.46 -47.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.9 m -120.39 -62.08 1.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.54 116.34 14.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.815 0.34 . . . . 0.0 110.898 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -119.45 114.96 23.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.87 103.49 10.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -121.63 140.5 52.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.138 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -132.2 -65.92 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 mmt -112.89 130.78 55.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.906 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -163.75 31.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 ptt-85 -175.89 112.34 0.26 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.3 109.85 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.499 2.133 . . . . 0.0 112.37 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.07 57.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.053 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.891 ' HB3' HG22 ' A' ' 25' ' ' THR . 64.2 Cg_endo -73.14 165.15 33.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.537 2.158 . . . . 0.0 112.339 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.434 HG11 ' HE2' ' A' ' 139' ' ' LYS . 21.2 t -138.78 126.88 28.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.809 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.0 pt-20 -105.96 116.74 32.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.978 0.418 . . . . 0.0 111.559 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.689 HG12 ' CE2' ' A' ' 135' ' ' PHE . 45.3 t -107.82 118.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.06 151.9 42.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 0.0 112.223 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -145.13 151.07 37.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.962 178.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.625 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 44.71 -78.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.455 0.702 . . . . 0.0 112.623 -177.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -129.81 -41.58 1.31 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.624 ' HE1' ' CE2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -73.58 154.22 39.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 112.027 -178.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -135.7 164.25 28.29 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.064 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.624 ' CE2' ' HE1' ' A' ' 20' ' ' MET . 7.9 m-85 -139.28 150.08 45.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.052 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -121.24 132.0 54.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.466 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.017 HD12 HG13 ' A' ' 108' ' ' VAL . 2.6 mm -117.27 106.68 20.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.512 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.891 HG22 ' HB3' ' A' ' 12' ' ' PRO . 31.7 p -130.45 167.23 18.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.202 0.525 . . . . 0.0 111.773 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.497 ' CD2' ' CE2' ' A' ' 36' ' ' PHE . 42.1 p-80 -80.89 152.29 28.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.39 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -62.45 153.93 74.66 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.3 Cg_exo -54.71 142.4 73.3 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.393 2.062 . . . . 0.0 113.46 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.484 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.1 p -98.5 174.44 6.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.053 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -94.01 -12.48 28.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.7 -31.02 14.61 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.4 p -139.86 89.81 2.34 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.691 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.651 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.5 OUTLIER -80.23 -52.32 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.212 0.529 . . . . 0.0 111.136 177.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.555 ' O ' HG13 ' A' ' 37' ' ' ILE . 1.5 m -57.45 -36.11 71.0 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.211 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -65.88 -35.48 80.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.919 0.39 . . . . 0.0 110.927 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.638 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -73.94 -47.97 33.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.072 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.588 HD13 ' HB3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -58.62 -37.02 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 110.472 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.48 -51.94 60.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.262 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -69.78 -49.88 48.63 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 111.552 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.699 HD23 HG21 ' A' ' 25' ' ' THR . 27.3 mt -54.96 -44.82 74.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.99 0.424 . . . . 0.0 110.502 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -78.4 -26.76 46.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.181 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 11.9 mttt -54.56 -41.89 70.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.351 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.052 ' CD1' HD21 ' A' ' 23' ' ' LEU . 13.3 t80 -63.58 -38.7 92.13 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.804 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.644 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 168.84 -178.84 41.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.706 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.83 118.36 20.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.804 HG22 ' H ' ' A' ' 47' ' ' THR . 3.3 m -164.7 -171.35 2.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.305 -0.862 . . . . 0.0 108.696 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.804 ' H ' HG22 ' A' ' 46' ' ' THR . 1.6 t -65.52 163.09 16.7 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.064 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.797 HG21 HD12 ' A' ' 66' ' ' ILE . 50.0 t -137.26 133.5 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.082 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.815 HG12 HG22 ' A' ' 105' ' ' VAL . 14.9 p -115.4 105.18 18.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.55 0.69 . . . . 0.0 111.514 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -114.64 110.84 20.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.845 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.791 HG13 ' HB3' ' A' ' 71' ' ' TRP . 14.5 t -105.87 91.83 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.629 0.728 . . . . 0.0 109.936 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.41 172.04 19.3 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.229 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' CD ' ' N ' ' A' ' 53' ' ' GLU . 1.5 mm-40 -64.28 130.33 43.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.491 HG12 ' OD1' ' A' ' 70' ' ' ASP . 12.0 m -69.07 121.95 19.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 m -120.53 -47.45 2.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.074 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.425 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 6.7 m-85 -130.41 84.51 2.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.34 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.52 -35.86 45.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -78.97 -48.45 14.47 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.651 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -45.67 -49.79 34.99 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.215 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 44.6 Cg_exo -57.44 -42.22 63.8 Favored 'Trans proline' 0 N--CA 1.471 0.189 0 C-N-CA 122.63 2.22 . . . . 0.0 113.572 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.602 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -71.3 -45.52 62.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.57 -49.1 19.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.588 ' HB3' HD13 ' A' ' 37' ' ' ILE . 11.0 mttt -75.15 -26.72 59.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.464 ' CG ' HD11 ' A' ' 66' ' ' ILE . 2.5 t0 -101.06 -11.39 19.67 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.95 25.53 3.81 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.138 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.797 HD12 HG21 ' A' ' 48' ' ' VAL . 4.2 pt -122.22 148.73 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.649 0.262 . . . . 0.0 110.531 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 47' ' ' THR . 1.3 m -77.29 135.05 38.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.965 0.412 . . . . 0.0 110.233 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.602 HG12 ' CD2' ' A' ' 61' ' ' LEU . 7.1 p -142.56 148.52 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.697 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.476 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.2 t -103.63 131.2 52.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.138 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' OD1' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -101.1 106.65 17.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.097 0.475 . . . . 0.0 110.651 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.895 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.6 m0 -109.21 103.5 52.62 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.815 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -108.46 171.22 0.09 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.553 2.836 . . . . 0.0 112.559 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.445 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -126.34 139.99 52.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.768 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.429 ' H ' ' HB2' ' A' ' 77' ' ' ALA . 12.4 p30 178.85 -175.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.692 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -54.86 -24.25 22.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.927 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.7 41.34 2.26 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.511 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -102.81 102.82 29.31 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.489 0.185 . . . . 0.0 110.922 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.598 ' O ' HG21 ' A' ' 83' ' ' VAL . 89.2 Cg_exo -47.02 101.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.676 2.251 . . . . 0.0 112.775 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.696 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 27.1 Cg_exo -63.27 -36.91 53.94 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.88 2.386 . . . . 0.0 114.677 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.696 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 9.5 Cg_endo -53.36 154.09 15.7 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.948 1.765 . . . . 0.0 113.697 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -59.68 -20.09 51.08 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.462 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.15 -29.63 14.24 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.467 0.175 . . . . 0.0 111.081 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.895 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 18.4 t -56.2 -52.34 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.683 HG13 HD13 ' A' ' 120' ' ' LEU . 1.4 t -53.81 -40.01 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.391 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -60.55 -31.34 70.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.955 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -50.29 63.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.284 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.76 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -67.86 -33.75 75.36 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.726 HD21 ' CB ' ' A' ' 120' ' ' LEU . 11.8 mt -59.32 -44.88 92.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.525 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -65.99 -39.91 90.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.203 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.507 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.7 tm? -60.16 -51.23 70.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.623 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.911 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.5 p -72.46 -35.99 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.295 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -56.41 -45.02 80.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.686 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.31 -42.23 72.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.709 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -67.49 -27.15 66.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.446 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 2.7 m-85 -81.97 -52.06 7.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.835 0.35 . . . . 0.0 111.331 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.3 t -57.08 -37.43 71.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.101 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -76.11 -33.05 59.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.339 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.13 84.63 61.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.539 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -66.27 136.75 44.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.714 2.276 . . . . 0.0 111.987 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.58 56.9 22.22 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.46 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.05 -161.8 0.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 111.189 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.644 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 1.5 m -125.36 114.05 18.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.268 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.51 HG11 ' HE1' ' A' ' 22' ' ' PHE . 39.1 t -106.88 151.05 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.789 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -119.0 140.9 49.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.79 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.815 HG22 HG12 ' A' ' 49' ' ' VAL . 99.4 t -139.36 166.37 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.57 ' N ' HG12 ' A' ' 105' ' ' VAL . 2.8 t60 -67.06 156.19 36.72 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.147 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 25' ' ' THR . 44.3 t -68.46 105.68 2.28 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.017 HG13 HD12 ' A' ' 24' ' ' ILE . 34.7 m -75.32 0.28 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.107 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.411 ' HB3' ' SG ' ' A' ' 107' ' ' CYS . . . -60.54 -8.56 2.89 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.08 -138.42 4.87 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mt -114.36 127.4 55.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.9 -156.29 8.71 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.154 -1.022 . . . . 0.0 113.121 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.691 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.31 -17.11 7.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.977 0.417 . . . . 0.0 111.758 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.669 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.67 -46.37 98.33 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.79 ' HD3' HG12 ' A' ' 108' ' ' VAL . 8.6 Cg_endo -52.82 -48.45 21.99 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.059 1.84 . . . . 0.0 112.506 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.638 HG22 ' HG3' ' A' ' 148' ' ' GLN . 59.8 t -56.55 -51.74 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.007 0.432 . . . . 0.0 110.285 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.6 HD12 ' CG2' ' A' ' 49' ' ' VAL . 10.3 mt -52.97 -48.35 67.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.614 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.739 HG22 HG21 ' A' ' 105' ' ' VAL . 41.6 t -51.76 -50.56 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.721 0.296 . . . . 0.0 111.464 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.748 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -52.8 -46.91 67.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.327 0.584 . . . . 0.0 110.484 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.726 ' CB ' HD21 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -57.51 -31.41 66.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.623 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.911 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.28 -44.33 62.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.4 . . . . 0.0 110.517 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.445 ' HA ' HD12 ' A' ' 122' ' ' LEU . 7.3 tp -66.82 -15.84 63.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.656 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 1.04 HD11 HD21 ' A' ' 152' ' ' LEU . 2.5 mt -57.23 -30.53 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.696 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -17.2 63.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.013 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.9 m -79.99 -23.31 41.65 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.13 -96.64 0.17 Allowed Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.778 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.583 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 1.3 ptt? -63.55 72.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.941 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.95 -67.42 0.43 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.506 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 7.0 t80 -67.74 -32.73 73.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.004 0.43 . . . . 0.0 110.959 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.48 -52.11 17.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.252 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 41.6 t0 -69.32 -35.86 76.38 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.748 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -61.63 -50.31 73.05 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.771 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -73.92 -37.99 48.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.537 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -74.08 -49.71 22.82 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.689 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.19 -34.32 72.8 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.72 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.23 -29.86 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 110.473 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.16 -43.23 82.81 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.633 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -45.55 91.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 110.598 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.434 ' HE2' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -87.37 151.41 23.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.223 179.301 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.407 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.7 116.47 14.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.568 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.35 163.67 15.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.074 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.04 -174.86 0.08 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.555 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.4 9.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.56 0.68 . . . . 0.0 111.443 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.801 HD12 HD21 ' A' ' 149' ' ' LEU . 1.6 pt -88.4 109.57 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.543 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -113.13 -76.72 0.58 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.75 -60.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.824 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 10.5 tmtt? -55.94 -52.05 65.51 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.693 ' OE1' HD22 ' A' ' 149' ' ' LEU . 17.6 tm0? -58.3 -51.52 69.43 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.801 HD21 HD12 ' A' ' 144' ' ' ILE . 3.2 mm? -72.02 -41.0 68.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 50.0 m -70.53 -39.69 73.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.779 0.323 . . . . 0.0 111.524 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.824 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.35 -50.97 63.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.228 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.04 HD21 HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -66.87 -31.23 71.69 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.708 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.57 -37.7 87.19 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -23.94 59.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.545 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CB ' HD23 ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.21 -40.63 90.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.286 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.9 88.21 3.45 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.563 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.68 153.08 79.73 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.669 2.246 . . . . 0.0 112.521 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -147.24 123.47 10.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.477 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -57.99 -32.6 68.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.035 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.3 -30.8 69.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.95 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.38 -41.41 76.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.38 92.73 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -74.11 156.04 37.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -138.18 132.63 32.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.56 138.1 44.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.446 ' HG3' ' CE1' ' A' ' 169' ' ' HIS . 42.9 Cg_endo -67.58 158.74 55.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.495 2.13 . . . . 0.0 112.29 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -75.62 -37.4 59.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.977 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -143.03 147.1 34.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.446 ' CE1' ' HG3' ' A' ' 166' ' ' PRO . 1.7 m-70 -116.71 154.95 29.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -101.24 -33.49 10.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.85 175.94 9.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.879 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -107.32 98.72 8.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.878 0.371 . . . . 0.0 110.894 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -115.37 -39.82 3.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -150.07 -60.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.906 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.17 110.81 3.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -76.33 -37.9 56.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -167.69 162.79 14.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -156.15 159.63 39.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.0 133.96 9.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.771 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.16 90.94 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.357 2.038 . . . . 0.0 112.364 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.33 153.71 95.62 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.011 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.728 ' HB3' HG23 ' A' ' 25' ' ' THR . 58.1 Cg_endo -71.52 160.22 49.07 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.596 2.197 . . . . 0.0 112.378 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.429 HG11 ' CD ' ' A' ' 139' ' ' LYS . 18.5 t -143.26 126.89 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.853 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 5.5 pt-20 -109.38 116.68 32.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.895 0.379 . . . . 0.0 111.618 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.75 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -107.42 118.53 55.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.3 p -140.97 140.53 34.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.106 0.479 . . . . 0.0 112.056 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' CD2' ' HE1' ' A' ' 127' ' ' MET . 0.0 OUTLIER -141.03 147.56 38.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.701 178.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 1.3 mmmp? 64.59 -90.73 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.273 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.51 -45.02 1.21 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.531 ' SD ' HD21 ' A' ' 122' ' ' LEU . 2.7 ppp? -73.68 164.76 26.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 111.728 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -139.2 164.32 30.11 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.475 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.698 ' CE1' HG11 ' A' ' 103' ' ' VAL . 0.3 OUTLIER -134.18 141.63 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.4 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.075 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -114.9 133.86 55.63 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.107 0.48 . . . . 0.0 111.038 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.965 HD12 HG13 ' A' ' 108' ' ' VAL . 1.7 mm -117.92 106.56 20.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.156 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.728 HG23 ' HB3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -134.67 166.83 22.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.15 0.5 . . . . 0.0 111.509 -179.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.522 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 7.3 p80 -81.31 151.77 27.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.175 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -63.02 154.42 77.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.023 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.524 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.3 Cg_exo -54.72 139.03 77.17 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.329 2.019 . . . . 0.0 113.245 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.439 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 29.8 p -98.59 174.21 6.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.096 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -92.75 -9.89 39.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.64 -30.85 14.73 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 p -139.79 89.56 2.32 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.244 -0.582 . . . . 0.0 112.357 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.503 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -80.27 -52.27 7.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 0.0 111.169 178.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -58.59 -46.09 87.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.352 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.7 m -57.83 -32.45 67.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.841 0.353 . . . . 0.0 111.148 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.687 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.16 -47.99 32.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.114 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.946 HG21 ' HB3' ' A' ' 63' ' ' LYS . 10.8 pt -56.12 -38.84 55.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.55 . . . . 0.0 110.539 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.1 -51.94 61.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.369 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.1 m-20 -69.43 -50.21 47.91 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.866 0.365 . . . . 0.0 111.72 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.687 HD21 ' CE1' ' A' ' 36' ' ' PHE . 57.6 mt -56.12 -44.75 79.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.958 0.408 . . . . 0.0 110.326 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -78.18 -26.67 47.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -52.74 -44.13 66.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.311 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.075 ' CD1' HD21 ' A' ' 23' ' ' LEU . 16.8 t80 -63.45 -38.17 90.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.73 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.72 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.41 -176.96 40.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.943 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.71 118.05 20.33 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.752 HG22 ' H ' ' A' ' 47' ' ' THR . 1.3 m -165.06 -170.27 1.89 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.822 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.752 ' H ' HG22 ' A' ' 46' ' ' THR . 1.5 t -64.91 150.75 47.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.458 0.647 . . . . 0.0 110.122 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.786 HG21 HD12 ' A' ' 66' ' ' ILE . 48.2 t -126.33 133.69 68.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.817 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.039 HG13 HG13 ' A' ' 105' ' ' VAL . 8.5 p -115.24 105.45 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.155 0.502 . . . . 0.0 111.184 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.52 110.9 21.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.755 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.952 HG11 ' HB2' ' A' ' 113' ' ' ARG . 39.6 t -103.28 91.27 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.55 0.691 . . . . 0.0 110.236 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.2 171.43 20.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.05 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.78 130.7 44.51 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -68.55 121.93 18.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.0 p -120.63 -47.38 2.32 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.948 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.43 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 4.2 m-85 -130.23 84.4 2.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.288 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.4 -35.85 46.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -78.84 -48.43 14.74 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.503 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -45.67 -50.26 33.39 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.43 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 39.4 Cg_exo -61.64 -42.13 34.72 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.543 2.162 . . . . 0.0 113.639 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.91 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -71.32 -45.65 62.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.68 -49.29 18.78 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.946 ' HB3' HG21 ' A' ' 37' ' ' ILE . 10.4 mttt -61.41 -39.4 90.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.89 ' OD2' HG22 ' A' ' 37' ' ' ILE . 45.8 m-20 -101.76 -11.39 19.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 53.2 25.17 24.63 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.771 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.786 HD12 HG21 ' A' ' 48' ' ' VAL . 8.9 pt -107.52 149.08 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.854 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 47' ' ' THR . 63.9 p -77.46 135.44 38.26 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.91 HG12 ' CD2' ' A' ' 61' ' ' LEU . 11.7 p -140.17 150.08 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.464 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.6 t -103.35 132.08 50.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.86 106.65 18.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.172 0.51 . . . . 0.0 110.706 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.768 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.5 m95 -111.25 103.73 55.3 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.498 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -107.43 178.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.472 2.782 . . . . 0.0 113.008 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.425 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -126.27 120.48 30.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.686 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.34 -176.28 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -54.9 -24.82 25.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.843 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.42 88.19 0.2 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.441 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.437 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -85.71 124.65 70.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 O-C-N 122.91 -0.17 . . . . 0.0 110.749 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.71 101.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.68 2.253 . . . . 0.0 112.582 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.666 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 51.3 Cg_exo -55.05 -44.06 53.27 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.813 2.342 . . . . 0.0 114.021 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 5.0 Cg_endo -49.27 147.94 11.05 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.277 1.985 . . . . 0.0 113.465 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.591 ' HA2' ' HZ2' ' A' ' 147' ' ' LYS . . . -66.1 -19.32 67.91 Favored Glycine 0 C--N 1.33 0.208 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.103 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 2.6 tttt -50.23 -29.53 9.67 Favored 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 123.457 0.151 . . . . 0.0 111.146 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.72 HG12 ' CH2' ' A' ' 71' ' ' TRP . 21.6 t -54.73 -48.17 72.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.828 HG11 ' HG ' ' A' ' 120' ' ' LEU . 78.4 t -59.34 -38.05 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.207 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.748 ' HA ' HD12 ' A' ' 88' ' ' LEU . 8.1 mt-10 -58.16 -31.18 67.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.57 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.07 -50.68 63.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.912 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.827 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -67.1 -27.03 67.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.804 HD21 ' HB3' ' A' ' 120' ' ' LEU . 26.3 mt -63.42 -39.29 94.1 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.966 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.4 m -66.8 -44.95 79.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.029 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.1 tm? -57.27 -51.41 69.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.483 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.838 HG21 ' HB1' ' A' ' 121' ' ' ALA . 9.0 p -69.77 -35.87 67.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.718 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.65 -45.22 73.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.81 -43.91 74.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.687 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -26.22 65.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.126 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.548 ' HE1' HG21 ' A' ' 103' ' ' VAL . 1.6 m-85 -82.04 -52.0 7.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 111.192 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 15.9 t -67.05 -34.96 78.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.176 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -33.08 59.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.161 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.12 96.3 37.26 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.386 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.94 132.42 23.01 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.457 2.105 . . . . 0.0 112.058 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.04 56.12 27.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.174 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.573 ' OG ' HG21 ' A' ' 46' ' ' THR . 82.5 p -101.07 169.38 8.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 111.232 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.72 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -100.68 113.78 26.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.573 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.698 HG11 ' CE1' ' A' ' 22' ' ' PHE . 24.4 t -107.85 151.29 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.757 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -120.94 140.87 51.25 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.323 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.057 HG11 HG22 ' A' ' 118' ' ' VAL . 3.0 t -140.07 166.54 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.548 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.7 t60 -67.97 155.84 38.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -68.84 105.61 2.41 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.965 HG13 HD12 ' A' ' 24' ' ' ILE . 32.0 m -75.39 -0.04 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.01 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.77 -8.5 3.06 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.97 -128.77 3.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.543 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.902 HD21 ' HB2' ' A' ' 143' ' ' ALA . 0.1 OUTLIER -132.09 127.4 35.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -171.31 -142.31 3.63 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.397 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.952 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.44 -21.8 5.67 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.994 0.426 . . . . 0.0 111.89 -178.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.661 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.17 -46.8 82.9 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.727 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.5 Cg_endo -52.13 -48.49 21.42 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.296 1.997 . . . . 0.0 112.867 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.747 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.2 t -59.23 -41.79 84.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.674 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.453 HD11 ' CE3' ' A' ' 71' ' ' TRP . 7.1 mt -61.06 -50.08 74.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.737 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 1.057 HG22 HG11 ' A' ' 105' ' ' VAL . 12.0 t -53.76 -55.52 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -60.2 -47.14 87.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.129 0.49 . . . . 0.0 110.839 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.828 ' HG ' HG11 ' A' ' 84' ' ' VAL . 3.3 mm? -54.59 -30.76 55.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.044 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.838 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.33 -49.99 30.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.046 0.45 . . . . 0.0 110.54 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.531 HD21 ' SD ' ' A' ' 20' ' ' MET . 0.3 OUTLIER -62.62 -15.67 52.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.083 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.931 ' CD1' HD21 ' A' ' 152' ' ' LEU . 1.2 mt -57.45 -34.58 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.637 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.31 -15.38 15.65 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.81 11.38 3.28 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 116.99 -85.53 0.39 Allowed Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.158 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.42 78.39 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.892 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -62.37 -67.71 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.531 ' HD1' HD22 ' A' ' 152' ' ' LEU . 6.4 t80 -74.98 -30.52 61.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.122 0.487 . . . . 0.0 110.544 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -72.6 -46.64 53.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.034 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 127' ' ' MET . 51.5 t0 -70.22 -47.3 62.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.381 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.816 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -58.32 -50.32 74.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.871 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 129' ' ' TYR . 32.7 mm -69.54 -37.85 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.46 -49.93 20.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.75 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.61 -34.67 74.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.647 0.261 . . . . 0.0 110.977 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 119' ' ' ALA . 1.8 tt -74.21 -34.05 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.0 110.645 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -63.46 -45.9 88.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -39.79 85.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.023 0.44 . . . . 0.0 110.499 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.429 ' CD ' HG11 ' A' ' 13' ' ' VAL . 14.7 mmtt -87.09 152.27 22.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.68 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.66 117.89 14.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.457 ' HD3' HG23 ' A' ' 136' ' ' ILE . 0.1 OUTLIER -114.28 163.34 15.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.946 -179.081 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -62.26 -156.55 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.329 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.902 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -90.2 98.71 11.93 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.942 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.583 HG22 ' HG3' ' A' ' 148' ' ' GLN . 1.1 pt -88.9 108.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.815 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -113.66 -77.38 0.58 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 119.88 -0.728 . . . . 0.0 112.756 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.49 -60.8 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.728 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -53.21 -51.78 61.02 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.693 ' HG3' HG22 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -56.84 -52.09 66.47 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.28 -40.0 59.14 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.3 m -69.47 -42.71 74.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.878 0.37 . . . . 0.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.728 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -63.59 -50.56 68.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.931 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -65.29 -36.51 84.3 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.784 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -55.92 -39.82 72.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.405 ' C ' ' HD2' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -74.13 -24.85 59.5 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.213 178.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.663 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -66.17 -39.99 90.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.34 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.413 ' HB2' ' HB2' ' A' ' 129' ' ' TYR . 0.0 OUTLIER -106.97 113.91 62.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.168 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.05 153.31 26.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.57 2.18 . . . . 0.0 112.063 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -141.21 123.27 15.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.118 0.485 . . . . 0.0 110.45 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -71.6 -21.0 61.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.17 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -61.27 -36.8 81.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.09 -48.06 8.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.181 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -171.9 3.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.16 160.62 27.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.34 124.67 10.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -89.6 106.96 15.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.41 177.11 4.91 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.439 2.093 . . . . 0.0 112.286 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -157.04 130.44 7.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.5 m -147.54 158.66 44.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.19 -38.8 3.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.402 ' HD3' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -139.9 -53.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.402 HG22 ' HD3' ' A' ' 170' ' ' LYS . 3.9 t -151.28 -48.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 46.0 mtt85 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.904 179.901 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.3 p -98.34 120.24 38.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -91.9 -64.31 1.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.9 mtt 60.55 92.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.93 124.39 24.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.067 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -98.12 106.14 18.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.8 mmt -142.66 123.92 14.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -105.04 105.84 16.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.95 101.98 1.44 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.63 98.36 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.345 2.03 . . . . 0.0 112.428 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.31 151.48 53.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.014 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 58.7 Cg_endo -72.1 152.03 56.19 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.468 2.112 . . . . 0.0 112.305 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.416 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 19.1 t -144.09 126.94 11.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 mp0 -112.77 116.84 30.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.904 0.383 . . . . 0.0 111.611 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.81 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -106.84 118.33 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.5 p -141.29 143.68 34.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.732 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -133.36 158.8 42.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.248 178.167 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 45.7 -93.16 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.302 0.241 . . . . 0.0 111.384 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -127.04 -29.31 2.8 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.589 ' HE3' HD13 ' A' ' 122' ' ' LEU . 4.3 ppp? -73.65 159.13 33.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.58 0.228 . . . . 0.0 111.183 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -141.63 164.06 31.22 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.143 0.497 . . . . 0.0 111.807 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' HE1' HG11 ' A' ' 103' ' ' VAL . 3.4 m-85 -138.14 144.31 40.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.933 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.056 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -119.39 135.49 54.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.033 0.444 . . . . 0.0 111.002 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.886 HG21 HG22 ' A' ' 108' ' ' VAL . 5.1 mm -118.51 106.69 20.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.64 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.611 HG21 HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -130.36 165.31 22.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.48 0.657 . . . . 0.0 111.943 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.525 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.4 p80 -81.89 152.58 26.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.941 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -62.42 154.76 70.81 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.1 Cg_exo -54.09 136.65 68.14 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.246 1.964 . . . . 0.0 113.162 -177.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -98.64 147.03 25.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.302 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -68.68 -12.36 61.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.49 -31.41 14.58 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.2 p -139.97 88.81 2.26 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.119 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.5 OUTLIER -80.91 -52.23 7.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.221 0.534 . . . . 0.0 111.359 178.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.44 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.7 m -56.44 -46.17 80.44 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.49 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.8 m -57.62 -31.92 66.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.853 0.359 . . . . 0.0 111.286 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.689 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.3 -47.77 26.34 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.81 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.8 pt -55.83 -39.12 54.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.192 0.52 . . . . 0.0 110.648 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.38 -52.08 56.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.46 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.547 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 7.1 m-20 -68.06 -50.12 57.13 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.82 0.343 . . . . 0.0 111.799 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.689 HD21 ' CE1' ' A' ' 36' ' ' PHE . 63.4 mt -55.76 -45.78 78.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.427 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -77.05 -26.64 53.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.119 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 7.0 mttt -53.12 -44.74 67.93 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.288 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.056 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.0 t80 -63.43 -38.56 91.6 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.709 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.702 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.35 -179.57 39.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.038 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.55 117.25 19.31 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 101' ' ' SER . 0.8 OUTLIER -164.9 -169.77 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.892 177.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' THR . 9.1 p -64.59 160.08 20.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.455 0.645 . . . . 0.0 110.686 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 104' ' ' ALA . 57.2 t -139.0 137.01 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.078 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.825 HG12 HG22 ' A' ' 105' ' ' VAL . 11.3 p -115.52 104.3 16.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.479 0.657 . . . . 0.0 111.385 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -115.21 111.04 20.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.028 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.794 HG13 ' HB3' ' A' ' 71' ' ' TRP . 11.9 t -106.49 91.48 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.405 0.621 . . . . 0.0 109.914 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.4 p -157.68 171.24 20.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.77 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.403 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 2.2 mm-40 -66.62 130.5 43.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 54' ' ' VAL . 14.9 p -73.37 122.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.9 p -120.0 -47.7 2.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.254 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.404 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 1.2 m-85 -130.6 83.67 2.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.467 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.2 -36.61 39.89 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -79.6 -48.58 13.55 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.478 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -44.56 -56.97 7.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 61.5 Cg_endo -72.99 -34.71 6.11 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.47 2.113 . . . . 0.0 113.811 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.037 HD21 HG11 ' A' ' 68' ' ' VAL . 2.0 mm? -71.1 -45.44 63.68 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.21 -28.91 60.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.81 ' HB3' HG21 ' A' ' 37' ' ' ILE . 3.5 mtpp -78.92 -36.57 41.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.517 ' O ' HG13 ' A' ' 66' ' ' ILE . 1.2 m-20 -101.76 -12.27 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.28 23.95 6.52 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.11 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 64' ' ' ASP . 28.1 mt -93.15 147.38 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.728 0.299 . . . . 0.0 111.029 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 47' ' ' THR . 27.8 m -78.52 129.58 35.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.037 HG11 HD21 ' A' ' 61' ' ' LEU . 6.1 p -145.07 152.46 14.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.261 0.553 . . . . 0.0 111.945 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.76 129.25 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.258 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.0 106.72 18.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.972 0.415 . . . . 0.0 110.946 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 1.008 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 5.2 m0 -107.38 103.55 49.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.626 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -107.96 -163.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 123.617 2.878 . . . . 0.0 112.439 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -119.51 95.78 4.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.888 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -176.97 -99.57 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -76.22 -34.05 59.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.078 0.466 . . . . 0.0 110.509 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.08 76.63 0.39 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.781 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -85.74 154.75 58.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 0.0 111.541 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.497 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 35.1 Cg_exo -61.9 -40.69 42.23 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.971 2.448 . . . . 0.0 113.768 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 87.6 Cg_exo -40.24 -55.18 1.92 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.629 2.219 . . . . 0.0 113.915 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 79' ' ' PRO . 18.0 Cg_endo -59.37 135.09 62.85 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.671 1.581 . . . . 0.0 111.823 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.481 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -67.07 -33.63 84.11 Favored Glycine 0 C--O 1.239 0.418 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.612 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 -45.46 69.16 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.675 0.274 . . . . 0.0 111.165 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 1.008 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 26.1 t -55.05 -41.55 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.709 HG22 ' CD1' ' A' ' 120' ' ' LEU . 0.5 OUTLIER -53.55 -41.65 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -65.83 -31.21 72.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.504 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -64.08 -50.94 66.37 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.749 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -67.52 -32.85 73.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.696 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.811 HD21 ' HB3' ' A' ' 120' ' ' LEU . 12.0 mt -57.01 -45.67 82.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.467 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -43.13 94.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.493 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.511 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.5 tm? -58.35 -51.66 68.87 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.009 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.886 HG21 ' HB1' ' A' ' 121' ' ' ALA . 13.8 p -70.96 -39.96 75.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.376 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -58.55 -41.02 84.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.924 0.393 . . . . 0.0 110.547 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.75 -48.17 75.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.642 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -71.59 -25.7 62.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.485 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.0 m-85 -75.11 -51.73 12.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.7 t -60.0 -42.26 93.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.788 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -76.09 -33.06 59.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -126.08 92.12 46.55 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.275 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.22 138.29 15.89 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.637 2.225 . . . . 0.0 112.489 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.401 ' HA2' ' CB ' ' A' ' 20' ' ' MET . . . 58.24 56.35 25.69 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.712 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.691 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.8 OUTLIER -101.24 -172.49 2.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 111.176 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.702 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 m -108.29 113.55 26.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.145 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.64 HG11 ' HE1' ' A' ' 22' ' ' PHE . 46.0 t -111.3 149.55 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.183 0.516 . . . . 0.0 112.306 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.858 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -119.96 144.3 47.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.949 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.825 HG22 HG12 ' A' ' 49' ' ' VAL . 96.5 t -140.17 166.32 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.711 0.291 . . . . 0.0 111.6 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.571 ' N ' HG12 ' A' ' 105' ' ' VAL . 3.2 t60 -67.34 155.74 38.19 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.344 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 26' ' ' HIS . 0.2 OUTLIER -68.61 106.59 2.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.413 0.625 . . . . 0.0 112.615 -178.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.886 HG22 HG21 ' A' ' 24' ' ' ILE . 28.0 m -75.33 0.53 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.221 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.19 -8.58 2.57 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.07 -124.86 2.87 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 111' ' ' LEU . 8.4 mt -128.15 127.34 42.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.98 -158.17 9.17 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.261 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.626 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.19 -18.81 6.74 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.063 0.459 . . . . 0.0 111.776 -178.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.806 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -52.75 -46.2 96.53 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.687 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.6 Cg_endo -52.78 -48.44 22.01 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.043 1.829 . . . . 0.0 112.509 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.774 HG22 ' HG3' ' A' ' 148' ' ' GLN . 58.5 t -55.95 -51.88 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 0.0 109.94 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.674 HD12 ' CG2' ' A' ' 49' ' ' VAL . 8.8 mt -54.47 -46.2 73.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.583 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 114' ' ' ALA . 17.0 t -51.42 -50.58 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 111.076 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.818 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -54.03 -48.04 70.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.29 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.811 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.2 mt -53.97 -31.32 50.33 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.205 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.886 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.51 -50.61 29.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.716 0.293 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.768 HD23 ' OD2' ' A' ' 131' ' ' ASP . 8.5 tp -66.55 -14.63 62.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.714 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.999 HD11 HD21 ' A' ' 152' ' ' LEU . 2.2 mt -58.49 -30.95 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.063 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -70.49 -16.55 62.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.44 -23.24 40.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.67 -96.96 0.17 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.792 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.647 ' HE3' ' CD2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -63.12 74.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.904 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -70.73 -67.47 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.472 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 6.9 t80 -65.49 -34.86 79.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.933 0.397 . . . . 0.0 111.341 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -71.77 -51.5 22.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.454 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.768 ' OD2' HD23 ' A' ' 122' ' ' LEU . 32.8 t70 -70.14 -32.51 70.53 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.943 0.402 . . . . 0.0 111.06 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.818 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -62.3 -50.16 72.76 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.97 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.478 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 32.9 mm -74.5 -40.32 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.269 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -50.03 19.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.81 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.48 -38.98 88.47 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.29 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -74.43 -27.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.709 0.29 . . . . 0.0 110.877 179.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 1.9 ttp85 -65.08 -42.2 94.31 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.797 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -45.43 91.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.888 0.375 . . . . 0.0 110.41 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' ILE . 6.7 mmtt -87.72 151.72 22.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.273 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.36 117.0 14.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.163 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 163.81 14.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.288 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -53.52 -173.61 0.05 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.011 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.417 ' N ' HD22 ' A' ' 111' ' ' LEU . . . -84.13 99.5 10.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.213 0.507 . . . . 0.0 111.473 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 1.09 HD12 HD21 ' A' ' 149' ' ' LEU . 1.8 pt -88.17 109.5 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.407 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -113.13 -76.5 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.313 0.856 . . . . 0.0 113.313 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.7 p -99.63 -60.84 1.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.897 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.3 tmtt? -56.81 -51.87 67.27 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -176.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.774 ' HG3' HG22 ' A' ' 116' ' ' VAL . 9.8 tm0? -56.73 -51.22 69.68 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.09 HD21 HD12 ' A' ' 144' ' ' ILE . 3.9 mm? -72.98 -43.09 62.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 m -70.27 -39.71 74.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.771 0.319 . . . . 0.0 111.661 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.897 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -66.54 -50.91 61.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.999 HD21 HD11 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -66.49 -30.17 70.44 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.413 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.93 -40.12 96.66 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -22.72 61.46 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.58 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.467 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.21 -47.95 72.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.608 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.98 97.07 16.45 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.42 133.01 33.12 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.37 2.046 . . . . 0.0 112.189 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -147.15 123.58 11.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.67 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -77.99 -2.83 38.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.422 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -58.88 -31.08 68.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.876 0.37 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.25 -36.86 78.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -102.54 30.34 4.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -101.09 -62.8 1.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.63 136.89 36.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.8 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.36 129.81 94.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.817 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.29 -44.27 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.486 2.124 . . . . 0.0 112.304 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -75.92 -40.63 53.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.7 m -71.11 128.48 36.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -92.44 123.47 35.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.29 107.6 12.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.922 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.4 p -96.06 137.32 35.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.194 -0.907 . . . . 0.0 110.902 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -162.67 90.06 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 110.937 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -108.25 109.26 20.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.35 -47.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.82 108.6 18.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.073 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.18 -48.18 3.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.824 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 36.2 mtm -115.71 164.41 14.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -127.45 -45.3 1.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.2 130.59 49.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.36 122.91 12.06 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.412 2.075 . . . . 0.0 112.292 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . . . -81.52 129.01 67.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.028 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.6 ' HB3' HG23 ' A' ' 25' ' ' THR . 37.5 Cg_exo -57.03 161.91 10.0 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.408 2.072 . . . . 0.0 112.126 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.733 HG11 ' CE ' ' A' ' 139' ' ' LYS . 3.7 t -137.74 126.97 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.817 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 11.6 pt-20 -107.42 116.92 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 111.752 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.836 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.7 OUTLIER -108.92 118.53 56.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.499 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.9 p -140.99 147.56 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 111.95 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CD2' ' HG2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -144.04 126.35 15.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.282 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 38.0 mmtt 77.92 -87.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.278 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -129.38 -40.62 1.43 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.631 ' CE ' HD13 ' A' ' 122' ' ' LEU . 2.7 tmm? -73.74 154.41 39.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.884 0.373 . . . . 0.0 111.289 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.11 161.66 35.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.621 ' CE2' ' HE1' ' A' ' 20' ' ' MET . 8.6 m-85 -132.09 145.75 51.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.069 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.3 mm? -117.81 129.21 55.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 110.791 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.871 HD12 HG13 ' A' ' 108' ' ' VAL . 2.1 mm -112.56 106.63 21.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.6 HG23 ' HB3' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -130.89 164.54 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.243 0.544 . . . . 0.0 111.987 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.519 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.4 p80 -81.24 152.33 27.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.797 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.6 153.46 77.76 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.521 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 9.6 Cg_endo -54.43 139.58 74.34 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.564 2.176 . . . . 0.0 113.475 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.439 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.6 p -98.86 174.38 6.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.095 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -98.24 -8.08 27.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -30.6 14.91 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 p -139.37 89.73 2.36 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.487 -0.485 . . . . 0.0 112.112 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.448 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.6 OUTLIER -79.99 -52.28 8.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.122 0.487 . . . . 0.0 111.421 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 37' ' ' ILE . 1.2 m -57.62 -45.38 85.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.083 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -32.03 67.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.797 0.332 . . . . 0.0 111.464 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.646 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.57 -48.01 24.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.915 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.9 pt -55.88 -39.21 55.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.178 0.513 . . . . 0.0 110.746 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.12 -52.08 51.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.58 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.559 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 4.8 m-20 -67.67 -50.14 59.26 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.905 0.384 . . . . 0.0 111.945 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.646 HD21 ' CE1' ' A' ' 36' ' ' PHE . 80.0 mt -55.79 -46.35 78.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.359 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -76.95 -26.71 54.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.083 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 5.3 mttt -52.91 -44.46 66.98 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.069 ' CD1' HD21 ' A' ' 23' ' ' LEU . 15.4 t80 -63.54 -38.62 91.81 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.734 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.692 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.6 -178.82 39.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.991 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.38 19.54 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 47' ' ' THR . 0.9 OUTLIER -165.19 -169.93 1.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.92 177.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.647 ' H ' HG22 ' A' ' 46' ' ' THR . 3.0 t -64.55 152.52 41.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.705 0.764 . . . . 0.0 110.437 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.81 HG22 ' HB3' ' A' ' 104' ' ' ALA . 83.6 t -132.2 136.5 56.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.006 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.062 HG13 HG13 ' A' ' 105' ' ' VAL . 14.9 p -115.66 105.31 18.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.147 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.423 ' HG2' ' CG2' ' A' ' 68' ' ' VAL . 17.1 ptt180 -113.59 110.85 20.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.748 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 113' ' ' ARG . 41.9 t -108.57 91.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.571 0.7 . . . . 0.0 110.327 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.7 p -157.82 171.03 21.02 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.041 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.27 130.25 42.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.689 HG23 ' HB3' ' A' ' 72' ' ' PRO . 17.6 t -70.22 122.19 21.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.5 p -120.51 -47.93 2.31 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.179 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.422 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.3 m-85 -130.77 83.91 2.15 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.623 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.13 -36.78 40.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.65 -48.58 13.5 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.448 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -45.92 -54.3 17.28 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 8.2 Cg_exo -73.1 -35.6 5.07 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.659 2.239 . . . . 0.0 113.653 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.977 HD21 HG11 ' A' ' 68' ' ' VAL . 2.1 mm? -71.03 -45.24 64.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.01 -28.97 60.72 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.915 ' HB3' HG21 ' A' ' 37' ' ' ILE . 5.7 mttp -81.02 -35.09 32.33 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.541 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -101.56 -12.45 18.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.48 25.61 4.6 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.378 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 64' ' ' ASP . 20.8 mt -95.36 147.72 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.672 0.272 . . . . 0.0 111.079 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 47' ' ' THR . 1.8 m -78.16 127.94 33.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.977 HG11 HD21 ' A' ' 61' ' ' LEU . 10.5 p -145.18 153.95 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.151 0.501 . . . . 0.0 112.209 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.7 t -103.33 132.75 48.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -101.08 106.84 18.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.124 0.488 . . . . 0.0 110.931 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.74 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.8 m95 -111.4 103.25 54.8 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.739 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.689 ' HB3' HG23 ' A' ' 54' ' ' VAL . 31.1 Cg_endo -109.45 -177.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.62 2.88 . . . . 0.0 112.657 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -126.41 122.22 34.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.848 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.16 -164.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.442 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -20.99 50.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.951 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -102.22 20.9 43.41 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.911 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -107.46 102.71 45.58 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.718 0.259 . . . . 0.0 110.711 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.688 ' HB2' HG13 ' A' ' 83' ' ' VAL . 17.6 Cg_exo -67.14 109.42 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.745 2.297 . . . . 0.0 112.502 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 52.5 Cg_exo -53.02 -45.53 40.45 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.692 2.261 . . . . 0.0 113.852 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.745 ' O ' HG22 ' A' ' 83' ' ' VAL . 8.0 Cg_endo -51.39 154.09 9.06 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.422 2.081 . . . . 0.0 113.662 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.73 -19.55 58.51 Favored Glycine 0 C--O 1.235 0.216 0 CA-C-N 114.979 -1.01 . . . . 0.0 113.52 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -50.85 -35.68 33.78 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.623 0.211 . . . . 0.0 111.009 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -54.04 -44.7 63.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.628 HG11 ' HE2' ' A' ' 151' ' ' TYR . 39.4 t -55.33 -43.53 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.344 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.527 ' HA ' HD12 ' A' ' 88' ' ' LEU . 21.0 mm-40 -55.37 -31.62 61.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.263 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -50.07 70.15 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.419 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.754 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.9 -30.3 70.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.897 HD21 ' HB3' ' A' ' 120' ' ' LEU . 22.9 mt -59.6 -48.32 82.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.451 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 m -63.63 -40.45 96.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.189 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.476 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.3 tm? -59.57 -51.26 70.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.616 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.917 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.8 p -69.92 -35.92 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.092 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -48.06 78.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.76 92.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.748 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -26.78 63.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.139 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.462 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.7 m-85 -82.08 -52.0 7.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.229 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.0 t -59.51 -37.95 79.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.25 -33.05 59.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.278 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.09 95.31 39.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.509 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.46 134.12 15.14 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.553 2.169 . . . . 0.0 112.223 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 56.09 27.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.494 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.642 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.9 OUTLIER -101.0 -164.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 0.0 111.248 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.692 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 m -117.74 113.51 21.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.32 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.0 t -108.71 151.03 11.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 111.983 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.81 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.99 141.79 51.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.963 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.062 HG13 HG13 ' A' ' 49' ' ' VAL . 10.1 t -140.3 166.9 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.527 ' N ' HG12 ' A' ' 105' ' ' VAL . 3.1 t60 -66.76 156.1 36.37 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.441 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.514 ' N ' ' O ' ' A' ' 25' ' ' THR . 49.8 t -68.34 106.05 2.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.314 0.578 . . . . 0.0 112.457 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.871 HG13 HD12 ' A' ' 24' ' ' ILE . 28.8 m -75.2 0.21 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.097 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.65 -8.63 3.03 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.47 -131.31 3.67 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.402 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 14.0 mt -124.42 127.42 47.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.75 -151.49 6.5 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.33 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.808 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.19 -21.26 5.95 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 111.805 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.663 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -51.28 -46.42 89.46 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.751 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.2 Cg_endo -52.02 -48.51 21.24 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.2 1.934 . . . . 0.0 112.978 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.837 HG12 HD11 ' A' ' 120' ' ' LEU . 25.5 t -60.1 -41.09 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.67 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.507 HD12 ' CG2' ' A' ' 49' ' ' VAL . 13.0 mt -60.24 -45.25 93.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.531 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.673 ' CG2' HG11 ' A' ' 105' ' ' VAL . 38.2 t -57.34 -55.14 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.749 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.72 -51.74 59.15 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.264 0.554 . . . . 0.0 110.94 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.897 ' HB3' HD21 ' A' ' 88' ' ' LEU . 6.7 mt -55.27 -30.48 60.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.16 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.917 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.93 -40.08 69.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 110.148 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.631 HD13 ' CE ' ' A' ' 20' ' ' MET . 6.4 tp -71.26 -14.36 62.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 1.001 HD11 HD21 ' A' ' 152' ' ' LEU . 2.8 mt -57.2 -30.7 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.661 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -16.61 63.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.9 p -79.53 -23.39 42.91 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.55 -96.66 0.17 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.805 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.528 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 1.4 ptt? -64.0 72.61 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.941 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.16 -67.61 0.42 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.596 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.8 t80 -67.73 -32.68 73.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 111.046 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 127' ' ' MET . 12.1 mp0 -72.29 -51.91 18.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.321 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 46.8 t0 -67.12 -39.78 86.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 111.043 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.749 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -59.43 -50.0 75.63 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.203 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 35.6 mm -73.94 -36.28 44.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.645 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.22 -49.51 23.09 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.836 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.37 -36.91 74.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.627 0.251 . . . . 0.0 110.793 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.5 tt -74.22 -28.23 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.815 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 8.0 ttm180 -68.35 -47.92 66.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.818 0.342 . . . . 0.0 110.399 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -59.89 -45.02 93.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.443 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.733 ' CE ' HG11 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -84.7 151.73 24.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.319 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.6 116.48 14.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.063 0.459 . . . . 0.0 110.667 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -115.39 163.47 15.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.844 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.402 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -55.07 -176.78 0.15 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.247 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.05 98.75 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.772 0.786 . . . . 0.0 110.751 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.63 HD12 HD21 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -88.94 109.68 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.972 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -112.88 -76.71 0.58 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.397 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.747 ' O ' HG22 ' A' ' 150' ' ' THR . 4.8 p -99.77 -60.79 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.738 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.8 tmtt? -49.04 -51.44 31.1 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -177.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.543 ' HG3' HG21 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -56.29 -51.67 67.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.63 HD21 HD12 ' A' ' 144' ' ' ILE . 3.4 mm? -75.27 -39.37 59.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 146' ' ' SER . 12.3 t -74.12 -36.25 64.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.577 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.738 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -70.16 -50.68 37.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.193 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -67.11 -35.08 79.0 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.216 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.1 -43.58 82.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -25.24 65.27 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.336 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.715 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -66.11 -32.53 74.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.373 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.54 91.77 6.33 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.747 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.46 153.29 78.87 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.663 2.242 . . . . 0.0 112.585 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -146.98 123.56 11.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.44 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -53.72 -23.94 13.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.347 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -58.8 -27.86 65.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.016 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.17 -48.02 74.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.42 -169.49 1.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -115.47 156.25 26.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.983 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? 60.08 164.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -83.52 109.63 19.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.28 111.15 2.42 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.425 2.083 . . . . 0.0 112.325 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -90.78 -42.48 10.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.955 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.9 m -95.53 139.06 32.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.91 176.57 5.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.52 89.12 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.4 p -81.71 -46.38 14.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.951 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.947 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -104.94 -31.83 9.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -133.64 155.79 49.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -129.46 147.13 51.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.47 160.61 30.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.097 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -56.14 3.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.824 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.71 149.26 28.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -104.68 145.73 29.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -141.17 147.06 45.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.81 115.02 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.516 2.144 . . . . 0.0 112.31 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.6 145.76 40.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HB3' HG23 ' A' ' 25' ' ' THR . 60.8 Cg_endo -73.09 165.2 33.38 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.628 2.219 . . . . 0.0 112.327 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 t -141.07 126.96 19.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.671 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -109.6 116.99 32.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.974 0.416 . . . . 0.0 111.607 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.835 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -107.06 118.6 55.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.603 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.6 p -140.78 144.76 35.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.97 0.414 . . . . 0.0 111.72 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.594 ' CD2' ' HE2' ' A' ' 127' ' ' MET . 0.2 OUTLIER -142.46 122.71 13.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.467 179.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 16.0 mmtt 84.12 -88.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.274 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -129.41 -40.46 1.43 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.733 0.302 . . . . 0.0 111.763 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.516 ' HE1' HD12 ' A' ' 122' ' ' LEU . 10.2 ptm -73.77 162.83 28.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.23 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -143.34 164.04 31.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.121 0.486 . . . . 0.0 111.5 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.768 ' CE1' HG11 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -135.35 142.37 45.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.892 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -114.67 136.44 53.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.061 0.458 . . . . 0.0 110.939 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.889 HD13 ' HB ' ' A' ' 105' ' ' VAL . 14.4 mm -118.3 106.46 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.37 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -134.55 165.34 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.218 0.533 . . . . 0.0 112.008 -179.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.478 ' CA ' ' HB2' ' A' ' 107' ' ' CYS . 48.6 p-80 -81.4 152.09 27.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.454 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -62.89 154.73 74.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.679 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.5 Cg_exo -54.64 139.93 76.27 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.187 1.925 . . . . 0.0 113.171 -177.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -98.69 174.31 6.47 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.108 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.475 ' H ' HG22 ' A' ' 29' ' ' THR . 3.6 t-20 -93.78 -10.7 33.32 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.84 14.74 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.3 p -139.62 89.73 2.35 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.403 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.457 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.29 -52.22 7.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.077 0.465 . . . . 0.0 111.228 178.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.442 ' O ' HG13 ' A' ' 37' ' ' ILE . 2.7 p -57.55 -45.8 84.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.33 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 m -57.72 -31.98 66.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.851 0.357 . . . . 0.0 111.187 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.721 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.39 -47.78 25.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.861 HG21 ' HB3' ' A' ' 63' ' ' LYS . 10.9 pt -55.64 -38.85 51.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 110.609 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.19 -51.4 58.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.486 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.565 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -68.27 -50.19 55.41 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.87 0.367 . . . . 0.0 111.989 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.721 HD21 ' CE1' ' A' ' 36' ' ' PHE . 85.6 mt -55.7 -45.52 77.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.481 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.98 -26.57 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.02 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 12.2 mttt -52.49 -44.56 65.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.358 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.066 ' CD1' HD21 ' A' ' 23' ' ' LEU . 11.0 t80 -63.45 -38.43 91.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.664 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.682 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 162.99 -178.41 38.71 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.921 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.52 19.76 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.676 HG22 ' H ' ' A' ' 47' ' ' THR . 1.3 m -164.9 -170.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.833 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.676 ' H ' HG22 ' A' ' 46' ' ' THR . 2.6 t -64.51 159.64 21.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.355 0.598 . . . . 0.0 110.456 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.791 HG13 ' O ' ' A' ' 104' ' ' ALA . 57.7 t -138.48 138.83 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.322 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.09 HG13 HG13 ' A' ' 105' ' ' VAL . 12.4 p -115.57 104.71 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.261 0.553 . . . . 0.0 110.816 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -114.56 110.79 20.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.322 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.802 HG13 ' HB3' ' A' ' 71' ' ' TRP . 6.3 t -107.17 90.95 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.421 0.629 . . . . 0.0 109.376 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.3 p -158.02 171.38 20.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.938 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -66.45 130.41 43.11 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 m -76.0 122.35 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -120.15 -47.66 2.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.44 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.425 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -130.63 83.88 2.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.708 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.09 -36.54 40.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -79.51 -48.57 13.66 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.437 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.34 -54.13 19.75 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 8.1 Cg_exo -73.26 -34.67 5.82 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.623 2.216 . . . . 0.0 113.48 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.968 HD21 HG11 ' A' ' 68' ' ' VAL . 2.1 mm? -71.09 -45.19 64.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.21 -28.86 60.13 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.861 ' HB3' HG21 ' A' ' 37' ' ' ILE . 5.6 mmtm -79.04 -36.63 40.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' O ' HG13 ' A' ' 66' ' ' ILE . 3.8 m-20 -101.57 -12.4 18.51 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.03 23.95 6.06 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.285 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 64' ' ' ASP . 24.6 mt -92.82 147.38 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 110.927 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' THR . 82.2 p -78.69 129.19 34.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.968 HG11 HD21 ' A' ' 61' ' ' LEU . 5.9 p -145.16 154.44 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.2 0.524 . . . . 0.0 112.123 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.51 HG22 ' HG ' ' A' ' 90' ' ' LEU . 3.2 t -103.75 133.59 47.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.108 178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.99 106.78 18.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.139 0.495 . . . . 0.0 110.396 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.889 ' CH2' HG12 ' A' ' 83' ' ' VAL . 4.4 m95 -111.91 104.27 55.91 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.049 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -104.08 160.43 0.22 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.162 2.575 . . . . 0.0 112.645 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.444 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 15.9 t80 -126.25 95.99 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.833 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.1 -175.99 3.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.703 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.83 -24.08 21.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.049 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.46 75.61 0.39 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.584 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 73' ' ' PHE . . . -85.97 148.91 49.25 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.497 0.189 . . . . 0.0 110.901 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.691 ' HG2' HG21 ' A' ' 83' ' ' VAL . 65.9 Cg_endo -73.72 109.64 2.9 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.637 2.225 . . . . 0.0 112.597 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.648 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 26.5 Cg_exo -63.44 -37.76 46.81 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.895 2.397 . . . . 0.0 114.492 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 18.3 Cg_endo -61.49 144.89 98.26 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.934 1.756 . . . . 0.0 113.596 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.428 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -66.1 -19.8 68.37 Favored Glycine 0 C--O 1.236 0.275 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.088 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -50.58 -29.52 11.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.503 0.192 . . . . 0.0 110.977 -178.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.889 HG12 ' CH2' ' A' ' 71' ' ' TRP . 40.1 t -56.98 -47.8 82.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 151' ' ' TYR . 54.4 t -55.22 -40.87 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.817 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.582 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.7 mt-10 -57.3 -31.39 65.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.532 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.04 -50.46 68.33 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.257 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.745 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.08 -29.9 70.32 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 120' ' ' LEU . 8.7 mt -62.46 -38.61 90.47 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.312 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.57 -43.78 79.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.036 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.51 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.4 tm? -60.47 -51.29 70.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.603 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.491 ' CG2' ' CE1' ' A' ' 95' ' ' PHE . 10.2 p -69.14 -35.9 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -57.3 -46.38 83.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.756 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.5 84.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -26.58 64.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.241 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.543 ' CE1' HG21 ' A' ' 103' ' ' VAL . 3.8 m-30 -81.99 -50.88 8.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.25 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 51.4 t -59.88 -38.04 81.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.921 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -76.21 -33.09 59.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.96 90.21 50.76 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.425 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.12 135.77 25.71 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.879 2.386 . . . . 0.0 112.231 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.07 55.39 30.91 Favored Glycine 0 C--N 1.329 0.154 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.696 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.577 ' HB2' HG21 ' A' ' 46' ' ' THR . 4.5 m -101.3 -163.46 1.02 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.25 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.682 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.0 m -119.34 113.87 21.48 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.319 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.768 HG11 ' CE1' ' A' ' 22' ' ' PHE . 38.1 t -109.2 151.0 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.791 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -120.65 145.12 47.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.224 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.09 HG13 HG13 ' A' ' 49' ' ' VAL . 4.0 t -140.31 166.78 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.786 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 3.4 t60 -67.29 155.52 38.68 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.018 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.55 ' N ' ' O ' ' A' ' 25' ' ' THR . 38.5 t -69.0 98.36 0.95 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.506 0.67 . . . . 0.0 112.37 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.844 HG23 HD12 ' A' ' 24' ' ' ILE . 2.7 t -75.76 1.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.854 -1.067 . . . . 0.0 112.347 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.42 -8.62 1.87 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.86 -120.62 2.55 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.424 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 8.3 mt -126.46 127.29 45.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.91 -154.34 7.47 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.839 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.509 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.25 -17.65 7.06 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.082 0.468 . . . . 0.0 111.834 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.878 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -51.44 -46.21 90.22 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 9.4 Cg_endo -52.11 -48.51 21.27 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.491 2.128 . . . . 0.0 113.303 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.737 ' O ' HD23 ' A' ' 120' ' ' LEU . 24.0 t -61.64 -44.6 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.029 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.785 HD12 ' CG2' ' A' ' 49' ' ' VAL . 2.3 mt -59.66 -46.06 90.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.573 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.654 ' CG2' HG11 ' A' ' 105' ' ' VAL . 97.5 t -56.44 -55.19 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.645 0.26 . . . . 0.0 111.562 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.615 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.76 -48.61 66.65 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.181 0.515 . . . . 0.0 110.835 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 116' ' ' VAL . 3.3 mm? -56.88 -30.87 64.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.588 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.745 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -70.92 -34.23 71.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.4 . . . . 0.0 110.092 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.734 HD23 ' OD2' ' A' ' 131' ' ' ASP . 1.4 tp -75.32 -16.66 60.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.528 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.917 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.9 mt -57.28 -30.66 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.179 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.409 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 10.6 pt-20 -73.81 -16.72 61.14 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.3 t -79.49 -23.29 43.08 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.66 -97.6 0.18 Allowed Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.576 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.594 ' HE2' ' CD2' ' A' ' 17' ' ' TYR . 1.1 ptt? -63.03 73.61 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.917 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.03 -67.58 0.42 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.592 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.2 t80 -69.33 -32.3 71.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.042 0.448 . . . . 0.0 110.914 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.28 -50.44 27.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.36 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.734 ' OD2' HD23 ' A' ' 122' ' ' LEU . 43.3 t0 -67.59 -37.17 82.19 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.615 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -61.05 -50.2 74.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.991 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 129' ' ' TYR . 24.6 mm -72.8 -38.45 57.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 111.681 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -49.6 22.9 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.835 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.64 -34.11 71.71 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.864 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.9 OUTLIER -74.07 -30.64 27.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.798 0.332 . . . . 0.0 110.393 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -65.42 -48.95 71.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.29 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -59.93 -45.1 93.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.593 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -83.19 151.89 25.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.637 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 117.46 14.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.6 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.482 ' HG3' HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -114.44 163.17 15.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.968 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -61.02 -157.49 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.274 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.43 98.71 11.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.568 0.684 . . . . 0.0 110.461 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.739 HG23 ' CB ' ' A' ' 148' ' ' GLN . 61.4 mt -88.71 109.0 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.058 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -113.87 -77.74 0.58 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.854 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.5 p -101.13 -60.95 1.43 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.831 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.2 tmtt? -48.99 -52.06 27.07 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.739 ' CB ' HG23 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -56.2 -51.82 66.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.431 ' CD2' ' CG2' ' A' ' 144' ' ' ILE . 3.1 mm? -73.24 -47.0 46.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.5 m -66.92 -37.24 83.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.831 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -67.89 -50.92 53.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.319 -179.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.835 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -70.71 -31.32 68.15 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.344 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 1.2 tt0 -59.14 -39.02 81.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -29.17 64.78 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.448 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.711 ' HE2' HD12 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -66.06 -30.17 70.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.665 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.76 88.98 3.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.03 153.25 78.44 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.63 2.22 . . . . 0.0 112.378 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -147.1 123.48 10.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.485 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -13.27 62.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.332 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -41.58 87.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.879 0.371 . . . . 0.0 110.978 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.8 tp -86.09 -47.94 9.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -74.58 166.37 23.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -91.12 129.94 37.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -102.1 120.65 40.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.31 138.05 68.0 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.63 -44.8 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.449 2.099 . . . . 0.0 112.309 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -105.22 129.04 53.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.9 p -99.0 108.88 21.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -87.31 118.59 26.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.51 125.05 52.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 171' ' ' THR . 8.3 t -98.49 116.18 30.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.962 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.894 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -86.51 -177.51 6.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 110.83 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -112.11 129.69 56.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.7 ptp -88.22 168.75 12.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.99 95.17 2.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -124.59 120.13 31.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.2 tpp -102.26 111.7 24.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.36 126.18 40.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.833 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -167.97 104.16 0.56 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 49.4 Cg_endo -68.85 116.86 4.66 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.346 2.031 . . . . 0.0 112.281 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -80.85 160.68 65.88 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.544 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 56.3 Cg_endo -70.38 152.67 66.22 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.565 2.176 . . . . 0.0 112.386 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.478 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.5 t -144.07 127.64 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.903 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -110.71 116.8 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.805 0.336 . . . . 0.0 111.353 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.787 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -106.72 118.33 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.1 p -141.2 142.84 33.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.643 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 1.4 p90 -134.51 170.21 16.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.113 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 43.63 -96.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.053 0.141 . . . . 0.0 111.167 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.402 ' H ' ' CG ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -128.92 -30.78 2.21 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.76 ' HE1' HD11 ' A' ' 122' ' ' LEU . 3.9 ppp? -73.74 169.13 17.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.687 0.28 . . . . 0.0 111.23 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -147.94 161.23 41.74 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.979 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.839 ' CD2' HG13 ' A' ' 118' ' ' VAL . 1.3 m-85 -134.11 150.72 51.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.377 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -121.13 136.36 54.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.122 0.487 . . . . 0.0 111.557 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.916 HD12 HG13 ' A' ' 108' ' ' VAL . 1.9 mm -118.19 106.58 20.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.13 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -134.78 166.99 21.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.287 0.565 . . . . 0.0 111.745 -178.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 36' ' ' PHE . 49.1 p-80 -81.33 152.03 27.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.103 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -62.88 154.53 75.66 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.043 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.7 Cg_exo -54.77 138.91 77.5 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.389 2.059 . . . . 0.0 113.312 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.44 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 28.9 p -98.72 174.41 6.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.231 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -93.79 -9.73 36.53 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.59 -30.81 14.77 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -139.62 89.58 2.33 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.274 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.44 -52.27 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.138 0.494 . . . . 0.0 111.174 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.433 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.1 p -58.49 -45.21 89.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.162 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 m -57.99 -32.78 68.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.9 0.381 . . . . 0.0 111.339 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.691 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.51 -48.11 29.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.148 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.751 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.0 pt -56.08 -39.15 56.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.265 0.555 . . . . 0.0 110.645 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.3 -50.9 63.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.513 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -69.63 -50.13 47.26 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.887 0.375 . . . . 0.0 111.813 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.691 HD21 ' CE1' ' A' ' 36' ' ' PHE . 53.0 mt -56.19 -44.19 79.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.305 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -78.89 -26.75 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.021 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -52.92 -43.48 66.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.29 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.066 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.6 t80 -63.41 -38.4 90.99 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.663 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.682 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 166.31 -177.43 41.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.793 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.56 117.47 19.62 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.706 HG22 ' H ' ' A' ' 47' ' ' THR . 1.4 m -165.25 -169.93 1.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.687 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.721 ' HA ' HG23 ' A' ' 67' ' ' THR . 5.1 p -64.81 144.49 57.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.572 0.701 . . . . 0.0 110.448 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.956 HG21 HD12 ' A' ' 66' ' ' ILE . 61.0 t -122.18 128.14 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.868 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.041 HG13 HG13 ' A' ' 105' ' ' VAL . 2.1 p -115.44 105.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.355 0.597 . . . . 0.0 111.692 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -113.89 111.02 21.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.737 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.823 HG11 ' HB2' ' A' ' 113' ' ' ARG . 38.8 t -101.22 92.38 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.498 0.666 . . . . 0.0 110.405 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.18 171.46 20.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.072 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -64.62 130.7 44.62 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 m -68.73 122.05 19.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.553 HG22 ' CE1' ' A' ' 56' ' ' TYR . 6.5 m -120.45 -47.0 2.36 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.143 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.553 ' CE1' HG22 ' A' ' 55' ' ' THR . 2.8 m-85 -129.79 84.89 2.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.362 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.411 ' HA ' ' NH2' ' A' ' 50' ' ' ARG . 6.0 p-10 -78.21 -35.64 48.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -78.81 -48.49 14.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.41 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -46.45 -51.24 36.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 47.5 Cg_exo -57.13 -42.33 64.62 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.242 . . . . 0.0 113.83 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.73 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -71.21 -45.47 63.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -49.12 19.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.751 ' HB3' HG21 ' A' ' 37' ' ' ILE . 28.1 mmtt -74.46 -26.86 60.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.46 ' CG ' HD11 ' A' ' 66' ' ' ILE . 3.1 t0 -99.92 -11.57 20.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.54 25.98 3.49 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.14 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.956 HD12 HG21 ' A' ' 48' ' ' VAL . 4.7 pt -122.76 148.73 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.601 0.239 . . . . 0.0 110.573 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.721 HG23 ' HA ' ' A' ' 47' ' ' THR . 10.3 t -77.15 132.87 39.03 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.73 HG12 ' CD2' ' A' ' 61' ' ' LEU . 8.0 p -139.71 149.38 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.155 0.502 . . . . 0.0 111.984 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.446 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.8 t -103.3 131.6 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.91 106.63 17.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.585 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.888 ' CH2' HG12 ' A' ' 83' ' ' VAL . 4.4 m95 -110.22 103.46 53.86 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.555 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -108.78 -175.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 123.538 2.825 . . . . 0.0 112.882 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.434 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 2.4 t80 -126.4 102.11 7.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.756 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.24 173.02 7.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.776 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -55.02 -24.26 23.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.54 45.17 1.36 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.488 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.45 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . . . -85.87 102.66 2.82 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.551 0.176 . . . . 0.0 110.656 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.551 ' O ' HG21 ' A' ' 83' ' ' VAL . 8.2 Cg_endo -50.93 102.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.646 2.23 . . . . 0.0 112.69 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.687 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 52.8 Cg_exo -55.75 -43.26 59.12 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.717 2.278 . . . . 0.0 114.102 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.687 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 4.1 Cg_endo -48.72 154.16 3.15 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.361 2.041 . . . . 0.0 113.572 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -63.68 -19.79 63.22 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.347 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 5.7 tmtp? -50.81 -29.66 12.27 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 120.609 0.242 . . . . 0.0 110.833 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.888 HG12 ' CH2' ' A' ' 71' ' ' TRP . 42.1 t -56.56 -46.71 82.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG21 ' NZ ' ' A' ' 147' ' ' LYS . 89.3 t -56.08 -40.37 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.039 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 2.0 mt-10 -58.2 -31.44 67.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.746 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.72 -50.74 63.72 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.498 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.856 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.03 -28.9 69.21 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.715 HD21 ' HB3' ' A' ' 120' ' ' LEU . 11.3 mt -64.74 -38.5 91.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.228 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.8 m -66.93 -39.99 87.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.994 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.502 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.6 tm? -63.44 -51.3 66.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.874 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.675 HG21 ' HB1' ' A' ' 121' ' ' ALA . 13.5 p -69.76 -43.42 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.457 ' N ' HG13 ' A' ' 91' ' ' VAL . 21.2 mttm -60.82 -34.76 75.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.393 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.2 -47.96 72.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.418 ' HE2' HG21 ' A' ' 67' ' ' THR . 9.4 mptt -74.6 -25.59 59.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.652 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 3.3 m-85 -82.02 -34.48 29.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.992 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.1 t -72.26 -46.4 56.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -76.35 -33.36 58.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.35 141.99 41.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.91 159.32 53.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.406 2.071 . . . . 0.0 112.125 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.09 90.75 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -81.44 -83.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.68 0.276 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.682 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.6 m -153.26 113.05 3.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.792 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.652 HG21 ' HZ ' ' A' ' 95' ' ' PHE . 23.5 t -108.07 151.21 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.694 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.4 140.45 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.27 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.041 HG13 HG13 ' A' ' 49' ' ' VAL . 2.5 t -139.6 166.79 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.612 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.637 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.0 t60 -67.16 156.27 36.64 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.52 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -68.06 105.07 1.93 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.916 HG13 HD12 ' A' ' 24' ' ' ILE . 29.8 m -75.28 -0.02 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.025 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 10' ' ' PRO . . . -60.72 -8.72 3.17 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.93 -136.32 4.68 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' CD2' ' HA2' ' A' ' 142' ' ' GLY . 13.0 mt -120.9 127.46 51.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.74 -147.42 5.22 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.374 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.823 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.24 -20.01 6.32 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.907 0.384 . . . . 0.0 111.89 -178.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.666 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -52.64 -46.56 95.87 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.817 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.5 Cg_endo -52.1 -48.31 22.31 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.264 1.976 . . . . 0.0 112.73 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.68 ' O ' HD23 ' A' ' 120' ' ' LEU . 39.0 t -60.95 -44.47 98.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.917 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.463 HD12 ' CG2' ' A' ' 51' ' ' VAL . 9.4 mt -58.12 -45.31 87.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.212 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.934 ' CG2' HG11 ' A' ' 105' ' ' VAL . 94.9 t -55.0 -55.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.776 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.669 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -56.36 -49.25 74.95 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.147 0.499 . . . . 0.0 110.748 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.715 ' HB3' HD21 ' A' ' 88' ' ' LEU . 2.7 mm? -53.91 -30.91 48.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.732 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.856 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -69.58 -43.32 73.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.05 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.782 HD23 ' OD2' ' A' ' 131' ' ' ASP . 0.7 OUTLIER -66.98 -15.63 63.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.757 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.919 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.6 mt -57.04 -30.64 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -72.45 -17.02 61.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.424 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.5 m -84.54 11.25 9.09 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 113.79 -99.5 0.98 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.763 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.482 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.0 ptt? -62.45 79.73 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.919 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.9 -67.69 0.54 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.619 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.2 t80 -67.33 -32.05 72.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.959 0.409 . . . . 0.0 111.001 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.37 -52.04 17.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.25 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.782 ' OD2' HD23 ' A' ' 122' ' ' LEU . 32.3 t0 -68.24 -38.13 81.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.816 0.341 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.669 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -60.04 -49.98 75.54 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.007 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.4 mm -73.67 -37.61 49.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -74.17 -49.6 22.92 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.787 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.57 -35.8 73.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.583 0.23 . . . . 0.0 110.902 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.4 tt -74.14 -29.26 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.395 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -66.31 -48.44 70.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.477 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -44.94 93.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.443 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -82.81 152.25 25.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.29 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 117.25 14.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.503 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -114.53 163.54 15.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.01 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.416 ' HA2' ' CD2' ' A' ' 111' ' ' LEU . . . -59.15 -164.08 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.485 -0.865 . . . . 0.0 111.173 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.06 98.96 11.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.709 0.755 . . . . 0.0 110.745 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.768 HD13 HD21 ' A' ' 149' ' ' LEU . 1.6 pp -88.48 109.03 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.074 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -113.45 -77.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.456 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.4 m -100.27 -60.7 1.48 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.822 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.5 tmtt? -53.19 -51.8 60.91 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.642 ' HG3' HG22 ' A' ' 144' ' ' ILE . 3.7 tm0? -56.03 -52.03 65.68 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.768 HD21 HD13 ' A' ' 144' ' ' ILE . 3.6 mm? -75.04 -45.3 42.56 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.4 m -67.09 -35.0 78.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.629 0.252 . . . . 0.0 111.622 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.822 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -69.51 -50.87 41.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.387 -179.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.831 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -69.47 -32.25 71.04 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.323 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 51.3 tt0 -59.73 -39.55 85.08 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -27.46 63.52 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.585 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.651 ' HE2' HD12 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -66.23 -33.77 76.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.621 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.82 85.9 2.09 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.662 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.93 153.14 63.68 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.618 2.212 . . . . 0.0 112.502 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.31 123.5 10.84 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.427 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -77.98 -30.88 50.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.005 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -62.55 -30.6 71.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.64 -48.0 12.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -71.48 -55.35 8.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.9 122.38 20.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.5 pttp -155.48 164.97 37.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -86.83 112.55 47.94 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.69 176.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.44 2.093 . . . . 0.0 112.22 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.78 115.53 12.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 75.3 p -138.49 157.37 46.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -83.94 105.2 14.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -138.8 -47.31 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.36 -66.42 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -159.73 157.89 30.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 110.957 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.95 120.83 40.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 ttp -83.35 -56.1 3.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.05 169.06 21.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -148.54 131.02 15.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.78 160.82 23.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.957 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -136.13 -63.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -101.41 148.55 35.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.53 126.45 12.82 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.582 2.188 . . . . 0.0 112.237 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.65 139.59 97.12 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.064 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.02 165.16 33.55 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.538 2.159 . . . . 0.0 112.368 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.93 126.83 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.534 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.55 ' HB3' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -116.82 136.01 53.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.015 0.436 . . . . 0.0 111.898 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.682 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.8 137.02 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.12 129.3 37.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.245 0.545 . . . . 0.0 111.963 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.447 ' CE1' ' HE1' ' A' ' 127' ' ' MET . 25.7 t80 -145.57 132.74 20.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.268 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 64.08 -103.49 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.204 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.4 14.04 6.07 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.521 ' HE2' HD21 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -119.26 169.0 10.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.775 0.322 . . . . 0.0 110.96 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.8 mtm-85 -141.79 164.08 31.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.122 0.486 . . . . 0.0 111.733 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.502 ' HE1' HG11 ' A' ' 103' ' ' VAL . 3.9 m-85 -134.59 150.19 50.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.872 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.062 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -126.21 135.49 51.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 111.143 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.846 HD12 HG23 ' A' ' 108' ' ' VAL . 10.9 mm -118.33 106.27 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.554 HG21 HD23 ' A' ' 40' ' ' LEU . 1.2 p -131.07 163.74 26.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.197 0.522 . . . . 0.0 111.756 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.527 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.5 p80 -81.24 152.44 27.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.261 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.38 154.81 70.29 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.802 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 51.8 Cg_exo -53.89 136.6 66.73 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.32 2.013 . . . . 0.0 113.15 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.53 143.53 28.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.21 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -64.79 -12.78 51.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.338 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -31.31 14.59 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.4 p -139.97 88.8 2.26 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.282 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.89 -52.28 7.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.259 0.552 . . . . 0.0 111.256 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.466 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.3 m -56.84 -46.36 81.76 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.624 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -57.58 -31.9 66.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.961 0.41 . . . . 0.0 111.145 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.704 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.85 -47.59 29.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.175 -179.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.904 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.6 pt -55.62 -39.06 52.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.136 0.493 . . . . 0.0 110.605 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -65.18 -52.03 57.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.51 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.536 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 2.4 m-20 -67.99 -50.15 57.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.902 0.382 . . . . 0.0 111.935 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.704 HD21 ' CE1' ' A' ' 36' ' ' PHE . 74.2 mt -55.84 -45.2 78.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.556 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.8 tttm -77.34 -26.71 52.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.085 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.2 mttt -53.04 -44.99 67.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.217 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.062 ' CD1' HD21 ' A' ' 23' ' ' LEU . 11.5 t80 -63.57 -38.32 90.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.748 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.675 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 161.05 -177.74 37.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.934 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.67 122.33 27.17 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.848 HG22 ' H ' ' A' ' 47' ' ' THR . 4.1 m -164.54 -171.39 2.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.513 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.848 ' H ' HG22 ' A' ' 46' ' ' THR . 1.7 t -65.44 162.22 18.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.816 HG13 ' O ' ' A' ' 104' ' ' ALA . 91.8 t -138.01 137.99 44.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.834 HG12 HG22 ' A' ' 105' ' ' VAL . 11.2 p -115.23 104.2 16.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.421 0.629 . . . . 0.0 111.002 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.22 110.98 20.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.05 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.828 HG13 ' HB3' ' A' ' 71' ' ' TRP . 6.1 t -105.8 91.26 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.462 0.649 . . . . 0.0 109.704 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 t -157.87 171.29 20.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.911 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -67.61 130.45 43.08 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 54' ' ' VAL . 34.7 m -74.83 122.48 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.4 p -120.16 -47.66 2.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.376 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.449 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -130.56 83.34 2.11 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.457 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.17 -36.38 40.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -79.06 -48.55 14.17 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -43.91 -60.22 2.9 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.61 -34.31 15.35 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.551 2.167 . . . . 0.0 113.871 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.037 HD21 HG11 ' A' ' 68' ' ' VAL . 1.6 mm? -71.13 -45.19 64.08 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -75.1 -29.37 60.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.904 ' HB3' HG21 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -81.09 -33.8 33.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.23 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.539 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -101.31 -12.41 18.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.11 24.19 4.48 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.473 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 64' ' ' ASP . 12.7 mt -96.4 147.47 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.946 0.373 . . . . 0.0 110.835 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 47' ' ' THR . 3.4 m -78.47 132.57 37.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.037 HG11 HD21 ' A' ' 61' ' ' LEU . 7.5 p -145.05 152.78 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.337 0.589 . . . . 0.0 112.125 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.83 130.54 54.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.001 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.09 106.84 18.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.082 0.468 . . . . 0.0 111.044 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.828 ' HB3' HG13 ' A' ' 51' ' ' VAL . 5.5 m95 -109.35 103.9 53.82 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.51 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -105.83 153.95 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.262 2.642 . . . . 0.0 112.94 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' CZ ' ' O ' ' A' ' 77' ' ' ALA . 1.1 t80 -126.24 99.85 6.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.08 173.54 0.62 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.15 -34.02 71.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.969 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.45 52.07 0.84 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.378 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.415 ' O ' ' CZ ' ' A' ' 73' ' ' PHE . . . -103.93 102.98 34.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.484 0.183 . . . . 0.0 111.232 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.456 ' O ' ' CD ' ' A' ' 80' ' ' PRO . 70.9 Cg_exo -50.8 164.31 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.311 2.007 . . . . 0.0 111.89 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -100.28 70.89 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.472 2.781 . . . . 0.0 113.257 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.866 ' O ' HG22 ' A' ' 83' ' ' VAL . 57.4 Cg_endo -69.92 135.68 30.68 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.116 1.877 . . . . 0.0 111.827 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.469 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -66.52 -22.52 71.51 Favored Glycine 0 C--O 1.238 0.386 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.243 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -38.8 63.22 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.647 0.26 . . . . 0.0 111.09 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 80' ' ' PRO . 31.2 m -58.65 -44.4 89.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.707 HG22 ' CD1' ' A' ' 120' ' ' LEU . 0.8 OUTLIER -53.42 -39.41 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.229 0.538 . . . . 0.0 109.591 178.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.63 -31.35 70.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.726 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.04 -50.88 64.5 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.712 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -68.86 -34.76 75.99 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.785 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.705 HD21 ' HB3' ' A' ' 120' ' ' LEU . 10.2 mt -55.17 -43.67 74.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.411 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -40.6 82.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.316 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.416 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.2 tm? -58.39 -51.35 70.18 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.9 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.065 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.2 p -73.9 -36.06 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.878 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 -44.06 64.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.934 0.397 . . . . 0.0 110.597 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.08 -43.6 57.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.951 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.721 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.7 OUTLIER -64.74 -27.62 69.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.263 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.06 -40.71 21.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 111.0 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 7.2 t -67.0 -46.05 75.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -76.1 -33.04 59.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.08 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -109.37 87.99 5.63 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.293 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.27 115.91 4.04 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.584 2.189 . . . . 0.0 112.363 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.15 52.14 19.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 t -101.17 -174.16 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.62 0.247 . . . . 0.0 111.179 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.675 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 3.1 m -112.94 114.12 26.48 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.502 HG11 ' HE1' ' A' ' 22' ' ' PHE . 16.3 t -106.81 151.28 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.816 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -121.33 145.7 47.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.643 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.834 HG22 HG12 ' A' ' 49' ' ' VAL . 97.5 t -139.86 166.25 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.659 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 3.0 t60 -67.81 155.43 39.36 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.825 0.345 . . . . 0.0 110.725 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.541 ' N ' ' O ' ' A' ' 25' ' ' THR . 43.7 t -69.36 104.23 2.21 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.846 HG23 HD12 ' A' ' 24' ' ' ILE . 3.0 t -75.73 1.39 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.417 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.16 -8.37 1.54 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.73 -121.32 2.62 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 111' ' ' LEU . 7.8 mt -132.12 127.32 35.74 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.13 -154.48 7.55 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.146 -1.025 . . . . 0.0 113.255 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.572 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.37 -15.12 7.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.91 0.386 . . . . 0.0 111.943 -178.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.77 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -53.34 -46.79 97.79 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 10.1 Cg_endo -52.98 -48.1 23.97 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.352 2.035 . . . . 0.0 112.446 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.525 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 41.8 t -55.84 -53.23 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.859 0.362 . . . . 0.0 110.479 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.819 HD12 ' CG2' ' A' ' 49' ' ' VAL . 2.7 mt -54.44 -48.76 71.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.773 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 114' ' ' ALA . 17.0 t -51.28 -49.71 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 111.354 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.706 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -55.91 -45.26 78.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.668 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.785 HD13 ' OH ' ' A' ' 151' ' ' TYR . 0.5 OUTLIER -57.54 -30.88 65.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.766 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 1.065 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.05 -44.76 62.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.939 0.4 . . . . 0.0 110.597 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.723 HD13 ' OD2' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -69.63 -15.9 63.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.791 179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 1.068 HD11 HD21 ' A' ' 152' ' ' LEU . 1.3 mt -57.77 -41.72 80.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.871 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.52 -15.81 3.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.45 ' OG ' HD23 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -80.83 11.24 4.06 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 117.79 -88.08 0.44 Allowed Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.307 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.532 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.97 79.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.288 0.566 . . . . 0.0 109.662 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.91 ' CB ' HG23 ' A' ' 123' ' ' ILE . 20.9 mttm -62.61 -68.08 0.36 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.005 -177.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 152' ' ' LEU . 7.1 t80 -74.34 -30.47 62.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.229 0.537 . . . . 0.0 110.499 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -72.57 -47.15 50.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.107 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.723 ' OD2' HD13 ' A' ' 122' ' ' LEU . 50.8 t0 -68.88 -47.23 66.39 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.349 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.755 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -59.07 -50.16 75.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.941 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 35.4 mm -72.44 -36.18 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -74.21 -49.56 22.9 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.682 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.69 -37.5 76.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 110.815 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 132' ' ' ALA . 3.3 tt -74.44 -28.55 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.464 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 0.9 OUTLIER -69.51 -46.73 65.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.944 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -41.52 91.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.118 0.485 . . . . 0.0 110.027 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -87.14 152.64 22.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.154 179.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.38 117.81 14.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.112 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -114.19 163.66 14.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.234 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -57.95 -163.36 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.946 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.17 100.18 13.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.156 0.478 . . . . 0.0 111.51 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.637 HG22 ' NE2' ' A' ' 148' ' ' GLN . 0.1 OUTLIER -87.91 109.17 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.482 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.65 -77.52 0.58 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.544 ' O ' HG22 ' A' ' 150' ' ' THR . 14.6 m -100.48 -61.41 1.37 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 8.8 tmtt? -64.29 -46.39 83.85 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -176.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.637 ' NE2' HG22 ' A' ' 144' ' ' ILE . 0.9 OUTLIER -56.23 -52.13 65.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -176.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 149' ' ' LEU . 2.2 mm? -75.35 -37.19 60.81 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.963 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.618 HG22 ' HA ' ' A' ' 147' ' ' LYS . 5.1 t -71.76 -37.11 70.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.844 0.355 . . . . 0.0 110.968 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.799 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.85 -50.56 64.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.643 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.068 HD21 HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -66.7 -31.64 72.44 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.643 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.82 -37.45 84.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -23.0 55.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.883 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.493 ' CB ' HD23 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -66.22 -43.84 85.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.507 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 48.0 ttt85 -107.0 115.31 60.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.607 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.48 138.41 59.74 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.421 2.081 . . . . 0.0 112.369 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -147.31 123.46 10.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.559 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.19 2.83 29.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.596 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -59.08 -37.07 76.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.71 0.29 . . . . 0.0 110.983 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.557 HD12 ' HD2' ' A' ' 162' ' ' ARG . 0.6 OUTLIER -81.54 -29.56 33.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.955 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.557 ' HD2' HD12 ' A' ' 161' ' ' LEU . 0.4 OUTLIER -122.3 96.09 4.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -73.67 97.73 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -129.2 162.69 27.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -94.05 103.09 9.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.78 116.78 4.72 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.452 2.101 . . . . 0.0 112.269 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -137.42 120.68 16.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.815 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.3 t -97.04 133.66 41.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.811 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -104.85 122.01 44.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -154.7 128.12 8.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.78 33.28 20.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.883 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.5 p -135.25 142.13 45.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.64 126.58 24.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 35.4 mtm -106.37 125.6 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.8 -39.45 7.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.074 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -149.85 -61.07 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -169.3 -64.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -162.06 114.06 1.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -60.1 127.77 86.37 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.8 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HB3' ' CB ' ' A' ' 109' ' ' ALA . 72.3 Cg_endo -76.21 123.34 7.14 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.508 2.139 . . . . 0.0 112.4 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.63 153.93 55.85 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.26 165.14 32.51 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.99 126.85 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -106.89 132.64 52.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.448 . . . . 0.0 111.657 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.811 HG12 ' CE2' ' A' ' 135' ' ' PHE . 2.1 t -106.78 124.78 62.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.224 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.6 p -122.32 140.88 52.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 111.823 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.53 ' CB ' HD21 ' A' ' 122' ' ' LEU . 26.5 t80 -155.25 131.04 9.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.7 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm 59.04 -100.24 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.082 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -129.56 14.09 5.98 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.54 ' CE ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -117.06 164.65 14.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 110.949 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -132.72 164.01 27.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.421 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.677 ' CE1' HG13 ' A' ' 118' ' ' VAL . 1.2 m-85 -142.89 146.22 33.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.847 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.035 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -122.66 136.28 54.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 111.259 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.97 HG21 HG22 ' A' ' 108' ' ' VAL . 5.6 mm -118.49 106.3 19.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.69 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.568 HG21 HD23 ' A' ' 40' ' ' LEU . 1.9 p -132.38 164.79 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.057 0.456 . . . . 0.0 111.506 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.509 ' CD2' ' CZ ' ' A' ' 36' ' ' PHE . 31.3 p-80 -81.46 152.12 27.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.074 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -62.8 154.54 74.99 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.978 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 51.2 Cg_exo -54.03 134.7 61.07 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.425 2.083 . . . . 0.0 113.068 -177.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -98.5 152.96 18.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.267 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -71.81 -11.41 60.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.53 -31.58 14.49 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -140.08 88.75 2.25 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.135 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.527 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -81.07 -52.38 7.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.184 0.516 . . . . 0.0 111.533 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.429 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.6 p -57.2 -46.78 82.57 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.635 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.2 m -57.82 -32.27 67.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.881 0.372 . . . . 0.0 111.255 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.687 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.67 -47.95 28.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.939 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.0 pt -55.93 -39.03 55.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.207 0.527 . . . . 0.0 110.623 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.83 -52.01 59.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.558 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.563 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 3.7 m-20 -68.88 -50.08 52.77 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.929 0.395 . . . . 0.0 111.832 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.687 HD21 ' CE1' ' A' ' 36' ' ' PHE . 53.5 mt -55.92 -45.21 78.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -26.77 48.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.027 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.563 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -53.32 -43.36 67.56 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.367 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.035 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.0 t80 -63.28 -38.65 92.0 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.689 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.647 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.68 -178.38 40.5 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.821 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.56 117.4 19.51 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.775 HG21 ' OG ' ' A' ' 101' ' ' SER . 1.3 m -165.18 -170.41 1.9 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.806 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.684 ' H ' HG22 ' A' ' 46' ' ' THR . 3.6 t -65.09 159.83 22.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.484 0.659 . . . . 0.0 110.617 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.792 HG13 ' O ' ' A' ' 104' ' ' ALA . 60.0 t -136.27 138.15 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.073 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.027 HG13 HG13 ' A' ' 105' ' ' VAL . 14.9 p -115.55 104.65 17.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.551 0.691 . . . . 0.0 111.211 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -115.13 110.79 20.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.251 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.815 HG13 ' HB3' ' A' ' 71' ' ' TRP . 12.9 t -106.62 91.84 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.366 0.603 . . . . 0.0 109.722 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.32 171.42 20.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.719 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -64.69 130.47 43.71 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.61 121.86 19.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -120.66 -47.38 2.32 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.133 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.429 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 9.0 m-85 -130.33 84.62 2.21 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.483 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -78.33 -36.05 46.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -48.55 14.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.615 HG22 ' CD ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -45.14 -49.99 28.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 34.2 Cg_exo -60.93 -40.67 50.82 Favored 'Trans proline' 0 N--CA 1.471 0.193 0 C-N-CA 122.646 2.23 . . . . 0.0 113.605 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.504 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -71.14 -45.05 64.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -49.13 20.18 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.939 ' HB3' HG21 ' A' ' 37' ' ' ILE . 11.4 mttm -76.16 -25.72 55.54 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.446 ' CG ' HD11 ' A' ' 66' ' ' ILE . 2.8 t0 -99.35 -11.48 21.16 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.42 26.85 2.61 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.278 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.446 HD11 ' CG ' ' A' ' 64' ' ' ASP . 4.2 pt -122.54 148.12 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.688 0.28 . . . . 0.0 110.737 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.53 HG23 ' HA ' ' A' ' 47' ' ' THR . 11.0 t -77.83 135.11 37.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.064 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.504 HG12 ' CD2' ' A' ' 61' ' ' LEU . 3.6 p -141.59 154.46 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.277 0.561 . . . . 0.0 111.733 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.404 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.7 t -103.68 131.28 52.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.145 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -100.8 106.81 18.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.201 0.524 . . . . 0.0 110.193 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.884 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.5 m95 -111.26 104.51 56.24 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 48.9 Cg_endo -103.21 153.72 0.24 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.204 2.602 . . . . 0.0 112.344 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -122.32 121.43 36.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.008 0.433 . . . . 0.0 110.984 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' A' ' 77' ' ' ALA . 0.5 OUTLIER 175.5 -161.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.369 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -63.96 -15.76 59.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.223 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.8 -4.72 45.39 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.194 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.434 ' HB3' ' H ' ' A' ' 74' ' ' ASP . . . -85.96 112.55 46.11 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.952 0.376 . . . . 0.0 111.066 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.643 ' O ' HG21 ' A' ' 83' ' ' VAL . 51.6 Cg_exo -55.31 106.1 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.502 2.134 . . . . 0.0 112.482 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.7 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 42.2 Cg_exo -57.81 -39.38 87.57 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.017 2.478 . . . . 0.0 114.589 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 2.0 Cg_endo -47.56 154.09 1.87 Allowed 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.142 1.894 . . . . 0.0 113.635 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.423 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -64.71 -20.67 66.45 Favored Glycine 0 C--O 1.237 0.34 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.332 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -29.83 16.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.563 0.22 . . . . 0.0 110.936 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.884 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 11.6 t -59.93 -48.23 88.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.529 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 1.1 t -53.52 -38.69 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.227 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.414 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.2 mt-10 -66.45 -31.19 71.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.355 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -63.35 -50.64 69.17 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.551 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.721 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -67.44 -32.64 73.64 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.89 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.788 HD21 ' HB3' ' A' ' 120' ' ' LEU . 13.5 mt -55.93 -48.02 76.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.607 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -41.34 95.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.487 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.435 ' C ' HD13 ' A' ' 90' ' ' LEU . 1.9 tm? -57.68 -51.59 68.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.875 HG21 ' HB1' ' A' ' 121' ' ' ALA . 13.2 p -74.75 -35.82 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.383 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -55.04 -40.95 70.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.963 0.411 . . . . 0.0 110.513 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.28 -46.75 39.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.227 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -62.3 -37.57 86.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.631 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.441 ' HE1' HG23 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -82.02 -33.49 30.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.763 0.316 . . . . 0.0 111.171 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.04 -46.04 58.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -76.1 -31.5 58.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.273 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -117.35 87.25 23.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.479 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.45 136.35 42.8 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.745 2.297 . . . . 0.0 112.168 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 20' ' ' MET . . . 58.12 58.23 15.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.662 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.775 ' OG ' HG21 ' A' ' 46' ' ' THR . 51.8 p -101.2 -169.98 1.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.808 0.337 . . . . 0.0 111.263 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.647 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -123.46 113.67 19.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.091 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.631 HG11 ' CE1' ' A' ' 22' ' ' PHE . 7.4 t -111.98 151.38 14.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.135 0.493 . . . . 0.0 112.323 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.792 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -118.93 145.34 45.85 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.422 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.027 HG13 HG13 ' A' ' 49' ' ' VAL . 7.6 t -140.3 167.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.708 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.605 ' O ' HG23 ' A' ' 24' ' ' ILE . 9.8 t60 -66.87 155.49 38.22 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.498 ' HB2' ' CA ' ' A' ' 26' ' ' HIS . 10.5 t -69.1 122.5 18.89 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.97 HG22 HG21 ' A' ' 24' ' ' ILE . 5.1 m -75.75 -0.2 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.475 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' A' ' 10' ' ' PRO . . . -60.95 -8.78 3.43 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.99 -156.38 6.8 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.5 mt -92.91 127.27 38.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.83 -169.38 16.61 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.223 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.637 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.22 -24.63 5.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.069 0.461 . . . . 0.0 111.407 -179.252 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -54.48 -43.07 97.5 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.669 ' HG3' HG12 ' A' ' 108' ' ' VAL . 58.4 Cg_exo -52.35 -48.38 22.07 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.844 1.696 . . . . 0.0 111.67 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 91.3 t -55.98 -51.14 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.701 HD12 ' CG2' ' A' ' 49' ' ' VAL . 8.5 mt -51.97 -45.3 64.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.137 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 114' ' ' ALA . 15.9 t -51.81 -53.18 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.951 0.405 . . . . 0.0 110.909 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.601 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -53.5 -43.27 68.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.177 0.513 . . . . 0.0 110.519 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.788 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -58.64 -30.83 67.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.529 179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.875 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.26 -40.38 71.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.115 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.54 HD11 ' CE ' ' A' ' 20' ' ' MET . 0.2 OUTLIER -71.59 -16.68 62.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.734 179.026 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 1.047 HD11 HD21 ' A' ' 152' ' ' LEU . 2.7 mt -57.31 -30.7 36.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.284 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -16.61 62.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.7 m -79.76 -23.34 42.28 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 150.43 -96.58 0.17 Allowed Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.946 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.528 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 6.1 ptt? -63.87 71.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.938 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.61 -67.37 0.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 6.0 t80 -65.88 -32.42 73.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.894 0.378 . . . . 0.0 111.139 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -72.55 -52.43 15.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.259 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 5.2 t0 -67.05 -36.75 82.74 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 110.486 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.622 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -61.07 -50.42 73.36 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.162 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.9 mm -73.43 -39.3 54.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.569 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -49.97 19.79 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.811 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.28 -37.35 80.59 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.581 -179.31 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.575 HD11 ' C ' ' A' ' 115' ' ' PRO . 0.6 OUTLIER -74.16 -28.72 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.736 0.303 . . . . 0.0 110.407 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -63.8 -44.92 91.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.399 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -45.1 93.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.668 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 136' ' ' ILE . 2.5 mptt -87.08 151.44 23.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.633 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.484 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.93 116.78 14.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 0.0 110.972 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.14 163.21 15.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.81 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.31 -179.99 0.18 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.307 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.09 99.4 4.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.62 0.71 . . . . 0.0 111.015 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.586 HD12 HD21 ' A' ' 149' ' ' LEU . 11.3 pt -88.22 109.53 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.763 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -112.95 -76.62 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.628 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.558 ' O ' HG22 ' A' ' 150' ' ' THR . 0.3 OUTLIER -99.91 -60.93 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.794 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.6 tmtt? -52.49 -51.81 57.6 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.453 ' OE1' HD22 ' A' ' 149' ' ' LEU . 1.3 tm0? -60.23 -51.75 68.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.586 HD21 HD12 ' A' ' 144' ' ' ILE . 3.5 mm? -73.03 -34.77 66.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 146' ' ' SER . 3.9 t -75.29 -40.77 58.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.082 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.794 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -64.03 -50.76 67.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.047 HD21 HD11 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -69.0 -33.82 74.28 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.932 -179.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.22 -38.03 78.95 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -25.43 55.35 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.551 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.58 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -66.43 -31.34 72.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.471 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 157' ' ' PRO . 0.0 OUTLIER -106.71 104.33 50.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.427 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 156' ' ' ARG . 24.6 Cg_endo -61.97 146.98 96.06 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.476 2.117 . . . . 0.0 112.579 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -147.27 123.53 10.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.373 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -4.92 46.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.469 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.91 -30.52 67.88 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.8 tt -74.26 -31.03 62.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.912 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.04 -170.65 1.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.91 155.82 16.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -79.39 116.93 19.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -70.25 137.92 86.79 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.841 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.19 174.73 10.96 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.541 2.161 . . . . 0.0 112.269 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -171.56 -54.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.7 t -167.13 168.64 13.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -84.29 176.29 8.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -143.55 134.37 25.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.6 t -140.34 151.09 44.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.962 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -170.47 172.8 5.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.2 -58.55 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.04 108.51 3.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -105.88 128.78 53.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -140.66 -47.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -125.57 138.5 53.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -83.19 133.61 35.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.7 ttm-85 -120.62 131.11 24.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.32 118.3 5.61 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.387 2.058 . . . . 0.0 112.232 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.36 145.85 85.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.78 165.13 33.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.596 2.197 . . . . 0.0 112.265 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.4 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.7 t -137.51 126.99 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.776 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -114.37 128.95 56.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.993 0.425 . . . . 0.0 111.698 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.721 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.87 127.66 62.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.509 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.41 147.63 42.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.119 0.485 . . . . 0.0 111.786 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.547 ' HD2' HD21 ' A' ' 122' ' ' LEU . 26.4 t80 -155.15 117.93 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.642 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 29.2 mmtp 64.28 -95.77 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.408 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.39 13.99 6.07 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.969 ' HE1' HD21 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -121.67 169.05 11.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.754 0.311 . . . . 0.0 110.886 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -145.62 164.03 33.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 111.697 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.707 ' CE1' HG11 ' A' ' 103' ' ' VAL . 3.0 m-85 -134.29 148.9 50.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.561 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -122.48 135.77 54.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.21 0.529 . . . . 0.0 111.334 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.011 HD12 HG13 ' A' ' 108' ' ' VAL . 2.5 mm -118.17 106.58 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.223 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -132.54 165.34 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.286 0.565 . . . . 0.0 111.644 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.52 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.2 p80 -81.1 152.08 28.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -62.83 154.04 77.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.514 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 10.0 Cg_endo -54.38 138.53 73.47 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.64 2.227 . . . . 0.0 113.439 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.441 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -98.93 174.24 6.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.249 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.8 -8.66 30.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.53 -30.67 14.88 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.6 p -139.36 89.62 2.35 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.109 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.441 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.18 -52.18 8.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.19 0.519 . . . . 0.0 111.22 178.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.448 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.6 p -57.8 -45.67 85.75 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.225 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.4 m -57.85 -32.13 67.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.747 0.308 . . . . 0.0 111.276 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.667 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.3 -47.89 25.75 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.148 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.723 HG21 ' HB3' ' A' ' 63' ' ' LYS . 11.6 pt -55.66 -39.03 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.179 0.514 . . . . 0.0 110.761 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.32 -51.83 53.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.543 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.559 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.1 m-20 -68.13 -50.12 56.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.838 0.351 . . . . 0.0 111.915 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.667 HD21 ' CE1' ' A' ' 36' ' ' PHE . 87.9 mt -55.8 -46.22 78.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.986 0.422 . . . . 0.0 110.42 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -77.05 -26.63 53.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.102 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -53.13 -44.48 67.77 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.532 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.066 ' CD1' HD21 ' A' ' 23' ' ' LEU . 10.9 t80 -63.56 -38.53 91.48 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.959 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.693 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.93 -178.35 39.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.006 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.53 117.4 19.53 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.831 HG21 ' OG ' ' A' ' 101' ' ' SER . 1.0 OUTLIER -165.19 -169.69 1.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.166 -0.924 . . . . 0.0 108.853 177.416 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.671 ' H ' HG22 ' A' ' 46' ' ' THR . 3.5 p -64.48 146.49 54.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.555 0.693 . . . . 0.0 110.544 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.057 HG22 ' HB3' ' A' ' 104' ' ' ALA . 59.5 t -125.38 132.72 70.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.565 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.822 HG12 HG22 ' A' ' 105' ' ' VAL . 12.9 p -115.41 105.52 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.372 0.606 . . . . 0.0 111.315 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 110.64 20.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.735 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 71' ' ' TRP . 23.0 t -104.08 90.44 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.635 0.731 . . . . 0.0 109.734 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -158.78 171.62 19.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.352 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 1.8 mm-40 -64.95 130.35 43.07 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.58 HG22 ' OD1' ' A' ' 70' ' ' ASP . 16.4 t -77.56 122.63 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 p -120.2 -47.87 2.35 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.169 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.8 83.45 2.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.363 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -79.36 -36.77 38.8 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -79.44 -48.65 13.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.408 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -43.95 -51.66 17.18 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.408 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 12.6 Cg_exo -71.51 -42.62 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.491 2.127 . . . . 0.0 113.973 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.477 HD11 ' O ' ' A' ' 66' ' ' ILE . 2.9 tp -71.44 -45.19 63.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -56.27 -46.47 79.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.723 ' HB3' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -81.21 -20.45 41.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.547 ' OD2' HG22 ' A' ' 37' ' ' ILE . 72.7 m-20 -101.0 -11.52 19.61 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 42.64 52.78 5.36 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.852 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.536 HD12 HG21 ' A' ' 48' ' ' VAL . 4.2 pt -133.01 148.53 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.733 0.302 . . . . 0.0 111.144 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' THR . 73.8 p -78.1 135.21 37.66 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 48' ' ' VAL . 11.2 p -141.75 149.54 19.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -103.55 130.22 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.58 ' OD1' HG22 ' A' ' 54' ' ' VAL . 4.4 t0 -100.72 106.88 18.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.161 0.505 . . . . 0.0 110.474 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.776 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.1 m95 -111.57 103.63 55.28 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.094 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -108.18 175.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 123.64 2.893 . . . . 0.0 112.487 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.482 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 0.4 OUTLIER -126.32 105.55 8.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.844 0.355 . . . . 0.0 110.93 179.256 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -142.56 -173.92 4.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.674 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -56.65 -22.61 35.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.993 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -105.24 41.93 2.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.822 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.31 102.74 42.16 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.442 0.163 . . . . 0.0 110.712 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.512 ' O ' HG21 ' A' ' 83' ' ' VAL . 31.6 Cg_exo -59.17 107.27 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.569 2.179 . . . . 0.0 112.554 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.689 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 50.7 Cg_exo -53.93 -43.51 57.52 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.818 2.345 . . . . 0.0 114.171 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 2.8 Cg_endo -47.62 154.03 1.97 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.346 2.03 . . . . 0.0 113.578 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -64.12 -19.81 64.21 Favored Glycine 0 C--O 1.237 0.307 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.402 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.61 -29.73 11.64 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.546 0.173 . . . . 0.0 110.907 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.766 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 26.1 t -56.12 -48.1 79.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.491 HG11 ' CE2' ' A' ' 151' ' ' TYR . 86.5 t -55.72 -39.22 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.216 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.508 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.6 mt-10 -59.26 -31.46 69.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.914 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -66.85 -50.84 61.27 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.619 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.714 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -68.23 -26.89 65.92 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.534 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.634 HD13 ' OH ' ' A' ' 155' ' ' TYR . 15.3 mt -63.88 -47.2 81.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.319 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -42.09 98.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.298 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -53.91 -51.37 63.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.795 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 121' ' ' ALA . 8.6 p -72.33 -41.73 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.488 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.419 ' N ' HG13 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -54.56 -38.92 67.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 0.0 110.992 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.42 53.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 3.6 mmtt -73.17 -20.53 60.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.909 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE1' HG23 ' A' ' 91' ' ' VAL . 1.9 m-85 -82.07 -40.71 21.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.9 t -69.1 -42.73 75.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -75.99 -31.19 58.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.106 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -121.68 90.78 48.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.327 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.27 137.38 18.92 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.606 2.204 . . . . 0.0 112.363 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 20' ' ' MET . . . 58.78 57.38 20.19 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.588 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.831 ' OG ' HG21 ' A' ' 46' ' ' THR . 51.5 p -101.22 -168.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.328 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.693 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -120.91 113.44 20.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.053 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.707 HG11 ' CE1' ' A' ' 22' ' ' PHE . 43.8 t -105.46 151.02 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.057 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -123.92 139.43 53.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.207 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.822 HG22 HG12 ' A' ' 49' ' ' VAL . 45.1 t -140.12 166.71 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.623 ' N ' HG12 ' A' ' 105' ' ' VAL . 2.7 t60 -66.97 155.97 37.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.381 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 25' ' ' THR . 49.3 t -68.5 106.94 2.72 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.011 HG13 HD12 ' A' ' 24' ' ' ILE . 34.1 m -75.42 0.09 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.022 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.45 -8.72 2.9 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.37 -139.4 5.31 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.543 HD22 ' HA2' ' A' ' 142' ' ' GLY . 11.7 mt -117.93 127.34 53.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.19 -146.28 4.82 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.349 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.7 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.3 -20.94 5.99 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.018 0.437 . . . . 0.0 111.936 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.655 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -51.93 -46.29 92.56 Favored Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.785 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.4 Cg_endo -52.59 -48.65 20.82 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.223 1.948 . . . . 0.0 113.274 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.52 ' O ' HD23 ' A' ' 120' ' ' LEU . 39.4 t -62.25 -41.0 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.079 0.466 . . . . 0.0 110.127 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.477 HD22 ' CD1' ' A' ' 87' ' ' TRP . 6.4 mt -59.06 -41.11 87.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.81 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.77 HG22 HG21 ' A' ' 105' ' ' VAL . 17.6 t -64.15 -55.53 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.65 ' HB1' ' HA ' ' A' ' 132' ' ' ALA . . . -60.32 -53.07 61.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 110.903 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.793 HD13 HD12 ' A' ' 123' ' ' ILE . 3.1 mm? -55.25 -30.31 59.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.038 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.714 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.56 -50.62 24.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 110.614 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.969 HD21 ' HE1' ' A' ' 20' ' ' MET . 0.4 OUTLIER -65.27 -10.09 29.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.586 179.04 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 1.007 HG23 ' CB ' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -56.78 -34.26 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.687 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -62.28 -16.56 54.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.908 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.0 m -79.88 11.06 3.53 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 120.27 -98.8 0.71 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.251 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.49 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 1.1 ptt? -62.61 73.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.36 0.6 . . . . 0.0 109.469 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 1.007 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.9 -68.03 0.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.635 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.3 t80 -68.71 -32.68 72.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.946 0.403 . . . . 0.0 111.186 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.26 -49.44 34.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.479 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 39.2 t0 -70.04 -45.6 66.81 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.914 0.387 . . . . 0.0 111.294 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 152' ' ' LEU . . . -57.84 -49.72 75.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.649 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 33.5 mm -70.29 -40.81 78.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -74.28 -49.8 21.61 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.721 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -67.87 -35.19 78.1 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.937 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.4 tt -74.24 -32.79 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.707 0.289 . . . . 0.0 110.74 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -63.95 -43.05 97.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.714 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -44.69 93.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.46 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.42 ' CE ' HG13 ' A' ' 15' ' ' VAL . 6.7 mptt -86.21 151.84 23.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.256 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.26 117.11 14.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 110.63 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -114.82 163.66 15.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.543 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -57.71 -165.83 0.09 OUTLIER Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.42 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.26 99.22 11.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.589 0.695 . . . . 0.0 111.0 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.642 HD12 HD21 ' A' ' 149' ' ' LEU . 1.4 pt -88.45 109.44 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.809 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -113.14 -76.65 0.58 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -99.78 -60.74 1.47 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.864 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 2.0 tmtt? -52.83 -51.9 59.13 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.455 ' HG3' HG22 ' A' ' 144' ' ' ILE . 7.1 tm0? -56.59 -51.63 67.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.642 HD21 HD12 ' A' ' 144' ' ' ILE . 4.3 mm? -75.24 -40.94 58.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 m -69.95 -40.53 75.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.933 0.397 . . . . 0.0 111.1 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.864 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -65.46 -50.02 66.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.854 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -65.02 -38.03 89.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.919 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -55.77 -44.0 77.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -24.31 62.83 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.685 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.634 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -66.28 -32.62 74.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.731 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -106.58 118.46 54.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.06 153.48 72.09 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.61 2.207 . . . . 0.0 112.458 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -138.16 123.39 19.3 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.131 0.491 . . . . 0.0 110.337 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -60.41 -18.9 53.76 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.377 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -39.09 80.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.803 0.335 . . . . 0.0 111.025 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.4 tp -86.05 -35.07 20.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.34 113.98 27.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.94 118.25 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -167.44 133.27 2.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.41 138.03 44.99 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.75 -47.5 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.414 2.076 . . . . 0.0 112.346 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 55.9 94.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.019 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.9 p -143.77 123.12 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -155.15 -51.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.0 tttt 59.94 92.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.0 t -124.66 -44.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.906 -179.97 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -101.85 170.83 7.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 110.924 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -174.06 145.25 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.797 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.48 -39.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.966 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.3 99.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -114.87 129.15 56.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 133.0 47.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.882 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.91 99.01 10.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 111.17 3.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.1 66.32 0.99 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.475 2.117 . . . . 0.0 112.336 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.33 151.82 85.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.855 ' HB3' HG22 ' A' ' 25' ' ' THR . 57.2 Cg_endo -71.03 165.01 33.77 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.635 2.224 . . . . 0.0 112.443 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.742 HG11 ' HD3' ' A' ' 139' ' ' LYS . 19.5 t -144.02 127.44 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 10.3 pt-20 -110.07 116.73 32.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.816 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.6 OUTLIER -108.01 118.7 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.4 p -140.83 145.26 36.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.715 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -136.4 159.93 40.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.734 178.183 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.622 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 9.4 ptpt 48.64 -103.79 0.11 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -177.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -120.44 -26.68 5.34 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.141 -0.349 . . . . 0.0 111.643 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.752 ' CE ' HD13 ' A' ' 122' ' ' LEU . 5.6 ppp? -73.84 165.71 24.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.654 0.264 . . . . 0.0 111.316 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -147.6 164.05 34.71 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.088 0.471 . . . . 0.0 111.507 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.765 ' CE1' HG13 ' A' ' 118' ' ' VAL . 1.7 m-85 -137.89 146.5 43.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.058 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -119.36 133.61 55.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.988 0.423 . . . . 0.0 110.954 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.043 HD12 HG13 ' A' ' 108' ' ' VAL . 2.1 mm -118.17 106.68 20.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.404 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.855 HG22 ' HB3' ' A' ' 12' ' ' PRO . 60.4 p -131.61 165.52 23.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.283 0.563 . . . . 0.0 111.876 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.52 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.2 p80 -81.25 152.44 27.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.728 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.42 154.38 72.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.442 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.7 Cg_exo -54.2 137.24 70.3 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.472 2.114 . . . . 0.0 113.264 -177.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.63 145.89 26.4 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.197 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -68.58 -11.13 59.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.26 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.5 -31.71 14.46 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -140.12 88.73 2.24 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.064 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.673 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.5 OUTLIER -81.01 -51.9 8.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.106 0.479 . . . . 0.0 111.515 178.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.451 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.9 m -55.77 -45.48 78.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.438 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -57.81 -36.14 71.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.408 . . . . 0.0 111.321 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.645 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -72.92 -47.91 41.58 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.634 HG22 ' OD2' ' A' ' 64' ' ' ASP . 12.1 pt -55.87 -40.06 60.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 110.882 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.67 -52.1 59.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.497 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.54 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.6 OUTLIER -67.62 -50.17 59.36 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.799 0.333 . . . . 0.0 111.807 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.645 HD21 ' CE1' ' A' ' 36' ' ' PHE . 62.9 mt -55.04 -46.29 75.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.614 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -26.77 52.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.2 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.1 mtmt -53.85 -42.33 68.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.382 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.058 ' CD1' HD21 ' A' ' 23' ' ' LEU . 16.8 t80 -63.3 -38.48 91.33 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.933 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.653 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.31 -178.59 40.2 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.885 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.64 117.43 19.49 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.656 HG22 ' H ' ' A' ' 47' ' ' THR . 1.0 OUTLIER -165.18 -170.03 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.732 177.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' THR . 2.5 t -64.58 160.46 19.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.367 0.603 . . . . 0.0 110.502 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 104' ' ' ALA . 57.5 t -138.4 135.74 44.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.226 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.872 HG12 HG22 ' A' ' 105' ' ' VAL . 14.6 p -115.62 104.68 17.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.474 0.654 . . . . 0.0 110.974 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 110.86 20.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.724 178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.835 HG11 ' HB2' ' A' ' 113' ' ' ARG . 25.0 t -108.0 91.6 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.592 0.71 . . . . 0.0 110.141 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.77 171.22 20.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.005 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.91 130.32 43.0 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.22 122.49 26.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -120.2 -47.67 2.36 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.227 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -130.63 83.8 2.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.535 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -78.95 -36.22 41.97 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.09 -48.55 14.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.673 HG21 ' HG ' ' A' ' 33' ' ' LEU . 2.0 m -45.71 -48.32 38.59 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.497 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 8.4 Cg_exo -73.19 -41.19 1.36 Allowed 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.613 2.209 . . . . 0.0 113.503 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.85 HD21 ' CG1' ' A' ' 68' ' ' VAL . 4.0 mm? -65.5 -45.27 84.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.34 -31.06 60.45 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.62 ' HB3' HG21 ' A' ' 37' ' ' ILE . 2.2 mmpt? -81.09 -34.22 32.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.634 ' OD2' HG22 ' A' ' 37' ' ' ILE . 17.2 m-20 -101.68 -11.53 19.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.54 27.75 3.15 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.294 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.574 HD12 HG21 ' A' ' 48' ' ' VAL . 1.1 pt -105.01 148.74 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.775 0.322 . . . . 0.0 111.072 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.7 OUTLIER -77.42 133.34 38.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.85 ' CG1' HD21 ' A' ' 61' ' ' LEU . 4.0 p -145.06 149.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.048 0.451 . . . . 0.0 111.796 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.584 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.0 t -103.07 128.96 55.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -100.94 106.71 18.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.097 0.475 . . . . 0.0 111.198 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.924 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 5.5 m0 -109.72 103.51 53.31 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.188 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -108.23 179.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 123.498 2.798 . . . . 0.0 113.028 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.462 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 1.5 t80 -126.33 105.26 8.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.677 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.52 -174.79 4.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.777 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -56.76 -22.77 38.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.984 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.41 37.7 3.69 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.676 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.411 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . . . -87.64 102.96 3.93 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.4 0.143 . . . . 0.0 110.723 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.473 ' O ' HG21 ' A' ' 83' ' ' VAL . 12.6 Cg_endo -56.52 105.41 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.52 2.147 . . . . 0.0 112.51 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.676 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 29.2 Cg_exo -62.71 -37.39 57.02 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.94 2.427 . . . . 0.0 114.441 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 10.9 Cg_endo -56.48 154.21 31.25 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.875 1.717 . . . . 0.0 113.632 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.77 -20.16 59.31 Favored Glycine 0 C--O 1.236 0.271 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.407 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -29.84 14.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.348 0.118 . . . . 0.0 111.29 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.924 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 35.4 t -55.38 -50.99 61.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 2.6 t -53.77 -43.4 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.307 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -56.34 -31.21 63.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.876 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.7 -50.4 62.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.757 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -65.14 -33.93 77.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.743 179.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.94 HD21 ' HB3' ' A' ' 120' ' ' LEU . 17.8 mt -57.87 -46.89 84.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.723 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.83 -42.21 99.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.28 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.463 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.3 tm? -59.05 -51.46 69.97 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.757 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.986 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.2 p -69.7 -35.86 67.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.075 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -56.94 -45.02 83.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.319 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.04 91.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.497 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.12 -24.1 61.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.229 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.585 ' CD1' HG22 ' A' ' 91' ' ' VAL . 2.1 m-85 -81.76 -51.86 7.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.793 0.33 . . . . 0.0 111.179 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.4 -40.51 97.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -76.07 -32.94 59.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.213 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -125.53 90.81 49.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.323 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.78 132.49 14.45 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.539 2.159 . . . . 0.0 112.375 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.5 56.3 25.81 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.584 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.632 ' HB2' HG21 ' A' ' 46' ' ' THR . 1.1 m -101.21 -164.77 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.816 0.341 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.653 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 m -117.88 113.54 21.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.684 HG11 ' CE1' ' A' ' 22' ' ' PHE . 38.5 t -110.03 149.73 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.148 0.499 . . . . 0.0 112.243 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.833 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -119.11 143.29 47.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.946 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.872 HG22 HG12 ' A' ' 49' ' ' VAL . 92.7 t -139.98 166.16 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.579 ' N ' HG12 ' A' ' 105' ' ' VAL . 2.7 t60 -67.36 156.12 37.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.126 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 25' ' ' THR . 48.5 t -68.38 105.52 2.2 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.043 HG13 HD12 ' A' ' 24' ' ' ILE . 34.3 m -75.42 0.62 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.185 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HB3' ' SG ' ' A' ' 107' ' ' CYS . . . -60.07 -8.55 2.45 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.29 -129.24 3.46 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.0 mt -127.9 127.42 43.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.59 -150.45 6.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.273 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.835 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.47 -19.02 6.52 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.025 0.441 . . . . 0.0 111.775 -178.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.672 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -53.15 -46.39 97.79 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.741 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.1 Cg_endo -52.41 -48.15 23.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.179 1.919 . . . . 0.0 112.428 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.521 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 23.0 t -56.85 -52.04 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 110.341 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.719 HD12 ' CG2' ' A' ' 49' ' ' VAL . 8.0 mt -51.88 -48.79 63.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.889 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.765 HG13 ' CE1' ' A' ' 22' ' ' PHE . 17.4 t -54.01 -54.09 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.58 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -52.62 -42.79 64.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.039 0.447 . . . . 0.0 111.17 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.94 ' HB3' HD21 ' A' ' 88' ' ' LEU . 9.6 mt -64.12 -30.78 71.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.195 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.986 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -69.24 -38.25 78.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.211 0.529 . . . . 0.0 109.748 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.752 HD13 ' CE ' ' A' ' 20' ' ' MET . 6.0 tp -77.26 -15.97 59.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.204 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.933 HG23 ' CB ' ' A' ' 128' ' ' LYS . 1.7 mt -57.78 -31.74 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.816 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -16.53 63.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 122' ' ' LEU . 5.0 m -83.81 11.04 8.13 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 118.08 -99.99 0.83 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.193 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.481 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.9 ptt? -62.48 76.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.933 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.52 -67.51 0.55 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -177.09 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.571 ' CD1' HD22 ' A' ' 152' ' ' LEU . 7.5 t80 -67.52 -32.46 73.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.926 0.393 . . . . 0.0 111.102 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -52.1 18.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.152 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 29.5 t0 -68.7 -41.02 79.74 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.127 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.673 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -58.53 -49.03 78.89 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.288 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.3 mm -72.25 -40.19 65.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.804 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -74.35 -49.6 22.13 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.816 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.63 -37.25 84.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.711 0.291 . . . . 0.0 110.525 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.6 tt -74.17 -27.93 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 110.465 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.411 ' HG2' ' NH2' ' A' ' 141' ' ' ARG . 6.2 mtt180 -65.47 -46.28 80.4 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.629 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -45.07 93.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.61 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.742 ' HD3' HG11 ' A' ' 13' ' ' VAL . 3.9 mmpt? -86.76 151.97 22.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.196 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.14 116.8 14.11 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.46 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.411 ' NH2' ' HG2' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -114.81 163.79 15.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.133 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -54.92 -171.08 0.07 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.86 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.78 100.17 12.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.24 0.52 . . . . 0.0 111.349 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.861 HG22 ' NE2' ' A' ' 148' ' ' GLN . 0.2 OUTLIER -87.63 109.73 19.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.825 178.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -113.62 -76.8 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.6 p -99.9 -60.87 1.45 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.811 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 9.7 tmtt? -63.09 -49.81 73.01 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.861 ' NE2' HG22 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -55.87 -52.42 64.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.424 HD21 HG13 ' A' ' 144' ' ' ILE . 3.9 mm? -75.38 -40.53 57.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.8 m -70.72 -33.8 71.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.805 0.336 . . . . 0.0 111.475 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.811 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -70.48 -50.69 35.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.057 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.895 HD21 HD11 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -64.6 -31.42 72.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.638 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -61.81 -38.68 89.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -26.5 66.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.118 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.491 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -66.04 -41.49 90.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.936 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.8 86.01 2.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.349 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.18 145.68 84.86 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.687 2.258 . . . . 0.0 112.637 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -147.42 123.43 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.304 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -78.6 -37.99 41.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.968 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -66.77 -29.8 69.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.35 -47.98 83.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.027 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -88.23 -42.6 12.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.007 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -60.02 -57.74 11.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -103.47 165.06 11.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.1 106.64 15.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.15 132.32 22.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.372 2.048 . . . . 0.0 112.318 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -95.15 123.68 38.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.872 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.9 m -160.94 -44.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.966 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 7.2 m170 62.35 155.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.786 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -96.25 -52.54 3.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.2 m -67.0 98.2 0.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.962 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.912 -179.988 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.6 p -153.98 134.8 13.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.772 0.32 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -121.13 137.05 54.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.4 ttt -167.16 168.64 13.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.52 -179.65 8.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.092 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -126.28 -50.5 1.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.5 mtt -139.49 178.65 7.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -167.51 -46.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -137.62 115.69 9.77 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.06 140.74 55.28 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.495 2.13 . . . . 0.0 112.328 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.33 145.29 79.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.014 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.99 164.81 34.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.566 2.177 . . . . 0.0 112.314 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.403 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.5 t -144.14 126.84 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.2 pp20? -114.16 129.56 56.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.034 0.445 . . . . 0.0 111.844 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.788 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -108.2 120.34 59.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.01 158.1 21.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.156 0.503 . . . . 0.0 111.977 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.718 ' CD2' HD11 ' A' ' 122' ' ' LEU . 9.7 t80 -150.06 107.48 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.528 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 4.7 mmtp 62.9 -83.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.165 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -129.3 14.11 6.12 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.869 ' CE ' HD13 ' A' ' 122' ' ' LEU . 24.2 ttp -110.6 162.02 15.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.683 0.278 . . . . 0.0 110.969 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.5 mtt180 -148.53 134.9 19.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.093 0.473 . . . . 0.0 111.623 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.645 ' CE1' HG11 ' A' ' 103' ' ' VAL . 3.6 m-85 -115.34 151.35 34.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.729 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.058 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.8 mm? -124.45 135.93 53.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.113 0.482 . . . . 0.0 111.424 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.842 HD13 ' HB ' ' A' ' 105' ' ' VAL . 15.9 mm -118.34 106.54 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.654 HG21 HD23 ' A' ' 40' ' ' LEU . 2.2 p -129.84 163.47 26.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.358 0.599 . . . . 0.0 111.896 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.523 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.7 p80 -81.16 152.58 27.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.933 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -62.41 154.6 71.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.968 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.452 ' HA ' ' HD2' ' A' ' 36' ' ' PHE . 50.5 Cg_exo -54.27 138.21 72.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.396 2.064 . . . . 0.0 113.433 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.7 p -98.54 145.49 26.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.217 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -68.47 -12.26 60.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.56 -31.25 14.6 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.3 p -139.81 88.99 2.28 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.172 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.432 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.6 OUTLIER -80.7 -52.3 7.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.175 0.512 . . . . 0.0 111.417 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.441 ' HA ' HG12 ' A' ' 37' ' ' ILE . 74.9 m -55.95 -45.64 78.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.59 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.2 m -57.65 -33.11 67.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.874 0.369 . . . . 0.0 111.314 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.677 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -74.52 -47.71 31.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.698 HD13 ' HB3' ' A' ' 63' ' ' LYS . 11.5 pt -55.81 -39.5 56.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.133 0.492 . . . . 0.0 110.63 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -65.12 -52.16 57.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.46 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.6 OUTLIER -67.68 -50.04 59.69 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 120.803 0.335 . . . . 0.0 111.831 -179.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.677 HD21 ' CE1' ' A' ' 36' ' ' PHE . 76.2 mt -54.95 -46.2 74.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.6 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -77.65 -26.82 50.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.05 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 5.9 mttt -52.4 -43.21 64.63 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.07 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.058 ' CD1' HD21 ' A' ' 23' ' ' LEU . 12.5 t80 -63.48 -38.49 91.36 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.585 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.699 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.96 -178.54 39.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.078 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.47 117.52 19.77 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.662 HG21 ' HB3' ' A' ' 101' ' ' SER . 0.7 OUTLIER -165.2 -169.67 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.973 177.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.64 ' H ' HG22 ' A' ' 46' ' ' THR . 7.8 t -64.37 156.81 28.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.463 0.649 . . . . 0.0 110.51 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.809 HG13 ' O ' ' A' ' 104' ' ' ALA . 66.5 t -136.78 134.29 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.135 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.941 HG13 HG13 ' A' ' 105' ' ' VAL . 13.1 p -115.66 105.07 17.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.393 0.616 . . . . 0.0 111.49 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.434 ' HD2' HG21 ' A' ' 68' ' ' VAL . 4.8 ptm180 -114.77 110.88 20.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.108 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 71' ' ' TRP . 14.6 t -105.25 91.62 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.468 0.651 . . . . 0.0 109.736 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.63 171.55 20.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.851 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.39 129.97 41.58 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -77.33 122.66 32.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.9 p -119.87 -47.73 2.39 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.063 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.413 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -130.57 83.45 2.12 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.398 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -79.44 -36.84 38.26 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.73 -48.54 13.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.558 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -47.02 -55.39 15.46 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 64.0 Cg_endo -73.37 -42.79 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.261 1.974 . . . . 0.0 114.204 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.687 ' CD2' HG11 ' A' ' 68' ' ' VAL . 27.1 mt -71.66 -45.36 62.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -66.24 -32.1 73.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.68 0.276 . . . . 0.0 111.565 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.698 ' HB3' HD13 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -81.23 -30.67 34.14 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.12 -11.46 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 45.52 67.2 1.31 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.804 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.1 mt -136.36 147.69 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.624 0.25 . . . . 0.0 110.84 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 47' ' ' THR . 70.9 p -78.07 128.02 33.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.687 HG11 ' CD2' ' A' ' 61' ' ' LEU . 8.3 p -145.23 151.73 14.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.091 0.472 . . . . 0.0 112.1 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.566 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.3 t -103.52 130.69 53.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -101.1 106.85 18.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.04 0.448 . . . . 0.0 111.143 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.804 ' HB3' HG13 ' A' ' 51' ' ' VAL . 5.7 m0 -110.89 103.96 55.44 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.367 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -106.21 149.97 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.258 2.639 . . . . 0.0 112.841 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.424 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -126.22 109.99 12.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.906 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.4 174.84 11.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.857 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.43 -34.02 71.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.847 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.84 42.88 1.58 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.307 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.423 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . -112.06 106.43 56.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.445 0.164 . . . . 0.0 111.191 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.633 ' C ' ' HD3' ' A' ' 80' ' ' PRO . 37.6 Cg_endo -66.13 165.35 24.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.255 1.97 . . . . 0.0 111.728 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -102.76 55.87 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.475 2.783 . . . . 0.0 114.353 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.891 ' O ' HG22 ' A' ' 83' ' ' VAL . 62.4 Cg_exo -47.99 138.36 21.62 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 121.888 1.725 . . . . 0.0 111.894 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -66.18 -22.63 70.98 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.675 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -43.25 68.12 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.578 0.228 . . . . 0.0 111.06 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.891 HG22 ' O ' ' A' ' 80' ' ' PRO . 15.2 m -55.12 -43.03 68.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.079 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.721 HG22 ' CD1' ' A' ' 120' ' ' LEU . 0.8 OUTLIER -53.49 -41.08 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -64.96 -31.38 72.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.324 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -66.48 -50.34 63.61 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.826 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -66.87 -30.34 70.48 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.87 HD21 ' HB3' ' A' ' 120' ' ' LEU . 18.2 mt -61.05 -46.71 89.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.339 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -64.05 -40.08 95.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.31 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.506 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.7 tm? -59.67 -51.34 70.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.725 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.059 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.4 p -71.07 -35.92 60.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.066 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.52 -46.85 76.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.46 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.89 -43.41 83.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.66 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -69.13 -25.71 64.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.511 ' CD1' HG22 ' A' ' 91' ' ' VAL . 1.7 m-85 -76.58 -52.02 10.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.948 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.2 t -59.67 -39.8 85.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.13 -33.08 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.126 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.09 88.23 54.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.304 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.95 128.15 12.09 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.536 2.158 . . . . 0.0 112.194 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.51 57.48 19.35 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.321 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.662 ' HB3' HG21 ' A' ' 46' ' ' THR . 1.5 t -101.03 -163.08 0.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.616 0.246 . . . . 0.0 111.123 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.699 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 m -115.44 113.26 23.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.337 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.645 HG11 ' CE1' ' A' ' 22' ' ' PHE . 25.7 t -110.42 150.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 112.016 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.809 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -121.58 142.0 50.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.188 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.941 HG13 HG13 ' A' ' 49' ' ' VAL . 20.0 t -140.1 166.14 20.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.357 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 3.3 t60 -67.17 155.37 38.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.95 0.405 . . . . 0.0 110.81 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.5 ' N ' ' O ' ' A' ' 25' ' ' THR . 34.4 t -69.27 110.33 4.57 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.734 HG13 HD12 ' A' ' 24' ' ' ILE . 13.2 m -75.6 0.63 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.372 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.04 -8.66 2.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.35 -137.7 4.44 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.544 HD22 ' HA2' ' A' ' 142' ' ' GLY . 4.1 mt -111.49 127.13 55.6 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.69 -162.42 12.52 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 119.952 -1.118 . . . . 0.0 113.522 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.668 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.38 -19.88 6.29 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.08 0.467 . . . . 0.0 111.735 -178.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.802 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -53.43 -46.42 98.06 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 8.0 Cg_endo -52.69 -48.51 21.6 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.948 1.766 . . . . 0.0 112.359 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.599 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 89.4 t -55.87 -53.34 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.571 HD12 ' CG2' ' A' ' 49' ' ' VAL . 10.6 mt -52.28 -45.57 65.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.692 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 114' ' ' ALA . 13.8 t -51.42 -52.63 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 111.177 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.469 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -54.99 -45.6 75.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.025 0.441 . . . . 0.0 110.436 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.87 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.5 mt -55.16 -30.92 60.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.039 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 1.059 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.96 -49.19 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.869 HD13 ' CE ' ' A' ' 20' ' ' MET . 22.5 tp -67.08 -14.02 62.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.805 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 1.001 ' CD1' HD21 ' A' ' 152' ' ' LEU . 2.1 mt -57.74 -32.41 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.977 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -16.21 63.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.673 ' HB2' HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -79.75 -23.45 42.23 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 151.2 -96.46 0.17 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.899 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.534 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.17 73.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.917 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -72.07 -67.8 0.51 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -176.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 5.3 t80 -66.14 -34.58 78.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.931 0.396 . . . . 0.0 111.227 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.27 -52.75 14.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.414 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 25.8 t70 -70.78 -32.65 69.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.716 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -60.42 -49.98 75.4 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 32.1 mm -71.04 -41.18 76.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.576 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.86 -50.37 17.28 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.788 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.1 -35.82 81.54 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.704 0.287 . . . . 0.0 110.55 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.3 tt -74.24 -40.47 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.677 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 52.0 ttt-85 -58.6 -36.61 74.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.177 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -59.52 -45.55 91.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.819 0.343 . . . . 0.0 110.747 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.402 ' CG ' HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -87.78 151.28 23.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.61 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.48 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -73.73 116.71 14.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.842 0.353 . . . . 0.0 110.155 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.447 ' HD3' HG23 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -115.39 164.1 14.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.355 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.544 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -53.39 -172.8 0.05 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.586 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.18 9.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.62 0.71 . . . . 0.0 111.616 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.458 HD12 ' CD2' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -88.62 109.75 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.457 178.43 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.63 -76.55 0.59 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.67 -60.78 1.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.846 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.9 tmtt? -53.42 -51.74 61.64 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.496 ' HG3' HG22 ' A' ' 116' ' ' VAL . 1.1 tm0? -56.79 -51.98 66.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 149' ' ' LEU . 3.7 mm? -73.62 -41.31 62.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.9 m -69.74 -41.3 75.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.793 0.33 . . . . 0.0 111.265 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.846 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -62.84 -50.66 70.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.223 -179.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.001 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -67.19 -31.22 71.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.923 -179.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -39.56 90.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -23.1 55.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.91 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.591 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -66.4 -39.56 89.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.72 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.89 124.48 35.27 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.755 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.53 151.75 83.9 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.496 2.131 . . . . 0.0 112.382 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.36 123.48 10.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.525 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -59.41 -22.22 61.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.113 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -59.06 -41.26 87.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.908 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.5 tp -60.05 -46.85 88.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 169.53 5.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -75.05 -49.44 19.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -62.85 115.45 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.99 138.08 49.69 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.35 -178.11 2.4 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.494 2.129 . . . . 0.0 112.273 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -167.15 -65.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.4 p -147.98 161.69 40.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -134.59 -47.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -141.1 163.59 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 171' ' ' THR . 9.8 t -71.19 98.79 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.847 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.77 -37.65 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -106.98 124.14 49.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 30.1 ttm -124.37 123.5 40.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.27 137.79 20.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -106.68 113.96 27.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.0 mmm -132.31 134.74 45.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.16 -37.95 9.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.8 mtm105 -132.3 116.02 15.21 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.09 106.61 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.419 2.079 . . . . 0.0 112.198 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.64 154.5 94.33 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.21 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HB3' HG23 ' A' ' 25' ' ' THR . 52.7 Cg_endo -69.37 165.27 31.09 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.651 2.234 . . . . 0.0 112.345 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 t -130.32 126.69 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.795 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.425 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -103.81 122.67 45.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.536 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.734 HG12 ' CE2' ' A' ' 135' ' ' PHE . 2.3 t -106.82 134.17 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.317 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 p -132.17 133.63 44.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.171 0.51 . . . . 0.0 112.16 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.655 ' HD2' HD11 ' A' ' 122' ' ' LEU . 41.2 t80 -155.13 141.98 19.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.371 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mmtt 61.97 -103.59 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.932 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -129.84 -1.62 4.75 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.605 ' HE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -113.34 168.43 9.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.038 0.447 . . . . 0.0 111.478 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -125.9 164.2 21.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.009 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.712 ' CE1' HG11 ' A' ' 103' ' ' VAL . 1.5 m-85 -136.65 137.44 40.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.339 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.062 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -114.88 132.8 56.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.002 0.429 . . . . 0.0 111.134 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.81 HG21 HG12 ' A' ' 108' ' ' VAL . 1.2 mm -115.85 106.35 20.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -135.33 167.1 21.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 111.921 -178.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.426 ' CA ' ' HB2' ' A' ' 107' ' ' CYS . 3.0 t-80 -81.09 151.53 28.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.689 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -63.42 154.84 77.63 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.83 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.44 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.7 Cg_exo -54.57 140.11 75.59 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.222 1.948 . . . . 0.0 112.954 -178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.465 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 67.8 p -98.61 174.27 6.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -92.52 -13.06 30.35 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.57 -31.04 14.68 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 p -139.72 89.56 2.33 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.49 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.465 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.3 OUTLIER -80.4 -52.19 7.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.106 0.479 . . . . 0.0 111.31 178.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.446 ' HA ' HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -55.97 -45.38 78.92 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.549 -178.637 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.7 -34.47 69.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.897 0.379 . . . . 0.0 111.354 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.637 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.17 -47.75 33.73 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.845 HG22 ' OD2' ' A' ' 64' ' ' ASP . 12.5 pt -55.54 -39.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.155 0.502 . . . . 0.0 110.605 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -65.43 -51.97 56.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.483 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.569 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 2.5 m-20 -68.35 -50.2 54.89 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.637 HD21 ' CE1' ' A' ' 36' ' ' PHE . 84.9 mt -55.69 -45.38 77.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.556 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -78.45 -26.63 46.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.102 0.477 . . . . 0.0 110.059 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 1.3 mttp -52.01 -43.98 63.91 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.283 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.062 ' CD1' HD21 ' A' ' 23' ' ' LEU . 20.2 t80 -63.31 -38.39 90.98 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.696 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.747 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 166.24 -178.83 40.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.928 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.49 117.17 19.23 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.825 HG21 ' OG ' ' A' ' 101' ' ' SER . 0.6 OUTLIER -165.22 -169.38 1.62 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.853 177.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.636 ' H ' HG22 ' A' ' 46' ' ' THR . 2.9 t -64.33 143.07 58.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.692 0.758 . . . . 0.0 110.557 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.789 HG13 ' HB3' ' A' ' 104' ' ' ALA . 25.4 t -122.23 132.12 71.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.113 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.057 HG13 HG13 ' A' ' 105' ' ' VAL . 9.8 p -115.47 105.25 18.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.181 0.515 . . . . 0.0 111.175 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 110.93 20.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.906 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.893 HG11 ' HB2' ' A' ' 113' ' ' ARG . 44.0 t -103.98 91.74 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.556 0.693 . . . . 0.0 110.493 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.6 t -157.79 171.19 20.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.733 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.74 130.2 42.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -72.36 122.0 23.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 p -120.57 -47.71 2.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.046 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.411 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -130.75 84.24 2.18 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.503 179.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -78.77 -36.51 42.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -79.5 -48.59 13.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.452 HG21 ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -44.5 -49.7 24.91 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.416 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 9.6 Cg_exo -72.97 -42.46 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.702 2.268 . . . . 0.0 113.731 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.836 HD12 HG12 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -71.39 -45.21 63.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -70.54 -28.9 65.28 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.495 ' CB ' HG21 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -81.02 -34.72 32.65 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.845 ' OD2' HG22 ' A' ' 37' ' ' ILE . 44.0 m-20 -101.54 -11.37 19.33 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.56 41.56 49.69 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.423 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.757 ' CD1' HG21 ' A' ' 48' ' ' VAL . 1.1 pt -118.77 148.71 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 122.313 0.245 . . . . 0.0 111.047 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' THR . 21.9 p -77.39 135.03 38.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.836 HG12 HD12 ' A' ' 61' ' ' LEU . 7.4 p -144.98 149.68 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.073 0.463 . . . . 0.0 112.054 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.453 HG22 ' HG ' ' A' ' 90' ' ' LEU . 2.2 t -103.31 131.04 52.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.11 106.55 17.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 111.021 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.857 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.9 m95 -110.53 103.47 54.28 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.199 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -108.58 -176.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.469 2.779 . . . . 0.0 113.042 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -126.27 140.0 52.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.531 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -152.67 172.74 16.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.63 -25.22 37.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.945 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -120.47 59.99 0.53 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.499 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.417 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -85.69 135.56 37.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 122.938 -0.154 . . . . 0.0 110.703 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.718 ' HG2' HG21 ' A' ' 83' ' ' VAL . 39.4 Cg_endo -66.31 107.75 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.569 2.18 . . . . 0.0 112.666 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.656 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 24.1 Cg_exo -64.62 -36.62 41.31 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.004 2.469 . . . . 0.0 114.603 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 18.2 Cg_endo -62.06 152.26 76.66 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.823 1.682 . . . . 0.0 113.713 -178.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.445 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -66.09 -19.34 67.9 Favored Glycine 0 C--O 1.236 0.263 0 CA-C-N 114.948 -1.024 . . . . 0.0 113.266 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -50.11 -29.4 8.95 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.428 0.156 . . . . 0.0 110.93 -177.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.857 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 55.3 t -55.36 -47.98 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.717 HG11 ' HE2' ' A' ' 151' ' ' TYR . 88.0 t -56.13 -39.8 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.05 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.786 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.8 mt-10 -58.21 -31.25 67.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.481 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.87 -50.25 67.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.988 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.859 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -68.04 -26.79 66.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.896 HD21 ' HB3' ' A' ' 120' ' ' LEU . 25.9 mt -62.79 -41.44 99.26 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.159 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 t -67.78 -41.72 82.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.026 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.453 ' HG ' HG22 ' A' ' 69' ' ' VAL . 1.8 tm? -58.98 -51.23 70.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.779 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.762 HG21 ' HB1' ' A' ' 121' ' ' ALA . 7.8 p -71.81 -41.06 69.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.261 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -55.34 -38.49 68.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.936 0.398 . . . . 0.0 110.706 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.04 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.763 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -29.58 67.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.145 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.501 ' CE1' HG21 ' A' ' 103' ' ' VAL . 3.3 m-85 -76.78 -52.06 10.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.032 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.3 t -59.8 -36.95 77.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -31.87 59.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.06 94.4 41.59 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.287 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.13 129.09 16.61 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.425 2.083 . . . . 0.0 112.219 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.95 59.46 10.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.292 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.825 ' OG ' HG21 ' A' ' 46' ' ' THR . 83.5 p -101.2 -170.09 1.79 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.927 0.394 . . . . 0.0 111.442 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.747 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.6 m -113.03 113.61 25.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.308 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.712 HG11 ' CE1' ' A' ' 22' ' ' PHE . 76.0 t -104.23 149.98 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.789 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -122.52 140.58 52.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.787 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.057 HG13 HG13 ' A' ' 49' ' ' VAL . 2.2 t -140.6 166.74 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.688 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.4 t60 -67.49 156.14 37.35 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.651 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.576 ' N ' ' O ' ' A' ' 25' ' ' THR . 50.4 t -68.41 102.44 1.42 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.381 0.61 . . . . 0.0 112.287 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.81 HG12 HG21 ' A' ' 24' ' ' ILE . 7.1 p -75.27 -0.02 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.025 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HB3' ' SG ' ' A' ' 107' ' ' CYS . . . -60.81 -8.68 3.21 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.452 ' O ' HD23 ' A' ' 111' ' ' LEU . . . -122.3 -134.06 4.39 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 110' ' ' GLY . 22.3 mt -125.29 127.58 46.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.2 -143.19 3.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.993 -1.099 . . . . 0.0 113.597 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.893 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.13 -19.37 6.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.968 0.413 . . . . 0.0 111.794 -178.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.701 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -50.62 -46.46 85.68 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 7.0 Cg_endo -51.98 -48.39 21.84 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.46 2.107 . . . . 0.0 112.869 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.595 ' O ' HD23 ' A' ' 120' ' ' LEU . 22.1 t -61.73 -38.51 80.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.932 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.455 HD12 ' CG2' ' A' ' 51' ' ' VAL . 6.8 mt -64.61 -49.1 72.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.527 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 1.017 HG22 HG11 ' A' ' 105' ' ' VAL . 12.5 t -54.59 -55.4 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.742 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -59.23 -49.4 78.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.214 0.531 . . . . 0.0 111.091 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.896 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.2 mm? -53.92 -30.66 47.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.859 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -71.24 -47.66 55.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.04 0.447 . . . . 0.0 110.085 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.655 HD11 ' HD2' ' A' ' 17' ' ' TYR . 14.4 tp -61.58 -16.99 53.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.746 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.903 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.9 mt -57.08 -30.81 35.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.494 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.402 ' OE2' ' CG ' ' A' ' 95' ' ' PHE . 3.3 pt-20 -68.14 -17.29 64.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.557 0.218 . . . . 0.0 111.456 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.7 t -84.75 11.04 9.83 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 104.02 -81.69 0.35 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.873 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 51.8 ttp -63.16 66.47 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.903 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -74.63 -67.91 0.59 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -176.239 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.6 ' CD1' HD22 ' A' ' 152' ' ' LEU . 5.1 t80 -71.59 -31.54 67.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.057 0.456 . . . . 0.0 110.806 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.404 ' HB2' ' HG3' ' A' ' 127' ' ' MET . 1.3 mt-10 -72.53 -47.32 49.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.311 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.687 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 10.8 t0 -70.09 -43.77 70.44 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 110.836 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.742 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -58.36 -50.04 75.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.879 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.0 mm -71.65 -42.38 71.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.904 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -49.33 27.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.734 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -68.62 -39.66 80.7 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.189 -0.204 . . . . 0.0 111.016 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.7 OUTLIER -72.62 -27.79 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.318 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -47.18 79.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.949 0.404 . . . . 0.0 110.034 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -45.13 93.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.667 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -86.5 152.54 22.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.346 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -72.83 117.07 14.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.004 0.43 . . . . 0.0 110.299 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.455 ' HA ' HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -114.82 163.29 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.158 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.461 ' H ' ' HG3' ' A' ' 115' ' ' PRO . . . -58.06 172.47 3.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.197 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.23 99.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.528 0.664 . . . . 0.0 110.447 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.834 HD12 HD21 ' A' ' 149' ' ' LEU . 2.2 pt -88.31 109.06 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.098 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -113.55 -76.88 0.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.562 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.06 -60.61 1.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.631 ' O ' ' CB ' ' A' ' 151' ' ' TYR . 0.8 OUTLIER -54.76 -51.93 64.14 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.295 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.493 ' HG3' HG22 ' A' ' 144' ' ' ILE . 1.1 tm0? -56.35 -51.87 66.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.834 HD21 HD12 ' A' ' 144' ' ' ILE . 3.4 mm? -75.22 -47.46 28.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.7 m -64.96 -34.82 79.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.733 0.301 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.717 ' HE2' HG11 ' A' ' 84' ' ' VAL . 6.9 t80 -68.2 -50.95 50.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.281 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.772 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -72.01 -32.76 67.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.525 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.59 -37.7 79.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -28.24 62.4 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.642 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.556 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -65.88 -34.34 77.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.679 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.02 89.52 4.56 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.28 150.33 87.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.536 2.157 . . . . 0.0 112.363 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.27 123.57 10.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -70.42 -11.96 61.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.339 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.9 -38.71 79.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.817 0.341 . . . . 0.0 111.037 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -38.84 84.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -109.76 -169.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -124.01 111.01 15.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.45 138.06 54.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -86.66 108.58 18.72 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.8 112.35 2.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.404 2.069 . . . . 0.0 112.277 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 4.9 t60 61.72 152.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.6 m -142.79 149.35 38.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -151.33 137.06 17.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 60.69 106.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.3 m -101.9 -64.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.814 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t -163.91 126.13 2.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.36 . . . . 0.0 110.946 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -149.76 150.18 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.84 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.2 mtt 60.64 168.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.64 -67.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -91.21 84.36 5.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.03 161.34 30.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.35 145.44 48.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -74.68 141.05 75.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.28 110.09 3.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.515 2.143 . . . . 0.0 112.336 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.76 148.04 92.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.068 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.29 163.43 39.15 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.526 2.151 . . . . 0.0 112.297 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.05 126.83 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -108.5 126.25 52.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.523 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.786 HG12 ' CE2' ' A' ' 135' ' ' PHE . 2.4 t -106.65 129.79 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 p -132.87 139.25 47.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.222 0.534 . . . . 0.0 112.136 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 18' ' ' LYS . 10.8 t80 -155.12 129.17 8.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.104 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 2.0 mmmp? 63.46 -92.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.198 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.42 -39.06 1.52 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.455 ' HE1' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -73.77 151.66 40.56 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 111.273 -179.398 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.62 164.24 21.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.067 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.665 ' CE1' HG11 ' A' ' 103' ' ' VAL . 2.0 m-85 -136.76 139.16 41.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.646 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.078 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -117.77 138.5 52.01 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.118 0.485 . . . . 0.0 111.343 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.772 HG21 HG12 ' A' ' 108' ' ' VAL . 2.6 mm -118.22 106.64 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.211 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -131.05 164.29 25.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.476 0.655 . . . . 0.0 112.451 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.532 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 10.8 p80 -81.74 152.55 26.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.248 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -62.48 154.44 72.75 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.2 Cg_exo -54.85 139.03 78.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.391 2.061 . . . . 0.0 113.601 -177.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.7 p -98.97 145.94 26.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.977 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -71.3 -10.12 59.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.83 14.74 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 p -139.59 89.43 2.32 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.382 -0.527 . . . . 0.0 112.244 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.38 -52.25 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.177 0.513 . . . . 0.0 111.23 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.457 ' HA ' HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -56.7 -45.19 81.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.321 -178.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.5 m -57.69 -31.91 66.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.739 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.22 -47.56 27.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.142 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.732 HD13 ' HB3' ' A' ' 63' ' ' LYS . 11.3 pt -55.44 -38.39 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.227 0.537 . . . . 0.0 110.334 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.43 -51.75 58.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.374 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.547 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.2 m-20 -68.8 -50.29 51.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.918 0.389 . . . . 0.0 111.953 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.739 HD21 ' CE1' ' A' ' 36' ' ' PHE . 83.6 mt -56.89 -44.45 82.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.993 0.425 . . . . 0.0 110.303 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -77.19 -26.65 53.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.886 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 2.1 mtmt -52.79 -47.52 67.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.306 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.078 ' CD1' HD21 ' A' ' 23' ' ' LEU . 11.6 t80 -63.63 -38.5 91.37 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.656 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.671 ' HA3' ' CB ' ' A' ' 102' ' ' CYS . . . 160.03 -177.44 36.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.041 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.62 122.93 28.34 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.833 HG22 ' H ' ' A' ' 47' ' ' THR . 3.8 m -164.52 -171.2 2.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.46 177.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.833 ' H ' HG22 ' A' ' 46' ' ' THR . 1.8 t -65.33 149.63 49.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.329 0.585 . . . . 0.0 109.862 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.037 HG22 ' HB3' ' A' ' 104' ' ' ALA . 74.4 t -126.64 135.18 64.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.882 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.032 HG13 HG13 ' A' ' 105' ' ' VAL . 9.3 p -115.46 104.91 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.111 0.482 . . . . 0.0 111.27 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -114.74 111.01 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.399 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.796 HG13 ' HB3' ' A' ' 71' ' ' TRP . 8.1 t -103.71 90.39 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.451 0.643 . . . . 0.0 109.303 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -158.63 171.87 19.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.953 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -65.06 130.62 44.02 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 m -81.07 122.32 36.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.6 p -120.15 -47.52 2.37 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.663 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.419 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -130.33 83.86 2.16 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -79.4 -36.6 38.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.65 -48.58 13.48 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.454 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -46.22 -56.65 10.21 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 65.4 Cg_endo -73.17 -42.35 1.0 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.493 2.129 . . . . 0.0 114.182 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.737 HD21 HG11 ' A' ' 68' ' ' VAL . 28.9 mt -71.19 -45.21 63.89 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.3 -30.83 70.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.817 0.341 . . . . 0.0 111.422 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.732 ' HB3' HD13 ' A' ' 37' ' ' ILE . 13.3 mttm -81.37 -32.67 32.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 66' ' ' ILE . 18.1 p30 -101.23 -11.35 19.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 61' ' ' LEU . . . 48.11 31.29 8.25 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.284 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 64' ' ' ASP . 5.6 mt -97.42 147.53 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.679 0.276 . . . . 0.0 110.974 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' THR . 50.1 p -78.41 131.14 36.82 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.737 HG11 HD21 ' A' ' 61' ' ' LEU . 9.1 p -145.36 152.24 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.63 132.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -100.57 106.79 18.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 109.947 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.861 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 3.4 m95 -111.72 104.07 55.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.677 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -106.83 88.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 123.573 2.849 . . . . 0.0 112.344 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.632 ' CD1' ' HB1' ' A' ' 77' ' ' ALA . 1.5 t80 -85.79 95.85 9.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 110.963 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.74 -165.39 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -55.25 -24.74 29.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.112 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -114.68 39.49 2.78 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.632 ' HB1' ' CD1' ' A' ' 73' ' ' PHE . . . -85.98 155.07 58.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.623 0.249 . . . . 0.0 111.029 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.798 ' HG2' HG21 ' A' ' 83' ' ' VAL . 57.4 Cg_endo -70.62 109.55 2.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.682 2.255 . . . . 0.0 112.586 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 32.7 Cg_exo -60.32 -40.17 60.98 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.914 2.409 . . . . 0.0 114.354 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 12.4 Cg_endo -58.06 143.15 96.95 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.936 1.758 . . . . 0.0 113.544 -178.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -66.03 -19.9 68.34 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.179 -0.919 . . . . 0.0 113.04 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -50.73 -29.57 11.72 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.561 0.22 . . . . 0.0 110.763 -178.234 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.861 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 41.4 t -56.79 -48.3 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.737 HG11 ' HE2' ' A' ' 151' ' ' TYR . 90.3 t -55.34 -37.47 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.986 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.838 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.8 mt-10 -60.42 -31.32 70.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.429 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.91 -50.17 69.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.245 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.731 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -66.56 -27.42 67.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.838 HD12 ' HA ' ' A' ' 85' ' ' GLU . 37.1 mt -64.49 -38.16 90.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.095 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -69.03 -41.42 77.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.803 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -59.53 -51.32 70.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.381 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.562 HG21 ' HB1' ' A' ' 121' ' ' ALA . 8.5 p -71.74 -35.9 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.909 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -56.23 -47.19 78.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.502 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.31 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.636 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 1.7 mmtp -68.0 -24.28 65.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.077 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.548 ' HE1' HG21 ' A' ' 103' ' ' VAL . 2.4 m-85 -82.09 -52.04 7.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.167 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.3 t -63.93 -39.87 95.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.992 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.11 -31.72 58.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.226 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -124.15 89.1 52.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.52 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.64 135.07 14.19 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.594 2.196 . . . . 0.0 112.236 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 20' ' ' MET . . . 64.95 46.23 89.94 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.468 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 t -101.04 -176.59 3.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.66 0.267 . . . . 0.0 111.118 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.671 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 2.2 m -111.98 114.05 26.71 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.665 HG11 ' CE1' ' A' ' 22' ' ' PHE . 28.0 t -101.94 151.28 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.037 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.05 141.74 51.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.146 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.032 HG13 HG13 ' A' ' 49' ' ' VAL . 2.5 t -140.68 166.95 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.78 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.3 t60 -67.38 156.51 36.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.639 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 26' ' ' HIS . 0.1 OUTLIER -68.01 98.79 0.79 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.375 0.607 . . . . 0.0 112.469 -178.042 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.772 HG12 HG21 ' A' ' 24' ' ' ILE . 7.5 p -75.41 -0.08 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.96 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.66 -8.76 3.13 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.03 -124.71 2.96 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 143' ' ' ALA . 13.1 mt -129.11 127.39 41.36 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.86 -144.41 4.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.807 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.481 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.14 -20.56 6.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.033 0.444 . . . . 0.0 111.931 -178.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.78 ' HB2' ' HB3' ' A' ' 106' ' ' HIS . . . -52.11 -44.94 93.63 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 114' ' ' ALA . 6.4 Cg_endo -51.62 -48.3 22.05 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.524 2.149 . . . . 0.0 113.165 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 ' CG ' ' A' ' 148' ' ' GLN . 62.1 t -62.48 -46.45 96.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.02 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 49' ' ' VAL . 13.4 mt -58.85 -41.89 88.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.973 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.856 ' CG2' HG11 ' A' ' 105' ' ' VAL . 54.0 t -61.63 -55.44 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.609 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -58.09 -52.51 65.24 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.157 0.504 . . . . 0.0 111.032 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.738 ' HB3' HD21 ' A' ' 88' ' ' LEU . 4.3 mm? -53.82 -30.82 46.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.668 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.731 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -72.26 -42.38 65.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.078 0.466 . . . . 0.0 110.115 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.455 ' CD1' ' HE1' ' A' ' 20' ' ' MET . 3.4 tp -67.51 -14.04 62.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.928 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.4 mt -57.25 -30.77 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.031 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.28 -16.87 63.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.6 m -83.93 11.2 8.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 115.19 -101.58 1.06 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.211 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.484 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 3.7 ptt? -62.49 77.78 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.928 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.65 -67.59 0.54 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.655 ' CD1' HD22 ' A' ' 152' ' ' LEU . 4.1 t80 -66.26 -33.77 76.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.926 0.393 . . . . 0.0 111.187 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.26 -51.67 19.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.294 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 30.0 t0 -70.03 -36.25 74.92 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.841 0.353 . . . . 0.0 111.029 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -61.31 -50.16 74.09 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.654 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.9 mm -74.31 -37.61 45.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.531 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -74.24 -49.68 22.27 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.786 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.24 -35.84 76.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.473 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.3 tt -74.0 -27.91 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 0.0 110.227 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -65.14 -52.31 55.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.539 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.86 -45.17 93.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.633 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 136' ' ' ILE . 7.3 mmtt -81.54 152.22 27.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.253 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.83 117.21 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.344 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.423 ' HA ' ' CG2' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -114.64 163.39 15.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.12 -179.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.484 ' H ' ' HG3' ' A' ' 115' ' ' PRO . . . -60.15 -163.35 0.14 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.276 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.457 ' N ' HD22 ' A' ' 111' ' ' LEU . . . -90.1 99.28 12.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.427 0.614 . . . . 0.0 110.633 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.603 HG22 ' HG3' ' A' ' 148' ' ' GLN . 6.8 pt -88.35 109.26 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.119 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.67 -76.98 0.58 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.605 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.23 -60.69 1.48 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.641 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.6 tmtt? -57.35 -51.89 67.59 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.765 ' CG ' HG22 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -56.14 -52.09 65.61 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 149' ' ' LEU . 3.4 mm? -75.27 -45.55 39.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 56.3 m -66.44 -33.47 75.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.807 0.336 . . . . 0.0 111.147 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.737 ' HE2' HG11 ' A' ' 84' ' ' VAL . 2.2 t80 -68.68 -50.93 47.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.735 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -70.25 -34.26 72.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.407 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -36.44 76.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -26.26 60.55 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.71 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.728 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -65.93 -37.58 86.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.451 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.91 85.92 2.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.614 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.01 151.61 67.73 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.609 2.206 . . . . 0.0 112.486 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.33 123.5 10.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.472 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -65.21 -20.68 66.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.208 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -30.37 67.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.82 0.343 . . . . 0.0 110.985 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.2 mt -67.86 -48.03 67.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.12 126.53 46.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.56 -60.58 2.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -63.25 119.11 8.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -94.05 103.5 10.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.9 177.43 4.99 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.437 2.091 . . . . 0.0 112.264 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -141.78 176.12 9.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.7 m -111.82 133.63 53.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -109.39 168.74 9.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -170.73 97.21 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.6 m -124.4 110.94 15.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.996 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.935 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 t -176.11 164.61 2.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.814 0.34 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -97.23 -62.52 1.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.5 ptp -66.26 110.88 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -167.99 -55.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.74 36.56 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.939 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -130.8 120.83 24.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -141.77 88.7 2.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -161.47 80.71 2.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.05 148.82 29.16 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.6 2.2 . . . . 0.0 112.326 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.534 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -86.56 160.78 49.96 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.588 ' HB3' HG22 ' A' ' 25' ' ' THR . 54.6 Cg_endo -69.83 163.67 37.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.577 2.185 . . . . 0.0 112.306 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.461 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 21.4 t -144.26 129.26 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.964 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HG2' ' CE2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -111.34 116.6 31.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.868 0.366 . . . . 0.0 111.269 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.804 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -109.05 118.29 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' A' ' 21' ' ' ARG . 70.3 p -141.24 142.46 33.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.616 ' CD2' ' HE1' ' A' ' 127' ' ' MET . 1.2 p90 -136.61 164.48 28.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.413 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.584 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 pttp 50.09 -95.99 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.202 0.201 . . . . 0.0 110.973 -177.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.491 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 t-160 -128.92 -32.36 2.09 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.859 ' HE1' HD11 ' A' ' 122' ' ' LEU . 3.8 ppp? -73.65 168.05 20.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.645 0.259 . . . . 0.0 111.329 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HA ' ' CB ' ' A' ' 16' ' ' SER . 3.4 mtp180 -146.05 161.54 39.9 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.012 0.434 . . . . 0.0 111.752 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.86 ' CD2' HG13 ' A' ' 118' ' ' VAL . 0.9 OUTLIER -135.05 148.78 49.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.555 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.08 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.6 mm? -120.28 135.96 54.83 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.106 0.479 . . . . 0.0 111.206 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.918 HD12 HG13 ' A' ' 108' ' ' VAL . 2.2 mm -117.98 106.66 20.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.25 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 12' ' ' PRO . 1.3 p -132.62 164.44 26.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.197 0.523 . . . . 0.0 111.819 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.463 ' CD2' ' CZ ' ' A' ' 36' ' ' PHE . 45.4 p-80 -81.31 152.17 27.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.738 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -62.71 154.42 74.65 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.492 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 51.9 Cg_exo -54.61 140.58 75.86 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.296 1.997 . . . . 0.0 113.2 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.462 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.5 p -98.69 174.38 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.129 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -94.26 -11.4 30.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.66 -30.75 14.76 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.0 p -139.5 89.61 2.34 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.45 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.604 ' HG ' HG21 ' A' ' 59' ' ' THR . 0.4 OUTLIER -80.27 -52.22 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.19 0.519 . . . . 0.0 111.173 178.212 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.438 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.8 p -56.86 -45.05 82.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.308 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.1 m -57.92 -32.82 68.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.828 0.347 . . . . 0.0 111.288 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.749 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.8 -47.92 28.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.146 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.825 HG21 ' HB3' ' A' ' 63' ' ' LYS . 12.1 pt -55.7 -38.93 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.233 0.54 . . . . 0.0 110.655 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -51.9 57.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.46 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.554 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.7 OUTLIER -68.7 -50.29 52.07 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.749 HD21 ' CE1' ' A' ' 36' ' ' PHE . 72.4 mt -56.47 -43.64 79.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.437 . . . . 0.0 110.392 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -78.6 -26.73 45.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.077 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 3.7 mttt -53.25 -44.6 68.28 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.374 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.08 ' CD1' HD21 ' A' ' 23' ' ' LEU . 16.5 t80 -63.52 -38.56 91.6 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.949 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.663 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.32 -178.47 39.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.951 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.64 117.67 19.84 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.652 HG22 ' H ' ' A' ' 47' ' ' THR . 0.8 OUTLIER -164.88 -170.16 1.89 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.966 177.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.652 ' H ' HG22 ' A' ' 46' ' ' THR . 16.8 p -64.94 155.11 35.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.474 0.654 . . . . 0.0 110.788 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.054 HG22 ' HB3' ' A' ' 104' ' ' ALA . 65.6 t -134.0 139.1 49.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.04 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.022 HG13 HG13 ' A' ' 105' ' ' VAL . 3.3 p -115.77 105.37 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.164 0.507 . . . . 0.0 110.936 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.23 110.92 20.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.22 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.82 HG13 ' HB3' ' A' ' 71' ' ' TRP . 10.8 t -105.62 91.38 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.331 0.586 . . . . 0.0 109.914 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 10.4 p -158.01 171.28 20.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.948 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.64 130.48 43.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.59 121.75 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 p -120.77 -47.63 2.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.212 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.426 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.7 m-85 -130.43 84.29 2.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.488 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -78.61 -36.24 44.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -79.1 -48.49 14.24 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.63 HG22 ' HD2' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -44.56 -49.88 24.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' CD ' ' O ' ' A' ' 56' ' ' TYR . 17.2 Cg_exo -68.08 -42.1 6.5 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.574 2.183 . . . . 0.0 113.427 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.737 HD21 HG12 ' A' ' 68' ' ' VAL . 1.4 mm? -66.19 -45.43 80.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.61 -41.08 55.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.825 ' HB3' HG21 ' A' ' 37' ' ' ILE . 18.1 mttt -80.92 -27.51 36.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HB3' ' CG1' ' A' ' 66' ' ' ILE . 2.7 t0 -101.15 -11.49 19.53 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.45 29.5 1.16 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.522 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.434 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 2.4 pt -117.56 148.06 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.714 0.293 . . . . 0.0 110.982 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' THR . 24.6 p -77.77 135.15 37.96 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.737 HG12 HD21 ' A' ' 61' ' ' LEU . 9.4 p -143.87 154.91 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.46 134.18 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -100.82 106.77 18.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.241 0.544 . . . . 0.0 110.319 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.82 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.1 m95 -111.96 104.35 55.97 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.091 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -103.79 165.02 0.23 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 123.225 2.617 . . . . 0.0 112.275 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.425 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 2.5 t80 -126.13 122.47 35.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.009 0.433 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -178.11 -167.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.36 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.93 -20.89 40.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.241 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -105.59 27.33 18.4 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.897 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' A' ' 79' ' ' PRO . . . -110.59 102.73 52.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.643 0.222 . . . . 0.0 110.974 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.667 ' HB2' HG13 ' A' ' 83' ' ' VAL . 76.4 Cg_exo -50.68 102.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.633 2.222 . . . . 0.0 112.717 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.68 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 9.7 Cg_endo -53.66 -43.36 58.45 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.773 2.316 . . . . 0.0 113.863 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.81 ' O ' HG22 ' A' ' 83' ' ' VAL . 4.5 Cg_endo -47.66 148.41 5.86 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.343 2.028 . . . . 0.0 113.49 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.448 ' HA2' ' CE ' ' A' ' 147' ' ' LYS . . . -57.45 -19.78 35.04 Favored Glycine 0 C--O 1.237 0.293 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.399 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -32.0 19.39 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.546 0.173 . . . . 0.0 111.014 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -55.01 -46.86 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' A' ' 151' ' ' TYR . 79.7 t -55.02 -43.13 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.268 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.64 ' HA ' HD12 ' A' ' 88' ' ' LEU . 1.3 mt-10 -56.27 -31.28 63.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.802 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.94 -50.54 62.02 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.827 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -68.63 -26.96 65.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.828 HD21 ' HB3' ' A' ' 120' ' ' LEU . 18.8 mt -61.34 -50.98 70.74 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.117 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 m -60.53 -41.09 93.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.12 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.503 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.9 tm? -56.84 -51.12 70.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.725 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.803 HG21 ' HB1' ' A' ' 121' ' ' ALA . 11.3 p -70.67 -36.66 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.383 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 3.2 tmtt? -64.87 -41.37 95.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 110.71 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.07 -48.07 77.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.36 -26.79 62.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.743 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 3.6 m-30 -82.01 -33.91 29.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.885 0.374 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 16.0 t -72.24 -39.44 68.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.067 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -76.16 -33.07 59.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.535 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.56 137.33 26.89 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.679 0.276 . . . . 0.0 111.486 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.58 -166.75 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.547 2.165 . . . . 0.0 112.046 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 20' ' ' MET . . . -46.76 96.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.727 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.528 ' HB3' HG21 ' A' ' 46' ' ' THR . 0.2 OUTLIER -101.1 -160.72 0.81 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.726 0.298 . . . . 0.0 111.017 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.663 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -116.09 113.48 23.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.86 0.362 . . . . 0.0 111.266 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.743 HG21 ' HZ ' ' A' ' 95' ' ' PHE . 25.1 t -106.84 151.18 8.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.229 0.538 . . . . 0.0 112.147 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.054 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -123.17 139.87 53.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.986 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.022 HG13 HG13 ' A' ' 49' ' ' VAL . 5.4 t -140.09 166.8 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.7 t60 -66.9 156.1 36.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.391 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.519 ' HA ' HG23 ' A' ' 24' ' ' ILE . 25.5 t -68.3 105.61 2.2 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.918 HG13 HD12 ' A' ' 24' ' ' ILE . 35.2 m -75.47 0.25 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.099 178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.66 -8.77 3.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.53 -135.81 4.39 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.432 HD22 ' HA2' ' A' ' 142' ' ' GLY . 12.8 mt -120.51 127.29 52.05 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.2 -144.03 3.93 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.822 -1.18 . . . . 0.0 113.671 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.567 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -122.19 -25.63 4.84 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.925 0.393 . . . . 0.0 112.005 -178.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.748 ' HB2' ' HB3' ' A' ' 106' ' ' HIS . . . -50.94 -46.36 87.71 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.825 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.1 Cg_endo -52.26 -48.44 21.73 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.29 1.993 . . . . 0.0 112.964 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.836 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.6 t -61.01 -46.74 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.097 0.475 . . . . 0.0 110.105 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 49' ' ' VAL . 14.4 mt -59.37 -40.2 85.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.743 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.86 HG13 ' CD2' ' A' ' 22' ' ' PHE . 47.9 t -59.96 -55.65 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.613 0.244 . . . . 0.0 111.629 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.589 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -57.7 -47.13 83.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.609 0.719 . . . . 0.0 110.23 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.836 HD23 ' O ' ' A' ' 116' ' ' VAL . 4.5 mm? -54.52 -30.26 53.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.667 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.827 ' HB2' ' CZ2' ' A' ' 87' ' ' TRP . . . -70.32 -47.47 60.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 110.164 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.859 HD11 ' HE1' ' A' ' 20' ' ' MET . 3.7 mp -63.61 -16.01 59.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.698 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.919 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.3 mt -57.06 -30.92 35.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.401 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 2.4 pt-20 -73.58 -16.58 61.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.405 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.3 m -85.18 11.03 10.68 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 117.51 -102.65 1.01 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.182 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.616 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 3.6 ptt? -62.42 79.56 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.919 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -72.85 -67.77 0.54 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -176.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.663 ' CD1' HD22 ' A' ' 152' ' ' LEU . 6.3 t80 -66.81 -32.03 73.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.0 111.054 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.46 -52.05 17.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.685 ' OD2' HD23 ' A' ' 122' ' ' LEU . 29.9 t0 -69.24 -36.21 76.93 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.589 ' CB ' ' HB1' ' A' ' 119' ' ' ALA . . . -61.25 -50.26 73.76 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.812 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.4 mm -74.35 -37.62 45.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.551 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -74.07 -49.71 22.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.804 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.07 -34.98 73.88 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.666 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.9 tt -74.19 -27.86 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.327 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.18 -48.19 68.7 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.52 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.79 -45.23 92.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.594 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' ILE . 73.7 mmtt -85.51 152.01 23.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.114 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.23 116.81 14.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.055 0.455 . . . . 0.0 110.62 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.503 ' HG3' HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -115.12 163.57 15.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.86 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.432 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -57.57 -169.16 0.14 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.496 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.51 99.63 11.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.391 0.596 . . . . 0.0 110.762 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.519 HG22 ' HG3' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -88.05 109.4 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.989 179.189 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -113.16 -76.32 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.4 t -99.75 -60.51 1.52 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.904 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 1.0 OUTLIER -57.65 -52.65 64.57 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.761 ' HG3' HG22 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -56.88 -51.68 68.12 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.05 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 149' ' ' LEU . 3.6 mm? -73.26 -42.55 62.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.2 m -71.76 -40.76 69.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.785 0.326 . . . . 0.0 111.486 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.904 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -63.75 -50.29 69.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.409 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.8 HD21 ' CD1' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -67.5 -34.07 76.38 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.645 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -55.95 -44.96 78.93 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -27.97 63.63 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.728 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.61 ' HB3' HD23 ' A' ' 152' ' ' LEU . 0.9 OUTLIER -66.73 -25.98 66.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.891 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.87 143.02 26.24 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.673 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.59 152.7 71.9 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.499 2.133 . . . . 0.0 112.352 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -147.31 123.48 10.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.522 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -30.59 61.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.039 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -65.41 -31.24 72.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.5 -35.77 68.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.08 155.83 38.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -77.29 -177.88 4.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 62.85 120.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -92.74 138.1 23.8 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.32 171.41 16.16 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.52 2.147 . . . . 0.0 112.32 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -64.88 113.16 3.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 64.5 p -134.18 148.59 50.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.962 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.31 -43.43 2.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -149.63 -65.01 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 63.0 p -115.63 -38.92 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.953 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m -83.57 174.65 10.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -112.81 -41.44 3.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -31.64 72.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.71 -179.02 3.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -68.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -109.98 144.06 39.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -149.51 115.13 5.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -119.73 90.42 43.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.54 113.92 3.32 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.522 2.148 . . . . 0.0 112.311 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.447 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -76.45 158.19 81.64 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 59.7 Cg_endo -72.02 163.55 38.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.613 2.209 . . . . 0.0 112.344 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -144.09 126.84 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.9 pt-20 -102.93 118.5 36.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.364 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.705 HG12 ' CE2' ' A' ' 135' ' ' PHE . 18.4 t -106.74 118.53 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.814 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 p -141.24 149.3 41.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.889 0.376 . . . . 0.0 111.957 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.692 ' CE1' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -149.57 120.22 7.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.157 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.514 ' HG2' ' CD2' ' A' ' 17' ' ' TYR . 40.4 mmtt 84.4 -87.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.262 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -129.41 -38.51 1.55 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.74 ' CE ' HD13 ' A' ' 122' ' ' LEU . 4.8 ppp? -73.54 163.8 27.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 111.473 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -145.67 164.05 32.95 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.067 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.782 ' CE1' HG11 ' A' ' 103' ' ' VAL . 3.0 m-85 -135.67 155.37 50.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.38 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.058 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -125.27 124.75 42.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.315 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.866 HD13 HG23 ' A' ' 105' ' ' VAL . 2.0 mm -106.37 106.85 21.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.541 HG21 HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -130.71 165.66 22.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.463 0.649 . . . . 0.0 112.546 -178.407 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.528 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 12.0 p80 -81.61 152.64 27.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.907 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.3 154.35 71.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.449 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.4 Cg_exo -54.96 138.36 77.92 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.482 2.121 . . . . 0.0 113.527 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.0 p -98.85 139.57 34.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.929 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -65.65 -10.27 34.57 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.49 -31.14 14.69 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.4 p -139.85 89.04 2.28 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.238 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.75 -52.2 7.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.005 0.431 . . . . 0.0 111.485 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.575 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -55.92 -38.68 70.6 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.187 -178.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -33.71 76.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.913 0.387 . . . . 0.0 111.035 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.674 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -76.12 -48.03 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.205 -179.16 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.821 HG21 ' CB ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -57.36 -37.18 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.092 0.473 . . . . 0.0 110.458 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -52.14 51.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.189 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 1.2 m-20 -67.94 -50.06 58.15 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.811 0.339 . . . . 0.0 111.688 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.674 HD21 ' CE1' ' A' ' 36' ' ' PHE . 31.9 mt -56.17 -39.52 72.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.013 0.435 . . . . 0.0 110.418 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -26.74 34.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.085 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -55.11 -43.0 73.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.181 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.058 ' CD1' HD21 ' A' ' 23' ' ' LEU . 13.5 t80 -63.58 -38.42 91.04 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.621 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.7 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 164.69 -178.52 39.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.912 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.57 117.93 20.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.726 HG22 ' H ' ' A' ' 47' ' ' THR . 1.4 m -164.71 -170.66 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.045 177.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.726 ' H ' HG22 ' A' ' 46' ' ' THR . 4.6 t -65.18 158.7 25.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.338 0.59 . . . . 0.0 110.718 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.042 HG22 ' HB3' ' A' ' 104' ' ' ALA . 63.1 t -136.39 136.55 48.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.927 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.003 HG12 HG12 ' A' ' 105' ' ' VAL . 14.8 p -115.87 104.73 17.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.364 0.602 . . . . 0.0 111.288 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -114.58 110.94 20.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.046 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.8 HG13 ' HB3' ' A' ' 71' ' ' TRP . 15.5 t -107.18 91.46 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 121.29 0.567 . . . . 0.0 109.798 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 m -157.81 171.28 20.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.865 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.406 ' CD ' ' N ' ' A' ' 53' ' ' GLU . 2.2 mm-40 -65.26 130.51 43.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' A' ' 70' ' ' ASP . 18.4 t -76.01 122.27 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -120.2 -47.69 2.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.309 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.6 83.54 2.13 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.522 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.43 -36.74 38.47 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -48.54 13.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -45.84 -54.14 17.63 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 59' ' ' THR . 8.3 Cg_exo -73.11 -41.97 1.14 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.645 2.23 . . . . 0.0 113.575 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.065 HD21 HG11 ' A' ' 68' ' ' VAL . 1.3 mm? -63.68 -45.34 90.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -75.27 -28.65 59.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.821 ' CB ' HG21 ' A' ' 37' ' ' ILE . 34.7 mttm -76.41 -37.78 56.58 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.735 ' HB3' HG22 ' A' ' 37' ' ' ILE . 56.3 p30 -101.74 -11.98 18.71 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.88 24.75 6.53 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.017 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 64' ' ' ASP . 9.2 mt -94.47 147.68 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.638 0.256 . . . . 0.0 110.975 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 47' ' ' THR . 23.0 p -78.21 129.21 34.83 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.065 HG11 HD21 ' A' ' 61' ' ' LEU . 8.5 p -145.08 153.04 14.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 111.977 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.463 HG21 ' HE3' ' A' ' 87' ' ' TRP . 2.3 t -103.56 131.36 52.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -101.09 106.85 18.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.147 0.499 . . . . 0.0 110.849 -178.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.909 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.9 m95 -110.74 103.83 55.11 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -105.82 161.74 0.15 Allowed 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.395 2.73 . . . . 0.0 112.605 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.443 ' HB2' ' NH2' ' A' ' 113' ' ' ARG . 0.6 OUTLIER -126.23 95.99 4.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.905 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.96 -160.94 1.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.456 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.02 -23.25 18.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.163 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.82 56.8 0.54 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.729 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.72 102.82 13.51 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.488 0.185 . . . . 0.0 110.94 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.754 ' O ' HG21 ' A' ' 83' ' ' VAL . 26.9 Cg_exo -62.35 108.56 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.587 2.191 . . . . 0.0 112.362 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.732 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 41.4 Cg_endo -68.35 -31.22 28.77 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.663 2.242 . . . . 0.0 114.97 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.732 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 3.4 Cg_endo -47.9 148.4 6.5 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.8 1.667 . . . . 0.0 113.421 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.417 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -57.27 -21.1 38.73 Favored Glycine 0 C--O 1.237 0.318 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.175 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -51.96 -38.81 57.9 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.599 0.238 . . . . 0.0 110.689 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.909 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 14.9 t -55.19 -42.93 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.597 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 0.4 OUTLIER -53.24 -42.31 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.301 178.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 88' ' ' LEU . 22.2 mm-40 -62.8 -31.47 72.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.164 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.39 -50.6 69.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.63 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.807 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.2 OUTLIER -66.42 -28.87 68.96 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.872 179.249 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.958 HD21 ' HB3' ' A' ' 120' ' ' LEU . 33.0 mt -62.68 -44.0 97.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.641 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.1 m -66.52 -38.35 86.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.392 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.401 ' HG ' HG22 ' A' ' 69' ' ' VAL . 1.4 tm? -61.9 -51.47 68.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.988 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.032 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.3 p -74.36 -37.69 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.353 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -44.21 89.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.387 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.78 -43.77 78.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.523 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -69.93 -23.91 63.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -81.76 -52.07 7.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.068 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.5 t -59.51 -37.6 78.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.94 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.99 -33.09 59.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.97 93.2 44.39 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.36 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.89 133.95 20.86 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.504 2.136 . . . . 0.0 112.251 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 59.35 10.97 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.432 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.423 ' HB2' HG21 ' A' ' 46' ' ' THR . 4.4 m -101.1 -163.7 1.04 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.7 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.8 m -121.01 113.56 20.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.251 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.782 HG11 ' CE1' ' A' ' 22' ' ' PHE . 44.6 t -105.97 150.23 8.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.042 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -122.22 135.14 54.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.361 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.003 HG12 HG12 ' A' ' 49' ' ' VAL . 34.0 m -140.68 167.81 17.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.741 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.5 t60 -66.87 155.75 37.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.115 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.571 ' HA ' HG23 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -68.46 109.11 3.54 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.396 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.8 HG13 ' CD1' ' A' ' 24' ' ' ILE . 18.7 m -75.79 0.26 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.2 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.48 -8.58 2.84 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.78 -143.37 5.69 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.493 HD22 ' HA2' ' A' ' 142' ' ' GLY . 7.1 mt -115.05 127.27 55.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.99 -144.85 4.23 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.981 -1.104 . . . . 0.0 113.408 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.483 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.4 -17.11 7.15 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.799 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -55.18 -47.03 99.51 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.763 ' HD3' HG12 ' A' ' 108' ' ' VAL . 7.6 Cg_endo -52.49 -48.19 23.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.31 2.006 . . . . 0.0 112.773 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.749 HG12 HD11 ' A' ' 120' ' ' LEU . 22.0 t -60.06 -54.15 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.702 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.812 HD12 ' CG2' ' A' ' 49' ' ' VAL . 2.4 mt -52.26 -51.23 59.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.969 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.874 HG22 HG11 ' A' ' 105' ' ' VAL . 21.9 t -52.08 -55.19 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' A' ' 136' ' ' ILE . . . -53.19 -50.18 65.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.333 0.587 . . . . 0.0 111.053 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.958 ' HB3' HD21 ' A' ' 88' ' ' LEU . 13.5 mt -54.38 -30.55 52.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.977 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 1.032 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -71.94 -39.79 69.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.034 0.445 . . . . 0.0 110.004 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.74 HD13 ' CE ' ' A' ' 20' ' ' MET . 3.4 tp -69.45 -15.54 63.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.636 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.943 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.4 mt -57.12 -30.6 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.886 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -17.0 64.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.0 m -79.79 -23.41 42.17 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 149.11 -95.79 0.17 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.749 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.492 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 2.7 ptt? -63.84 71.85 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.943 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.37 -67.52 0.44 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.557 ' CD1' HD22 ' A' ' 152' ' ' LEU . 8.0 t80 -65.69 -33.24 75.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.948 0.404 . . . . 0.0 111.068 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.52 -52.34 16.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.219 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.623 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.2 t0 -69.99 -35.91 74.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.857 0.36 . . . . 0.0 110.864 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.649 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -61.36 -50.04 74.5 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.605 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 28.1 mm -74.53 -37.32 43.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.49 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -49.87 21.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.705 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.76 -36.96 79.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.668 0.27 . . . . 0.0 110.485 -179.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.6 tt -74.18 -27.85 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.488 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 4.4 ttt-85 -66.63 -45.79 77.89 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.465 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -45.01 93.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 110.434 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.477 ' HE2' HG22 ' A' ' 15' ' ' VAL . 6.2 mptt -86.18 152.12 23.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.107 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 116.57 13.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.11 0.481 . . . . 0.0 110.531 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.13 163.82 15.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.135 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.493 ' HA2' HD22 ' A' ' 111' ' ' LEU . . . -55.64 -170.4 0.09 OUTLIER Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.689 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.93 100.0 12.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.258 0.529 . . . . 0.0 111.303 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.847 HD12 HD21 ' A' ' 149' ' ' LEU . 14.5 pt -87.75 109.54 19.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.571 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.32 -76.71 0.58 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.0 t -99.65 -60.95 1.43 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.858 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 8.9 tmtt? -62.55 -50.8 69.9 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.644 ' NE2' HG22 ' A' ' 144' ' ' ILE . 1.7 mt-30 -55.61 -51.76 66.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.847 HD21 HD12 ' A' ' 144' ' ' ILE . 4.2 mm? -73.58 -45.34 53.83 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.2 m -67.42 -37.4 82.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.754 0.311 . . . . 0.0 111.559 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.858 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -65.67 -50.31 65.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.147 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -63.85 -34.68 78.49 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.477 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -57.24 -45.22 84.14 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -22.79 62.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.658 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.677 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -66.5 -36.21 82.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.923 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 125.51 32.86 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.11 153.39 62.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.656 2.237 . . . . 0.0 112.46 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -145.85 123.47 11.82 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.341 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.66 -0.55 38.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.506 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.92 -29.07 66.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.803 0.335 . . . . 0.0 110.959 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mp -80.23 -46.82 15.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.62 92.05 3.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -74.15 90.55 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.01 131.2 55.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.66 119.66 68.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.812 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.35 -175.54 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.386 2.058 . . . . 0.0 112.297 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -140.49 140.85 35.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.4 p -137.22 115.37 11.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -135.99 -63.77 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 -31.92 7.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.0 m -137.37 128.83 28.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.7 t -86.75 -55.2 3.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -85.01 164.78 18.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.78 171.58 8.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.97 105.75 14.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mtp-105 -137.57 126.55 24.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.847 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt -134.34 -46.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.945 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -171.87 156.24 4.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -130.23 145.98 59.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.38 112.14 3.46 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.556 2.17 . . . . 0.0 112.374 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.02 143.03 69.78 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.106 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.02 162.63 40.45 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.518 2.146 . . . . 0.0 112.368 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.406 HG11 ' HG3' ' A' ' 139' ' ' LYS . 17.5 t -144.2 126.81 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.739 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 mp0 -110.51 129.8 55.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.396 . . . . 0.0 111.503 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.852 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -106.61 118.89 55.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.95 153.07 29.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.529 . . . . 0.0 112.206 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.514 ' CD2' HD11 ' A' ' 122' ' ' LEU . 18.5 t80 -155.16 112.71 3.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.11 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 9.8 mmtm 65.88 -82.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.27 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -129.26 -42.59 1.34 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.864 ' CE ' HD13 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -73.8 149.53 41.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.945 0.402 . . . . 0.0 111.154 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.02 164.19 26.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.528 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.473 ' C ' HD22 ' A' ' 23' ' ' LEU . 12.2 m-85 -127.59 155.58 43.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.269 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.061 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.5 mm? -125.6 135.88 52.67 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.128 0.489 . . . . 0.0 111.205 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.87 HD13 ' HB ' ' A' ' 105' ' ' VAL . 21.3 mm -118.23 106.42 19.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.275 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -132.27 163.14 29.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.233 0.539 . . . . 0.0 111.824 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.531 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 11.0 p80 -81.29 152.41 27.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.026 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -62.52 154.54 72.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 50.6 Cg_exo -54.38 136.53 69.5 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.369 2.046 . . . . 0.0 113.279 -177.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -98.75 146.57 25.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.041 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -69.39 -10.32 57.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.256 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.55 -31.24 14.61 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 p -139.85 88.97 2.27 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.127 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.79 -52.22 7.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 111.396 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.454 ' HA ' HG12 ' A' ' 37' ' ' ILE . 1.9 t -56.11 -46.94 78.96 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.596 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -57.67 -32.09 66.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.89 0.376 . . . . 0.0 111.195 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.734 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.15 -47.6 27.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.868 HG22 ' OD2' ' A' ' 64' ' ' ASP . 12.1 pt -55.54 -38.78 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.158 0.504 . . . . 0.0 110.573 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -65.74 -51.75 56.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.511 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 9.4 m-20 -68.52 -50.25 53.53 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.734 HD21 ' CE1' ' A' ' 36' ' ' PHE . 75.2 mt -56.45 -44.98 81.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.417 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -77.43 -26.54 51.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.997 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 4.2 mttt -53.12 -46.17 68.64 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.416 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.061 ' CD1' HD21 ' A' ' 23' ' ' LEU . 14.1 t80 -63.61 -38.52 91.43 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.809 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.69 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 163.87 -179.31 38.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.01 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.58 117.79 20.07 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 47' ' ' THR . 1.3 m -164.78 -170.29 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.857 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.704 ' H ' HG22 ' A' ' 46' ' ' THR . 2.9 t -64.85 154.02 38.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.43 0.633 . . . . 0.0 110.707 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.05 HG22 ' HB3' ' A' ' 104' ' ' ALA . 57.8 t -131.42 135.39 59.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.992 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.91 HG13 HG13 ' A' ' 105' ' ' VAL . 11.7 p -115.6 105.06 17.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.273 0.559 . . . . 0.0 111.1 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.08 110.79 20.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.69 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.8 HG13 ' HB3' ' A' ' 71' ' ' TRP . 14.5 t -102.26 90.97 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.1 171.59 19.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.737 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -67.1 129.9 41.39 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 54' ' ' VAL . 14.8 p -78.43 122.53 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.09 -47.65 2.37 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.448 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.476 ' HB3' ' OG1' ' A' ' 59' ' ' THR . 0.4 OUTLIER -130.63 83.63 2.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.611 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.574 ' O ' HD13 ' A' ' 61' ' ' LEU . 2.8 p30 -78.91 -35.73 43.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -78.26 -48.11 16.43 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -40.88 -60.04 1.83 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 59' ' ' THR . 33.3 Cg_endo -65.16 -42.43 13.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.436 2.091 . . . . 0.0 113.837 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.065 HD11 HG11 ' A' ' 68' ' ' VAL . 5.4 mp -71.37 -28.98 64.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.04 -44.6 46.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.759 ' CB ' HG21 ' A' ' 37' ' ' ILE . 1.6 mttp -81.18 -28.36 35.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.845 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.868 ' OD2' HG22 ' A' ' 37' ' ' ILE . 40.4 m-20 -101.48 -11.61 19.19 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.05 32.44 1.51 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.34 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.454 HG12 ' CB ' ' A' ' 64' ' ' ASP . 1.3 pt -102.56 148.22 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 0.0 111.303 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.2 OUTLIER -78.02 135.36 37.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.065 HG11 HD11 ' A' ' 61' ' ' LEU . 11.3 p -145.02 152.03 14.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.117 0.484 . . . . 0.0 111.919 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.23 132.05 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -100.66 106.76 18.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.289 0.566 . . . . 0.0 110.31 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.972 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 4.5 m95 -112.88 104.64 55.94 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.794 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -103.75 150.11 0.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 123.096 2.531 . . . . 0.0 112.707 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CB ' ' NH2' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -125.98 96.0 4.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.9 179.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.586 ' H ' ' HB2' ' A' ' 77' ' ' ALA . 1.3 t0 -147.76 -160.2 1.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.533 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.87 -24.08 21.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.794 0.331 . . . . 0.0 111.124 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.86 60.68 0.55 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.537 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -120.66 104.84 41.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.519 0.2 . . . . 0.0 111.045 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.592 ' HB2' HG21 ' A' ' 83' ' ' VAL . 98.0 Cg_exo -43.53 101.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.816 2.344 . . . . 0.0 112.891 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.721 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 33.1 Cg_endo -65.97 -34.17 39.4 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.618 2.212 . . . . 0.0 114.733 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.721 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 4.2 Cg_endo -48.0 148.04 7.14 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.923 1.749 . . . . 0.0 113.414 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.407 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -66.19 -21.24 69.92 Favored Glycine 0 C--O 1.238 0.351 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.014 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -52.2 -29.98 25.07 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.683 0.278 . . . . 0.0 110.536 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.972 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 39.4 t -60.27 -46.49 94.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.519 HG11 ' CZ ' ' A' ' 151' ' ' TYR . 1.2 t -53.47 -38.69 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 88' ' ' LEU . 14.7 mm-40 -65.29 -31.5 72.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.993 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.95 -50.5 70.54 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.332 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.819 ' CZ2' ' HB2' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -66.84 -30.29 70.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.199 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.86 HD21 ' HB3' ' A' ' 120' ' ' LEU . 16.3 mt -60.64 -48.03 83.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.558 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -62.81 -42.16 99.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.172 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -55.08 -51.19 67.14 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.558 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.999 HG21 ' HB1' ' A' ' 121' ' ' ALA . 7.1 p -71.4 -35.94 59.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.047 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 1.7 tmtt? -55.85 -45.36 78.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.903 0.382 . . . . 0.0 110.543 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.67 -41.18 75.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.977 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.673 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.92 -30.61 69.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.363 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' ' OE2' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -82.13 -37.21 26.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.99 -46.1 58.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.873 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -76.26 -33.02 59.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 94' ' ' LYS . . . -115.52 89.87 23.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.08 129.23 11.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.607 2.205 . . . . 0.0 112.228 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.37 56.15 25.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.451 ' HB3' HG21 ' A' ' 46' ' ' THR . 0.4 OUTLIER -101.13 -164.75 1.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 111.066 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.69 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 1.7 m -124.76 113.53 18.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.33 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 42.0 t -104.45 150.5 7.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.05 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -123.46 135.9 54.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.098 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.926 HG21 HG22 ' A' ' 118' ' ' VAL . 8.0 t -134.05 166.42 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -177.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.74 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 2.0 t60 -67.45 155.72 38.34 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.862 0.363 . . . . 0.0 110.873 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 25' ' ' THR . 42.2 t -69.07 106.08 2.66 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.829 HG12 ' HD3' ' A' ' 115' ' ' PRO . 2.6 m -75.88 0.57 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.3 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.05 -8.65 2.49 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.69 -140.8 5.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mt -106.56 127.08 53.04 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.65 -158.82 10.21 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.423 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.541 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.62 -14.35 7.77 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.375 -0.413 . . . . 0.0 111.861 -178.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.856 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -58.06 -46.93 99.65 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.829 ' HD3' HG12 ' A' ' 108' ' ' VAL . 9.5 Cg_endo -52.52 -48.49 21.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.131 1.888 . . . . 0.0 112.381 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.82 HG21 ' CD ' ' A' ' 148' ' ' GLN . 87.0 t -58.65 -52.44 59.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.232 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 51' ' ' VAL . 9.4 mt -51.9 -49.08 63.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.732 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.926 HG22 HG21 ' A' ' 105' ' ' VAL . 85.7 t -51.46 -49.68 31.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.914 0.388 . . . . 0.0 110.638 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.699 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -54.65 -47.85 73.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.672 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.86 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.6 mt -55.03 -31.63 61.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.87 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.999 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.24 -51.68 19.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.219 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.864 HD13 ' CE ' ' A' ' 20' ' ' MET . 5.8 tp -68.31 -13.98 62.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.581 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 1.071 HD11 HD21 ' A' ' 152' ' ' LEU . 1.1 mt -58.15 -36.38 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.157 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.403 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 4.5 pt-20 -63.03 -16.04 58.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.626 ' HB2' HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -79.77 11.17 3.39 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 116.89 -95.44 0.67 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.79 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.493 ' O ' ' CB ' ' A' ' 131' ' ' ASP . 4.8 ptt? -62.67 75.48 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.946 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -71.76 -67.59 0.52 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 152' ' ' LEU . 9.8 t80 -68.65 -32.19 71.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.977 0.418 . . . . 0.0 111.165 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.45 -50.56 25.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.301 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 31.0 t0 -70.09 -40.05 75.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.772 0.32 . . . . 0.0 111.363 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.7 ' CB ' HD11 ' A' ' 152' ' ' LEU . . . -61.89 -48.51 80.16 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.005 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 34.6 mm -73.06 -41.23 59.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.494 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -74.73 -50.12 18.58 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.852 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -67.99 -39.75 83.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.594 0.235 . . . . 0.0 110.812 -179.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 2.2 tp -74.54 -28.61 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.774 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 5.8 ttm-85 -64.53 -41.68 96.22 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -41.6 90.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.016 0.436 . . . . 0.0 110.061 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.494 ' HE2' HG13 ' A' ' 15' ' ' VAL . 5.6 mptt -87.17 151.85 22.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.102 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 116.73 14.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 110.607 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.474 ' HD2' HG23 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -114.97 163.5 15.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.209 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -57.06 -166.64 0.07 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.715 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.19 100.0 12.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.298 0.549 . . . . 0.0 111.599 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.945 HD12 ' CD2' ' A' ' 149' ' ' LEU . 12.5 pt -87.87 109.46 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.476 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -113.2 -76.64 0.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.9 t -99.8 -61.1 1.41 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.793 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 10.0 tmtt? -65.78 -49.87 66.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -176.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.82 ' CD ' HG21 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -56.33 -52.04 66.02 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.308 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.945 ' CD2' HD12 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -72.86 -46.6 52.02 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.528 -179.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 81.2 m -62.61 -39.16 92.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.23 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.793 ' HB3' ' O ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -62.34 -50.56 71.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.761 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.071 HD21 HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -62.01 -37.1 83.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.501 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -57.08 -37.95 72.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -22.74 58.81 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.646 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.544 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -66.19 -34.08 77.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.993 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.52 85.86 1.95 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.374 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.29 153.34 71.23 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.814 2.342 . . . . 0.0 112.752 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.1 123.45 10.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.317 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -69.78 -11.16 60.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.4 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -30.98 68.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.767 0.318 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.05 -44.29 12.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -76.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -71.6 175.05 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.97 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.28 110.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -68.9 112.97 13.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.77 -177.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.519 2.146 . . . . 0.0 112.204 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.63 -45.93 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.802 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.5 t -64.36 -32.11 73.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 150.18 26.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 171' ' ' THR . 2.3 mtmp? -142.6 154.89 44.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 170' ' ' LYS . 0.8 OUTLIER -161.98 152.45 17.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.853 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.456 -0.257 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 m -99.52 162.33 13.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.832 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.42 119.0 5.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.09 -46.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.71 108.33 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -63.08 139.47 58.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -151.8 -47.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -83.46 173.49 11.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -134.16 158.33 75.56 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.39 111.76 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.642 2.228 . . . . 0.0 112.31 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.04 155.84 60.68 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.084 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.662 ' HB3' HG22 ' A' ' 25' ' ' THR . 56.4 Cg_endo -70.58 162.47 42.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.496 2.131 . . . . 0.0 112.272 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.522 HG11 ' HD2' ' A' ' 139' ' ' LYS . 24.6 t -144.13 127.04 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.805 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.17 116.67 31.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.836 0.35 . . . . 0.0 111.46 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.803 HG12 ' CE2' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -109.66 118.45 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.1 p -140.96 142.69 34.31 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.59 ' HE1' HD11 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -137.37 162.08 34.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.162 178.291 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 3.0 pttp 48.92 -100.65 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.014 0.126 . . . . 0.0 110.76 -177.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.452 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -124.35 -25.68 4.05 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.157 -0.34 . . . . 0.0 111.908 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.728 ' HE3' HD13 ' A' ' 122' ' ' LEU . 5.1 ppp? -74.01 165.91 24.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 111.464 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -143.5 156.74 44.71 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.282 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.721 ' CE1' HG11 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -137.42 138.39 39.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.299 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.06 HD21 ' CD1' ' A' ' 43' ' ' TYR . 3.7 mm? -115.09 135.53 54.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.051 0.453 . . . . 0.0 111.359 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.816 HD12 HG13 ' A' ' 108' ' ' VAL . 1.9 mm -118.23 106.61 20.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 12' ' ' PRO . 1.4 p -131.01 166.55 20.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.606 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.536 ' CE1' ' CZ ' ' A' ' 36' ' ' PHE . 5.9 p80 -81.25 152.0 27.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.731 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -62.64 153.71 77.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HA ' ' CD2' ' A' ' 36' ' ' PHE . 52.1 Cg_exo -54.94 142.37 76.0 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.476 2.118 . . . . 0.0 113.291 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.483 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 6.4 p -98.7 174.35 6.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.158 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -94.95 -12.35 26.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.54 -30.83 14.8 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -139.51 89.77 2.36 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.452 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -80.23 -52.2 8.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.055 0.455 . . . . 0.0 111.16 178.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.456 ' HA ' HG12 ' A' ' 37' ' ' ILE . 2.0 m -55.96 -43.51 77.57 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.358 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 m -58.04 -37.38 74.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.878 0.37 . . . . 0.0 111.257 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.674 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.21 -48.13 53.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.933 HG21 ' HB3' ' A' ' 63' ' ' LYS . 13.7 pt -55.94 -39.63 58.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.183 0.516 . . . . 0.0 110.79 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -62.85 -52.01 64.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.336 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -69.84 -50.28 44.3 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.884 0.374 . . . . 0.0 111.774 -179.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.674 HD21 ' CE1' ' A' ' 36' ' ' PHE . 48.5 mt -56.27 -43.68 79.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.046 0.451 . . . . 0.0 110.265 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -78.6 -26.83 45.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.098 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -53.0 -43.81 66.75 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.151 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.06 ' CD1' HD21 ' A' ' 23' ' ' LEU . 13.5 t80 -63.35 -38.52 91.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.671 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.735 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . 165.21 -179.92 39.45 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.803 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.44 117.07 19.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.927 HG21 ' OG ' ' A' ' 101' ' ' SER . 0.4 OUTLIER -165.42 -169.12 1.51 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.94 177.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.709 ' HA ' HG23 ' A' ' 67' ' ' THR . 9.8 t -64.05 154.0 35.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.676 0.75 . . . . 0.0 110.578 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 104' ' ' ALA . 60.3 t -134.2 137.57 51.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.453 -178.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.02 HG13 HG13 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -115.56 105.18 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.067 0.461 . . . . 0.0 110.445 178.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -113.6 111.0 21.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.637 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.885 HG11 ' HB2' ' A' ' 113' ' ' ARG . 44.0 t -107.9 92.09 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.642 0.734 . . . . 0.0 110.59 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.42 171.15 20.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.453 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.62 130.2 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.612 HG13 ' HB3' ' A' ' 72' ' ' PRO . 9.3 m -68.89 121.91 19.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.61 -47.65 2.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.82 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.414 ' O ' ' CD ' ' A' ' 60' ' ' PRO . 1.8 m-85 -130.74 84.36 2.19 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.213 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -78.55 -35.92 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -78.93 -48.52 14.41 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.88 HG22 ' HD3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -44.53 -50.92 22.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HB ' ' A' ' 59' ' ' THR . 32.3 Cg_exo -59.25 -40.37 69.39 Favored 'Trans proline' 0 N--CA 1.471 0.196 0 C-N-CA 122.622 2.215 . . . . 0.0 113.653 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.766 ' CD2' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -71.09 -45.02 64.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -75.2 -49.31 19.83 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.933 ' HB3' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -64.7 -35.53 81.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.911 ' OD2' HG22 ' A' ' 37' ' ' ILE . 49.1 m-20 -101.22 -11.45 19.5 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.09 24.81 9.49 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.789 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.464 HG12 ' CB ' ' A' ' 64' ' ' ASP . 16.2 pt -110.78 148.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.763 HG21 ' HD2' ' A' ' 94' ' ' LYS . 6.7 t -77.7 135.1 38.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.075 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.766 HG12 ' CD2' ' A' ' 61' ' ' LEU . 7.4 p -145.21 151.91 14.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.052 0.453 . . . . 0.0 111.649 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.608 HG22 ' HG ' ' A' ' 90' ' ' LEU . 3.6 t -103.5 133.33 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.97 106.64 17.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.156 0.503 . . . . 0.0 110.478 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.736 ' HB3' HG13 ' A' ' 51' ' ' VAL . 4.3 m95 -110.03 103.24 53.16 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.63 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HB3' HG13 ' A' ' 54' ' ' VAL . 24.8 Cg_endo -109.61 -178.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 123.547 2.831 . . . . 0.0 112.82 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -126.45 95.93 4.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.578 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.33 177.78 4.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.32 -25.26 33.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.933 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.02 72.02 0.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.492 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.96 102.92 19.27 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.497 0.189 . . . . 0.0 110.791 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.526 ' O ' HG21 ' A' ' 83' ' ' VAL . 87.8 Cg_exo -41.57 98.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.85 2.367 . . . . 0.0 112.954 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.686 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 50.8 Cg_exo -54.98 -42.34 70.12 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.009 2.472 . . . . 0.0 114.277 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 79' ' ' PRO . 2.6 Cg_endo -47.48 144.96 9.41 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.285 1.99 . . . . 0.0 113.609 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' NZ ' ' A' ' 147' ' ' LYS . . . -57.35 -19.65 33.8 Favored Glycine 0 C--O 1.236 0.228 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.448 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.82 -29.87 12.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.514 0.157 . . . . 0.0 111.092 -178.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.714 HG12 ' CZ2' ' A' ' 71' ' ' TRP . 16.1 t -56.33 -48.46 79.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.897 HG11 HD22 ' A' ' 120' ' ' LEU . 71.4 t -54.19 -40.99 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.092 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.751 ' HA ' HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -57.84 -31.47 66.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.456 178.338 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -50.32 70.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.274 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.616 ' CZ3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.08 -33.2 75.24 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.858 HD21 ' HB3' ' A' ' 120' ' ' LEU . 11.1 mt -55.94 -47.75 76.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.4 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -63.0 -39.89 96.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.083 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.608 ' HG ' HG22 ' A' ' 69' ' ' VAL . 2.8 tm? -61.56 -51.17 69.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.94 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.73 HG21 ' HB1' ' A' ' 121' ' ' ALA . 14.7 p -68.79 -42.49 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.639 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.438 ' N ' HG13 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -53.87 -47.39 71.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 111.038 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -48.08 76.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.826 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.763 ' HD2' HG21 ' A' ' 67' ' ' THR . 21.3 mmtt -66.12 -26.54 67.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.018 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 103' ' ' VAL . 2.4 m-85 -79.27 -51.92 8.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.969 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 t -56.89 -33.71 67.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.047 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.0 -33.06 59.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.046 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.25 84.02 62.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.52 128.23 26.49 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.601 2.201 . . . . 0.0 112.101 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.37 59.8 10.08 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.282 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.927 ' OG ' HG21 ' A' ' 46' ' ' THR . 84.9 p -101.1 -171.26 1.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.308 . . . . 0.0 111.425 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.735 ' SG ' ' HA3' ' A' ' 44' ' ' GLY . 2.1 m -106.21 113.77 27.49 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.324 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.721 HG11 ' CE1' ' A' ' 22' ' ' PHE . 44.5 t -111.26 150.86 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 48' ' ' VAL . . . -122.45 142.5 50.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.069 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.02 HG13 HG13 ' A' ' 49' ' ' VAL . 3.2 t -140.09 167.08 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.727 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 3.6 t60 -67.2 155.61 38.37 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.7 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' THR . 26.9 p -68.86 105.18 2.27 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.32 0.581 . . . . 0.0 112.433 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.844 HG12 ' HD3' ' A' ' 115' ' ' PRO . 26.6 m -75.22 0.02 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.919 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.65 -8.79 3.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.419 ' O ' HD23 ' A' ' 111' ' ' LEU . . . -123.74 -134.87 4.39 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.48 ' HA ' ' HA2' ' A' ' 142' ' ' GLY . 7.3 mt -118.83 127.46 53.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.41 -153.97 7.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.63 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.885 ' HB2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -122.3 -20.2 6.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.114 0.483 . . . . 0.0 111.669 -178.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.661 ' N ' ' HD2' ' A' ' 115' ' ' PRO . . . -50.81 -46.29 86.9 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.844 ' HD3' HG12 ' A' ' 108' ' ' VAL . 6.6 Cg_endo -52.01 -48.5 21.3 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.157 1.905 . . . . 0.0 113.078 -178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.614 ' O ' HD13 ' A' ' 120' ' ' LEU . 11.7 t -60.95 -39.99 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.693 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.503 HD12 ' CG2' ' A' ' 49' ' ' VAL . 9.7 mt -59.5 -55.0 40.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.633 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.854 ' CG2' HG11 ' A' ' 105' ' ' VAL . 55.6 t -52.01 -55.21 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.725 ' HB1' ' HB1' ' A' ' 132' ' ' ALA . . . -52.85 -53.22 51.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.009 0.433 . . . . 0.0 111.31 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.897 HD22 HG11 ' A' ' 84' ' ' VAL . 7.7 mp -54.92 -30.18 57.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.98 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.73 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -72.27 -47.72 48.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.886 0.374 . . . . 0.0 110.403 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.728 HD13 ' HE3' ' A' ' 20' ' ' MET . 12.6 tp -65.1 -13.06 57.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.816 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.928 HG23 ' CB ' ' A' ' 128' ' ' LYS . 2.1 mt -57.05 -36.37 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.311 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.425 ' OE2' ' CD2' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -63.22 -16.79 61.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.7 m -80.03 7.45 9.05 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 128' ' ' LYS . . . 114.39 -99.09 0.92 Allowed Glycine 0 N--CA 1.46 0.246 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.922 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.571 ' HE1' ' CD2' ' A' ' 17' ' ' TYR . 3.6 ptt? -62.56 75.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.928 ' CB ' HG23 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -73.4 -67.86 0.55 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -176.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.666 ' CD1' HD22 ' A' ' 152' ' ' LEU . 4.4 t80 -66.72 -32.86 74.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.949 0.404 . . . . 0.0 111.162 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.17 -51.86 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.208 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 135' ' ' PHE . 25.8 t0 -70.12 -40.39 74.9 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.918 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.725 ' HB1' ' HB1' ' A' ' 119' ' ' ALA . . . -58.01 -49.17 77.75 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.315 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.7 mm -69.7 -42.56 80.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -49.76 21.84 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.803 ' CE2' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -66.27 -34.29 77.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 110.724 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 1.7 tt -74.27 -33.34 34.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.974 0.416 . . . . 0.0 110.49 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -40.76 96.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.087 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.58 -45.29 92.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.984 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.522 ' HD2' HG11 ' A' ' 13' ' ' VAL . 68.5 mmtt -87.33 151.65 22.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.419 ' C ' ' HD2' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -73.31 117.25 14.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.896 0.379 . . . . 0.0 110.419 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.467 ' HG2' ' CG1' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -115.36 163.43 15.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.691 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 111' ' ' LEU . . . -55.45 -176.05 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.346 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.54 98.81 3.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.692 0.746 . . . . 0.0 110.716 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.457 HG21 ' HG3' ' A' ' 148' ' ' GLN . 1.3 pp -88.67 109.24 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -113.22 -76.59 0.58 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.214 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.757 ' O ' HG22 ' A' ' 150' ' ' THR . 36.5 m -99.77 -60.62 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.643 ' O ' ' CB ' ' A' ' 151' ' ' TYR . 1.2 tmtt? -48.66 -51.43 28.42 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.457 ' HG3' HG21 ' A' ' 144' ' ' ILE . 1.9 tm0? -55.77 -52.08 65.17 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.576 ' N ' HD22 ' A' ' 149' ' ' LEU . 3.2 mm? -75.66 -45.29 37.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 146' ' ' SER . 6.5 t -67.78 -34.37 76.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.361 . . . . 0.0 111.34 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.643 ' CB ' ' O ' ' A' ' 147' ' ' LYS . 1.3 t80 -68.17 -50.8 52.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.3 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.825 HD21 HD11 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -71.25 -38.92 71.91 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.519 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -36.48 68.0 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -26.35 59.92 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.465 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.631 ' OH ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -65.82 -29.46 69.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.205 179.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -105.81 121.61 45.26 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.882 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.23 153.06 62.08 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.542 2.161 . . . . 0.0 112.671 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -147.25 123.62 10.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.337 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -75.29 -5.03 42.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.68 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -33.82 71.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 110.938 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.02 -44.31 12.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.94 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.94 132.24 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.888 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -89.7 171.89 9.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.974 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -167.37 134.6 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.853 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -71.32 138.12 84.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.91 170.7 18.22 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.482 2.121 . . . . 0.0 112.34 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -152.15 -65.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.01 110.06 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -111.84 87.31 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 104.62 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.6 m -119.69 134.68 55.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.856 -179.99 . . . . . . . . 0 0 . 1 stop_ save_